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Abstract
The synthesis of enantioenriched, air-stable secondary alkylmetallic reagents has gained much attention over
the past few years; however, competition between product-forming reductive elimination and β-hydride
elimination has hindered their efficient cross-coupling. The paradigm of employing a hemilabile ligand to
favor reductive elimination has been extended to include an array of amides and benzylic ethers. The synthesis
of protected secondary benzylic alcohols through a cross-coupling reaction was explored. Potassium
1-(benzyloxy)alkyltrifluoroborates, synthesized through a diboration of aldehydes, serve as nucleophilic
partners in a stereospecific Suzuki-Miyaura reaction, where the benzyl group serves as a stabilizing group to
prevent β-hydride elimination. ^ An improved synthesis of potassium β-trifluoroboratoamides utilizing
tetrahydroxydiboron and tetrakis(dimethylamino)diboron as greener, more atom-economical dibora sources
was explored. Enantioenriched potassium β-trifluoroboratoamides were cross-coupled with aryl chlorides to
afford β-arylated amines. In this coupling, the carbonyl of the amide serves as a stabilizing group to prevent β-
hydride elimination. ^ The replacement of a C=C bond with an isoelectronic B-N unit within an aromatic
system results in azaborines, a class of compounds with stability and aromaticity similar to the all-carbon
parent. Based on the potential of azaborines in the fields of medicinal chemistry and materials science,
methods for the synthesis and functionalization of azaborines could have an impact by increasing structural
diversity and creating new chemical space.
A convergent, modular synthesis of 2,1-borazaronaphthalenes was developed from 2-aminostyrenes and
potassium organotrifluoroborates, providing a transition metal-free route to elaborated azaborines. ^
Functionalization of 2,1-borazaronaphthalenes was envisioned to build molecular complexity and
demonstrate the stability of azaborines to various transformations. The first general method for the Suzuki-
Miyaura cross-coupling of brominated azaborine with potassium (hetero)aryltrifluoroborates was developed
to afford 3-(hetero)arylated-2,1-borazaronaphthalenes in high yield. ^ Whereas
3-bromo-2-aryl-2,1-borazaronaphthalenes undergo cross-coupling with an aryltrifluoroborate,
1-alkyl-2-aryl-3-bromo-2,1-borazaronaphthalenes undergo a self-arylation, in which the azaborine serves as
both the electrophilic and nucleophilic species in the cross-coupling. A Kumada coupling with Grignard
reagents provides access to the 1,2,3-trisubstituted 2,1-borazaronaphthalenes. ^ A nickel-catalyzed reductive
coupling was explored with brominated 2,1-borazaronaphthalenes and alkyl iodides. This method
demonstrates the inherent stability of azaborines to transition-metal catalysis and provides the first examples
of C3 alkylated 2,1-borazaronaphthalenes. ^ ^Please refer to dissertation for diagrams.
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ABSTRACT 
 
POTASSIUM ORGANOTRIFLUOROBORATES: RELIABLE CROSS-
COUPLING PARTNERS AND STEPPING STONES TO FUNCTIONALIZED 
AZABORINE CORES 
 
Steven R. Wisniewski 
Professor Gary A. Molander 
 
The synthesis of enantioenriched, air-stable secondary alkylmetallic reagents has 
gained much attention over the past few years; however, competition between product-
forming reductive elimination and β-hydride elimination has hindered their efficient 
cross-coupling. The paradigm of employing a hemilabile ligand to favor reductive 
elimination has been extended to include an array of amides and benzylic ethers. 
The synthesis of protected secondary benzylic alcohols through a cross-coupling 
reaction was explored. Potassium 1-(benzyloxy)alkyltrifluoroborates, synthesized 
through a diboration of aldehydes, serve as nucleophilic partners in a stereospecific 
Suzuki-Miyaura reaction, where the benzyl group serves as a stabilizing group to prevent 
β-hydride elimination. 
 
 An improved synthesis of potassium β-trifluoroboratoamides utilizing 
tetrahydroxydiboron and tetrakis(dimethylamino)diboron as greener, more atom-
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economical dibora sources was explored. Enantioenriched potassium β-
trifluoroboratoamides were cross-coupled with aryl chlorides to afford β-arylated amines. 
In this coupling, the carbonyl of the amide serves as a stabilizing group to prevent β-
hydride elimination. 
 
The replacement of a C=C bond with an isoelectronic B-N unit within an aromatic 
system results in azaborines, a class of compounds with stability and aromaticity similar 
to the all-carbon parent. Based on the potential of azaborines in the fields of medicinal 
chemistry and materials science, methods for the synthesis and functionalization of 
azaborines could have an impact by increasing structural diversity and creating new 
chemical space. 
A convergent, modular synthesis of 2,1-borazaronaphthalenes was developed 
from 2-aminostyrenes and potassium organotrifluoroborates, providing a transition metal-
free route to elaborated azaborines.  
 
 Functionalization of 2,1-borazaronaphthalenes was envisioned to build molecular 
complexity and demonstrate the stability of azaborines to various transformations. The 
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first general method for the Suzuki-Miyaura cross-coupling of brominated azaborine with 
potassium (hetero)aryltrifluoroborates was developed to afford 3-(hetero)arylated-2,1-
borazaronaphthalenes in high yield. 
 
 Whereas 3-bromo-2-aryl-2,1-borazaronaphthalenes undergo cross-coupling with 
an aryltrifluoroborate, 1-alkyl-2-aryl-3-bromo-2,1-borazaronaphthalenes undergo a self-
arylation, in which the azaborine serves as both the electrophilic and nucleophilic species 
in the cross-coupling. A Kumada coupling with Grignard reagents provides access to the 
1,2,3-trisubstituted 2,1-borazaronaphthalenes.  
 
A nickel-catalyzed reductive coupling was explored with brominated 2,1-
borazaronaphthalenes and alkyl iodides. This method demonstrates the inherent stability 
of azaborines to transition-metal catalysis and provides the first examples of C3 alkylated 
2,1-borazaronaphthalenes. 
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Chapter 1: The Suzuki-Miyaura Reaction and Evolution of Potassium 
Organotrifluoroborates 
1.1 The Emergence of the Suzuki-Miyaura Reaction 
 Transition-metal catalyzed cross-coupling reactions have become one of the most 
powerful methods in organic synthesis for the generation of carbon-carbon bonds.1 
Traditional cross-coupling reactions involve the reaction between an electrophilic 
component, specifically an alkyl, alkenyl, or aryl halide, or pseudo halide, with an 
organometallic reagent, which serves as the nucleophilic component, in the presence of a 
palladium or nickel catalyst (Eq 1.1). An array of organometallic species have been 
demonstrated to be effective partners in the cross-coupling reaction: The Kumada-Corriu 
reaction is a carbon-carbon bond-forming reaction employing Grignard reagents,
2
 
whereas the Negishi reaction uses organozinc species as the nucleophilic partner.
3
 The 
organometallic coupling partner in the Stille reaction is an organostannane,
4
 and the 
partner in the Hiyama reaction is an organosilane.
5
 The Suzuki-Miyaura reaction is a 
coupling reaction that employs organoboron reagents as the organometallic species.
6
 
Equation 1.1 
 
Each cross-coupling reaction has its own set of strengths and limitations, but the 
Suzuki-Miyaura reaction has emerged as the favored carbon-carbon bond-forming 
reaction because of the milder reaction conditions required for the coupling.
6
 Before the 
2 
 
discovery of Suzuki-Miyaura reaction 1979, the first reported cross-coupling was the 
nickel-catalyzed reaction of organomagnesium reagents with alkenyl or aryl halides. 
Reported independently by Kumada and Tamao
7
 and Corriu
8
 in 1972, these methods 
employ less than 1 mol % of a nickel catalyst to form the desired carbon-carbon bond 
(Eqs 1.2 and 1.3, respectively). 
Equation 1.2 
 
Equation 1.3 
 
Further research in the area expanded the scope of transition metals that can 
catalyze the transformation. Kochi showed that Grignard reagents can be coupled with 
alkenyl bromides in the presence of a catalytic amount of iron (Eq 1.4),
9
 and the first 
palladium-catalyzed reaction of Grignard reagents was reported by Murahashi in 1975.
10
 
Equation 1.4 
 
Realizing the potential for employing catalytic amounts of palladium to form 
carbon-carbon bonds, Negishi first demonstrated the coupling of organoalanes in 1976 by 
reaction of in situ formed alkenylalanes with an aryl halide in the presence of Ni(PPh3)4 
(Eq 1.5).
11
 The following year Negishi showed the cross-coupling of in situ generated 
zirconium reagents with aryl iodides, bromides, and chlorides (Eq 1.6).
12
 
3 
 
Equation 1.5 
 
Equation 1.6 
 
Negishi’s first use of organozincs as the nucleophilic partners in a cross-coupling 
reaction was the 1977 report in which he demonstrated the cross-coupling of arylzinc 
reagents with aryl iodides and electron-poor aryl bromides (Eq 1.7).
13
 The cross-coupling 
with organozinc compounds has been greatly expanded and improved since this initial 
report. Many diorganozinc species can be generated in situ and coupled to a wide array of 
aryl, alkenyl, and alkyl electrophiles.
4
 
Equation 1.7 
 
Negishi’s reports on the various nucleophilic partners laid the groundwork for 
cross-coupling with several other organometallic species. Despite their high reactivity, 
the cross-coupling of organolithiums was reported by Murahashi in 1979. The coupling 
of alkenyl bromides with alkyllithium reagents in the presence of Pd(PPh3)4 afforded the 
desired products in high yield (Eq 1.8).
14
  
4 
 
Equation 1.8 
 
The palladium-catalyzed coupling reaction with organostannanes as the 
nucleophilic partner was first reported by Eaborn in 1976.
15
 The next year Migita
16
 
reported the palladium catalyzed reaction of acid chlorides with organostannanes, and 
Stille
17
 reported the same transformation with HMPA as a solvent at a much lower 
temperature (Eq 1.9 and Eq 1.10, respectively). Despite the toxicity associated with tin, 
the Stille reaction has become a very versatile cross-coupling method. Bench-stable 
reagents can be employed under milder reaction conditions, which improve functional 
group tolerance relative to most other organometallic reagents.
2
  
Equation 1.9 
 
Equation 1.10 
 
Through the 1970s an array of organometallic reagents were found to be effective 
nucleophiles in metal-catalyzed cross-coupling reactions. However, all of the 
organometallics employed in the reagents had some limitations. For example, the high 
nucleophilicity of Grignard, organolithium, and organozinc reagents severely limit 
5 
 
functional group tolerability in the cross-coupling reactions. Although organostannanes 
alleviate this limitation, they are difficult to handle and isolate from reactions. Further, 
their toxicity limits their use on large scale. Therefore, there was a need for an 
organometallic reagent that would allow high functional group tolerance as well as have 
improved stability to air and moisture relative to the other organometallic species. To that 
end, organoboron species were explored for their applications in cross-couplings. 
 The first example of an organoboron species interacting with a transition-metal 
was reported by Heck in 1975.
18
 1-Hexenylboronic acid was reacted with ethyl acrylate 
in the presence of Pd(OAc)2. After transmetalation of the boronic acid with the metal 
center, the alkene underwent migratory insertion followed by β-hydride elimination to 
yield the desired diene (Eq 1.11). 
Equation 1.11 
 
Negishi demonstrated that lithium 1-alkynyltributylborates can participate in 
palladium-catalyzed cross-couplings with aryl iodides. (Eq 1.12).
19
 The mechanism 
originally proposed by Negishi was insertion into the alkyne, followed by β-boron 
elimination to afford the desired product and regenerate the active Pd species. 
Equation 1.12 
 
 Despite these advances, there was still not a general procedure for employing 
organoboron compounds in cross-coupling reactions. The following year Suzuki and 
6 
 
Miyaura reported the cross-coupling of 1-alkenylboronate esters and 1-halo-1-alkenes in 
the presence of base and a palladium catalyst (Eq 1.13).
20
 The success of the reaction was 
attributed to the addition of base, which led to the formation of tetracoordinate boronate, 
increasing the nucleophilicity of the complex and facilitating transmetalation of the 
organic moiety. An array of bases accelerated the reaction, but alkoxides were found to 
be the most efficient.  
Equation 1.13 
 
Kishi later reported a rate enhancement in the alkenyl-alkenyl coupling step of the 
synthesis of a fragment of palytoxin. The desired transformation proceeded with 25 
mol % Pd(PPh3)4 at 50 °C in 30 minutes; however, changing the base to TlOH resulted in 
complete conversion in 30 minutes at room temperature with only 3 mol % Pd(PPh3)4.
21
 
In addition to this enhancement, weaker bases, such as NaHCO3 and Na2CO3, were also 
shown to mediate the cross-coupling of arylboronic acids,
22
 demonstrating that the type 
of base in the reaction plays an important role in the transformation. 
The implementation of organoborons as nucleophiles in cross-coupling reactions 
greatly expanded the scope of transition-metal catalysis. Although trialkylboranes are 
pyrophoric and not easy to handle, Suzuki and Miyaura demonstrated in 1981 that a 
boronic acid could serve as the nucleophilic partner in the cross-coupling reaction (Eq 
1.14).
22
 The cross-coupling of phenylboronic acid with an array of aryl iodides, bromides, 
7 
 
and triflates in the presence of Pd(PPh3)4 afforded the desired products in high yield. Aryl 
chlorides were not suitable electrophiles for the reaction.  
Equation 1.14 
 
Low yields were originally obtained for the cross-coupling of sterically hindered 
arylboronic acids, presumably due to slow transmetalation of an ortho-disubstituted 
arylboronic acid. Changing the base to NaOH or Ba(OH)2 alleviated this limitation by 
increasing the rate of transmetalation such their cross-coupling with aryl iodides and 
bromides proceeds in high yield (Eq 1.15).
23
 
Equation 1.15 
 
1.2 Development of Ligands and for Cross-Coupling Reactions 
 The discovery that boronic acids can serve as nucleophilic partners in the Suzuki-
Miyaura cross-coupling reaction had significant impact on the field of organic chemistry. 
Because of the relative stability and lowered toxicity of boronic acids relative to other 
organometallic reagents, the Suzuki-Miyaura reaction has become the preferred 
transition-metal catalyzed route for the installation of carbon-carbon bonds. A 2011 
review on the reactions employed by medicinal chemists showed that the Suzuki-Miyaura 
cross-coupling accounted for 40.2% of all C-C bond forming reactions. The next closest 
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transformation was the Sonogashira reaction at 18.4%, less than half the amount of the 
Suzuki-Miyaura reaction.
24
 
 As the emergence of this new transformation became more and more popular, 
several limitations of the cross-coupling were evident.
25
 Aryl chlorides had been 
unsuccessful electrophiles in the reaction because of the strength of the C-Cl bond. Also, 
there was not a method that detailed a broad substrate scope of both electrophile and 
nucleophile. One reason that this method did not exist was that hindered biaryl systems 
(i.e., ortho-disubstituted nucleophile and electrophile) were unable to be synthesized 
under the conditions developed at the time. Further, the use of electron-deficient aryl and 
heteroarylboronic acids resulted primarily in protodeboronation,
26
 yielding the 
corresponding arene as opposed to the cross-coupled product. The last major limitation 
was that alkyl halides and alkylboronates were not suitable substrates in the cross-
coupling reaction because of competing β-hydride elimination. Miyaura reported in 1976 
that the stoichiometric reaction between trialkylboranes and π-allylpalladium(II) chloride 
resulted in exclusive formation of the β-hydride eliminated products.
27
 Therefore, there 
was a need for new ligands and precatalysts to be developed to overcome these 
limitations. 
 PPh3 was the most commonly employed ligand for palladium cross-couplings 
until the mid-1990s. The use of PPh3 allowed oxidative addition of aryl iodides and 
bromides but was limited in the implementation of aryl chlorides.
28
 It was determined 
that the oxidative addition step of the cross-coupling could be improved by employing a 
sterically bulky ligand that coordinates to the metal center, forming a monoligated, 12-
electron organometallic complex. For example, an L1Pd(0) species can easily facilitate 
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the oxidative addition step because of decreased steric shielding. Hartwig reported that an 
L1Pd(0) species is the most likely intermediate in the catalytic cycle with bulky 
phosphine ligands, such as P(o-tol)3. Other sterically encumbered ligands, including P(t-
Bu)3 and 1,2,3,4,5-Pentaphenyl-1"-(di-tertbutylphosphino)ferrocene (QPhos), were also 
reported to enter the catalytic cycle monoligated.
29
 
 Because oxidative addition is favored by electron-rich metal centers, the use of 
sterically bulky ligands lowers the energy of activation by donation of electron density to 
the metal center, leading to the oxidative addition of previously unattainable 
electrophiles, such as aryl chlorides and alkyl halides. One of the early examples 
employing an electron-rich phosphine to aid in the oxidative addition of aryl chlorides 
was reported by Shen, who cross-coupled phenylboronic acid with 2-chlorobenzaldehyde 
in 89% yield (Eq 1.16).
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Equation 1.16 
 
Fu then reported the use of bulky, electron-rich phosphines in the cross-coupling 
of aryl bromides, iodides, and triflates under much milder conditions by performing the 
reaction at room temperature with less than 2 mol % palladium.
31
 Fu demonstrated that 
P(t-Bu)3 as the ligand and KF as the base are an effective combination, such that 
palladium loading can be lowered to 0.005 mol % (Eq 1.17). 
10 
 
Equation 1.17 
 
In 1998, Buchwald introduced bulky, monodentate, electron-rich 
dialkylbiarylphosphines to serve as ligands in cross-coupling reactions (Figure 1.1). In 
addition to facilitating oxidative addition, monoligated palladium complexes undergo 
faster transmetalation and reductive elimination than bisligated palladium complexes 
because of decreased steric interactions around the metal center.
32
 
 
Figure 1.1. Structures of Common Buchwald Ligands 
 The Buchwald family of ligands can be easily prepared in a one-pot procedure by 
addition of an aryl Grignard reagent or aryllithium to a benzyne intermediate, which can 
then be reacted with a chlorophosphine to provide the desired ligand. Based on this 
synthetic pathway, a large number of ligands have been synthesized, many of which are 
commercially available. These ligands are air- and thermally stable, crystalline 
compounds.
32
   
The role of the substituents on these ligands has been reported by Buchwald. Most 
of the substituents serve to ensure the ligand is monocoordinate to the metal center. The 
installation of large alkyl groups on the phosphine increase electron density at 
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phosphorus to aid oxidative addition, but also enhance the rate of reductive elimination 
due to steric factors. ortho-Substituents on the bottom ring of these ligands lead to 
increased activity and stability by preventing palladacycle formation. The addition of 
ortho-substituents also increases the size of the ligand to favor a monoligated species 
(Figure 1.2).
32
  
 
Figure 1.2. Benefits of Buchwald Ligands 
Buchwald’s first report of dialkylbiarylphosphines in Suzuki-Miyaura cross-
coupling was the use of DavePhos as a ligand in the room temperature cross-coupling of 
arylboronic acids with aryl halides (Eq 1.18).
33
 
Equation 1.18 
 
Buchwald ligands have been successfully employed in the cross-coupling of 
organoboron compounds since the initial report in 1998. However, other ligand systems 
have also been developed to advance the field of cross-coupling. Most notably is the 
cataCXium family of ligands, whose steric bulk and electron-rich substituents favor 
monoligation with palladium.
34
 Non-phosphine based ligands, such as N-heterocyclic 
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carbenes (NHC), have also been developed to serve as effective ligands. Because they are 
stronger σ-donors than phosphines, rates of oxidative addition are increased with NHC 
ligands. Ligand dissociation is less likely due to the strong metal-carbenic bond formed 
upon complexation of the ligand to the metal center. Further, reductive elimination is 
favored by installing sterically encumbered substituents on the carbene (Figure 1.3).
35
 
 
Figure 1.3. Examples of Other Ligand Classes 
1.3 Development of Palladium Precatalysts for Cross-Coupling 
 Miyaura determined in the late 1970s that the nature of the base played a pivotal 
role in the success of a cross-coupling. Buchwald and others have shown that employing 
a bulky, electron rich ligand is key to achieving a palladium center with the right steric 
and electronic properties. One remaining variable in the development of cross-couplings 
was the palladium source. The number of ligands on palladium, and the properties of that 
ligand, in addition to the oxidation state, and the spectator ion can be readily varied to 
access catalysts that increase the rate of the product formation.
28
  
 Kumada was the first to realize the effect of varying a preformed catalyst in the 
cross-coupling of secondary alkyl Grignard reagents with aryl bromides. Low yields of 
the coupling were obtained with 1,3-bis(diphenylphosphino)propane (dppp) as a ligand 
because of β-hydride elimination. Because a large bite angle accelerates the rate of 
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reductive elimination, changing the ligand to one with a larger bite angle, PdCl2(dppf), 
provided the desired product in the highest yield (Eq 1.19).
36
 
Equation 1.19 
 
Before the introduction of bulky ligands, PPh3 was the predominantly the only 
ligand employed, and therefore Pd(PPh3)4 and the analogous PdCl2(PPh3)2 were the 
preferred catalysts. Because of their low cost, these catalysts are commonly used today in 
the coupling of aryl iodides and bromides. However, there was a need for precatalysts for 
the newly developed ligands that would allow access to transformations that would have 
been very difficult otherwise.  
Another important aspect of the precatalyst is the oxidation state. Many Pd(0) 
species, such as Pd2dba3, slowly oxidize to Pd(II) upon prolonged exposure to air and 
therefore are stored in a glovebox to maintain their activity. Pd(II) complexes, such as 
Pd(OAc)2 and PdCl2, are air-stable but must be reduced to the active Pd(0) species in situ. 
There are several mechanisms in which this reduction can occur. The most commonly 
accepted mechanism for the reductive of Pd(OAc)2 with tertiary phosphines is a redox 
reaction in which one of the phosphine ligands is oxidized and the metal center is reduced 
(Scheme 1.1).
37
 Because one ligand is oxidized to the corresponding phosphine oxide, a 
1:2 metal-to-ligand ratio is employed with many Pd(II) sources. 
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Scheme 1.1. Mechanism for Phosphine-Mediated Reduction of Pd(II) 
 
The reduction of Pd(II) to Pd(0) can also proceed by subsequent transmetalations 
and reductive elimination of the nucleophilic partner in the coupling reaction. For 
example, the reduction of palladium in the cross-coupling of phenylboronic acid with an 
aryl halide provides biphenyl and Pd(0) (Scheme 1.2).
38
 If 5 mol % Pd(II) is used in the 
reaction, then 10 mol % phenylboronic acid is consumed in forming the active palladium 
complex, providing one explanation for why an excess of boronic acid is commonly 
employed in coupling reactions. 
Scheme 1.2. Formation of Pd(0) From Double Transmetalation 
 
Specific to the cross-coupling of potassium organotrifluoroborates, Lloyd-Jones 
reported that homocoupling was not observed upon the reduction of Pd(II) to Pd(0), 
presumably because of their tetracoordinate nature, and therefore a different mechanism 
must be followed.
38
 He proposed a fluoride-catalyzed reduction of Pd(II), which was first 
reported by Verkade in 1982 (Scheme 1.3).
39
 Subsequent nucleophilic attack of two 
equivalents of fluoride on a phosphine ligand, possibly by prior coordination to 
palladium, followed by the transfer of two electrons from phosphorus to palladium results 
in the formation of palladium(0) and difluorophosphorane. The difluorophosphorane is 
then hydrolyzed to the corresponding phosphine oxide. Fluoride is not acting as a catalyst 
as the HF formed in the reduction readily converts to the more stable HF2
-
. However, 
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addition of a strong nonionic base prevents this formation such that the reduction is 
catalytic in fluoride. 
Scheme 1.3. Fluoride Mediated Reduction of Pd(II) 
  
Preformed L2Pd(0) and L2PdCl2 complexes have been reported in the literature, 
many of which are commercially available.
28
 However, several air-stable palladium (II) 
sources have been designed to reduce to Pd(0) rapidly through a nonconventional 
method. The rate and efficiency at which the palladium is reduced to Pd(0) can have a 
significant impact on the reaction, such that protodeboronation or other side reactions do 
not occur before the desired transformation. Further, the precatalyst should provide rapid 
access to a monoligated Pd(0) complex, the most reactive species for cross-coupling. 
To that end, several groups reported the synthesis of palladacycles as palladium 
precatalysts. Early palladacycles were formed via C-H activation of the ligand itself.
40
 
Although these were suitable precatalysts, a second class of palladacycles improved the 
efficiency of forming the monoligated Pd(0) species. The first generation class of 
palladacycles, reported by Buchwald in 2008, formed the L1Pd(0) species after addition 
of base, loss of HCl, and reductive elimination of indoline.
41
 The precatalysts were 
synthesized through the reaction of (tmeda)PdCl2, which was converted to the 
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dimethylated Pd(II) complex with MeLi. Addition of 2-aminoethylchlorobenzene and the 
desired ligand afforded the precatalyst in high yield (Scheme 1.4). 
Scheme 1.4. Synthesis of L-Pd-G1 
 
Buchwald demonstrated that the first generation precatalysts with XPhos as the 
ligand (XPhos-Pd-G1) rapidly formed Pd(0) at room temperature upon addition of NaO-
t-Amyl within three minutes. Further, subjecting XPhos-Pd-G1 to a room temperature 
amination results in 80% of the desired product formed in 10 minutes whereas less than 
20% product is observed with Pd2dba3, [Pd(allyl)Cl]2 and Pd(OAc)2/PhB(OH)2 as the 
palladium source.
41
  
Because the synthesis of the precatalyst is three steps and involves the handling of 
organometallic reagents, a second generation catalyst was developed by Buchwald in 
2010.
42
 The aminobiphenyl precatalysts are synthesized from 2-aminobiphenyl and 
Pd(OAc)2 followed by addition of LiCl and ligand in a one-pot manner (Scheme 1.5). 
Procedures to access the G1 and G2 precatalysts through a C-H 
activation/cyclopalladation sequence were reported by Vincente
43
 and Albert,
44
 
respectively. 
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Scheme 1.5. Synthesis of XPhos-Pd-G2 
 
One of the drawbacks of the G1 catalysts was the slow activation with weak bases 
that required elevated temperatures. Buchwald showed that the use of 2-aminobiphenyl 
provides a precatalyst with a much more acidic amine such that the reduction to Pd(0) 
occurs at room temperature almost instantaneously with weak base through loss of HCl 
and reductive elimination of carbazole.
42
  
 The second generation catalyst with XPhos as a ligand, XPhos-Pd-G2, was 
shown to catalyze the room-temperature cross-coupling of polyfluoroboronic acids with 
aryl chlorides, bromides, and triflates (Eq 1.20).
42
 
Equation 1.20 
 
Various derivatives of the second generation precatalysts have been employed by 
Molander in the cross-coupling of potassium organotrifluoroborates, specifically 
potassium Boc-protected secondary aminomethyltrifluoroborates,
45
 
ammoniomethyltrifluoroborates,
46
 and the α-arylation,
47
 alkenylation,
48
 and 
alkynylation
49
 of 2-chloroacetates and 2-chloroacetamides. The second generation 
catalysts, however, are not stable in solution for extended periods of time, and the second 
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generation precatalysts for larger Buchwald ligands such as t-BuXPhos and BrettPhos 
also cannot be synthesized.
50
 To overcome this limitation, the chloride ion was replaced 
with a non-coordinating anion that would make the palladium center less encumbered. 
Therefore, changing the anion to a methanesulfonate anion renders the palladium center 
more electron poor and allows synthesis of an array of precatalysts that were previously 
unattainable.  
 The dimer of both the second and third generation precatalysts can be easily 
synthesized by starting from the corresponding amine salt.
50
 Addition to Pd(OAc)2 to the 
amine salt forms the µ-Cl and µ-OMs dimer in high yield (Eq 1.21). The dimer can easily 
be converted to the desired precatalyst by stirring at room temperature and isolating by 
filtration. Further, the dimer for both precatalysts are air- and moisture stable. The active 
catalysts can be formed in situ by addition of the ligand and dimer to the reaction, with 
the activity of the in situ generated catalyst similar to that of the isolated precatalyst.  
Equation 1.21 
 
1.4 Mechanistic Investigations into the Suzuki-Miyaura Reaction 
 The catalytic cycle for a traditional Suzuki-Miyaura cross-coupling is shown in 
Scheme 1.6.
6
 Oxidative addition of an aryl halide, or pseudo halide, (Ar-X) results in 
formation of a palladium(II) complex. Base-mediated transmetalation with an 
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organoboron species leads to the diorganopalladium(II) complex. Reductive elimination 
yields the desired product and regenerates the active Pd(0) catalyst. 
Scheme 1.6. General Catalytic Cycle for the Suzuki-Miyaura Reaction 
 
 The mechanisms behind oxidative addition and reductive elimination in cross-
coupling reactions are well understood, in most cases proceeding through a three-
centered transition state.
51
 However, until recently, there were two competing mechanism 
for transmetalation (Scheme 1.7). The first route involves coordination between an oxo-
palladium complex acting as a Lewis base toward a boronic acid, generating a four-
coordinate complex capable of undergoing transmetalation (pathway A). The second 
proposed mechanism requires a tetracoordinate, trihydroxyborate to facilitate transfer of 
the organic group from boron to palladium. Anion exchange of the halide on palladium 
with the trihydroxyborate generates a complex which then undergoes transmetalation 
(pathway B). 
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Scheme 1.7. Possible Routes for Transmetalation 
 
Early reports on the mechanism of transmetalation proposed the formation of a 
four-coordinate ‘ate’ complex, favoring pathway B.
20,52
 However, six years later, in 1985, 
transmetalation via alkoxo-palladium complexes was proposed by Suzuki based on 
several observations.
53
 The cross-coupling failed when the base was changed from 
NaOMe or NaOEt to NEt3, providing evidence for pathway A because the tetracoordinate 
borate formed with NEt3 should undergo transmetalation if pathway B is favored. 
Additionally, subjecting the lithium B-methylated borate salt to the developed conditions 
afforded the desired product in only 9% yield in the absence of base; however, the neutral 
boron reagent provided the cross-coupled product in yields up to 73% in the presence of 
base. Further, protodebromination of the alkenyl bromide suggested β-hydride 
elimination of the alkoxo-palladium species (MeO-Pd-R or EtO-Pd-R). 
Computational studies between pathways A and B was completed by Maseras
54
 in 
the late 2000s comparing the possible routes of transmetalation for phenyl and 
vinylboronic acids. Maseras concluded that pathway B is responsible for transmetalation 
because formation of the desired oxo-palladium complex was not an energetically 
favorable process. 
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Further evidence for pathway B was reported in the cross-coupling of an aryl 
bromide, where an arylboronic acid with two equivalents of K2CO3 and water were 
required to afford the desired product.
55
 The second equivalent of base was for 
sequestration of the generated boric acid. Changing the base to KHCO3 resulted in no 
product formation. Because of the difference in pKa between carbonate and bicarbonate 
in water, 10.3 and 6.4, respectively, the use of K2CO3 base allows formation of a 
trihydroxyborate, and therefore the transmetalation must proceed through that route. 
Soderquist then reported that the mechanism of transmetalation is dependent upon 
the nature of the organoboron species (Figure 1.4).
56
 More Lewis acidic boronates would 
preferentially undergo transmetalation through pathway B, whereas less Lewis acidic 
boronates proceed through pathway A. Based on the number of equivalents of NaOH 
required for the transmetalation, Soderquist concluded that the rate-limiting step for 
pathway A is the formation of the oxo-palladium complex. In the case of the more Lewis 
acidic boronate, two equivalents were required: one to form the hydroxy salt of the 
starting organoboron and a second to sequester the boronate formed after transmetalation. 
However, formation of an ‘ate’ complex for the less Lewis acidic boronate is much less 
favored, resulting in a trivalent boron species and formation of the oxo-palladium 
complex. 
 
Figure 1.4. Competing Pathways for Transmetalation 
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The first compelling evidence for pathway A was reported by Miyaura in 2002, 
when he disclosed that palladium complex [Ph3PPd(OH)Ph]2 reacted with p-
methoxyboronic acid to provide homo- and cross-coupled products in 85%. Several years 
later, Amatore and Jutand,
57
 Hartwig,
58
 and Schmidt
59
 have reported separately that the 
transmetalation through pathway A is more favorable. 
 Despite being energetically disfavored computationally, Hartwig reported that 
transmetalation occurs between an oxo-palladium complex and a boronic acid (pathway 
A).
58
 Kinetic studies were performed on the stoichiometric reaction of an oxo-palladium 
complex with a boronic acid and a palladium halide complex and a trihydroxyborate (Eq 
1.22 and 1.23). Hartwig first showed that the populations of the two palladium complexes 
are similar to each other during the course of a cross-coupling. Also, the populations of 
boronic acid and trihydroxyborate are similar in standard coupling conditions with a 
carbonate base. Therefore, because the rate of the reaction for the trihydroxyborate 
reaction is about 1.4 x 10
4
 times slower than that of the boronic acid reaction, the 
transmetalation proceeds through pathway A.  
Equation 1.22 
 
Equation 1.23 
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 Other boronate esters (e. g., catechol, neopentyl esters) react with the oxo-
palladium complex to form the desired product rapidly and efficiently, demonstrating the 
rate increase does not only apply to arylboronic acids. Under the same conditions, no 
product is observed for the reaction of the palladium halide complex and a 
trihydroxyborate, suggesting that the transmetalation proceeds through the neutral boron 
species and the oxo-palladium complex.
58
 
 In studying the roles of inorganic bases in the Suzuki-Miyaura reaction, Jutand 
and Amatore determined that the transmetalation between the oxo-palladium complex 
and boronic acid is most favorable.
57
 As Hartwig showed with a carbonate base, Jutand 
demonstrated that the oxo-palladium complex and palladium halide complex exist in a 
rapid equilibrium in the presence of hydroxide. Transmetalation of the boronic acid with 
the oxo-palladium complex proceeded rapidly, providing evidence for pathway A. In fact, 
under the conditions tested, there was no reaction between ArPd(Br)L2 and PhB(OH)3
-
. 
Although the cross-coupling of aryltrihydroxyborate salts without additional base are 
known,
60
 this result suggests the in situ loss of hydroxide to form the boronic acid and 
oxo-palladium complex. Jutand attributed this result to the higher oxophilicity of boron 
compared to its halogenophilicity. 
 Through the course of their study, Jutand and Amatore determined the roles of 
inorganic bases as well as the effect of the counter cation in Suzuki-Miyaura reaction.
57
 
Hydroxide bases play three different roles in the transmetalation and reductive 
elimination steps of reaction (Scheme 1.8). The first role of hydroxide is the formation of 
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ArPd(OH)L2 from the oxidative addition complex ArPd(X)L2 to form the favored 
complex for transmetalation with Ar’B(OH)2.  
Scheme 1.8. Three Roles of Hydroxide in the Suzuki-Miyaura Reaction 
 
 The second role of hydroxide is to induce the reductive elimination of trans-
[ArPdAr’L2]. Only a catalytic amount of hydroxide is needed for this step, and such a 
rate enhancement is observed that the transmetalation becomes the rate-determining step 
of the reaction. Hydroxide serves as a fifth ligand of the trans-diorganopalladium 
complex, facilitating reductive elimination by providing an alternate route to 
isomerization to the cis-diorganopalladium complex.
57  
 
The final role of hydroxide ions is detrimental to the reaction: the competitive 
formation of Ar’B(OH)3
-
 from Ar’B(OH)2. Because the trihydroxyborate does not 
undergo transmetalation, the formation of the inactive boronate lowers the rate of the 
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reaction. Therefore the concentration of hydroxide in the reaction is vital to the success of 
the coupling. Low concentration of hydroxide result in a smaller amount of the 
ArPd(OH)L2 complex formed, hindering the reaction, whereas with higher concentrations 
of hydroxide, the reaction is slowed because more of the trihydroxyborate of the boronic 
acid is formed.
57  
 
The cation of the inorganic base has a significant effect on the cross-coupling. 
Addition of Ag2O, and Tl salts, such as TlOH, TlOEt, or Tl2CO3, were reported to 
accelerate the reaction.
21,61
 Jutand concluded that these additives quenched the halide ion 
in the form of an insoluble AgX or TlX, thereby promoting the formation of the 
ArPd(OH)L2 complex. Further, the counterion of the bases commonly employed in the 
reaction (i.e., Cs
+
, K
+
, Na
+
) lower the rate of the transmetalation by complexing with the 
OH group on the ArPd(OH)L2 complex. Based on the amount of complexation, the 
counter cations were ranked: Tl
+
 or Ag
+
 > n-Bu4N
+
 > K
+
 > Cs
+
 > Na
+
, where Na
+
 caused 
the largest rate deceleration and is therefore the least preferred counter cation. However, 
the concentration of hydroxide and ratio of hydroxide-to-boronic acid can override the 
deceleration observed from the cation.
57c
 
 Jutand determined that carbonate bases (Cs2CO3) have slower rates of reaction 
than n-Bu4NOH at the same concentration; however, the rate of the reactions with 
carbonate bases is increased in the presence of water. The addition in water results in the 
formation of low concentration of hydroxide ions, and therefore the coupling proceeds 
through a similar mechanism. Further, acetate bases (n-Bu4NOAc) are not suitable bases 
for the cross-couplings. A similar oxo-palladium species is formed, ArPd(OAc)L2; 
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however, this complex does not undergo transmetalation with Ar’B(OH)2, demonstrating 
why acetates are not employed in Suzuki-Miyaura reactions.
57  
 The role of fluoride ions in Suzuki-Miyaura reactions was also determined by 
Jutand. Fluoride anions can serve as bases in the reaction but can also be formed upon 
hydrolysis of a potassium organotrifluoroborate.
57c,62
 Therefore, the first role that the 
fluoride ions serve in the coupling is formation of mixed anionic arylfluoroborates 
[Ar’BF3-n(OH)n
-
]. Increasing amounts of fluoride lowers the rate of the reaction as the 
less reactive, fluorinated arylboronates are in higher concentration than Ar’B(OH)2. 
Similar to hydroxides, fluoride ions reversibly exchange the halide of the ArPd(X)L2 
complex to generate ArPd(F)L2, which can undergo transmetalation with Ar’B(OH)2 at a 
much faster rate, similarly to the oxo-palladium complex. Fluoride also catalyzes the 
reductive elimination from the trans-diorganopalladium complex by serving as a fifth 
ligand. Therefore, the roles of fluoride and hydroxide in the cross-coupling are quite 
similar, such that the concentration of fluoride is important to the reaction. Because the 
concentration of ArPd(F)L2 is dependent on the concentration of fluoride, low 
concentrations of fluoride will disfavor formation of this complex. However, high 
concentrations result in the formation of less active fluorinated boronates.  
 Lima and Santos recently published a study on the transmetalation of the Suzuki-
Miyaura reaction,
63
 in which they propose that despite the conclusions by Hartwig, 
Schmidt, and Amatore and Jutand, the preferred mechanism for transmetalation is from 
interaction between a trihydroxyborate and a palladium halide (Scheme 1.7). Their 
argument is based on the pKas of various boronic acids. Electron-rich (high pKa) 
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boronates undergo faster transmetalation than the electron-poor (lower pKa) boronates. 
By subjecting two arylboronic acids to the cross-coupling reaction with varying amounts 
of base, the conversions of each arylboronic acid was monitored. Increasing the amount 
of base favors the conversion of the boronic acid with higher pKa, suggesting that the 
transmetalation is decided by the rates of the trihydroxyborate species reacting with the 
ArPd(X)L species. At low base concentrations, there is a strong selectivity for the 
boronic acid with the lower pKa, as the formation of that trihydroxyborate is in greater 
concentration and favored to undergo transmetalation. At higher concentrations of base, 
the selectivity is reversed because the trihydroxyborate formed from the boronic acid 
higher in pKa, although present in smaller amounts, undergoes transmetalation at a faster 
rate. 
 Further, increasing the amount of base under these reaction conditions does not 
significantly lower the conversions as would be expected if pathway A was favored as 
was observed by Jutand. For couplings in which the pKa of the boronic acid is higher 
than that of boric acid, high concentrations of base will sequester the generated boric acid 
as MB(OH)4.  
 The reaction conditions tested by Hartwig were 25:1 or 50:1 THF/H2O at 
temperatures of -30 to -55 °C whereas the conditions tested by Lima and Santos were 1:1 
DMF/H2O at 100 °C. Hartwig and Jutand studied the kinetics of reacting preformed oxo-
palladium and palladium halide complexes with arylboronates and determined that the 
rates of transmetalation of the oxo-palladium complexes were much greater than the 
palladium halide complexes. Lima and Santos analyzed the products formed when 
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subjecting two different arylboronates to the coupling with bromobenzene and 
determined that based on the ratio of products the transmetalation must proceed through 
pathway B. 
 Analyzing the study performed by Lima and Santos raises a couple questions. The 
arylboronic acid with the lower pKa would be favored to react first under both pathways. 
Because the boronic acid lower in pKa is more acidic, it will preferentially coordinate to 
the Lewis basic oxo-palladium complex, resulting in the transmetalation of that aryl 
moiety. At higher base concentrations, the majority of the more acidic boronic acid is 
converted to the corresponding less reactive trihydroxyborate. Transmetalation can then 
proceed more efficiently with the more basic boronic acid, resulting in higher selectivity 
for the less acidic boronic acid. It is possible, however, that the exact mechanism for 
transmetalation is dependent upon the reaction conditions, as concluded by Lima and 
Santos. 
1.5 The Emergence of Potassium Organotrifluoroborates as the Preferred 
Organoboron Reagent  
Boronic acids and boronate esters have emerged as the preferred class of 
organometallic reagents in transition-metal catalyzed cross-coupling reactions because of 
their low toxicity relative to other metals, specifically organostannanes.
6
 Organoboranes 
are limited by the use of reactive hydroboration reagents, which suffer from high 
sensitivity to air and poor functional group compatibility. For example, alkyl-9BBN 
compounds must be formed in situ and reacted with an electrophile without isolation. 
Additionally, controlling the hydroboration in the presence of multiple unsaturated bonds 
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can lead to problems with chemoselectivity. On the other hand, boronic acids and 
boronate esters are reasonably stable upon storage, allowing high functional group 
tolerance under mild reaction conditions. Boronic acids can be prepared through many 
different methods including transmetalation from an organometallic reagent, 
hydroboration, C-H activation and Miyaura borylation (Scheme 1.9).
6
 A vast number of 
boronic acids are also commercially available.  
Scheme 1.9. Methods to Access Boronic Acids. 
 
However, boronic acids are not without limitations. Many boronic acids are 
difficult to purify because they are waxy solids. Several classes of boronic acids (e. g., 
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cyclopropyl, vinyl, and many heteroaryl) are not stable upon prolonged exposure to air or 
moisture.
6g
 Further, boronic acids do not exist as monomeric species, but are constantly 
in equilibrium with cyclic anhydrides (boroxines) (Scheme 1.10). This equilibrium does 
not affect the cross-coupling as the boroxines are hydrolyzed back to the boronic acid 
under aqueous reaction conditions. However, because it is difficult to determine the 
relative amount of boronic acid and boroxine, many procedures require an excess of up to 
2.0 equivalents of boronic acid to ensure complete conversion in the cross-coupling.
6
  
Scheme 1.10. Dehydration of Boronic Acids to Boroxines 
 
A final limitation of boronic acids is their sensitivity to many common reagents 
and reaction conditions, such that boronic acids are normally cross-coupled immediately 
after installation without building molecular complexity. Boronate esters alleviate some 
of the concerns of boronic acids, but bring their own set of limitations. The most common 
boronate esters are prepared from the addition of pinacol to the boronic acid, and cross-
coupling of various pinacol boronates are reported in the literature (Eq 1.24).
6
 A limited 
number of reactions can be performed to build molecular complexity on the organic 
moiety in the presence of boronate esters. Boronate esters are monomeric species, and 
many pinacol boronates are stable to purification by column chromatography. However, 
pinacol is a reasonably expensive diol, and its large size decreases the atom economy 
from boronic acids.
6
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Equation 1.24 
 
 Several groups have explored boronic acid surrogates, that is the conversion of a 
boronic acid to a boronate capable of withstanding an array of reaction conditions. 
Because the Lewis acidity of the boron is the key factor in transmetalation of a boronic 
acid, a diaminoborane would be much less reactive because donation from nitrogen 
lowers the acidity of the boronate. Therefore, Suginome realized that the boronates 
derived from 1,8-naphthalenediamine [B(dan)] are easily synthesized in refluxing 
toluene.
64
 Cross-coupling of X-Ar-B(dan) with a boronic acid results in the desired cross-
coupled product with the Bdan unit inert under the reaction conditions (Eq 1.25). The 
Bdan can then be hydrolyzed back to the corresponding boronic acid by addition of acid. 
This conversion decreases the synthetic efficiency by requiring an extra step. Further, 
because a boronic acid is formed upon hydrolysis, the limitations of boronic acids still 
apply. 
Equation 1.25 
 
 Burke reported that N-methyliminodiacetic acid (MIDA) boronates serve as air-
stable boronic acid surrogates.
65
 MIDA boronates can be synthesized by heating MIDA 
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and the corresponding boronic acid in 10:1 DMSO/toluene with a Dean Stark trap and 
can be purified by column chromatography. An array of reactions can be performed on 
the organic moiety without affecting the protected boronate. Burke has demonstrated that 
MIDA substituted aryl halide can selectively react with a boronic acid to form a C-C 
bond without disturbing the MIDA boronate.
65a
 Further, aryl MIDA boronates slowly 
release the corresponding boronic acid in situ via hydrolysis of the MIDA group and 
therefore undergo cross-coupling with aryl chlorides in high yield in basic aqueous 
conditions (Eq 1.26).
65b
 However, as with pinacol esters, MIDA boronates suffer from a 
loss of atom economy as well as the increased cost of an expensive protecting group. 
Equation 1.26 
 
 Potassium organotrifluoroborates
66
 have emerged as the preferred nucleophilic 
partner in Suzuki-Miyaura cross-coupling reactions. Owing to their tetracoordinate 
nature, potassium trifluoroborates are air- and moisture stable, crystalline solids that can 
be stored on the bench indefinitely without any particular precaution. Trifluoroborates 
can be easily prepared from inexpensive starting materials (especially when compared to 
the cost of pinacol and MIDA), and the byproducts from cross-coupling are relatively 
nontoxic, unreactive inorganic salts. Because the trifluoroborate moiety is relatively low 
molecular weight, trifluoroborates are the most atom-efficient boronic acid surrogates 
available. 
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 The first potassium organotrifluoroborate was prepared by Chambers in 1960 (Eq 
1.27).
67a
 Addition of gaseous BF3 to Me3SnCF3 resulted in transmetalation to form the 
corresponding CF3BF2 species, which was in equilibrium with Me3Sn(CF3BF3). Addition 
of KF in H2O converted this intermediate to potassium trifluoromethyltrifluoroborate; 
however, no yield was given. This trifluoroborate was reported to be non-hygroscopic 
and thermally stable as it did not decompose upon heating to 300 °C. Several other 
potassium alkyl, alkenyl, and aryltrifluoroborates were synthesized by this method in 
yields up to 62%.
67
  
Equation 1.27 
 
 The addition of KF/H2O to organodihaloboranes also results in their conversion to 
the corresponding trifluoroborate in high yield.
68
 However, the high reactivity and 
instability of the organodihaloboranes limits the application of this method. Therefore, a 
mild, efficient conversion of arylboronic acids to the corresponding potassium 
aryltrifluoroborates was reported by Vedejs in 1995 by the addition of KHF2 to the 
boronic acid in aqueous methanol.
69
 Complete conversion of the boronic acid (with an 
unknown amount of boroxine) was achieved, and the desired trifluoroborate isolated in 
high yield (Eq 1.28). Further studies showed that conversion of boronate esters and other 
boron compounds with labile groups to trifluoroborates can be easily achieved upon 
addition of KHF2.
70
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Equation 1.28 
 
 The addition of KHF2 to various boronate species has become the most common 
method to prepare trifluoroborates. KHF2 causes extensive etching of glassware and 
requires separation of the trifluoroborate from a mixture of salts remaining after the 
conversion. However, the isolation of the trifluoroborate is easily achieved by Soxhlet 
extraction. Lloyd-Jones reported a new method to convert boronic acids to 
trifluoroborates.
71
 Addition of four equivalents of KF and 2.05 equivalents of tartaric acid 
results in the conversion to the trifluoroborates in high yield under nonetching conditions 
(Eq 1.29). 
Equation 1.29 
 
 Because potassium organotrifluoroborates can be easily purified by 
crystallization, purified boronic acids do not need to be used. Therefore, it is possible to 
quench many different borylation reactions with KHF2 and isolate the desired 
trifluoroborate cleanly. For example, lithium-halogen exchange followed by addition of a 
trialkyl borate can be quenched with KHF2 to access the corresponding trifluoroborates in 
high yield (Eq 1.30).
69,72
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Equation 1.30 
 
 Darses and Genet first reported the use of potassium organotrifluoroborates in 
cross-coupling reactions in 1997.
73
 The cross-coupling of aryltrifluoroborates with 
arenediazonium tetrafluoroborates was catalyzed by 5 mol % Pd(OAc)2 or Pd2(µ-
OAc)2[P(o-tolyl)3]2 at room temperature, providing the desired products in yields up to 
96% (Eq 1.31). 
Equation 1.31 
 
 Two years later, Chen reported the cross-coupling of aryltrifluoroborates and 
diaryliodonium salts.
74
 The biaryl products were isolated in yields up to 99% with 5 mol 
% Pd(OAc)2 (Eq 1.32). 
Equation 1.32 
 
 The reported couplings with arenediazonium and aryliodonium salts were 
achieved at room temperature without the addition of base. However, the cross-coupling 
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with aryl halides and triflates resulted in no product formation in the absence of base. The 
first cross-coupling reported by Molander was the cross-coupling of potassium 
alkyltrifluoroborates with aryl and 1-alkenyl mesylates in 2001.
75
 Molander demonstrated 
the slow hydrolysis of trifluoroborates by obtaining high yields with only 1.0 equiv of the 
nucleophilic partner. For primary alkyltrifluoroborates, 9 mol % PdCl2(dppf)•CH2Cl2 
with 3 equiv Cs2CO3 afforded the cross-coupled product (Eq 1.33). However, attempts to 
couple secondary trifluoroborates were unsuccessful, as the desired product was only 
isolated in 4% yield. 
Equation 1.33 
 
 Molander later reported the cross-coupling of secondary alkyltrifluoroborates with 
aryl chlorides. The reaction was optimized with the aid of high-throughput 
experimentation (HTE).
76
 When cross-coupling secondary alkyltrifluoroborate, β-hydride 
elimination followed by reinsertion can lead to formation of the linear product. 
Conditions were optimized for the cross-coupling of cyclopentyl- and 
cyclohexyltrifluoroborate with an array of aryl and heteroaryl chlorides (Eq 1.34). 
However, attempts to optimize acyclic secondary trifluoroborates led to a 8.2:1 
branched/linear ratio when changing the ligand to t-Bu2PPh. 
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Equation 1.34 
 
Molander demonstrated the ability of potassium alkenyltrifluoroborates to serve 
as nucleophiles in the cross-coupling reaction with aryl and heteroaryl triflates, bromides, 
and iodides.
77
 One example with a heteroaryl chloride was shown in moderate yield. The 
focus of the cross-coupling was the vinylation of various electron rich and electron poor 
arenes with 2 mol % PdCl2(dppf)•CH2Cl2 as the palladium source and NEt3 as base in a 
solvent of n-propanol (Eq 1.35). In a follow-up study, the cross-coupling was extended to 
include an array of aryl and heteroaryl bromides and iodides under slightly modified 
conditions.
78
 The same palladium source was employed as in the vinylation but the 
solvent system and base were changed to isopropanol/water and t-BuNH2, respectively. 
Molander showed that alkenyltrifluoroborates can be synthesized via hydroboration of a 
terminal alkyne followed by addition of KHF2. Various potassium alkenyltrifluoroborates 
were also shown to be efficient nucleophiles in the reaction, providing the desired 
products in yields up to 87% (Eq 1.36). 
Equation 1.35 
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Equation 1.36 
 
The cross-coupling of potassium alkenyltrifluoroborates with alkenyl bromides 
was investigated by Molander.
79
 Employing 5 mol % Pd(OAc)2, 10 mol % PPh3 with 3 
equiv of Cs2CO3 in a solvent system of THF/H2O, the conjugated dienes were 
synthesized in relatively high yield. The cross-coupling proceeds with high 
chemoselectivity and stereoselectivity, such that no cis-to-trans isomerization was 
observed (Eq 1.37).  
Equation 1.37 
 
In 2002, Molander reported the cross-coupling of alkynyltrifluoroborates with 
aryl and heteroaryl bromides and triflates as a complementary approach to the 
Sonogashira reaction.
80
 The trifluoroborates were prepared by deprotonation of terminal 
alkynes, followed by addition of trimethyl borate and conversion to the trifluoroborates 
with KHF2. The alkynyltrifluoroborates were cross-coupled with an array of aryl 
bromides in high yield with 9 mol % PdCl2(dppf)•CH2Cl2 as the palladium source, 3 
equiv Cs2CO3 as the base in a solvent system of THF/H2O (Eq 1.38). 
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Equation 1.38 
 
Despite advances in the cross-coupling of alkyl and alkenyltrifluoroborates, the 
most important general class of couplings is the synthesis of biaryls. The cross-coupling 
of tetrabutylammonium aryltrifluoroborates was reported by Batey in 2001 to proceed 
with 5 mol % Pd(OAc)2 and 5 mol % dppb.
81
 A year later Molander improved these 
conditions by demonstrating that the cross-coupling of potassium aryltrifluoroborates 
proceeds with only 0.5 mol % Pd(OAc)2 under ligandless conditions in which K2CO3 is 
the base and methanol is the solvent.
70c
 An array of aryl and heteroaryl bromides were 
subjected to the standard reaction conditions with the desired products obtained in high 
yield (Eq 1.39). Molander showed that tetrabutylammonium trifluoroborates and boronic 
acids also couple under these general conditions. Remarkably, under these conditions, the 
reactions can be performed in air, affording the cross-coupled product in similar yield. 
Equation 1.39 
 
Although the conditions reported by Molander are extremely efficient for an array 
of aryl bromides, conditions for the cross-coupling of aryl chlorides were not yet 
reported. In 2004, Buchwald published the synthesis of biaryls from aryltrifluoroborates 
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and aryl chlorides with 0.05-2 mol % Pd(OAc)2, 1-4 mol % SPhos, 3.0 equiv of K2CO3 in 
refluxing methanol (Eq 1.40).
82
 The coupling was extended to an array of heteroaryl 
chlorides as well as several heteroaryltrifluoroborates. Sterically hindered biaryls can be 
also be synthesized in high yield. 
Equation 1.40 
 
In addition to the three main classes of trifluoroborates (alkyl, alkenyl, and aryl), 
Molander demonstrated that functionalized alkyltrifluoroborates are suitable nucleophiles 
in cross-coupling reactions. For example, he showed that bromo- and 
chloromethyltrifluoroborate can be synthesized in a one-pot fashion from dibromo- or 
bromochloromethane, both of which are now commercially available.
83
 This 
trifluoroborate can be reacted with an array of nucleophiles to form aminomethyl or 
alkoxymethyltrifluoroborates. Eleven different derivatives of halomethylboronates have 
been prepared by the Molander group (Scheme 1.11).
 45,46,83b,84
 All of them are effective 
nucleophiles in the cross-coupling with aryl and heteroaryl halides. Effectively, the 
synthesis of these trifluoroborates provides a dissonant retrosynthetic connection. For 
example, aside from converting a benzyl halide to the corresponding benzylamine, a 
cross-coupling between an aryl halide and an aminomethyltrifluoroborate can be 
performed. 
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Scheme 1.11. Various Alkoxy- and Aminomethyltrifluoroborates Cross-Coupled by 
the Molander Group 
 
In addition to serving as nucleophilic partners in cross-coupling reactions, 
organotrifluoroborates can also be viewed as protected boronic acids, such that an array 
of transformations can be performed on the organic moiety in the presence of the 
trifluoroborate. The first example reported by Molander was the epoxidation of 
alkenyltrifluoroborates, which proceeds in acetone at room temperature with 
dimethyldioxirane (DMDO).
85
 The product can then be subjected to a cross-coupling 
with an aryl bromide to afford the desired product in 80% yield (Eq 1.41). Increasing the 
amount of water in the cross-coupling from 40:1 to 10:1 resulted in the epoxide opening 
during the course of the coupling, such that corresponding diol was isolated in 74% yield. 
Equation 1.41 
 
Molander demonstrated a wide variety of reactions that can be performed in the 
presence of a trifluoroborate, including: nucleophilic displacement,
83,84
 dihydroxylation,
86
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oxidation of an alcohol,
87
 click-chemistry,
88
 metal-halogen exchange,
89
 Wittig and 
Horner-Wadsworth-Emmons reactions,
90
 ozonolysis,
91
 and reductive amination.
92
 
To validate the trifluoroborate as a protected boronic acid, Molander reported that 
trifluoroborates can be easily hydrolyzed to the corresponding boronic acid by addition of 
SiO2 in water (Eq 1.42).
93
 Potassium aryl-, heteroaryl-, alkenyl-, and alkyltrifluoroborates 
can be hydrolyzed under the standard conditions in varied yields. Further, addition of a 
diol (e. g., pinacol) to the reaction mixture resulted in the formation of the corresponding 
boronate ester. 
Equation 1.42 
 
Potassium organotrifluoroborates have become valuable alternatives to boronic 
acids and boronate esters because they are stable under a range of reaction conditions. 
After protecting the boronic acid as a trifluoroborate, the organic moiety can be further 
functionalized before hydrolyzing the trifluoroborate back to the boronic acid or boronate 
ester. In lieu of hydrolysis, the trifluoroborate can be subjected to a Suzuki-Miyaura 
cross-coupling reaction with an electrophilic (hetero)arene or alkene. In addition to this 
C-C bond forming reaction, Molander demonstrated that alkyltrifluoroborates can react 
with heterocycles through a Minisci reaction.
94
 However, Molander also showed that the 
C-B bond can be converted to an array of other functional groups by conversion of the 
trifluoroborate to the corresponding alcohol,
95
 chloride,
96
 trifluoromethyl group,
97
 and 
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nitrosoarenes.
98
 Other groups have reported the conversion of trifluoroborates to 
bromides
99
 and amines.
100
 
1.6 Mechanistic Investigations into the Hydrolysis of Potassium 
Organotrifluoroborates 
 Because transmetalation requires an empty orbital on boron to interact with an 
oxo-palladium complex, trifluoroborates are not capable of undergoing transmetalation. 
The active transmetalation species is a mixed boronate [RBF3-n(OH)n
-
], resulting from the 
hydrolysis of potassium aryltrifluoroborates. The mechanism of this hydrolysis has been 
explored by Lloyd-Jones.
38
 Addition of three equivalents of K2CO3 or Cs2CO3, or six 
equivalents of KOH resulted in the complete conversion of an aryltrifluoroborate to the 
corresponding boronic acid (Scheme 1.12).  
Scheme 1.12. Hydrolysis of Trifluoroborates 
 
The equilibrium between boronic acid and trifluoroborate is driven toward 
boronic acid by sequestration of fluoride by the base and glassware, resulting in the slow 
but complete conversion of the trifluoroborate. However, after dissociation of KF, three 
different boronates are capable of undergoing transmetalation. The energy barrier for 
transmetalation was determined to be directly proportional to the number of fluorides 
coordinated to boron, such that the difluoroborate has a much higher energy barrier than 
the boronic acid. This result can be explained by the decreased ability of boron to 
complex with palladium, and the reduced nucleophilicity of the aryl moiety on the 
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difluoroborate. The difference in energies for transmetalation suggests that the 
transmetalation proceeds almost exclusively through the boronic acid.
38
 
 One of the benefits of employing organotrifluoroborates in cross-coupling 
reactions is a reduction in the amount of side-products formed in the reaction. Oxidation 
of an arylboronic acid by trace peroxides in the solvent (such as THF) results in the 
formation of phenol derivatives. However, trifluoroborates are not as easily oxidized in 
the same reaction conditions. Because of the strength of the B-F bond, the boron is more 
Lewis acidic, thereby reducing the ability for the aryl group to transfer, leading to 
degradation of the peroxide. Further, homocoupling of a boronic acid is also attributed to 
the presence of oxygen in the reaction (Scheme 1.13). One molecule of O2 results in the 
loss of three molecules of arylboronic acid. Coordination of the boronic acid to oxygen 
and subsequent transmetalation results in a diorganopalladium complex, which 
reductively eliminates the homocoupled product. The side product from transmetalation 
is hydrolyzed to the peroxide (HO)2BO2H, which reacts with a third equivalent of boronic 
acid to form an equivalent of a phenol derivative. The slow hydrolysis of 
aryltrifluoroborates disfavors this pathway by having a large concentration of aryl halide 
and low concentration of the active arylboronic acid, thereby favoring cross coupling.
38
 
Scheme 1.13. Formation of Side Products from Trace Oxygen 
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A detailed study on the mechanism for the hydrolysis of trifluoroborates in the 
context of Suzuki-Miyaura reactions was reported by Lloyd-Jones.
101
 Although the 
hydrolysis is dependent on the organic substituent, the reaction vessel shape, material, 
size, and stirring rate also factor into the hydrolysis. The amount of water in the reaction 
has a significant effect on the hydrolysis such that the trifluoroborate is stabilized in 
higher concentrations of water. Aqueous solvation of the potassium counterion results in 
slower conversion to the boronic acid.  
The nature of the solvent system also has an impact on the hydrolysis. For 
example, water with an immiscible co-solvent, such as toluene, forms two distinct layers 
during the cross-coupling reaction. However, with water-miscible solvents, such as DMF 
and THF, phase splitting is induced from the homogeneous solution (Scheme 1.14). The 
volume in the minor phase is dependent on the amount of base in the reaction and can be 
present in less than 5% of the total reaction volume. The majority of base is located in the 
minor phase rather than the bulk phase, which allows a higher concentration of the 
hydrolyzed boronic acid in the bulk phase while allowing formation of the more active 
transmetalation complex, ArPd(OH)L, in the minor phase. Because the minor phase 
sequesters the halide and boron salts, the vessel shape and stirring rate can affect the 
hydrolysis by altering the contact between the two phases.
101
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Scheme 1.14. Biphasic Medium For Suzuki-Miyaura Couplings 
 
Monitoring the hydrolysis of 4-fluorophenyltrifluoroborate in the bulk phase 
showed a long induction period in which the trifluoroborate underwent slow hydrolysis. 
After reaching a critical point, the hydrolysis was rapid with a sharp drop in pH of the 
bulk phase. The pH of the bulk phase then slowly rose until the reaction was complete. 
This result suggests an acid-catalyzed mechanism because base in the bulk phase retards 
hydrolysis of the trifluoroborate, such that rapid hydrolysis was only achieved when a 
certain pH of the bulk phase was reached (Scheme 1.15).
101
 
Because the hydrolysis of 4-fluorophenyltrifluoroborate was determined to be 
acid-catalyzed, the length of the induction period and rate of hydrolysis were determined 
by factors that affect the pH of the bulk phase. The rate of the equilibrium of the 
trifluoroborate to the boronic acid is important as it releases HF and KHF2, which will 
lower the pH of the bulk phase. However, sequestration of the HF/KHF2 by base or the 
glass of the reaction vessel can hinder the hydrolysis by affecting the transfer rate of base 
from the minor to bulk phase.
101
 
 The acid-catalyzed loss of KF is one of three possible routes to hydrolyze a 
trifluoroborate. This route results in the slow release of boronic acid under the reaction 
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conditions (Scheme 1.15, I). This pathway is preferred for simple aryl and 
benzyltrifluoroborates. Direct dissociation of KF to generate the difluoroborate followed 
by conversion the boronic acid is a second pathway (Scheme 1.15, II). This route is 
accelerated by base and favored by trifluoroborates which can stabilize the RBF2 species 
by hyperconjugation or π-donation, such as alkyl, electron-rich aryl and 
alkenyltrifluoroborates. The final route applies to only trifluoroborates that are 
hydrolyzed very slowly due to increasing s-character of the C-B bond, such as 
alkynyltrifluoroborates, in which transmetalation proceeds through a direct mechanism 
rather than through hydrolysis of the trifluoroborate (Scheme 1.15, III).
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Scheme 1.15. Mechanisms of Organotrifluoroborate Hydrolysis 
 
1.7 Conclusions 
The Suzuki-Miyaura reaction has become one of the most important 
transformations in organic synthesis, allowing the rapid introduction of carbon-carbon 
bonds under mild reaction conditions that allow high functional-group compatibility. 
Potassium organotrifluoroborates have emerged as valuable coupling partners in the 
Suzuki-Miyaura reaction because of their favorable properties, including their low 
toxicity relative to other organometallic reagents commonly employed in cross-coupling 
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reactions. Trifluoroborates can be stored on the bench indefinitely. Their stability to air- 
and moisture is attributed to their tetracoordinate nature. Whereas the corresponding 
boronic acids or boronate esters are prone to protodeboronation and therefore can require 
up to an excess of 1 equivalent, trifluoroborates can be employed in near stoichiometric 
amounts relative to the electrophilic partner.  
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Chapter 2. Stereospecific Cross-Coupling of Secondary Organotrifluoroborates: 
Potassium 1-(Benzyloxy)alkyltrifluoroborates 
 
2.1 Introduction 
 Because of their inherent reactivity, secondary benzylic alcohols are both 
important synthetic intermediates and components in biologically active molecules. 
Secondary alcohol and ether functional groups are commonly employed in drugs for the 
treatment of depression,
1
 asthma,
2
 and hypercholesterolemia,
3
 and they are also present in 
the naturally occurring hormone epinephrine
4
 (Figure 1). 
 
Figure 2.1. Examples of Bioactive Molecules Containing the Secondary Alcohol or 
Ether Moiety. 
 
2.2 Synthesis of Benzylic Alcohols: Addition of an Organometallic Reagent 
 One general method to access secondary benzylic alcohols is the addition of an 
aryl- or alkylmetallic reagent to the corresponding aldehyde (Scheme 2.1).
5
 Although 
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effective, the harsh reaction conditions associated with the addition of organolithium, 
organozinc, or Grignard reagents will severely limit the scope of the reaction. 
Scheme 2.1. Accessing Secondary Benzylic Alcohols by Addition of an 
Organometallic Reagent 
 
 To synthesize an enantioenriched secondary benzylic alcohol, the majority of 
existing methods rely on the conversion of the sp
2
 prochiral center of a carbonyl to the 
sp
3
 stereocenter containing the hydroxyl functional group. Because of the high 
nucleophilicity associated with organomagnesium reagents, synthesis of enantioenriched 
benzylic alcohols often results in modest levels of enantiomeric excess.
6
 For example, 
addition of a dialkylmagnesium to a chiral secondary amine results in a chiral 
organomagnesium amide, which can alkylate aryl aldehydes with an enantiomeric excess 
of 4-82% (Eq 2.1).
7
 
Equation 2.1 
 
A method for the synthesis of enantioenriched secondary benzylic alcohols by the 
addition of an organolithium reagent to an aldehyde with consistently high levels of 
asymmetric induction is virtually unknown because of the high nucleophilicity associated 
with organolithium reagents.
6
 To achieve high levels of conversion and enantiomeric 
excess, a superstoichiometric amount of organolithium and chiral ligand can be employed 
(Eq 2.2).
8
 Aside from employing an exorbitant excess of reagents, this reaction is carried 
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out at a reaction temperature that is not practical to run on large scale as it is conducted at 
-116 ºC. 
Equation 2.2 
 
The synthesis of enantioenriched secondary benzylic alcohols can be achieved 
through the asymmetric addition of diorganozinc species. This efficient method allows 
the desired products to be synthesized in high yield with a range of ees up to 99%. For 
example, Noyori discovered that a secondary benzylic alcohol can be synthesized with 
high yield and enantiomeric excess by employing catalytic amounts of chiral cyclic 
amino alcohols, specifically, (-)-3-exo-(dimethylamino)isoborneol (DAIB) (Eq 2.3).
9
 
Equation 2.3 
 
 Whereas the addition to aryl aldehydes can proceed in high yield with high levels 
of enantiomeric excess, the addition of organozinc reagents to alkyl aldehydes remains a 
challenge. Addition of a dialkylzinc reagent proceeds slowly without the use of a catalyst, 
but, the addition of diphenylzinc can occur readily without a catalyst, making it difficult 
to develop enantioselective catalysts. For example, the arylation of benzaldehyde with a 
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triphenylethanol derived catalyst proceeds with high enantiomeric excess; however, the 
arylation of alkyl aldehydes proceeds with maximum ees of only 63% (Eq 2.4).
10
 
Equation 2.4 
 
 To overcome this limitation, the addition of organozincs to alkyl aldehydes often 
requires the use of Lewis acids in addition to the catalyst. For example, addition of two 
equivalents of trimethylaluminum, a strong Lewis acid that is not stable to air and 
moisture, in addition to the chiral catalyst can result in a moderate yield and high 
enantiomeric ratio of the desired product (Eq 2.5).
11
 The use of an external Lewis acid is 
also common for the addition of less reactive dialkylzinc species, such as dimethylzinc.
6
 
Equation 2.5 
 
 Although methods have been developed that employ the use of organozinc 
reagents to achieve the desired transformation in variable yields and levels of asymmetric 
induction, these methods suffer from several limitations. Employing a more substituted 
organozinc requires the generation of the active organozinc species in situ, which often 
employs pyrophoric diethylzinc and/or trialkylboranes. Most methods also require an 
62 
 
excess of the organozinc reagent. Lastly, the use of organozinc reagents will limit 
functional group tolerability due to the harsh reaction conditions. 
Triphenylborane was discovered to be a less expensive, alternative phenyl source 
for the arylation of aldehydes. Addition of triphenylborane with diethylzinc in the 
presence of a catalyst led to the asymmetric arylation of aldehydes in high yield (up to 
98%) and variable levels of enantiomeric excess (80-98% ee) (Eq 2.6).
12
 Although this 
method successfully affords the desired product, only a single aryl group is delivered of 
the triphenylborane, and the use of diethylzinc carries its own set of limitations, as 
explained above. 
Equation 2.6 
 
 Another method to generate secondary benzylic alcohols is the asymmetric 
addition of a triarylalanes to aldehydes (Eq 2.7).
13
 These reagents are not readily 
available and only deliver a single aryl group of a reagent that is used in excess, thus, 
generating a large amount of waste. This method also requires use of a 
superstoichiometric amount of Ti(Oi-Pr)4, which can limit functional group tolerability. 
However, the method allows the synthesis of the desired enantioenriched alcohols in high 
yield and enantiomeric excess. 
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Equation 2.7 
 
 Arylboronic acids alleviate many of the limitations associated with the use of 
other organometallic reagents by expanding functional group tolerability under milder 
reaction conditions.
14
 Arylboronic acids have been employed in a Ru(II)-catalyzed 
arylation with aryl aldehydes in high yield and high enantiomeric excess (Eq 2.8).
15
 The 
method requires an excess of the arylboronic acid, and to the best of our knowledge, 
addition to alkanals has not been examined. 
Equation 2.8 
 
2.3 Synthesis of Benzylic Alcohols: Reduction of a Ketone 
A second route for the synthesis of secondary benzylic alcohols is the reduction of 
a ketone (Scheme 2.2). There are many different methods available to perform this 
reduction, and most provide the secondary benzylic alcohol in excellent yield.  
Scheme 2.2. Accessing Secondary Benzylic Alcohols by Reduction. 
 
The reduction of ketones can be performed through several different methods, 
including transition metal-catalyzed hydrogenation,
16
 transfer hydrogenation,
17
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hydrosilylation,
17
 catalytic hydroboration,
17
 reduction with metal hydrides or boranes,
18
 
or enzymatic methods.
19
 Each method has its own set of advantages and limitations. 
Generally, these methods developed for the asymmetric reduction of a ketone can 
be limited by their ability to access enantioenriched secondary benzylic alcohols with 
consistently high levels of asymmetric induction across a broad class of substrates. The 
asymmetric reduction can often be substrate dependent and substrate variable, even 
within groups of substrates that are structurally similar because the transformation relies 
on the conversion of a planar, prochiral ketone to a tetrahedral alcohol. 
The asymmetric reduction of ketones is an efficient method for synthesizing 
enantioenriched secondary alcohols. However, this retrosynthetic disconnection is not 
without some limitations. Many reductions require the use of excess reducing agent, 
which provides a drawback for large-scale reactions in terms of separation and 
purification.
16
 In terms of substrate control, aryl alkyl ketones are capable of undergoing 
addition with reasonable stereochemical induction. However, the diaryl ketone 
counterparts are much more difficult. As the asymmetric induction is mostly determined 
by differences in steric bulk, the reduction of diaryl ketones often requires ortho-
substituted aryl rings. Another way to achieve high levels of asymmetric induction with 
diaryl ketones is the use of electronically differentiated aryl groups, which often leads to 
modest levels of enantiomeric excess.
6
 
2.4 Synthesis and Reactivity of α-(Alkoxy)stannanes 
 To avoid the limitations associated with the reduction of a ketone and the addition 
of an organometallic reagent to an aldehyde, a third retrosynthetic disconnection can be 
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envisioned. The cross-coupling between an enantiopure, configurationally stable 1-
(alkoxy)alkylmetallic species and an aryl halide would result in the synthesis of a 
protected enantioenriched secondary benzylic alcohol (Scheme 2.3). By installing the 
stereocenter through a cross-coupling reaction, the challenge of asymmetric synthesis is 
moved to an earlier, more reliable stage in the assembly of an enantiopure cross-coupling 
partner, which then alleviates the problems associated with the late-stage conversion of 
prochiral centers to stereocenters. 
Scheme 2.3. Accessing Secondary Benzylic Alcohols by Cross-Coupling 
 
 The installation of a protected alcohol through a cross-coupling reaction has been 
illustrated using α-(alkoxy)stannanes. Enantioenriched α-(alkoxy)stannanes can be 
synthesized by addition of ethyl(tri-n-butylstannyl)zinc to an aldehyde in the presence of 
a catalytic amount of (S)-α,α-diphenyl-2-pyrrolidinemethanol followed by addition of 
acetyl chloride.
20
 Ethyl(tri-n-butylstannyl)zinc was generated in situ from four 
equivalents of tributyltin hydride and four equivalents of diethylzinc, resulting in a 
method with limited functional group tolerability. The corresponding α-
(alkoxy)stannanes were synthesized in yields up to 86% with enantiomeric excesses up to 
98% (Eq 2.9). 
Equation 2.9 
 
66 
 
 α-(Alkoxy)stannanes have become important synthetic intermediates as they 
provides routes to other reactive organometallic species in addition to their ability to 
serve as nucleophilic partners in cross-coupling reactions. α-(Alkoxy)stannanes have 
been demonstrated to react with acid chlorides in a palladium-catalyzed coupling to 
synthesize ketones. Employing an enantioenriched α-(alkoxy)stannane resulted in 
complete retention of configuration in the desired product (Eq 2.10).
21
 However, 
inversion of configuration had been reported in a similar palladium-catalyzed coupling of 
benzoyl chloride with tetraalkylstannanes.
22
 
Equation 2.10 
 
 Falck demonstrated the ability for pyrrolindinylthiocarbamoyl (PTC)-protected 
stannanes to undergo cross-coupling with an array of aryl, heteroaryl, and alkenyl iodides 
in the presence of a superstoichiometric amount of CuTC (TC = thiophene-2-carboxylate) 
(Eq 2.11).
23
 As observed with the coupling of enantioenriched α-(alkoxy)stannanes with 
ketones, this coupling proceeds with complete retention of configuration. However, an 
unexpected O-to-S rearrangement during the reaction led to the formation of 
thiocarbamates as the reaction products.  
Equation 2.11 
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 The desired cross-coupling to synthesize protected secondary benzylic alcohols 
was successfully achieved by Falck by performing a Stille reaction with aryl, heteroaryl, 
and alkenyl bromides and iodides.
24
 An array of α-(alkoxy)stannanes were shown to be 
effective nucleophilic partners in the cross-coupling reaction; however, the 
trifluoromethylbenzoate (TFMB) protected stannane was chosen for future study as it 
was the easiest to handle and purify. The reaction with this stannane and an aryl halide 
proceeds in moderate yield with 10 mol % of a palladium catalyst (Eq 2.12). Falck 
demonstrated that the Stille reaction proceeds with complete retention of configuration 
when an enantioenriched α-(alkoxy)stannane is employed in the reaction. 
Equation 2.12 
 
2.5 Synthesis of Potassium 1-(Hydroxy)alkyltrifluoroborates 
 Although the use of α-(alkoxy)stannanes allows the synthesis of secondary 
benzylic alcohols, the method requires the use of a toxic stannane.
25
 Trialkylstannanes are 
also inherently difficult to handle and purify. The reaction requires an excess of aryl 
bromide or iodide and only proceeds in moderate yield. Lastly, the protecting group 
chosen for future study can only be removed by strong base or electrolysis.
26
 Therefore, 
to reduce exposure to potentially toxic reagents and to use a more atom economical 
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protecting group that can be cleaved under milder conditions, a different 1-
(alkoxy)alkylmetallic species was desired. 
 The use of potassium 1-(alkoxy)alkyltrifluoroborates would alleviate many of the 
limitations associated with using stannanes by serving as the nucleophile in the cross-
coupling with aryl and heteroaryl chlorides. To that end, our initial efforts focused on a 
directed lithiation sequence. Hoppe has demonstrated the ability to direct lithiation at the 
carbon next to a carbamate-protected alcohol to form the corresponding pinacol boronate 
(Scheme 2.4).
27
 This pinacol boronate ester was then reacted with a Grignard reagent, 
which displaced the carbamate by coordination to boron and subsequent α-transfer to 
form a secondary alkyl boronate with complete inversion of configuration. The C-B bond 
was then oxidized with H2O2/NaOH to form a secondary alcohol in good yield and high 
enantiomeric excess. 
Scheme 2.4. Directed Lithiation Route to Install Boron 
 
Based on this reaction pathway, we believed that a similar directed lithiation route 
could be employed to synthesize the desired organotrifluoroborate. Instead of isolating 
the pinacol boronate ester, addition of KHF2 would yield the trifluoroborate in a one-pot 
fashion. After optimization of the reaction, potassium 1-(N,N-diisopropylcarbamoyl)-3-
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phenylpropyltrifluoroborate was synthesized in 64% yield (Eq 2.13). To synthesize the 
racemic trifluoroborate, TMEDA was employed in place of (-)-sparteine.
28
 
Equation 2.13 
 
Despite forming the product in good yield, the directed lithiation route was not the 
ideal method to synthesize the 1-(alkoxy)alkyltrifluoroborates as the harsh reaction 
conditions required would limit functional group tolerance. Therefore, a different method 
to synthesize 1-(alkoxy)alkyltrifluoroborates was required, and attention was turned to a 
copper-catalyzed diboration of aldehydes. 
Sadighi reported the copper-catalyzed addition of bispinacolatodiboron (B2pin2) 
to aldehydes in 2006.
29
 Requiring only 1 mol % of the catalyst, an array of dibora 
compounds was synthesized in yields up to 97%. Sadighi suggested that these 
compounds could serve as boryl equivalents to α-(alkoxy)stannanes; however, there are 
no examples of these dibora compounds being further functionalized.  
Equation 2.14 
 
These dibora products seemed promising for the synthesis of 1-
(alkoxy)alkyltrifluoroborates; however, there were several issues that needed to be 
addressed. Sadighi’s entire procedure, including the set-up, work-up, and isolation of the 
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dibora compounds, was completed in the glovebox, which limits the practicality of the 
method. Furthermore, the copper-catalyst, ICyCuOt-Bu, is a white foam which was 
stored in benzene in the glovebox and dosed into the reactions. To circumvent this 
problem, the catalytic precursor ICyCuCl, which is a solid and therefore does not need to 
be stored in benzene, can be reacted with NaOt-Bu to form ICyCuOt-Bu in situ. 
Additionally, the dibora products were found to be unstable in air as they readily oxidize 
back to the aldehyde starting material upon prolonged exposure to air, limiting their 
ability to serve as boryl equivalents to α-(alkoxy)stannanes. It was anticipated, however, 
that addition of KHF2 to the dibora compound would not only convert the boronate ester 
on carbon to the corresponding trifluoroborate, but also the acidic nature of KHF2 would 
cleave the O-B bond to generate the free alcohol, which, in turn, would allow the work-
up and isolation to be performed outside the glovebox. 
 The catalytic cycle for the diboration of aldehydes was based on a DFT study 
completed by Marder (Scheme 2.5).
30
 A similar catalytic cycle is proposed for the 
copper-catalyzed diboration of ketones with B2pin2.
31
 Subsequent transmetalations of 
ICyCuCl with NaOt-Bu followed by B2pin2 generate the active catalyst 2.3a. 
Coordination of the aldehyde to copper results in complex 2.3b. Insertion of Bpin into the 
aldehyde forms the copper alkoxide 2.3c. At this point, this alkoxide undergoes 
transmetalation with another molecule of B2pin2 in the rate limiting step to form the 
desired dibora product, 2.3d, and regenerate the active catalyst 2.3a. 
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Scheme 2.5. Catalytic Cycle for the Diboration of Aldehydes 
 
 The reported conditions for the diboration of aldehydes and ketones do not 
involve the addition of methanol. Because methanol has been shown to facilitate catalytic 
turnover of the catalyst in other diboration reactions,
32
 it was believed its addition to the 
diboration of aldehydes could increase both the rate of the reaction and the conversion of 
the aldehyde to the desired product. The diboration was optimized by performing the 
reaction in toluene with the addition of methanol. It was quickly realized that addition of 
two equivalents of methanol shortened the reaction time from 22 h to 1.5 h.  
The addition of methanol must therefore cause the reaction to proceed through a 
different mechanism (Scheme 2.5). Whereas the copper alkoxide 2.3c undergoes 
transmetalation with B2pin2 in the absence of methanol, the addition of methanol causes 
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protonation of the copper alkoxide 2.3c to form the copper methoxide 2.3e in addition to 
the 1-(hydroxyl)alkyl pinacol boronate ester. This boronate ester is then quenched with 
KHF2 to form the desired potassium 1-(hydroxy)alkyltrifluoroborate. The copper 
methoxide 2.3e then undergoes transmetalation with another molecule of B2pin2 to 
regenerate the active catalyst 2.3a. Therefore the rate increase observed by the addition of 
methanol is believed to be due to steric factors. The alkoxide on 2.3c is quite large due to 
the presence of the pinacol boronate ester and R group on the alkoxide. The 
corresponding methoxide (2.3e) is much smaller, and that complex is able to undergo 
transmetalation with B2pin2, which is also a sterically encumbered molecule, at a rate 
much faster than 2.3c. 
A variety of alkyl and aryl aldehydes were subjected to the optimized conditions, and the 
corresponding potassium 1-(hydroxy)alkyltrifluoroborates were synthesized in modest to 
excellent yield (Table 2.1). Whereas the dibora products were not air stable, the 
organotrifluoroborates are all solids that can be stored on the benchtop without particular 
precaution. Trifluoroborates were obtained in yields up to 98% from the diboration of 
simple aliphatic aldehydes (entries 1, 8, 10, and 13). Alpha- and beta-substitution on the 
aldehyde does not affect the diboration as trifluoroborates were prepared in high yield 
(entries 2, 4, 16, 18, 19, 20). Sterically hindered aldehydes were successful substrates in 
this reaction, providing the 1-(hydroxy)alkyltrifluoroborates in 96% and 77% yield 
(entries 4 and 16). Alkenes, protected alcohols, ethers, and protected amines do not 
interfere with the catalysis as the organotrifluoroborates were obtained in moderate to 
high yield (entries 6, 7, 9, 15, 20). Chiral aldehydes were subjected to the diboration, 
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resulting in the diasteroselective formation of the corresponding trifluoroborates. The 
diboration of Garner’s aldehyde afforded a single diastereomer (entry 20), whereas (S)-
citronellal provides a 1:1 mixture of diastereomers (entry 19), and 2-
phenylpropionaldehyde reacted with a 4:1 diastereoselectivity as determined by 
1
H NMR 
(entry 18). 
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Table 2.1. Preparation of Potassium 1-(Hydroxy)alkyltrifluoroborates 
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2.6 Installation of a Suitable Stabilizing Group 
After developing a method to synthesize potassium 1-
(hydroxy)alkyltrifluoroborates, attention was turned to their conversion to potassium 1-
(alkoxy)alkyltrifluoroborates. An easily cleavable protecting group was desired, but the 
protecting group should be capable of complexation with the intermediate 
diorganopalladium species to prevent β-hydride elimination.  
Despite recent advances in cross-coupling methods and the development of 
C(sp
2
)-C(sp
3
) bond-forming reactions, the possibility of β-hydride elimination remains an 
inherent obstacle in the cross-coupling of alkyl compounds.
33
 After transmetalation of the 
nucleophilic partner, product-forming reductive elimination competes with β-hydride 
elimination (Scheme 2.6).  
Scheme 2.6. Possible Pathways after Transmetalation of the Organoboron 
 
 Therefore, to ensure a successful cross-coupling reaction, one must find a way to 
favor reductive elimination over β-hydride elimination. A successful paradigm for 
accomplishing this task is to perform a cross-coupling, or related reaction, in the presence 
of an electron-donating group that can serve as a hemilabile ligand for the intermediate 
organometallic species. The first examples of stabilizing groups to favor reductive 
elimination over β-hydride elimination are olefin additives in cross-coupling reactions. 
The effect of olefin additives on the reductive elimination of dialkylnickel(II) complexes 
was investigated in 1971 (Scheme 2.7).
34
 The thermal decomposition of (dialkyl)Ni(bipy) 
complexes results in complete β-hydride elimination to the corresponding alkene. 
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However, addition of an external olefin increases the rate of reductive elimination, which 
in turn, allows reductive elimination to occur at room temperature. Out of the olefins 
tested, electron-deficient, monosubstituted olefins provided the fastest rate acceleration. 
Scheme 2.7. Addition of Olefin to (Dialkyl)Ni(II) Species 
 
The rate enhancement and reductive elimination observed from addition of an 
olefin was later determined to occur through an associative process, in which a 
pentavalent Ni(II) species is formed by coordination of the olefin to the nickel center.
35
 
This coordination reduces electron density at the nickel center, thus favoring reductive 
elimination. After addition of the external olefin, no β-hydride elimination products were 
observed as the coordination of the olefin to the nickel center fills the vacant coordination 
site on the metal center to inhibit β-hydride elimination. 
A related study on the effect of olefin additives on reductive elimination was 
performed in dialkylpalladium(II) complexes.
36
 Thermal decomposition of Pd(bipy)Et2 
resulted in the disproportionation products of ethane and ethylene. However, in the 
presence of methyl acrylate, only the reductive eliminated product was observed. A 
similar mechanism was proposed in which the olefin coordinates to palladium to occupy 
the empty coordination site to prevent β-hydride elimination and favor reductive 
elimination. Similar reports on the use of employing olefin additives to favor reductive 
elimination are present in the literature.
37
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One of the early examples of employing a stabilizing group in a cross-coupling 
reaction is a nickel-catalyzed Negishi coupling of alkyl iodides and dialkylzinc reagents 
(Eq 2.15).
38
 The presence of a double bond in the γ-position to the carbon-halogen bond 
facilitates the reductive elimination step of the cross-coupling. The double bond serves as 
a hemilabile ligand such that it coordinates to remove electron density from the nickel 
center, thereby favoring reductive elimination.  
Equation 2.15 
 
However, because the double bond is required on the iodoalkene at the γ-position 
to the carbon-iodine bond, the scope of the reaction is limited. To understand the 
stabilizing group further and improve on substrate scope, Knochel discovered that 
catalytic amounts of an additive, such as a styrene derivative, allows the Negishi coupling 
between alkyl iodides and diorganozinc compounds to proceed efficiently (Eq 2.16).
39
 
After testing an array of additives, it was determined that addition of 0.2-1.0 equivalents 
of 3-trifluoromethylstyrene to serve as a stabilizing additive improved reaction rates and 
decreased amounts of Zn-I exchange, leading to increased yields of the desired coupling. 
Equation 2.16 
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The addition of an olefin as a stabilizing group has also been demonstrated in 
palladium catalysis. A phosphine-electron deficient olefin ligand was designed for a 
C(sp
2
)-C(sp
3
) Negishi coupling.
40
 The rationale behind the ligand focused on accelerating 
the rate of the reductive elimination step through a different method than simply relying 
on the steric bulk of the phosphine ligand. In the case of palladium, the addition of an 
external olefin can stabilize the Pd(0) species such that oxidative addition is more 
challenging. To address the needs of both oxidative addition and reductive elimination, a 
ligand was designed that contained both the phosphine required for oxidative additive and 
an olefin that could serve as a hemilabile ligand that would favor reductive elimination. 
The effectiveness of this ligand is evident by the fact that the cross-coupling proceeds in 
81% yield with only 0.005 mol % Pd on a 50 g scale, demonstrating that β-hydride 
elimination is minimized in this reaction (Eq 2.17). 
Equation 2.17 
 
In recent years, the Fu group has installed stabilizing groups on the electrophilic 
partner in the alkyl cross-coupling reactions. The first stabilizing group was the aryl ring 
on a homobenzylic bromide in the nickel-catalyzed Negishi coupling with alkyl-9BBN 
compounds (Eq 2.18).
41
 Fu proposes that the high levels of asymmetric induction 
achieved in this coupling are a result of a secondary interaction between the benzyl 
substituent and the diorganonickel intermediate. Although not mentioned, this secondary 
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interaction should also stabilize the diorganonickel species to prevent β-hydride 
elimination. 
Equation 2.18 
 
Based on the success of the homobenzylic bromides, Fu expanded the scope over 
a series of publications to demonstrate that an array of functional groups can serve as 
stabilizing groups (SG) in the nickel-catalyzed Negishi coupling with alkyl-9BBN 
reagents (Eq 4.19). Fu has shown that secondary arylamines,
42
 carbamates,
43,44
 
sulfonamides,
43
 and sulfones
43
 are effective stabilizing groups, providing the 
enantioenriched products in high yields and enantiomeric excess. 
Equation 4.19 
 
Another example of a stabilizing group preventing β-hydride elimination is a 
ligand-to-C-H stabilization in the polymerization of ethylene.
45
 Marks and coworkers 
reported on two different nickel catalysts’ ability to polymerize ethylene (Scheme 2.8) 
(The only difference between the two catalysts is that the aryl rings are substituted 3,5-
dimethylphenyl in one catalyst whereas the other catalyst is substituted 3,5-
ditrifluoromethylphenyl). The difference in ligand structure, even though only present in 
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the aryl substituents, resulted in a significant difference in reactivity. The 
trifluoromethylated nickel catalyst resulted in high molecular weight polyethylene with 
molecular weights equal to 92,000 g/mol and only 7 branches per 1000 carbons. 
However, the 3,5-dimethyl nickel catalyst produced low molecular weight polyethylene 
with a molecular weight of 1,400 g/mol and a much higher 83 branches per 1000 carbon. 
These branches are formed when the polymer undergoes β-hydride elimination of the 
straight chain alkyl substituent followed by reinsertion to yield the branched polymer. 
The reason for this stark difference in reactivity is proposed to be a weak (ligand)C-
F•••H-C(polymer) interaction that prevents β-hydride elimination. This interaction is 
explained by Newman projections, which show that the weak coordination leads to the 
preferred staggered conformation. However, in the absence of fluorine substituents, as is 
the case in the 3,5-dimethylphenyl nickel catalyst, the interaction is non-existent, leading 
to the eclipsed form being more favorable. Once in the eclipsed conformation, the 
molecule is syn co-planar and aligned to undergo β-hydride elimination easily. Therefore, 
the stabilizing group in the polymerization is the ligand as the interaction from the CF3 
moieties prevent β-hydride elimination by disfavoring the syn co-planar geometry 
required for β-hydride elimination. 
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Scheme 2.8. Weak Ligand Effect Preventing β-Hydride Elimination 
 
The presence of a stabilizing group to prevent β-hydride elimination has been 
employed in the difunctionalization of alkenes.
46
 Because Pd(II) facilitates the addition of 
nucleophiles to alkenes, the resultant insertion complex can follow two different 
pathways. The most common route is β-hydride elimination, similar to a Wacker-type 
reaction. However, it is possible to change the system to allow this insertion complex to 
undergo a second functionalization by employing substrates containing a functional 
group that can stabilize the insertion complex and prevent β-hydride elimination (Scheme 
2.9).  
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Scheme 2.9. Difunctionalization of Alkenes 
 
 The first approach to the difunctionalization of alkenes was developed by 
Backvall, who employed dienes as substrates in the reaction (Scheme 2.10).
47
 After 
insertion, the palladium complex formed contained an adjacent alkene, resulting in 
formation of a π-allyl intermediate, which can stabilize the palladium complex and slow 
β-hydride elimination. The π-allyl intermediate also increases the electrophilicity of the 
complex, allowing a second nucleophilic attack to occur, yielding the difunctionalized 
alkene. 
Scheme 2.10. Use of Dienes in the Difunctionalization of Alkenes 
 
 A recent example of this approach to the difunctionalization of alkenes is the 
diamination with N,N’-diethylurea, which was chosen as an amine source as its Lewis 
basicity would prevent binding to palladium and inhibition of the reaction (Eq 2.20).
48
 
The use of a urea also allows the second nucleophilic attack to occur through an 
intramolecular fashion. 
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Equation 2.20 
 
 A second approach to prevent β-hydride elimination of the insertion complex is a 
subsequent insertion into a second alkene. In this case, the alkene would be serving as a 
stabilizing group to prevent β-hydride elimination but then serves as a substrate in the 
reaction. The net result is an overall oxygen/carbon difunctionalization. An example of 
this approach is the synthesis of tetrahydrofuran derivatives from allylic alcohols and 
vinylic ethers (Eq 2.21).
49
 
Equation 2.21 
 
 Sigman extended this approach to the diarylation of styrenes with arylstannanes 
(Eq 2.22).
50
 Whereas the previous π-allyl intermediate complex was formed by 
nucleophilic attack, insertion of the aryl group to the styrene would generate a similar π-
benzyl intermediate. β-Hydride elimination would lead to the Heck product. However, if 
it is possible to control the rates of β-hydride elimination and transmetalation of a second 
equivalent of arylstannane, then the diarylated product may be accessed. As with the π-
allyl complex, the π-benzyl intermediate should slow β-hydride elimination by filling the 
vacant coordination site on the palladium. 
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Equation 2.22 
 
 By varying the electrophilicity of the catalyst, the palladium-catalyzed diarylation 
of styrenes was achieved. The π-benzyl interaction was found to be stronger with more 
electrophilic catalysts, resulting in slower β-hydride elimination and thus allowing the 
second transmetalation to occur.
50
 
Through a palladium-catalyzed Heck/Suzuki domino reaction, Larhed has 
extended the diarylation of alkenes to dimethylaminoethyl substituted vinyl ethers.
51
 
Depending on the reaction conditions, the reaction of the vinyl ethers with arylboronic 
acids can yield three different products. The dimethylamino substituent has the ability to 
serve as a stabilizing group to prevent β-hydride elimination. However, when a large 
bidentate ligand is employed, such as dppp, the internal coordination between nitrogen 
and palladium is blocked. Therefore, the major product is the β-hydride eliminated Heck 
product (Eq 2.23). 
Equation 2.23 
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 Under ligandless conditions, the dimethylamine is able to coordinate the 
palladium, resulting in the monoarylation of the alkene (Eq 2.24). The chelation 
controlled product was obtained as a mixture of E and Z isomers.
51
 
Equation 2.24 
 
The choice of oxidizing agent has a major impact on the product outcome. The 
oxidizing agent for the Heck and chelation controlled products was molecular oxygen. 
However, changing the oxidizing agent to benzoquinone resulted in the diarylated 
product. Therefore, it was hypothesized that the alkylpalladium intermediate was 
stabilized by both an intramolecular coordination from the dimethylamine and a weak 
ligand interaction with benzoquinone. This added stabilization prevents β-hydride 
elimination and allows a second transmetalation with an arylboronic acid to proceed. 
Reductive elimination of that complex led to the diarylated product in high yield. These 
initial conditions were limited to the use of electron-rich arylboronic acids (Eq 2.25).
51
 A 
further study showed that by increasing the equivalents of benzoquinone to 1.1 and the 
reaction temperature to 60 °C, electron-poor arylboronic acids were suitable substrates 
for the diarylation reaction.
52
 
Equation 2.25 
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 Benzoquinone played three important roles in the reaction, as confirmed through 
DFT calculations (Scheme 2.11).
53
 The first role of benzoquinone was to serve as an 
oxidant for palladium to ensure catalytic turnover. Calculations showed that upon 
coordination of benzoquinone to palladium, the free-energy barrier for transmetalation 
with another equivalent of arylboronic acid is lowered such that it is more favorable than 
the oxidative Heck pathway. The benzoquinone coordination also fills a coordination site 
on the palladium to prevent β-hydride elimination. Furthermore, benzoquinone 
coordinates to the palladium complex after the second transmetalation to lower the barrier 
for reductive elimination of the diarylated product. 
Scheme 2.11. Role of Benzoquinone in the Diarylation of Alkenes 
 
An array of stabilizing groups was tested in the reaction to determine the 
importance of the dimethylamine (Scheme 2.12).
53
 Increasing steric bulk around the 
metal center has a negative impact on the reaction, as evident by the fact that the 
diethylamine stabilizing group decreased the yield of the reaction to 18%. The strength of 
the coordination of the stabilizing group to the metal center is also important as changing 
the stabilizing group to a methylamine or ether resulted in no product formation. Ethers 
form a weaker coordination with a Pd(II) complex according to experimental and 
computational studies.
54
 Lastly, the distance the stabilizing group is from the metal center 
played a significant role in the reaction. A two carbon linker resulted in a pseudo six-
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membered ring upon coordination of the dimethylamine to the metal center. However, 
upon increasing the linker the three carbons, no desired product was observed. 
Scheme 2.12. Variation of the Stabilizing Group. 
 
 The paradigm of employing an electron-donating group to serve as a hemilabile 
ligand was extended to the Suzuki-Miyaura cross-coupling reaction, in which potassium 
β-trifluoroboratoamides were cross-coupled with aryl and heteroaryl chlorides in high 
yield (Eq 2.26).
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Equation 2.26 
 
The success of this cross-coupling was attributed to the amide carbonyl, which 
served as a hemilabile ligand (Scheme 2.13). After transmetalation of the organoboron 
species, the carbonyl oxygen complexes to the diorganopalladium intermediate, filling 
the vacant coordination site to prevent β-hydride elimination. Reductive elimination then 
provides the desired product.
55
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Scheme 2.13. Proposed Mechanism for the Coupling of Potassium β-
Trifluoroboratoamides 
 
 A computational study into the cross-coupling of secondary alkyl boronates, 
specifically potassium β-trifluoroboratoamides, was completed by Janesko.
56
 By 
analyzing palladium complexes after transmetalation, they determined there were two 
classes of stable conformations, with either the reactant α- or β-hydrogens agostically 
interacting with the unsaturated metal center (Scheme 2.14).  
Scheme 2.14. Two Classes of Conformations of Diorganopalladium Complexes 
 
Reductive elimination occurs from the α-coordinated complexes whereas β-
hydride elimination occurs from the β-coordinated complexes. The free energy barriers 
for reductive and β-hydride elimination show that the β-coordinated complex is more 
stable than the α-coordinated complex. Calculations showed the β-hydrogen interactions 
are stronger than the α-hydrogen interactions, as evidenced by longer C-H bonds.  
In the case of the cross-coupling of a cyclopentylborate species with an aryl 
halide, calculations determined the agostic interactions with β-hydrogens were stronger 
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than the corresponding α-agostic interactions. As the α-coordinated complex is about 6 
kcal/mol higher in energy than the β-coordinated complex, presumably because of steric 
repulsion between the phenyl and cyclopentyl reactants, the product-forming reductive 
elimination pathway is not favored, perhaps explaining why low experimental yields 
were obtained from the cross-coupling cyclopentyltrifluorborate of with aryl bromides.
57
 
As secondary alkylboron species have two sets of β-hydrogens, calculations have 
shown that the β-hydrogens on the more substituted carbon undergo β-hydride 
elimination preferentially (Scheme 2.15). The transition state for the β-hydrogen 
elimination from the more substituted carbon of 2-pentyl boronate is 2.3 kcal/mol lower 
in energy than the terminal β-hydrogens.
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Scheme 2.15. Preferred Path of β-Hydride Elimination 
 
By modeling the mechanism of reductive elimination against β-hydride 
elimination for the β-trifluoroboratoamide coupling, it was evident that the electron 
withdrawing nature of the amide led to shorter C-H bonds of both the α- and β-
hydrogens, indicating weaker agostic interactions with the metal center. Although both α- 
and β-agostic interactions were smaller, a larger effect is evident for the β-agostic 
interactions. This weakened interaction in turns increases the barriers to both reductive 
and β-hydride elimination but selectivity toward reductive elimination tends to increase. 
Therefore part of the success of the coupling of β-trifluoroboratoamides is due to 
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deactivation of the β-hydrogens by the electron-withdrawing amide, this disfavoring β-
hydride elimination.
56
 
Calculations of the β-trifluoroboratoamides showed a third stable conformation of 
palladium in addition to the α-H and β-H conformers. The vacant site on palladium is 
filled by coordination from the carbonyl oxygen in the third conformer. To determine the 
strength of the stabilizing group, calculations on two palladium complexes were 
completed (Scheme 2.16).
58
 The first complex showed the empty coordination site on 
palladium filled by a β-hydrogen, which would lead to β-hydride elimination. The second 
complex showed the carbonyl oxygen serving as a hemilabile ligand by coordinating to 
the metal center. This complex is more stable by ~12 kcal/mol, illustrating the 
importance of the stabilizing group. Furthermore, the optimized geometry shows that 
upon complexation of the carbonyl oxygen, the β-hydrogens on the most substituted 
carbon are rotated such that they are no longer syn co-planar. Since β-hydride elimination 
occurs most readily on the hydrogens on the most substituted carbon, this complex is 
unable to undergo β-hydride elimination, and therefore product-forming reductive 
elimination is observed.  
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Scheme 2.16. Stability Imparted From Amide Serving as Hemilabile Ligand 
 
However, calculations performed with PMe3 as the ligand suggested that the 
added stabilization of palladium from the carbonyl coordination is detrimental to the 
reaction because it would increase the energy barriers of the reaction, thus decreasing the 
overall rate of cross-coupling. Additionally, the reductive elimination transition state does 
not contain a Pd-carbonyl interaction but rather an agostic bond to the α-hydrogen, 
further suggesting that the electron donation from the carbonyl to palladium disfavors the 
reductive elimination.
56
 
Upon switching the ligand from PMe3 to SPhos, a model for a ligand in a Suzuki 
coupling, the results changed dramatically. In combination with the amide, the use of a 
bulky, electron rich phosphine diminished the unfavorable interactions and improved the 
activity and selectivity to reductive elimination such that the barrier to β-hydride 
elimination was 3.5 kcal/mol higher in energy.
56
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As evidenced by their use as additives or installation on a reagent, stabilizing 
groups serve several different roles in cross-coupling reactions. By coordinating to an 
unsaturated diorganometal center, the stabilizing group serves as a hemilabile ligand by 
donating electron density to the electron deficient metal, which in turn reduces agostic 
interactions with the neighboring hydrogens that would lead to β-hydride elimination. If 
the hemilabile ligand is installed on one of the substrates, complexation with the metal 
center can enforce a conformation that inhibits syn β-hydride elimination. Installation of 
a stabilizing group that is electron-withdrawing in nature inhibits β-hydride elimination 
through an inductive effect. In the case of the potassium β-trifluoroboratoamides, the 
amide can be viewed as an electron withdrawing group that is removing electron density 
from the hydrogens β to the palladium, thereby disfavoring β-hydrogen agostic 
interactions and inhibiting β-hydride elimination. 
2.7 Synthesis and Attempted Cross-Coupling of Potassium 1-
(Acyloxy)alkyltrifluoroborates 
Because of the success of cross-coupling β-trifluoroboratoamides, installation of 
protecting group on the potassium 1-(hydroxy)alkyltrifluoroborate that could serve as a 
similar type of stabilizing group on the potassium 1-(hydroxy)alkyltrifluoroborate should 
prevent β-hydride elimination through a similar mechanism. An acyl protecting group 
should provide an inherent resistance to β-hydride elimination through a similar manner 
as that of the β-trifluoroboratoamides, including complexation of the carbonyl to the 
diorganopalladium as well as an electron-withdrawing inductive effect (Figure 2.2) 
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Figure 2.2. Proposed Stabilization of the Diorganopalladium Intermediate 
An array of potassium 1-(acyloxy)alkyltrifluoroborates were synthesized from the 
readily available potassium 1-(hydroxy)alkyltrifluoroborates by treatment with acid 
chlorides (entries 1-3) or anhydrides (entry 4) (Table 2.2). The 1-
(acyloxy)alkyltrifluoroborates were isolated as free-flowing solids and can be stored on 
the benchtop open to air without undergoing protodeboronation or other side reactions 
because of their tetracoordinate nature. The carbamate protected trifluoroborate 2.2 is the 
same trifluoroborate that was synthesized through the directed lithiation route in 64% 
yield. In this case, the synthesis was two steps in 93% overall yield (entry 3). 
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Table 2.2. Preparation of Potassium 1-(Acyloxy)alkyltrifluoroborates 
 
After synthesis of the protected trifluoroborates, the first reaction screened was 
the cross-coupling of 2.2 with 4-chloroanisole (Eq 2.27). The carbamate protecting group 
was chosen as donation from both oxygen and nitrogen should increase the electron 
density on the carbonyl oxygen, which would then aid in the complexation of the 
carbonyl oxygen to the diorganopalladium intermediate to prevent β-hydride elimination. 
In addition to the anticipated complexation, the electron-withdrawing nature of the 
carbamate could also prevent β-hydride elimination. 
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Equation 2.27 
 
Initial screening of this cross-coupling led to an interesting result. The desired 
cross-coupled product was not obtained under any set of reaction conditions tested; 
however, low yields of the oxidized ketone of the expected product were obtained. 
Because of the high temperatures and three equivalents of base required for the Suzuki 
coupling, the carbamate protecting group was cleaved under the reaction conditions, 
resulting in a palladium-mediated oxidation of the secondary alcohol to the 
corresponding ketone. The mechanism to this oxidized product was envisioned to be via 
deprotonation of the deprotected alcohol followed by coordination to form an 
alkoxypalladium species, which undergoes subsequent β-hydride elimination to form the 
ketone (Scheme 2.17). 
Scheme 2.17. Formation of Oxidized Ketone Product 
 
 A palladium-mediated oxidation of secondary alcohols in the presence of aryl 
chlorides has been reported in the literature.
59
 The proposed route to oxidation of the 
deprotected secondary alcohol was confirmed by subjecting an authentic sample of the 
alcohol to the initially developed reaction conditions (Eq 2.28). 
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Equation 2.28 
 
 As the carbamate was deprotected under the reaction conditions tested, it was 
evident that a different protecting group would need to be employed for a successful 
cross-coupling reaction. Prior research on the cross-coupling of alkyltrifluoroborates with 
aryl bromides showed that a terminal pivalate protected alcohol was not be deprotected 
under the reaction conditions of 10:1 toluene/H2O with Pd(OAc)2, RuPhos, and K2CO3 as 
base (Eq 2.29).
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Equation 2.29 
 
 Based on this precedence, a pivalate protected 1-(alkoxy)alkyltrifluoroborate 
(2.25) was synthesized and was screened as the nucleophilic partner with 4-chloroanisole 
(Eq 2.27). Attempts to couple this trifluoroborate were unsuccessful, presumably owing 
to deprotection and oxidation as observed for the carbamate. Based on these results, it 
was clear that carbonyl-containing protecting groups were not suitable stabilizing groups 
to perform the desired transformation because of their facile hydrolysis under the reaction 
conditions. 
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2.7 Synthesis of Potassium 1-(Benzyloxy)alkyltrifluoroborates and High-
Throughput Experimentation 
As carbonyl-containing protecting groups were no longer a viable option, a new 
protecting group was required to serve as a stabilizing group. Therefore, attention was 
turned to the installation of a benzyl group, where the aryl ring could coordinate to the 
diorganopalladium intermediate to prevent β-hydride elimination (Figure 2.3). Prior 
reports have shown that aromatic rings are able to coordinate to palladium through an 
ipso-carbon or η
2
-binding mode.
61
 Fu reported the nickel-catalyzed coupling of 
homobenzylic bromides with alkyl 9-BBN reagents, where the high levels of 
enantiomeric excess achieved were because of a secondary interaction between the 
benzyl substituent and the diorganonickel intermediate (Eq 2.18).
41
 Also, the benzyloxy 
group is inductively electron-withdrawing, which should help disfavor β-hydride 
elimination. 
 
Figure 2.3. Proposed Coordination From the Benzyl Stabilizing Group 
 
Potassium 1-(benzyloxy)-3-phenylpropyltrifluoroborate was synthesized via the 
addition of KH and benzyl bromide to potassium 1-(hydroxy)-3-
phenylpropyltrifluoroborate in THF at 50 °C overnight. Initial efforts to cross-couple this 
trifluoroborate with 4-chloroanisole were promising, which provided evidence of the 
desired stabilization from the benzyl protecting group to prevent β-hydride elimination. 
Therefore, an array of potassium 1-(arylmethyleneoxy)- and 1-
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(heteroarylmethyleneoxy)alkyltrifluoroborates were prepared (Table 2.3). Potassium 1-
(arylmethyleneoxy)alkyltrifluoroborates with electron-withdrawing (entries 2-3, 9) and 
electron-donating (entries 5-8) substituents were obtained in high yields. Substitution 
ortho-, meta-, and para did not affect the synthesis as the corresponding trifluoroborates 
were isolated in high yield. A para-methoxybenzyl (PMB) protected group could also be 
installed through this method in 90% yield (entry 7). Heteroaryl-containing 
trifluoroborates were obtained in modest yields (entries 10-11). The preparation of 1-
(alkoxy)alkyltrifluoroborates was extended to include allyl and methyl ethers, which 
were prepared in yields of 92% and 94%, respectively (entries 12-13). 
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Table 2.3. Preparation of Potassium 1-(Alkoxy)alkyltrifluoroborates 
 
 Optimization of cross-coupling of potassium 1-(benzyloxy)-3-
phenylpropyltrifluoroborate with 4-chloroanisole was optimized by high-throughput 
experimentation (HTE) (Eq 2.30).
62
 The results were analyzed by HPLC after addition of 
an internal standard (10 mol % of 4,4’-di-tert-butylbiphenyl). The product-to-internal 
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standard (P/IS) and starting material-to-internal standard (SM/IS) ratios were calculated 
to determine the conversion and product formation in each microscale reaction. 
Equation 2.30 
 
 HTE has become valuable tool to accelerate the development of new methods by 
allowing rapid, microscale reaction optimization.
63
 HTE allows 24 or 96 reactions to be 
completed in parallel on a 10 µmol scale over a wide variety of reaction conditions as it is 
possible to vary the palladium source, ligand, metal-to-ligand ratio, palladium loading, 
base (number of equivalents), solvent, co-solvent, and solvent ratio within one 96-well 
plate. Furthermore, performing the reactions on a 10 µmol scale allows smaller quantities 
of chemicals to be consumed during reaction optimization, generating exponentially less 
waste in the process. For example, one 96-well plate employing potassium 1-
(benzyloxy)-3-phenylpropyltrifluoroborate would only require ~320 mg, while the same 
reactions performed on a laboratory scale (0.1 mmol) require 3.2 g of material.  
 Several screens were performed to optimize the cross-coupling of potassium 1-
(benzyloxy)-3-phenylpropyltrifluoroborate with 4-chloroanisole, a few of which are 
detailed below. For each screen, the reactions were run for 24 h at either 105 or 110 °C. 
The first screen analyzed general reaction conditions to determine which type of solvent, 
co-solvent, ligand, and base would be best for the reaction. The ligands and co-solvents 
chosen were based on prior reports on the cross-couplings of secondary alkyl substrates 
as well as research that was being completed in the Molander laboratory at that time. 
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Therefore, a 96-well plate was designed to test four different ligands, four different bases, 
and six different solvents. The results of this screen can be seen in Figure 2.4. 
 
Figure 2.4. Graphical Summary of Screen 1. Reaction Conditions: 1.0 equiv of 2.24, 
1.0 equiv of 4-chloroanisole, 0.1 equiv of palladium, 3.0 equiv of Cs2CO3, 110 °C, 24 
h. t-amylOH = tert-amyl alcohol. CPME = cyclopentyl methyl ether. 
 
 Several conclusions about the cross-coupling reaction can be drawn based on the 
first screen. Based on the four ligand tested, cataCXium A [di-(1-adamantyl)-n-
butylphopsphine)] was the only ligand that provided the product with a P/IS ratio greater 
than 1. Both Cs2CO3 and K3PO4 performed much better than CsHCO3 and K2CO3. This 
screen also demonstrates the importance of water as a co-solvent for the coupling. When 
the co-solvent is changed to t-BuOH or tert-amyl alcohol, the product-to-internal 
standard ratio is decreased by about 75%. Based on these conclusions, a second screen 
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was designed to test an array of palladium sources and the ratio of co-solvent with 
cataCXium A as the ligand and both Cs2CO3 and K3PO4 as the bases. The results of this 
screen are displayed in Figure 2.5. 
 
Figure 2.5. Graphical Summary of Screen 2. Reaction Conditions: 1.0 equiv of 2.24, 
1.0 equiv of 4-chloroanisole, 0.1 equiv of palladium, 0.2 equiv of cataCXium A, 3.0 
equiv of base, 110 °C, 24 h. Pd G2 = cataCXium A-Pd-G2 (0.1 equiv). CPME = 
cyclopentyl methyl ether 
 
  The second screen demonstrates that the nature of the palladium precursor is 
important for the coupling. The palladium source resulting in the highest product-to-
internal standard ratio is cataCXium A-Pd-G2, the cataCXium A derivative of 
Buchwald’s second generation precatalyst
64
 (See Chapter 1, 1.X). cataCXium A-Pd-G2 
can be synthesized from the aminobiphenyl µ-Cl dimer in 92% isolated yield (Eq 2.31). 
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Equation 2.31 
 
 Analysis of the second screen reveals that a solvent ratio of 1:1 cyclopentyl 
methyl ether (CPME)/H2O is superior to 4:1 CPME/H2O, meaning that an increase in the 
amount of water in the reaction led to increased conversion to product. Subsequent 
screens were therefore focused on a 1:1 solvent/H2O ratio. The rate of cross-coupling 
relative to protodeboronation of the organotrifluoroborate is often increased with 
increasing the amount of water in the reaction.
65
 
 Up to this point, HTE had led to the discovery of the optimal palladium source, 
base, solvent, and co-solvent for the cross-coupling, with the ligand being the only 
variable left to be examined. Therefore, 48 different ligands were tested with 
[Pd(allyl)Cl]2 as the palladium source, 3.0 equiv of Cs2CO3, and a solvent system of 1:1 
THF/H2O at 110 °C. For those ligands which were also precatalysts, [Pd(allyl)Cl]2 was 
not added to the reaction. The results of this screen are depicted in Figure 2.6. 
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Figure 2.6. Graphical summary of Screen 3. Only the top ten ligands are shown. 
Reaction conditions: 1.0 equiv of 7a, 1.0 equiv of 4-chloroanisole, 0.1 equiv of 
palladium, 0.2 equiv of L, 3.0 equiv of Cs2CO3, 110 °C, 24 h. (Pd-L = L-Pd-G2). 
 
 The ligand screen confirmed that cataCXium A was the ideal ligand for the 
desired transformation. Although several other ligands provided product, only two 
reactions provided high levels of conversion and product formation. The top two hits 
from the screen both employed cataCXium A as the ligand. The top result utilized 
cataCXium A-Pd-G2, and the second hit employed [Pd(allyl)Cl]2 as the source of 
palladium. The HTE-aided optimization process provided the following conditions: a 1:1 
CPME/H2O solvent mixture with cataCXium A-Pd-G2 and Cs2CO3 at 105 °C. 
 These reaction conditions were applied to an array of aryl chlorides in yields up to 
75% (Table 2.4). An evaluation of the reaction after 24 h showed the low yields obtained 
were because of incomplete conversion of the starting materials. Therefore, optimization 
continued without increasing the reaction temperature and/or reaction time. Addition of a 
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stronger base in the reaction would help the conversion by facilitating hydrolysis and 
transmetalation of the trifluoroborate. Jutand
66
 and Hartwig
67
 have shown that hydroxide 
bases are the most effective for cross-couplings in which the transmetalation is the rate-
determining step as the higher concentration of hydroxide leads to the more reactive 
ArPd(OH)L complex, which undergoes transmetalation faster than the corresponding 
ArPd(X)L complex. Therefore, by simply changing the base from Cs2CO3 to CsOH•H2O, 
the yield of the reaction increased significantly.  
Table 2.4. Scope of the Cross-Coupling with Cs2CO3 as the Base 
 
To demonstrate the importance of CsOH•H2O for the cross-coupling reaction, a 
screen was designed to probe the amount and type of base by employing either 3.0 or 5.0 
equivalents of Cs2CO3 and CsOH•H2O. Additionally, the metal-to-ligand ratio was 
examined for two different palladium sources. 
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The results of this screen, as seen in Figure 2.7, confirmed the importance of the 
cataCXium A-Pd-G2 precatalyst, which led to the highest product-to-internal standard 
ratios independent of the nature and amount of base in the reaction. Also evident is that 
increasing the metal-to-ligand ratio by adding excess cataCXium A resulted in 
diminished conversion to the desired product. Of the two bases tested, CsOH•H2O 
performed better as 3.0 equiv of CsOH•H2O resulted in higher conversion to product than 
5.0 equiv of Cs2CO3. Increasing the equivalents of CsOH•H2O to 5.0 resulted in the 
highest conversion to product. Despite testing several ethereal solvents, all of which 
provide the desired product, the best solvent for the reaction was confirmed to be 
CPME/H2O. Therefore, by changing the base from Cs2CO3 to CsOH•H2O, the new 
optimized conditions were a 1:1 CPME/H2O solvent mixture, cataCXium A-Pd-G2 as the 
palladium source, CsOH•H2O as the base at 105 °C. 
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Figure 2.7. Graphical summary of Screen 4. Reaction conditions: 1.0 equiv of 7a, 1.0 
equiv of 4-chloroanisole, 0.075 equiv of palladium, 105 °C, 24 h. (A = [Pd(allyl)Cl]2 
with cataCXium A, B = cataCXium A-Pd-G2, 1:0/1:1/1:2 = palladium:ligand ratio). 
 
2.8 Cross-Coupling of Potassium 1-(Alkoxy)alkyltrifluoroborates with Aryl and 
Heteroaryl Chlorides 
 An array of aryl chlorides was subjected to the optimal reaction conditions to 
investigate the method fully (Table 2.5). Electron-poor (entries 1-6) and electron-rich 
(entries 7-20) aryl chlorides were successfully cross-coupled, providing the desired 
benzyl-protected secondary alcohols in yields up to 95%. Electron-withdrawing 
substituents can be present in the meta and para positions of the aryl chloride. A 3,5-
difluorosubstituted aryl chloride afforded the desired product in 74% yield. Methyl esters 
are not hydrolyzed to the corresponding acids under the reaction conditions when 
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changing the base to Cs2CO3 as the desired products are obtained in good yield (entries 4-
5). 2-, 3-, and 4-Chloroanisole/chlorotoluene are all suitable electrophiles for the reaction, 
demonstrating that electron donating groups can be substituted in any position around the 
ring. Several common functional function groups, including ketones (entry 6), 
carbamates (entry 11), and amines (entries 12-13) do not interfere with the cross-
coupling. Sterically hindered aryl chlorides were examined to determine the effect of 
mono or di-ortho-substituted aryl chlorides (entries 7, 15, 21, 22). The standard reaction 
conditions proved to be efficient for the coupling of o-methyl and o-methoxy substituted 
aryl chlorides; however, yields of the desired products were lowered when the aryl 
chloride was disubstituted in the ortho positions. The scalable nature of this cross-
coupling was demonstrated by performing the reaction on a 1 g scale by reducing the 
catalyst loading to 3.75%, providing the desired product in 79% yield (entry 9). 
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Table 2.5. Scope of the Cross-Coupling with Aryl Chlorides 
 
 The electrophilic compatibility was analyzed by subjecting potassium (1-
benzyloxy)-3-phenylpropyltrifluoroborate to the cross-coupling with a variety of 
electrophilic anisole derivatives (entry 9). 4-Bromo- and 4-iodoanisole were successful 
electrophiles under the standard reaction conditions providing, the desired product in 
yields of 60% and 35%, respectively. However, when 4-methoxyphenyl 
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methanesulfonate was employed as the electrophile, only unreacted starting material was 
detected after 24 h. 
 To expand the range of electrophiles, a variety of heteroaryl chlorides were 
subjected to the cross-coupling reaction (Table 2.6). Nitrogen-containing heterocycles 
proved to be efficient electrophiles as the desired products were isolated in yields up to 
89%. Substitution in the 2- or 4-position of 3-chloropyridine did not affect the cross-
coupling as the desired products were obtained in yields of 74% and 42%, respectively 
(entries 2-3). Chloroquinolines were successful electrophiles in the cross-coupling as 4-, 
6-, and 8-chloroquinoline afforded the cross-coupled products in yields up to 74% 
(entries 4-6). When the electrophile was 3-chlorothiophene, the product was prepared in a 
lower yield of 41% (entry 8). 
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Table 2.6. Scope of the Cross-Coupling with Heteroaryl Chlorides 
 
To prove that the cross-coupling reaction of the potassium 1-
(benzyloxy)alkyltrifluoroborates was not limited to the 3-phenylpropyl side chain, other 
potassium 1-(benzyloxy)alkyltrifluoroborates were synthesized under the same 
conditions to demonstrate the versatility of the method (Table 2.7). The benzyl protected 
trifluoroborates with various side chains were isolated in yields ranging from 52-96%. 
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Table 2.7. Preparation of Various Potassium 1-(Benzyloxy)alkyltrifluoroborates 
 
The newly synthesized potassium (1-benzyloxy)alkyltrifluoroborates were then 
subjected to the cross-coupling reaction with 4-chloroanisole as the electrophile (Table 
2.8). A straight chain alkyl group can be cross-coupled in 51% yield (entry 1). β-
Substitution on the side chain does not interfere with the coupling as the desired product 
is obtained in 95% yield (entry 3). However, a limitation on the method is that branching 
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α to the alkoxy group cannot be tolerated in the reaction. A protected diaryl methanol can 
be synthesized in 52% yield when changing the base to Cs2CO3 because the CsOH•H2O 
resulted primarily in protodeboronation of the trifluoroborate (entry 5). Other potassium 
(1-arylmethyleneoxy)alkyltrifluoroborates were subjected to the cross-coupling to 
confirm that substitution on the aryl ring did not interfere with the cross-coupling. 
Trifluoroborates with substitution on the benzyl group at the ortho-, meta-, and para- 
positions were successful nucleophiles, affording the desired product in yields up to 89% 
(entries 6-8). Although the currently developed method focuses on a benzyl protecting 
group, the PMB-protected organotrifluoroborate 2.33 was also a suitable stabilizing 
group, providing the desired product in high yield (entry 8). 
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Table 2.8. Scope of the Cross-Coupling with Various Potassium 1-
(Benzyloxy)alkyltrifluoroborates 
 
115 
 
The developed method was extended to include an intramolecular Suzuki-
Miyaura cross-coupling where the aryl chloride on the molecule serves as the 
electrophilic component and the trifluoroborate on the same molecule served as the 
nucleophilic component. If the aryl chloride is located on the benzyl group, a 1,3-
dihydroisobenzofuran derivative is synthesized in 80% yield through an unusual bond 
connection (Eq 2.32). 
Equation 2.32 
 
If the aryl chloride is located on the side chain of the 1-
(benzyloxy)alkyltrifluoroborate, the result of the intramolecular cross-coupling is a five 
membered carbocycle (Eq 2.33). This method to access cycloalkanol derivatives is 
complementary to that of intramolecular Barbier-type routes to the same class of 
molecules. 
Equation 2.33 
 
Regardless of the aryl halide or potassium 1-(alkoxy)alkyltrifluoroborate 
employed in the cross-coupling reaction, only 1.0 equiv of the trifluoroborate was 
engaged for each cross-coupling reaction. Therefore, the overall success of the coupling 
indicates that little to no protodeboronation is occurring under the reaction conditions.  
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Furthermore, the high yields of the secondary protected benzylic alcohols 
demonstrate the importance of the benzyl stabilizing group because the β-hydride 
elimination pathway is virtually nonexistent. To confirm the importance of the benzyl 
group on the success of the cross-coupling, potassium 1-(methoxy)-3-
phenylpropyltrifluoroborate was subjected to the cross-coupling with 4-chloroanisole (Eq 
2.34). After 24 h, only unreacted 4-chloroanisole was observed without any desired 
product, demonstrating the significant role the benzyl group is serving as a hemilabile 
ligand to stabilize the diorganopalladium intermediate and disfavor β-hydride 
elimination. 
Equation 2.34 
 
To validate the method as a means to synthesize secondary alcohols, the benzylic 
protecting group would need to be removed. The product of the cross-coupling contains 
both a primary and secondary benzylic ether, and deprotection of the primary ether has 
precedence in the literature.
68
 Therefore, deprotection via 10 mol % Pd/C in ethanol 
under an atmosphere of H2 provides clean conversion to the desired secondary alcohol in 
an unoptimized 79% yield (Eq 2.35). 
Equation 2.35 
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2.9 Stereospecificity in Secondary Alkyl Cross-Coupling Reactions 
 The importance of the cross-coupling method developed for the synthesis of 
secondary benzylic alcohols stems from the ability to employ configurationally stable and 
storable organoboron reagents, thereby allowing a complementary bond connection to 
those normally employed. Because a stereocenter is generated in the cross-coupling, it 
was important to determine the stereospecificity of the reaction. The stereochemical 
determining step in the cross-coupling of alkylboron species is the transmetalation. 
Woerpel
69
 and Soderquist
70
 reported simultaneously that the Suzuki coupling of primary 
alkylboranes proceeds with retention of configuration at the carbon atom. Woerpel 
demonstrated that the hydroboration of a deuterated alkene followed by its subsequent 
cross-coupling with an alkenyl iodide resulted in retention of configuration at the carbon 
atom (Eq 2.36-2.37). Because hydroboration is a syn process and reductive elimination 
occurs with retention of configuration, Woerpel concluded that transmetalation must 
occur with retention of configuration.
69
 
Equation 2.36 
 
Equation 2.37 
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Soderquist performed a similar study with a different deuterated alkene and 
coupled the alkylborane with bromobenzene instead of an alkenyl iodide. In each of the 
studies, the cross-coupled products were obtained with complete retention of 
configuration at the reacting carbon. Soderquist proposed that the transmetalation 
proceeds through a Ar-Pd-O-BR2R’ complex, which is formed by coordination of a 
hydroxyborate to palladium or by coordination of a palladium hydroxide to the borane. 
Transmetalation then proceeds through a four-membered transition structure to form the 
diorganopalladium complex, followed by reductive elimination to form the product 
(Scheme 2.18).
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Scheme 2.18. Proposed Four-Centered Transition Structure 
 
 The cross-coupling of secondary benzylic systems was reported by Crudden to 
proceed with retention of configuration.
71
 The enantioenriched substrate was prepared 
through a rhodium-catalyzed asymmetric hydroboration of styrene. The cross-coupling 
with aryl iodides to form enantioenriched diarylethanes proceeded with yields up to 64% 
and stereoretentions of 84-94%. Substitution on the aryl iodide did not affect the 
stereospecificity as the transmetalation occurs through a four-membered transition 
structure resulting in retention of configuration (Scheme 2.19). 
Scheme 2.19. Crudden's Stereospecific Suzuki-Miyaura Cross-Coupling 
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 Suginome reported the stereospecific cross-coupling of α-
(acylamino)benzylboronic esters to proceed with complete inversion of configuration 
(Scheme 2.20).
72
 Suginome proposed a strong intramolecular coordination of the 
carbonyl group of the amide to boron, which occupies the vacant orbital on boron. This 
coordination prevents formation of a four-membered transition structure. Therefore, 
backside attack of the palladium complex on the benzylic carbon atom is the preferred 
pathway, resulting in inversion of configuration. 
Scheme 2.20. Suginome's Stereospecific Suzuki-Miyaura Cross-Coupling 
 
 Shortly thereafter, Molander published the stereospecific cross-coupling of 
potassium β-trifluoroboratoamides, which also occurs with complete inversion of 
configuration (Scheme 2.21).
55
 Because the carbonyl of the amide can coordinate to the 
intermediate boronate species after hydrolysis of the trifluoroborate, the transmetalation 
does not occur through the traditional four-centered transition structure, but rather 
proceeds through an SE2 mechanism via an open transition state, in which the boron 
center undergoes electrophilic attack of the L(Ar)PdY species. 
Scheme 2.21. Molander's Stereospecific Suzuki-Miyaura Cross-Coupling 
  
Tetracoordinate boron “ate” complexes that react with soft electrophiles, such as 
I2 and Br2, with inversion of configuration through SE2-type reaction pathways have been 
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previously reported in the literature.
73
 Kabalka reported that the reaction between an 
enantioenriched trialkylborane and ICl proceeds with inversion of configuration (Eq 
2.38).
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Equation 2.38 
 
Aggarwal later showed that the reaction between tetracoordinate boronate complexes 
formed from the addition of an aryllithium to a pinacol boronate ester react with soft 
electrophiles with inversion of configuration (Eq 2.39).
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Equation 2.39 
 
 To determine the effect of a carbonyl stabilizing group on the stereospecificity of 
the cross-coupling reaction, Suginome studied the effect of Lewis acid additives.
76
 The 
addition of a Lewis acid was discovered to reverse the stereospecificity such that addition 
of 0.5 equiv of Zr(Oi-Pr)4-iPrOH resulted in retention of configuration. Upon addition of 
the Lewis acid, the intramolecular coordination between the carbonyl and the vacant 
orbital on boron is inhibited because the carbonyl coordinates preferentially to the Lewis 
acid. The resultant tricoordinate boron species then undergoes transmetalation via a four-
membered transition state, leading to retention of configuration. The mechanism for the 
transmetalation is through an electrophilic attack on the palladium atom from the same 
side as the boron atom (Scheme 2.22). 
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Scheme 2.22. Effect of Lewis Acid Additives on the Stereospecific Cross-Coupling 
 
 The stereospecificity of the cross-coupling of a secondary alkyl boronate is 
therefore dependent on the presence or absence of a strongly coordinating group. If a 
strongly coordinating group is present on the nucleophile, the vacant orbital on boron will 
be sufficiently filled through intramolecular coordination. Therefore, the transmetalation 
will proceed with inversion of configuration, as evident by Suginome
72,76
 and 
Molander.
55
 However, in the absence of a strongly coordinating group, such as in the 
work of Crudden
71
 and the original reports by Woerpel
69
 and Soderquist,
70
 the 
transmetalation proceeds with retention of configuration. The addition of an additive to 
disrupt the intramolecular coordination of the strongly coordinating group will also lead 
to transmetalation proceeding with retention of configuration. 
2.10 Synthesis and Cross-Coupling of an Enantioenriched Potassium 1-
(Benzyloxy)alkyltrifluoroborate 
 To determine the stereospecificity of the cross-coupling reaction, an 
enantiomerically enriched 1-(benzyloxy)trifluoroborate needed to be synthesized. As the 
diboration resulted in a racemic trifluoroborate, another route was required. Therefore, 
(S)-1-(benzyloxy)-3-phenylpropyltrifluoroborate was synthesized through Matteson 
homologation chemistry (Scheme 2.23).
77
 Homologation of the (S,S)-DICHED 
phenethylboronate with in situ generated chloromethyllithium followed by displacement 
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with in situ formed LiOBn
78
 led to the enantioenriched boronate 2.94 in high yield and 
enantiomeric excess. Conversion to the corresponding trifluoroborate was achieved by 
addition of KHF2 in MeCN/H2O. The enantiomeric ratios of the enantioenriched 
boronates were determined by SFC analysis. 
Scheme 2.23. Synthesis of Enantioenriched Potassium (S)-1-(Benzyloxy)-3-
phenylpropyltrifluoroborate 
 
The high levels of asymmetric induction achieved in the Matteson homologation 
are attributed to the addition of ZnCl2 to serve as a Lewis acid. The zinc cation 
complexes one of the boronate ester oxygen atoms to facilitate the displacement of the 
chloride ion (Scheme 2.24).
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Scheme 2.24. Explanation for the Diastereoselectivity in the Matteson Homologation 
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The enantioenriched trifluoroborate 2.97 was subjected to the standard reaction 
conditions with 4-chloroanisole as the electrophile. Examination of the product by SFC 
analysis revealed that the cross-coupling proceeded with complete stereospecificity and 
retention of configuration (Eq 2.40). 
Equation 2.40 
 
The other enantiomer of 2.97 was synthesized through the same synthetic 
pathway but starting from the (R,R)-DICHED phenethylboronate. The two 
enantioenriched organotrifluoroborates were tested as nucleophiles under the standard 
cross-coupling conditions with an array of aryl and heteroaryl chlorides to determine the 
effect of the electrophile on the enantiospecificity of the coupling (Table 2.9). Little to no 
erosion of enantiomeric excess is observed based on the aryl halide as both electron-poor 
(entries 1-2, 5-6) and electron-rich (entries 3, 7) can be obtained with high levels of 
enantiomeric excess. Isomeric chloropyridines were coupled under the standard 
conditions with little, if any, loss of enantiomeric excess as well (entries 4, 8). The 
couplings are presumed to occur with complete retention of chemistry. 
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Table 2.9. Scope of the Cross-Coupling with Enantioenriched 2.96 with Aryl and 
Heteroaryl Chlorides 
 
As mentioned previously, the stereospecificity of the cross-coupling of secondary 
alkyl boronates is determined by the presence or absence of a strongly coordinating 
group. If such a group is present, coordination to boron is prevented transmetalation from 
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occurring through a standard four-membered transition structure. As the benzyl 
protecting group is not strongly coordinating, meaning that the π-bonds of the arene will 
not coordinate to the empty orbital on boron, the transmetalation will proceed through a 
standard four-membered transition structure, resulting in complete retention of 
configuration (Scheme 2.25). 
Scheme 2.25. Explanation for the Stereospecificity of the Cross-Coupling 
 
The method developed proceeds with near complete stereospecificity, allowing an 
efficient and facile synthesis of protected secondary benzylic alcohols through a cross-
coupling reaction. The enantioenriched potassium 1-(benzyloxy)alkyltrifluoroborates 
serve as metal-centered “stereocenters in a bottle,” meaning they are enantioenriched, 
configurationally stable nucleophiles that could be stored indefinitely on the benchtop, 
allowing the installation of a defined stereocenter though a cross-coupling reaction, 
independent of the nature of the electrophilic partner. 
2.11 Conclusion 
 Utilizing a copper-catalyzed diboration of aldehydes, potassium 1-
(hydroxy)alkyltrifluoroborates have been synthesized in high yield. These air- and 
moisture-stable trifluoroborates were converted to a variety of potassium 1-(acyloxy)- 
and 1-(alkoxy)alkyltrifluoroborates. The potassium 1-(benzyloxy)alkyltrifluoroborates 
serve as nucleophilic partners in the Suzuki-Miyaura reaction with an array of aryl and 
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heteroaryl chlorides, providing access to protected secondary alcohols in high yield. The 
paradigm of installing a stabilizing group on the nucleophilic species in a cross-coupling 
reaction is extended to include a benzyl protecting group, which prevents β-hydride 
elimination by coordinating to the diorganopalladium intermediate, lowering the electron 
deficiency of the metal center Furthermore, the cross-coupling is stereospecific with 
complete retention of stereochemistry, allowing a stoichiometric amount of 
enantioenriched trifluoroborates to be employed with virtually no loss of enantiomeric 
excess. The developed method allows the direction installation of a protected secondary 
alcohol through a Suzuki-Miyaura reaction. 
2.11 Experimental 
General Considerations. All commercially obtained reagents were used as received, 
except aldehydes, which were distilled prior to use. Both solvents and deionized water 
were degassed with Ar each time prior to use. Standard benchtop techniques were 
employed for handling air-sensitive reagents. Melting points (°C) are uncorrected. NMR 
spectra were recorded on a 500 or 400 MHz spectrometer. 
19
F NMR chemical shifts were 
referenced to external CFCl3 (0.0 ppm). 
11
B NMR spectra were obtained on a 
spectrometer equipped with the appropriate decoupling accessories. All 
11
B NMR 
chemical shifts were referenced to an external BF3·OEt2 (0.0 ppm) with a negative sign 
indicating an upfield shift. Data are presented as follows: chemical shift (ppm), 
multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet, br = broad), coupling 
constant J (Hz) and integration. Analytical thin-layer chromatography (TLC) was 
performed on TLC silica gel plates (0.25 mm) precoated with a fluorescent indicator. 
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Standard flash chromatography procedures were followed using 32–63 μm silica gel or 
Florisil. Visualization was effected with ultraviolet light or Cerium Ammonium 
Molybdate (CAM) stain.  
 
ICyCuCl was synthesized according to the literature
29,31
. 
 
General Procedure for the Synthesis of Potassium 1-(Hydroxy)alkyltrifluoroborates. 
In the glovebox, ICyCuCl (0.03 mmol, 1.5 mol %) and NaOt-Bu (0.06 mmol, 3 mol %) 
were added to a flame-dried Biotage microwave vial with stir bar. Anhyd toluene (0.25 
mL) was added, and the reaction was stirred for 5 min. Bis(pinacolato)diboron (2 mmol, 
1 equiv) was added followed by toluene (1.75 mL). The vial was capped, removed from 
the glovebox, and stirred under Ar for 10 min. Aldehyde (2 mmol, 1 equiv) was added 
dropwise followed by anhyd MeOH (4 mmol, 2 equiv). The reaction stirred at rt for 1.5 h, 
after which it was poured onto cold MeOH (10 mL) and then cooled to 0 °C. 4.5 M aq 
KHF2 (16 mmol, 8 equiv) was added dropwise. After stirring the reaction at rt until 
complete by 
11
B NMR (about 10 min), the solvents were removed under reduced pressure 
(toluene was used to azeotrope both H2O and pinacol). The desired trifluoroborate was 
purified via Soxhlet extraction with acetone (75 mL), concentrating to a minimal amount 
(~ 5 mL), and precipitating with 1:1 Et2O/hexanes (20 mL). 
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Potassium 1-(hydroxy)-3-phenylpropyltrifluoroborate (2.4). Obtained as a white solid 
(474 mg, 98%). mp: 199-201 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.22-7.17 (m, 4H, 
ArCH), 7.09-7.06 (m, 1H, ArCH), 3.00-2.97 (m, 1H, C-H), 2.84-2.76 (m, 1H, C-H), 2.69 
(br s, 1H, OH), 2.56 (ddd, J = 13.4, 10.6, 6.2 Hz, 2H, CH2), 1.83-1.75 (m, 1H, CH2), 
1.75-1.67 (m, 1H, CH2). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 144.9, 128.9, 128.6, 
125.6, 37.3, 33.8. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.86 (br). 
19
F NMR (DMSO-
d6, 338.8 MHz): δ = -151.5. IR: ν = 3404, 2924, 2362, 1106, 957, 934, 702 cm
-1
. HRMS 
(ESI) m/z calc. for C9H11BOF3 (M-K) 203.0855, found 203.0861. 
 
Potassium 1-(hydroxy)-2-ethylbutyltrifluoroborate (2.5). Obtained as a white solid 
(370 mg, 89%). mp: 231-233 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 2.91 (s, 1H, OH), 
1.66-1.59 (m, 1H, B-C-H), 1.52-1.45 (m, 1H, C-H), 1.31-1.24 (m, 4H, CH2), 0.86-0.80 
(m, 6H, CH3). 
13
C NMR (acetone-d6, 125.8 MHz): δ = 45.0, 22.2, 22.0, 11.8, 11.3. 
11
B 
NMR (acetone -d6, 128.38 MHz): δ = 4.61 (br). 
19
F NMR (acetone -d6, 338.8 MHz): δ = -
146.5. IR: ν = 3564, 2964, 1128, 978, 914 cm
-1
. HRMS (ESI) m/z calc. for C6H13BOF3 
(M-K) 169.1012, found 169.1020. 
 
Potassium 1-(hydroxy)-1-methylethyltrifluoroborate (2.6). Obtained as a white solid 
(127 mg, 42%). mp: 212-214 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 2.71 (s, 1H, OH), 
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2.25-2.22 (m, 1H, C-H), 0.90-0.81 (m, 3H, CH3). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 
20.88. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 1.81 (m). 
19
F NMR (DMSO-d6, 338.8 
MHz): δ = -148.3. IR: ν = 3428, 2958, 2360, 1009, 914 cm
-1
. HRMS (ESI) m/z calc. for 
C2H5BOF3 (M-K) 113.0386, found 113.0382. 
 
Potassium 1-(hydroxy)-2,2-dimethylpropyltrifluoroborate (2.7). Obtained as a white 
solid (372 mg, 96%). mp: >250 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 2.26 (s, 1H, 
OH), 1.79 (s, 1H, C-H), 0.80 (s, 9H, CH3). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 34.5, 
28.3. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.66 (m). 
19
F NMR (DMSO-d6, 338.8 
MHz): δ = -140.3. IR: ν = 3584, 2953, 2361, 1099, 964, 722 cm
-1
. HRMS (ESI) m/z calc. 
for C5H11BOF3 (M-K) 155.0855, found 155.0848. 
 
Potassium 1-(hydroxy)-2-methylpropyltrifluoroborate (2.8) Obtained as a white solid 
(923 mg, 74%). mp: 240-241 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 2.31 (s, 1H, OH), 
1.89-.85 m, 1H, C-H), 0.82-0.77 (m, 6H, CH3). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 
31.8, 21.2, 20.5. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.76 (m). 
19
F NMR (DMSO-d6, 
338.8 MHz): δ = -143.6. IR: ν = 3585, 2956, 1467, 970, 927, 723 cm
-1
. HRMS (ESI) m/z 
calc. for C4H9BOF3 (M-K) 141.0699, found 141.0701. 
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Potassium (1-hydroxyundec-10-en-1-yl)trifluoroborate (2.9). Obtained as a white 
solid (601 mg, 61%). mp: 214-215 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 5.77-5.74 
(m, 1H, =C-H), 4.99-4.90 (m, 2H, H2C=), 2.49-2.46 (m, 1H, C-H), 1.99-1.95 (m, 3H, 
OH, CH2), 1.34-1.28 (m, 3H, CH2), 1.22-1.16 (m, 11H, CH2). 
13
C NMR (DMSO-d6, 
125.8 MHz): δ = 139.5, 115.2, 34.9, 33.8, 30.4, 29.9, 29.6, 29.2, 28.9, 27.4. 
11
B NMR 
(DMSO-d6, 128.38 MHz): δ = 3.79 (br). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -146.9. 
IR: ν = 3584, 2922, 2360, 1641, 949, 915 cm
-1
. HRMS (ESI) m/z calc. for C11H21BOF3 
(M-K) 237.1638, found 237.1634. 
 
Potassium (Z)-(1-hydroxydec-7-en-1-yl)trifluoroborate (2.10). Obtained as a white 
solid (1005 mg, 79%). mp: >250 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 5.27-5.22 (m, 
2H, =C-H), 2.46-2.43 (m, 1H, C-H), 2.02 (s, 1H, OH), 1.94-1.91 (m, 4H, CH2), 1.34-1.31 
(m, 1H, CH2), 1.21-1.12 (m, 7H, CH2), 0.87-8.84 (m, 3H, CH3). 
13
C NMR (DMSO-d6, 
125.8 MHz): δ = 131.7, 129.8, 34.8, 30.0, 27.2, 20.6, 14.9. 
11
B NMR (DMSO-d6, 128.38 
MHz): δ = 3.47 (m). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -146.9. IR: ν = 3585, 2922, 
2360, 1642, 1084, 950, 914, 726 cm
-1
. HRMS (ESI) m/z calc. for C10H19BOF3 (M-K) 
233.1481, found 233.1488. 
 
Potassium 1-hydroxyoctyltrifluoroborate (2.11). Obtained as a white solid (1338 mg, 
79%). mp: > 250 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 2.62-2.55 (m, 1H, C-H), 1.37 
(s, 1H, OH), 1.28-1.16 (m, 12H, CH2), 0.87-0.84 (m, 3H, CH3). 
13
C NMR (DMSO-d6, 
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125.8 MHz): δ = 34.9, 32.1, 30.4, 29.6, 27.4, 22.8, 14.6. 
11
B NMR (DMSO-d6, 128.38 
MHz): δ = 3.62 (m). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -146.9. IR: ν = 3455, 2957, 
2922, 1466, 1091, 949, 733 cm
-1
. HRMS (ESI) m/z calc. for C8H17BOF3 (M-K) 
197.1325, found 197.1329. 
 
Potassium 4-(benzyloxy)-1-hydroxybutyltrifluoroborate (2.12). Obtained as a white 
solid (1505 mg, 94%). mp: 182-185 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.36-7.27 
(m, 4H, ArCH), 7.27-7.24 (m, 1H, ArCH), 4.46-4.39 (m, 2H, CH2), 3.44-3.35 (m, 2H, 
CH2), 2.64-2.59 (m, 1H, C-H), 2.30 (s, 1H, OH), 1.73-1.66 (m, 1H, CH2), 1.59-1.49 (m, 
1H, CH2), 1.42-1.35 (m, 1H, CH2), 1.30-1.23 (m, 1H, CH2). 
13
C NMR (DMSO-d6, 125.8 
MHz): δ = 139.3, 128.6, 127.7, 127.6, 72.1, 71.3, 31.1, 27.5. 
11
B NMR (DMSO-d6, 
128.38 MHz): δ = 3.47 (m). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -146.9. IR: ν = 3393, 
2929, 2856, 1071, 946, 733 cm
-1
. HRMS (ESI) m/z calc. for C11H15BO2F3 (M-K) 
247.1117, found 247.1117. 
 
Potassium (1-hydroxy)-2-phenylethyltrifluoroborate (2.13). Obtained as a white solid 
(1229 mg, 81%). mp: 248-249 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.19-7.12 (m, 
4H, ArCH), 7.12-7.05 (m, 1H, ArCH), 2.86-2.82 (m, 1H, C-H), 2.61 (d, J = 13.7 Hz, 1H, 
CH2), 2.41 (t, J = 12.5 Hz, 1H, CH2), 2.06 (s, 1H, OH). 
13
C NMR (DMSO-d6, 125.8 
MHz): δ = 144.7, 129.6, 128.1, 125.2, 41.1. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.39 
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(br). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -147.5. IR: ν = 3579, 2922, 1083, 949, 914, 
724 cm
-1
. HRMS (ESI) m/z calc. for C8H9BOF3 (M-K) 189.0699, found 189.0695. 
 
Potassium ((3-(2-chlorophenyl)-1-hydroxypropyl)trifluoroborate (2.14). Obtained as 
a white solid (571 mg, 87%). mp: 175-178 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 
7.31-7.29 (m, 2H, ArCH), 7.16-7.12 (m, 2H, ArCH), 2.99-2.97 (m, 2H, C-H and OH), 
2.75-2.72 (m, 2H, CH2), 1.80-1.72 (m, 1H, CH2), 1.70-1.64 (m, 1H, CH2). 
13
C NMR 
(acetone-d6, 125.8 MHz): δ = 141.2, 133.6, 130.9, 129.0, 126.9, 34.5, 31.0. 
11
B NMR 
(acetone-d6, 128.38 MHz): δ = 4.27 (m). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -150.4. 
IR: ν = 3585, 2923, 1083, 972, 928, 725 cm
-1
. HRMS (ESI) m/z calc. for C9H10ClBOF3 
(M-K) 237.0465, found 237.0469.  
 
Potassium 1-hydroxy-3-phenylbutyltrifluoroborate (2.15). Obtained as a white solid 
(1263 mg, 73%), Isolated as mixture of diastereomers. mp: 222-225 °C. 
1
H NMR 
(acetone-d6, 500 MHz): δ = 7.24-7.19 (m, 4H, ArCH), 7.11-7.07 (m, 1H, ArCH), 3.00-
2.98 (m, 2H, C-H and C-H), 2.67 (s, 1H, OH), 1.70-1.60 (m, 2H, CH2), 1.21-1.17 (m, 3H, 
CH3). 
13
C NMR (acetone-d6, 125.8 MHz): δ = 151.0, 149.4, 128.9, 128.8, 128.3, 127.9, 
126.1, 126.0, 43.8, 43.5, 37.2, 36.6, 24.0, 21.4. 
11
B NMR (acetone-d6, 128.38 MHz): δ = 
3.51 (m). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -147.4. IR: ν = 3576, 2927, 2852, 1107, 
942, 698 cm
-1
. HRMS (ESI) m/z calc. for C10H13BOF3 (M-K) 217.1012, found 217.1007. 
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Potassium 1-hydroxy-4-phenylbutyltrifluoroborate (2.16). Obtained as a white solid 
(1332 mg, 73%). mp: 229-231 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.27-7.20 (m, 
2H, ArCH), 7.20-7.09 (m, 3H, ArCH), 2.65-2.57 (m, 1H, C-H), 2.57-2.48 (m, 2H, CH2), 
2.13 (s, 1H, OH), 1.77-1.64 (m, 1H, CH2), 1.54-1.44 (m, 1H, CH2), 1.36-1.23 (m, 2H, 
CH2). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 143.8, 128.9, 128.7, 125.9, 36.6, 34.6, 
29.6. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.62 (m). 
19
F NMR (DMSO-d6, 338.8 
MHz): δ = -146.7. IR: ν = 3575, 2925, 2852, 1107, 942, 698 cm
-1
. HRMS (ESI) m/z calc. 
for C10H13BOF3 (M-K) 217.1012, found 217.1018. 
 
Potassium (1-hydroxy)-1-phenyltrifluoroborate (2.17). Obtained as a white solid (685 
mg, 34%). mp: 186-188 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.30-7.28 (m, 2H, 
ArCH), 7.12-7.09 (m, 2H, ArCH), 6.95-6.92 (m, 1H, ArCH), 4.03 (s, 1H, C-H), 2.83 (br 
s, 1H, OH). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 149.9, 126.6, 125.5, 123.2. 
11
B NMR 
(DMSO-d6, 128.38 MHz): δ = 4.0 (q). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -150.0. IR: 
ν = 3585, 2922, 2341, 1072, 966, 707 cm
-1
. HRMS (ESI) m/z calc. for C7H7BOF3 (M-K) 
175.0542, found 175.0540. 
 
Potassium 1-(hydroxy)-(4-methoxyphenyl)methyltrifluoroborate (2.18). Obtained as 
a white solid (244 mg, 50%). mp: 188-193 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.07 
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(d, J = 8.1 Hz, 2H, ArCH), 6.70 (d, J = 8.3 Hz, 2H, ArCH), 3.72 (s, 1H, C-H), 3.68 (s, 
3H, CH3), 2.93 (s, 1H, OH). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 156.4, 142.2, 126.9, 
112.6, 55.3. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 1.12 (br). 
19
F NMR (DMSO-d6, 
338.8 MHz): δ = -147.8. IR: ν = 3556, 2936, 1510, 968, 834, 706 cm
-1
. HRMS (ESI) m/z 
calc. for C8H9BO2F3 (M-K) 205.0648, found 205.0645. 
 
Potassium 1-(hydroxy)-(2,6-dimethylphenyl)methyltrifluoroborate (2.19). Obtained 
as a white solid (476 mg, 77%). mp: 162-163 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 
6.76-6.74 (m, 3H, Ar CH), 4.28 (s, 1H, C-H), 2.84 (s, 1H, OH), 2.29 (s, 6H, CH3). 
13
C 
NMR (DMSO-d6, 125.8 MHz): δ = 145.87, 136.0, 128.3, 123.8, 22.0. 
11
B NMR (DMSO-
d6, 128.38 MHz): δ = 4.85 (br). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -144.6. IR: ν = 
3552, 2935, 1095, 976, 833 cm
-1
. HRMS (ESI) m/z calc. for C9H11BOF3 (M-K) 
203.0855, found 203.0845. 
 
Potassium 1-(hydroxy)-1-(2-naphthyl)methyltrifluoroborate (2.20). Obtained as a 
white solid (502 mg, 95%). mp: 245-248 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.77 
(dd, J = 12.2, 8.3 Hz, 2H, ArCH), 7.67-7.64 (m, 2H, ArCH), 7.42-7.38 (m, 2H, ArCH), 
7.35-7.32 (m, 1H, ArCH), 3.97 (s, 1H, C-H), 3.2 (s, 1H, OH). 
13
C NMR (DMSO-d6, 
125.8 MHz): δ = 148.8, 133.7, 131.5, 128.8, 127.6, 126.8, 126.0, 125.6, 124.2, 122.4. 
11
B 
NMR (DMSO-d6, 128.38 MHz): δ = 3.92 (q). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -
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149.6. IR: ν = 3548, 2922, 1087, 985, 745 cm
-1
. HRMS (ESI) m/z calc. for C11H9BOF3 
(M-K) 225.0699, found 225.0709. 
 
Potassium 1-(hydroxy)-2-methyl-2-phenylethyltrifluoroborate (2.21). Obtained as a 
white solid (387 mg, 80%). mp: 200-201 °C. 
1
H NMR (DMSO-d6, 500 MHz): Major 
diastereomer: δ = 7.19-1.17 (m, 2H, ArCH), 7.16 (d, J = 6.8 Hz, 2H, ArCH), 7.03 (d, J = 
5.8 Hz, 1H, ArCH), 2.82-2.77 (m, 1H, C-H), 2.75-2.72 (m, 1H, C-H), 1.90 (s, 1H, OH), 
1.13 (d, J = 6.2 Hz, 3H, CH3) Minor diasteromer: δ = 7.19-1.17 (m, 2H, ArCH), 7.16 (d, 
J = 6.8 Hz, 2H, ArCH), 7.03 (d, J = 5.8 Hz, 1H, ArCH), 2.75-2.72 (m, 1H, C-H), 2.69-
2.64 (m, 1H, C-H), 1.63 (s, 1H, OH), 1.02 (d, J =6.0 Hz, 3H, CH3). 
13
C NMR (DMSO-d6, 
125.8 MHz): Major diasteromer: δ = 150.9, 128.4, 128.1, 125.2, 44.6, 20.3 Minor 
diastereomer: 150.1, 128.2, 128.0, 125.0, 42.4, 16.8. 
11
B NMR (DMSO-d6, 128.38 MHz): 
δ = 3.63 (br). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -144.3. IR: ν = 3558, 2923, 983, 
952, 699 cm
-1
. HRMS (ESI) m/z calc. for C9H11BOF3 (M-K) 203.0855, found 203.0848. 
 
Potassium ((3S)-1-hydroxy-3,7-dimethyloct-6-en-1-yl)trifluoroborate (2.22). 
Obtained as a white solid (1033 mg, 64%). mp: 234-238 °C. 
1
H NMR (acetone-d6, 500 
MHz): δ = 5.14-5.08 (m, 1H, C=C-H), 3.09-3.02 (m, 1H, C-H), 2.62 (br s, 1H, OH), 
1.95-1.85 (m, 1H, C-H), 1.64-1.52 (m, 8H, CH2/CH3), 1.37-1.28 (m, 1H, CH2), 1.16-
1.10 (m, 2H, CH2), 0.90 (m, 4H, CH2/CH3). 
13
C NMR (acetone-d6, 125.8 MHz): δ = 
129.7, 129.6, 125.5, 125.4, 41.6, 41.0, 38.7, 36.3, 25.6, 25.4, 25.0, 20.4, 18.2, 16.9. 
11
B 
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NMR (acetone-d6, 128.38 MHz): δ = 5.54 (br). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -
150.2. IR: ν = 3598, 2912, 2358, 1080, 923, 728 cm
-1
. HRMS (ESI) m/z calc. for 
C10H19BOF3 (M-K) 223.1481, found 223.1482. 
 
Potassium 1-(hydroxy)- ((S)-((R)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-
yl)(hydroxy)methyl)trifluoroborate (2.23). Obtained as a white solid (1 mmol scale, 
286 mg, 85%). mp: 210-212 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 4.00-3.97 (m, 1H, 
C-H), 3.72-3.70 (m, 2H, CH2), 3.17 (s, 1H, OH), 1.94 (d, J = 4.7 Hz, 1H, C-H), 1.41 (s, 
3H, CH3), 1.39 (s, 12H, CH3/tBu). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 92.3, 78.0, 
64.1, 61.4, 28.6, 26.2, 25.7, 24.5. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.21 (br). 
19
F 
NMR (DMSO-d6, 338.8 MHz): δ = -146.8. IR: ν = 3585, 2978, 1678, 1394, 1174, 1105, 
985, 953 cm
-1
. HRMS (ESI) m/z calc. for C11H20BNO4F3 (M-K) 298.1437, found 
298.1426. 
 
General Procedure for the Synthesis of Potassium α-(Alkoxy)alkyltrifluoroborates. 
KH (0.62 mmol, 1.5 equiv) was added to a Biotage microwave vial followed by anhyd 
THF (3 mL) and potassium 3-phenylpropyltrifluoroborate (0.412 mmol, 1 equiv). The 
desired electrophile was then added dropwise (0.62 mmol, 1.5 equiv), and the reaction 
was stirred at rt until complete by 
19
F NMR (5 - 18 h). MeOH (1 mL) was added 
dropwise followed by 4.5 M KHF2 (0.41 mmol, 1 equiv). The solvents were removed 
under reduced pressure, and the desired trifluoroborate was purified via Soxhlet 
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extraction withi-PrOAc (50 mL), concentrating to a minimal amount (~ 5 mL), and 
precipitating with hexanes (20 mL). 
 
Potassium 1-(benzoyloxy)-3-phenylpropyltrifluoroborate (2.24). Obtained as a white 
solid (124 mg, 87%). mp: 208-209 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.93-7.91 
(m, 2H, ArCH), 7.50 (m, 1H, ArCH), 7.48 (m, 1H, ArCH), 7.22 (t, J = 7.3 Hz, 2H), 7.14 
(d, J = 6.8 Hz, 3H), 4.47-4.43 (m, 1H, C-H), 2.58-2.55 (m, 2H, CH2), 1.85-1.80 (m, 2H, 
CH2). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 166.9, 143.8, 132.8, 132.6, 129.5, 128.9, 
128.8, 128.7, 125.9, 34.2, 33.6. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.19 (m). 
19
F 
NMR (DMSO-d6, 338.8 MHz): δ = -148.7. IR: ν = 2928, 1695, 1293, 1024, 712 cm
-1
. 
HRMS (ESI) m/z calc. for C16H15BO2F3 (M-K) 307.1117, found 307.1115. 
 
Potassium 1-(pivaloyloxy)-3-phenylpropyltrifluoroborate (2.25). Obtained as a white 
solid (116 mg, 86%). mp: 191-193 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.27-7.24 
(m, 2H, ArCH), 7.09 (d, J = 7.1 Hz, 3H, ArCH), 4.18-4.14 (m, 1H, C-H), 2.55-2.49 (m, 
1H, CH2), 2.43-2.37 (m, 1H, CH2), 1.68-1.63 (m, 2H, CH2), 1.10 (s, 9H, tBu). 
13
C NMR 
(DMSO-d6, 125.8 MHz): δ = 178.2, 144.0, 128.8, 128.7, 125.8, 38.8, 34.4, 33.5, 28.0. 
11
B 
NMR (DMSO-d6, 128.38 MHz): δ = 3.04 (br). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -
148.7. IR: ν = 2981, 1683, 1195, 996, 939, 745, 700 cm
-1
. HRMS (ESI) m/z calc. for 
C14H19BO2F3 (M-K) 287.1430, found 287.1428. 
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Potassium 1-(N,N-diisopropylcarbamoyl)-3-phenylpropyltrifluoroborate (2.2). 
Obtained as a white solid (89 mg, 95%). mp: 223-224 °C. 
1
H NMR (CD3CN, 500 MHz): 
δ = 7.23-7.20 (m, 2H, ArCH), 7.10 (d, J = 7.1 Hz, 3H, ArCH), 4.04 (m, 1H, C-H), 4.00-
3.56 (br s, 2H, iPr C-H), 2.55-2.50 (m, 1H, CH2), 2.50-2.48 (m, 1H, CH2), 1.69-1.67 (m, 
2H, CH2), 1.14 (s, 12H, CH3). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 156.8, 143.9, 
128.1, 125.1, 44.6, 34.5, 33.0, 21.0. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 2.75 (br). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -145.0. 
IR: ν = 2972, 2938, 1651, 1442, 1304, 1000, 697 cm
-1
. HRMS (ESI) m/z calc. for 
C16H24BNOF3 (M-K) 330.1852, found 330.1866. 
 
Potassium 1-(acetyloxy)-3-phenylpropyltrifluoroborate (2.26). Obtained as a white 
solid (108 mg, 92%). mp: 114-116 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.23-7.20 
(m, 2H, ArCH), 7.18-7.16 (m, 2H, ArCH), 7.13-7.09 (m, 1H, ArCH), 4.34-4.29 (m, 1H, 
C-H), 2.68-2.60 (m, 1H, CH2), 2.56-2.50 (m, 1H, CH2), 1.90 (s, 3H, CH3), 1.86-1.80 (m, 
2H, CH2). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 171.2, 144.0, 128.8, 128.7, 125.8, 34.1, 
33.6, 22.1. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 2.43 (m). 
19
F NMR (DMSO-d6, 
338.8 MHz): δ = -148.9. IR: ν = 3020, 1702, 1278, 976, 754, 701 cm
-1
. HRMS (ESI) m/z 
calc. for C11H13BO2F3 (M-K) 245.0961, found 245.0962. 
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General Procedure for the Synthesis of Potassium 1-(Benzyloxy)trifluoroborates. 
KH (0.62 mmol, 1.5 equiv) was added to a Biotage microwave vial followed by anhyd 
THF (3 mL) and potassium 3-phenylpropyltrifluoroborate (0.412 mmol, 1 equiv). The 
desired electrophile was then added dropwise (0.62 mmol, 1.5 equiv), and the reaction 
was stirred at 50 °C until complete by 
19
F NMR (overnight). After cooling to rt, MeOH 
(1 mL) was added dropwise followed by 4.5 M KHF2 (0.41 mmol, 1 equiv). The solvents 
were removed under reduced pressure, and the desired trifluoroborate was purified via 
Soxhlet extraction with i-PrOAc (50 mL), concentrating to a minimal amount (~5 mL), 
and precipitating with hexanes (20 mL). 
 
Potassium 1-(benzyloxy)-3-phenylpropyltrifluoroborate (2.27). Obtained as a white 
solid (133 mg, 97%). mp: 125-127 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.41-7.40 
(m, 2H, ArCH), 7.30-7.27 (m, 2H, ArCH), 7.23-7.17 (m, 5H, ArCH), 7.10-7.08 (m, 1H, 
ArCH), 4.56 (dd, J = 20, 45 Hz, 2H, OCH2), 2.83-2.78 (m, 2H, C-H, CH2), 2.70-2.64 (m, 
1H, CH2), 1.90-1.80 (m, 2H, CH2). 
13
C NMR (CD3CN, 125.8 MHz): δ = 144.8, 142.3, 
128.9, 128.6, 128.4, 127.7, 127.0, 125.6, 70.1, 34.4, 33.8. 
11
B NMR (acetone-d6, 128.38 
MHz): δ = 3.8 (m). 
19
F NMR (acetone -d6, 338.8 MHz): δ = -146.5. IR: ν = 3027, 2856, 
1044, 1003, 929, 700 cm
-1
. HRMS (ESI) m/z calc. for C16H17BO2F3 (M-K) 293.1325, 
found 293.1338. 
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Potassium 1-(4-trifluoromethylbenzyloxy)-3-phenylpropyltrifluoroborate (2.28). 
Obtained as a white solid (140 mg, 85%). mp: 106-108 °C. 
1
H NMR (DMSO-d6, 500 
MHz): δ =  7.69-7.62 (m, 2H, ArCH), 7.58-7.53 (m, 2H, ArCH), 7.25-7.19 (m, 2H, 
ArCH), 7.14-7.08 (m, 3H, ArCH), 4.67-4.59 (m, 1H, OCH2), 4.49-4.42 (m, 1H, OCH2), 
2.75-2.69 (m, 1H, CH2), 2.60-2.55 (m, 2H, CH2), 1.72-1.65 (m, 2H, CH2). 
13
C NMR 
(DMSO-d6, 125.8 MHz): δ = 162.0, 144.2, 137.8, 129.9 (d, J = 25 Hz), 128.0, 125.0, 
114.6, 114.4, 69.6, 33.7, 33.1. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.60 (br). 
19
F 
NMR (DMSO-d6, 338.8 MHz): δ = -142.8, -60.1. IR: ν = 2929, 2361, 1326, 1122, 1066, 
824 cm
-1
. HRMS (ESI) m/z calc. for C17H16BOF6 (M-K) 361.1198, found 361.1189. 
 
Potassium 1-(4-fluorobenzyloxy)-3-phenylpropyltrifluoroborate (2.29). Obtained as a 
white solid (111 mg, 77%). mp: 170-172 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.43-
7.40 (m, 2H, ArCH), 7.22-7.17 (m, 5H, ArCH), 7.10-7.09 (m, 1H, ArCH), 7.07-7.01 (m, 
2H, ArCH), 4.57-4.55 (m, 1H, OCH2), 4.52-4.49 (m, 1H, OCH2), 2.67-2.70 (m, 1H, 
CH2), 2.66-2.61 (m, 1H, CH2), 1.88-1.79 (m, 2H, CH2). 
13
C NMR (CD3CN-d6, 125.8 
MHz): δ = 145.5, 138.0, 130.5 (d, J = 25 Hz), 129.5, 129.2, 126.2, 115.8, 115.6, 71.3, 
34.0, 33.9. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.82 (br). 
19
F NMR (DMSO-d6, 
338.8 MHz): δ = -142.7, -116.8. IR: ν = 2859, 1602, 1508, 1223, 931, 826, 701 cm
-1
. 
HRMS (ESI) m/z calc. for C16H16BOF4 (M-K) 311.1230, found 311.1219. 
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Potassium 1-(naphthalen-2-ylmethoxy)-3-phenylpropyltrifluoroborate (2.30). 
Obtained as a white solid (133 mg, 84%). mp: 160-163 °C. 
1
H NMR (acetone-d6, 500 
MHz): δ = 7.92-7.84 (m, 4H, ArCH), 7.58-7.57 (m, 1H, ArCH), 7.48-7.43 (m, 2H, 
ArCH), 7.22-7.17 (m, 4H, ArCH), 7.09-7.08 (m, 1H, ArCH), 4.81-4.70 (m, 2H, OCH2), 
2.87-2.83 (m, 1H, CH2), 2.74-2.69 (m, 1H, CH2), 1.93-1.87 (m, 2H, CH2). 
13
C NMR 
(acetone-d6, 125.8 MHz): δ =145.4, 139.6, 133.7, 129.3, 128.8, 128.7, 128.5, 128.4, 
127.2, 126.7, 126.6, 125.8, 72.1, 34.0, 33.9. 
11
B NMR (acetone-d6, 128.38 MHz): δ = 
3.92 (br). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -146.8. IR: ν = 2861, 2360, 1042, 950, 
820, 754 cm
-1
. HRMS (ESI) m/z calc. for C20H19BOF3 (M-K) 343.1481, found 343.1479. 
 
Potassium 1-(4-isopropylbenzyloxy)-3-phenylpropyltrifluoroborate (2.31). Obtained 
as a white solid (143 mg, 93%). mp: 172-174 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 
7.24-7.21 (m, 4H, ArCH), 7.20-7.18 (m, 2H, ArCH), 7.17-7.09 (m, 3H, ArCH), 4.48 (d, J 
= 10 Hz, 1H, OCH2), 4.30 (d, J = 10 Hz, 1H, OCH2), 2.88-2.84 (m, 1H, CH2), 2.70-2.68 
(m, 1H, CH2), 2.57-2.53 (m, 1H, C-H), 1.66-1.61 (m, 2H, CH2), 1.19 (d, J = 6.8 Hz, 6H, 
CH3). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 147.0, 144.9, 139.7, 128.9, 128.6, 127.9, 
126.3, 125.6, 70.9, 34.4, 33.8, 33.7, 24.7. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.88 
(br). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -141.1. IR: ν = 2960, 2360, 1703, 1172, 
1062, 700 cm
-1
. HRMS (ESI) m/z calc. for C19H23BOF3 (M-K) 335.1794, found 
335.1789. 
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Potassium 1-(3-methoxybenzyloxy)-3-phenylpropyltrifluoroborate (2.32). Obtained 
as a white solid (121 mg, 81%). mp: 117-119 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 
7.22-7.17 (m, 5H, ArCH), 7.10-7.09 (m, 1H, ArCH), 7.01 (s, 1H, ArCH), 6.94 (d, J = 7.5 
Hz, 1 H, ArCH), 6.76 (dd, J = 7.9, 1.9 Hz, 1H, ArCH) 4.54 (dd, J = 15, 35Hz, 2H, 
OCH2), 3.76 (s, 3H, OCH3), 2.80-2.77 (m, 1H, CH2), 2.76-2.66 (m, 1H, C-H), 1.86-1.82 
(m, 2H, CH2). 
13
C NMR (acetone-d6, 125.8 MHz): δ = 160.0, 144.8, 143.1, 129.0, 128.5, 
128.1, 125.0, 119.7, 112.9, 112.4, 71.0, 54.6, 33.4, 33.2. 
11
B NMR (acetone-d6, 128.38 
MHz): δ = 3.58 (br). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -146.6. IR: ν = 2941, 2800, 
1270, 1046, 698 cm
-1
. HRMS (ESI) m/z calc. for C17H19BO2F3 (M-K) 323.1430, found 
323.1439. 
 
Potassium 1-(4-methoxybenzyl)oxy)-3-phenylpropyltrifluoroborate (2.33). Obtained 
as a white solid (134 mg, 90%). mp: 117-119 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 
7.33 (d, J = 8.3 Hz, 2H, ArCH), 7.28-7.18 (m, 4H, ArCH), 7.13-7.10 (m, 1H, ArCH), 
6.67 (d, J = 8.5 Hz, 2H, ArCH), 4.50 (s, 2H, OCH2), 3.78 (s, 3H, OCH3), 2.82-2.77 (m, 
2H, C-H, CH2), 2.78-2.66 (m, 1H, C-H), 1.91-1.83 (m, 2H, CH2). 
13
C NMR (acetone-d6, 
125.8 MHz): δ = 158.9, 144.9, 133.3, 129.1, 128.5, 128.0, 125.0, 113.5, 70.9, 54.7, 33.4, 
33.2. 
11
B NMR (acetone-d6, 128.38 MHz): δ = 3.71 (br). 
19
F NMR (acetone-d6, 338.8 
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MHz): δ = -147.0. IR: ν = 2936, 2856, 1252, 1034, 699 cm
-1
. HRMS (ESI) m/z calc. for 
C17H19BO2F3 (M-K) 323.1430, found 323.1438. 
 
Potassium 1-(2-methybenzyloxy)-3-phenylpropyltrifluoroborate (2.34). Obtained as a 
white solid (102 mg, 71%). mp: 137-140 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.45-
7.42 (m, 1H, ArCH), 7.22-7.20 (m, 2H, ArCH), 7.19-7.15 (m, 2H, ArCH), 7.13-7.06 (m, 
4H, ArCH), 4.60-4.58 (d, J = 15 Hz, 1H, OCH2), 4.53-4.50 (d, J = 15 Hz, 1H, OCH2), 
2.79-2.72 (m, 2H, CH2), 2.68-2.60 (m, 1H, CH2), 2.31 (s, 3H, CH3), 1.89-1.79 (m, 2H, 
CH2). 
13
C NMR (acetone-d6, 125.8 MHz): δ = 144.9, 139.3, 136.1, 129.7, 128.5, 128.2, 
128.0, 126.8, 125.6, 125.0, 69.6, 33.7, 33.4, 18.2. 
11
B NMR (acetone-d6, 128.38 MHz): δ 
= 3.82 (br). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -146.5. IR: ν = 3021, 2930, 1054, 
989, 931, 749, 698 cm
-1
. HRMS (ESI) m/z calc. for C17H19BOF3 (M-K) 307.1481, found 
307.1480. 
 
Potassium 1-(2-chlorobenzyloxy)-3-phenylpropyltrifluoroborate (2.35). Obtained as a 
white solid (121 mg, 80%). mp: 142-143 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.76 
(d, J = 7.7 Hz, 1H, ArCH), 7.34-7.25 (m, 2H, ArCH), 7.24-7.13 (m, 5H, ArCH), 7.12-
7.05 (m, 1H, ArCH), 4.75 (d, J = 14.1 Hz, 1H, OCH2), 4.59 (d, J = 14.1 Hz, 1H, OCH2), 
2.86-2.84 (m, 1H, C-H), 2.80-2.79 (m, 1H, CH2), 2.71-2.65 (m, 1H, CH2), 1.92-1.88 (m, 
2H, CH2). 
13
C NMR (acetone-d6, 125.8 MHz): δ = 144.8, 139.2, 131.9, 129.2, 128.7, 
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128.5, 128.0, 127.9, 126.9, 125.0, 68.2, 33.6, 33.3. 
11
B NMR (acetone-d6, 128.38 MHz): 
δ = 4.17 (br). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -146.4. IR: ν = 2931, 1054, 1038, 
931, 749, 698 cm
-1
. HRMS (ESI) m/z calc. for C16H16BClOF3 (M-K) 327.0935, found 
327.0937. 
 
Potassium 1-((2-bromothien-3-yl)methoxy)-3-phenylpropyltrifluoroborate (2.36). 
Obtained as a white solid (91 mg, 53%). mp: 181-183 °C. 
1
H NMR (acetone-d6, 500 
MHz): δ = 7.42-7.40 (m, 1H, ArCH), 7.23-7.16 (m, 5H, ArCH), 7.10-7.08 (m, 1H, 
ArCH), 4.58-4.55 (d, J = 12.5 Hz, 1H, OCH2), 4.47-4.45 (d, J = 12.5 Hz, 1H, OCH2), 
2.86-2.84 (m, 1H, C-H), 2.80-2.79 (m, 1H, CH2), 2.67-2.63 (m, 1H, CH2), 1.85-1.78 (m, 
2H, CH2). 
13
C NMR (acetone-d6, 125.8 MHz): δ = 144.8, 141.6, 129.3, 128.5, 128.1, 
125.9, 125.1, 108.3, 65.5, 33.4, 33.2. 
11
B NMR (acetone-d6, 128.38 MHz): δ = 4.01 (br). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -146.7. IR: ν = 3022, 2931, 1023, 990, 931, 749, 
698 cm
-1
. HRMS (ESI) m/z calc. for C14H14BBrOSF3 (M-K) 376.9994, found 376.9999. 
 
Potassium 1-(pyridin-3-ylmethoxy)-3-phenylpropyltrifluoroborate (2.37). Obtained 
as a white solid (62 mg, 45%). mp: 164-166 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 
8.58 (s, 1H, ArCH), 8.41 (d, J = 5 Hz, 1H, ArCH), 7.77 (d, J = 10 Hz, 1H, ArCH), 7.26-
7.22 (m, 1H, ArCH), 7.19-7.12 (m, 4H, ArCH), 7.10-7.08 (m, 1H, ArCH), 4.65 (d, J = 
13.5 Hz, 1H, OCH2), 4.54 (d, J = 13.5 Hz, 1H, OCH2), 2.86-2.84 (m, 1H, C-H), 2.80-2.79 
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(m, 1H, CH2), 2.65-2.63 (m, 1H, CH2), 1.85-1.83 (m, 2H, CH2). 
13
C NMR (acetone-d6, 
125.8 MHz): δ = 149.3, 144.6, 136.5, 128.5, 128.1, 125.1, 122.0, 121.7, 72.3, 32.3, 30.2. 
11
B NMR (acetone-d6, 128.38 MHz): δ = 3.82 (br). 
19
F NMR (acetone-d6, 338.8 MHz): δ 
= -146.6. IR: ν = 2932, 2854, 973, 955, 698 cm
-1
. HRMS (ESI) m/z calc. for 
C15H16BNOF3 (M-K) 294.1277, found 294.1263. 
 
Potassium 1-(allyloxy)-3-phenylpropyltrifluoroborate (2.38). Obtained as a white 
solid (107 mg, 92%). mp: >250 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.24-7.21 (m, 
2H, ArCH), 7.13-7.09 (m, 3H, ArCH), 5.91-5.85 (m, 1H, OCH2(C-H)CH2), 5.16 (d, J = 
17.7 Hz, 1H, OCH2(C-H)CH2), 4.98 (d, J = 10.3 Hz, 1H, OCH2(C-H)CH2), 3.98-3.95 (m, 
1H, OCH2), 3.81-3.79 (m, 1H, OCH2), 2.70-2.64 (m, 1H, C-H), 2.49-2.44 (m, 1H, CH2), 
1.57 (q, J = 7.5 Hz, 2H, CH2). 
13
C NMR (Acetone-d6, 125.8 MHz): δ = 144.7, 137.7, 
128.5, 128.1, 125.1, 114.8, 70.6, 33.2, 33.0. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.71 
(br). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -147.0. IR: ν = 1696, 1295, 1023, 807, 745 
cm
-1
. HRMS (ESI) m/z calc. for C12H15BOF3 (M-K) 243.1168, found 243.1163. 
 
Potassium 1-(methoxy)-3-phenylpropyltrifluoroborate (2.39). Obtained as a white 
solid (100 mg, 94%). mp: 241-244 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.26-7.21 
(m, 2H, ArCH), 7.16-7.10 (m, 3H, ArCH), 3.17 (s, 3H, CH3), 2.67-2.61 (m, 1H, C-H), 
2.49-2.44 (m, 1H, CH2), 2.33-2.29 (m, 1H, CH2), 1.62-1.56 (m, 2H, CH2). 
13
C NMR 
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(DMSO-d6, 125.8 MHz): δ = 144.6, 128.6, 128.4, 125.4, 57.1, 33.5, 33.3. 
11
B NMR 
(DMSO-d6, 128.38 MHz): δ = 3.45 (br). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -147.3. 
IR: ν = 2933, 1645, 1442, 998, 698 cm
-1
. HRMS (ESI) m/z calc. for C10H13BOF3 (M-K) 
217.1012, found 217.1014. 
 
General Procedure for the Cross-Coupling of Potassium 1-(Benzyloxy)-3-phenyl-
propyltrifluoroborate. In a Biotage microwave vial equipped with a stir bar was 
successively introduced cataCXium A-Pd-G2 (2.5 µmol, 0.075 equiv), potassium 1-
(benzyloxy)-3-phenyl-propyltrifluoroborate (0.3 mmol, 1 equiv), and CsOH-H2O (1.5 
mmol, 5 equiv). The vial was sealed with a cap lined with a disposable Teflon septum, 
and evacuated under vacuum and purged with Ar three times. The electrophile was then 
added using a microsyringe (0.3 mmol, 1 equiv) followed by 0.3 mL of degassed CPME 
and 0.3 mL of degassed H2O. The resulting mixture was placed in an oil bath preheated 
to 105 °C and stirred for 24 h. After cooling to rt, the vial was uncapped, and the reaction 
mixture was diluted with EtOAc (3 mL) and H2O (3 mL). The reaction mixture was 
extracted with EtOAc (3 x 3 mL) and dried (MgSO4). The solvent was removed in vacuo, 
and the product was purified by flash column chromatography on silica gel or Florisil 
using a mixture of EtOAc/hexanes as the eluent. 
 
1-(1-(Benzyloxy)-3-phenylpropyl)-4-(trifluoromethyl)benzene (2.41). Obtained as a 
yellow oil (94 mg, 84%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.62 (d, J = 7.9 Hz, 2H, 
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ArCH), 7.44 (d, J = 7.9 Hz, 2H, ArCH), 7.39-7.22 (m, 7H, ArCH), 7.17-7.13 (m, 3H, 
ArCH), 4.45 (d, J = 11.9 Hz, 1H, OCH2), 4.38-4.34 (m, 1H, C-H), 4.26 (d, J = 11.9 Hz, 
1H, OCH2), 2.81-2.75 (m, 1H, CH2), 2.70-2.62 (m, 1H, CH2), 2.22-2.13 (m, 1H, CH2), 
1.98-1.89 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 146.5, 141.2, 138.3, 130.1 
(J = 32 Hz), 128.6, 128.62, 128.60, 125.56, 128.0, 127.2, 126.1, 125.6 (J = 3.6 Hz), 124.3 
(J = 272 Hz), 80.1, 71.0, 40.0, 32.0. IR: ν = 3029, 2358, 1324, 1123, 1066, 698 cm
-1
. 
HRMS (ESI) m/z calc. for C23H21F3ONa (M+Na)
+
 393.1442, found 393.1436. 
 
1-(1-(Benzyloxy)-3-phenylpropyl)-4-fluorobenzene (2.42). Obtained as a yellow oil (74 
mg, 77%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.40-7.24 (m, 9H, ArCH), 7.23-7.13 (m, 3H, 
ArCH), 7.07 (t, J = 8.5 Hz, 2H, ArCH), 4.45 (d, J = 11.8 Hz, 1H, OCH2), 4.36 (dd, J = 
7.9, 5.1 Hz, 1H, C-H), 4.26 (d, J = 11.8 Hz, 1H, OCH2), 2.83-2.77 (m, 1H, CH2), 2.68-
2.63 (m, 1H, CH2), 2.25-2.17 (m, 1H, CH2), 1.99-1.92 (m, 1H, CH2). 
13
C NMR (CDCl3, 
125.8 MHz): δ = 142.0, 138.6, 138.3, 128.6, 128.56, 128.51, 128.0, 127.8, 126.0, 115.6, 
115.4, 80.1, 70.6, 40.1, 32.2. IR: ν = 3027, 2862, 1508, 1221, 835, 698 cm
-1
.
 
HRMS (CI) 
m/z calc. for C22H21O (M-F)
+
 301.1592, found 301.1586.
 
 
1-(1-(Benzyloxy)-3-phenylpropyl)-3,5-difluorobenzene (2.43). Obtained as a yellow oil 
(103 mg, 74%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.40-7.25 (m, 7H, ArCH), 7.22-7.12 
(m, 3H, ArCH), 7.47-7.44 (m, 1H, ArCH), 6.91-6.87 (m, 2H, ArCH), 6.77-6.71 (m, 1H, 
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ArCH), 4.50 (d, J = 11.5 Hz, 1H, OCH2), 4.31-4.28 (m, 2H, C-H and OCH2), 2.83-2.79 
(m, 1H, CH2), 2.71-2.65 (m, 1H, CH2), 2.18-2.13 (m, 1H, CH2), 1.95-1.92 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 163.4 (dd, J = 11.3, 260 Hz), 147.2, 141.6, 138.8, 
128.7, 128.6, 128.0, 127.9, 126.1, 109.6 (dd, J = 5, 25 Hz), 103.1 (t, J = 26 Hz), 79.8, 
71.0, 39.9, 32.0. IR: ν = 3028, 2864, 1623, 1454, 1117, 698 cm
-1
.
 
HRMS (CI) m/z calc. 
for C22H20FO (M-F)
+
 319.1498, found 319.1497.
 
 
Methyl 3-(1-(benzyloxy)-3-phenylpropyl)benzoate (2.44). Obtained as a yellow oil (56 
mg, 52%). 
1
H NMR (CDCl3, 500 MHz): δ = 8.02-7.99 (m, 2H, ArCH), 7.58 (d, J = 7.5 
Hz, 1H, ArCH), 7.47-7.44 (m, 1H, ArCH), 7.37-7.27 (m, 4H, ArCH), 7.27-7.24 (m, 3H, 
ArCH), 7.21-7.15 (m, 3H, ArCH), 4.46 (d, J = 11.8 Hz, 1H, OCH2), 4.38 (dd, J = 7.9, 4.9 
Hz, 1H, C-H), 4.27 (d, J = 11.5 Hz, 1H, OCH2), 3.94 (s, 3H, CH3), 2.84-2.78 (m, 1H, 
CH2), 2.70-2.66 (m, 1H, CH2), 2.24-2.20 (m, 1H, CH2), 1.99-1.96 (m, 1H, CH2). 
13
C 
NMR (CDCl3, 125.8 MHz): δ = 167.2, 143.2, 141.9, 138.5, 131.4, 130.6, 129.1, 128.9, 
128.6, 128.5, 128.2, 128.0, 127.8, 126.0, 80.4, 70.8, 52.3, 40.0, 32.2. IR: ν = 3027, 2949, 
1722, 1285, 1200, 753, 698 cm
-1
. HRMS (ESI) m/z calc. for C24H24O3Na (M+Na)
+
 
383.1623, found 383.1614. 
 
Methyl 4-(1-(benzyloxy)-3-phenylpropyl)benzoate (2.45). Obtained as a yellow oil (62 
mg, 57%). 
1
H NMR (CDCl3, 500 MHz): δ = 8.05 (d, J = 7.9 Hz, 2H, ArCH), 7.42 (d, J = 
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7.9 Hz, 2H, ArCH), 7.37-7.24 (m, 7H, ArCH), 7.21-7.14 (m, 3H, ArCH), 4.46 (d, J = 
11.9 Hz, 1H, OCH2), 4.38 (dd, J = 8.2, 4.9 Hz, 1H, C-H), 4.27 (d, J = 11.6 Hz, 1H, 
OCH2), 3.93 (s, 3H, CH3), 2.80-2.77 (m, 1H, CH2), 2.70-2.66 (m, 1H, CH2), 2.20-2.17 
(m, 1H, CH2), 2.01-1.95 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 166.9, 147.8, 
141.6, 138.2, 129.9, 129.5, 128.4, 128.3, 127.8, 127.6, 126.7, 125.9, 80.1, 70.7, 52.1, 
39.8, 31.9. IR: ν = 3027, 2949, 2861, 1722, 1277, 1110, 1102, 702 cm
-1
. HRMS (ESI) 
m/z calc. for C24H24O3Na (M+Na)
+
 383.1623, found 383.1609. 
 
(4-(1-(Benzyloxy)-3-phenylpropyl)phenyl)(phenyl)methanone (2.46). Obtained as a 
yellow oil (78 mg, 64%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.84 (d, J = 7.9 Hz, 4H, 
ArCH), 7.63-7.61 (m, 1H, ArCH), 7.52-7.46 (m, 4H, ArCH), 7.40-7.27 (m, 7H, ArCH), 
7.21-7.16 (m, 3H, ArCH), 4.51 (d, J = 11.8 Hz, 1H, OCH2), 4.42 (dd, J = 8.0, 4.8 Hz, 
1H, C-H), 4.32 (d, J = 11.8 Hz, 1H, OCH2), 2.86-2.82 (m, 1H, CH2), 2.74-2.70 (m, 1H, 
CH2), 2.25-2.21 (m, 1H, CH2), 2.04-2.00 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ 
= 196.6, 147.7, 141.8, 138.4, 137.8, 137.1, 135.6, 130.6, 130.2, 128.61, 128.56, 128.5, 
128.0, 127.9, 126.8, 126.0, 80.4, 71.0, 40.0, 32.2. IR: ν = 3028, 2863, 1657, 1277, 698 
cm
-1
. HRMS (ESI) m/z calc. for C29H27O2 (M+H)
+
 407.2011, found 407.1995. 
 
1-(1-(Benzyloxy)-3-phenylpropyl)-2-methoxybenzene (2.47). Obtained as a yellow oil 
(73 mg, 73%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.54 (d, J = 7.3 Hz, 1H, ArCH), 7.40-
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7.37 (m, 4H, ArCH), 7.34-7.27 (m, 4H, ArCH), 7.21 (d, J = 7.1 Hz, 3H, ArCH), 7.06-
7.03 (t, J = 7.3 Hz, 1H, ArCH), 6.92-6.90 (d, J = 8.1 Hz, 1H, ArCH), 4.91-4.89 (m, 1H, 
C-H), 4.52 (d, J = 11.7 Hz, 1H, OCH2), 4.33 (d, J = 11.7 Hz, 1H, OCH2), 3.82 (s, 3H, 
CH3), 2.91-2.87 (m, 1H, CH2), 2.76-2.71 (m, 1H, CH2), 2.12-2.06 (m, 2H, CH2). 
13
C 
NMR (CDCl3, 125.8 MHz): δ = 157.0, 142.4, 138.9, 130.7, 128.4, 128.2, 128.1, 128.0, 
127.7, 127.3, 126.6, 125.5, 120.7, 110.3, 74.6, 70.7, 55.2, 38.4, 32.1. IR: ν = 3028, 2915, 
1489, 1240, 753, 735, 698 cm
-1
. HRMS (ESI) m/z calc. for C23H24O2 Na (M+Na)
+
 
355.1674, found 355.1686. 
 
1-(1-(Benzyloxy)-3-phenylpropyl)-3-methoxybenzene (2.48). Obtained as a yellow oil 
(77 mg, 77%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.39-7.37 (m, 4H, ArCH), 7.34-7.27 (m, 
4H, ArCH), 7.20-7.18 (m, 3H, ArCH), 6.97-6.95 (m, 2H, ArCH), 6.89-6.87 (m, 1H, 
ArCH), 4.52 (d, J = 11.5 Hz, 1H, OCH2), 4.33-4.32 (m, 1H, C-H), 4.31 (d, J = 11.5 Hz, 
1H, OCH2), 3.85 (s, 3H, CH3), 2.84-2.81 (m, 1H, CH2), 2.73-2.68 (m, 1H, CH2), 2.25-
2.22 (m, 1H, CH2), 2.02-2.00 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 159.8, 
144.2, 141.9, 138.6, 129.4, 128.4, 128.3, 128.2, 127.8, 127.5, 125.7, 119.2, 113.0, 112.0, 
80.6, 70.5, 55.2, 39.8, 32.0. IR: ν = 3027, 2942, 1259, 1046, 698 cm
-1
. HRMS (ESI) m/z 
calc. for C23H24O2Na (M+Na)
+
 355.1674, found 355.1669. 
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1-(1-(Benzyloxy)-3-phenylpropyl)-4-methoxybenzene (2.49). Obtained as a yellow oil 
(87 mg, 87%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.39-7.36 (m, 4H, ArCH), 7.33-7.27 (m, 
5H, ArCH), 7.21-7.17 (m, 3H, ArCH), 6.94 (d, J = 8.5 Hz, 2H, ArCH), 4.46 (d, J = 11.8 
Hz, 1H, OCH2), 4.31-4.25 (m, 2H, C-H and OCH2), 3.85 (s, 3H, CH3), 2.82-2.77 (m, 1H, 
CH2), 2.69-2.65 (m, 1H, CH2), 2.27-2.22 (m, 1H, CH2), 2.00-1.95 (m, 1H, CH2). 
13
C 
NMR (CDCl3, 125.8 MHz): δ = 159.3, 142.2, 138.9, 134.5, 128.6, 128.5, 128.4, 128.2, 
128.0, 127.7, 125.9, 114.0, 80.3, 70.4, 55.4, 40.0, 32.3. IR: ν = 3027, 2928, 1246, 698 cm
-
1
. HRMS (ESI) m/z calc. for C23H24O2Na (M+Na)
+
 355.1674, found 355.1663. 
 
1-(1-(Benzyloxy)-3-phenylpropyl)-3,5-dimethoxybenzene (2.50). Obtained as a yellow 
oil (73 mg, 67%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.38-7.35 (m, 4H, ArCH), 7.34-7.31 
(m, 3H, ArCH), 7.21-7.17 (m, 3H, ArCH), 6.54 (d, J = 2.2 Hz, 2H, ArCH), 6.43 (t, J = 
2.3 Hz, 1H), 4.52 (d, J = 11.7 Hz, 1H, OCH2), 4.31-4.26 (m, 2H, C-H and OCH2), 3.82 
(s, 6H, CH3), 2.84-2.79 (m, 1H, CH2), 2.72-2.66 (m, 1H, CH2), 2.22-2.18 (m, 1H, CH2), 
2.00-1.96 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 161.1, 145.3, 142.1, 138.7, 
128.8, 128.6, 128.5, 128.4, 128.0, 127.7, 125.9, 104.8, 80.9, 70.7, 55.5, 40.0, 32.3. IR: ν 
= 3027, 2940, 1596, 1154, 698 cm
-1
. HRMS (ESI) m/z calc. for C24H26O3Na (M+Na)
+
 
385.1780, found 385.1767. 
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tert-Butyl (4-(1-(benzyloxy)-3-phenylpropyl)phenyl)carbamate (2.51). Obtained as a 
white solid (84 mg, 67%). mp: 116-118 °C. 
1
H NMR (CDCl3, 500 MHz): δ = 7.38-7.22 
(m, 11H, ArCH), 7.18-7.13 (m, 3H, ArCH), 6.49 (s, 1H, NH), 4.42 (d, J = 11.8 Hz, 1H, 
OCH2), 4.26-4.21 (m, 2H, C-H and OCH2), 2.78-2.72 (m, 1H, CH2), 2.65-2.60 (m, 1H, 
CH2), 2.21-2.16 (m, 1H, CH2), 1.95-1.90 (m, 1H, CH2), 1.55-1.51 (s, 9H, tBu). 
13
C NMR 
(CDCl3, 125.8 MHz): δ = 153.0, 142.1, 138.8, 137.9, 137.0, 128.6, 128.5, 128.4, 128.0, 
127.7, 125.9, 118.8, 80.3, 70.4, 39.9, 32.2, 28.5. IR: ν = 3316, 1697, 1535, 1318, 1160, 
698 cm
-1
. HRMS (ESI) m/z calc. for C27H31NO3Na (M+Na)
+
 440.2202, found 440.2203. 
 
3-(1-(benzyloxy)-3-phenylpropyl)-N,N-dimethylaniline (2.52). Obtained as a white 
solid (81 mg, 84%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.35 (d, J = 4.3 Hz, 4H, ArCH), 
7.31-7.24 (m, 4H, ArCH), 7.18-7.15 (m, 3H, ArCH), 6.74-6.72 (m, 1H, ArCH), 6.71-6.67 
(m, 2H, ArCH), 4.50 (d, J = 11.6 Hz, 1H, OCH2), 4.28-4.25 (m, 2H, C-H and OCH2), 
2.96 (s, 6H, CH3), 2.83-2.78 (m, 1H, CH2), 2.70-2.66 (m, 1H, CH2), 2.23-2.18 (m, 1H, 
CH2), 2.00-1.95 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 150.7, 143.3, 142.1, 
138.8, 129.0, 128.4, 128.3, 128.2, 127.8, 127.4, 125.6, 115.3, 118.8, 110.7, 81.2, 70.4, 
40.6, 39.9, 32.1. IR: ν = 3027, 2856, 1602, 1496, 1096, 1062, 698 cm
-1
. HRMS (ESI) m/z 
calc. for C24H28NO (M+H)
+
 346.2171, found 346.2170. 
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1-(4-(1-(Benzyloxy)-3-phenylpropyl)phenyl)-1H-pyrrole (2.53). Obtained as a yellow 
oil (87 mg, 79%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.45-7.26 (m, 11H, ArCH), 7.22-7.12 
(m, 5H, ArCH), 6.41-6.39 (br s, 2H, ArCH), 4.52 (d, J = 11.8 Hz, 1H, OCH2), 4.38 (t, J = 
7.7 Hz, 1H, C-H), 4.33 (d, J = 11.8 Hz, 1H, OCH2), 2.86-2.82 (m, 1H, CH2), 2.74-2.70 
(m, 1H, CH2), 2.28-2.24 (m, 1H, CH2), 2.05-1.99 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 
MHz): δ = 142.0, 140.3, 140.0, 138.6, 128.62, 128.58, 128.52, 128.1, 128.0, 127.8, 126.0, 
120.7, 119.5, 110.6, 80.2, 70.7, 40.0, 32.2. IR: ν = 3026, 2860, 1520, 1328, 1070, 724, 
698 cm
-1
. HRMS (ESI) m/z calc. for C26H26NO (M+H)
+
 368.2014, found 368.2016. 
 
1-(1-(Benzyloxy)-3-phenylpropyl)-2-methylbenzene (2.54). Obtained as a yellow oil 
(76 mg, 76%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.51 (d, J = 7.7 Hz, 1H, ArCH), 7.40-
7.32 (m, 5H, ArCH), 7.28-7.25 (m, 3H, ArCH), 7.21-7.13 (m, 5H, ArCH), 4.57 (dd, J = 
8.9, 3.3 Hz, 1H, C-H), 4.49 (d, J = 11.8 Hz, 1H, OCH2), 4.23 (d, J = 11.8 Hz, 1H, OCH2), 
2.92-2.88 (m, 1H, CH2), 2.74-2.70 (m, 1H, CH2), 2.15-2.12 (m, 4H, CH2 and CH3), 1.94-
1.90 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 142.2, 140.7, 138.8, 135.4, 130.6, 
128.7, 128.5, 128.4, 120.1, 127.7, 127.2, 126.1, 125.9, 76.8, 70.6, 39.1, 32.4, 18.9. IR: ν 
= 2936, 1510, 1029, 968, 706 cm
-1
. HRMS (CI) m/z calc. for C15H15O (M-C8H9)
+
 
211.1123, found 211.1119. 
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1-(1-(Benzyloxy)-3-phenylpropyl)-3-methylbenzene (2.55). Obtained as a yellow oil 
(73 mg, 77%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.41-7.39 (m, 4H, ArCH), 7.35-7.28 (m, 
4H, ArCH), 7.21-7.15 (m, 6H, ArCH), 4.51 (d, J = 11.8 Hz, 1H, OCH2), 4.32-4.29 (m, 
2H, C-H and OCH2), 2.86-2.82 (m, 1H, CH2), 2.73-2.69 (m, 1H, CH2), 2.41 (s, 3H, CH3), 
2.26-2.23 (m, 1H, CH2), 2.02-1.99 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 
142.6, 142.3, 138.9, 138.3, 128.7, 128.6, 128.5, 128.0, 127.7, 127.6, 125.9, 124.1, 80.9, 
70.7, 40.1, 32.4, 27.7. IR: ν = 3026, 2862, 1453, 1093, 698 cm
-1
. HRMS (CI) m/z calc. 
for C15H15O (M-C8H9)
+
 211.1123, found 211.1120. 
 
1-(1-(Benzyloxy)-3-phenylpropyl)-4-methylbenzene (2.56). Obtained as a yellow oil 
(83 mg, 87%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.36-7.30 (s, 3H, ArCH), 7.29-7.21 (m, 
5H, ArCH), 7.17-7.09 (m, 6H, ArCH), 4.44 (d, J = 11.8 Hz, 1H, OCH2), 4.30 (dd, J = 
7.6, 5.2 Hz, 1H, C-H), 4.26 (d, J = 11.8 Hz, 1H, OCH2), 2.79-2.74 (m, 1H, CH2), 2.66-
2.62 (m, 1H, CH2), 2.35 (s, 3H, CH3), 2.20-2.17 (m, 1H, CH2), 1.96-1.93 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 142.3, 139.5, 138.9, 137.5, 129.4, 128.7, 128.6, 
128.54, 128.49, 128.0, 127.7, 127.0, 125.9, 80.7, 70.5, 40.1, 32.3, 21.4. IR: ν = 3026, 
2959, 1454, 1094, 698 cm
-1
. HRMS (ESI) m/z calc. for C23H24ONa (M+Na)
+
 339.1725, 
found 339.1728. 
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1-(1-(Benzyloxy)-3-phenylpropyl)naphthalene (2.57). Obtained as a yellow oil (100 
mg, 95%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.97-7.92 (br s, 1H, ArCH), 7.89 (d, J = 8.1 
Hz, 1H, ArCH), 7.81 (d, J = 8.1 Hz, 1H, ArCH), 7.67-7.63 (br s, 1H, ArCH), 7.52-7.43 
(m, 3H, ArCH), 7.39-7.30 (m, 5H, ArCH), 7.30-7.24 (br s, 2H, ArCH), 7.21-7.14 (m, 3H, 
ArCH), 5.08-5.04 (m, 1H, C-H), 4.46-4.44 (d, J = 9.8 Hz, 1H, OCH2), 4.32-4.30 (d, J = 
11.2 Hz, 1H, OCH2), 2.93-2.89 (m, 1H, CH2), 2.81-2.78 (m, 1H, CH2), 2.35-2.32 (m, 1H, 
CH2), 2.20-2.16 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 142.1, 138.8, 
138.159, 138.157, 131.2, 129.0, 128.8, 128.7, 128.5, 128.2, 128.1, 128.0, 127.8, 126.1, 
126.0, 125.7, 124.2, 123.5, 71.0, 39.5, 32.6. IR: ν = 3027, 2860, 1453, 1091, 800, 780, 
736, 698 cm
-1
. HRMS (CI) m/z calc. for C26H24O (M)
+
 352.1827, found 352.1830. 
 
2-(1-(Benzyloxy)-3-phenylpropyl)naphthalene (2.58). Obtained as a white solid (90 
mg, 85%). mp: 59-62 °C. 
1
H NMR (CDCl3, 500 MHz): δ = 7.94-7.87 (m, 3H, ArCH), 
7.82-7.80 (s, 1H, ArCH), 7.60-7.52 (m, 3H, ArCH), 7.41-7.31 (m, 7H, ArCH), 7.26-7.21 
(m, 3H, ArCH), 4.46-4.43 (m, 2H, C-H and OCH2), 4.36 (d, J = 11.7 Hz, 1H, OCH2), 
2.89-2.86 (m, 1H, CH2), 2.79-2.74 (m, 1H, CH2), 2.38-2.35 (m, 1H, CH2), 2.14-2.11 (m, 
1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 141.9, 138.8, 138.6, 133.2, 133.1, 128.5, 
128.4, 128.3, 127.82, 128.80, 127.7, 127.5, 126.1. 126.0, 125.8, 125.7, 124.5, 80.7, 70.5, 
39.7, 32.1. IR: ν = 3026, 2860, 1453, 1097, 824, 748, 732, 698 cm
-1
. HRMS (ESI) m/z 
calc. for C26H24ONa (M+Na)
+
 375.1725, found 375.1742. 
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(1-(Benzyloxy)propane-1,3-diyl)dibenzene (2.59). Obtained as a yellow oil (69 mg, 
76%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.38-7.27 (m, 9H, ArCH), 7.20-7.13 (m, 3H, 
ArCH), 7.07 (t, J = 8.7 Hz, 2H, ArCH), 4.44 (d, J = 11.8 Hz, 1H, OCH2), 4.31 (dd, J = 
8.2, 5.2 Hz, 1H, C-H), 4.26 (d, J = 11.8 Hz, 1H, OCH2), 2.81-2.78 (m, 1H, CH2), 2.69-
2.65 (m, 1H, CH2), 2.22-2.18 (m, 4H, CH2 and CH3), 1.97-1.93 (m, 1H, CH2). 
13
C NMR 
(CDCl3, 125.8 MHz): δ = 142.0, 138.6, 138.3, 128.6, 128.49, 128.48, 128.0, 127.8, 126.0, 
115.6, 115.4, 80.0, 70.6, 40.1, 32.2. IR: ν = 3026, 2860, 1453, 1095, 735, 698 cm
-1
. 
HRMS (ESI) m/z calc. for C22H21O (M-H)
+
 301.1592, found 301.1591. 
 
2-(1-(Benzyloxy)-3-phenylpropyl)-5-methoxy-1,3-dimethylbenzene (2.60). Obtained 
as a yellow oil (62 mg, 57%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.38-7.20 (m, 5H, 
ArCH), 7.28-7.24 (m, 2H, ArCH), 7.19-7.14 (m, 3H, ArCH), 6.58-6.54 (br s, 2H, ArCH), 
4.70 (dd, J = 9.5, 4.2 Hz, 1H,C-H), 4.45 (d, J = 11.8 Hz, 1H, OCH2), 4.16 (d, J = 12.0 
Hz, 1H, OCH2), 3.79 (s, 3H, OMe), 2.94-2.90 (m, 1H, CH2), 2.68-2.64 (m, 1H, CH2), 
2.62-2.46 (br s, 3H, CH3), 2.45-2.40 (m, 1H, CH2), 2.13-1.93 (br s, 3H, CH3), 1.91-1.86 
(m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 158.1, 142.2, 139.0, 129.7, 128.9, 
128.7, 128.5, 128.4, 128.0, 127.8, 127.6, 125.9, 76.5, 70.1, 55.1, 36.7, 32.8, 20.9. IR: ν = 
2950, 1602, 1308, 1143, 1067, 698 cm
-1
. HRMS (ESI) m/z calc. for C25H28O2Na 
(M+Na)
+
 383.1987, found 383.1981. 
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2-(1-(Benzyloxy)-3-phenylpropyl)-1,3-dimethylbenzene (2.61). Obtained as a yellow 
oil (39 mg, 39%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.38-7.31 (m, 5H, ArCH), 7.28-7.23 
(m, 2H, ArCH), 7.19-7.14 (m, 3H, ArCH), 7.07-7.04 (m, 1H, ArCH), 7.00-6.96 (br s, 2H, 
ArCH), 4.77 (dd, J = 9.7, 3.7 Hz, 1H,C-H), 4.46 (d, J = 11.8 Hz, 1H, OCH2), 4.18 (d, J = 
12.0 Hz, 1H, OCH2), 2.96-2.92 (m, 1H, CH2), 2.72-2.68 (m, 1H, CH2), 2.63-2.46 (br s, 
3H, CH3), 2.46-2.42 (m, 1H, CH2), 2.16-1.95 (br s, 3H, CH3), 1.90-1.86 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 141.9, 138.7, 137.2, 136.7, 130.0, 128.5, 128.3, 
128.2, 127.8, 127.4, 126.9, 125.7, 76.7, 70.1, 36.2, 32.5, 20.4. IR: ν = 3026, 2950, 1453, 
1094, 698 cm
-1
. HRMS (ESI) m/z calc. for C24H26ONa (M+Na)
+
 353.1881, found 
353.1888. 
 
3-(1-(Benzyloxy)-3-phenylpropyl)pyridine (2.62). Obtained as a yellow oil (52 mg, 
57%). 
1
H NMR (CDCl3, 500 MHz): δ = 8.59 (s, 2H, ArCH), 7.72 (d, J = 7.8 Hz, 1H, 
ArCH), 7.39-7.27 (m, 7H, ArCH), 7.21-7.18 (m, 1H, ArCH), 7.15 (d, J = 7.3 Hz, 1H, 
ArCH), 4.47 (d, J = 11.5 Hz, 1H, OCH2), 4.37 (dd, J = 8.2, 5.0 Hz, 1H, C-H), 4.30 (d, J = 
11.5 Hz, 1H, OCH2), 2.84-2.78 (m, 1H, CH2), 2.72-2.66 (m, 1H, CH2), 2.26-2.22 (br s, 
3H, CH3), 2.01-1.96 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 149.4, 149.0, 
141.6, 138.2, 137.9, 134.4, 128.62, 128.57, 127.99, 127.92, 126.1, 123.8, 78.4, 70.9, 39.9, 
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32.0. IR: ν = 3027, 2862, 1720, 1269, 714, 699 cm
-1
. HRMS (ESI) m/z calc. for 
C21H21NO (M+H)
+
 304.1701, found 304.1697. 
 
5-(1-(Benzyloxy)-3-phenylpropyl)-2-methoxypyridine (2.63). Obtained as a yellow oil 
(74 mg, 74%). 
1
H NMR (CDCl3, 500 MHz): δ = 8.08 (d, J = 1.9 Hz, 1H, ArCH), 7.62 
(dd, J = 8.5, 2.1 Hz, 1H, ArCH), 7.37-7.25 (m, 7H, ArCH), 7.20-7.14 (m, 3H, ArCH), 
6.79 (d, J = 8.5 Hz, 1H, ArCH), 4.43 (d, J = 11.8 Hz, 1H, OCH2), 4.27-4.27 (m, 2H, C-H 
and OCH2), 3.99-3.96 (s, 3H, CH3), 2.79-2.75 (m, 1H, CH2), 2.68-2.64 (m, 1H, CH2), 
2.25-2.22 (m, 1H, CH2), 1.97-1.94 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 
164.2, 145.9, 141.8, 138.4, 137.3, 130.3, 128.6, 128.5, 128.0, 127.8, 126.0, 111.4, 78.0, 
70.5, 53.6, 39.6, 32.1. IR: ν = 3027, 2944, 1607, 1492, 1283, 1026, 698 cm
-1
. HRMS 
(ESI) m/z calc. for C22H24NO2 (M+H)
+
 334.1807, found 334.1797. 
 
3-(1-(Benzyloxy)-3-phenylpropyl)-4-methylpyridine (2.64). Obtained as a yellow oil 
(40 mg, 42%).
1
H NMR (CDCl3, 500 MHz): δ = 8.63 (s, 1H, ArCH), 8.38 (s, 1H, ArCH), 
7.34-7.31 (m, 3H, ArCH), 7.26-7.23 (m, 3H, ArCH), 7.18-7.12 (m, 3H, ArCH), 7.05-7.02 
(m, 2H, ArCH), 4.49-4.45 (m, 2H, C-H, OCH2), 4.24 (d, J = 11.5 Hz, 1H, OCH2), 2.87-
2.84 (m, 1H, CH2), 2.71-2.68 (m, 1H, CH2), 2.18-2.13 (m, 4H, CH2, CH3), 1.91-1.88 (m, 
1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 148.4, 148.3, 144.7, 142.8, 141.5, 138.0, 
135.8, 128.4, 128.3, 128.0, 127.7, 125.9, 125.5, 75.7, 70.8, 38.6, 32.0, 18.3. IR: ν = 3027, 
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1718, 1601, 1270, 1070, 699 cm
-1
. HRMS (ESI) m/z calc. for C22H24NO (M+H)
+
 
318.1858, found 318.1858. 
 
6-(1-(Benzyloxy)-3-phenylpropyl)quinoline (2.65). Obtained as a yellow oil (78 mg, 
74%). 
1
H NMR (CDCl3, 500 MHz): δ = 8.93 (d, J = 2.8 Hz, 1H, ArCH), 8.15 (t, J = 7.1 
Hz, 2H, ArCH), 7.77-7.74 (m, 2H, ArCH), 7.43 (dd, J = 8.3, 4.1 Hz, 1H, ArCH), 7.39-
7.26 (m, 7H, ArCH), 7.19-7.14 (m, 3H, ArCH), 4.54-4.49 (m, 2H, C-H and OCH2), 4.32 
(d, J = 11.8 Hz, 1H, OCH2), 2.84-2.81 (m, 1H, CH2), 2.74-2.70 (m, 1H, CH2), 2.32-2.28 
(m, 1H, CH2), 2.06-2.02 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 150.5, 148.3, 
141.9, 141.0, 138.5, 136.1, 130.1, 128.62, 128.60, 128.4, 128.3, 128.0, 127.8, 126.0, 
125.7, 121.5, 80.5, 70.9, 40.0, 32.2. IR: ν = 3026, 2864, 1092, 737, 698 cm
-1
. HRMS 
(ESI) m/z calc. for C22H24NO (M+H)
+
 334.1807, found 334.1797. 
 
7-(1-(Benzyloxy)-3-phenylpropyl)-2-methylquinoline (2.66). Obtained as a yellow oil 
(50 mg, 45%).
1
H NMR (CDCl3, 500 MHz): δ = 8.03 (d, J = 8.3 Hz, 1H, ArCH), 7.92 (d, 
J = 7.1 Hz, 1H, ArCH), 7.70 (d, J = 7.9 Hz, 1H, ArCH), 7.54-7.51 (m, 1H, ArCH), 7.44-
7.36 (m, 4H, ArCH), 7.33-7.24 (m, 6H, ArCH), 7.19-7.16 (m, 1H, ArCH), 5.91 (dd, J = 
8.3, 3.6 Hz, 1H, C-H), 4.54 (d, J = 11.5 Hz, 1H, OCH2), 4.43 (d, J = 11.5 Hz, 1H, OCH2), 
2.97-2.91 (m, 1H, CH2), 2.89-2.83 (m, 1H, CH2), 2.72-2.70 (s, 3H, CH3), 2.33-2.29 (m, 
1H, CH2), 2.21-2.16 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 158.0, 146.0, 
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142.7, 140.5, 139.3, 136.2, 128.8, 128.5, 128.3, 128.0, 127.5, 126.6, 126.4, 125.9, 125.7, 
125.6, 121.8, 76.0, 71.3, 39.2, 32.4, 25.7. IR: ν = 3027, 2918, 1497, 1096, 697, 644 cm
-1
. 
HRMS (ESI) m/z calc. for C26H26NO (M+H)
+
 368.2014, found 368.2032. 
 
4-(1-(Benzyloxy)-3-phenylpropyl)-2-methylquinoline (2.67). Obtained as a yellow oil 
(58 mg, 53%). 
1
H NMR (CDCl3, 500 MHz): δ = 8.07 (d, J = 8.3 Hz, 1H, ArCH), 7.74 (d, 
J = 8.1 Hz, 1H, ArCH), 7.68 (t, J = 7.7 Hz, 1H, ArCH), 7.44 (s, 1H, ArCH) 7.43-7.35 (m, 
5H, ArCH), 7.30-7.26 (m, 3H, ArCH), 7.23-7.21 (m, 1H, ArCH), 7.15-7.13 (m, 2H, 
ArCH), 5.00 (dd, J = 8.9, 3.1 Hz, 1H, C-H), 4.56 (d, J = 11.7 Hz, 1H, OCH2), 4.32 (d, J = 
11.5 Hz, 1H, OCH2), 2.94-2.88 (m, 1H, CH2), 2.83-2.79 (m, 1H, CH2), 2.77 (s, 3H, CH3), 
2.29-2.23 (m, 1H, CH2), 2.15-2.11 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 
158.8, 148.3, 147.9, 141.3, 138.0, 129.5, 129.0, 128.5, 128.4, 128.3, 127.9, 127.8, 125.9, 
125.5, 122.7, 119.0, 71.2, 39.0, 32.1, 25.4. IR: ν = 3026, 2923, 1600, 1092, 762, 698 cm
-
1
. HRMS (ESI) m/z calc. for C26H26NO (M+H)
+
 368.2014, found 368.2013. 
 
6-(1-(Benzyloxy)-3-phenylpropyl)isoquinoline (2.68). Obtained as a yellow oil (93 mg, 
88%). 
1
H NMR (CDCl3, 500 MHz): δ = 9.31-9.26 (s, 1H, ArCH), 8.48 (d, J = 4.5 Hz, 1H, 
ArCH), 7.92 (d, J = 8.1 Hz, 1H, ArCH), 7.83 (d, J = 7.1 Hz, 1H, ArCH), 7.70 (d, J = 5.3 
Hz, 1H, ArCH), 7.62 (t, J = 7.6 Hz, 1H, ArCH), 7.40-7.34 (m, 5H, ArCH), 7.30-7.26 (m, 
2H, ArCH), 7.23-7.18 (m, 1H, ArCH), 7.15-7.12 (m, 2H, ArCH), 4.98 (dd, J = 8.7, 4.0 
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Hz, 1H, C-H), 4.52 (d, J = 11.5 Hz, 1H, OCH2), 4.30 (d, J = 11.5 Hz, 1H, OCH2), 2.92-
2.87 (m, 1H, CH2), 2.79-2.76 (m, 1H, CH2), 2.34-2.31 (m, 1H, CH2), 2.13-2.10 (m, 1H, 
CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 96.1, 93.5, 93.1, 92.3, 92.1, 91.1, 90.0, 89.86, 
89.85, 89.83, 89.74, 89.68, 89.5, 89.2, 86.8, 77.0, 75.4, 67.4, 65.7. IR: ν = 3027, 2861, 
1467, 1094, 698 cm
-1
. HRMS (ESI) m/z calc. for C25H24NO (M+H)
+
 354.1858, found 
354.1856. 
 
3-(1-(Benzyloxy)-3-phenylpropyl)thiophene (2.69). Obtained as a yellow oil (38 mg, 
41%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.37-7.25 (m, 8H, ArCH), 7.18-7.11 (m, 5H, 
ArCH), 4.50 (d, J = 11.5 Hz, 1H, OCH2), 4.45 (dd, J = 7.6, 5.7 Hz, 1H, C-H), 4.30 (d, J = 
11.5 Hz, 1H, OCH2), 2.80-2.73 (m, 1H, CH2), 2.70-2.64 (m, 1H, CH2), 2.28-2.22 (m, 1H, 
CH2), 2.04-1.98 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 143.9, 142.0, 138.7, 
128.6, 128.51, 128.47, 128.0, 127.7, 126.3, 126.2, 125.9, 122.2, 76.5, 70.5, 39.0, 32.1. 
IR: ν = 3026, 2862, 1453, 1095, 698 cm
-1
. HRMS (ESI) m/z calc. for C20H20OSNa 
(M+Na)
+
 331.1133, found 331.1130. 
 
2-(1-(Benzyloxy)-3-phenylpropyl)-6-methoxypyridine (2.70). Obtained as a yellow oil 
(63 mg, 63%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.60 (t, J = 7.7 Hz, 1H, ArCH), 7.41-
7.37 (m, 4H, ArCH), 7.33-7.26 (m, 3H, ArCH), 7.21-7.17 (m, 3H, ArCH), 7.06 (d, J = 
7.3 Hz, 1H, ArCH), 6.66 (d, J = 8.1 Hz, 1H, ArCH), 4.58 (d, J = 11.8 Hz, 1H, OCH2), 
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4.43-4.41 (m, 2H, C-H and OCH2), 3.96-3.94 (s, 3H, CH3), 2.88-2.80 (m, 1H, CH2), 2.74-
2.68 (m, 1H, CH2), 2.20-2.14 (m, 2H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 163.9, 
160.1, 142.3, 139.1, 138.7, 128.7, 128.5, 128.4, 128.0, 127.7, 125.9, 113.3, 109.1, 81.8, 
71.3, 53.5, 38.2, 32.0. IR: ν = 2953, 1099, 964, 897, 722 cm
-1
. HRMS (ESI) m/z calc. for 
C22H24NO2 (M+H)
+
 334.1807, found 334.1801. 
 
General Procedure for the Synthesis of Potassium 1-(Benzyloxy)trifluoroborates. 
KH (0.62 mmol, 1.5 equiv) was added to a Biotage microwave vial followed by anhyd 
THF (3 mL) and potassium 3-phenylpropyltrifluoroborate (0.412 mmol, 1 equiv). The 
desired electrophile was then added dropwise (0.62 mmol, 1.5 equiv), and the reaction 
was stirred at 50 °C until complete by 
19
F NMR (overnight). After cooling to rt, MeOH 
(1 mL) was added dropwise followed by 4.5 M KHF2 (0.41 mmol, 1 equiv). The solvents 
were removed under reduced pressure, and the desired trifluoroborate was purified via 
Soxhlet extraction with i-PrOAc (50 mL), concentrating to a minimal amount (~ 5 mL), 
and precipitating with hexanes (20 mL). 
 
Potassium 1-(benzyloxy)-2-methylpropyltrifluoroborate (2.71). Obtained as a white 
solid (502 mg, 93%). mp: 167-169 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.37 (d, J = 
7.3 Hz, 2H, ArCH), 7.27 (t, J = 7.6 Hz, 2H, ArCH), 7.20-7.17 (m, 1H, ArCH), 4.58 (d, J 
= 12 Hz, 1H, OCH2), 4.47 (d, J = 12.2 Hz, 1H, OCH2), 1.95-1.89 (m, 1H, C-H), 0.95-
0.92 (m, 6H, CH3), 0.89-8.86 (m, 1H, C-H). 
13
C NMR (acetone-d6, 125.8 MHz): δ = 
142.3, 128.9, 128.4, 127.5, 73.2, 20.9, 20.6. 
11
B NMR (acetone-d6, 128.38 MHz): δ = 4.2 
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(m). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -142.8. IR: ν = 2952, 2847, 1049, 953, 744, 
702 cm
-1
. HRMS (ESI) m/z calc. for C11H15BOF3 (M-K) 233.1168, found 231.1163. 
 
Potassium 1-(benzyloxy)-2,2-dimethylpropyltrifluoroborate (2.72). Obtained as a 
white solid (148 mg, 52%). mp: 237-239 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.31-
7.25 (m, 4H, ArCH), 7.19-7.16 (m, 1H, ArCH), 4.66 (d, J = 12.2 Hz, 1H, OCH2), 4.21 (d, 
J = 12.2 Hz, 1H, OCH2), 2.14 (s, 1H, C-H), 0.86 (s, 9H, CH3). 
13
C NMR (acetone-d6, 
125.8 MHz): δ = 141.4, 127.8, 127.1, 126.4, 74.4, 34.5, 27.6. 
11
B NMR (acetone-d6, 
128.38 MHz): δ = 2.7 (br). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -140.7. IR: ν = 2951, 
2865, 1108, 1058, 952, 754 cm
-1
. HRMS (ESI) m/z calc. for C12H17BOF3 (M-K) 
245.1325, found 245.1322. 
 
Potassium 1-(benzyloxy)-2-ethylbutyltrifluoroborate (2.73). Obtained as a white solid 
(194 mg, 65%). mp: 172-174 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.27-7.26 (m, 4H, 
ArCH), 7.18-7.17 (m, 1H, ArCH), 4.54 (d, J = 12.4 Hz, 1H, OCH2), 4.26 (d, J = 12.4 Hz, 
1H, OCH2), 2.59-2.58 (m, 1H, C-H), 1.58-1.50 (m, 1H, CH2), 1.46-1.42 (m, 1H, CH2), 
1.27-1.22 (m, 2H, CH2), 0.79-0.75 (m, 6H, CH3). 
13
C NMR (acetone-d6, 125.8 MHz): δ = 
142.2, 128.8, 128.3, 127.4, 72.7, 44.3, 34.1, 23.6, 13.1, 12.9. 
11
B NMR (acetone-d6, 
128.38 MHz): δ = 2.3 (m). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -142.0. IR: ν = 2952, 
2874, 1053, 972, 742, 703 cm
-1
. HRMS (ESI) m/z calc. for C13H19BOF3 (M-K) 259.1481, 
found 259.1477. 
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Potassium 1-(benzyloxy)-2-phenylethyltrifluoroborate (2.74). Obtained as a white 
solid (302 mg, 95%). mp: 164-167 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.27-7.26 
(m, 2H, ArCH), 7.20-7.14 (m, 7H, ArCH), 7.13-7.08 (m, 1H, ArCH), 4.44 (d, J = 12.2 
Hz, 1H, OCH2), 4.26 (d, J = 12.2 Hz, 1H, OCH2), 3.03-3.01 (m, 1H, C-H), 2.88-2.85 (m, 
1H, CH2), 2.78-2.73 (m, 1H, CH2). 
13
C NMR (acetone-d6, 125.8 MHz): δ = 145.4, 142.0, 
130.1, 128.7, 128.4, 128.2, 127.2, 125.6, 72.9, 39.4. 
11
B NMR (acetone-d6, 128.38 MHz): 
δ = 4.0 (m). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -147.7. IR: ν = 3026, 2937, 1061, 
988, 735, 696 cm
-1
. HRMS (ESI) m/z calc. for C15H15BOF3 (M-K) 279.1168, found 
279.1172. 
 
Potassium 1-(benzyloxy)-3-phenylbutyltrifluoroborate (2.75). Obtained as a white 
solid (391 mg, 95%), Mixture of diastereomers. mp: 175-177 °C. 
1
H NMR (DMSO-d6, 
500 MHz): δ = 7.31-7.27 (m, 8H, ArCH), 7.25-7.18 (m, 6H, ArCH), 7.18-7.13 (m, 2H, 
ArCH), 7.18-7.13 (m, 1H, ArCH), 7.13-7.02 (m, 4H, ArCH), 4.51 (t, J = 11.7 Hz, 2H, 
OCH2), 4.30 (d, J = 12.2 Hz, 1H, OCH2), 4.14 (d, J = 12.2 Hz, 1H, OCH2), 2.97-2.93 (m, 
2H, C-H), 2.65-2.63 (m, 1H, C-H), 2.30-2.28 (m, 1H, C-H), 1.70-1.64 (m, 2H, CH2), 
1.56-1.47 (m, 2H, CH2), 1.18-1.12 (m, 3H, CH3), 1.12-1.08 (m, 3H, CH3). 
13
C NMR 
(DMSO-d6, 125.8 MHz): δ = 149.9, 148.4, 141.7, 141.6, 128.0, 127.8, 127.7, 127.7, 
127.2, 127.1, 127.0, 126.7, 126.3, 126.2, 125.1, 125.0, 70.4, 70.3, 40.9, 40.8, 36.3, 35.6, 
23.5, 20.9. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.58 (m), 3.34 (m). 
19
F NMR 
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(DMSO-d6, 338.8 MHz): δ = -146.7. IR: ν = 3026, 2927, 1027, 944, 699 cm
-1
. HRMS 
(ESI) m/z calc. for C17H19BOF3 (M-K) 307.1481, found 307.1486. 
 
Potassium 1-(benzyloxy)-3-(2-chlorophenyl)propyltrifluoroborate (2.76). Obtained as 
a white solid (110 mg, 75%). mp: 168-170 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 
7.42-7.40 (m, 2H, ArCH), 7.36-7.23 (m, 4H, ArCH), 7.23-7.09 (m, 3H, ArCH), 4.63-4.57 
(m, 2H, OCH2), 2.96-2.88 (m, 2H, C-H, CH2), 2.83-2.79 (m, 1H, CH2), 1.92-1.84 (m, 2H, 
CH2). 
13
C NMR (acetone-d6, 125.8 MHz): δ = 142.7, 141.8, 134.2, 131.5, 129.9, 128.9, 
128.4, 127.6, 127.5, 100.8, 71.9, 31.9, 31.6. 
11
B NMR (acetone-d6, 128.38 MHz): δ = 4.2 
(m). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -146.8. IR: ν = 3027, 2835, 1039, 939, 750 
cm
-1
. HRMS (ESI) m/z calc. for C16H16BOF3Cl (M-K) 327.0935, found 327.0947. 
 
Potassium 1-(benzyloxy)-4-phenylbutyltrifluoroborate (2.77). Obtained as a white 
solid (812 mg, 85%). mp: 169-172 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.28-7.22 
(m, 6H, ArCH), 7.21-7.17 (m, 1H, ArCH), 7.15-7.11 (m, 2H, ArCH), 4.48 (d, J = 12.2 
Hz, 1H, OCH2), 4.34 (d, J = 12.2 Hz, 1H, OCH2), 2.60-2.56 (m, 1H, C-H), 2.54-2.50 (m, 
2H, CH2), 1.75-1.71 (m, 1H, CH2), 1.57-1.54 (m, 1H, CH2), 1.43 (q, J = 7 Hz, 2H, CH2). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 143.1, 141.6, 128.2, 128.0, 127.8, 127.0, 126.3, 
125.2, 70.5, 36.0, 31.3, 19.0. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.8 (m). 
19
F NMR 
(DMSO-d6, 338.8 MHz): δ = -144.0. IR: ν = 3025, 2924, 1097, 950, 742 cm
-1
. HRMS 
(ESI) m/z calc. for C17H19BOF3 (M-K) 307.1481, found 307.1487. 
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Potassium 1,4-bis(benzyloxy)butyltrifluoroborate (2.78). Obtained as a white solid 
(526 mg, 67%). mp: 165-166 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.38-7.22 (m, 9H, 
ArCH), 7.22-7.15 (m, 1H, ArCH), 4.53 (s, 2H, OCH2), 4.46 (s, 2 H, OCH2), 3.44 (t, J = 
6.5 Hz, 2H, CH2), 2.79-2.75 (m, 1H, C-H), 1.71-1.58 (m, 4H, CH2). 
13
C NMR (acetone-
d6, 125.8 MHz): δ = 140.2, 140.4, 129.0, 128.8, 128.3, 128.2, 127.9, 127.4, 73.0, 72.2, 
71.9, 28.0, 27.9. 
11
B NMR (acetone-d6, 128.38 MHz): δ = 3.5 (m). 
19
F NMR (acetone-d6, 
338.8 MHz): δ = -146.8. IR: ν = 3028, 2857, 1026, 947, 685 cm
-1
. HRMS (ESI) m/z calc. 
for C18H21BO2F3 (M-K) 337.1587, found 337.1578. 
 
Potassium 1-(benzyloxy)octyltrifluoroborate (2.79). Obtained as a white solid (604 
mg, 61%). mp: 161-164 °C. 
1
H NMR (DMSO-d6, 500 MHz): δ = 7.30-7.26 (m, 4H, 
ArCH), 7.20-7.18 (m, 1H, ArCH), 4.49 (d, J = 12.5 Hz, 1H, OCH2), 4.36 (d, J = 12.5 Hz, 
1H, OCH2), 2.54 (s, 1H, C-H), 1.39-1.36 (m, 3H, CH2), 1.27-1.12 (m, 9H, CH2), 0.87-
0.83 (m, 3H, CH3). 
13
C NMR (DMSO-d6, 125.8 MHz): δ = 141.6, 127.7, 127.0, 126.3, 
70.4, 31.4, 31.2, 29.8, 29.0, 26.8, 22.1, 14.0. 
11
B NMR (DMSO-d6, 128.38 MHz): δ = 3.6 
(m). 
19
F NMR (DMSO-d6, 338.8 MHz): δ = -146.9. IR: ν = 3026, 2852, 1107, 942, 698 
cm
-1
. HRMS (ESI) m/z calc. for C15H23BOF3 (M-K) 287.1794, found 287.1793.
 
 
Potassium (Z)-1-(benzyloxy)dec-7-en-1-yltrifluoroborate (2.80). Obtained as a white 
solid (257 mg, 73%). mp: 122-124 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.37-7.33 
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(m, 2H, ArCH), 7.30-7.24 (m, 2H, ArCH), 7.23-7.17 (m, 1H, ArCH), 5.35-5.29 (m, 2H, 
C=C-H), 4.56-4.50 (m, 2H, OCH2), 2.79-2.74 (m, 1H, C-H), 2.04-2.00 (m, 4H, CH2), 
1.54-1.44 (m, 3H, CH2), 1.38-1.26 (m, 5H, CH2), 0.93 (t, J = 7.5 Hz, 3H, CH3). 
13
C NMR 
(acetone-d6, 125.8 MHz): δ = 141.9, 131.9, 130.2, 129.0, 128.8, 128.4, 127.4, 72.0, 31.6, 
30.8, 27.8, 27.6, 21.0, 14.7. 
11
B NMR (acetone-d6, 128.38 MHz): δ = 4.5 (m). 
19
F NMR 
(acetone-d6, 338.8 MHz): δ = -146.9. IR: ν = 2926, 2853, 1653, 1047, 966, 698 cm
-1
. 
HRMS (ESI) m/z calc. for C17H25BOF3 (M-K) 313.1951, found 313.1952.
 
 
Potassium (benzyloxy)(phenyl)methyltrifluoroborate (2.81). Obtained as a white solid 
(240 mg, 79%). mp: 134-136 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.37-7.34 (m, 2H, 
ArCH), 7.32-7.27 (m, 4H, ArCH), 7.24-7.17 (m, 3H, ArCH), 7.07-7.02 (m, 1H, ArCH), 
4.53 (d, J = 12.2 Hz, 1H, OCH2), 4.21 (d, J = 12.2 Hz, 1H, OCH2), 3.84 (s, 1H, C-H). 
13
C 
NMR (acetone-d6, 125.8 MHz): δ = 146.6, 141.1, 129.0, 128.4, 128.0, 127.7, 125.2, 71.7. 
11
B NMR (acetone-d6, 128.38 MHz): δ = 3.3 (m). 
19
F NMR (acetone-d6, 338.8 MHz): δ = 
-148.2. IR: ν = 3027, 2926, 1046, 991, 700, 619 cm
-1
. HRMS (ESI) m/z calc. for 
C14H13BOF3 (M-K) 265.1012, found 265.1019.
 
 
Potassium (benzyloxy)(naphthalen-2-yl)methyltrifluoroborate (2.82). Obtained as a 
white solid (483 mg, 89%). mp: 142-144 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.76 
(dd, J = 14.9 Hz, 2H, ArCH), 7.72-7.69 (m, 2H, ArCH), 7.58 (d, J = 8.5 Hz, 1H, ArCH), 
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7.41-7.28 (m, 6H, ArCH), 7.25-7.19 (m, 1H, ArCH), 4.58 (d, J = 12.4 Hz, 1H, OCH2), 
4.28 (d, J = 12.4 Hz, 1H, OCH2), 4.01 (s, 1H, C-H). 
13
C NMR (DMSO-d6, 125.8 MHz): δ 
= 144.9, 140.5, 133.0, 131.3, 127.9, 127.2, 127.0, 126.8, 126.6, 126.0, 125.1, 124.0. 
11
B 
NMR (acetone-d6, 128.38 MHz): δ = 3.3 (m). 
19
F NMR (acetone-d6, 338.8 MHz): δ = -
148.0. IR: ν = 3060, 2861, 1092, 1024, 750 cm
-1
. HRMS (ESI) m/z calc. for C18H15BOF3 
(M-K) 315.1168, found 315.1163.
 
 
General Procedure for the Cross-Coupling of Potassium 1-
(Benzyloxy)alkyltrifluoroborates. In a Biotage microwave vial equipped with a stir bar 
was successively introduced cataCXium A-Pd-G2 (1.9 µmol, 0.075 equiv), potassium 1-
(benzyloxy)-3-phenyl-propyltrifluoroborate (0.25 mmol, 1 equiv), and CsOH-H2O (1.25 
mmol, 5 equiv). The vial was sealed with a cap lined with a disposable Teflon septum, 
evacuated under vacuum, and purged with Ar three times. The electrophile was then 
added using a microsyringe (0.25 mmol, 1 equiv) followed by 0.25 mL of degassed 
CPME and 0.25 mL of degassed H2O. The resulting mixture was placed in an oil bath 
preheated to 105 °C and stirred for 24 h. After cooling to rt, the vial was uncapped, and 
the reaction mixture was diluted with EtOAc (3 mL) and H2O (3 mL). The reaction 
mixture was extracted with EtOAc (3 x 3 mL) and dried (MgSO4). The solvent was 
removed in vacuo, and the product was purified by flash column chromatography on 
silica gel or Florisil using a mixture of EtOAc/hexanes as the eluent. 
 
169 
 
1-(1-(Benzyloxy)octyl)-4-methoxybenzene (2.83). Obtained as a yellow oil (42 mg, 
51%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.36-7.28 (m, 4H, ArCH), 7.27-7.24 (m, 3H, 
ArCH), 6.91 (d, J =8.6 Hz, 2H, ArCH), 4.43 (d, J = 12.0 Hz, 1H, OCH2), 4.25-4.21 (m, 
2H, C-H and OCH2), 3.82 (s, 3H, CH3), 1.89-1.82 (m, 1H, CH2), 1.64-1.58 (m, 1H, CH2), 
1.43-1.37 (m, 1H, CH2), 1.29-1.23 (m, 9H, CH2), 0.86 (t, J = 6.8 Hz, 3H, CH3). 
13
C NMR 
(CDCl3, 125.8 MHz): δ = 159.0, 138.8, 134.8, 128.3, 128.0, 127.7, 127.4, 113.8, 81.0, 
70.0, 55.2, 38.3, 31.8, 29.5, 29.2, 26.0, 22.6, 14.0. IR: ν = 2927, 28522, 1510, 1246, 830, 
732 cm
-1
. HRMS (ESI) m/z calc. for C22H30O2Na (M+Na)
+
 349.2144, found 349.2157. 
 
1-(1-(Benzyloxy)-4-phenylbutyl)-4-methoxybenzene (2.84). Obtained as a yellow oil 
(62 mg, 72%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.36-7.26 (m, 9H, ArCH), 7.20-7.15 (m, 
3H, ArCH), 6.93 (d, J = 8.3 Hz, 2H, ArCH), 4.45 (d, J = 11.7 Hz, 1H, OCH2), 4.27 (t, J = 
6.5 Hz, 1H, C-H), 4.24 (d, J = 11.7 Hz, 1H, OCH2), 3.85 (s, 3H, CH3), 2.63-2.59 (m, 2H, 
CH2), 1.96-1.92 (m, 1H, CH2), 1.83-1.76 (m, 1H, CH2), 1.76-1.71 (m, 1H, CH2), 1.61-
1.56 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 159.0, 142.4, 138.7, 134.5, 128.4, 
128.3, 128.2, 128.0, 127.8, 127.4, 125.6, 123.8, 80.8, 70.1, 55.2, 37.9, 35.8, 27.7. IR: ν = 
2939, 2836, 1510, 1246, 1034, 697 cm
-1
. HRMS (ESI) m/z calc. for C24H26O2Na 
(M+Na)
+
 369.1831, found 369.1847. 
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1-(1-(Benzyloxy)-3-phenylbutyl)-4-methoxybenzene (2.85). Obtained as a yellow oil 
(82 mg, 95%), Mixture of diastereomers. 
1
H NMR (CDCl3, 500 MHz): δ = 7.39-1.19 (m, 
14H, ArCH), 6.97-6.88 (m, 4H, ArCH), 4.40-4.32 (m, 2H, C-H and OCH2), 4.23-4.19 (m, 
1H, OCH2), 4.14-4.10 (m, 2H, C-H and OCH2), 4.07-4.00 (m, 1H, OCH2), 3.86 (s, 3H, 
CH3), 3.84 (s, 3H, CH3) 3.17-3.10 (m, 1H, C-H), 2.86-2.76 (m, 1H, C-H), 2.36-2.30 (m, 
1H, CH2) 2.21-2.15 (m, 1H, CH2), 1.95-1.79 (m, 2H, CH2), 1.30-1.25 (m, 3H, CH3), 
1.25-1.19 (m, 3H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 159.1, 159.0, 147.2, 126.9, 
138.7, 138.6, 134.8, 134.2, 128.4, 128.3, 128.27, 128.17, 128.0, 127.7, 127.4, 127.3, 
127.2, 127.0, 125.91, 125.90, 113.8, 79.04, 78.98, 70.4, 70.0, 55.2, 47.5, 46.3, 36.6, 36.0, 
22.9, 22.4. IR: ν = 2956, 2835, 1510, 1245, 1034, 699 cm
-1
. HRMS (ESI) m/z calc. for 
C24H26O2Na (M+Na)
+
 369.1831, found 369.1840. 
 
1-(1-(Benzyloxy)-2-phenylethyl)-4-methoxybenzene (2.86). Obtained as a yellow oil 
(53 mg, 66%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.32-7.22 (m, 8H, ArCH), 7.17 (dd, J = 
18.3, 8.3 Hz, 4H, ArCH), 6.91 (d, J = 8.3 Hz, 2H, ArCH), 4.51-4.46 (m, 2H, C-H and 
OCH2), 4.24 (d, J = 12.0 Hz, 1H, OCH2), 3.85 (s, 3H, CH3), 3.22-3.18 (m, 1H, CH2), 
2.97-2.94 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 159.0, 138.6, 138.5, 133.8, 
129.6, 128.2, 120.0, 127.9, 127.5, 127.2, 126.0, 113.7, 82.0, 70.1, 55.2, 44.9. IR: ν = 
2911, 2935, 1510, 1245, 1070, 698 cm
-1
. HRMS (ESI) m/z calc. for C22H22O2Na 
(M+Na)
+
 341.1517, found 341.1501. 
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1-((Benzyloxy)(phenyl)methyl)-4-methoxybenzene (2.87). Obtained as a yellow oil (40 
mg, 52%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.36-7.30 (m, 8H, ArCH), 7.30-7.27 (m, 4H, 
ArCH), 6.86 (d, J = 8.1 Hz, 2H, ArCH), 5.40 (s, 1H, C-H), 4.52 (s, 2H, OCH2), 3.78 (s, 
3H, CH3). 
13
C NMR (CDCl3, 125.8 MHz): δ = 159.0, 142.4, 138.5, 128.4, 128.3, 127.7, 
127.5, 127.3, 127.0, 113.8, 82.0, 70.3, 55.2. IR: ν = 2934, 2835, 1510, 1246, 1029, 736, 
698 cm
-1
. HRMS (ESI) m/z calc. for C21H20O2Na (M+Na)
+
 327.1361, found 327.1367. 
 
1-((1-(4-Methoxyphenyl)-3-phenylpropoxy)methyl)-2-methylbenzene (2.88). 
Obtained as a yellow oil (53 mg, 61%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.23-7.14 (m, 
5H, ArCH), 7.14-7.07 (m, 4H, ArCH), 7.07-7.01 (m, 2H, ArCH), 6.83 (d, J = 7.9 Hz, 2H, 
ArCH), 4.32 (d, J = 11.6 Hz, 1H, OCH2), 4.21-4.13 (m, 2H, C-H, OCH2), 3.75 (s, 3H, 
CH3), 2.72-2.65 (m, 1H, CH2), 2.56-2.50 (m, 1H, CH2), 2.22 (s, 3H, CH3), 2.16-2.10 (m, 
1H, CH2), 1.88-1.83 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 159.1, 142.0, 
136.7, 136.5, 134.4, 130.2, 128.8, 128.4, 128.3, 128.0, 127.7, 125.7, 125.6, 113.8, 80.3, 
68.6, 55.3, 39.9, 32.2, 18.9. IR: ν = 3025, 2930, 1510, 1246, 1035, 831, 743, 699 cm
-1
. 
HRMS (CI) m/z calc. for C24H26O2 (M)
+
 346.1933, found 346.1926. 
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1-Methoxy-3-((1-(4-methoxyphenyl)-3-phenylpropoxy)methyl)benzene (2.89). 
Obtained as a yellow oil (80 mg, 89%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.28-7.23 (m, 
5H, ArCH), 7.17-7.13 (m, 3H, ArCH), 6.91-6.83 (m, 4H, ArCH), 6.82 (d, J = 7.6 Hz, 1H, 
ArCH), 4.40 (d, J = 11.9 Hz, 1H, OCH2), 4.27-4.23 (m, 1H, C-H), 4.20 (d, J = 11.9 Hz, 
1H, OCH2), 3.81 (s, 3H, CH3), 3.80 (s, 3H, CH3), 2.78-2.73 (m, 1H, CH2), 2.65-2.60 (m, 
1H, CH2), 2.22-2.14 (m, 1H, CH2), 1.97-1.90 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 
MHz): δ = 159.7, 159.1, 142.0, 140.3, 134.3, 129.3, 128.4, 128.3, 128.0, 125.7, 120.0, 
113.8, 113.2, 113.0, 80.2, 70.0, 55.3, 55.2, 39.8, 32.1. IR: ν = 3025, 2834, 1610, 1510, 
1247, 1037, 832, 697 cm
-1
. HRMS (ESI) m/z calc. for C24H26O3Na (M+Na)
+
 385.1780, 
found 385.1779. 
 
1-Methoxy-4-(1-((4-methoxybenzyl)oxy)-3-phenylpropyl)benzene (2.90). Obtained as 
a yellow oil (76 mg, 84%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.29-7.25 (m, 6H, ArCH), 
7.20-7.13 (m, 3H, ArCH), 6.91 (dd, J = 14.6, 8.4 Hz, 4H, ArCH), 4.39 (d, J = 11.3 Hz, 
1H, OCH2), 4.26 (dd, J = 7.7, 5.6 Hz, 1H, C-H), 4.18 (d, J = 11.3 Hz, 1H, OCH2), 3.84 
(s, 3H, CH3), 3.83 (s, 3H, CH3), 2.80-2.74 (m, 1H, CH2), 2.65-2.60 (m, 1H, CH2), 2.23-
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2.16 (m, 1H, CH2), 1.97-1.92 (m, 1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 159.1, 
159.0, 142.0, 134.5, 130.8, 129.4, 128.3, 128.0, 125.6, 113.8, 113.7, 79.8, 69.8, 55.3, 
55.2, 39.8, 32.1. IR: ν = 3026, 2921, 1610, 1512, 1246, 1033, 831, 698 cm
-1
. HRMS 
(ESI) m/z calc. for C24H26O3Na (M+Na)
+
 385.1780, found 385.1790. 
 
1-Phenethyl-1,3-dihydroisobenzofuran (2.91). Obtained as a yellow oil (45 mg, 80%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.33-7.28 (m, 4H, ArCH), 7.27-7.23 (m, 3H, ArCH), 
7.22-7.17 (m, 2H, ArCH), 5.31 (s, 1H, C-H) , 5.20 (d, J = 12 Hz, 1H, OCH2), 5.13 (d, J = 
12 Hz, 1H, OCH2), 2.84-2.82 (m, 1H, CH2), 2.23-2.21 (m, 1H, CH2), 2.06-2.03 (m, 1H, 
CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 142.0, 141.8, 139.4, 128.4, 128.3, 127.4, 
127.2, 125.7, 121.01, 120.95, 83.2, 72.6, 38.0, 31.4. IR: ν = 3027, 2934, 1029, 751, 699 
cm
-1
. HRMS (ESI) m/z calc. for C16H15 (M-OH)
+
 207.1174, found 207.1173. 
 
1-(Benzyloxy)-2,3-dihydro-1H-indene (2.92). Obtained as a yellow oil (41 mg, 73%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.47-7.40 (m, 3H, ArCH), 7.40-7.33 (m, 2H, ArCH), 
7.32-7.22 (m, 4H, ArCH), 5.06 (dd, J = 6.5, 4.5 Hz, 1H, C-H), 4.70-4.64 (m, 2H, OCH2), 
3.16-3.11 (m, 1H, CH2), 2.88-2.85 (m, 1H, CH2), 2.41-2.37 (m, 1H, CH2), 2.21-2.18 (m, 
1H, CH2). 
13
C NMR (CDCl3, 125.8 MHz): δ = 144.0, 142.8, 138.8, 128.3, 127.7, 127.5, 
126.3, 125.0, 124.9, 82.6, 70.5, 32.4, 30.0. IR: ν = 3061, 2931, 1712, 1274, 754 cm
-1
. 
HRMS (CI) m/z calc. for C16H15O (M-H)
+
 223.1123, found 223.1124. 
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Procedure for the Synthesis of cataCXium. A-Pd-G2. µ-Chloro aminobiphenyl 
palladium dimer (0.69 mmol, 0.525 equiv) and cataCXium A (1.36 mmol, 1 equiv) were 
added to a Biotage microwave vial. The vial was sealed with a cap lined with a 
disposable Teflon septum, and evacuated under vacuum and purged with Ar three times. 
Degassed acetone was added (5 mL), and the reaction stirred at rt overnight. The product 
was collected by vacuum filtration and washed with hexane (15 mL) to yield cataCXium 
A-Pd-G2. 
 
cataCXium A-Pd-G2 (2.40). Obtained as an off-white solid (886 mg, 92%). mp: >250 
°C. 
1
H NMR (CDCl3, 500 MHz): δ = 7.42-7.38 (m, 2H, ArCH), 7.23-7.15 (m, 4H, 
ArCH), 7.09-7.02 (m, 2H, ArCH), 4.79-4.74 (br s, 1H), 4.68-4.64 (br s, 1H), 2.34-2.27 
(br s, 3H), 2.24-2.14 (m, 7H), 2.11-2.05 (m, 6H), 1.84-1.76 (br s, 6H), 1.76-1.71 (m, 3H), 
1.67-1.55 (m, 6H), 1.53-1.46 (m, 1H), 1.11-1.02 (br s, 1H), 0.90-0.83 (br s, 1H), 0.61-
0.57 (t, J = 6.9 Hz, 3H), 0.51-0.36 (br s, 2H). 
13
C NMR (CDCl3, 125.8 MHz): δ = 140.7, 
140.6, 135.8, 128.0, 127.3, 125.3, 125.08, 119.8, 40.5, 39.9, 36.8, 36.7, 29.1, 29.0, 28.9, 
28.8, 25.4, 14.0. 
31
P NMR (CDCl3, 145.8 MHz): δ = 52.3 (s). IR: ν = 3311, 2910, 1092, 
1044, 1022, 744 cm
-1
. HRMS (ESI) m/z calc. for C36H49NPPd (M-HCl)
+
 632.2637, found 
632.2624. 
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Procedure for the Debenzylation of 2.49. Pd/C (0.03 mmol, 10 mol %) was added to a 
Biotage microwave vial followed by 2.49 (0.3 mmol) and degassed EtOH (1 mL). The 
reaction stirred overnight at rt under an H2 atmosphere. The reaction was filtered through 
Celite, rinsed with Et2O (5 mL), and concentrated. The crude reaction mixture was 
purified by flash chromatography using 15% EtOAc/hexanes to yield the desired 
compound. 
 
1-(4-Methoxyphenyl)-3-phenylpropan-1-ol (2.93). Obtained as a yellow oil (57 mg, 
79%). Physical and spectral data were in accordance with literature data.
79
 
1
H NMR 
(CDCl3, 500 MHz): δ = 7.29-7.27 (m, 4H, ArCH), 7.20 (d, J = 7.3 Hz, 3H, ArCH), 6.90 
(d, J = 8.3 Hz, 2H, ArCH), 4.64 (t, J = 6.5 Hz, 1H, C-H), 3.82 (s, 3H, CH3), 2.76-2.70 
(m, 1H, CH2), 2.69-2.62 (m, 1H, CH2), 2.17-2.10 (m, 1H, CH2), 2.05-1.98 (m, 1H, CH2), 
1.92 (s, 1H, OH). 
13
C NMR (CDCl3, 125.8 MHz): δ = 159.0, 141.8, 136.6, 128.4, 128.3, 
127.1, 125.8, 113.8, 73.4, 55.2, 40.3, 32.0. HRMS (ESI) m/z calc. for C16H17O2 (M-OH)
+
 
241.1229, found 241.1202. 
Procedure for the Synthesis of Enantioenriched 7a. (1R, 2R)-1,2-Dicyclohexyl-1,2-
ethanediol was prepared according to a literature procedure.
80
 (1S, 2S)-1,2-Dicyclohexyl-
1,2-ethanediol was prepared from the corresponding (1S, 2S)-1,2-diphenyl-1,2-ethanediol 
following the same procedure. 
Phenethylboronic acid (900 mg, 6 mmol) and (1R, 2R)-1,2-dicyclohexyl-1,2-
ethanediol (1358 mg, 6 mmol) were added to an oven dried round bottom flask. The flask 
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was evacuated under vacuum and purged with Ar three times, after which anhyd Et2O (10 
mL) was added. The reaction was stirred overnight at rt and was concentrated. The crude 
reaction mixture was purified by flash chromatography using 2-5% EtOAc/hexanes to 
yield the desired compound. 
 
(4R, 5R)-4,5-Dicyclohexyl-2-phenethyl-1,3,2-dioxaborolane. Obtained as a colorless 
oil (2000 mg, 98%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.29-7.19 (m, 4H, ArCH), 7.18-
7.13 (m, 1H, ArCH), 3.83-3.81 (m, 2H, CH2), 2.78-2.75 (m, 2H, CH2), 1.77-1.64 (m, 
8H), 1.54 (d, J = 12.7 Hz, 2H), 1.31-1.23 (m, 2H), 1.22-1.11 (m, 8H), 1.06-0.98 (m, 2H), 
0.93-0.85 (m, 2H). 
13
C NMR (CDCl3, 125.8 MHz): δ = 144.4, 128.1, 128.0, 125.5, 83.4, 
43.0, 30.0, 28.3, 27.3, 26.4, 26.0, 25.9. 
11
B NMR (CDCl3, 128.38 MHz): δ = 33.53 (m). 
IR: ν = 2921, 2850, 1449, 1371, 1240, 1231, 754 cm
-1
. HRMS (ESI) m/z calc. for 
C22H33BO2 (M)
+
 340.2574 found 340.2568. 
 
(4S, 5S)-4,5-Dicyclohexyl-2-phenethyl-1,3,2-dioxaborolane. Run on a 4.2 mmol scale. 
Obtained as a colorless oil (1346 mg, 94%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.29-7.19 
(m, 4H, ArCH), 7.18-7.13 (m, 1H, ArCH), 3.83-3.81 (m, 2H, CH2), 2.78-2.75 (m, 2H, 
CH2), 1.77-1.64 (m, 8H), 1.54 (d, J = 12.7 Hz, 2H), 1.31-1.23 (m, 2H), 1.22-1.11 (m, 
8H), 1.06-0.98 (m, 2H), 0.93-0.85 (m, 2H). 
13
C NMR (CDCl3, 125.8 MHz): δ = 144.4, 
128.1, 128.0, 125.5, 83.4, 43.0, 30.0, 28.3, 27.3, 26.4, 26.0, 25.9. 
11
B NMR (CDCl3, 
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128.38 MHz): δ = 33.5 (m). IR: ν = 2921, 2850, 1449, 1371, 1240, 1231, 754 cm
-1
. 
HRMS (ESI) m/z calc. for C22H33BO2 (M)
+
 340.2574 found 340.2568. 
 
 The homologation procedure followed is based on a literature procedure by 
Matteson.
78
 To a flame dried 25 mL round bottom flask under Ar was successively added 
CH2Cl2 (1069 mg, 12.59 mmol), and THF (5 mL). The resultant solution was cooled to -
78 °C and n-BuLi (2.82 mL, 7.05 mmol) was added dropwise, keeping the temperature 
below -70 °C. After 5 min, a solution of (S, S)-DICHED phenethylboronate (2000 mg, 
5.88 mmol) in THF (1.5 mL) was added dropwise, keeping the temperature below -70 
°C. After 10 min, freshly fused ZnCl2 (641 mg, 4.7 mmol) was added to the solution. The 
solution was warmed to rt and stirred for 36 h. The reaction was cooled to 0 °C and 
quenched with sat. aq NH4Cl (3 mL), extracted with 1:1 Et2O/hexanes, dried (MgSO4), 
and concentrated. 
1
H NMR of the crude material showed complete conversion, and the 
material was carried over without purification. 
 
 
(4R, 5R)-2-((S)-1-Chloro-3-phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane. 
1
H 
NMR (CDCl3, 500 MHz): 7.29-7.26 (m, 4H, ArCH), 7.21-7.17 (m, 1H, ArCH), 3.96-3.94 
(m, 2H, CH2), 3.46 (t, J = 7.3 Hz, 1H, C-H), 2.84 (d, J = 6.8 Hz, 1H, CH2), 2.78 (d, J = 
6.8 Hz, 1H, CH2), 2.14 (q, J = 7.3 Hz, 2H), 1.77-1.53 (m, 10H), 1.47-0.88 (m, 12H). 
13
C 
NMR (CDCl3, 125.8 MHz): δ = 144.4, 128.1, 128.0, 125.5, 83.4, 43.0, 30.0, 28.3, 27.3, 
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26.4, 26.0, 25.9. 
11
B NMR (CDCl3, 128.38 MHz): 33.53 (m). IR: ν = 2925, 2853, 1450, 
1403, 1374, 1242, 982, 699 cm
-1
. HRMS (ESI) m/z calc. for C23H34BClO2Na (M+Na)
+
 
411.2238, found 411.2243. 
 
(4S, 5S)-2-((R)-1-chloro-3-phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane. 
1
H 
NMR (CDCl3, 500 MHz): 7.29-7.26 (m, 4H, ArCH), 7.21-7.17 (m, 1H, ArCH), 3.96-3.94 
(m, 2H, CH2), 3.46 (t, J = 7.3 Hz, 1H, C-H), 2.84 (d, J = 6.8 Hz, 1H, CH2), 2.78 (d, J = 
6.8 Hz, 1H, CH2), 2.14 (q, J = 7.3 Hz, 2H), 1.77-1.53 (m, 10H), 1.47-0.88 (m, 12H). 
13
C 
NMR (CDCl3, 125.8 MHz): δ = 144.4, 128.1, 128.0, 125.5, 83.4, 43.0, 30.0, 28.3, 27.3, 
26.4, 26.0, 25.9. 
11
B NMR (CDCl3, 128.38 MHz): 30.6 (m). IR: ν = 2925, 2853, 1450, 
1403, 1374, 1242, 982, 699 cm
-1
. HRMS (ESI) m/z calc. for C23H34BClO2Na (M+Na)
+
 
411.2238, found 411.2243. 
 
 To a flame dried 25 mL round bottom flask under Ar was successively added 
THF (5 mL), and benzyl alcohol (328 mg, 3.04 mmol). The resultant soln was cooled to -
78 °C and n-BuLi (1.2 mL, 3.09 mmol)) was added dropwise, keeping the temperature 
below -70 °C. Anhyd DMSO (603 mg, 7.72 mmol) was added dropwise, and the soln was 
warmed to rt and stirred for 18 h. (4S, 5S)-2-((S)-1-Chloro-3-phenylpropyl)-4,5-
dicyclohexyl-1,3,2-dioxaborolane (~1000 mg, 2.58 mmol) in THF (1.5 mL) was added to 
the reaction mixture at -78 °C. The resulting mixture was allowed to warm to rt and 
stirred for 36 h. The reaction was cooled to 0 °C and quenched with sat. aq NH4Cl (3 
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mL), extracted with 1:1 Et2O/hexanes, dried (MgSO4), and concentrated. The crude 
reaction mixture was purified by flash chromatography using 2-5% EtOAc/hexanes to 
yield the desired compound. 
 
(4R, 5R)-2-((R)-1-(Benzyloxy)-3-phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 
(2.94). Obtained as colorless oil (950 mg, 80%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.39-
7.37 (m, 2H, ArCH), 7.33 (t, J = 7.5 Hz, 2H, ArCH), 7.27-7.23 (m, 3H, ArCH), 7.18-7.15 
(m, 3H, ArCH), 4.62 (d, J = 11.7 Hz, 1H, OCH2), 4.48 (d, J = 11.7 Hz, 1H, OCH2), 3.92 
(d, J = 3.9 Hz, 2H, CH2), 3.38 (dd, J = 8.1, 5.4 Hz, 1H, C-H), 2.80-2.75 (m, 1H, CH2), 
2.74-2.70 (m, 1H, CH2), 2.06-1.99 (m, 1H), 1.99-1.92 (m, 1H), 1.80-1.73 (m, 6H), 1.68 
(d, J = 11.2 Hz, 2H), 1.62-1.57 (m, 2H), 1.37-1.31 (m, 2H), 1.26-1.03 (m, 8H), 1.01-0.93 
(m, 2H). 
13
C NMR (CDCl3, 125.8 MHz): δ = 142.5, 139.1, 128.6, 128.23, 128.20, 127.3, 
125.6, 83.7, 72.3, 42.9, 33.5, 32.8, 28.3, 27.4, 26.4, 26.0, 25.9. 
11
B NMR (CDCl3, 128.38 
MHz): δ = 32.4 (m). IR: ν = 2924, 2852, 1451, 1396, 1097, 733, 698 cm
-1
. HRMS (ESI) 
m/z calc. for C30H41BO3Na (M+Na)
+
 483.3046, found 483.3047. 
 
(4S, 5S)-2-((S)-1-(Benzyloxy)-3-phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 
(2.94). Obtained as a colorless oil (996 mg, 84%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.39-
7.37 (m, 2H, ArCH), 7.33 (t, J = 7.5 Hz, 2H, ArCH), 7.27-7.23 (m, 3H, ArCH), 7.18-7.15 
(m, 3H, ArCH), 4.62 (d, J = 11.7 Hz, 1H, OCH2), 4.48 (d, J = 11.7 Hz, 1H, OCH2), 3.92 
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(d, J = 3.9 Hz, 2H, CH2), 3.38 (dd, J = 8.1, 5.4 Hz, 1H, C-H), 2.80-2.75 (m, 1H, CH2), 
2.74-2.70 (m, 1H, CH2), 2.06-1.99 (m, 1H), 1.99-1.92 (m, 1H), 1.80-1.73 (m, 6H), 1.68 
(d, J = 11.2 Hz, 2H), 1.62-1.57 (m, 2H), 1.37-1.31 (m, 2H), 1.26-1.03 (m, 8H), 1.01-0.93 
(m, 2H).
 13
C NMR (CDCl3, 125.8 MHz): δ = 142.5, 139.1, 128.6, 128.23, 128.20, 127.3, 
125.6, 83.7, 72.3, 42.9, 33.5, 32.8, 28.3, 27.4, 26.4, 26.0, 25.9. 
11
B NMR (CDCl3, 128.38 
MHz): δ = 32.4 (m). IR: ν = 2924, 2852, 1451, 1396, 1097, 733, 698 cm
-1
. HRMS (ESI) 
m/z calc. for C30H41BO3Na (M+Na)
+
 483.3046, found 483.3047. 
 
 To a 50 mL round bottom flask was added (4S, 5S)-2-((S)-1-(benzyloxy)-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane (996 mg, 2.16 mmol) and MeCN 
(15 mL). The solution was cooled to 0 C, and 4.5 M KHF2 (3.9 mL, 17.3 mmol) was 
added dropwise. MeOH (5 mL) was then added, and the resulting mixture was stirred at 
rt until the reaction was complete as indicated by 
11
B NMR (about 10 min). The reaction 
was concentrated in vacuo. The diol was extracted via hot filtration with pentane (3x25 
mL) followed by a separate hot filtration with MeCN (3x25 mL) to isolate the 
organotrifluoroborate. The MeCN solution was concentrated to a minimal amount (~5 
mL) and precipitated with hexanes (20 mL) to yield potassium (S)-1-(benzyloxy)-3-
phenylpropyltrifluoroborate. 
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Potassium (R)-1-(Benzyloxy)-3-phenylpropyltrifluoroborate (2.95). Obtained as a 
white solid (656 mg, 92%). mp: 125-127 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.41-
7.40 (m, 2H, ArCH), 7.30-7.27 (m, 2H, ArCH), 7.23-7.17 (m, 5H, ArCH), 7.10-7.08 (m, 
1H, ArCH), 4.56 (dd, J = 20, 45 Hz, 2H, OCH2), 2.83-2.78 (m, 2H, C-H, CH2), 2.70-2.64 
(m, 1H, CH2), 1.90-1.80 (m, 2H, CH2). 
13
C NMR (CD3CN, 125.8 MHz): δ = 144.8, 
142.3, 128.9, 128.6, 128.4, 127.7, 127.0, 125.6, 70.1, 34.4, 33.8. 
11
B NMR (acetone-d6, 
128.38 MHz): δ = 3.8 (m). 
19
F NMR (acetone -d6, 338.8 MHz): δ = -146.5. IR: ν = 3027, 
2856, 1044, 1003, 929, 700 cm
-1
. HRMS (ESI) m/z calc. for C16H17BO2F3 (M-K) 
293.1325, found 293.1338. 
 
Potassium (S)-1-(Benzyloxy)-3-phenylpropyltrifluoroborate (2.95). Obtained as a 
white solid (645 mg, 89%). mp: 125-127 °C. 
1
H NMR (acetone-d6, 500 MHz): δ = 7.41-
7.40 (m, 2H, ArCH), 7.30-7.27 (m, 2H, ArCH), 7.23-7.17 (m, 5H, ArCH), 7.10-7.08 (m, 
1H, ArCH), 4.56 (dd, J = 20, 45 Hz, 2H, OCH2), 2.83-2.78 (m, 2H, C-H, CH2), 2.70-2.64 
(m, 1H, CH2), 1.90-1.80 (m, 2H, CH2). 
13
C NMR (CD3CN, 125.8 MHz): δ = 144.8, 
142.3, 128.9, 128.6, 128.4, 127.7, 127.0, 125.6, 70.1, 34.4, 33.8. 
11
B NMR (acetone-d6, 
128.38 MHz): δ = 3.8 (m). 
19
F NMR (acetone -d6, 338.8 MHz): δ = -146.5. IR: ν = 3027, 
2856, 1044, 1003, 929, 700 cm
-1
. HRMS (ESI) m/z calc. for C16H17BO2F3 (M-K) 
293.1325, found 293.1338. 
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Procedure for the Synthesis of Enantioenriched Standard 
 
Stereochemistry of reduction based on:
81
 
 
 To an oven dried 5 mL round bottom flask with stir bar was added (+)-Ipc2BCl 
(292 mg, 0.91 mmol) and THF (1 mL) and cooled to 0 °C. 1-(4-Methoxyphenyl)-3-
phenylpropan-1-one (200 mg, 0.83 mmol) was added in THF (0.5 mL). The reaction was 
warmed to rt and stirred overnight. Diethanolamine (168 mg, 1.6 mmol) was added 
dropwise and stirred for 1 h. The reaction mixture was filtered through Celite, washed 
with EtOAc (5 mL), dried (MgSO4) and concentrated. The crude reaction mixture was 
purified by flash chromatography using 15% EtOAc/hexanes to yield the desired 
compound. 
 
(S)-1-(4-Methoxyphenyl)-3-phenylpropan-1-ol. Obtained as a yellow oil (180 mg, 
90%). Physical and spectral data were in accordance with literature data.
3
 
1
H NMR 
(CDCl3, 500 MHz): δ = 7.29-7.27 (m, 4H, ArCH), 7.20 (d, J = 7.3 Hz, 3H, ArCH), 6.90 
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(d, J = 8.3 Hz, 2H, ArCH), 4.64 (t, J = 6.5 Hz, 1H, C-H), 3.82 (s, 3H, CH3), 2.76-2.70 
(m, 1H, CH2), 2.69-2.62 (m, 1H, CH2), 2.17-2.10 (m, 1H, CH2), 2.05-1.98 (m, 1H, CH2), 
1.92 (s, 1H, OH). 
13
C NMR (CDCl3, 125.8 MHz): δ = 159.0, 141.8, 136.6, 128.4, 128.3, 
127.1, 125.8, 113.8, 73.4, 55.2, 40.3, 32.0. HRMS (ESI) m/z calc. for C16H17O2 (M-OH)
+
 
241.1229, found 241.1202. 
 
To an oven dried 5 mL round bottom flask was added NaH (27 mg, 1.1 mmol) 
and THF (1 mL). The reaction was cooled to 0 °C, and (S)-1-(4-methoxyphenyl)-3-
phenylpropan-1-ol (180 mg, 0.74 mmol) and benzyl bromide (190 mg, 1.1 mmol) were 
succesively added dropwise. The reaction was warmed to rt and stirred overnight. The 
reaction was quenched with sat. aq NH4Cl, extracted with EtOAc (3x2mL), and dried 
(MgSO4). The crude reaction mixture was purified by flash chromatography using 5% 
EtOAc/hexanes to yield the desired compound. 
 
(S)-1-(1-(Benzyloxy)-3-phenylpropyl)-4-methoxybenzene (2.96). Obtained as a yellow 
oil (213 mg, 87%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.39-7.36 (m, 4H, ArCH), 7.33-7.27 
(m, 5H, ArCH), 7.21-7.17 (m, 3H, ArCH), 6.94 (d, J = 8.5 Hz, 2H, ArCH), 4.46 (d, J = 
11.8 Hz, 1H, OCH2), 4.31-4.25 (m, 2H, C-H and OCH2), 3.85 (s, 3H, CH3), 2.82-2.77 (m, 
1H, CH2), 2.69-2.65 (m, 1H, CH2), 2.27-2.22 (m, 1H, CH2), 2.00-1.95 (m, 1H, CH2). 
13
C 
NMR (CDCl3, 125.8 MHz): δ = 159.3, 142.2, 138.9, 134.5, 128.6, 128.5, 128.4, 128.2, 
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128.0, 127.7, 125.9, 114.0, 80.3, 70.4, 55.4, 40.0, 32.3. IR: ν = 3027, 2928, 1246, 698 cm
-
1
. HRMS (ESI) m/z calc. for C23H24O2Na (M+Na)
+
 355.1674, found 355.1663. 
 
Spectral data for the enantioenriched cross-coupled products is the same as the racemic 
products and can be seen in “General Procedure for the Cross-Coupling of Potassium 1-
(Benzyloxy)-3-phenylpropyltrifluoroborate with Aryl and Heteroaryl Chlorides.” The 
optical rotations for these compounds are in the table below.  
Structure [α]
D
23 (c = 1.0, CHCl3) 
 
 
+39.8 
 
+51.3 
 
+48.7 
 
+42.8 
 
+46.0 
 
+51.4 
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Chapter 3. Synthesis and Suzuki-Miyaura Cross-Coupling of Enantioenriched 
Secondary Potassium β-Trifluoroboratoamides: Catalytic, Asymmetric Conjugate 
Addition of Bisboronic Acid and Tetrakis(dimethylamino)diboron to α,β-
Unsaturated Carbonyl Compounds 
3.1 Introduction 
 The preparation of stable, enantiopure building blocks for the direct installation of 
stereocenters has allowed significant advances over the last decade.
1
 Because of their 
favorable properties, including low toxicity and increased air- and moisture stability 
relative to other organometallic reagents, organoboron compounds have become 
preferred organometallic reagents in the synthesis of configurationally stable, enantiopure 
“stereocenters in a bottle.” The Suzuki-Miyaura cross-coupling of enantioenriched 
secondary alkyl boronates proceeds with complete stereochemical fidelity, which can be 
predicted based on the presence or absence of an electron-donating stabilizing group. 
Further, the enantioenriched boronate can be easily converted to the corresponding 
alcohols, amines, or halides with complete stereochemical control to provide access to 
other enantioenriched systems.
2
 Therefore, methods to prepare enantioenriched secondary 
organoboron compounds in high yield and enantiomeric excess are important for 
accessing complex molecules in an enantiopure form. 
3.2 Catalytic, Asymmetric Conjugate Addition of Bispinacolatodiboron to α,β-
Unsaturated Carbonyl Compounds 
 The transition-metal catalyzed conjugate addition of dibora reagents to afford 
secondary β-borylated carbonyl compounds is an important transformation in organic 
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synthesis as it provides access to a useful class of synthetic intermediates whose synthons 
exhibit umpolung reactivity, leading to strategic C-C bond formation (Scheme 3.1).  
Scheme 3.1. Umpolung Reactivity of β-Borylated Carbonyl Compounds 
 
Specifically, the 1,4-addition of bispinacolatodiboron (B2pin2) to α,β-unsaturated 
carbonyl compounds has been mediated by an array of transition metals. Platinum,
3
 
nickel,
4
 copper,
5
 rhodium
6
 and palladium
7
 have been employed in the synthesis of 
racemic β-borylated compounds. The first examples of the nickel- and palladium-
catalyzed, asymmetric addition of B2pin2 employing chiral ligands was first reported in 
2009.
8
 Of the six different chiral ligands tested in the nickel-catalyzed reaction, (R, S)-
Taniaphos provided the product with the highest levels of enantiomeric excess. The 
developed conditions were applied to three different α,β-unsaturated esters in high yield 
and enantiomeric excess (Eq 3.1). 
Equation 3.1 
 
 (R, S)-Taniaphos also provided a high level of asymmetric induction for the 
palladium-catalyzed addition of B2pin2. However, the conversion to the desired product 
was only 31%. By changing the ligand to (R, S)-Josiphos, the desired enantioenriched β-
borylated ester was isolated in 81% yield with 91% ee (Eq 3.2).
8
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Equation 3.2 
 
The asymmetric, conjugate addition of B2pin2 can also be mediated by a chiral 
rhodium catalyst.
9
 After addition of B2pin2, the intermediate borylated product was 
oxidized in situ to the corresponding alcohol by addition of NaBO3•4H2O. An array of 
Rh(Phebox) catalysts were tested in the 1,4-addition with varying results. Rh(Phebox-ip) 
proved to be an efficient catalyst for this reaction as the secondary alcohol was isolated in 
82% yield with 94% ee (Eq 3.3). 
Equation 3.3 
 
 Transition-metal free additions of B2pin2, catalyzed by chiral phosphines
10
 or N-
heterocyclic carbenes,
11
 have been reported. The asymmetric induction achieved results 
from the chiral ligand filling the vacant orbital on one of the boron atoms of the dibora 
reagent, generating a nucleophilic boronate species capable of undergoing 1,4-addition. 
For example, the addition of 4 mol % of (R,S)-Josiphos catalyzes the asymmetric, 1,4-
addition of B2pin2 to α,β-unsaturated esters and ketones in high conversion and moderate 
to good levels of enantiomeric excess (Eq 3.4). 
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Equation 3.4 
 
 Despite advances with these transition metals and metal-free methods, copper is 
the cheapest and least toxic of the transition metals shown to facilitate this 
transformation.
12
 Copper has been shown to be an effective metal for the conjugate 
addition as methods exist for the racemic and asymmetric borylation of α,β-unsaturated 
ketones, esters, and amides.
5
 Initial reports on the copper-mediated borylation were 
limited by the use of activated enones and copper loadings of 10-110 mol %. Yun 
reported a method to alleviate these limitations by employing a Xantphos-type ligand, 
which would increase the reactivity of the copper catalyst. Yun also employed an alcohol 
additive, which would increase the reaction rate by facilitating protolytic turnover of the 
catalyst. Therefore, addition of 2 equiv of methanol with DPEPhos as a ligand resulted in 
reaction times of 1.5 h to yield racemic β-borylated esters and ketones in high yield (Eq 
3.5).
13
 
Equation 3.5 
 
The borylation of α,β-unsaturated amides was unsuccessful under the previously 
optimized conditions because of the decreased reactivity of these compounds as Michael 
acceptors. For the borylation of α,β-unsaturated amides, a bidentate phosphine ligand 
which chelates to a single copper center was the most effective type of ligand for the 
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conjugate borylation. Therefore, ligands such as 1,2-bis(diphenylphosphino)benzene 
(dppbz) and 1,1′-bis(di-tert-butylphosphino)ferrocene (dtbpf) were suitable for the 
synthesis of racemic β-borylated amides. Yun extended this 1,4-addition to the synthesis 
of an enantioenriched β-borylated amide by employing (R, S)-Josiphos as the ligand. The 
corresponding product was oxidized in situ with NaBO3•4H2O and isolated as the 
secondary alcohol in 81% yield with 99% ee (Eq 3.5).
14
 
Equation 3.6 
 
3.3 The Emergence of Greener, More-Atom Economical Dibora Reagents 
 Although B2pin2 is an air-stable dibora reagent capable of providing the β-
borylated in high yield and enantiomeric excess, tetrahydroxydiboron (bisboronic acid or 
BBA) and tetrakis(dimethylamino)diboron have been demonstrated to be more 
sustainable and more atom economical dibora species (Figure 3.1). A more suitable 
dibora source is needed to overcome the fact that only 10% of the mass of B2pin2 is 
incorporated into the product if the desired product is a boronic acid whereas a much 
improved 50% of BBA is incorporated. In fact, a >50% reduction in mass of the starting 
material can be achieved when changing the borylating agent from B2pin2 to BBA. 
Furthermore, hydrolysis of B2pin2 to the corresponding boronic acid or potassium 
organotrifluoroborate results in a large amount of waste in the form of pinacol, which is 
difficult to remove from reaction mixtures.
15
 The by-product from the conversion to the 
198 
 
corresponding trifluoroborate from BBA or tetrakis(dimethylamine) is water or 
dimethylamine, respectively, greatly improving the isolation of the product.  
 
Figure 3.1. Comparison of Various Dibora Sources 
 The first reported synthesis of BBA was the addition of water to 
tetrachlorodiboron in 1955, which provided BBA in quantitative yield (Eq 3.7).
16
 The 
BBA was subsequently dehydrated to synthesize boron monoxide. 
Equation 3.7 
 
The synthesis of tetrakis(dimethyl)aminodiboron was first reported in 1960
17
 and 
has been adapted to the modern synthesis of bispinacolatodiboron.
18
 Boron tribromide 
reacts with dimethylamine to form the tris-amine borate, which then reacts with another 
equivalent of boron tribromide to form bromo-bis(dimethylamino)aminoborane. 
Subsequent Wurtz-type coupling with sodium provides the desired 
tetrakis(dimethylamino)diboron (Scheme 3.2). 
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Scheme 3.2. Synthesis of Tetrakis(dimethylamino)diboron 
 
 Tetrakis(dimethylamino)diboron is the synthetic precursor to both BBA and 
B2pin2.
19
 Addition of aqueous HCl to tetrakis(dimethylamino)diboron provides BBA, 
whereas addition of pinacol and HCl in a pentane/ether solvent mixture results in B2pin2 
(Figure 3.1). 
 The promising utility of BBA as a dibora reagent for the installation of boronic 
acids and boronate esters was first realized by Szabo in 2005 in the synthesis of allyl 
boronate species. Szabo demonstrated that BBA can be employed in a palladium pincer 
complex-catalyzed substitution of vinyl cyclopropanes, aziridines, and allylic acetates to 
form the corresponding potassium trifluoroborates after addition of KHF2 in 60-98% 
yield (Eq 3.8).
20
 Szabo extended this method to the synthesis of allylic trifluoroborates 
from the corresponding allylic alcohols.
21
 
Equation 3.8 
 
Szabo then demonstrated that the allylboronates generated from the borylation of 
allylic alcohols can undergo subsequent transformation in a one-pot manner. The allylic 
alcohols can be converted to the allylic boronate ester and further subjected to a Petasis 
Borono-Mannich reaction or an allylation of carbonyl compounds. This method showed 
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that the in situ formed allylic boronate is stable to acid, base, alcohols, water, and air to 
such an extent that the reaction with various aldehydes, ketones, and imines proceeds in 
high yield (Eq 3.9).
22
 
Equation 3.9 
 
 Molander realized the potential of BBA to serve as a more atom economical 
dibora reagent in the synthesis of aryl and heteroaryltrifluoroborates. Molander 
developed a palladium-catalyzed Miyaura borylation of aryl chlorides with BBA, 
employing the XPhos derivative of Buchwald’s first generation precatalyst
23
 (XPhos-Pd-
G1) (Eq 3.10).
24
 Molander demonstrated that the in situ generated arylboronate can easily 
be converted to an array of boronate esters including both the MIDA boronate and 
potassium trifluoroborate. Further, the in situ generated aryl boronate can be subjected to 
a Suzuki-Miyaura cross-coupling via addition of a second aryl chloride, without isolation 
of the intermediate boronate species. 
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Equation 3.10 
  
Molander extended the method to an array of aryl and heteroaryl halides under 
improved reaction conditions, which decreased catalyst loading and reaction temperatures 
(Eq 3.11).
25
 XPhos-Pd-G2, the XPhos derivative of Buchwald’s second general 
precatalyst,
26
 proved to be a superior palladium source as the palladium loading was 
lowered to 0.5 mol %. The one-pot Suzuki-Miyaura couplings were also extended to 
include a wide array of aryl and heteroaryl bromides. 
Equation 3.11 
  
Because of the high cost of palladium catalysts, Molander developed a nickel-
catalyzed method for synthesis of aryl and heteroaryltrifluoroborates from aryl halides.
27
 
This reaction proceeds at room-temperature for a large variety of substrates with only 1 
mol % of the nickel catalyst (Eq 3.12). This method also employs a non-proprietary, 
inexpensive ligand compared to the palladium-catalyzed method. 
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Equation 3.12 
 
As tetrakis(dimethyl)aminodiboron is the synthetic precursor to BBA, employing 
tetrakis(dimethyl)aminodiboron as a dibora source in the palladium-catalyzed borylation 
of aryl halides allows the use of a more atom-economical reagent. By simply switching 
the solvent from EtOH to MeOH and increasing the concentration, an array of aryl and 
heteroaryltrifluoroborates were synthesized in high yield (Eq 3.13).
19
  
Equation 3.13 
   
Tetrakis(dimethylamino)diboron can be converted to an array of dibora reagents 
in situ by addition of an alcohol to form tetra(alkoxy)diboron reagents. These 
tetra(alkoxy)diboron reagents can subsequently be reacted with aryl bromides to form the 
arylboronates with high conversion.
28
 
3.4 Catalytic, Asymmetric Addition of Bisboronic Acid and 
Tetrakis(dimethylamino)diboron to α,β-Unsaturated Carbonyl Compounds 
 The copper-catalyzed synthesis of potassium β-trifluoroboratoamides, -esters, 
and -ketones utilizing BBA as a dibora source was reported by Molander in 2011. The 
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1,4-addition required only 1.2 equiv of BBA and 2 mol % CuCl with CyJohnPhos as the 
ligand to provide the desired trifluoroborates in high yield (Eq 3.14).
29
 
Equation 3.14 
 
 Based on this precedent, the synthesis of enantioenriched potassium β-
trifluoroboratoamides through a copper-catalyzed conjugate addition with BBA and/or 
tetrakis(dimethylamino)diboron was envisioned. Enantioenriched potassium β-
trifluoroboratoamides are present in the literature as they were prepared by employing the 
conditions developed by Yun for the asymmetric, conjugate addition of B2pin2 to α,β-
unsaturated amides, followed by conversion to the β-trifluoroboratoamide by addition of 
KHF2 (Eq 3.15).
30
 
Equation 3.15 
 
 (E)-N-(4-Methoxyphenyl)but-2-enamide was chosen as the model substrate for 
optimizing the reaction, with BBA as a dibora species, as it was shown to undergo the 
copper-catalyzed conjugate addition to provide the corresponding trifluoroborate with an 
enantiomeric ratio of 93:7 (Eq 3.15). High-throughput experimentation (HTE) was 
utilized to determine optimal reaction conditions. One of the main benefits in performing 
HTE in the synthesis of enantioenriched compounds is the minimal use of expensive 
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chiral ligands required as performing the reactions on a 10-µmol scale allows a variety of 
reaction conditions to be tested with a minute amount of ligand. 
 The purpose of the first screen was to determine if there was an ideal ligand to 
provide both high levels of conversion and asymmetric induction for the desired 
transformation. Yun reported that the asymmetric addition of α,β-unsaturated amides 
with B2pin2 required a chiral ligand, the backbones or chain lengths of which were 
similar to those effective in the racemic borylation (dppbz or dppp), and therefore, (R,S)-
Josiphos provided two enantioenriched products in high yield (81%) and enantiomeric 
ratios (up to 99:1) (Eq 3.6).
14
 
 The ligands chosen for the screen were based largely on Yun’s platform but also 
included several structurally diverse ligands. A total of 50 chiral ligands were screened 
under various conditions with BBA as the dibora species. Several copper sources were 
screened in the reaction, including CuCl, which served as the copper source for both 
Yun’s asymmetric borylation
14
 and Molander’s synthesis of racemic β-
trifluoroboratoamides.
29
 Several alcohol solvents were screened in the reaction. A protic 
solvent will convert the dibora reagent to the corresponding tetra(alkoxy)dibora source in 
situ.
19
 A protic solvent also facilitates protolytic turnover of the catalyst.
31
 The last 
variable is the type and amount of alkoxide base. The alkoxide base undergoes 
transmetalation with the CuX species to form a Cu-[OR] species, which is capable of 
undergoing transmetalation with the dibora reagent to form the active Cu-B(OR)2 
catalyst. Various amounts of base were screened because the synthesis of racemic 
potassium β-trifluoroboratoamides requires excess base to sequester the produced B(OR)3 
in the form of MB(OR)4.
29
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The conjugate addition of (E)-N-(4-methoxyphenyl)but-2-enamide with BBA 
results in the synthesis of a secondary alkylboronate. For ease of analysis, this 
intermediate was converted to the corresponding alcohol via oxidation with NaBO3•4H2O 
(Eq 3.16).  
Equation 3.16 
 
The reactions in the screen were analyzed by HPLC after addition of an internal 
standard to determine the relative amounts of unreacted starting material and desired 
product. The ratios of product-to-internal standard (P/IS) and starting material-to-internal 
standard (SM/IS) can be directly compared for each reaction in a screen. However, for 
comparison between two different screens, the results can only be correlated if the same 
internal standard and HPLC conditions are used for analyzing both screens. 
The top hits from the screen with 50 different chiral ligands are depicted in Figure 
3.2. SFC analysis was performed to determine the enantiomeric ratios; however, only 
those reactions with high P/IS ratios were subjected to SFC analysis. The P/IS ratios were 
normalized for ease of comparison with the enantiomeric ratios. The results from only the 
top twelve ligands are displayed; the remaining screening results can be viewed in the 
Appendix A2A. 
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Figure 3.2. Graphical summary of Screen 1. Reaction conditions: 1.0 equiv of 1, 2.0 
equiv of BBA, 0.05 equiv of CuCl, 0.05 equiv of ligand, 0.30 equiv of NaOt-Bu or 
KOMe, EtOH, rt, 24 h. L1 = 1,2-bis[(2S,5S)-2,5-diisopropylphospholano]ethane. L2 
= (2R,5R)-1-{[(2R,5R)-2,5-diphenylpyrrolidin-1-yl]methylene}-2,5-
diphenylpyrrolidinium tetrafluoroborate. 
Only three ligands (ROPhos,
32
 Taniaphos T001,
33
 and (2R, 5R)-1-{[(2R, 5R)-2,5-
phenylpyrrolidin-1-yn]methylene}-2,5-diphenylpyrrolidinium tetrafluoroborate
34
 3.1) out 
of the fifty screened provided an enantiomeric excess of greater than 70% (Figure 3.3). 
Interestingly, (R, S)-Josiphos, which provided high levels of asymmetric induction when 
B2pin2 was the borylating agent, was not effective when the borylating agent was 
switched to BBA, as the secondary alcohol was synthesized in modest yield and 
enantiomeric ratio. 
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Figure 3.3. Structures of Taniaphos T001, ROPhos, and 3.1 
When ROPhos was the ligand, the corresponding enantioenriched alcohol was 
synthesized in an enantiomeric ratio of 86:14. Further optimization with ROPhos as the 
ligand did not provide any higher level of asymmetric induction. Taniaphos T001 as the 
ligand provided the product in an enantiomeric excess of >99:1. However, the conversion 
from this initial screen was under 50%. Attempts to increase the conversion by varying 
the solvent, concentration, base, and copper source resulted in only 50% yield of the 
enantioenriched alcohol after oxidation with NaBO3•4H2O. 
Further optimization of two out of the top three ligands did not lead to optimal 
reaction conditions. The only ligand with high levels of both asymmetric induction and a 
high P/IS ratio was 3.1. This carbene precursor forms the active ligand upon 
deprotonation with base and subsequently coordinates to copper. Two structurally similar 
carbene precursors provided much lower levels of asymmetric induction. Therefore, 
optimization continued with 3.1 as the ligand for the asymmetric borylation. 
HTE allowed rapid optimization of this reaction as only one additional screen was 
required to arrive at the optimized reaction conditions. The screen analyzed an array of 
alkoxide bases (KOMe, NaOt-Bu, LiOMe), solvents (EtOH, MeOH, THF/EtOH, 
toluene/EtOH) with CuCl as the only copper source and 3.1 as the only ligand. The 
results of this screen are displayed in Figure 3.4. 
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Figure 3.4. Graphical summary of Screen 2. Reaction conditions: 1.0 equiv of 1, 2.0 
equiv of BBA, 0.05 equiv of CuCl, 0.05 equiv of 3.1, 1.0 or 2.0 equiv of base, rt, 24 h. 
Of the alkoxide bases tested in this screen, both KOMe and NaOt-Bu are superior 
to LiOMe, which led to low conversion of the starting material. Addition of a second 
equivalent of KOMe resulted in lower P/IS ratios than when only one equivalent was 
employed. The solvent that provided the highest P/IS ratios was 1:1 THF/EtOH, slightly 
greater than that of 1:1 toluene/EtOH. 
The results of this second screen showed that several different systems provide a 
high P/IS ratio. Analysis of the enantioselectivity of the reaction by SFC analysis led to 
the conclusion that the enantioselectivity is only marginally affected by the solvent 
system. SFC analysis also showed that when 3.1 is the ligand, the (R) alcohol of the 
product is obtained. With CuCl as the copper source, NaOt-Bu as the base, 3.1 as the 
ligand in a solvent system of 1:1 THF/EtOH, complete conversion was achieved with an 
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enantiomeric ratio of 93:7. The same enantiomeric ratio was achieved by Molander, 
utilizing Yun’s conditions for the asymmetric borylation with B2pin2. 
With conditions that resulted in complete conversion, final optimization was 
completed on a 0.5 mmol scale to synthesize the desired β-trifluoroboratoamide (Table 
3.1). The copper source was switched to the air-stable Cu(MeCN)PF6 with no effect on 
the yield or enantiomeric ratio to develop a method that did not require a glovebox. 
Increasing the concentration to 0.5 M resulted in 90% yield of the trifluoroborate with an 
enantiomeric ratio of 93:7, confirming that the conditions developed with HTE were 
scalable to 0.5 mmol (entry 3). Decreasing the equivalents of BBA from 2 to 1.5 or 1.2 
resulted in a decrease in yield but no loss of enantiomeric excess (entries 4-5). Lowering 
the temperature of the reaction to 0 °C did not increase the enantiomeric ratio; however, 
the yield of the reaction was lowered significantly. The enantiomeric excess of these β-
trifluoroboratoamides was determined by SFC analysis after oxidation to the 
corresponding alcohol. 
Table 3.1. Optimization of the Asymmetric, Catalytic Borylation 
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As the developed method requires the use of a carbene ligand, and the metal-free, 
carbene-catalyzed asymmetric addition of B2pin2 to α,β-unsaturated compounds has been 
reported in the literature, it was important to confirm that the 1,4-addition with BBA was 
not carbene-catalyzed. Performing the borylation reaction without copper such that 5 mol 
% 3.1 could serve as a carbene catalyst did not result in product formation. Furthermore, 
preformation of the copper, ligand, and base in THF before adding BBA and the α,β-
unsaturated amide resulted in the same yield and enantiomeric ratio as when the copper 
complex was not preformed. 
The optimized borylation conditions were then applied to a variety of α,β-
unsaturated amides, providing the corresponding potassium β-trifluoroboratoamides in 
high yield and enantiomeric ratios (Table 3.2). The enantiomeric ratios were determined 
by oxidation of the β-trifluoroboratoamide to the corresponding alcohol followed by SFC 
analysis. Installation of an alkyl side chain on the terminal olefin improved the 
enantiomeric excess (entries 2 and 6); however, the installation of a phenyl ring led to a 
decrease in enantiomeric ratio in most cases (entries 9, 13, and 14). A morpholine-
derived amide provided the desired product in 84% with an enantiomeric ratio of 97:3, 
showing that other heteroatoms do not interfere with the borylation. Unsymmetrical 
amides can be subjected to the borylation with the desired product obtained in 71% yield 
(entry 10). The scalable nature of the borylation was demonstrated by performing the 
reaction on a 5.5 mmol scale with the catalyst loading decreased to 2.5 mol % (from 5 
mol %), and the β-trifluoroboratoamide was synthesized in 85% yield with an 
enantiomeric ratio of 93:7 (entry 1). Decreasing the equivalents of BBA from 2 to 1.5 
equiv decreased the yield of the β-trifluoroboratoamide (entry 4). 
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Table 3.2. Scope of the Catalytic, Asymmetric Borylation of α,β-Unsaturated 
Amides 
 
The standard reaction conditions were then applied to a variety of α,β-unsaturated 
ketones and esters (Table 3.3). Two β-trifluoroboratoesters were prepared in yields of 
55% and 91% with enantiomeric ratios of 90:10 and 95:5, respectively (entries 1-2). The 
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installation of a phenyl group on the terminal olefin resulted in decreased levels of 
asymmetric induction in the borylation of α,β-unsaturated ketones (entry 4). A cyclic 
substrate was borylated in high yield with modest levels of asymmetric induction (entry 
5). 
Table 3.3. Scope of the Asymmetric, Catalytic Borylation with α,β-Unsaturated 
Ketones and Esters 
 
Because of the success with BBA as a borylating agent, 
tetrakis(dimethylamino)diboron was tested under the standard reaction conditions with 
3.2; however, the corresponding β-trifluoroboratoamide was synthesized in only 19% 
yield. Changing the co-solvent from EtOH to MeOH resulted in the desired product 
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isolated in a yield of 91% with an enantiomeric ratio of 93:7, which is the same 
enantiomeric ratio achieved with BBA as the borylating agent. The same trend has been 
observed in the palladium-catalyzed Miyaura borylation of aryl halides with BBA and 
tetrakis(dimethylamino)diboron, where changing the solvent to MeOH resulted in 
increased yields for the borylation with tetrakis(dimethylamino)diboron.
19,24,25
 An array 
of α,β-unsaturated amides were subjected to the modified reaction conditions (Table 3.4). 
In general, tetrakis(dimethylamino)diboron resulted in β-trifluoroboratoamides with 
similar or improved enantiomeric ratios but a lower yield compared to the conjugate 
additions with BBA. 
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Table 3.4. Scope of the Catalytic, Asymmetric Borylation with 
Tetrakis(dimethylamino)diboron as the Dibora Species 
 
During the course of the borylation, tetra(alkoxy)diboron, B2(OR)4, is formed by 
esterification of the dibora reagent by the alcohol co-solvent. As both 
tetrakis(dimethylamino)diboron and BBA form the same B2(OR)4 species in situ, it was 
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believed that the enantiomeric excess of the reaction should be similar regardless of the 
dibora source. However, experimental results showed different levels of asymmetric 
induction with each dibora species. As the esterification of 
tetrakis(dimethylamino)diboron results in the loss of four equivalents of dimethylamine 
per molecule of tetrakis(dimethylamino)diboron, the dimethylamine could serve as a 
ligand for copper, leading to increased levels of asymmetric induction. Therefore, in an 
attempt to improve the enantiomeric ratios with BBA as the borylating agent, one 
equivalent of dimethylamine or N-methylaniline was added to the reaction, resulting in 
recovered starting amide for the addition of dimethylamine. The desired β-
trifluoroboratoamide was obtained with N-methylaniline as an additive; however, no 
change in the enantiomeric ratio was observed. 
The catalytic cycle for the asymmetric, conjugate addition of BBA to α,β-
unsaturated carbonyl compounds is based on the catalytic cycle reported by Molander for 
the synthesis of racemic β-trifluoroboratoamides (Scheme 3.3).
29
 After formation of the 
carbene ligand and its coordination to copper, subsequent transmetalations of L-
Cu(MeCN)PF6 with NaOt-Bu and B2(OR)4 result in the active catalyst 3.21a. Conjugate 
addition of the boronate in the enantiodetermining step results in the copper enolate 
3.21b. Protonation of the enolate by ethanol affords the β-borylated carbonyl compounds, 
which are converted to the β-trifluoroboratoamide upon addition of KHF2, and the copper 
alkoxide 3.21c. Transmetalation with another molecule of B2(OR)4 regenerates the active 
catalyst. 
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Scheme 3.3. Catalytic Cycle for the Catalytic, Asymmetric Borylation 
 
 
3.5 Synthesis of β-Arylated Amides: Transition-Metal Catalyzed Hydrogenation 
 After developing an approach to enantioenriched β-trifluoroboratoamides using 
greener dibora reagents, research was then focused on their cross-coupling with aryl and 
heteroaryl chlorides to form β-arylated amides. Several methods are present in the 
literature for the synthesis of β-arylated amides. One general method is the transition-
metal catalyzed reduction of α,β-unsaturated amides (Scheme 3.4).  
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Scheme 3.4. Accessing β-Arylated Amides Via Reduction of an α,β-Unsaturated 
Amide 
 
A cobalt-catalyzed reduction employing DIBAL as the reductant affords racemic 
β-arylated amides in good yield.
35
 An asymmetric cobalt-catalyzed reduction employing 
sodium borohydride provides the β-arylated amides in moderate yield and enantiomeric 
excesses of 49-74% (Eq 3.17). Greater enantiomeric ratios are achieved for the 
asymmetric reduction of β,β-dialkyl α,β-unsaturated amides.
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Equation 3.17 
 
 The asymmetric reduction of α,β-unsaturated Weinreb amides was catalyzed by a 
chiral iridium catalyst and proceeds with high conversion and enantiomeric excess (Eq 
3.18).
37
 However, Weinreb amides serve as synthetic intermediates as they are important 
acylating agents, requiring further functionalization to reach the desired product. 
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Equation 3.18 
 
The ruthenium-catalyzed asymmetric reduction of a β,β-diarylated α,β-
unsaturated amides was tested with an array of chiral ligands. Of the ligands tested, (R)-
DM-SEGPHOS provided the desired product in 98% HPLC yield with an enantiomeric 
excess of 74% (Eq 3.19).
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Equation 3.19 
 
3.6 Synthesis of β-Arylated Amides: Conjugate Addition of an Arylmetallic Species 
to an α,β-Unsaturated Amide 
 A second route to synthesize β-arylated amides is the conjugate addition of an 
arylmetallic species to an α,β-unsaturated amide (Scheme 3.5). The rhodium-catalyzed 
addition of arylboronic acids to α,β-unsaturated carbonyl compounds has emerged as a 
viable route to highly functionalized molecules.  
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Scheme 3.5. Accessing β-Arylated Amides Through Conjugate Addition 
 
The addition of arylboronates to α,β-unsaturated ketones and esters has been 
extensively studied, such that the desired products are obtained in high yield and 
enantiomeric ratios; however, few reports of the addition to α,β-unsaturated amides have 
appeared.
39
 The asymmetric addition of arylboronic acid to lactams affords the β-arylated 
compounds in yields of 97-99% with enantiomeric excesses of 97-99% (Eqn 3.20).
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Equation 3.20 
 
Although the addition to lactams provides the product in high yield and 
enantiomeric excess, the addition to an acyclic α,β-unsaturated amide affords the β-
arylated product in only 40% yield with an enantiomeric ratio of 90:10 (Eqn 3.21).
41
 
Equation 3.21 
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3.7 Synthesis of β-Arylated Amides: Transition-Metal Catalyzed Cross-Coupling 
Reactions 
 A final approach to β-arylated amides is a transition metal-catalyzed cross-
coupling reaction (Scheme 3.6). Although directed C-H activation and coupling with 
diarylhyperiodonium salts affords the β-arylated amides in high yield,
42
 the asymmetric 
version of this coupling is not reported. 
Scheme 3.6. Accessing B-Arylated Amides Through Cross-Couplings 
 
 The Suzuki-Miyaura cross-coupling of an enantioenriched trifluoroborate with an 
aryl halide results in the direct installation of a stereocenter with complete chemical 
integrity. This approach moves the challenging aspect of asymmetric synthesis, that is the 
late stage conversion of a prochiral center, to a more reliable stage through the 
preparation of enantioenriched starting materials. Because of the wide array of readily 
available and highly functionalized aryl and heteroaryl halide coupling partners, this 
polarity-inverted coupling greatly expands the diversity of products that can accessed 
through this route. 
 Snieckus first reported the use of β-borylated esters as nucleophiles in the Suzuki-
Miyaura reaction in 2006 with only a single example.
43
 Molander then reported the 
synthesis and cross-coupling of potassium trifluoroboratohomoenolates with an array of 
aryl bromides in 2008.
44
 The requisite β-trifluoroboratohomoenolates were prepared 
through two different methods. The first method was a copper-catalyzed conjugate 
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addition of B2pin2 to α,β-unsaturated carbonyl compounds (Eq 3.22). The β-
trifluoroboratohomoenolates were isolated in yields of 46-90%. 
Equation 3.22 
 
Another method for the preparation of β-trifluoroboratohomoenolates is the 
alkylation of a halomethyl boronate species (Eq 3.23). The reaction between 
iodomethylpinacol boronate and the lithium enolate of tert-butyl acetate afforded the 
desired product in 56% yield after conversion to the β-trifluoroboratoester.
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Equation 3.23 
 
Focusing primarily on the cross-coupling of β-trifluoroboratoketones with aryl 
bromides, the corresponding β-arylated ketones were obtained in high yield (Eq 3.24).
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An array of electron-rich and electron-poor aryl bromides were successfully cross-
coupled. The developed conditions were extended to 3-bromopyridine as well as two aryl 
chlorides, affording the desired products in good yield. 
Equation 3.24 
 
The method was extended to demonstrate the ability of β-trifluoroboratoesters and 
β-trifluoroboratoamides to serve as nucleophiles in the cross-coupling (Eq 3.25).
 44
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Equation 3.25 
 
Molander expanded the cross-coupling of β-trifluoroboratoketones by 
demonstrating their ability to serve as nucleophilic partners with an array of aryl and 
heteroaryl chlorides, thereby extending the scope of the first report. A variety of β-
trifluoroboratoketones were synthesized with various substitution patterns and shown to 
be efficient partners in the cross-coupling with aryl halides.
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Because of the success of the β-trifluoroboratoketones, and the preliminary result 
reported by Molander, the cross-coupling of potassium β-trifluoroboratoamides with aryl 
and heteroaryl chlorides was optimized. Employing RuPhos as the ligand afforded high 
yields of the cross-coupled products with aryl chlorides (Eq 3.26). However, the 
developed conditions provided low yields when attempting to cross-couple heteroaryl 
chlorides. By changing the ligand to SPhos, high yields were attained for an array of 
heteroaryl chlorides. Molander then demonstrated that several different β-
trifluoroboratoamides with various substitution patterns could serve as the nucleophilic 
partner in the cross-coupling reaction.
46
 
Equation 3.26 
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Molander demonstrated that substitution at the α-position of the β-
trifluoroboratoamide did not affect the cross-coupling, affording the desired cross-
coupled products in high yield.
46
 Therefore, synthesis of an enantiomerically enriched α-
chiral β-trifluoroboratoamide could afford products without loss of enantiomeric excess 
at the α-carbon. By using pseudoephedrine as a chiral auxiliary, a variety of 
enantiomerically enriched α-chiral β-trifluoroboratoamides were synthesized and shown 
to be effective nucleophilic partners in the cross-coupling with aryl and heteroaryl 
chlorides (Eq 3.27). The diasteroselectivities achieved from the synthesis of the β-
trifluoroboratoamides (>95:5) were preserved during the cross-coupling.
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Equation 3.27 
 
Molander then reported the synthesis of enantioenriched potassium β-
trifluoroboratoamides by utilizing an asymmetric, copper-catalyzed diboration of α,β-
unsaturated amides with B2pin2 (Eq 3.15). Two enantioenriched β-trifluoroboratoamides 
were successfully cross-coupled, affording the desired products in high yield and without 
loss of stereochemical fidelity. The reported conditions for this cross-coupling were 10 
mol % Pd(OAc)2 and 20 mol % XPhos with 3 equiv of Cs2CO3 in a solvent system of 
CPME/H2O, affording the product in 82% yield (Eq 3.28).
30
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Equation 3.28 
 
After developing conditions for the asymmetric, copper-catalyzed conjugate 
addition of BBA and tetrakis(dimethylamino)diboron, researched focused on their cross-
coupling with aryl and heteroaryl chlorides. The report of Buchwald’s second and third 
generation precatalysts
26,48
 suggested that lower catalyst loadings could be employed for 
the desired cross-coupling by changing the palladium source to one of these precatalysts. 
Optimization with the XPhos derivatives of Buchwald’s second and third 
generation precatalysts are outlined in Table 3.5. Side products include the sum of 
materials resulting from protodeboronation of the potassium β-trifluoroboratoamide, 
homocoupling of the aryl chloride, and unidentifiable side products. The reported 
conditions for the cross-coupling are shown in entry 7. Lowering the catalyst loading of 
the reported conditions results in a large amount of aryl halide remaining. Switching the 
catalyst to XPhos-Pd-G2, the second generation precatalyst with XPhos as ligand, 
resulted in complete conversion (entry 2). Decreasing the catalyst loading of XPhos-Pd-
G2 to 5 mol % resulted in complete conversion at 100 °C (entry 1). Lowering the 
temperature of the reaction to 80 °C with 5 mol % XPhos-Pd-G2 as the catalyst resulted 
in incomplete conversion of the aryl halide (entry 3). Employing the third generation 
precatalyst (XPhos-Pd-G3) resulted in incomplete conversion at both 100 °C and 80 °C 
(entries 4-5). Therefore, the palladium loading for the desired cross-coupling was 
decreased to 5 mol % using XPhos-Pd-G2 as the palladium source. 
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Table 3.5. Optimization of the Cross-Coupling with Buchwald's Precatalysts 
 
XPhos-Pd-G2, which is now commercially available, is readily prepared from the 
aminobiphenyl palladium µ-Cl dimer in 90% yield (Eq 3.29). 
Equation 3.29 
 
The cross-coupling of 3.2 with chlorobenzene with the new palladium source 
provided the desired product in 85% yield (Eq 3.30). More importantly, however, is that 
the reaction proceeds with complete stereochemical integrity. The results of this coupling 
are comparable to those reported previously (Eq 3.28). 
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Equation 3.30 
 
The optimized reaction conditions were applied to a representative set of 
heteroaryl chlorides, which had not been examined previously, with potassium N-(4-
methoxyphenyl)-3-trifluoroborato-butanamide 3.2 as the nucleophile in the coupling 
reaction (Table 3.6). 3-Chloropyridine was an effective electrophile, affording the desired 
product in 56% yield (entry 1). Isomeric chlorothiophenes provided the cross-coupled 
products in good yield (entries 2-3). A chloroquinoline and chloroindole were 
successfully employed in the cross-coupling as the products were obtained in good yield 
(entries 4-5). The scalable nature of the cross-coupling was demonstrated by performing 
the cross-coupling on a 1 g scale with 2.5 mol % XPhos-Pd-G2 (entry 1). 
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Table 3.6. Cross-Coupling with a Representative Set of Heteroaryl Chlorides 
 
The electrophilic compatibility of the cross-coupling was next determined (Table 
3.6, entry 6). The desired product was not obtained when the electrophile was 
iodobenzene; however, an array of other electrophilic components afforded the desired 
product in moderate to high yields. Optimization of the reaction was completed with 
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chlorobenzene, demonstrating aryl chlorides are efficient electrophilic species in the 
coupling (Eq 3.30). The cross-coupling of potassium β-trifluoroboratoamides was 
previously reported,
30
 but changing the palladium source resulted in the desired product 
isolated in 68% yield. The developed conditions proved to be efficient for C-O activation 
as employing both phenyl mesylate and phenyl tosylate afforded the cross-coupled 
product in good yield. Most importantly, changing the electrophilic partner does not 
result in a loss of enantiomeric excess, demonstrating that the cross-coupling proceeds 
with complete stereochemical integrity independent of the electrophile. 
The developed cross-coupling conditions were applied to an array of potassium β-
trifluoroboratoamides with various substitution patterns to expand the scope of the 
nucleophilic partner with 1-chloro-4-fluorobenzene as the electrophile (Table 3.7). Five 
secondary and tertiary amides afforded the desired β-arylated products in high yield. 
Each of these cross-coupling reaction proceeds with complete stereochemical fidelity and 
are presumed to occur with inversion of configuration, based on previously established 
precedents. 
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Table 3.7. Cross-Coupling of Various Potassium β-Trifluoroboratoamides 
 
The cross-coupling of potassium β-trifluoroboratoamides proceeds with complete 
inversion of stereochemistry. Cross-couplings resulting in inversion of configuration have 
been reported in the literature with chiral benzylstannanes,
49
 silanes,
50
 and α-
(acylamino)benzyl boronates.
51
 However the stereospecific coupling of enantioenriched 
secondary benzylic boronates occurs with retention of configuration.
52
 
The rationale for the inversion of configuration has been previously reported
30
 
(see Chapter 2.9), and has been attributed to the presence of an electron-donating group 
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on the nucleophilic species. Reports by Suginome
51
 and Molander
30
 have shown that the 
stereochemical-determining step in the cross-coupling is the transmetalation. The 
carbonyl of the amide of the β-trifluoroboratoamides can coordinate to the boronate 
species after hydrolysis of the trifluoroborate, preventing transmetalation from 
proceeding through the traditional four-membered transition structure. The 
transmetalation occurs through an SE2-type mechanism via an open transition structure 
(Scheme 3.7). Reactions of borate substrates resulting in inversion of configuration 
through an SE2 mechanism have been previously reported.
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Scheme 3.7. Rationale for the Inversion of Configuration in the Cross-Coupling of 
Potassium β-Trifluoroboratoamides 
 
 Suginome reported that the addition of a Lewis acid, such as Zr(OiPr)4•iPrOH, 
altered the stereochemical outcome of the reaction. The cross-coupling of 
enantioenriched α-(acylamino)benzyl boronates proceeds with complete inversion of 
configuration because of an intramolecular coordination to boron (similar to Scheme 3.7), 
but addition of Zr(OiPr)4•iPrOH results in retention of configuration as the Lewis acid 
binds selectively to the carbonyl of the amide, allowing transmetalation to proceed 
through a traditional four-centered transition structure. The addition of Zr(OiPr)4•iPrOH 
to the cross-coupling of potassium β-trifluoroboratoamides resulted in no product 
formation. The aryl halide was consumed during the reaction; however, several different 
side products formed, including some β-hydride eliminated product. 
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Equation 3.31 
 
3.8 Conclusions 
 Enantioenriched potassium β-trifluoroboratoamides were synthesized through an 
asymmetric, copper-catalyzed addition of BBA and tetrakis(dimethylamino)diboron. This 
method utilizes greener, more atom economical sources of diboron in comparison to 
B2pin2. The cross-coupling of β-trifluoroboratoamides was extended to include heteroaryl 
chlorides as the electrophilic species, and an array of enantioenriched β-
trifluoroboratoamides were cross-coupled with 1-chloro-4-fluorobenzene in high yield. 
The cross-couplings proceed with complete inversion of configuration regardless of the 
electrophilic component or the β-trifluoroboratoamide. The inversion of configuration is 
attributed to the carbonyl of the amide, which prevents transmetalation from proceeding 
through the traditional four-membered transition structure because of an intramolecular 
coordination between the carbonyl of the amide and the hydrolyzed trifluoroborate. 
3.9 Experimental 
General Considerations. All starting materials, reagents, and catalysts were used as 
received. THF, EtOH, MeOH and CPME were distilled from sodium/benzophenone prior 
to use. Both solvents and H2O was degassed prior to use. 
Tetrakis(dimethylamino)diboron was distilled prior to use and stored under Ar. Standard 
benchtop techniques were employed for handling air–sensitive reagents. Melting points 
(°C) are uncorrected. 
19
F NMR chemical shifts were referenced to external CFCl3 (0.0 
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ppm). 
11
B NMR spectra at 128.4 MHz were obtained on a spectrometer equipped with the 
appropriate decoupling accessories. All 
11
B NMR chemical shifts were referenced to 
external BF3·OEt2 (0.0 ppm) with a negative sign indicating an upfield shift. 
Determination of the absolute configurations was based on our previous work.
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General Procedure for the Preparation of Enantioenriched Potassium β-
Trifluoroboratoamides with BBA. An oven dried microwave vial with stir bar was 
charged with Cu(MeCN)4PF6 (0.0093 g, 0.025 mmol, 5 mol %), NaOt-Bu (0.0480 g, 0.5 
mmol, 1 equiv), (2R, 5R)-1{[(2R, 5R)-2,5-diphenylpyrrolidin-1-yl]methylene}2,5-
diphenylpyrrolidinium-tetrafluoroborate (0.0136 g, 0.025 mmol, 5 mol %), (HO)2B-
B(OH)2 (0.0896 g, 1 mmol, 2 equiv), and amide (0.5 mmol, 1 equiv). The vial was sealed 
with a cap lined with a disposable Teflon septum, evacuated under vacuum and purged 
with Ar (three times). Anhyd THF (0.5 mL) was added under Ar followed by anhyd 
EtOH (0.5 mL), and the reaction mixture was stirred at rt for 24 h. After cooling to 0 
o
C, 
MeOH (1 mL) and sat. aq KHF2 (3 mmol, 6 equiv) was added dropwise. The reaction 
mixture was stirred at rt until deemed complete by 
11
B NMR (about 10 min), 
concentrated, and placed on the high vacuum overnight. The crude product was isolated 
by filtration with hot acetone (3 x 10 mL), then concentrated to a minimal amount (~2 
mL), and precipitating with Et2O (20 mL). 
 
Potassium (R)-N-(4-Methoxyphenyl)-3-(trifluoroborato)butanamide (3.2).
30 
According to the general procedure using (E)-N-(4-methoxyphenyl)but-2-enamide 
(0.0955 g, 0.5 mmol), the product was obtained as a white crystalline solid in 90% yield 
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(135 mg). mp =168-170 
o
C.
1
H NMR (360 MHz, acetone-d6) δ = 8.82 (br s, 1H), 7.56 (d, 
J = 8.7 Hz, 2H), 6.80 (d, J = 8.8 Hz, 2H), 3.73 (s, 3H), 2.26-2.42 (m, 1H), 1.99-2.03 (m, 
1H), 0.82 (m, 4H). 
13
C NMR (125.8 MHz, acetone-d6): δ = 174.2, 155.2, 133.2, 120.6, 
113.4, 54.6, 41.8, 15.5. 
19
F NMR (338.8 MHz, acetone-d6): δ = -147.17. 
11
B NMR (128.4 
MHz, acetone-d6) δ = 5.25. [α]D
20
= +10.8 (c = 0.34, MeOH). 
 
Potassium (R)-N-(4-Methoxyphenyl)-3-(trifluoroborato)methyloctanamide (3.3). 
According to the general procedure using (E)-N-(4-methoxyphenyl)oct-2-enamide 
(0.1235 g, 0.5 mmol), the product was obtained as a white crystalline solid in 82% yield 
(146 mg). mp = 224-226 
o
C. 
1
H NMR (360 MHz, DMSO-d6) δ = 9.31 (s, 1H), 7.47 (d, J 
= 8.6 Hz, 2H), 6.80 (d, J = 8.5 Hz, 2H), 3.68 (s, 3H), 2.19 (dd, J = 14.0, 4.8 Hz, 1H), 1.90 
(dd, J = 14.0, 9.8 Hz, 1H), 1.00-1.31 (m, 8H), 0.79 (t, J = 7.0 Hz, 3H), 0.62 (brs, 1H). 
13
C 
NMR (90.5 MHz, DMSO-d6) δ = 174.8, 154.9, 133.7, 120.8, 114.0, 55.5, 32.9, 31.8, 
28.83, 22.7, 14.5.
 19
F NMR (338.8 MHz, DMSO-d6): δ = -141.73. 
11
B NMR (128.4 MHz, 
DMSO-d6) δ = 4.92. IR (neat) 3290, 2953, 2920, 2851, 1650, 1523, 1409, 1247, 1080, 
980, 825, 657, 636 cm
-1
. HRMS (ESI) calcd. for C16H24BFNO3 [M-(KF2)+(CH2O)]
-
 
308.1833, found 308.1833. [α]D
20
= -3.5 (c = 0.2, MeOH). 
 
Potassium (R)-N-Phenyl-3-(trifluoroborato)butanamide (3.4). According to the 
general procedure using (E)-N-phenylbut-2-enamide (0.0805 g, 0.5 mmol), the product 
was obtained as a white crystalline solid in 80% yield (108 mg). mp = 135-138 
o
C. 
1
H 
NMR (300 MHz, acetone-d6) δ = 8.99 (s, 1H), 7.76-7.64 (m, 2H), 7.24 (d, J = 8.5 Hz, 
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2H), 6.90-7.05 (m, 1H), 2.46 (dd, J = 13.8, 5.1 Hz, 1H), 2.09-2.17 (m, 1H), 0.83-0.95 (m, 
4H). 
13
C NMR (75.4 MHz, acetone-d6) δ = 174.6, 139.9, 128.2, 122.4, 119.1, 41.9, 15.43. 
19
F NMR (282.4 MHz, acetone-d6): δ = -147.18 
11
B NMR (128.4 MHz, acetone-d6) δ = 
5.74. IR (Neat) 3290, 2949, 2876, 1639, 1599, 1513, 1441, 1308, 1244, 1059, 1010, 907, 
748, 690, 656 cm
-1
. HRMS (ESI) calcd. for C11H14BFNO2 [M-(KF2)+(CH2O)]
-
 222.1102, 
found 222.1102. [α]D
20
= +18.8 (c = 0.26, MeOH). 
 
Potassium (R)-N-Cyclohexyl-3-(trifluoroborato)butanamide (3.5).
30 
According to the 
general procedure using (E)-N-cyclohexylbut-2-enamide (0.0836 g, 0.5 mmol), the 
product was obtained as a white crystalline solid in 82% yield (113 mg). mp = 213-215 
o
C. 
1
H NMR (300 MHz, DMSO-d6) δ = 7.19 (d, J = 8.0 Hz, 1H), 3.37-3.58 (m, 1H), 1.99 
(dd, J = 13.7, 3.8 Hz, 1H), 1.47-1.72 (m, 6H), 1.16 (m, 5H), 0.43-0.65 (m, 4H). 
13
C NMR 
(75.4 MHz, DMSO-d6) δ = 174.5, 47.3, 40.7, 33.0, 25.6, 25.0, 15.9. 
19
F NMR (282.4 
MHz, DMSO-d6) δ = -128.4. 
11
B NMR (128.4 MHz, DMSO-d6) δ = 5.25. [α]D
20
= -8.0 (c 
= 0.1, MeOH). 
 
Potassium (R)-N-Cyclopropyl-3-(trifluoroborato)butanamide (3.6).
29 
According to 
the general procedure using (E)-N-cyclopropylbut-2-enamide (0.0.625 g, 0.5 mmol), the 
product was obtained as a white crystalline solid in 51% yield (60 mg). mp =165-167 
o
C.
 
1
H NMR (500 MHz, DMSO-d6) δ = 7.42 (d, J = 5.0 Hz, 1H), 2.53-2.56 (m, 1H), 1.95-
2.07 (m, 1H), 1.53-1.66 (m, 1H), 0.55-0.65 (m, 4H), 0.50-0.56 (m, 2H), 0.33 (s, 2H). 
13
C 
NMR (125.8 MHz, DMSO-d6) δ = 176.9, 22.4, 16.0, 6.1, 5.9.
 19
F NMR (470.8 MHz, 
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DMSO-d6): δ = -144.97. 
11
B NMR (128.4 MHz, DMSO-d6) δ = 5.76. [α]D
20
= +19.0 (c = 
0.2, MeOH). 
 
Potassium (R)-N-Cyclohexyl-3-(trifluoroborato)pentanamide (3.7).
29
 According to 
the general procedure using (E)-N-cyclohexylpent-3-enamide (0.0906 g, 0.5 mmol), the 
product was obtained as a white crystalline solid in 86% yield (124 mg). mp = 237-239 
o
C. 
1
H NMR (300 MHz, DMSO-d6) δ = 7.13 (d, J = 7.9 Hz, 1H), 3.47 (m, 1H), 1.96 (dd, 
J = 14.1, 4.6 Hz, 1H), 1.46-1.74 (m, 6H), 0.97-1.28 (m, 7H), 0.75 (t, J = 7.4 Hz, 3H), 
0.45 (br s, 1H). 
13
C NMR (75.4 MHz, DMSO-d6) δ = 174.8, 47.3, 33.1, 32.9, 25.8, 25.1, 
24.0, 14.3.
 19
F NMR (338.8 MHz, DMSO-d6): δ = -141.10. 
11
B NMR (128.4 MHz, 
DMSO-d6) δ = 49.94. [α]D
20
= -14.6 (c = 0.13, MeOH). 
 
Potassium 1-(Piperidin-1-yl)-3-(trifluoroborato)butan-1-one (3.8).
30 
According to the 
general procedure for the racemic preparation using (E)-1-(piperidin-1-yl)but-2-en-1-one 
(0.0765 g, 0.5 mmol), the product was obtained as a light yellow amorphous solid in 82% 
yield (107 mg). 
1
H NMR (500 MHz, acetone-d6) δ = 3.33-3.58 (m, 4H), 2.22-2.29 (m, 
1H), 2.24-210 (m, 1H), 1.43-1.63 (m, 6H), 0.76-0.79 (m, 3H), 0.71 (br s, 1H). 
13
C NMR 
(125.8 MHz, acetone-d6) δ = 173.7, 46.5, 41.7, 38.4, 26.3, 25.4, 24.4, 16.2. 
19
F NMR 
(470.8 MHz, acetone-d6) δ = -147.68. 
11
B NMR (128.4 MHz, acetone-d6) δ = 5.46. 
[α]D
20
= -13.0 (c = 0.1, MeOH). 
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Potassium (R)-1-Morpholino-3-(trifluoroborato)butan-1-one (3.9).
29
 According to the 
general procedure for the racemic preparation using (E)-1-morpholinobut-2-en-1-one 
(0.0775 g, 0.5 mmol), the product was obtained as a white crystalline solid in 84% yield 
(111 mg). mp = 175-177 
o
C. 
1
H NMR (500 MHz, DMSO-d6) δ = 3.46-4.00 (m, 4H), 
3.27-3.46 (m, 4H), 2.29 (d, J = 13.7 Hz, 1H), 1.66-1.86 (m, 1H), 0.66 (d, J = 6.9 Hz, 3H), 
0.45 (brs, 1H). 
13
C NMR (125.8 MHz, DMSO-d6) δ = 174.2, 66.6, 46.3, 41.5, 37.3, 16.3. 
19
F NMR (470.8 MHz, DMSO-d6) δ = -145.78. 
11
B NMR (128.4 MHz, acetone-d6) δ = 
4.25. [α]D
20
= +2.9 (c = 0.34, MeOH). 
 
Potassium (S)-N-(4-Methoxyphenyl)-3-phenyl-3-(trifluoroborato)propanamide 
(3.10). According to the general procedure using N-(4-methoxyphenyl)cinnamide (0.1265 
g, 0.5 mmol), the product was obtained as a white crystalline solid in 92% yield (166 
mg). mp = 176-179 
o
C. 
1
H NMR (300 MHz, acetone-d6) δ = 8.66 (s, 1H), 7.45 (d, J = 8.6 
Hz, 2H), 7.26 (d, J = 7.6 Hz, 2H), 7.10 (t, J = 7.5 Hz, 2H), 6.89-6.98 (m, 1H), 6.77 (d, J = 
8.5 Hz, 2H), 3.73 (s, 3H), 2.61-2.84 (m, 2H), 2.36-2.39 (m, 1H). 
13
C NMR (75.4 MHz, 
acetone-d6) δ = 173.2, 155.3, 148.9, 133.0, 128.1, 127.0, 122.9, 120.6, 113.3, 54.6, 40.2. 
19
F NMR (282.4 MHz, DMSO-d6) δ = -144.72. 
11
B NMR (128.4 MHz, DMSO-d6) δ = 
5.46. IR (neat) 3367, 3342, 1658, 1641, 1515, 1241, 980, 824, 703, 659, 640 cm
-1
. HRMS 
(ESI) calcd. for C16H16BF3NO2 [M]
-
 322.1222, found 322.1223. [α]D
20
= +21.0 (c = 0.2, 
MeOH). 
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Potassium N-Ethyl-N-(o-tolyl)-3-(trifluoroborato)butanamide (3.11).
30
 According to 
the general procedure for the racemic preparation using (E)-N-ethyl-N-(o-tolyl)but-2-
enamide (0.1015 g, 0.5 mmol), the product was obtained as a white crystalline solid in 
71% yield (110 mg). mp = 228-230 
o
C. 
1
H NMR (300 MHz, asterisk denotes minor 
rotamer peaks, DMSO-d6) δ = 7.31-7.33 (m, 1H), 7.16-7.29 (m, 2H), 7.01-7.07 (m, 1H), 
3.88-3.99 (m, 1H), 3.11-3.23* (m, 1H), 2.96-3.01 (m, 1H), 2.08-2.14 (m, 3H), 1.72-1.91 
(m, 1H), 1.48* (dd, J = 14.6, 9.8 Hz, 1H), 1.32 (dd, J = 15.7, 10.3 Hz, 1H), 0.96-1.08 (m, 
3H), 0.56-0.77 (m, 4H). 
13
C NMR (75.4 MHz, asterisk denotes rotamer peaks, DMSO-d6) 
δ = 174.6, 174.2*, 142.1, 141.9*, 136.1, 135.6*, 131.4, 131.3*, 129.9, 129.8*, 127.9, 
127.8*, 127.1, 42.6, 42.2*, 38.4, 37.1*, 17.5, 16.5, 16.3*, 13.4, 13.2*. 
19
F NMR (470.8 
MHz, DMSO-d6) δ = -147.65. 
11
B NMR (128.4 MHz, DMSO-d6) δ = 4.97. [α]D
20
= -8.1 (c 
= 0.16, MeOH). 
 
Potassium (R)-N,N-Dimethyl-3-(trifluoroborato)butanamide (3.12).
29 
According to 
the general procedure for the racemic preparation using (E)-N,N-dimethylbut-2-enamide 
(0.0565 g, 0.5 mmol), the product was obtained as a yellow amorphous solid in 86% 
yield (95 mg). 
1
H NMR (500 MHz, acetone-d6) δ = 3.00 (s, 3H), 2.83 (s, 3H), 2.24-2.31 
(m, 1H), 2.05 (s, 1H), 0.79 (m, 4H). 
13
C NMR (125.8 MHz, acetone-d6) δ = 175.9, 37.6, 
37.0, 34.4, 15.9.
 19
F NMR (470.8 MHz, acetone-d6) δ = -147.34. 
11
B NMR (128.4 MHz, 
DMSO-d6) δ = 5.42. [α]D
20
= -5.6 (c = 0.34, MeOH). 
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Potassium (R)-N,N-Dibenzyl-3-(trifluoroborato)butanamide (3.13).
30 
According to 
the general procedure for the racemic preparation using (E)-N,N-dibenzylbut-2-enamide 
(0.1865 g, 0.5 mmol), the product was obtained as a white crystalline solid in 80% yield 
(149 mg). mp = 236-238 
o
C. 
1
H NMR (360 MHz, DMSO-d6) δ = 7.09-7. 44 (m, 10H), 
4.67 (d, J = 15.2 Hz, 2H), 4.59 (d, J = 17.1 Hz, 2H), 4.31 (d, J = 17.0 Hz, 1H), 4.18 (d, J 
= 15.1 Hz, 1H), 2.40 (dd, J = 13.9, 3.1 Hz, 1H), 1.80 (dd, J = 13.9, 11.1 Hz, 1H), 0.72 (d, 
J = 6.9 Hz, 3H), 0.59 (br s, 1H). 
13
C NMR (90.5 MHz, DMSO-d6) δ = 176.1, 138.2, 
129.0, 128.7, 127.8, 127.5, 127.2, 126.8, 126.4, 50.1, 47.5, 37.6, 16.5.
 19
F NMR (338.8 
MHz, acetone-d6) δ = -148.19. 
11
B NMR (128.4 MHz, acetone-d6) δ = 5.46. [α]D
20
= -7.0 
(c = 0.1, MeOH). 
 
Potassium (S)-N-Cyclohexyl-3-phenyl-3-(trifluoroborato)propanamide (3.14).
29
 
According to the general procedure for the racemic preparation using N-
cyclohexylcinnamide (0.1145 g, 0.5 mmol), the product was obtained as a white 
crystalline solid in 77% yield (130 mg). mp = 168-170 
o
C. 
1
H NMR (500 MHz, DMSO-
d6) δ = 7.10-7.00 (m, 4H), 6.96 (d, J = 8.2 Hz, 1H), 6.87 (t, J = 6.9 Hz, 1H), 3.28-3.36 
(m, 1H), 2.27-2.36 (m, 2H), 1.99-2.02 (m, 1H), 1.41-1.62 (m, 4H), 1.31-1.41 (m, 1H), 
0.85-1.18 (m, 5H). 
13
C NMR (125.8 MHz, DMSO-d6) δ = 173.5, 149.4, 128.5, 126.9, 
122.7, 47.1, 39.3, 38.7, 32.7, 25.6, 24.8, 24.8. 
19
F NMR (470.8 MHz, DMSO-d6) δ = -
142.19. 
11
B NMR (128.4 MHz, DMSO-d6) δ = 5.22. [α]D
20
= +5.0 (c = 0.2, MeOH). 
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Potassium (S)-3-Phenyl-1-(pyrrolidin-1-yl)-3-(trifluoroborato)propan-1-one (3.15).
30 
According to the general procedure for the racemic preparation using (E)-3-phenyl-1-
(pyrrolidin-1-yl)prop-2-en-1-one (0.1545 g, 0.5 mmol), the product was obtained as a 
white amorphous solid in 85% yield (131 mg). 
1
H NMR (500 MHz, acetone-d6) δ = 7.20 
(d, J = 7.0 Hz, 2H), 7.08 (t, J = 6.7 Hz, 2H), 6.93 (t, J = 8.1 Hz, 1H), 3.39 (s, 1H), 3.23-
3.34 (m, 3H), 2.63 (dd, J = 13.2, 7.2 Hz, 1H), 2.45 (dd, J = 14.0, 7.5 Hz, 1H), 2.21 (s, 
1H), 1.70-1.82 (m, 4H). 
13
C NMR (125.8 MHz, acetone-d6) δ = 173.3, 149.6, 128.3, 
126.9, 122.9, 46.1, 45.0, 38.2, 25.7, 23.9. 
19
F NMR (470.8 MHz, acetone-d6) δ = -144.31. 
11
B NMR (128.4 MHz, acetone-d6) δ = 5.14. [α]D
20
= +37.1 (c = 0.1, MeOH). 
 
Potassium Ethyl (R)-3-(Trifluoroborato)butanoate (3.16).
29
 According to the general 
procedure using ethyl (E)-but-2-enoate (0.0720 g, 0.5 mmol), the product was obtained as 
a white crystalline solid in 91% yield (100 mg). mp = 128-130 
o
C. 
1
H NMR (500 MHz, 
DMSO-d6) δ = 4.48 (q, J = 7.1 Hz, 2H), 2.71-2.80 (m, 1H), 2.31-2.42 (m, 1H), 1.63 (t, J 
= 7.1 Hz, 3H), 1.17-1.32 (m, 4H). 
13
C NMR (125.8 MHz, acetone-d6) δ = 176.2, 59.1, 
38.7, 15.57, 14.1. 
19
F NMR (470.8 MHz, acetone-d6) δ = -148.24. 
11
B NMR (128.4 MHz, 
acetone-d6) δ = 5.96. [α]D
20
= +4.0 (c = 0.25, MeOH). 
 
Potassium Ethyl (R)-3-(Trifluoroborato)octanoate (3.17). According to the general 
procedure using ethyl (E)-oct-2-enoate (0.0851 g, 0.5 mmol), the product was obtained as 
a white crystalline solid in 55% yield (77 mg). mp = 220-222 
o
C. 
1
H NMR (500 MHz, 
acetone-d6) δ = 4.01 (q, J = 7.0 Hz, 2H), 2.23 (dd, J = 13.9, 6.2 Hz, 1H), 2.00 (dd, J = 
13.9, 8.9 Hz, 1H), 1.07-1.45 (m, 11H), 0.85 (t, J = 7.1 Hz, 3H), 0.75 (br s, 1H). 
13
C NMR 
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(125.8 MHz, acetone-d6) δ = 176.3, 58.5, 36.7, 32.6, 31.4, 22.5, 13.6, 13.5. 
19
F NMR 
(470.8 MHz, acetone-d6) δ = -145.99. 
11
B NMR (128.4 MHz, acetone-d6) δ = 5.79. IR 
(neat) 2949, 2924, 2851, 2356, 2332, 1717, 1467, 1445, 1368, 1249, 1217, 1126, 1073, 
996, 937, 643 cm
-1
. HRMS (ESI) calcd. For C11H22BF2O3 [M-(KF)+(MeO)]
- 
251.1630, 
found 251.1631. [α]D
20
= +5.7 (c = 0.2, MeOH). 
 
Potassium (R)-3-Trifluoroborato-1-phenylbutan-1-one (3.18). According to the 
general procedure using (E)-1-phenylbut-2-en-1-one (0.0730 g, 0.5 mmol), the product 
was obtained as a white crystalline solid in 75% yield (95 mg). mp =110-112 
o
C. 
1
H 
NMR (300 MHz, acetone-d6) δ = 8.00 (d, J = 7.5 Hz, 2H), 7.38-7.3861 (m, 3H), 3.13 (m, 
1H), 2.56 (m, 1H), 1.07-0.92 (br s, 1H), 0.83 (d, J = 6.9 Hz, 3H). 
13
C NMR (75.4 MHz, 
acetone-d6) δ = 203.3, 137.8, 131.9, 128.1, 128.1, 42.9, 15.2. 
19
F NMR (282.4 MHz, 
acetone-d6) δ = -148.08. 
11
B NMR (128.4 MHz, acetone-d6) δ = 5.03. IR (neat) 2937, 
2868, 1667, 1597, 1446, 1306, 1278, 1073, 1014, 924, 893, 690, 645 cm
-1
. HRMS (ESI) 
calcd. For C10H11BF3O [M-K]
-
 251.0855, found 251.0934. [α]D
20
= +61.0 (c = 0.1, 
MeOH). 
 
Potassium (S)-1,3-Diphenyl-3-(trifluoroborato)butan-1-one (3.19).
29
 According to the 
general procedure using (E)-chalcone (0.104 g, 0.5 mmol), the product was obtained as a 
white crystalline solid in 52% yield (82 mg). mp = 147-150 
o
C. 
1
H NMR (500 MHz, 
acetone-d6) δ = 7.94 (d, J = 8.0 Hz, 2H), 7.50 (t, J = 8.1 Hz, 1H), 7.41 (t, J = 7.8 Hz, 2H), 
7.21 (d, J = 9.5 Hz, 2H), 7.00-7.14 (m, 2H), 6.83-6.99 (m, 1H), 3.39 (d, J = 7.7 Hz, 2H), 
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2.44-2.59 (m, 1H). 
13
C NMR (125.8 MHz, acetone-d6) δ = 202.0, 148.5, 137.8, 131.9, 
128.1, 128.1, 128.0, 127.1, 123.0, 41.3. 
19
F NMR (470.8 MHz, acetone-d6) δ = -144.96. 
11
B NMR (128.4 MHz, acetone-d6) δ = 4.57. [α]D
20
= +27.3 (c = 0.23, MeOH). 
 
Potassium (R)-3-(Trifluoroborato)cyclohexanone (3.20).
29
 According to the general 
procedure using cyclohex-2-enone (0.0480 g, 0.5 mmol), the product was obtained as a 
white crystalline solid in 90% yield (92 mg). mp = 235-237 
o
C. 
1
H NMR (360 MHz, 
DMSO-d6) δ = 2.13-2.22 (m, 1H), 2.11-1.87 (m, 4H), 1.56-1.59 (m, 1H), 1.36-1.53 (m, 
1H), 1.21-1.32 (m, 1H), 0.47 (br s, 1H). 
13
C NMR (90.5 MHz, DMSO-d6) δ = 215.4, 
45.21, 42.3, 30.2, 27.7. 
19
F NMR (338.8 MHz, DMSO-d6) δ = -145.3. 
11
B NMR (128.4 
MHz, acetone-d6) δ = 5.25. [α]D
20
= +55.0 (c = 0.34, MeOH). 
 
General Procedure for the Preparation of Enantioenriched Potassium β-
Trifluoroboratoamides with Tetrakis(dimethylamino)diboron. An oven dried 
microwave vial with stir bar was charged with Cu(MeCN)4PF6 (0.0093 g, 0.025 mmol, 5 
mol %), NaOt-Bu (0.0480 g, 0.5 mmol, 1 equiv), and (2R, 5R)-1{[(2R,5R)-2,5-
diphenylpyrrolidin-1-yl]methylene}2,5-diphenylpyrrolidinium tetrafluoroborate (0.0136 
g, 0.025 mmol, 5 mol %). The vial was sealed with a cap lined with a disposable Teflon 
septum, evacuated under vacuum and purged with Ar (three times). Anhyd THF (0.5 mL) 
was added under Ar followed by tetrakis(dimethylamino)diboron (1 mmol, 2 equiv) in 
anhyd MeOH (0.5 mL). The reaction was stirred at rt for 5 min before adding the amide 
(0.5 mmol, 1 equiv). The reaction mixture was stirred at rt for 24 h. After cooling to 0 
o
C, 
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MeOH (1 mL) and sat. aq KHF2 (3 mmol, 6 equiv) was added dropwise. The reaction 
mixture was stirred at rt until complete by 
11
B NMR (about 10 min), concentrated, and 
placed on the high vacuum overnight. The crude product was isolated by hot filtration 
with acetone (3 x 10 mL), concentrating to a minimal amount (~2 mL), and precipitating 
with Et2O (20 mL).  
 
Spectral data for the enantioenriched cross-coupled products is the same as the racemic 
products and can be seen in “General Procedure for the Preparation of Enantioenriched 
Potassium β-Trifluoroboratoamides with BBA.” 
 
Determination of Absolute Configuration and Enantiomeric Ratio of 
Enantioenriched Potassium Trifluoroboratoamides: The purpose of the oxidation of 
the enantioenriched potassium trifluoroboratoamides was to determine the enantiomeric 
ratio of the corresponding alcohol. Therefore a small sample of the potassium 
trifluoroboratoamide was oxidized with oxone. After confirming the product by NMR, 
the sample was subjected to SFC analysis. 
 
General Procedure for the Oxidation of Enantioenriched Potassium β-
Trifluoroboratoamides (Method A). To a flask containing a mixture of potassium β-
trifluoroboratoamides, esters, or ketones (1 mmol, 1 equiv) and acetone (2.5 mL) (MeOH 
was added dropwise in the case of insoluble trifluoroborates), was added Oxone (2.5 mL 
of a 0.2 M solution in H2O, 1 equiv) in one portion. The reaction mixture was stirred at rt 
until 
11
B NMR indicated completion of the reaction (~10 min). To the crude reaction 
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mixture was added H2O (2.5 mL) and aq HCl (0.3 M, 3 mL), and the aqueous layer was 
extracted with CH2Cl2 (3x15 mL). The combination organic layers were dried (MgSO4), 
filtered, and concentrated in vacuo.  
 
General Procedure for the Preparation of Both (R)- and (S)-MTPA Ester 
Enantiomers (Method B). To a solution of β-hydroxy amides or ketones (which was 
prepared by method A) (0.027 mmol) in CH2Cl2 (1.8 mL) in a round bottom flask under 
Ar was added Et3N (19 mL, 0.137 mmol), (R)-MTPA chloride (25.5 mL, 0.137 mmol), 
and DMAP (3.6 mg, 0.030 mmol). The resulting mixture was stirred for 16 h at rt and 
then the solvent was concentrated in vacuo. Enantiomeric ratios were determined by 
19
F 
NMR of the unpurified material. 
 
3-Hydroxy-N-(4-methoxyphenyl)butanamide.
30
 According to the general procedure 
(Method A) using potassium (R)-N-(4-methoxyphenyl)-3-(trifluoroborato)butanamide 
(0.299 g, 1 mmol) the title compound was obtained as a white crystalline solid (90%, 188 
mg). mp = 134-136 
o
C. 
1
H NMR (300 MHz, CDCl3) δ = 7.68 (s, 1H), 7.33 (d, J = 8.9 Hz, 
3H), 6.79 (d, J = 8.9 Hz, 2H), 4.17-4.27 (m, 1H), 3.72 (s, 3H), 2.90 (s, 1H), 2.50-2.32 (m, 
2H), 1.22 (d, J = 6.3 Hz, 3H). 
13
C NMR (90.5 MHz, CDCl3) δ = 170.2, 156.5, 130.5, 
122.0, 114.1, 64.9, 55.4, 44.9, 29.6, 22.9. A method was developed to separate the 
enantiomers using SFC analysis (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-
isomer retention time = 8.76 min and (R)-isomer retention time = 9.80 min.  
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(R)-3-Hydroxy-N-(4-methoxyphenyl)butanamide (3.2-OH). Following the procedure 
described above for oxidation using the enantioselective borylated intermediate, the title 
compound was obtained as a white crystalline solid with spectra in accordance with that 
described above for the racemate (0.25 mmol scale, 88%, 46 mg). mp = 135-136 
o
C. 
[α]D
20 
= -31.5 (c = 1.0, MeOH). A method was developed to separate the enantiomers 
using SFC analysis (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa); the enantiomeric ratio 
was measured to be 5:95. The major enantiomer having an absolute configuration of R. 
(S)-isomer retention time = 8.64 min and (R)-isomer retention time = 9.55 min. 
 
3-Hydroxy-N-(4-methoxyphenyl)octanamide. According to the general procedure 
(Method A) using potassium N-(4-methoxyphenyl)-3-(trifluoroborato)methyloctanamide 
(0.355 g, 1 mmol) the title compound was obtained as a white solid. mp = 120-122 
o
C. 
1
H 
NMR (300 MHz, CDCl3) δ = 7.67 (s, 1H), 7.39 (d, J = 9.0 Hz, 2H), 6.85 (d, J = 9.0 Hz, 
2H), 4.07 (d, J = 11.3 Hz, 1H), 3.79 (s, 3H), 3.19 (s, 1H), 2.37-2.60 (m, 2H), 1.70-1.17 
(m, 8H), 0.90 (t, J = 6.9 Hz, 3H). 
13
C NMR (125.8 MHz, CDCl3) δ = 170.3, 1566.4, 
130.5, 123.4, 121.8, 114.0, 113.0, 68.6, 55.3, 43.4, 36.8, 31.6, 25.0, 22.4, 13.9.IR (neat) 
3314, 2957, 2924, 2855, 1655, 1548, 1513, 1250, 1031, 825, 665, 648 cm
-1
. HRMS (ESI) 
calcd. For C15H24NO3 [M+H]
+
 266.1756, found 266.1751. A method was developed to 
separate the enantiomers using SFC analysis (Column OD-H, 10% i-PrOH, 2 mL, 10 
MPa); (S)-isomer retention time = 9.47 min and (R)-isomer retention time = 11.55 min.  
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(R)-3-Hydroxy-N-(4-methoxyphenyl)octanamide (3.3-OH). Following the procedure 
described above for oxidation using the enantioselective borylated intermediate, the title 
compound was obtained as a white solid with spectra in accordance with that described 
above for the racemate. mp = 119-122 
o
C. [α]D
20 
= -20.8 (c = 0.25, MeOH). Using SFC 
analysis (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa); the enantiomeric ratio was 
measured to be 3:97. The major enantiomer having an absolute configuration of R. (S)-
isomer retention time = 9.67 min and (R)-isomer retention time = 11.71 min. 
 
3-Hydroxy-N-phenylbutanamide.
54
 According to the general procedure (Method A) 
using potassium (R)-N-phenyl-3-(trifluoroborato)butanamide (0.269 g, 1 mmol) the title 
compound was obtained as a white crystalline solid. mp = 92-94
 o
C. 
1
H NMR (500 MHz, 
acetone-d6) δ = 9.19 (s, 1H), 7.64 (d, J = 8.7 Hz, 2H), 7.22-7.34 (m, 2H), 7.09-6.98 (m, 
1H), 4.19-4.30 (m, 1H), 4.10 (br s, 1H), 2.39-2.53 (m, 2H), 1.19 (d, J = 6.4 Hz, 3H). 
13
C 
NMR (125.8 MHz, acetone–d6) δ = 170.1, 139.1, 128.48, 123.14, 119.17, 64.33, 45.70, 
22.60. A method was developed to separate the enantiomers using SFC analysis (Column 
OD-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time = 8.51 min and (R)-
isomer retention time = 10.49 min.  
 
(R)-3-Hydroxy-N-phenylbutanamide (3.4-OH). Following the procedure described 
above for oxidation using the enantioselective borylated intermediate, the title compound 
was obtained as a white crystalline solid with spectra in accordance with that described 
above for the racemate. mp = 93-95
 o
C [α]D
20 
= -14.8 (c = 0.25, MeOH). A method was 
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developed to separate the enantiomers using SFC analysis (Column OD-H, 10% i-PrOH, 
2 mL, 10 MPa); the enantiomeric ratio was measured to be 8:92. The major enantiomer 
having an absolute configuration of R. (S)-isomer retention time = 8.51 min and (R)-
isomer retention time = 10.11 min. 
 
N-Cyclohexyl-3-hydroxybutanamide.
30 
According to the general procedure (Method A) 
using potassium N-cyclohexyl-3-(trifluoroborato)butanamide (0.274 g, 1 mmol) the title 
compound was obtained as a white crystalline solid. mp = 134-136 
o
C. 
1
H NMR (300 
MHz, CDCl3) δ = 5.74 (s, 1H), 4.16 (m, 1H), 3.95 (s, 1H), 3.78 (m, 1H), 2.16-2.40 (m, 
2H), 1.84-1.99 (m, 2H), 1.54-1.80 (m, 3H), 1.04-1.48 (m, 8H). 
13
C NMR (75.4 MHz, 
CDCl3) δ = 171.3, 64.7, 48.0, 43.8, 32.9, 25.3, 24.6, 22.6. A method was developed to 
separate the enantiomers using SFC analysis (Column OD-H, 10% i-PrOH, 2 mL, 10 
MPa); (S)-isomer retention time = 5.27 min and (R)-isomer retention time = 5.57 min. 
 
 
(R)-N-Cyclohexyl-3-hydroxybutanamide (3.5-OH).
30 
Following the procedure 
described above for oxidation using the enantioselective borylated intermediate, the title 
compound was obtained as a white crystalline solid with spectra in accordance with that 
described above for the racemate. mp = 134-136 
o
C [α]D
20 
= -17.0 (c = 0.2, MeOH). 
Using SFC analysis (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa); the enantiomeric ratio 
was measured to be 5:95. The major enantiomer having an absolute configuration of R. 
(S)-isomer retention time = 6.19 min and (R)-isomer retention time = 6.93 min.
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N-Cyclopropyl-3-hydroxyoctanamide. According to the general procedure (Method A) 
using potassium N-(4-methoxyphenyl)-3-(trifluoroborato)methyloctanamide (0.233 g, 1 
mmol) the title compound was obtained as a yellow oil. 
1
H NMR (500 MHz, CDCl3) δ = 
6.20 (s, 1H), 4.03-4.22 (m, 1H), 3.56 (br s, 1H), 2.64 (s, 1H), 2.12-2.29 (m, 2H), 1.15 (t, J 
= 5.5 Hz, 3H), 0.71 (t, J = 6.6 Hz, 2H), 0.44 (t, J = 6.3 Hz, 2H). 
13
C NMR (125.8 MHz, 
CDCl3) δ = 173.9, 64.7, 43.6, 22.7, 22.3, 8.0, 6.4. IR (neat) 3283, 2965, 2920, 1641, 
1542, 1455, 1376, 1302, 1196, 1123, 852, 664, 638 cm
-1
. HRMS (ESI) calcd. For 
C7H13NO2 [M]
+
 143.0946, found 143.0948. A method was developed to separate the 
enantiomers using SFC analysis (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-
isomer retention time = 6.87 min and (R)-isomer retention time = 7.81 min.  
 
(R)-N-Cyclopropyl-3-hydroxyoctanamide (3.6-OH). Following the procedure 
described above for oxidation using the enantioselective borylated intermediate, the title 
compound was obtained as a yellow oil with spectra in accordance with that described 
above for the racemate. [α]D
20 
= -25.0 (c = 0.1, MeOH). Using SFC analysis (Column 
AS-H, 10% i-PrOH, 2 mL, 10 MPa); the enantiomeric ratio was measured to be 7:93. The 
major enantiomer having an absolute configuration of R. (S)-isomer retention time = 6.07 
min and (R)-isomer retention time = 7.44 min. 
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N-Cyclohexyl-3-hydroxypentanamide. According to the general procedure (Method A) 
using potassium N-cyclohexyl-3-(trifluoroborato)pentanamide (0.289 g, 1 mmol) the title 
compound was obtained as a white crystalline solid (76%, 151 mg). mp = 106-108 
o
C. 
1
H 
NMR (300 MHz, CDCl3) δ = 5.98 (br s, 1H), 3.79-3.88 (m, 2H), 3.6174-3.74 (m, 1H), 
2.05-2.32 (m, 2H), 1.78-1.86 (m, 2H), 1.70-0.96 (m, 10H), 0.86 (t, J = 7.4 Hz, 3H). 
13
C 
NMR (75.4 MHz, CDCl3) δ = 171.6, 69.9, 48.0, 41.8, 32.9, 29.6, 25.3, 24.6, 9.7.IR (neat) 
3292, 2932, 2852, 1639, 1556, 1445, 1386, 1194, 1125, 984, 870, 699, 630 cm
-1
. HRMS 
(ESI) calcd. For C11H22NO2 [M+H]
- 
200.1651, found 200.1651. A method was developed 
to separate the enantiomers using SFC analysis (Column AS-H, 10% i-PrOH, 2 mL, 10 
MPa); (S)-isomer retention time = 8.77 min and (R)-isomer retention time = 10.67 min. 
 
 
(R)-N-Cyclohexyl-3-hydroxypentanamide (3.7-OH). Following the procedure 
described above for oxidation using the enantioselective borylated intermediate, the title 
compound was obtained as a white crystalline solid with spectra in accordance with that 
described above for the racemate. mp = 105-106 
o
C. [α]D
20 
= -17.0 (c = 0.2, MeOH). 
Using SFC analysis (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa); the enantiomeric ratio 
was measured to be 2:98. The major enantiomer having an absolute configuration of R. 
(S)-isomer retention time = 8.75 min and (R)-isomer retention time = 9.21 min. 
 
3-Hydroxy-1-(piperidin-1-yl)butan-1-one.
55 
According to the general procedure 
(Method A) using potassium 1-(piperidin-1-yl)-3-(trifluoroborato)butan-1-one (0.261 g, 1 
mmol) the title compound was obtained as a yellow oil. 
1
H NMR (500 MHz, CDCl3) δ = 
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4.20 (s, 1H), 3.98-4.2 (m, 1H), 3.49-3.61 (m, 2H), 3.27-3.44 (m, 2H), 2.49 (d, J = 16.0 
Hz, 1H), 2.31 (dd, J = 16.5, 9.4 Hz, 1H), 1.64-1.72 (m, 2H), 1.51-1.60 (m, 4H), 1.10-1.28 
(m, 3H). 
13
C NMR (125.8 MHz, CDCl3) δ = 170.6, 64.1, 46.2, 42.3, 40.5, 26.1, 25.3, 
24.2, 22.0. A method was developed to separate the enantiomers using SFC analysis 
(Column AD-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time= 6.04 min and 
(R)-isomer retention time = 5.51 min.  
 
(R)-3-Hydroxy-1-(piperidin-1-yl)butan-1-one (3.8-OH). Following the procedure 
described above for oxidation using the enantioselective borylated intermediate, the title 
compound was obtained as a yellow oil with spectra in accordance with that described 
above for the racemate. [α]D
20 
= -24.4 (c = 0.25, MeOH). A method was developed to 
separate the enantiomers using SFC analysis (Column AD-H, 10% i-PrOH, 2 mL, 10 
MPa); the enantiomeric ratio was measured to be 8:92. The major enantiomer having an 
absolute configuration of R. (S)-isomer retention time = 6.10 min and (R)-isomer 
retention time = 5.49 min. 
 
3-Hydroxy-1-morpholinobutan-1-one.
56 
According to the general procedure (Method 
A) using potassium morpholino-3-(trifluoroborato)butan-1-one (0.263 g, 1 mmol) the 
title compound was obtained as a colorless oil (35%, 60 mg). 
1
H NMR (360 MHz, 
CDCl3) δ = 4.19-4.23 (m, 1H), 4.10 (s, 1H), 3.51-3.75 (m, 6H), 3.44 (dd, J = 5.9, 3.8 Hz, 
2H), 2.45 (dd, J = 16.4, 2.6 Hz, 1H), 2.30 (dd, J = 16.4, 9.4 Hz, 1H), 1.22 (d, J = 5.3 Hz 
3H). 
13
C NMR (90.5 MHz, CDCl3) δ = 171.1, 66.7, 66.4, 64.1, 45.6, 41.7, 40.7, 22.2. A 
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method was developed to separate the enantiomers using SFC analysis (Column AD-H, 
10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time = 4.96 min and (R)-isomer 
retention time = 5.61 min. 
 
 
(R)-3-Hydroxy-1-morpholinobutan-1-one (3.9-OH). Following the procedure 
described above for oxidation using the enantioselective borylated intermediate, the title 
compound was obtained as a colorless oil with spectra in accordance with that described 
above for the racemate. [α]D
20 
= -10.7 (c = 1.0, MeOH). A method was developed to 
separate the enantiomers using SFC analysis (Column AD-H, 10% i-PrOH, 2 mL, 10 
MPa); the enantiomeric ratio was measured to be 28:72. The major enantiomer having an 
absolute configuration of R. (S)-isomer retention time = 4.85 min and (R)-isomer 
retention time = 5.11 min. 
 
3-Hydroxy-N-(4-methoxyphenyl)-3-phenylpropanamide. According to the general 
procedure (Method A) using potassium (S)-N-(4-methoxyphenyl)-3-phenyl-3-
(trifluoroborato)propanamide (0.361 g, 1 mmol) the title compound was obtained as a 
white crystalline solid. mp = 144-146 
o
C. 
1
H NMR (500 MHz, DMSO-d6) δ = 9.73 (s, 
1H), 7.50 (d, J = 8.8 Hz, 2H), 7.30-7.47 (m, 4H), 7.24 (m, 1H), 6.86 (d, J = 8.5 Hz, 2H), 
5.06 (dd, J = 8.9, 4.7 Hz, 1H), 3.71 (s, 3H), 3.40 (br s, 1H), 2.62-2.66 (m, 1H), 2.46-2.59 
(m, 1H). 
13
C NMR (125.8 MHz, DMSO-d6) δ = 168.9, 155.4, 145.7, 132.7, 128.4, 127.2, 
126.0, 121.0, 114.1, 70.1, 55.4, 47.2. IR (neat) 3326, 2953, 2916, 2851, 1653, 1536, 
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1511, 1469, 1409, 1244, 1030, 1018, 822, 756, 701, 689, 656 cm
-1
. HRMS (ESI) calcd. 
For C16H18NO3 [M+H]
+
 272.1287, found 272.1296. Both (R)- and (S)-MTPA esters were 
prepared according to general procedure B, and the enantiomeric ratio was determined by 
19
F NMR (338.8 MHz, CDCl3): (R)-MTPA derivative of (S) enantiomer δ = = -71.73, (R) 
enantiomer δ = = -71.50. 
 
 (S)-3-Hydroxy-N-(4-methoxyphenyl)-3-phenylpropanamide (3.10-OH). Following 
the procedure described above for oxidation using the enantioselective borylated 
intermediate, the title compound was obtained as a white crystalline solid with spectra in 
accordance with that described above for the racemate. mp = 144-147 
o
C. [α]D
20
= -18.0 (c 
= 0.2, MeOH). Both (R)- and (S)-MTPA esters were prepared according to general 
procedure B, and the enantiomeric ratio was determined by 
19
F NMR (338.8 MHz, 
CDCl3): (R)-MTPA derivative of (S) enantiomer δ = = -71.78, (R) enantiomer δ = = -
71.52. The enantiomeric ratio was measured to be 4:96, the major enantiomer having an 
absolute configuration of S.  
 
N-Ethyl-3-hydroxy-N-(o-tolyl)butanamide. According to the general procedure 
(Method A) using potassium N-ethyl-N-(o-tolyl)-3-(trifluoroborato)butanamide (0.311 g, 
1 mmol) the title compound was obtained as a yellow oil (90%, 199 mg). 
1
H NMR (500 
MHz, asterisk denotes minor rotamer peaks, CDCl3) δ = 7.19-7.31 (m, 3H), 7.03 (t, J = 
8.9 Hz, 1H), 4.21 (s, 1H), 4.00-4.17 (m, 2H), 3.21 (m, 1H), 2.19 (d, J = 7.9 Hz, 3H), 
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1.77-2.16 (m, 2H, 1H*), 1.09-1.13 (m, 3H), 1.03 (dd, J = 6.4, 2.9 Hz, 3H). 
13
C NMR 
(125.8 MHz, asterisk denotes minor rotamer peaks, CDCl3) δ = 172.5, 172.3*, 140.1, 
140.0*, 135.6, 135.3*, 131.5, 131.4*, 129.1, 128.8*, 128.4, 127.1, 127.1*, 64.4, 64.2*, 
42.7, 42.7*, 41.6, 22.1, 22.1*, 17.3, 12.7, 12.6*. IR (neat) 3436, 2977, 2929, 2876, 1712, 
1631, 1493, 1447, 1409, 1293, 1255, 1138, 1091, 958, 77, 728, 648 cm
-1
. HRMS (ESI) 
calcd. For C13H20NO2 [M+H]
-
 222.1494, found 222.1493. A method was developed to 
separate the enantiomers using SFC analysis (Column AD-H, 10% i-PrOH:CH3CN 
(85:15), 2 mL, 10 MPa); (S)-isomer retention time = 4.63 min and (R)-isomer retention 
time = 5.22 min. 
 
 (R)-N-Ethyl-3-hydroxy-N-(o-tolyl)butanamide (3.11-OH). Following the procedure 
described above for oxidation using the enantioselective borylated intermediate, the title 
compound was obtained as a yellow oil with spectra in accordance with that described 
above for the racemate. [α]D
20 
= -18.0 (c = 0.1, MeOH). A method was developed to 
separate the enantiomers using SFC analysis (Column AD-H, 10% i-PrOH/CH3CN 
(85:15), 2 mL, 10 MPa); the enantiomeric ratio was measured to be 28:72. The major 
enantiomer having an absolute configuration of R. (S)-isomer retention time = 4.85 min 
and (R)-isomer retention time = 5.38 min. 
 
3-Hydroxy-N,N-dimethylbutanamide.
57 
According to the general procedure (Method 
A) using potassium N-(4-methoxyphenyl)-3-(trifluoroborato)methyloctanamide (0.221 g, 
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1 mmol) the title compound was obtained as a yellow oil.
 1
H NMR (500 MHz, CDCl3) δ 
= 4.39 (br s, 1H), 4.13-4.23 (m, 1H), 2.98 (s, 3H), 2.95 (s, 3H), 2.47 (dd, J = 16.5, 2.4 Hz, 
1H), 2.29 (dd, J = 16.5, 9.6 Hz, 1H), 1.21 (d, J = 6.4 Hz, 3H). 
13
C NMR (125.8 MHz, 
CDCl3) δ = 172.6, 64.0, 40.7, 36.9, 35.0, 22.0. A method was developed to separate the 
enantiomers using SFC analysis (Column R,R-Whelk, 10% i-PrOH, 2 mL, 10 MPa); (S)-
isomer retention time = 12.41 min and (R)-isomer retention time = 11.87 min.  
 
(R)-3-Hydroxy-N,N-dimethylbutanamide (3.12-OH). Following the procedure 
described above for oxidation using the enantioselective borylated intermediate, the title 
compound was obtained as a yellow oil with spectra in accordance with that described 
above for the racemate. [α]D
20 
= +11.7 (c = 1.0, MeOH). Using SFC analysis (Column 
R,R-Whelk, 10% i-PrOH, 2 mL, 10 MPa); the enantiomeric ratio was measured to be 
30:70. The major enantiomer having an absolute configuration of R. (S)-isomer retention 
time = 12.41 min and (R)-isomer retention time = 11.47 min. 
 
N,N-Dibenzyl-3-hydroxybutanamide. According to the general procedure (Method A) 
using potassium (R)-N,N-dibenzyl-3-(trifluoroborato)butanamide (0.373 g, 1 mmol) the 
title compound was obtained as a white crystalline solid (98%, 277 mg). mp = 64-66
 o
C. 
1
H NMR (500 MHz, CDCl3) δ = 7.27-7.42 (m, 6H), 7.23 (d, J = 5.0 Hz, 2H), 7.16 (d, J = 
5.0 Hz, 2H), 4.71 (d, J = 14.8 Hz, 1H), 4.55 (d, J = 14.8 Hz, 1H), 4.40-4.52 (m, 1H), 
4.27-4.31 (m, 2H), 4.22 (br s, 1H), 2.60 (dd, J = 16.4, 2.5 Hz, 1H), 2.42-2.54 (m, 1H), 
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1.23 (dd, J = 6.6, 3.0 Hz, 3H). 
13
C NMR (125.8 MHz, CDCl3) δ = 173.3, 136.7, 135.8, 
128.9, 128.6, 128.1, 127.7, 127.4, 126.2, 64.3, 49.7, 47.9, 40.8, 22.1. A method was 
developed to separate the enantiomers using SFC analysis (Column OD-H, 10% i-PrOH, 
2 mL, 10 MPa); (S)-isomer retention time = 12.11 min and (R)-isomer retention time = 
11.15 min.  
 
(R)-N,N-Dibenzyl-3-hydroxybutanamide (3.13-OH). Following the procedure 
described above for oxidation using the enantioselective borylated intermediate, the title 
compound was obtained as a white crystalline solid with spectra in accordance with that 
described above for the racemate. mp = 65-66
 o
C. [α]D
20 
= -5.0 (c = 0.3, MeOH). A 
method was developed to separate the enantiomers using SFC analysis (Column OD-H, 
10% i-PrOH, 2 mL, 10 MPa); the enantiomeric ratio was measured to be 34:66. The 
major enantiomer having an absolute configuration of R. (S)-isomer retention time = 
12.20 min and (R)-isomer retention time = 11.09 min. 
 
N-Cyclohexyl-3-hydroxy-3-phenylpropanamide. According to the general procedure 
(Method A) using potassium (S)-N-cyclohexyl-3-phenyl-3-(trifluoroborato)propanamide 
(0.337 g, 1 mmol) the title compound was obtained as a white crystalline solid (89%, 219 
mg). mp = 132-134 
o
C. 
1
H NMR (300 MHz, CDCl3) δ = 7.17-7.41 (m, 5H), 6.30 (s, 1H), 
4.97 (dd, J = 7.4, 4.6 Hz, 1H), 4.74 (s, 1H), 3.66-3.69 (m, 1H), 2.36-2.54 (m, 2H), 1.30-
1.82 (m, 2H), 1.49-1.74 (m, 3H), 1.27-1.31 (m, 2H), 1.05-1.17 (m, 3H). 
13
C NMR (75.4 
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MHz, CDCl3) δ = 170.9, 143.1, 128.2, 127.4, 125.5, 70.7, 48.1, 44.5, 32.74, 25.3, 24.6. 
IR (neat) 3395, 3299, 2932, 2847, 1635, 1552, 1445, 1359, 1206, 1052, 1016, 984, 891, 
755, 696, 646 cm
-1
. HRMS (ESI) calcd. For C15H22NO2 [M+H]
-
 248.1651, found 
248.1650. A method was developed to separate the enantiomers using SFC analysis 
(Column OD-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time = 11.16 min and 
(R)-isomer retention time = 10.69 min.  
 
(S)-N-Cyclohexyl-3-hydroxy-3-phenylpropanamide (3.14-OH). Following the 
procedure described above for oxidation using the enantioselective borylated 
intermediate, the title compound was obtained as a white crystalline solid with spectra in 
accordance with that described above for the racemate. mp = 131-134 
o
C. [α]D
20 
= +140.5 
(c = 0.2, MeOH). A method was developed to separate the enantiomers using SFC 
analysis (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa); the enantiomeric ratio was 
measured to be 28:72. The major enantiomer having an absolute configuration of S. (S)-
isomer retention time = 10.95 min and (R)-isomer retention time = 10.50 min. 
 
3-Hydroxy-3-phenyl-1-(pyrrolidin-1-yl)propan-1-one.
56 
According to the general 
procedure (Method A) using potassium (S)-3-phenyl-1-(pyrrolidin-1-yl)-3-
(trifluoroborato)propan-1-one (0.309 g, 1 mmol) the title compound was obtained as a 
white crystalline solid. mp = 48-50
 o
C. 
1
H NMR (500 MHz, CDCl3) δ = 7.32-7.53 (m, 
4H), 7.25-7.32 (m, 1H), 5.18 (s, 1H), 4.93 (s, 1H), 3.49-3.51 (m, 2H), 3.27-3.43 (m, 2H), 
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2.51-2.76 (m, 2H), 1.91 (m, 4H). 
13
C NMR (75.4 MHz, CDCl3) δ =170.0, 143.0, 128.3, 
127.3, 125.6, 70.2, 46.5, 45.4, 42.9, 25.8, 24.2. A method was developed to separate the 
enantiomers using SFC analysis (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-
isomer retention time = 13.12 min and (R)-isomer retention time = 14.10 min. 
 
 
(S)-3-Hydroxy-3-phenyl-1-(pyrrolidin-1-yl)propan-1-one (3.15-OH). Following the 
procedure described above for oxidation using the enantioselective borylated 
intermediate, the title compound was obtained as a white crystalline solid with spectra in 
accordance with that described above for the racemate. mp = 48-51
 o
C. [α]D
20
= -12.0 (c = 
0.1, MeOH). A method was developed to separate the enantiomers using SFC analysis 
(Column OD-H, 10% i-PrOH, 2 mL, 10 MPa); the enantiomeric ratio was measured to be 
22:78. The major enantiomer having an absolute configuration of S. (S)-isomer re= 14.41 
min and (R)-isomer retention time = 15.11 min. 
 
Ethyl 3-Hydroxybutanoate.
58 
According to the general procedure using potassium (R)-
ethyl 3-(trifluoroborato)butanoate (0.222 g, 1 mmol) the title compound was obtained as 
a yellow oil (98%, 129 mg). 
1
H NMR (300 MHz, CDCl3) δ = 4.11-4.26 (m, 3H), 3.07 (s, 
1H), 2.35-2.53 (m, 2H), 1.27 (t, J = 7.1 Hz, 3H), 1.22 (d, J = 6.3 Hz, 3H). 
13
C NMR (75.4 
MHz, CDCl3) δ = 172.7, 64.1, 60.5, 42.6, 22.3, 14.0. A method was developed to 
separate the enantiomers using SFC analysis (Column OD-H, 10% i-PrOH, 2 mL, 10 
MPa); (S)-isomer retention time = 10.3 min and (R)-isomer retention time = 11.29 min.  
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Ethyl (R)-3-Hydroxybutanoate (3.16-OH). Following the procedure described above 
for oxidation using the enantioselective borylated intermediate, the title compound was 
obtained as a yellow oil with spectra in accordance with that described above for the 
racemate. [α]D
20
= -6.7 (c = 0.55, MeOH). A method was developed to separate the 
enantiomers using SFC analysis (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa); the 
enantiomeric ratio was measured to be 5:95, the major enantiomer having an absolute 
configuration of R. (S)-isomer retention time = 10.71 min and (R)-isomer retention time = 
11.64 min. 
 
Ethyl 3-Hydroxyoctanoate.
59 
According to the general procedure using potassium ethyl 
(R)-3-(trifluoroborato)octanoate (0.278 g, 1 mmol) the title compound was obtained as a 
colorless oil. 
1
H NMR (500 MHz, CDCl3) δ = 4.36-4.10 (m, 2H), 4.10-3.93 (m, 1H), 3.01 
(br s, 1H), 2.45 (m, 2H), 1.65-1.16 (m, 11H), 1.02-0.80 (m, 3H). 
13
C NMR (125.8 MHz, 
CDCl3) δ = 172.9, 67.9, 60.5, 41.2, 36.4, 31.6, 25.0, 22.4, 14.0, 13.8. A method was 
developed to separate the enantiomers using SFC analysis (Column AD-H, 10% i-PrOH, 
2 mL, 10 MPa); (S)-isomer retention time = 3.97 min and (R)-isomer retention time = 
3.09 min. 
 
 
Ethyl (R)-3-Hydroxyoctanoate (3.17-OH). Following the procedure described above for 
oxidation using the enantioselective borylated intermediate, the title compound was 
obtained as a colorless oil with spectra in accordance with that described above for the 
racemate. [α]D
20
= -4.61 (c = 0.26, MeOH). A method was developed to separate the 
enantiomers using SFC analysis (Column AD-H, 10% i-PrOH, 2 mL, 10 MPa); the 
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enantiomeric ratio was measured to be 12:88, the major enantiomer having an absolute 
configuration of R. (S)-isomer retention time = 3.93 min and (R)-isomer retention time = 
2.99 min. 
 
3-Hydroxy-1-phenylbutan-1-one.
60 
According to the general procedure using potassium 
(R)-3-trifluoroborato-1-phenylbutan-1-one (0.254 g, 1 mmol) the title compound was 
obtained as a yellow oil (65%, 106 mg). 
1
H NMR (300 MHz, CDCl3) δ = 7.96 (d, J = 7.1 
Hz, 2H), 7.53-7.64 (m, 1H), 7.42-7.53 (m, 2H), 4.41 (m, 1H), 3.40 (br s, 1H), 3.23-2.98 
(m, 2H), 1.31 (d, J = 6.3 Hz, 3H). 
13
C NMR (75.4 MHz, CDCl3) δ = 200.6, 136.6, 133.4, 
128.5, 127.9, 76.5, 63.9, 46.4, 22.3. A method was developed to separate the enantiomers 
using SFC analysis (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention 
time = 3.13 min and (R)-isomer retention time = 3.47 min.  
 
(R)-3-Hydroxy-1-phenylbutan-1-one (3.18-OH). Following the procedure described 
above for oxidation using the enantioselective borylated intermediate, the title compound 
was obtained as a yellow oil with spectra in accordance with that described above for the 
racemate. [α]D
20 
= -1.53 (c = 0.26, MeOH). A method was developed to separate the 
enantiomers using SFC analysis (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa); the 
enantiomeric ratio was measured to be 14:86, the major enantiomer having an absolute 
configuration of R. (S)-isomer retention time = 3.17 min and (R)-isomer retention time = 
3.47 min. 
259 
 
 
3-Hydroxy-1,3-diphenylpropan-1-one.
61 
According to the general procedure using 
potassium (S)-1,3-diphenyl-3-(trifluoroborato)butan-1-one (0.316 g, 1 mmol) the title 
compound was obtained as a yellow oil. 
1
H NMR (360 MHz, CDCl3) δ = 7.97 (d, J = 7.1 
Hz, 2H), 7.55-7.65 (m, 1H), 7.28-7.53 (m, 7H), 5.34-5.41 (m, 1H), 3.58 (s, 1H), 3.39 (d, 
J = 6.0 Hz, 2H). 
13
C NMR (90.5 MHz, CDCl3) δ = 200.1, 142.9, 136.6, 133.6, 128.7, 
128.5, 128.1, 127.6, 125.7, 70.0, 47.4. A method was developed to separate the 
enantiomers using SFC analysis (Column R,R-Whelk, 10% i-PrOH, 2 mL, 10 MPa); (R)-
isomer retention time = 8.79 min and (S)-isomer retention time = 11.35 min.  
 
(S)-3-Hydroxy-1,3-diphenylpropan-1-one (3.19-OH). Following the procedure 
described above for oxidation using the enantioselective borylated intermediate, the title 
compound was obtained as a yellow oil with spectra in accordance with that described 
above for the racemate. [α]D
20 
= +8.0 (c = 0.25, MeOH). A method was developed to 
separate the enantiomers using SFC analysis (Column R,R-Whelk, 10% i-PrOH, 2 mL, 
10 MPa); the enantiomeric ratio was measured to be 21:79, the major enantiomer having 
an absolute configuration of S. (R)-isomer retention time = 8.82 min and (S)-isomer 
retention time = 11.47 min. 
 
3-Hydroxycyclohexan-1-one. According to the general procedure using potassium (R)-
3-(trifluoroborato)cyclohexanone (0.204 g, 1 mmol) the title compound was obtained as a 
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yellow oil (87%, 99 mg). 
1
H NMR (500 MHz, CDCl3) δ = 4.18-4.22 (m, 1H), 2.67 (dd, J 
= 14.0, 4.4 Hz, 1H), 2.40-2.45 (m, 1H), 2.30-2.40 (m, 2H), 2.18-1.98 (m, 2H), 1.62-1.90 
(m, 3H). 
13
C NMR (125.8 MHz, CDCl3) δ = 209.4, 69.6, 50.3, 40.7, 32.7, 20.51.  
 
(R)-3-Hydroxycyclohexane-1-one (3.20-OH). Following the procedure described above 
for oxidation using the enantioselective borylated intermediate, the title compound was 
obtained as a yellow oil with spectra in accordance with that described above for the 
racemate. [α]D
20 
= -1.4 (c = 0.1, MeOH). Both (R)- and (S)-MTPA esters were prepared 
according to general procedure B, and the enantiomeric ratio was determined by 
19
F 
NMR (338.8 MHz, CDCl3): (R)-MTPA derivative of (R) enantiomer δ = = -71.89, (S) 
enantiomer δ = = -71.33. The enantiomeric ratio was measured to be 26:74, the major 
enantiomer having an absolute configuration of R.  
 
General Procedure for the Suzuki-Miyaura Cross-Coupling with Aryl Electrophiles. 
To a Biotage microwave vial was added precatalyst (0.0125 mmol, 5 mol %), K2CO3 
(0.1037 g, 0.75 mmol, 3 equiv), aryl electrophile (0.25 mmol, 1 equiv), and potassium β-
trifluoroboratoamide (0.25 mmol, 1 equiv). This mixture was sealed in the microwave 
vial and purged with Ar (three times). To the vial was added CPME (1.0 mL) and H2O 
(0.15 mL), and then the reaction was heated to 100 ºC for 24 h. The reaction mixture was 
allowed to cool to rt and diluted with H2O (1 mL). The reaction mixture was extracted 
with EtOAc (3 x 3 mL) and dried (MgSO4). The solvent was removed in vacuo, and the 
product was purified by flash column chromatography on silica gel. 
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Determination of Absolute Configuration and Enantiomeric Ratio of 
Enantioenriched Cross-Coupled Products:  
 
N-(4-Methoxyphenyl)-3-(pyridin-3-yl)butanamide. Using the general procedure 
described for the Suzuki-Miyaura cross-coupling of potassium N-(4-methoxyphenyl)-3-
(trifluoroborato)butanamide and 3-chloropyridine, the title compound was obtained in 
56% yield (38 mg) as a pale yellow oil after silica gel column chromatography. 
1
H NMR 
(300 MHz, CDCl3) δ = 8.42-8.58 (m, 2H), 7.76 (br s, 1H), 7.59 (d, J = 7.8 Hz, 1H), 7.33 
(d, J = 8.9 Hz, 2H), 7.22-7.27 (m, 1H), 6.82 (d, J = 9.0 Hz, 2H), 3.78 (s, 3H), 3.36-3.51 
(m, 1H), 2.60 (d, J = 7.4 Hz, 2H), 1.40 (d, J = 7.0 Hz, 3H). 
13
C NMR (75.4 MHz, CDCl3) 
δ = 169.1, 156.3, 148.3, 147.7, 141.1, 134.7, 130.7, 123.5, 121.8, 114.0, 55.3, 45.7, 34.5, 
21.0. Using SFC analysis (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-isomer 
retention time = 16.82 min and (R)-isomer retention time = 14.60 min. 
 
(S)-N-(4-Methoxyphenyl)-3-(pyridin-3-yl)butanamide (3.23). Using the general 
procedure described for the Suzuki-Miyaura cross-coupling of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide (2a) and 3-chloropyridine, the title 
compound was obtained as a pale yellow oil in 56% yield (38 mg), with spectral data in 
accordance with that described for the racemate. [α]D
20
 = +33.8 (c = 0.54, MeOH). The 
title compound was found to have an enantiomeric ratio of 9:91 with an absolute 
262 
 
configuration of S for the major enantiomer using SFC analysis (Column OJ-H, 10% i-
PrOH, 2 mL, 10 MPa); (S)-isomer retention time= 16.59 min and (R)-isomer retention 
time= 14.99 min.  
 
N-(4-Methoxyphenyl)-3-(thiophen-3-yl)butanamide. Using the general procedure 
described for the Suzuki-Miyaura cross-coupling of potassium N-(4-methoxyphenyl)-3-
(trifluoroborato)butanamide and 3-chlorothiophene, the title compound was obtained in 
60% (41 mg) yield as a pale yellow solid after silica gel column chromatography. mp = 
102-105 
o
C. 
1
H NMR (300 MHz, CDCl3) δ = 7.23-7.36 (m, 3H), 7.03-7.05 (m, 3H), 6.83 
(d, J=8.9 Hz, 2H), 3.79 (s, 3H), 3.51 (q, J = 7.2 Hz, 1H), 2.44-2.65 (m, 2H), 1.38 (d, J = 
6.9 Hz, 3H). 
13
C NMR (75.4 MHz, CDCl3) δ = 169.6, 156.3, 146.5, 130.6, 126.4, 125.9, 
121.8, 119.6, 113.9, 55.3, 46.3, 32.3, 21.2. IR (neat) 3279, 2961, 2933, 2835, 1649, 1603, 
1531, 1510, 1245, 1032, 828, 776, 640 cm
-1
. HRMS (ESI) calcd. for C15H18NO2S 
[M+H]
+
 276.1058, found 276.1051. Using SFC analysis (Column OJ-H, 10% i-PrOH, 2 
mL, 10 MPa); (S)-isomer retention time= 10.2 min and (R)-isomer retention time= 11.8 
min. 
 
 (S)-N-(4-Methoxyphenyl)-3-(thiophen-3-yl)butanamide (3.24). Using the general 
procedure described for the Suzuki-Miyaura cross-coupling of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide (2a) and 3-chlorothiophene, the title 
compound was obtained as a pale yellow oil in 60% (41 mg) yield, with spectral data in 
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accordance with that described for the racemate. mp = 102-104 
o
C. [α]D
20
 = +9.5 (c = 
0.23, MeOH). The title compound was found to have an enantiomeric ratio of >99:1 with 
an absolute configuration of S for the major enantiomer using SFC analysis (Column OJ-
H, 10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time = 10.2 min. 
 
N-(4-Methoxyphenyl)-3-(thiophen-2-yl)butanamide. Using the general procedure 
described for the Suzuki-Miyaura cross-coupling of potassium N-(4-methoxyphenyl)-3-
(trifluoroborato)butanamide and 2-chlorothiophene, the title compound was obtained in 
53% yield (37 mg) as a pale yellow solid after silica gel column chromatography. mp = 
84-86 
o
C. 
1
H NMR (360 MHz, CDCl3) δ = 7.28 (d, J = 9.0 Hz, 2H), 7.17 (d, J = 6.1 Hz, 
1H), 7.07 (br s, 1H), 6.92-6.94 (m, 1H), 6.87-6.92 (m, 1H), 6.82 (d, J = 9.0 Hz, 2H), 3.82 
(s, 3H), 3.67-3.75 (m, 1H), 2.55-2.68 (m, 2H), 1.44 (d, J = 6.9 Hz, 3H). 
13
C NMR (90.5 
MHz, CDCl3) δ = 169.3, 156.5, 149.7, 130.7, 126.8, 123.3, 123.1, 122.0, 114.0, 55.4, 
47.4, 32.6, 22.6. IR (neat) 3281, 2961, 2933, 2831, 1648, 1605, 1528, 1508, 1247, 1034, 
825, 695, 686, 633 cm
-1
. HRMS (ESI) calcd. For C15H17NO2NaS [M+Na]
+
 298.0878, 
found 298.0876. Using SFC analysis (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-
isomer retention time = 9.5 min and (R)-isomer retention time = 11.5 min. 
 
(S)-N-(4-Methoxyphenyl)-3-(thiophen-2-yl)butanamide (3.25). Using the general 
procedure described for the Suzuki-Miyaura cross-coupling of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide (2a) and 2-chlorothiophene, the title 
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compound was obtained as a pale yellow solid in 56% yield (37 mg), with spectral data in 
accordance with that described for the racemate. mp = 82-85 
o
C. [α]D
20
 = +15.0 (c = 0.1, 
MeOH). The title compound was found to have an enantiomeric ratio of >99:1 with an 
absolute configuration of S for the major enantiomer using SFC analysis (Column OJ-H, 
10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time = 9.5 min. 
 
N-(4-Methoxyphenyl)-3-(quinolin-6-yl)butanamide. Using the general procedure 
described for the Suzuki-Miyaura cross-coupling of potassium N-(4-methoxyphenyl)-3-
(trifluoroborato)butanamide and 6-chloroquinoline, the title compound was obtained in 
58% yield (47 mg) as a pale yellow oil after silica gel column chromatography. mp = 
132-135 
o
C. 
1
H NMR (500 MHz, CDCl3) δ = 8.87 (br s, 1H), 8.03- 8.14 (m, 2H), 7.62 -
7.70 (m, 2H), 7.37-7.45 (m, 1H), 7.23 (d, J = 9.0 Hz, 2H), 7.09 (s, 1H), 6.78 (d, J = 9.0 
Hz, 2H), 3.76 (s, 3H), 3.62 (q, J = 7.0 Hz, 1H), 2.66-2.69 (m, 2H), 1.47 (d, J = 7.0 Hz, 
3H). 
13
C NMR (125.8 MHz, CDCl3) δ = 169.6, 156.3, 149.7, 147.0, 144.1, 135.9, 130.8, 
129.3, 128.8, 128.2, 125.0, 121.9, 121.1, 114.0, 113.9, 55.3, 45.9, 36.7, 21.4. IR (neat) 
3290, 3054, 2965, 2924, 1654, 1601, 1510, 1243, 1173, 1035, 833, 685, 635 cm
-1
. HRMS 
(ESI) calcd. for C20H21N2O2 [M+H]
+
 321.1603, found 321.1606. Using SFC analysis 
(Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time= 7.75 min and 
(R)-isomer retention time= 8.51 min. 
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(S)-N-(4-Methoxyphenyl)-3-(quinolin-6-yl)butanamide (3.26). Using the general 
procedure described for the Suzuki-Miyaura cross-coupling of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide (2a) and 6-chloroquinoline, the title 
compound was obtained as a white solid in 58% yield (47 mg), with spectral data in 
accordance with that described for the racemate. mp = 133-135 
o
C. [α]D
20
 = +47.3 (c = 
0.15, MeOH). The title compound was found to have an enantiomeric ratio of 92:7 with 
an absolute configuration of S for the major enantiomer using SFC analysis (Column OJ-
H, 10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time= 7.73 min and (R)-isomer 
retention time= 8.51 min. 
 
tert-Butyl 5-(4-((4-Methoxyphenyl)amino)-4-oxobutan-2-yl)-1H-indole-1-
carboxylate. Using the general procedure described for the Suzuki-Miyaura cross-
coupling of potassium N-(4-methoxyphenyl)-3-(trifluoroborato)butanamide and tert-butyl 
5-chloro-1H-indole-1-carboxylate, the title compound was obtained in 43% yield (44 mg) 
as a pale yellow oil after silica gel column chromatography. 
1
H NMR (500 MHz, CDCl3) 
δ = 8.10 (br s, 1H), 7.59 (d, J = 3.7 Hz, 1H), 7.45 (s, 1H), 7.16-7.26 (m, 3H), 6.83-6.98 
(m, 1H), 6.79 (d, J = 8.9 Hz, 2H), 6.52 (d, J = 3.7 Hz, 1H), 3.76 (s, 3H), 3.46-3.49 (m, 
1H), 2.61-2.66 (m, 2H), 1.68 (s, 9H), 1.42 (d, J = 6.9 Hz, 3H). 
13
C NMR (90.5 MHz, 
CDCl3) δ = 169.9, 156.3, 149.7, 140.1, 134.0, 130.9, 130.7, 126.2, 123.1, 121.9, 118.9, 
115.3, 114.8, 114.0, 107.2, 83.6, 55.4, 47.0, 37.0, 28.2, 22.2. IR (neat) 3277, 2973, 2933, 
1734, 1656, 1511, 1450, 1368, 1345, 1244, 1157, 1130, 1083, 1023, 835, 789, 764, 725, 
686, 636 cm
-1
. HRMS (ESI) calcd. for C24H29N2O4 [M+H]
+
 409.2127, found 409.2119. 
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Using SFC analysis (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention 
time = 14.4 min and (R)-isomer retention time = 15.3 min. 
 
tert-Butyl (S)-5-(4-((4-Methoxyphenyl)amino)-4-oxobutan-2-yl)-1H-indole-1-
carboxylate (3.27). Using the general procedure described for the Suzuki-Miyaura cross-
coupling of potassium (R)-N-(4-methoxyphenyl)-3-(trifluoroborato)butanamide (2a) and 
tert-butyl 5-chloro-1H-indole-1-carboxylate, the title compound was obtained as a yellow 
oil in 43% yield (44 mg), with spectral data in accordance with that described for the 
racemate. [α]D
20
 = +38.8 (c = 0.43, MeOH). The title compound was found to have an 
enantiomeric ratio of >99:1 with an absolute configuration of S for the major enantiomer 
using SFC analysis (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention 
time= 15.3 min. 
 
N-(4-Methoxyphenyl)-3-phenylbutanamide.
30
 Using the general procedure described 
for the Suzuki-Miyaura cross-coupling of potassium N-(4-methoxyphenyl)-3-
(trifluoroborato)butanamide and chlorobenzene, the title compound was obtained in 85% 
yield (57 mg) as a white solid after silica gel column chromatography. mp = 125-128 
o
C. 
1
H NMR (360 MHz, CDCl3) δ = 7.21-7.25 (m, 7H), 6.98 (br s, 1H), 6.80 (d, J = 9.0 Hz, 
2H), 3.76 (s, 3H), 3.34-3.40 (m, 1H), 2.55-2.59 (m, 2H), 1.37 (d, J = 7.0 Hz, 3H). 
13
C 
NMR (90.5 MHz, CDCl3) δ = 169.8, 156.6, 145.7, 130.7, 128.7, 126.8, 126.6, 122.0, 
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113.9, 55.4, 46.6, 37.1, 21.6. Using SFC analysis (Column OJ-H, 10% i-PrOH, 2 mL, 10 
MPa); (S)-isomer retention time = 11.19 min and (R)-isomer retention time = 12.13 min. 
 
(S)-N-(4-Methoxyphenyl)-3-phenylbutanamide (3.22). Using the general procedure 
described for the Suzuki-Miyaura cross-coupling of potassium (R)-N-(4-methoxyphenyl)-
3-(trifluoroborato)butanamide (2a) and chlorobenzene the title compound was obtained 
as a white solid in 85% yield (57 mg) with spectral data in accordance with that described 
for the racemate. mp = 123-126 
o
C. [α]D
20
 = +57.5 (c = 0.2, MeOH). The title compound 
was found to have an enantiomeric ratio of 8:92 with an absolute configuration of S for 
the major enantiomer using SFC analysis (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa); 
(S)-isomer retention time = 10.61 min and (R)-isomer retention time = 11.35 min.  
 
3-(4-Fluorophenyl)-N-(4-methoxyphenyl)butanamide.
30 
Using the general procedure 
described for the Suzuki-Miyaura cross-coupling of potassium N-(4-methoxyphenyl)-3-
(trifluoroborato)butanamide and 4-chlorofluorobenzene, the title compound was obtained 
in 89% yield (64 mg) as a pale yellow solid after silica gel column chromatography. mp = 
107-109 
o
C. 
1
H NMR (300 MHz, CDCl3) δ = 7.27 (d, J = 8.9 Hz, 2H), 7.18-7.25 (m, 2H), 
7.10 (s, 1H), 7.00 (t, J = 8.7 Hz, 2H), 6.82 (d, J = 9.0 Hz, 2H), 3.78 (s, 3H), 3.33-3.44 (m, 
1H), 2.54 (d, J = 7.4 Hz, 2H), 1.35 (d, J = 7.0 Hz, 3H). 
13
C NMR (75.4 MHz, CDCl3) δ = 
169.5, 156.4, 141.3, 130.5, 128.1 (d, J = 7.8 Hz), 128.0, 121.9, 115.3 (d, J = 32 Hz), 
113.9, 55.3, 46.5, 36.2, 21.6. 
19
F NMR (282.4 MHz, CDCl3) δ = -116.58. Using SFC 
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analysis (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time= 19.29 
min and (R)-isomer retention time= 20.82 min. 
 
(S)-3-(4-Fluorophenyl)-N-(4-methoxyphenyl)butanamide (3.28). Using the general 
procedure described for the Suzuki-Miyaura cross-coupling of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide (2a) and 4-chlorofluorobenzene, the title 
compound was obtained as a white solid in 89% yield (64 mg) with spectral data in 
accordance with that described for the racemate. mp = 107-110 
o
C. [α]D
20
 = +26.5 (c = 
0.2, MeOH). The title compound was found to have an enantiomeric ratio of 9:91 with an 
absolute configuration of S for the major enantiomer using SFC analysis (Column AS-H, 
10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time = 19.47 min and (R)-isomer 
retention time = 21.15 min. 
 
3-(4-Fluorophenyl)-N-phenylbutanamide. Using the general procedure described for 
the Suzuki-Miyaura cross-coupling of potassium 3-(trifluoroborato)-N-phenylbutanamide 
and 4-chlorofluorobenzene, the title compound was obtained in 88% yield (57 mg) as a 
yellow solid after silica gel column chromatography. mp = 80-82 
o
C. 
1
H NMR (500 
MHz, CDCl3) δ = 7.29-7.44 (m, 2H), 7.13-7.28 (m, 2H), 7.04-7.08 (m, 1H), 6.97-7.03 
(m, 2H), 6.81-6.87 (m, 2H), 3.36-3.40 (m, 1H), 2.57 (dd, J = 7.4, 3.1 Hz, 2H), 1.34 (d, J 
= 6.8 Hz, 3H). 
13
C NMR (125.8 MHz, CDCl3) δ = 169.8, 161.3 (d, J = 243.2 Hz), 141.2, 
137.5, 128.8, 128.1 (d, J = 7.8 Hz), 124.3, 120.0, 115.3 (d, J = 21.3 Hz), 46.6, 36.1, 
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21.6.
19
F NMR (470.8 MHz, CDCl3) δ = -116.51. IR (neat) 3241, 3196, 3135, 3075, 2965, 
1649, 1598, 1555, 150 1442, 1311, 1224, 833, 757, 692, 658 cm
-1
. HRMS (ESI) calcd. 
for C16H17NOF [M+H]
+
 258.1294, found 258.1291. Using SFC analysis (Column OJ-H, 
10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time= 11.19 min and (R)-isomer 
retention time= 11.85 min. 
 
 (S)-3-(4-Fluorophenyl)-N-phenylbutanamide (3.29). Using the general procedure 
described for the Suzuki-Miyaura cross-coupling of potassium (R)-3-(trifluoroborato)-N-
phenylbutanamide (2c) and 4-chlorofluorobenzene, the title compound was obtained as a 
white solid in 88% yield (57 mg), with spectral data in accordance with that described for 
the racemate. mp = 80-82 
o
C. [α]D
20
 = +17.5 (c = 0.2, MeOH). The title compound was 
found to have an enantiomeric ratio of 7:93 with an absolute configuration of S for the 
major enantiomer using SFC analysis (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa); (S)-
isomer retention time = 11.18 min and (R)-isomer retention time = 11.83 min.  
 
N-Ethyl-3-(4-fluorophenyl)-N-(o-tolyl)butanamide. Using the general procedure 
described for the Suzuki-Miyaura cross-coupling of potassium N-ethyl-3-
(trifluoroborato)-N-(o-tolyl)butanamide and 4-chlorofluorobenzene, the title compound 
was obtained in 81% yield (61 mg) as a colorless oil. 
1
H NMR (360 MHz, asterisk 
denotes minor rotamer peaks, CDCl3) δ = 6.90-7.24 (m, 8H), 6.46-6.48* (m, 1H), 4.05-
4.09 (m, 1H), 3.37-3.41 (m, 1H), 3.09-3.15 (m, 1H), 2.20 (s, 3H), 2.07-2.17 (m, 2H), 
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1.93* (s, 3H), 1.16-1.19 (m, 3H), 1.08-1.12 (t, J = 7.1 Hz, 3H), 1.00-1.04* (t, J = 7.1 Hz, 
3H). 
13
C NMR (90.5 MHz, asterisk denotes rotamer peaks, CDCl3) δ = 171.0, 170.9*, 
140.7, 135.9, 131.4, 131.2*, 129.4, 129.3*, 128.5, 128.4*, 128.3, 128.2*, 126.9, 126.8*, 
115.1, 115.0*, 114.8, 114.7*, 43.0, 42.9*, 42.8, 42.7*, 35.8, 35.5*, 21.6, 21.5*, 17.5, 
17.2*, 12.8. 
19
F NMR (338.8 MHz, CDCl3) δ = -117.30. IR (neat) 2965, 2929, 2864, 
1712, 1651, 1510, 1361, 1220, 769, 727, 686, 639 cm
-1
. HRMS (ESI) calcd. for 
C19H23NOF [M+H]
+ 
300.1764, found 300.1759. Using SFC analysis (Column OD-H, 
10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time = 14.4 min and (R)-isomer 
retention time = 15.3 min. 
 
(S)-N-Ethyl-3-(4-fluorophenyl)-N-(o-tolyl)butanamide (3.30). Using the general 
procedure described for the Suzuki-Miyaura cross-coupling of potassium (R)-N-ethyl-3-
(trifluoroborato)-N-(o-tolyl)butanamide (2j) and 4-chlorofluorobenzene, the title 
compound was obtained as a colorless oil in 81% yield (61 mg) with spectral data in 
accordance with that described for the racemate. [α]D
20
 = -3.2 (c = 0.7, MeOH). The title 
compound was found to have an enantiomeric ratio of 15:85 with an absolute 
configuration of S for the major enantiomer using SFC analysis (Column OD-H, 10% i-
PrOH, 2 mL, 10 MPa); (S)-isomer retention time = 11.75 min and (R)-isomer retention 
time = 14.4 min. 
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N-Cyclohexyl-3-(4-fluorophenyl)butanamide.
30 
Using the general procedure described 
for the Suzuki-Miyaura cross-coupling of potassium N-cyclohexyl-3-
(trifluoroborato)butanamide and 4-chlorofluorobenzene, the title compound was obtained 
in 83% yield (55 mg) as a white solid after silica gel column chromatography. mp = 132-
134 
o
C. 
1
H NMR (300 MHz, CDCl3) δ = 7.12-7.26 (m, 2H), 6.90-7.04 (m, 2H), 5.32 (d, J 
= 9.1 Hz, 1H), 3.60-3.81 (m, 1H), 3.26-3.30 (m, 1H), 2.31-2.47 (m, 2H), 1.79-1.93 (m, 
1H), 1.50-1.76 (m, 4H), 1.27 (d, J-7.0 Hz, 3H), 0.83-1.25 (m, 5H). 
13
C NMR (75 MHz, 
CDCl3) δ = 170.2, 162.9 (d, J = 243.5 Hz), 141.4, 128.10 (d, J = 7.8 Hz), 115.0 (d, 
J=21.1 Hz), 47.8, 46.0, 36.3, 32.9, 32.8, 25.3, 24.7, 24.6, 21.5. 
19
F NMR (282.4 MHz, 
CDCl3) δ = -116.94. Using SFC analysis (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa); 
(S)-isomer retention time = 8.41 min and (R)-isomer retention time = 9.81 min. 
 
(S)-N-Cyclohexyl-3-(4-fluorophenyl)butanamide (3.31). Using the general procedure 
described for the Suzuki-Miyaura cross-coupling of potassium (R)-N-cyclohexyl-3-
(trifluoroborato)butanamide (2d) and 4-chlorofluorobenzene, the title compound was 
obtained as a white solid in 83% yield (55 mg) with spectral data in accordance with that 
described for the racemate. mp = 131-134 
o
C. [α]D
20
 = -41.3 (c = 0.15, MeOH). The title 
compound was found to have an enantiomeric ratio of 5:95 with an absolute 
configuration of S for the major enantiomer using SFC analysis (Column AS-H, 10% i-
PrOH, 2 mL, 10 MPa); (S)-isomer retention time = 8.19 min and (R)-isomer retention 
time = 9.64 min. 
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N-Cyclohexyl-3-(4-fluorophenyl)pentanamide. Using the general procedure described 
for the Suzuki-Miyaura cross-coupling of potassium N-cyclohexyl-3-
(trifluoroborato)pentanamide and 4-chlorofluorobenzene, the title compound was 
obtained in 85% yield (59 mg) as a white solid after silica gel column chromatography. 
mp = 102-104
 o
C. 
1
H NMR (360 MHz, CDCl3) δ = 7.14-7.18 (m, 2H), 6.90-7.06 (m, 2H), 
4.96 (s, 1H), 3.65-3.69 (m, 1H), 2.95-3.03 (m, 1H), 2.48 (dd, J = 13.7, 6.0 Hz, 1H), 2.25 
(dd, J = 13.7, 9.1 Hz, 1H), 1.51-1.84 (m, 8H), 1.21-1.36 (m, 2H), 0.90-1.18 (m, 2H), 0.79 
(t, J = 7.4 Hz, 3H). 
13
C NMR (90.5 MHz, CDCl3) δ = 170.4, 161.3 (d, J = 239 Hz), 139.7, 
128.9 (d, J = 8.1 Hz), 115.18 (d, J = 20.9 Hz), 47.8, 44.9, 44.0, 33.0, 29.1, 25.4, 24.7, 
11.9. 
19
F NMR (338.8 MHz, CDCl3) δ = -117.44. IR (neat) 3302, 2930, 2851, 1637, 
1542, 1508, 1445, 1223, 1160, 834, 684, 649, 638 cm
-1
. HRMS (ESI) calcd. For 
C17H25NOF [M+H]
+ 
278.1920, found 278.1916. Using SFC analysis (Column AS-H, 
10% i-PrOH, 2 mL, 10 MPa); (S)-isomer retention time = 13.9 min and (R)-isomer 
retention time = 14.4 min. 
 
(S)-N-Cyclohexyl-3-(4-fluorophenyl)pentanamide (3.32). Using the general procedure 
described for the Suzuki-Miyaura cross-coupling of potassium (R)-N-cyclohexyl-3-
(trifluoroborato)pentanamide (2f) and 4-chloroflourobenzene, the title compound was 
obtained as a white solid in 85% yield (59 mg), with spectral data in accordance with that 
described for the racemate. mp = 102-104
 o
C. [α]D
20
 = +109.5 (c = 0.2, MeOH). The title 
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compound was found to have an enantiomeric ratio of 10:90 with an absolute 
configuration of (S) for the major enantiomer using SFC analysis (Column AS-H, 10% i-
PrOH, 2 mL, 10 MPa); (S)-isomer retention time = 19.11 min and (R)-isomer retention 
time = 14.4 min.  
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Chapter 4. Modernizing Azaborines: Synthesis and Reactivity of 2,1-
Borazaronaphthalenes 
4.1 Introduction 
 The replacement of a C=C bond with a B-N bond within an aromatic system 
creates azaborines, a class of compounds that possess different photophysical properties 
and reactivity than the corresponding all-carbon parent.
1
 Within a six-membered aromatic 
ring, there are three different B-N isosteres, with the boron and nitrogen substituted either 
1,2-, 1,3-, or 1,4- (Figure 4.1). Of the three different azaborines, calculations and 
experimental results have shown that 1,2-azaborines are significantly the most stable, 
followed by 1,4-azaborines.
2
 As a Lewis structure for 1,3-azaborines does not exist 
without formal charges, this azaborine is the least stable.
3
 
 
Figure 4.1. Azaborine Analogs of Benzene 
Because B-N and C=C are isoelectronic, donation from the lone pair of nitrogen 
to boron results in a resonance form with a pseudo BN-double bond. Despite the 
significant π-donation, the B-N bond is not significantly polarized because of an 
opposing σ-contribution, resulting from the higher electronegativity of nitrogen relative 
to boron (Figure 4.2). Calculations have shown that the net formal charges of boron and 
nitrogen in an azaborine are similar to those of carbon in the corresponding all-carbon 
aromatic compound.
4
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Figure 4.2. Explanation of B-N/C=C Isosterism 
 The strength of the donation from nitrogen to boron results in compounds that 
retain much of the aromatic character of the parent compound.
5
 Nucleus-independent 
chemical shift (NICS) calculations determine the aromaticity of a molecule by calculating 
the magnetic field in the center of the molecule both in the plane of the molecule and 1Å 
above the plane. The more aromatic molecule will have a lower NICS value. The NICS 
values for benzene, 1,2-dihydro-1,2-azaborine, and borazine show that although the B-N-
benzene is not as aromatic as the all-carbon analog, it is significantly more aromatic than 
borazine (Figure 4.3).
5 
 
Figure 4.3. Determining the Aromaticity of Azaborines (Calculated at the 
B3LYP/Alhrichs-vtzp Level of Theory) 
 
4.2 Azaborines in Medicinal Chemistry 
 Azaborines have promising applications in medicinal chemistry with the potential 
to serve as drug candidates to help overcome the belief that undruggable targets exist 
because of limitations in chemical space.
6
 Realizing their ability to increase chemical 
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diversity of bioactive molecules, Katzenellenbogen examined the isosteric replacement of 
C=C with B-N in the synthesis of estrogen receptor (ER) ligands.
7
 The anilino 
diarylboranes are easily prepared from Grignard reagents (Scheme 4.1). These 
hydrolytically stable azaborines serve as analogs to triarylethylene estrogens and bind the 
estrogen receptor with high affinity. 
Scheme 4.1. Synthesis of Anilino Diarylboranes 
 
One of the main classes of azaborines examined for their applications in 
medicinal chemistry are diazaborines. One of the earliest reports of their ability to serve 
as potential drug candidates is a 1981 study on the inhibition of lipopolysaccharide 
biosynthesis. Inhibiting this biosynthesis is an effective methods of action of antibacterial 
agents for Gram-negative organisms. The diazaborine tested showed inhibition against 
both E. coli K-12 and Salmonella Typhimuriam (Figure 4.4). The mechanism for the 
inhibition was determined to occur by affecting 2-keto-3-deoxyoctonic acid (KDO) 
metabolism.
8
 
 
Figure 4.4. Diazaborine Inhibiting Lipopolysaccharide Biosynthesis 
 Further studies revealed that the activity of diazaborines is almost exclusively 
limited to Gram-negative bacteria, 
9
 and that the mechanism of action of diazaborines 
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was not the prevention of lipopolysaccharide biosynthesis bur rather inhibition of the 
enoyl acyl carrier protein (Enoyl-ACP) reductase.
10
 
After the initial report that diazaborines inhibit the growth of Gram-negative 
bacteria, the synthesis of a library of diazaborines was reported by Grassberger, and their 
bioactivity was tested in vitro and in vivo against six different bacterial strains of E. coli. 
The diazaborines synthesized in this study were derived from a six-membered 
diazaborine ring with a sulfonyl group on one of the nitrogens. This six-membered ring 
was fused to a five- or six-membered ring with introduction of various O, N or S 
heterocycles. The results of the testing showed varied outcomes based on the substitution 
pattern and heterocycles present in the molecule.
9
 
This study also attempted to determine whether the active species of the 
diazaborine is the closed-ring system or the opened-ring system as a result of B-N bond 
cleavage. One approach to determine the active species was based on BN/CC isosterism. 
The all-carbon analog of one of the diazaborines did not show any inhibition, suggesting 
the ring-opened system is the active species. The inhibition from the corresponding ring-
opened derivative was 10x less active than the diazaborine. Therefore, a conclusive 
determination on the active species cannot be made based on these results. However, 
there is some evidence to suggest that ring opening may be required for antibacterial 
action.
9
 
Recently, a structure-activity relationship of diazaborines was completed to 
determine which parts of the core azaborine was important for binding Enoyl-ACP 
reductase.
11
 By first analyzing the activities of the library synthesized by Grassberger, it 
was concluded that of the diazaborines tested, thieno-diazaborines were the most potent 
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inhibitors in comparison to benzo- and furo-diazaborines. This SAR focused on every site 
around the various diazaborine rings to determine if a substituent had a positive or 
negative impact on the inhibition of the enzyme. 
 In addition to the research conducted on diazaborines, studies toward 
demonstrating the medicinal chemistry applications of 1,2-dihydro-1,2-azaborines have 
been completed by Liu. To that end, Liu compared the difference of N-ethyl-1,2-
azaborine and ethylbenzene in binding the T4 lysozyme (Figure 4.5).
12
  
 
Figure 4.5. Ethylbenzene and its BN-Isosteres 
The mutation Leu99→Ala (L99a) of the T4 lysozyme creates a nonpolar, internal 
cavity capable of binding various arenes. Both the azaborine and ethylbenzene bind the 
pocket of the lysozyme in a similar fashion and occupy the same binding site as benzene. 
The formation of the complex requires three days at room temperature, demonstrating the 
stability of the azaborine in the pocket as it does not decompose or undergo any side 
reactions during that time. Analysis of the binding of the azaborine showed that the 
azaborine did not react chemically with the protein. Slight differences in binding were 
observed between ethylbenzene and the azaborine, which were attributed to the length of 
the C-B bond, as it is approximately 0.1 Å longer than an aromatic C-C bond. X-ray 
structures determined that the atoms of the azaborine ring and the pseudo-benzylic carbon 
of the ethyl group are coplanar. The binding of the azaborine confirms the aromatic 
nature of the azaborine as the azaborine binds as a nonpolar molecule, such that polar 
interactions are not observed with the ligand. Additionally, the N-H, B-H 1,2-azaborine 
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binds the hydrophobic pocket despite having a polar N-H bond, demonstrating the 
inherent aromaticity of the azaborine.
12
 
After demonstrating that 1,2-azaborines are biochemically active, Liu revealed 
that the B-N isosteres of ethylbenzene are strong inhibitors of ethylbenzene 
dehydrogenase (EbDH).
13
 This enzyme is responsible for catalyzing the oxygen-
independent hydroxylation of ethylbenzene to (S)-1-phenethanol via consecutive radical 
and carbocation formation at the benzylic position of the substrate. Both N-ethyl- and B-
ethyl-1,2-azaborine are not oxidized by the enzyme but rather inhibit the enzyme with 
IC50 values of 2.8 µM and 100 µM, respectively (Figure 4.5). Molecular mechanics 
modeling showed that the 1,2-azaborines bind similarly to ethylbenzene and that B-ethyl-
1,2-azaborine's lower activity is due to less favorable van der Waals interactions with the 
hydrophobic residues of the active site. Because the mechanism of action of the enzyme 
involves sequential oxidations to the benzylic carbocation, the substantially higher energy 
for radical and carbocation formation of the 1,2-azaborines provides a plausible rationale 
for the inhibition observed. 
4.3 Azaborines in Materials Science 
Azaborines have made significant impact in the field of materials science because 
of their photophysical properties.
14
 Replacement of a carbon atom in a polyaromatic 
hydrocarbon (PAH) with electron-deficient and/or electron-rich heteroatoms has a 
significant effect on the frontier molecular orbitals, altering the electronic properties of 
the compound. The isosteric replacement of C=C with B-N changes the HOMO-LUMO 
gap of the material such that different photophysical properties are obtained in 
comparison to the parent compound. The limitation of B-N bonds in materials science has 
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been their ability to undergo hydrolysis in the presence of moisture; however, the stability 
associated with azaborines has overcome this limitation. Azaborines with various 
substitution patterns, including both electron-donating and electron-withdrawing groups, 
can be synthesized to tune their assembly, solubility, absorption, and emission 
behavior.
14b
 
 Many different azaborines have been examined for their photophysical 
properties.
14
 For example, the absorption and emission spectra of BN-phenanthrene were 
collected and compared to phenanthrene (Figure 4.6).
14a
 
 
Figure 4.6. Structures of Phenanthrene and BN-Phenanthrene 
 Phenanthrene is a known fluorophile with an emission of 347 nm and a quantum 
yield of 0.09. Despite this low quantum yield, phenanthrene has been employed as a 
conjugated component in luminescent materials. Therefore, an azaborine analog with 
improved properties can be of significance. The BN-phenanthrene provides an emission 
maximum at 450 nm with a quantum yield of 0.58. The azaborine’s quantum efficiency 
increases six-fold, and there is a shift of 103 nm in the emission. An emission of 450 nm 
means that the azaborine emits blue light, which is the hardest emission to obtain for a 
molecule with high stability and quantum efficiency because of the large HOMO/LUMO 
gap required.
14a
 This result shows the potential impact that azaborines can have by 
serving as organic light-emitting diodes (OLEDs) to access novel luminescent materials 
with improved photophysical properties. 
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 Azaborines have also been demonstrated to serve as organic field-effect 
transistors (OFETs) (Figure 4.7). The alkyl side chains ensure solubility and tune the 
intermolecular interactions. The thiophene rings are installed to improve the aromaticity 
of the compound. The azaborine exhibited stability to ambient conditions as well as 
stability to acid, base, and fluoride. The OFET performed better than the carbon analog 
with a larger π-conjugated plane.
14c
 
 
Figure 4.7. Azaborines as Organic-Field Effect Transistors 
4.4 History of 2,1-Borazaronaphthalenes 
 After realizing the potential of azaborines in both medicinal chemistry and 
materials science, and deciding to venture into this field, 2,1-borazaronaphthalene was 
chosen as a model system to determine if the chemistry of azaborines could be 
modernized by performing metal-catalyzed reactions to build complex structures and 
access new chemical space (Figure 4.8). 
 
Figure 4.8. Structures of Naphthalene and 2,1-Borazaronaphthalene 
 Dewar first synthesized 2-chloro-2,1-borazaronaphthalene in 1959 via an 
annulation reaction between 2-aminostyrene and boron trichloride.
15
 Isolation of this 
azaborine proved to be difficult as the B-Cl was easily hydrolyzed to the corresponding 
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anhydride (bis-(2,1-borazaro-2-naphthyl) ether) upon exposure to air. The latter was 
isolated in 45% yield (Eq 4.1). 
Equation 4.1 
 
Paetzold later showed that by employing gaseous boron trichloride, 2-chloro-2,1-
borazaronaphthalene could be synthesized and purified by sublimation to afford the 
product in 67% yield. He also synthesized 2-bromo-2,1-borazaronaphthalene by 
employing boron tribromide in the place of boron trichloride, providing the product in 
71% yield (Eq 4.2).
16
 However, these azaborines readily hydrolyze to the anhydride upon 
prolonged exposure to air.  
Equation 4.2 
 
2-Chloro-2,1-borazaronaphthalene can be reacted with an array of nucleophiles to 
obtain 2-substituted azaborines. Addition of an alcohol, such as methanol or tert-butanol, 
affords the corresponding 2-alkoxy-2,1-borazaronaphthalene in 82% and 67% yield, 
respectively.
16
 The same products can be obtained by starting from the anhydride. 
Heating the anhydride in methanol results in complete conversion to 2-methoxy-2,1-
borazaronaphthalene (Scheme 4.2).
17
 However, as with the 2-halo-2,1-
borazaronaphthalene, the 2-alkoxy-2,1-borazaronaphthalenes undergo slow hydrolysis to 
the anhydride upon prolonged exposure to air. 
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Scheme 4.2. Synthesis of 2-Alkoxy-2,1-Borazaronaphthalene 
 
Whereas a leaving group on boron results in slow hydrolysis to the anhydride, the 
corresponding 2-alkyl- and 2-aryl-2,1-borazaronaphthalenes are air- and moisture stable 
compounds. Several methods exist for the synthesis of the alkylated- and arylated 
azaborines. Addition of a Grignard or an organolithium reagent to the 2-chloro-2,1-
borazaronaphthalene provides the desired azaborine in moderate yield (Eq 4.3).
14d,15,16
  
Equation 4.3 
 
Dewar realized that addition of an organometallic reagent to both 2-methoxy-2,1-
borazaronaphthalene and bis-(2,1-borazaro-2-naphthyl) ether resulted in displacement of 
the alkoxide on boron in higher yield than starting from 2-chloro-2,1-
borazaronaphthalene, but required a large excess of the Grignard reagent (Eq 4.4).
17
 
Equation 4.4 
 
 The B-aryl substituted 2,1-borazaronaphthalene can also be prepared in one step. 
Dewar showed that the 2-phenyl-2,1-borazaronaphthalene can be synthesized from 2-
aminostyrene and phenyldichloroborane in 69% yield.
15
 Paetzold later showed two 
additional examples that proceeded in moderate yield (Eq 4.5).
16
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Equation 4.5 
 
 Recently, Liu developed a rhodium-catalyzed approach to functionalized 1,2-
dihydro-1,2-azaborines.
18
 They showed one example with 2-chloro-2,1-
borazaronaphthalene, reacting it with trimethylphenylstannane to afford the coupled 
product in 71% yield (Eq 4.6). 
Equation 4.6 
 
 The parent BN-naphthalene, 2,1-borazaronaphthalane, can be prepared via the 
reduction of several different 2,1-borazaronaphthalenes. Addition of lithium aluminum 
hydride (LAH) to 2-chloro-,
15
 2-methoxy-2,1-borazaronaphthalene
17
 and bis-(2,1-
borazaro-2-naphthyl) ether
17
 affords the N-H, B-H 2,1-borazaronaphthalene in moderate 
to good yield (Eq 4.7). 
Equation 4.7 
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 Paetzold reported the synthesis of 4-phenyl-2-aryl-2,1-borazaronaphthalenes via 
the thermal cyclization of aniline, an aryldichloroborane, and phenylacetylene (Eq 4.8).
19
 
The five azaborines were synthesized in yields of 43-92%. 
Equation 4.8 
 
 Paetzold attempted the same cyclization reaction with boron trichloride instead of 
phenyldichloroborane to synthesize the corresponding 2-chloro-2-1,-
borazaronaphthalene. Coordination of boron and nitrogen proceeded as expected; 
however, the reaction does not yield the desired azaborine. Upon heating, elimination of 
HCl is faster than condensation with phenylacetylene. Substituting the aniline alleviated 
this problem, and the corresponding borazaronaphthalene was synthesized in moderate 
yield (Eq 4.9).
16
 
Equation 4.9 
 
As with 2-chloro-2,1-borazaronaphthalene, this B-Cl bond was displaced by the 
addition of a strong nucleophile, such as a Grignard or organolithium, in yields of 8-54%. 
Paetzold also showed that NaHMDS can serve as a nucleophile to form the 
corresponding B-N azaborine (Eq 4.10); however, the stability of this compound upon 
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pronged exposure to air is unknown. Addition of Li2O affords the corresponding 
anhydride in 98% yield.
16
 
Equation 4.10 
 
Because of the ability to displace the chloride on boron, addition of 
organometallic reagents to functionalize the 2-position of 2,1-borazaronaphthalenes has 
been exploited by both Dewar and Paetzold. On the other hand, reports on the 
functionalization at nitrogen are limited to substitution reactions employing 
methyllithium. Attempting to prepare water-soluble derivatives of 2,1-
borazaronaphthalenes to serve as potential agents in neutron capture therapy for the 
treatment of cancer, Dewar discovered that the addition of methyllithium will generate 
the N-lithio-2,1-borazaronaphthalene, which can then be reacted with an array of 
electrophiles to generate the N-alkylated azaborines (Eq 4.11).
20
 
Equation 4.11 
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1-(3-Chloropropyl)-2-methyl-2,1-borazaronaphthalene can be subjected to a 
second displacement reaction with dimethylamine, diethylamine, morpholine, and 
potassium cyanide, affording the substituted products in 72%, 68%, 76%, and 67% 
yields, respectively (Eq 4.12). 
Equation 4.12 
 
 2-(4-Bromobutyl)-2,1-borazaronaphthalene was prepared through a similar route; 
however, the compound underwent partial dehydrobromination during distillation. The 
product was confirmed by displacement of the crude alkyl bromide with morpholine. 
Addition of magnesium to the alkyl bromide results in an intramolecular ring closure 
with loss of MeMgBr in 89% yield (Scheme 4.3). Dewar proposed that the reaction is 
reversible until it is quenched with water, and the driving force for the cyclization is the 
increased entropy in the formation the cyclized product and MeMgBr. 
Scheme 4.3. Reactions of 2-(4-bromobutyl)-2,1-Borazaronaphthalene 
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Based on the work of Dewar, Paetzold showed that a lithiated azaborine can react 
with tetrakis(dimethylamino)dichlorodiboron to form a diborane, which was isolated in 
only 80% purity (Eq 4.13). 
Equation 4.13 
 
Although methods exist for functionalizing nitrogen and boron of 2,1-
borazaronaphthalene, there are limited reports on the functionalization of the azaborine 
core. Paetzold showed that the azaborine could be reacted with 
tris(acetonitrile)tricarbonylchromium, where the chromium coordinates selectively to the 
all-carbon ring of the azaborine (Eq 4.14). 
Equation 4.14 
 
Dewar reported the halogenation of 2,1-borazaronaphthalenes via electrophilic 
aromatic substitution. Addition of Br2 affords the desired product in 60% yield whereas 
addition of Cl2 provides the chlorinated product in 25% yield (Eq 4.15). The side product 
in both reactions is halogenated, protodeboronated 2-aminostyrene, suggesting that the 
azaborine is not stable under the harsh reaction conditions. 
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Equation 4.15 
 
Dewar determined that the side product was not the result of protodeboronation 
from AcOH as the 3-halo-2,1-borazaronaphthalene remained unchanged after 20 h in 
AcOH. Further, addition of a large excess of HCl in AcOH did not protodeboronate the 
azaborine, showing that the mechanism is not from attack of the hydrogen halide. 
Therefore, Dewar proposed that after formation of the bromonium π-complex, two 
pathways are possible (Scheme 4.4). Addition to the three position followed by 
rearomatization with loss of H
+
 results in product formation (route A). However, if the 
alkene is dibrominated, addition of bromide to boron results in an ‘ate’-complex, which 
can eliminate to form the corresponding 2-aminostyrene. The N-B bond would then be 
cleaved during the work-up and isolation (route B). 
Scheme 4.4. Proposed Mechanism for Protodeboronation 
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4.6 Synthesis of 2,1-Borazaronaphthalenes from 2-Aminostyrenes and Potassium 
Organotrifluoroborates 
 The inherent stability of 2,1-borazaronaphthalenes was first reported by Dewar in 
1961. 2-Phenyl-2,1-borazaronaphthalene was completely recovered without 
decomposition after heating 3 h in boiling concentrated HCl and after 2 h of boiling in 
40% aq KOH.
21
 Further, 2,1-borazaronaphthalenes synthesized by the Molander group 
have also shown stability to both strong acid (HCl, pH 2 at 37 °C) and base (Cs2CO3 in 
H2O at 60 °C). However, the presence of a strong electron-withdrawing group on boron 
lowers the stability of the 2,1-borazaronaphthalene such that the group is hydrolyzed in 
refluxing aq KOH and protodeboronated in glacial AcOH (Scheme 4.5).  
Scheme 4.5. Decomposition Pathway for 2,1-Borazaronaphthalenes. 
 
 Because of their aromatic character and thermal stability, the synthesis and 
functionalization of 2,1-borazaronaphthalenes provides access to compounds that could 
have an impact on the fields of medicinal chemistry and materials science. However, 
there are a limited number of approaches to 2,1-borazaronaphthalenes, each with their 
own set of limitations. BCl3 and BBr3 are not ideal reagents for the transformation 
because of their strength as Lewis acids as well as their high reactivity (Eq 4.1 and 4.2). 
The use of aryl Grignard or organolithium reagents results in harsh reaction conditions 
that limit functional group tolerance (Eq 4.3). The use of superstoichiometric ZnCl2 and 
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the high temperature and long reaction times needed to perform the cyclization reported 
by Paetzold limit its ability to serve as a viable method to access 2,1-
borazaronaphthalenes (Eq 4.8 and 4.9). Liu greatly expanded the scope of the aryl 
substituents on boron by coupling cyano- and carbonyl-containing arylstannanes to form 
B-aryl-1,2-dihydro-1,2-azaborines in yields of 41 to 81%.
18
 However, Liu’s approach is 
limited by employing an expensive rhodium-catalyst, employing toxic and atom-
inefficient arystannanes, and a reaction temperature much greater than the boiling point 
of the solvent. 
 Accounting for these limitations and realizing that no 1,2-disubstituted-2,1-
borazaronaphthalenes have been reported via a one-step synthesis, a versatile, concise, 
metal-free synthesis of B- and N-substituted 2,1-borazaronaphthalenes under mild 
reaction conditions using inexpensive materials was envisioned. The approach to 
substituted 2,1-borazaronaphthalenes is loosely based on the original synthesis of 2-
chloro-2,1-borazaronaphthalene reported by Dewar (Eq 4.1).
15
 A plausible mechanism 
for the annulation from boron trichloride and 2-aminostyrene can be seen in Scheme 4.6. 
Coordination of nitrogen and boron to form an N-B bond with loss of HCl has 
precedence in the literature
22
 and is the first step of the reaction to form 4.2. The second 
step is cyclization via nucleophilic attack of the terminal alkene, which is stabilized by 
resonance from the amine, with loss of Cl
-
 to form the iminium intermediate 4.3. 
Aromatization by the elimination of HCl affords the desired 2-chloro-2,1-
borazaronaphthalene 4.4. 
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Scheme 4.6. Plausible Mechanism for the Synthesis of 2-Chloro-2,1-
borazaronaphthalene 
 
Analyzing the mechanism provides two different approaches to access highly 
functionalized 2,1-borazaronaphthalene. Because one N-H bond remains intact 
throughout the cyclization, substitution on nitrogen can easily be achieved by employing 
an N-substituted-2-aminostyrene, thus providing N-substituted-2,1-borazaronaphthalenes 
in one step. Similarly, only one of three chlorides of BCl3 is incorporated into the 
product, as the other two chlorides are lost as HCl. Therefore, employing an R-BX2 
species (X = halide) would allow synthesis of B-substituted-2,1-borazaronaphthalenes in 
one step. Dewar,
15
 and later Paetzold,
16
 confirmed this route by employing aryl- and 
alkyldichloroboranes to afford the corresponding 2,1-borazaronaphthalenes in yields up 
to 69% (Eq 4.5). Aside from being easily hydrolyzed, less than ten 
organodichloroboranes are commercially available. The conventional synthesis of 
aryldihaloboranes
23
 is a lengthy process, in which an aryl halide is converted first to the 
corresponding aryl Grignard or aryllithium reagent, followed by subsequent 
transmetalations to the arylstannane and then the aryldichloroborane (Scheme 4.7, Route 
I). This method generates an exorbitant amount of waste for a series of transmetalations, 
and sensitive functional groups cannot be tolerated because of the harsh reaction 
conditions. A second method to access aryldihaloboranes is the Friedel-Crafts-type 
addition of BCl3 to arenes in the presence of AlCl3 (Scheme 4.7, Route II). However this 
297 
 
route is limited by the use of strong Lewis acids which again limit functional group 
tolerability, and the regioselectivity of the addition of boron is also difficult to control.  
Scheme 4.7. Methods for Synthesizing Phenyldichloroborane 
 
Vedejs first reported an approach to organohaloboranes from potassium 
organotrifluoroborates by showing that the addition of a fluorophile, such as TMSCl, 
converts phenyltrifluoroborate to the corresponding phenyldifluoroborane in situ (Eq 
4.16).
24
 
Equation 4.16 
 
Batey later demonstrated that BF3•OEt2 could serve as a fluorophile to generate 
allyldifluoroborane, which can undergo allylations with aldehydes in high yield (Eq 
4.17).
25
 Attempts by Batey to employ TMSCl as the fluorophile resulted in long reaction 
times with low yield of the desired product. Batey later extended the method to include a 
diastereoselective allylation and crotylation by employing various substituted allylic 
trifluoroborates.
26
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Equation 4.17 
 
Matteson showed that potassium organotrifluoroborates can be converted to the 
corresponding organodichloroboranes upon addition of SiCl4 in THF or acetonitrile at 
room temperature. Conversion of an α-chlorotrifluoroborate to the dichloroborane 
followed by addition of ZnEt2 results in formation of the trialkylborane, which undergoes 
α-transfer and oxidation upon addition of MeOH/NaOMe and then H2O2/NaOH (Eq 
4.18).
27
 
Equation 4.18 
 
The precedence set by Vedejs, Batey, and Matteson shows that potassium 
organotrifluoroborates can be converted to organodihaloboranes upon addition of a 
fluorophile (Scheme 4.7, route III), suggesting that this route could be employed in the 
synthesis of 2,1-borazaronaphthalenes. Because nearly 500 structurally diverse 
organotrifluoroborates are commercially available, adapting this protocol by allowing the 
use of air- and moisture-stable organotrifluoroborates would greatly expand the range of 
functional groups that could be incorporated in 2,1-borazaronaphthalenes. Whereas 
previous syntheses of 2,1-borazaronaphthalenes were limited to aryl and alkyl 
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substitution on boron, this approach would allow heteroaryl, alkenyl, and 
alkynyltrifluoroborates, in addition to aryl and alkyl, as suitable precursors to synthesize 
a library of 2,1-borazaronaphthalenes. 
N-Benzyl-2-aminostyrene and potassium phenyltrifluoroborate were chosen as 
model substrates for the synthesis of 1-benzyl-2-phenyl-2,1-borazaronaphthalene (Table 
4.1). An array of solvents was screened in a 1:1 ratio with toluene. Toluene was chosen 
as a replacement for benzene, which was employed in the initial report by Dewar. Of the 
various co-solvents, cyclopentyl methyl ether (CPME), a coordinating solvent, increased 
the yield of the product relative to toluene (entries 1-5). Based on Matteson’s adaptation 
of the Vedejs protocol, SiCl4 was the first fluorophile tested in the synthesis of the 
desired azaborine. Because any R-BX2 species (X = Br, Cl, F) should be able to be 
employed in the reaction, several other fluorophiles were employed in the reaction 
(entries 6-10). However, SiCl4 provided the desired product in the highest yield. 
Screening various solvents and fluorophiles provided conditions that resulted in 60% 
yield of the desired product (entry 5). 
Table 4.1. Initial Reaction Conditions for the Synthesis of 2,1-Borazaronaphthalene. 
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Various temperatures, concentrations, and ratios of reagents were examined to 
determine the final reaction conditions (Table 4.2). The concentration was varied at 80 
°C, with more desired product obtained when increasing the concentration to 0.5 M 
(entries 1-4). As the reaction was complete after 30 min at 80 °C, lower temperatures 
were screened. The desired product was afforded in the same yield in 4 h at a temperature 
of 60 °C (entry 5). Increasing the equivalents of phenyltrifluoroborate did not increase the 
yield, but increasing the amount of amine increased the yield by 20% (entry 6-7). 
Decreasing the equivalents of SiCl4 lowered the yield of the desired product (entry 8). 
Lowering the reaction temperature to 40 °C increased the reaction time to 18 h; however, 
the desired product was obtained in 78% yield with the conditions from entry 6 (entry 9).  
Table 4.2. Final Reaction Refinement on the Synthesis of 2,1-Borazaronaphthalene. 
 
In addition to varying the solvent, temperature, concentration, and fluorophile, 
several additives were screened in the reaction. As HCl is generated in the reaction, one 
or two equivalents of K2CO3 were added, but no change in yield was observed. However, 
addition of one or two equivalents of two other bases, NaOt-Bu or NEt3, resulted in no 
product formation. KBr, which could form the corresponding R-BBr2 species in situ,
28
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was tested as an additive, but there was no change the yield of the reaction. Therefore the 
preferred conditions for the synthesis of 1,2-disubstituted-2,1-borazaronaphthalenes were 
1.5 equiv of amine, 1.0 equiv of organotrifluoroborate, 1.0 equiv of SiCl4 in a 1:1 mixture 
of toluene/CPME at 60 °C for 4 h. 
An array of functionalized potassium aryl- and heteroaryltrifluoroborates were 
subjected to the standard reaction conditions, providing the corresponding 1,2-
disubstituted-2,1-borazaronaphthalenes in moderate to good yields. (Table 4.3). 
Aryltrifluoroborates with electron-donating substituents in the meta- and para- positions 
afforded the desired products in yields up to 72% (entries 2-4 and 7). Electron-deficient 
aryltrifluoroborates were also suitable substrates for the reaction as the corresponding 
azaborines were synthesized in high yield. Fluorinated, difluorinated, and 
ditrifluoromethylated 2,1-borazaronaphthalenes were synthesized in yields up to 70%. 
The mild reaction conditions required allowed functional groups that would not have 
been compatible under the organometallic addition route to functionalize 2-chloro-2,1-
borazaronaphthalene. Aryltrifluoroborates with nitrile, ester, and nitro functional groups 
provided the desired products in yields of 49-65% (entries 8-10). 
Heteroaryltrifluoroborates allowed 2-heteroaryl-2,1-borazaronaphthalenes to be obtained 
in moderate yield after lowering the reaction temperature to 40 °C. Because of steric 
factors of substituting 2,1-borazaronaphthalene in the 1- and 2-positions, sterically 
hindered aryltrifluoroborates afforded the corresponding azaborines in lower yield. For 
example, the azaborine synthesized from 2-naphthyltrifluoroborate was obtained in 69% 
yield whereas the 1-naphthyltrifluoroborate provided the 2,1-borazaronaphthalene in 15% 
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yield. The scalable nature of this method was illustrated by performing the reaction on a 5 
mmol scale without loss of yield (entry 1). 
In comparison to the previously reported syntheses of 2,1-borazaronaphthalenes, 
the only reported examples of aryl substitution on boron in monosubstituted 2,1-
borazaronaphthalenes are phenyl,
15
 2-pyridinyl,
14d
 or pentafluorophenyl rings,
19
 where 
the desired products were synthesized in 43-69%, 13%, and 78-89% yields, respectively. 
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Table 4.3. Scope of the Reaction with Potassium (Hetero)aryltrifluoroborates. 
 
 After determining the scope of the annulation with aryl- and 
heteroaryltrifluoroborates, the method was extended to potassium alkenyl- and 
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alkynyltrifluoroborates to access azaborines with novel substitution patterns (Table 4.4). 
There are no reported example of alkenyl- or alkynyl substituted 2,1-
borazaronaphthalenes. An array of alkenyl- and alkynyltrifluoroborates were successfully 
employed in the synthesis of 2,1-borazaronaphthalenes with a decreased reaction 
temperature of 40 °C (Table 4.4). Both cis- and trans-3-propenyltrifluoroborate were 
employed in the reaction, and complete retention of stereochemistry of the olefin was 
observed (entries 1-2). The 2,1-borazaronaphthalene obtained from potassium 1-
hexynyltrifluoroborate was isolated in 47% yield (entry 4). 
Table 4.4. Scope of the Reaction with Potassium Alkenyl- and 
Alkynyltrifluoroborates 
 
 Accessing B-alkyl substituted 2,1-borazaronaphthalenes involved addition of an 
alkylmetallic reagent to the B-Cl, B-OMe or B-O anhydride derivatives in a second step 
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after assembly of the 2,1-borazaronaphthalene core. The examples reported by Dewar 
and Paetzold were limited to simple aliphatic groups, including methyl, ethyl, isopropyl, 
and tert-butyl systems, which were synthesized in yields of 43%, 54%, 8%, and 25%, 
respectively.
15,16
 The currently developed synthesis of 2,1-borazaronaphthalenes affords 
2-alkyl-2,1-borazaronaphthalenes through a direct, straightforward manner by employing 
readily available primary and secondary alkyltrifluoroborates (Table 4.5). β,β,β-
Trifluoroethyltrifluoroborate was a suitable substrate for the annulation, providing the 
2,1-borazaronaphthalene in 40% yield (entry 3). Secondary cyclic trifluoroborates afford 
the desired 2,1-borazaronaphthalenes in yields up to 51% (entries 5-7). The scalable 
nature of this method with alkyltrifluoroborates was demonstrated by performing the 
reaction on a 5 mmol scale with methyltrifluorobroate (entry 1). 
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Table 4.5. Scope of the Reaction with Potassium Alkyltrifluoroborates. 
 
 The method was next extended to include an array of N-substituted 2-
aminostyrenes, which were reacted with phenyltrifluoroborate to afford 2-phenyl-2,1-
borazaronaphthalenes in moderate to good yield, demonstrating how this convergent 
approach allows easy access to disubstituted 2,1-borazaronaphthalenes. The starting 
materials were prepared via a Buchwald-Hartwig amination of commercially available 2-
bromostyrene.
29
 Different protecting groups, including p-methoxybenzyl (PMB) and allyl 
on nitrogen afforded the corresponding 2,1-borazaronaphthalenes in yields up to 61% 
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(entries 2-3). Straight-chain alkyl and aryl substituents were installed on nitrogen and 
employed in the reaction, providing the desired products in 71% and 40%, respectively 
(entries 4-5).  
The steric restrictions that were evident in the cyclizations with 1- and 2-
naphthyltrifluoroborate are also apparent in the use of the sterically-hindered N-
diphenylmethyl-2-aminostyrene, as no desired product was obtained in the reaction (entry 
6). 
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Table 4.6. Scope of the Reaction with N-Substituted 2-Aminostyrenes. 
 
 Aryl-functionalized 2-aminostyrenes have not been employed in the synthesis of 
2,1-borazaronaphthalenes. Therefore, after preparing 2,1-borazaronaphthalenes with 
various substituents on nitrogen and boron, the method was extended to synthesize aryl-
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substituted 2,1-borazaronaphthalenes. The starting functionalized 2-aminostyrenes were 
prepared in a two-step process via a Wittig olefination and Buchwald-Hartwig amination 
of 2-bromobenzaldehydes. Both electron-withdrawing and electron-donating groups can 
be placed at various positions about the arene, providing the desired products in yields up 
to 75%. Azaborines containing a trifluoromethyl or fluorine substituent on the arene were 
synthesized in yields up to 73% (entries 1-2). Substitution of methyl and methoxy groups 
about the aromatic ring result in the corresponding 2,1-borazaronaphthalenes being 
obtained in yields of 75% and 59%, respectively (entries 3-4). By demonstrating the 
various substitution patterns that can be installed on the 2,1-borazaronaphthalene by 
starting from an array of 2-aminostyrenes, complete control of regiochemistry can be 
achieved in the placement of substituents on both rings, which is an advantage compared 
to the synthesis of substituted naphthalenes. 
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Table 4.7. Scope of the Reaction with Substituted 2-Aminostyrenes. 
 
 One potential route to access N-H monosubstituted 2,1-borazaronaphthalenes 
would be the synthesis of an N-protected azaborine, which could later be deprotected. To 
that end, N-benzyl-2-aminostyrene was chosen for optimization. However, because of the 
aromatic character of 2,1-borazaronaphthalenes, this protecting group was not cleaved 
under an array of reaction conditions, demonstrating that the N-C bond acts more like a 
C-C bond. Attempts to deprotect the N-PMB- and N-allyl-2,1-borazaronaphthalenes were 
also unsuccessful. In almost every reaction, starting material was recovered, illustrating 
the inherent stability of 2,1-borazaronaphthalenes. To synthesize N-H monosubstituted 
2,1-borazaronaphthalenes, therefore, the two-component annulation/aromatization 
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reactions were carried out with 2-aminostyrene. Lowering the concentration of the 
standard reaction conditions to 0.25 M allowed the desired product to be synthesized in 
66% yield (Table 4.8, entry 7). Addition of 1.5 equiv NEt3, to quench the HCl forming 
during the reaction, greatly improved the yield to 95%. These optimized conditions were 
applied to an array of potassium organotrifluoroborates, providing the desired 2,1-
borazaronaphthalenes in yields up to 95% (Table 4.8). Overall, yields increased for each 
class of trifluoroborate employed in the reaction. Acyclic and cyclic trifluoroborates 
afforded the desired azaborines in high yield (entries 1-4). The mild conditions allowed 
an alkyl bromide and alkyl iodide to be installed on the 2,1-borazaronaphthalene in yields 
of 80% and 69%, respectively. Alkenyl- and alkynyltrifluoroborates were also 
successfully employed in the reaction, providing the corresponding 2,1-
borazaronaphthalenes in moderate to good yield (entries 5-6). Arenes with electron-
donating and electron-withdrawing groups as well as various heterocycles were installed 
on boron in high yield (entries 8-12). 
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Table 4.8. Scope of the Reaction with 2-Aminostyrene 
 
 This method has been utilized to prepare 2,1-borazaronaphthalenes with the 
follow substitution patterns: 1-alkyl-2-aryl, 1,2-dialkyl, and 1,2-diaryl, all of which have 
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been synthesized in yields up to 95%. To demonstrate that the fourth complementary 
substitution pattern was accessible, N-phenyl-2-aminostyrene was reacted with potassium 
methyltrifluoroborate, affording the 1-aryl-2-alkyl-2,1-borazaronaphthalene in 43% yield 
(Eq 4.19). 
Equation 19 
 
 The overall impact of this method can be demonstrated by comparing the current 
method to synthesize 2,1-borazaronaphthalenes with methods to synthesize the isosteric 
substituted naphthalenes (Scheme 4.8). The synthesis of 1-alkyl-2-aryl and 1,2-
dialkylnaphthalenes often requires the use of alkyl- and aryl Grignard reagents to 
substitute the 2-position of naphthalene, followed by a high temperature oxidation, 
reaction conditions that limit functional group tolerance (Scheme 4.8, IA and IB, 
respectively). The corresponding 2,1-borazaronaphthalenes (4.6-4.21 and 4.26-4.32) can 
be synthesized under milder reaction conditions. 1-Alkyl-2-aryl- and 1,2-
diarylnaphthalenes can be accessed through a palladium catalyzed borylation and/or 
cross-coupling (Scheme 4.8, IB and IV). Despite improving functional group tolerability 
by employing boronate esters, the synthesis of the electrophilic naphthalene requires 
several steps and harsh reaction conditions. The corresponding 2,1-borazaronaphthalenes 
(4.6-4.21 and 4.33-4.36) can be prepared through a transition-metal free route which does 
not require multi-step synthesis of the starting materials. 1-Aryl-2-alkyl-naphthalenes can 
be synthesized through a gallium-catalyzed reaction. Although the product is formed in 
one-step, there are only a few examples, which are void of functional groups, and only 
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straight chain alkyl substituents were present on the alkyne (Scheme 4.8, III). Highly 
functionalized alkyltrifluoroborates can be employed in the synthesis of the 
corresponding 2,1-borazaronaphthalenes, which are prepared in similar yield (4.54). 1-
Substituted-2-alkynyl- and 1-substituted-2-alkenylnaphthalenes can be prepared through 
a cross-coupling similar to that of the 1,2-diarylnaphthalene (Scheme 4.8, IV). Limited 
reports on the synthesis of 1,2-disubstituted naphthalenes with further substitution on the 
naphthyl ring exist in the literature. For example, there are no reported examples of 
naphthalenes analogous to the fluorinated and trifluoromethylated 2,1-
borazaronaphthalenes 4.38 and 4.39. The 2,1-borazaronaphthalenes are prepared in a 
convergent, modular manner by reacting an aryl- and N-substituted 2-aminostyrene with 
an organotrifluoroborate to afford highly elaborated azaborines with complete control of 
regiochemistry that would be virtually impossible to replicate easily in naphthalenes 
themselves. 
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Scheme 4.8. Synthesis of Corresponding Naphthalenes 
 
 The isosteric 1,2-disubstituted naphthalenes can be synthesized by a variety of 
methods, some of which require strongly nucleophilic organometallic reagents that limit 
functional group tolerance. Other methods require the preactiviation of the rings or the 
use of expensive transition-metal catalysts. The synthesis of 2,1-borazaronaphthalenes, 
however, is a transition-metal free route that affords products in one-step with complete 
control of regioselectivity and control of substituents on both rings. Utilization of this 
method allowed a library of forty-nine B-and N-substituted 2,1-borazaronaphthalenes to 
be prepared from potassium organotrifluoroborates and various 2-aminostyrenes under 
mild reaction conditions. The use of SiCl4 as a fluorophile allowed an array of aryl-, 
heteroaryl-, alkynyl-, alkenyl-, and alkyltrifluoroborates to be employed in the reaction, 
resulting in great variety at the 2-position of the 2,1-borazaronaphthalene. More diversity 
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has been introduced into the 2,1-borazaronaphthalene platform as a result of this study 
than in all previous studies in the last 50+ years combined. 
4.7 Palladium-Catalyzed Suzuki-Miyaura Cross-Couplings of Brominated 2,1-
Borazaronaphthalenes and Potassium Organotrifluoroborates 
 Continuing our efforts to build the molecular complexity of azaborines, attention 
was turned to functionalization of the 2,1-borazaronaphthalenes. The synthesis of the 
azaborine core is just the starting point as further functionalization would allow access to 
novel, increasingly complex molecules. The method to synthesize 2,1-
borazaronaphthalenes has allowed a library of azaborines to be prepared with various 
substitution around the ring from simple starting materials. 2,1-borazaronaphthalenes 
substituted at the 1, 2, 5, 6, 7, and 8 positions can be easily prepared by employing the 
requisite 2-aminostyrene and potassium organotrifluoroborate. However, synthesis of the 
3-substituted-2,1-borazaronaphthalenes were not successful through this method. The 
reaction of potassium phenyltrifluoroborate and (E)-2-styrylaniline did not afford any of 
the desired product (Eq 4.20). 
Equation 4.20 
 
 An alternate method was required to synthesize the 3-substituted-2,1-
borazaronaphthalenes, and therefore, a different retrosynthetic scheme was envisioned 
(Scheme 4.9). A Suzuki-Miyaura cross-coupling between 3-bromo-2,1-
borazaronaphthalenes and potassium (hetero)aryltrifluoroborates was proposed to access 
elaborate 2,1-borazaronaphthalenes. A library of 3-(hetero)arylated-2,1-
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borazaronaphthalenes could be easily synthesized from a single brominated azaborine, 
thereby building substantial molecular complexity over two short steps.  
Scheme 4.9. Retrosynthetic Disconnection to Access 3-Aryl-2,1-
borazaronaphthalenes 
 
 Two isolated examples of a brominated azaborine undergoing a cross-coupling 
reaction are present in the literature. The Negishi coupling of an in situ generated 
azaborinylzinc species with an aryl bromides provides the desired product in 24% yield 
(Eq 4.21).
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Equation 4.21 
 
 The Suzuki-Miyaura coupling between a dibrominated azaborine and 
phenylboronic acid was reported to catalyzed by Pd(PPh3)4 (Eq 4.22). However, no yield 
on the reaction was provided.
31
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Equation 4.22 
 
 Because of an interaction between the vacant orbital on boron and an activated 
palladium complex, boronic acids and many boronic acid surrogates are capable of 
undergoing transmetalation in cross-coupling reactions.
32
 However, the empty p orbital 
on boron within the azaborine is occupied by electron donation from the nitrogen, which 
helps explain the azaborine’s aromatic stability. The strength of the B-N bond not only 
explains their stability and aromatic character, but also reduces their ability to participate 
in transmetalation such that selectivity in the transmetalation of a cross-coupling would 
proceed with the external nucleophile, leaving the B-C bond of the azaborine intact. 
 Toward the goal of achieving the Suzuki-Miyaura coupling of brominated 2,1-
borazaronaphthalenes with aryl- and heteroaryltrifluoroborates, research was first focused 
on the synthesis of the electrophilic 2,1-borazaronaphthalene required for the coupling. 
Because the B-N bond desymmetrizes the azaborine, 2,1-borazaronaphthalenes exhibit 
reactivity toward electrophilic aromatic substitution that is complementary to 
naphthalene, with different positions of the ring activated toward substitution for the 
azaborine than naphthalene. Although 2,1-borazaronaphthalenes retain aromatic character 
and thermal stability, they are activated toward electrophilic aromatic substitution 
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because their aromatic character is lower than the C=C analog, and therefore electrophilic 
aromatic substitution can occur under milder reaction conditions. 
 The halogenation of 2-methyl-2,1-borazaronaphthalene was first reported by 
Dewar in 1961 (Eq 4.15). Before this study, the only substitutions reported at the 3-
position of 2,1-borazaronaphthalenes were bromine and chlorine. The bromination of 2-
methyl-2,1-borazaronaphthalene afforded the desired product in 60% yield with a major 
brominated, protodehalogenated side product formed in 29% yield, presumably as a 
result of the harsh reaction conditions. Ashe reported the bromination of 1,2-dihydro-1,2-
azaborine, the BN-analog of benzene, to proceed in 91% yield under milder reaction 
conditions.
33
 By adapting these modified conditions (changing the solvent to 
dichloromethane and cooling the reaction to 0 °C), the bromination of 2,1-
borazaronaphthalene proceeded smoothly, affording over twenty 3-bromo-2,1-
borazaronaphthalenes in yields up to 99%. The rate of the addition of bromine was 
important to achieving high yields: a rate of ~1 mmol per hour provides the desired 
products in high yield, whereas a more rapid addition caused the reaction to exotherm, 
resulting in decomposition of the 2,1-borazaronaphthalene. The rate of addition of 
bromine can be increased by performing the reaction at -78 °C. 
 A large variety of 2,1-borazaronaphthalenes were brominated under these 
standard conditions to afford the desired 3-bromo-2,1-borazaronaphthalenes (Table 4.9). 
2-Alkyl-2,1-borazaronaphthalenes were brominated in high yield across a range of alkyl 
substituents (entries 1-5). 2-Aryl-2,1-borazaronaphthalenes with both electron-donating 
and electron-withdrawing groups on the arene were brominated in yields of 81-99% 
(entries 8-10, 13-17 and 19). Bromination of 2-heteroaryl-2,1-borazaronaphthalenes 
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provided the desired products in yields up to 89% (entries 11, 12 and 18). Substitution on 
nitrogen did not affect the bromination, as a large variety of N-substituted-2,1-
borazaronaphthalenes were brominated in high yield (entries 6, 7 and 13-19). The 
extraordinary activity of 2,1-borazaronaphthalenes toward electrophilic aromatic 
substitution was illustrated by performing the bromination in the presence of an allyl 
group
34
 or alkyne
35
 (entries 7, 13, 14, and 20), where the azaborine is brominated in 
preference to the other group.  
 The synthesis of 2,1-borazaronaphthalenes from electron-deficient 2-
aminostyrenes (i.e., 2-amino-5-trifluoromethylstyrene) was unsuccessful under the 
standard annulation conditions. However, N-substituted 2-aminostyrenes proved to be 
suitable substrates for synthesis and bromination, such that the corresponding brominated 
products were obtained in good yield (entries 21-22). Futhermore, these examples 
demonstrate that substitution on the all-carbon ring does not affect the bromination. 
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Table 4.9. Scope of the Bromination of 2,1-Borazaronaphthalenes 
 
 The conditions developed for the bromination allow aryl, heteroaryl, alkynyl, and 
alkyl substituents on boron. However, 2-alkenyl-2,1-borazaronaphthalenes do not 
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undergo bromination on the azaborine ring. Rather, dibromination of the alkene is the 
major product (Eq 4.23). The same reactivity is observed for the bromination of alkenyl-
substituted arenes, where dibromination of the alkene is followed by electrophilic 
aromatic substitution.
36 
Equation 4.23 
 
 Whereas addition of one equivalent of bromine results in the C3 site-selective 
bromination of 2,1-borazaronaphthalenes, addition of a second equivalent results in the 
site-selective dibromination at the C3 and C6 positions. The one-pot dibromination of 2-
methyl-2,1-borazaronaphthalenes provided 3,6-dibromo-2-methyl-2,1-
borazaronaphthalene in 92% yield (Eq 4.24). 
Equation 4.24 
 
Because the isosteric replacement of C=C with B-N effectively desymmetrizes the 
azaborine and selectively activates the azaborine for electrophilic aromatic substitution, 
both mono- and dibromination of the 2,1-borazaronaphthalene occur with complete 
regiochemical control. The nucleophilic positions on the 2,1-borazaronaphthalene can be 
shown by resonance structures to be the C3, C6, and C8 positions (Scheme 4.10). 
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Scheme 4.10. Resonance Forms of 2,1-Borazaronaphthalenes 
 
 
Resonance forms suggest that the C8 position should also be nucleophilic; 
however, bromination at this position is not observed. The preferred selectivity for 
electrophilic aromatic substitution at the C3 and C6 positions can be predicted by 
performing a rudimentary DFT calculation, analyzing the HOMO of the 2,1-
borazaronaphthalene (Figure 4.9). The calculation, completed at the B3LYP/6-31G(d) 
level of theory, shows the electron density at each carbon of the HOMO of 2,1-
borazaronaphthalene. Although it suggests the C4a carbon should be nucleophilic, 
addition of an electrophile to the fused carbon will break the aromaticity of both rings, 
increasing the energy barrier to the reaction. The electron density at the C3 position is 
0.342, which is the highest value of the three nucleophilic sites. The C6 position is only 
slightly lower with an electron density of 0.325, explaining the site-selective second 
bromination of 2,1-borazaronaphthalenes. However, the C8 position has an electron 
density of only 0.024, showing a lack of nucleophilicity at this position. Analysis of the 
electron densities of the HOMOs of 2,1-borazaronaphthalenes with substitution around 
the azaborine (i.e., 4.75 and 4.76) show a similar trend, confirming that the C3 position it 
the most nucleophilic carbon in the azaborine.  
324 
 
 
Figure 4.9. DFT Calculation of the HOMO of 2,1-Borazaronaphthalene (Calculated 
at the B3LYP/6-31G(d) level of theory) 
Additional information for explaining the site-selective bromination can be 
determined by performing a computational study. After the addition of bromine to the 
three possible positions of 2-methyl-2,1-borazaronaphthalene, three different 
intermediates are formed (Figure 4.10). A series of calculations, completed at the 
B3LYP/6-31G(d) level of theory, evaluated the relative energies of these three 
intermediates to determine which pathway was most favorable. The relative energy for 
the brominated intermediates at the C6 and C8 positions are significantly higher than that 
of the C3 positions. Because the B-N ring is less aromatic and thermally stable, its 
reactivity is increased to such an extent that addition to the C3 position is energetically 
favored by over 7 kcal/mol. Comparison between the C6 and C8 intermediates shows that 
the C6 intermediate is lower in energy by ~2 kcal/mol, providing a plausible rationale for 
why the second bromination occurs at the C6 position. 
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Figure 4.10. Relative Energies of the Addition of Bromine to 2-Methyl-2,1-
Borazaronaphthalene Intermediates [Calculated at B3LYP/6-31G(d) level of 
theory]. 
 The impact of the site-selective bromination can be demonstrated by comparison 
with the bromination of naphthalene. The natural site for electrophilic aromatic 
substitution of naphthalene is the C1 position,
37
 whereas 2,1-borazaronaphthalenes 
undergo electrophilic aromatic substitution at the C3 position. The bromination of 2-
methyl-naphthalene, the C=C analog of 2-methyl-2,1-borazaronaphthalene, proceeds in 
87% yield to form 1-bromo-2-methylnaphthalene.
38
 The bromination of the 
corresponding azaborine affords 3-bromo-2-methyl-2,1-borazaronaphthalene in 99% 
yield, illustrating how the electrophilic aromatic substitution of the BN-analog and all 
parent carbon parent compound are complementary. 
 A different method must therefore be employed to access 3-halonaphthalenes as 
electrophilic aromatic substitution provides the 1-halonaphthalene. The installation of a 
halogen at the 3-position of a naphthalene often requires a directing group in addition to 
harsh reaction conditions (Eq 4.25).
39
  
Equation 4.25 
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Another method to install a halogen in the C3 position of naphthalenes is a gold-
catalyzed cyclization in the presence of NIS, which requires a separate synthesis of the 
starting material and an expensive transition metal catalyst (Eq 4.26).
40
 The 
corresponding bromination of 2,1-borazaronaphthalene is a one-step process resulting in 
the addition of bromine to a highly functionalized molecule. 
Equation 4.26 
 
With a method to access brominated 2,1-borazaronaphthalenes in high yield, 3-
bromo-2-methyl-2,1-borazaronaphthalene and potassium phenyltrifluoroborate were 
chosen as model substrates for optimizing the Suzuki-Miyaura cross-coupling reaction 
(Eq 4.27). 
Equation 4.27 
 
Before optimizing the reaction, stability tests were performed on the 2,1-
borazaronaphthalenes to insure their stability in basic media at elevated temperatures. 
2,1-Borazaronaphthalenes were recovered without decomposition after heating to 60 °C 
in 1:1 THF/H2O with 3 equiv of Cs2CO3. Therefore, a limited screening process 
identified initial reaction conditions for the desired cross-coupling. Several palladium 
sources and ligands were tested, but the t-Bu3P 2
nd
 generation aminobiphenyl palladium 
chloride precatalyst (t-Bu3P-Pd-G2, Figure 4.11) showed the highest levels of conversion 
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and product formation in addition to containing a relatively inexpensive phosphine 
ligand. 
 
Figure 4.11. Structure of t-Bu3P-Pd-G2 
Optimization continued with t-Bu3-Pd-G2 as the palladium source (Table 4.10). 
Varying the reaction temperature showed complete conversion of the brominated 
azaborine at 60 °C (entries 1-2). Changing the co-solvent from dioxane had an effect on 
the rate of the reaction. CPME also resulted in complete conversion, whereas with THF 
and toluene, starting material remained after 18 h (entries 3-5). CPME was chosen as the 
co-solvent with H2O instead of dioxane because of its more favorable properties. 
Therefore, with 1:1 CPME/H2O at 60 ºC, the palladium loading can be lowered to 1 mol 
%; however, lowering to 0.5 mol % results in incomplete conversion of the starting 
material (entries 6-7). The concentration of the reaction can be increased to 0.5 M 
without loss of yield. Therefore, the final optimized conditions were determined to be 1 
mol % t-Bu3P-Pd-G2 as the palladium source, 3 equiv of Cs2CO3 as the base with a 1:1 
CPME/H2O solvent mixture at 60 °C for 18 h. 
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Table 4.10. Optimization of the Cross-Coupling of 3-Bromo-2-methyl-2,1-
borazaronaphthalene 
 
The scope of the cross-coupling with aryltrifluoroborates was examined by 
subjecting fourteen aryltrifluoroborate to the general reaction conditions (Table 4.11). 
Electron-donating groups substituted ortho, meta, and para provide the desired products 
in yields up to 95%. Both 1- and 2-naphthyltrifluoroborates were successful nucleophiles 
are the cross-coupled products were obtained in yields of 93% and 95%, respectively. 
Electron-poor aryltrifluoroborates were also employed in the reaction, affording the 3-
arylated-2,1-borazaronaphthalenes in yields up to 90% (entries 10-14). The mild nature 
of the developed conditions is evident by the successful coupling of nitro, ester, and 
cyano functional groups (entries 10, 11, and 14). The scalable nature of the cross-
coupling was illustrated by performing the cross-coupling on a 4.5 mmol scale with 0.5 
mol % t-Bu3P-Pd-G2 (entry 1). 
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Table 4.11. Scope of the Cross-Coupling with Potassium Aryltrifluoroborates 
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 The general reaction conditions were then applied to a representative set of 
potassium heteroaryltrifluoroborates (Table 4.12). Seven different 
heteroaryltrifluoroborates were employed in the reaction, providing the desired products 
in yields up to 86%. Isomeric thienyltrifluoroborates were successful nucleophiles as the 
cross-coupled products were obtained in 84% and 86% yields (entries 2-3). A five-
membered, dimethylated isoxazolyltrifluoroborate afforded the desired product in 51% 
yield (entry 4). Larger heterocyclic trifluoroborates were successfully engaged in the 
reaction, providing the cross-coupled products in good yield after lowering the 
concentration to 0.1 M (entries 6-7). 
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Table 4.12. Scope of the Cross-Coupling with Potassium Heteroaryltrifluoroborates 
 
To expand the scope of the method, an array of 3-bromo-2-alkyl-2,1-
borazaronaphthalenes were subjected to the standard reaction conditions with potassium 
3-methoxyphenyltrifluoroborate as the nucleophile (Table 4.13). Six different brominated 
azaborines provided the desired cross-coupled products in yields up to 93%. Substitution 
on nitrogen does not affect the cross-coupled as the desired products were obtained in 
yields of 93% and 83% (entries 1-2). Acyclic primary and secondary alkyl substituents on 
332 
 
boron do not interfere with the coupling as the cross-coupled products are synthesized in 
good yield (entries 3-4). Brominated 2,1-borazaronaphthalenes with cyclic secondary 
substituents on boron were successful electrophiles, affording the desired products in 
yields of 84% and 70% (entries 5-6). 
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Table 4.13. Scope of the Electrophilic 3-Bromo-2-alkyl-2,1-borazaronaphthalenes 
 
The cross-coupling conditions developed for the coupling of 3-bromo-2-alkyl-2,1-
borazaronaphthalenes provide the desired products in high yield. Therefore, the coupling 
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of the corresponding 3-bromo-2-aryl-2,1-borazaronaphthalenes was next investigated. 
Because transmetalation of B-alkyl systems would not likely compete with the 
transmetalation of the arylboronate, the cross-coupling proceeded smoothly. However, 
aryl groups are much more easily transferred, and therefore, there was concern that 3-
bromo-2-aryl-2,1-borazaronaphthalenes would not be stable in the cross-coupling 
reaction. Competition between the B-aryl group of the 2,1-borazaronaphthalene could 
compete with the nucleophilic aryltrifluoroborate, resulting in a mixture of products. 
Fortunately, the cross-coupling between 3-bromo-2-phenyl-2,1-borazaronaphthalene 4.62 
and either phenylboronic acid or potassium phenyltrifluoroborate resulted in the 
formation of 2,3-diphenyl-2,1-borazaronaphthalene in 54% and 77% yield, respectively 
(Table 4.14, entry 1). 
The scope of the cross-coupling of 3-bromo-2-phenyl-2,1-borazaronaphthalene 
was then investigated (Table 4.14). Electron-deficient aryltrifluoroborates were 
successful nucleophiles, affording the desired products in yields of 32-71%. An electron-
donating aryltrifluoroborate was also employed in the reaction, providing the cross-
coupled product in 52% yield (entry 4). Four different heteroaryltrifluoroborates were 
engaged in the reaction, and the desired products were obtained in yields up to 88% 
(entries 5-8). 
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Table 4.14. Scope of the Cross-Coupling with 3-Bromo-2-phenyl-2,1-
borazaronaphthalene 
 
To demonstrate the versatility of the method, several 3-bromo-2-(hetero)aryl-2,1-
borazaronaphthalenes were subjected to the developed conditions with potassium 3-
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methoxyphenyltrifluoroborate as the nucleophilic partner. Installation of a 4-fluoro- or 3-
methoxy substituent on the 2-aryl-2,1-borazaronaphthalene did not affect the coupling as 
the desired products were obtained in 62% and 50%, respectively (entries 1-2). Two 3-
bromo-2-heteroaryl-2,1-borazaronaphthalenes were successful electrophiles in the 
coupling. Steric hindrance of the 2,1-borazaronaphthalene resulted in a lower yield of the 
cross-coupled product, as evident by the use of 3-bromo-2-(4-dibenzofuryl)-2,1-
borazaronaphthalene as the electrophile (entry 4). 
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Table 4.15. Scope of the Electrophilic 3-Bromo-2-(hetero)aryl-2,1-
borazaronaphthalenes  
 
 The cross-coupling of both 3-bromo-2-alkyl- and 3-bromo-2-aryl-2,1-
borazaronaphthalenes proceed with high yield across a range of electrophilic 2,1-
borazaronaphthalenes and potassium hetero(aryl)trifluoroborates. Therefore, a 
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dibrominated azaborine as the electrophilic partner should provide access to doubly 
cross-coupled products. The cross-coupling of 3,6-dibromo-2-methyl-2,1-
borazaronaphthalene 4.78 with two equivalents of potassium 3-methoxy-2,1-
borazaronaphthalene affords the desired product in 97% yield (Eq 4.28). 
Equation 4.28 
 
Unfortunately, addition of one equivalent of nucleophile resulted in a mixture of 
products, indicating that the cross-coupling is not selective. Therefore, to access doubly 
cross-coupled product with different (hetero)aryl substituents, the product of one cross-
coupling can be subjected to a second site-selective bromination at the C6 position, 
affording the desired brominated 2,1-borazaronaphthalenes in yields up to 81% (Eq 4.29) 
Equation 4.29 
 
3-Aryl-6-bromo-2-methyl-2,1-borazaronaphthalenes can be subjected to the 
standard reaction conditions with an array of aryl and heteroaryltrifluoroborates to access 
highly complex azaborines (Table 4.16). A 3,5-disubstituted aryltrifluoroborate was 
successful as the nucleophile, affording the desired product in 86% yield (entry 1). Two 
different heteroaryltrifluoroborates were employed in the coupling, providing the 6-
heteroarylated-2,1-borazaronaphthalenes in yields of 84% and 69% (entries 2-3). 
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Table 4.16. Scope of the Cross-Coupling with Various Potassium 
Organotrifluoroborates 
 
The overall impact of this method can be demonstrated by comparing this method 
of synthesizing 3-(hetero)aryl-2,1-borazaronaphthalenes and 3,6-di(hetero)aryl-2,1-
borazaronaphthalenes with those of the isosteric, substituted naphthalenes. One method to 
synthesize 2,3-disubstituted naphthalenes is an iron-catalyzed benzannulation with 
alkynes (Eq 4.30).
41
 Although this method provides the desired products in good to 
excellent yield, unsymmetrical, disubstituted alkynes are limited to bromoethynylarenes, 
which require further functionalization. Use of other disubstituted alkynes could result in 
a mixture of products. The cross-coupling route described herein allows direct installation 
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of a (hetero)aryl unit at the C3 position, thus alleviating the limitation of obtaining 
regioisomeric products. 
Equation 4.30 
 
The products of the cross-coupling of brominated N-substituted 2,1-
borazaronaphthalenes are isosteric to 1,2,3-trisubstituted naphthalenes, whose synthesis 
often results in mixtures of regioisomers. For example, one method to synthesize 1,2,3-
trisubstituted naphthalenes is a rhodium-catalyzed cycloaddition with an alkyne,
42
 in 
which employing a disubstituted alkyne results in a ~70:30 mixture of isomers (Eq 4.31).  
Equation 4.31 
 
A second method to access 1,2,3-trisubstituted naphthalene relies on the 
subsequent cross-coupling of a symmetrical (Z)-1,2-dibora-alkene,
43
 in which an 
unsymmetrical alkene could again result in problems with regiochemistry (Eq 4.32). In 
the case of the cross-coupling, the synthesis of the 2,1-borazaronaphthalene, bromination, 
and subsequent cross-coupling allow a library of (hetero)arylated azaborines to be 
synthesized with complete regiocontrol. 
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Equation 4.32 
 
Lastly, the products of the diarylated 2,1-borazaronaphthalene are isosteres for 
2,3,6-trisubstituted naphthalenes. There are currently no examples of the naphthalenes 
with this substitution pattern,
44
 whereas the corresponding cross-couplings described 
herein allow synthesis of elaborate 2,1-borazaronaphthalenes in high yield. 
3-(Hetero)aryl- and 3,6-di(hetero)aryl-2,1-borazaronaphthalenes have been 
prepared through a Suzuki-Miyaura cross-coupling reaction with potassium aryl- and 
heteroaryltrifluoroborates. The method developed is the first reported for the cross-
coupling of a halogenated azaborine. The electrophilic partner, 3-bromo-2,1-
borazaronaphthalenes, were prepared via a site-selected electrophilic aromatic 
substitution of 2,1-borazaronaphthalenes. Twenty-six different brominated 2,1-
borazaronaphthalenes have been synthesized in high yield, many of which have been 
shown to be suitable electrophiles in the cross-coupling. 
This study greatly expands on the substitution of 2,1-borazaronaphthalenes at the 
C3 and C6 positions. Prior to this study, the only reported substituents were bromine and 
chlorine, which were synthesized in low to moderate yields in the early 1960s. Most of 
the other research on 2,1-borazaronaphthalenes focused on their synthesis or limited 
functionalization on boron and nitrogen. The current methods expand substitution at the 
C3 and C6 positions to include aryl and heteroaryl substituents, demonstrating that 
molecularly complex azaborines can be synthesized as isosteres of the all carbon analogs. 
Furthermore, this study demonstrates the remarkable stability of 2,1-
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borazaronaphthalenes to palladium catalysis, allowing highly functionalized molecules to 
be synthesized and opening the door to exploration of azaborines in other transition-metal 
catalyzed reaction. 
4.8 Self Arylation of Brominated N-Substituted B-Aryl 2,1-Borazaronaphthalenes 
 Through the course of studying the Suzuki-Miyaura cross-coupling reaction on 
brominated azaborines, free N-H B-alkyl and B-aryl 2,1-borazaronaphthalenes were 
shown to be effective electrophiles after bromination. Further, substitution on nitrogen in 
the case of the B-alkyl 2,1-borazaronaphthalenes did not affect the cross-coupling as the 
desired products were obtained in high yield. However, attempts to cross-couple N-
substituted B-aryl 2,1-borazaronaphthalenes led to an interesting result. The cross-
coupling between 1-allyl-3-bromo-2-phenyl-2,1-borazaronaphthalene and potassium 
phenyltrifluoroborate at 60 °C did not provide the desired cross-coupled product 4.124 
(Eq 4.33). However, a large amount of an unknown side product was isolated in the 
reaction. 
Equation 4.33 
 
 To elucidate the structure of product of this cross-coupling, the reaction was 
completed at room temperature, where some of the cross-coupled product was observed 
in addition to this side product. Furthermore, removing the potassium 
phenyltrifluoroborate from the reaction results in formation of only the side product, 
meaning the trifluoroborate is not involved in the reaction. Paetzold showed that a very 
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electron-deficient arene on boron could be displaced by heating the 2,1-
borazaronaphthalene in aq KOH (Scheme 4.5). Based on the shift in the 
11
B NMR, it was 
possible that the product of this reaction had a B-OR bond. However, stability tests 
completed showed that 2,1-borazaronaphthalenes are stable under the basic conditions of 
the reaction, leading to the conclusion that this process was palladium mediated. 
By realizing that the 2,1-borazaronaphthalene could serve as both the nucleophile 
and electrophile in the cross-coupling reaction, the answer became apparent. After 
oxidative addition of the C-Br bond, transmetalation of the B-Ph of the azaborine would 
lead to the cross-coupled product, and result in a B-OH bond. Therefore, this brominated 
2,1-borazaronaphthalene undergoes a self-arylation. At room temperature, the cross-
coupling between 1-allyl-3-bromo-2-phenyl-2,1-borazaronaphthalene and potassium 
phenyltrifluoroborate resulted in 40% yield of the cross-coupled product and 32% yield 
of the self-arylated product (Eq 4.34). 
Equation 4.34 
 
As phenyltrifluoroborate should not be required for the reaction, the cross-
coupling was performed with only the brominated 2,1-borazaronaphthalene to serve as 
both the nucleophile and electrophile in the reaction (Eq 4.35). However, under the 
developed conditions, with 2 mol % palladium, the self-arylated product was only 
isolated in 13% yield. 
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Equation 4.35 
 
Optimization of the self-arylation was completed with the aid of high-throughput 
experimentation (HTE). A screen was designed to test the type of ligand, base, and ratio 
of solvent to water in the self-arylation. To that end, a 24-well plate was run with four 
different ligands, three different solvent ratios, and two different bases. The results were 
analyzed by HPLC after addition of an internal standard (10 mol % of 4,4’-di-tert-
butylbiphenyl). The product-to-internal standard (P/IS) ratios were calculated to 
determine the relative amount of product formation in each microscale reaction and are 
displayed in Figure 4.12. 
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Figure 4.12. Graphical summary of Screen 1. Reaction conditions: 1 mol % 
aminobiphenyl Pd µ-Cl dimer, 2 mol % Ligand, 1.0 equiv of 1-allyl-3-bromo-2-
phenyl-2,1-borazaronaphthalene, 3.0 equiv of base, rt, 18 h. 
The results of the screen show that SPhos as a ligand provides the product in the 
highest amount. Also evident is that a CPME/H2O ratio of 9:1 was more effective than 
the previous conditions, which employed a 1:1 ratio. Most importantly, however, was that 
changing the base to CsOH led to a large increase in the formation of the desired product. 
The use of a stronger base could imply that the low yield of the self-arylation was 
because of slow transmetalation of the B-aryl group. Because the vacant orbital on boron 
is sufficiently filled by donation from nitrogen, which imparts aromatic character on the 
azaborine, transmetalation would be more difficult than with an arylboronic acid, which 
has a vacant orbital on boron. Jutand
45
 and Hartwig
32
 have both reported that hydroxide 
346 
 
bases provide the best conversion to product for cross-couplings in which the rate-
determining step is the transmetalation. Hydroxide bases increase the formation of the 
more reactive ArPd(OH)L complex, which undergoes transmetalation at a faster rate 
relative to the corresponding ArPd(X)L complex. 
Further optimization showed that changing the base from CsOH to KOH and the 
solvent from CPME to THF provided better conversion to the desired product. Therefore, 
the self arylation of 1-allyl-3-bromo-2-phenyl-2,1-borazaronaphthalene with 2 mol % 
SPhos-Pd-G2, 3 equiv KOH in a solvent system of 9:1 THF/H2O at room temperature for 
18 h afforded the desired self-arylated product in 86% yield (Eq 4.36). 
Equation 4.36 
 
 An array of brominated 1-alkyl-2-aryl-2,1-borazaronaphthalenes were subjected 
to the standard reaction conditions (Table 4.17). Four different alkyl groups on nitrogen 
were shown to facilitate the self-arylation, affording the desired product in yields up to 
98%. The scalable nature of the coupling was demonstrated by performing the reaction 
on 2.5 mmol, with half the palladium loading, to provide the desired product in 96% 
yield. 
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Table 4.17. Scope of the Self-Arylation of 1-Alkyl-3-bromo-2-phenyl-2,1-
borazaronaphthalenes. 
 
The self-arylation of a brominated azaborine has not been reported in the 
literature. Furthermore, this substitution pattern on 2,1-borazaronaphthalenes builds 
molecularly complexity by accessing novel systems. Having substituents in the N- and 
C3 positions allows the boron to have a hydroxyl group as a substituent whereas all other 
2,1-borazaronaphthalenes reported to date exist as the corresponding anhydride. When 
the anhydride was dissolved in ethanol and a dilute alkali solution added, the hydroxy-
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derivative is evident in equilibrium with the anhydride (Eq 4.37). However, only the 
anhydride exists in the solid state.
21
 
Equation 4.37 
 
Attempts to purify the 2,1-borazaronaphthols by column chromatography resulted 
in decomposition on silica gel; however, they can be converted to their respective 
anhydrides (to various extents) upon column chromatography with Florisil. The 
formation of the anhydride was confirmed by passing 4.128 through Florisil and 
obtaining an X-ray structure of the product (Fig 4.13). 
 
Figure 4.13. X-ray Structure of Bis-(1-benzyl-3-phenyl-2,1-borazaro-2-naphthyl) 
Ether 
The standard reaction conditions were applied to a variety of 1-allyl-2-
(hetero)aryl-3-bromo-2,1-borazaronaphthalenes (Table 4.18). After purification with 
column chromatography with Florisil, many of the self-arylated products were isolated as 
a mixture of the anhydride and monomer. Fortunately, subjecting the anhydride to basic 
aqueous THF (3 equiv KOH in THF/H2O) converted the anhydride to the 2,1-
borazaronaphthol. Heteroaryl (entries 8-9), in addition to electron-deficient (entries 3-5) 
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and electron-rich (entries 1, 2, and 6) aryl groups, underwent self-arylation in yields up to 
90%. 
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Table 4.18. Scope of the Self-Arylation of 1-Allyl-2-aryl-3-bromo-2,1-
borazaronaphthalenes. 
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Although the B-alkyl 2,1-borazaronaphthalenes easily undergo cross-coupling 
with an external trifluoroborate, 1-allyl-3-bromo-2-methyl-2,1-borazaronaphthalene was 
subjected to the developed conditions. Because the Calkyl-B bond is stronger than the 
Caryl-B bond,
46
 transmetalation is more difficult, and the self arylation is less likely to 
proceed. As expected, the azaborine did not undergo self-arylation as only unreacted 
starting material was observed after 18 h (Eq 4.37).  
Equation 4.38 
 
 Furthermore, subjecting the corresponding brominated free N-H 2,1-
borazaronaphthalene to the reaction conditions did not produce the self-arylated product 
(4.38). Therefore, substitution on nitrogen is required for the self-arylation to proceed 
smoothly. 
Equation 4.39 
 
 Because this result suggests that substitution on nitrogen is required for the self-
arylation to proceed smoothly, a series of calculations were performed to determine the 
relative strengths of the B-Caryl bond. Substitution on nitrogen causes the arene on boron 
to rotate such that it is no longer in plane with the 2,1-borazaronaphthalene, resulting in 
decreased molecular orbital overlap and a weaker donation of electron density to boron’s 
vacant orbital. The corresponding arene of the N-H 2,1-borazaonaphthalene is much more 
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in the plane of the azaborine, resulting in increased overlap and a stronger B-Caryl bond 
(Figure 4.14). 
 
Figure 4.14. Optimized Geometry and Bond Orders for N-Allyl and N-H 2,1-
Borazaronaphthalenes (Calculated at the B3LYP/6-31G(d,p) level of theory). 
Because transmetalation is favored to proceed from the interaction between a 
Lewis basic oxo-palladium species and a Lewis acidic boronate species to form a 
tetracoordinate ‘ate’ complex,
45
 increasing the Lewis acidity of boron will favor 
formation of the required ‘ate’ complex, thereby facilitating transmetalation. The relative 
charges of the boron atoms in the N-allyl and N-H 2,1-borazaronaphthalenes were 
therefore calculated, which showed that the loss of molecular orbital overlap upon 
substituting nitrogen results in a charge on the boron atom of the N-allyl azaborine 
(0.652) much greater than that of the free N-H azaborine (0.568). The relative energy of 
formation of a representative ‘ate’ complex were then calculated at the 
B3LYP/LANL2DZ level of theory, with PMe3 as a generic ligand and a vinyl group as a 
generic electrophile. The increased Lewis acidity of the N-allyl 2,1-borazaronaphthalene 
was demonstrated to favor formation of the ‘ate’ complex by ~2 kcal/mol. The 
calculations complete do not provide information about the mechanism of 
transmetalation; however, they suggest there is an increased stability of the ‘ate’ complex 
formed from the N-allyl 2,1-borazaronaphthalene. 
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Figure 4.15. Relative Energies of Formation of Pd-'ate' Complexes (Calculated at 
the B3LYP/ LANL2DZ Level of Theory). 
To probe the mechanism of the self-arylation, a cross-over experiment was 
completed to determine if the process was intermolecular or intramolecular. To that end, 
3-bromo-2-(3-methoxyphenyl)-1-(4-methylbenzyl)-2,1-borazaronaphthalene 4.69 and 3-
bromo-1-benzyl-2-phenyl-2,1-borazaronaphthalene 4.73 were subjected to the reaction 
conditions in one-pot (Eq 4.40). After complete consumption of the starting materials, 
four different products were obtained (1-benzyl-3-phenyl, 1-benzyl-3-(3-
methoxyphenyl), 1-(4-methylphenyl)-3-phenyl, and 1-(4-methylphenyl)-3-(3-
methoxyphenyl)-2,1-borazaronaphthalene). The aryl group on one azaborine can be 
transferred to either azaborine, concluding that this self-arylation proceeds through an 
intermolecular fashion. 
Equation 4.40 
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Attempts to cross-couple 4.67 with an external trifluoroborate were unsuccessful 
as a mixture of cross-coupled and self-arylated products were observed. The 
corresponding 1,2,3-trisubstituted-2,1-borazaronaphthalenes can be accessed through a 
Kumada coupling of the brominated 2,1-borazaronaphthalenes with aryl Grignard 
reagents. Subjecting 1-allyl-3-bromo-2-phenyl-2,1-borazaronaphthalene to developed 
conditions for the Kumada coupling with phenyl Grignard affords the desired product in 
84% yield (Eq 4.41). 
Equation 4.41 
 
 The developed conditions for the Kumada coupling were extended to an array of 
aryl Grignard nucleophiles (Table 4.19). Aryl Grignard reagents with ortho-, meta-, and 
para- substituents were successfully engaged in the reaction, affording the desired 
products in yields up to 89%. 
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Table 4.19. Scope of the Kumada Coupling of 3-Bromo-2,1-Borazaronaphthalenes. 
 
The next reaction investigated was the cross-coupling of the 1-benzyl-3,6-
dibromo-2-phenyl-2,1-borazaronaphthalene with 1 equivalent of an external boronate 
species. The addition of phenylboronic under slight modified conditions allows this 
dibrominated compound to perform the self-arylation in addition to a second cross-
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coupling with the other equivalent of boronate, providing the desired product in 92% 
isolated yield (Eq 4.42). The resultant molecule is a 1,3,6-trisubstituted-2,1-
borazaronaphth-2-ol, which could lend itself to further functionalization by displacement 
of the hydroxyl on boron with a nucleophile, as was previously demonstrated (Eq 4.42). 
Equation 4.42 
 
To confirm that the dibrominated azaborine underwent a dual cross-coupling, a 
crystal structure was obtained for 4.142 (Figure 4.16). The x-ray structure confirms the 
molecule underwent both a self-arylation and cross-coupling with the external 
trifluoroborate. The x-ray structure shows that upon rotation the molecule 90° such that it 
is lying horizontal, the BN ring of the 2,1-borazaronaphthalene is not planar, meaning 
that the synthesized azaborines retain aromatic character but are infact nonplanar 
heterocyclic compounds. The boron atom is located approximately 0.15 Å above the 
plane, which is ~3.5º out of plane. 
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Figure 4.16. X-ray structure of 1-Benzyl-3,6-diphenyl-2,1-borazaronaphthol. 
Horizontal view (right) shows nonplanar B-N ring (substituents have been omitted 
to clearly show the azaborine core). 
The overall impact of the self-arylation is demonstrated by comparison with 
methods to synthesize the isosteric naphthalene derivatives. The products of the self 
arylation would be isosteric to 1,3-disubstituted-2-naphthols, which could be accessed 
through a similar cross-coupling of a protected naphthol followed by deprotection (Eq 
4.42).
47
 The 2,1-borazaronaphthalene negates both the protecting and deprotection step 
by forming the pseudo-alcohol in one step.  
Equation 4.43 
 
A second method to generate the corresponding naphthols is a palladium-
catalyzed annulation in which use of an unsymmetrical 1,3-diphenylpropan-2-one could 
lead to a mixture of isomeric products (Eq 4.43).
48
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Equation 4.44 
 
The 2,1-borazaronaphthalenes synthesized via the Kumada coupling are isosteric 
to 1,2,3-trisubstituted naphthalenes. Methods to synthesize 1,2,3-trisubstituted 
naphthalenes have been previously discussed (Eq 4.31 and 4.32). 
Brominated N-H 2,1-borazaronaphthalenes undergo an intermolecular cross-
coupling with an external nucleophile whereas brominated 1-alkyl-2-aryl-3-bromo-2,1-
borazaronaphthalenes undergo a self arylation in which the azaborine serves as both the 
nucleophile and electrophile in the cross-coupling. The products of the self arylation have 
a unique substitution pattern, for the first time allowing access to B-OH 2,1-
borazaronaphthalenes. To access the corresponding trisubstituted 2,1-
borazaronaphthalenes, the 1-alkyl-2-aryl-3-bromo-2,1-borazaronaphthalenes have been 
shown to be effective electrophiles in the Kumada cross-coupling reaction. 
4.8 Reductive Coupling of 3-Bromo-2-substituted-2,1-borazaronaphthalenes with 
Alkyl Iodides 
 The Suzuki-Miyaura reaction of 3-bromo-2,1-borazaronaphthalenes is the first 
general transition metal-catalyzed coupling of a brominated azaborine with an aryl 
nucleophile. One of the most important aspects of this method is that it shows that 3-
bromo-2,1-borazaronaphthalenes are stable to palladium catalysis. Therefore, it should be 
possible to subject these brominated azaborines to other transition-metal catalyzed 
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processes to build elaborate systems and access substitution patterns that have been 
previously unavailable. To that end, we sought to develop a method to install alkyl 
groups in the C3 position of 2,1-borazaronaphthalenes since the Suzuki-Miyaura reaction 
previously discussed covers aryl and heteroaryl substituents. Although a Suzuki-Miyaura 
cross-coupling with alkyltrifluoroborates should be possible, a reductive coupling 
between 3-bromo-2,1-borazaronaphthalenes and alkyl iodides was envisioned as it would 
allow functionalized secondary substrates that have thus far been unsuccessfully 
employed in Suzuki-Miyaura reactions.
49
 
 One of the seminal reports on nickel-catalyzed reductive couplings was provided 
by Weix in 2010 (Eq 4.45).
50
 The reductive coupling of aryl halides with alkyl halides 
negates the need to employ an organometallic reagent or generate one in situ such that 
two halides can be directly coupled in single C-C bond-forming transformation.  
Equation 4.45 
 
 The reductive coupling reported allows high functional group tolerability 
including ketones, nitriles, boronate pinacol esters, amides, and free alcohols. The exact 
role of the additives in the reaction is unclear although the addition of pyridine reduced 
the amount of products formed from β-hydride elimination.
50 
 Weix reported a mechanistic study on the nickel-catalyzed reductive coupling of 
aryl halides and alkyl halides, in which he studied the reaction of an aryl iodide with an 
alkyl iodide.
51
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Weix proposed four different potential mechanisms for the reductive coupling: in situ 
formation of an organometallic reagent, transmetalation between two nickel centers, 
sequential oxidative additions of a single nickel center, and a radical chain reaction 
(Scheme 4.11). 
Scheme 4.11. Potential Reductive Coupling Mechanisms 
 
Because tetrakis(dimethylamino)ethylene (TDAE) can provide about six 
turnovers when replacing Mn in the reaction, the in situ formation of an organometallic 
reagent is ruled out because the corresponding anionic intermediate would not be stable. 
Further, if the mechanism for the reductive coupling was the transmetalation between two 
nickel centers, then the ratio of cross-coupled product-to-homocoupling should not 
depend on nickel concentration. However, the selectivity for the cross-coupled product 
improved at lower nickel concentrations, meaning the reductive coupling does not 
proceed through this mechanism.
51
 
 The remaining two mechanisms both involve an oxidative addition to nickel. 
Relative rates of oxidative addition show that the aryl iodide undergoes oxidative 
addition at a rate much faster than the alkyl iodide. The differentiation in mechanisms is 
the next step: a second oxidative addition of the alkyl iodide or the addition of an alkyl 
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radical to the oxidative addition complex. Although the oxidative addition of alkyl 
iodides can proceed through a radical mechanism, the addition of a radical to nickel must 
proceed through a radical intermediate. Radical clock experiments demonstrate that a 
radical intermediate is present, as only the rearranged products are formed. Therefore, to 
determine the mechanism, the degree of radical clock rearrangement was analyzed with 
respect to nickel concentration. The results suggest that the radical chain mechanism is 
preferred because higher catalyst concentrations result in less rearranged product, 
meaning the radical has less time to rearrange before interacting with another nickel 
center.
51
 
 The catalytic cycle proposed by Weix for the reductive coupling is shown in 
Figure 4.12. Oxidative addition of the aryl iodide forms the Ni(II) intermediate, which 
reacts with an alkyl radical to form the Ni(III) intermediate. Reductive elimination 
generates the product and a reactive Ni(I) species, which is oxidized by the alkyl iodide 
to generate Ni(II)I2 and the alkyl radical. Mn then reduces the Ni(II) species to regenerate 
the Ni(0) intermediate.
51
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Scheme 4.12. Proposed Catalytic Cycle for the Reductive Coupling 
 
The selectivity for the cross-coupled product over homocoupling of the two 
reagents is because of the selective oxidative addition of the aryl iodide over the alkyl 
iodide and selective formation of an alkyl radical over an aryl radical.
51
 
 Inspired by the reports by Weix, Molander published a reductive coupling of 
nonaromatic heterocyclic bromides with aryl and heteroaryl bromides, focusing on the 
secondary cyclic alkyl substrates of piperidines, pyrrolidines, azetidines, 
tetrahydropyrans, tetrahydrofurans, and oxetanes (Eq 4.46).
49
 
Equation 4.46 
 
 The incorporation of nonaromatic heterocyclic compounds through cross-
coupling has achieved limited success,
52
 but there is a need for methods to install these 
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medicinally important motifs efficiently. Many drug targets over the last decade have 
relied on flat, planar structures, which have been easy to prepare because of the progress 
in sp
2
-sp
2
 cross-coupling reactions. Since nonaromatic heterocycles are nonplanar 
systems, more three-dimensional space can be occupied than the corresponding aromatic 
rings, which can increase selectivity toward the target enzyme without loss of the 
preferred physical properties for absorption.
53
  
 The emergence of B-N isosteres for all carbon analogs in medicinal chemistry, 
combined with the importance of nonaromatic heterocycles, led us to investigate the 
reductive coupling 3-bromo-2,1-borazaronaphthalenes with alkyl halides. Remarkably, 
under the conditions reported by Molander and Traister, the reductive coupling of 3-
bromo-2-phenyl-2,1-borazaronaphthalene and 1-Boc-4-bromopiperidine provides the 
desired product in 44% yield (Eq 4.47). The only side product of the reaction was 
protodebromination of the 2,1-borazaronaphthalene, demonstrating inherent stability of 
these azaborines toward the transition-metal catalysis and reductive conditions. 
Equation 4.47 
 
 Initial optimization of the reductive coupling was completed through a limited 
screening process by varying the nickel source, ligands, additives, and solvents. It was 
quickly realized that the corresponding alkyl iodide provided the desired product in 
greater conversion than the bromide so further optimization continued with 1-Boc-4-
iodopiperidine. The initial screening revealed that NiCl2•glyme, NaBF4, and 4-
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ethylpyridine were the best nickel source, additive, and amine additive for the reductive 
coupling, respectively. 4,4'-Dimethyl-2,2'-bipyridine was a superior ligand to 
phenanthroline, and increasing the amount of 4-ethylpyridine to 1.0 equivalent decreased 
the amount of protodebromination of the 2,1-borazaronaphthalene. A solvent ratio of 1:1 
cyclohexane/dimethylacetamide (DMA) provided better conversion to the desired 
product, as did lowering the reaction temperature to 40 °C. With these initial conditions, 
the reductive coupling product 4.144 was isolated in 63% yield. 
 Final optimization was completed by varying the solvent ratio and relative 
amounts of reagents (Table 4.20). Increasing the amount of DMA in the reaction 
decreased the yield; however, increasing the amount of cyclohexane in the reaction 
significantly increased the amount of product formed (entries 2-3). Lowering the reaction 
temperature and decreasing the amount of alkyl iodide to 1.0 equivalent were detrimental 
to the reaction (entries 4-5). Decreasing the loading of the nickel and ligand to 5 mol % 
led to a similar P/IS ratio as with 10 mol % (entry 6). Finally, the use of anhydrous, 
degassed solvents provided a slightly lower amount of product, meaning the reductive 
coupling can be performed with solvents straight out of the bottle (entry 7).  
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Table 4.20. Optimization of the Reductive Coupling 
 
 The standard reaction conditions for the reductive coupling were: 5 mol % 
NiCl2•glyme, 5 mol % 4,4’-dimethyl-2,2’-bipyridine, 50 mol % NaBF4, 1.0 equiv of 4-
ethylpyridine, 2.0 equiv of Mn with a solvent system of 2:1 cyclohexane/DMA. An array 
of 3-bromo-2,1-borazaronaphthalenes were subjected to the reductive coupling (Table 
4.21). Thirteen different brominated azaborines were successful electrophiles, providing 
the desired products in yields up to 96%. Several other 2-aryl-2,1-borazaronaphthalenes 
were tested in the reductive coupling, including ones with fluoro, methoxy, and methyl 
ester functional groups, affording the desired products in yields up to 96% (entries 2-5). 
The reductive coupling was extended to include brominated azaborines with alkyl 
substituents on boron, including methyl, cyclobutyl, and cyclopropyl, which were 
successfully coupled to provide the products in good yield (entries 7-9). Substituents on 
the nitrogen of the 2,1-borazaronaphthalene did not affect the coupling as both allyl and 
benzyl groups were successfully coupled in similar yield to the free N-H 2,1-
borazaronaphthalenes (entries 6, 10-11). Two sterically hindered 2,1-
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borazaronaphthalenes, both of which have a heterocyclic substituent on boron, provided 
the desired products in 74% and 89% yield, demonstrating that bulky substituents on the 
azaborine do not affect the reductive coupling.  
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Table 4.21. Scope of the Reductive Coupling with 1-Boc-4-iodopiperadine 
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 The scope of alkyl iodides capable of undergoing reductive coupling with 3-
bromo-2-phenyl-2,1-borazaronaphthalene was next examined (Table 4.22). Other 
nonaromatic heterocyclic iodides were successful electrophiles in the reaction. An N-Boc 
protected azetidine can be installed in the C3-position in 61% yield (entry 1). Several 
oxygen-containing nonaromatic heterocyclic iodides provided the desired products in 
good yield, including tetrahydropyranyl, tetrahydrofuranyl, and oxetanyl (entries 2-4). 
The reductive coupling was extended to include secondary alkyl iodides, where 
cyclohexyl iodide was coupled in 62% yield (entry 5). Primary alkyl iodides were also 
effective substrates for the reaction as simple aliphatic and functionalized alkyl iodides 
afforded the desired product in good yield (entries 6-8). The scalable nature of the 
reductive coupling was demonstrated by performing the reductive coupling on a 3.0 
mmol scale with 2.5 mol % nickel and ligand, affording the product in 65% yield. 
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Table 4.22. Scope of the Reductive Couplings with Various Alkyl Iodides 
 
 The reductive coupling of 3-bromo-2,1-borazaronaphthalenes allows the 
installation of primary and secondary alkyl substituents at the C3 position of the 2,1-
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borazaronaphthalene. The mild reaction conditions allow 2,1-borazaronaphthalenes with 
sensitive functional groups to be coupled in high yield. Sterically hindered 2,1-
borazaronaphthalenes can also be engaged in the reaction with the desired products 
obtained in high yield. More importantly, the stability of 2,1-borazaronaphthalenes to the 
reductive couplings conditions, which involves the use of two metals, one in 
superstoichiometric amounts, demonstrates the impact that these azaborines can have in 
the fields of medicinal chemistry and materials science. 
 A 6-bromo-2,1-borazaronaphthalene was subjected to the standard reductive 
coupling conditions with N-Boc-4-iodopiperidine, affording the desired product in 51% 
(Eq 4.48). This result demonstrates that the developed conditions can be extended to 
other brominated azaborines to build molecular complexity. 
Equation 4.48 
 
4.9 Photophysical Properties of 2,1-Borazaronaphthalenes (spectroscopic data 
obtained with Shorouk Badir and Adriel Koschitzky) 
The isosteric replacement of C=C with B-N in polycyclic aromatic hydrocarbons 
(PAH) has made a significant impact in the synthesis of chemiluminescent materials.
14
 
The main framework of these azaborines is a π-conjugated hydrocarbon backbone with 
two main group elements serving as one conjugated bond. The electronic interactions 
between the π-orbitals and the B-N orbitals can decrease the HOMO-LUMO gap, leading 
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to compounds with different photophysical properties. In general, group 15 and 16 
elements are capable are serving as electron donors because of their lone pairs whereas 
group 13 and 14 elements serve as acceptors because of their vacant orbital. A 
tricoordinate boron atom is a strong acceptor because of its vacant p orbital, leading to 
significant overlap with the rest of the azaborine. The aromaticity of the azaborine also 
enhances delocalization of the electrons.
54
 
 One limitation of B-N units not associated with pseudo-aromatic ring systems in 
the synthesis of chemiluminescent materials is the ease of hydrolysis of B-N bonds. For 
that reason, the Mes2B (Mes = mesityl) unit is commonly employed for steric protection 
of the molecule. However, the inherent stability of azaborines alleviates this requirement, 
allowing access to air- and moisture stable B-N bond-containing compounds with 
potentially impactful photophysical properties. 
 Through the course of studying 2,1-borazaronaphthalenes, five different classes of 
azaborines were synthesized: (a) 2-aryl-2,1-borazaronaphthalenes, (b) 2-alkyl-3-aryl-2,1-
borazaronaphthalenes, (c) 2,3-diaryl-2,1-borazaronaphthalenes, (d) 2-alkyl-3,6-diaryl-
2,1-borazaronaphthalenes, and (e) 1-alkyl-3-aryl-2,1-borazaronaphthols. The 
photophysical properties of several representatives from each class were investigated 
(Figure 4.17). 
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Figure 4.17. Different Classes of 2,1-Borazaronaphthalenes Investigated 
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Before analyzing any of the functionalized azaborines, the absorption and 
emission spectra of 2,1-borazaronaphthalene were recorded and compared to the reported 
fluorescence of naphthalene
55
 (Figure 4.18). 2,1-Borazaronaphthalene
15,17
 exhibits a 
maximum emission at 335 nm and a second, smaller emission at 350 nm. Both of these 
emissions are approximately 15 nm longer than the emission of naphthalene, which emits 
at 319 nm and 334 nm, confirming the smaller HOMO-LUMO gap in the azaborine. 
Interestingly, the quantum yield of 2,1-borazaronaphthalene was calculated to be 0.42,
56
 
about twice that of naphthalene (0.23).
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Figure 4.18. Emission Spectra of Naphthalene and 2,1-Borazaronaphthalene 
(excitation wavelength of 270 nm and 317 nm, respectively). 
 
 Within the first class of azaborines synthesized, there are two subsets: N-H and N-
alkylated 2,1-borazaronaphthalenes. In general, the emission for each member of the 
subset is the same, meaning that slight differences in electronics from substitution on the 
arene on boron do not have any significant effect on the emission. The maximum 
emission is approximately 365 nm, but the highest intensity emission corresponds to 
approximately 350 nm (Figure 4.19). High quantum yields are generally observed with 
374 
 
this subset of azaborines, except in the case of B-heteroarylated azaborines. Interestingly, 
addition of bromine to the C3 position of the 2,1-borazaronaphthalene decreased the 
quantum yield to less than 1%, as observed by 3-bromo-2-(4-fluorophenyl)-2,1-
borazaronaphthalene (4.64).  
 
Figure 4.19. Photophysical Properties of N-H 2-Aryl-2,1-borazaronaphthalenes. (All 
measurements in cyclohexane solution with an excitation wavelength of 317 nm, abs 
= absorption, em = emission, ΦF = quantum yield, measured relative to anthracene 
in ethanol [ΦF = 0.27]) 
 The second subset in this class of compounds is the N-alkylated 2-aryl-2,1-
borazaronaphthalenes. The addition of any alkyl group on nitrogen red-shifted the 
emission by ~15 nm, making the largest intensity emission around 365 nm. Because 
nitrogen serves as an electron donor to boron’s vacant p orbital, substitution will allow 
stronger donation by stabilization of the nitrogen atom, resulting in longer emission 
wavelengths. The quantum yields for N-alkylated 2,1-borazaronaphthalenes are lower 
than the corresponding free N-H azaborines. Further, a 3-phenylpropenyl substituent on 
boron, which should extend conjugation and result in a longer wavelength, did not cause 
a large shift in the emission (4.24). This result suggests that the 3-phenylpropenyl groups 
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is not in the same plane as the azaborine, leading to poor orbital overlap. Because boron 
serves as an acceptor atom, extending conjugation via substitution on boron does not 
have the same effect as extending conjugation through a carbon-carbon bond.  
 
Figure 4.20. Photophysical Properties of N-Alkyl 2-Aryl-2,1-borazaronaphthalenes. 
(All measurements in cyclohexane solution with an excitation wavelength of 317 nm, 
abs = absorption, em = emission, ΦF = quantum yield, measured relative to 2-
aminopyridine in 0.1 M H2SO4 [ΦF = 0.60]) 
 The next class of azaborines investigated was the products from the Suzuki-
Miyaura cross-coupling reactions. Because aromaticity is extended by the addition of 
another aryl ring, the maximum emission wavelength shifted to a longer wavelength. The 
emission spectra for 2-alkyl-3-aryl-2,1-borazaronaphthalenes (class b) show the same 
general shape; however, the emission wavelength varies slightly based on the substituent 
(Figure 4.21). The emission is shifted by approximately ~20 nm when a simple arene is 
installed at the C3 position. Addition of a 4-naphthyl-1-phenyl group at the C3 position 
shifts the emission by ~40 nm, such that the emission wavelength is 391 nm. The large 
shifts observed show that the arene must in the same plane as the azaborine such that 
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delocalization of the electrons can be extended to the arene at the C3 position. Quantum 
yields from these azaborines vary based on the substituents on the arene. 
 
Figure 4.21. Photophysical Properties of 2-Alkyl-2-aryl-2,1-borazaronaphthalenes. 
(All measurements in cyclohexane solution with an excitation wavelength of 317 nm, 
abs = absorption, em = emission, ΦF = quantum yield, measured relative to 
anthracene in ethanol [ΦF = 0.27]) 
 The next class of azaborines investigated were the 2,3-diaryl-2,1-
borazaronaphthalenes. Despite extending conjugation on two positions of the azaborine, 
the installation of a arene at the C3 position causes a similar shift of ~20 nm as with the 
2-alkyl-3-aryl-2,1-borazaronaphthalene (Figure 4.22), Steric hindrance of the arene on 
boron and the arene at the C3 position results in weaker delocalization of the electrons as 
the arenes are rotated out of the plane. Substitution on nitrogen does not seem to have an 
effect on the emission wavelength (4.165), which again could be due to steric hindrance 
around the 1, 2, and 3-positions of the azaborine. The quantum yields are lowered when 
thiophene is installed in the azaborine, which is consistent with the quantum yields 
observed for 4.51 and 4.169. 
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Figure 4.22. Photophysical Properties of 2,3-Diaryl-2,1-borazaronaphthalenes. (All 
measurements in cyclohexane solution with an excitation wavelength of 317 nm, abs 
= absorption, em = emission, ΦF = quantum yield, measured relative to anthracene 
in ethanol [ΦF = 0.27]) 
 
 Extending the aromaticity further by installing an arene at the C6 position led to 
mixed results. In the case of 2-methyl-2,1-borazaronaphthalenes, a similar shift was 
observed as the C3-arylated azaborines; however, a dramatic drop in quantum yield was 
observed. Addition of the 4-naphthyl-1-phenyl group (4.167) to both the C3 and C6 
positions shifted the emission to 395 nm, one of the largest shifts from all those observed. 
Also, a high quantum yield was calculated for this substrate. Significant shifts were also 
observed for the 2,3,6-triaryl-2,1-borazaronaphthalenes. The triphenyl derivative has a 
maximum emission of 386 nm; however, a further shift of ~10 nm is observed when the 
4-naphthylphenyl group is installed at the C3 and C6 positions (4.166 and 4.168, 
respectively). Relatively high quantum yields were calculated for the triaryl azaborines. 
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These large shifts suggest a significant amount of delocalization is achieved upon 
extending conjugation at the C3 and C6 positions. 
 
Figure 4.23. Photophysical Properties of 3,6-Diaryl-2,1-borazaronaphthalenes. (All 
measurements in cyclohexane solution with an excitation wavelength of 317 nm, abs 
= absorption, em = emission, ΦF = quantum yield, measured relative to anthracene 
in ethanol [ΦF = 0.27])  
 The last azaborine investigated belonged to the class of 1-alkyl-3-aryl-2,1-
borazaronaphthols. Unlike all of the other azaborines, this 2,1-borazaronaphthol has a 
hydroxyl group on boron. Because the boron serves as an electron accepted and the 
hydroxyl group is not as electron donating as an arene, the HOMO-LUMO gap is 
significantly lowered, resulting in a shift to 380 nm with a quantum yield of 0.53. 
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Figure 4.24. Photophysical Properties of 1-Alkyl-3-aryl-2,1-borazaronaphthol. (All 
measurements in cyclohexane solution, abs = absorption, em = emission, ΦF = 
quantum yield, measured relative to anthracene in ethanol [ΦF = 0.27])  
The Stokes shift (the difference between the absorption and emission 
wavelengths) for the each of the azaborines varies from ~35 nm to ~100 nm. A low 
Stokes shift provides evidence for a rigid scaffold that does not undergo structural 
deformation upon photoexcitation.
54
 Because of the large range observed, the amount of 
deformation is dependent on the azaborine. 
2,1-Borazaronaphthalenes with various substitution patterns were investigated for 
their photophysical properties. Emission wavelengths of 350 nm to 400 nm have been 
observed for these azaborines, with quantum yields up to 0.97. Aryl substitution on boron 
results in an emission wavelength of ~350 nm whereas aryl substitution at the C3 position 
shifts the emission ~370 nm. Various substituents on the arene on boron and at the C3 
position do not cause a significant shift the emission wavelength, but can cause dramatic 
changes in the quantum yield. Installation of 4-naphthylphenyl groups at the C3 and C6 
position result in the longest emissions observed, close to 400 nm. 
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Further, 2-aryl-2,1-borazaronaphthalenes have generally high quantum yields and 
can be directly compared to the emission of phenanthrene. With an emission wavelength 
of 347 nm and a relatively low quantum yield of 0.09, phenanthrene has been explored 
for its applications as a conjugated component in luminescent organic materials.
58
 The 
photophysical properties of some of the 2,1-borazaronaphthalenes suggest that they can 
serve as a replacement for phenanthrene, providing access to chemiluminescent materials 
with similar emission wavelengths but high quantum yields. 
4.10 Conclusions 
 Derivatives of azaborines have the potential to impact in the fields of medicinal 
chemistry and materials science; however, until recently, the methods available to 
synthesize and functionalize azaborines have been limited because of the harsh reaction 
conditions required. 2,1-Borazaronaphthalenes were chosen to serve as a model system to 
probe stability of azaborines to an array of reaction conditions. Through the course of 
study, a new synthesis of 2,1-borazaronaphthalenes was developed by generating the 
required organodihaloborane in situ via the conversion of a potassium 
organotrifluoroborate with a fluorophile. The mild reaction conditions allowed a library 
of 2,1-borazaronaphthalenes to be prepared in high yield, extending substitution on boron 
to include functionalized aryl and alkyl groups, which would not have been possible 
under the previously reported methods. Novel 2,1-borazaronaphthalenes were also 
prepared through this method: employing heteroaryl-, alkenyl-, and 
alkynyltrifluoroborates resulted in 2-substituted-2,1-borazaronaphthalenes with new 
substitution patterns. The number of 2,1-borazaronaphthalenes prepared through this 
route is greater than all of the previous reports of 2,1-borazaronaphthalenes combined. 
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 2,1-Borazaronaphthalenes undergo site-selective electrophilic aromatic 
substitution, such that bromination occurs selectively at the C3 position. Addition of a 
second equivalent results in a second site-selective bromination at the C6 position. A 
computational study concluded that the relative energy of the intermediate after addition 
of bromine to the C3 position is significantly lower than the other positions. Furthermore, 
the nature of the electrophilic aromatic substitution can be predicted by performing a 
calculation and analyzing the HOMO of the 2,1-borazaronaphthalene. 
 The brominated 2,1-borazaronaphthalenes serve as electrophiles in the Suzuki-
Miyaura reaction with potassium aryl- and heteroaryltrifluoroborates to synthesize 3-
arylated-2,1-borazaronaphthalenes. Previously reported substitution at the C3 position 
was limited to bromine and chlorine, which were isolated in low yield. Brominated free 
N-H 2-alkyl- and 2-aryl-2,1-borazaronaphthalenes are suitable substrates for the cross-
coupling, affording the desired products in high yield. Brominated N-substituted 2-alkyl-
2,1-borazaronaphthalenes are also successful electrophiles in the cross-coupling; 
however, the corresponding brominated N-substituted 2-aryl-2,1-borazaronaphthalenes 
undergo a self-arylation under Suzuki-Miyaura conditions, resulting in the synthesis of 
2,1-borazaronaphth-2-ols. These derivatives have not been previously reported in the 
literature. The 1,2,3-trisubstituted-2,1-borazaronaphthalenes can be accessed through a 
Kumada coupling. 
 Because of the stability of 2,1-borazaronaphthalenes to palladium catalysis, the 
nickel-catalyzed reductive coupling of 3-bromo-2,1-borazaronaphthalenes with alkyl 
iodides was investigated. This method allows primary and secondary alkyl substituents at 
the C3 and C6 positions; there had been no previous examples of alkyl substitution at the 
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C3 position. Nonaromatic heterocyclic iodides, such as piperdinyl and azetidinyl, in 
addition to cyclic secondary alkyl iodides and functionalized primary alkyl iodides were 
all successful electrophiles in the reductive coupling. Furthermore, the inherent stability 
of the 2,1-borazaronaphthalenes is demonstrated by the isolation of the desired products 
in high yield. 
 2,1-Borazaronaphthalenes prepared through these methods are stable to both 
strong acid (pH 2 at 37 °C) and base (Cs2CO3 in H2O at 60 °C). The side products in the 
metal-catalyzed reactions did not arise from protodeboronation of the azaborine, 
demonstrating the aromaticity and stability of 2,1-borazaronaphthalenes. These advances 
in the synthesis and functionalization of 2,1-borazaronaphthalenes allow access to 2,1-
borazaronaphthalenes with substitution at the 1, 2, 3, 5, 6, 7, and 8 positions with 
complete regiochemical control. 
4.10 Experimental 
General Considerations. All azaborine syntheses and cross-coupling reactions were 
carried out under an Ar atmosphere. Amines were distilled prior to use. t-Bu3P-Pd-G2 
was synthesized according to the literature.
59
 Toluene and CPME were dried using a J.C. 
Meyer solvent system. Water was degassed prior to use. Standard benchtop techniques 
were employed for handling air-sensitive reagents. Melting points (°C) are uncorrected. 
NMR spectra were recorded on a 500 or 400 MHz spectrometer. 
19
F NMR chemical 
shifts were referenced to external CFCl3 (0.0 ppm). 
11
B NMR spectra were obtained on a 
spectrometer equipped with the appropriate decoupling accessories. All 
11
B NMR 
chemical shifts were referenced to an external BF3·OEt2 (0.0 ppm) with a negative sign 
indicating an upfield shift. Data are presented as follows: chemical shift (ppm), 
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multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet, br = broad), coupling 
constant J (Hz) and integration. Analytical thin-layer chromatography (TLC) was 
performed on TLC silica gel plates (0.25 mm) precoated with a fluorescent indicator. 
Standard flash chromatography procedures were followed using 32–63 μm silica gel. 
Visualization was effected with ultraviolet light. HRMS data was obtained by either ESI 
or CI using a TOF mass spectrometer. 
 
Spectral Data For Potassium Organotrifluoroborates. Potassium 
phenyltrifluoroborate,
60
 potassium 3-methoxyphenyltrifluoroborate,
61
 potassium 1-
naphthyltrifluoroborate,
61
 potassium 2-naphthyltrifluoroborate,
61
 potassium p-
tolyltrifluoroborate,
61
 potassium 2-methoxyphenyltrifluoroborate,
61
 potassium 3-
(methoxycarbonyl)phenyltrifluoroborate,
61
 potassium 3-cyanophenyltrifluoroborate,
61
 
potassium 3-nitrophenyltrifluoroborate,
60
 potassium 3-thienyltrifluoroborate,
61
 potassium 
dibenzo[b,d]furan-4-yltrifluoroborate,
62
 potassium methyltrifluoroborate,
63
 potassium 
isopropyltrifluoroborate,
64
 potassium cyclopropyltrifluoroborate,
60
 potassium 
cyclobutyltrifluoroborate,
60
 potassium (3-methoxy-5-
trifluoromethylphenyl)trifluoroborate,
65
 potassium 4-
trifluoromethylphenyltrifluoroborate,
61
 potassium 2-thienyltrifluoroborate,
66
 potassium 
(3,5-dimethylisoxazol-4-yl)trifluoroborate,
67
 and potassium 1-(tert-butyloxycarbonyl)-
1H-indol-5-yltrifluoroborate,
66 
potassium 4-fluorophenyltrifluoroborate,
66
 potassium (3-
methoxy-5-trifluoromethylphenyl)trifluoroborate
65
, potassium 3-furyltrifluoroborate
61
: 
The spectral data obtained are in accordance with those previously reported. 
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3-vinylphenylboronic acid, 4-(naphthalene-1-yl)phenylboronic acid, and 3-methoxy-5-
methylphenylboronic are commercially available. They could be converted to the 
corresponding potassium trifluoroborates upon treatment with sat. aq. KHF2.
68
 
 
 
Potassium β,β,β-trifluoroethyltrifluoroborate.
69
 White solid. mp > 250 ºC. 
1
H NMR 
(500 MHz, acetone-d6) δ 1.08 (br s, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 131.9 (J = 
280 Hz), 25.2 (br). 
11
B NMR (128.38 MHz, acetone-d6) δ 3.75.
 19
F NMR (338.8 MHz, 
acetone-d6) δ -56.6, -139.6. IR (neat) 1322, 1260, 1056, 957, 794, 662cm
-1
. HRMS (ESI) 
m/z calc. for C2H2BF6 [M-K]
-
 151.0154, found 151.0148. 
 
Potassium 3-Bromopropyltrifluoroborate.
70
 White solid. mp > 250 ºC. 
1
H NMR (500 
MHz, acetone-d6) δ 3.41-3.36 (m, 2H), 1.82-1.77 (m, 2H), 0.24-0.21 (m, 2H). 
13
C NMR 
(125.8 MHz, acetone-d6) δ 38.2, 29.8, 18.2 (br). 
11
B NMR (128.38 MHz, acetone-d6) δ 
6.03.
 19
F NMR (338.8 MHz, acetone-d6) δ -141.1. IR (neat) 2912, 1437, 1267, 1080, 
1009, 920, 868, 832 cm
-1
. HRMS (ESI) m/z calc. for C3H6BF3Br [M-K]
-
 188.9698, found 
188.9704. 
 
Potassium 3-Iodopropyltrifluoroborate.
70
 White solid. mp > 250 ºC. 
1
H NMR (500 
MHz, acetone-d6) δ 3.20 (t, J = 7.6 Hz, 2H), 1.83-1.77 (m, 2H), 0.25-0.18 (m, 2H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 30.9, 20.3 (br), 13.1. 
11
B NMR (128.38 MHz, acetone-
d6) δ 5.80.
 19
F NMR (338.8 MHz, acetone-d6) δ -141.0. IR (neat) 2918, 1267, 1215, 1084, 
992, 918, 859 cm
-1
. HRMS (ESI) m/z calc. for C3H6BF3I [M-K]
-
 236.9559, found 
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236.9577. Anal. Calcd. for C3H6BF3IK: C, 13.06; H, 2.19, F, 20.66. Found: C, 12.78; H, 
1.92; F, 20.06. 
 
Potassium Dibenzo[b,d]thiophen-4-yltrifluoroborate. White solid. mp > 250 ºC. 
1
H 
NMR (500 MHz, acetone-d6) δ 8.20-8.16 (m, 1H), 8.03 (d, J = 7.6 Hz, 1H), 7.85-7.81 (m, 
1H), 7.62 (d, J = 6.7 Hz, 1H), 7.39-7.36 (m, 2H), 7.31-7.27 (m, 1H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 142.9, 140.6, 136.0, 133.8, 130.3, 130.3, 125.7, 123.4, 122.2, 121.0, 
119.3. 
11
B NMR (128.38 MHz, acetone-d6) δ 4.28.
 19
F NMR (338.8 MHz, acetone-d6) δ -
141.3. IR (neat) 3064, 2357, 1374, 959, 798, 748 cm
-1
. HRMS (ESI) m/z calc. for 
C12H7BF3S [M-K]
-
 251.0316, found 251.0314. 
 
Potassium 3-vinylphenyltrifluoroborate. White solid. mp > 250 ºC. 
1
H NMR (500 
MHz, DMSO-d6) δ 7.46 (br s, 1H), 7.3 (d, J = 6.8 Hz, 1H), 7.18 (d, J = 7.1 Hz, 1H), 7.13-
7.10 (m, 1H), 6.72-6.67 (m, 1H), 5.70 (d, J = 17.9 Hz, 1H), 5.14 (d, J = 10.8 Hz, 1H). 
13
C 
NMR (125.8 MHz, DMSO-d6) δ 138.7, 135.2, 131.8, 129.9, 126.9, 123.5, 112.2. 
11
B 
NMR (128.38 MHz, DMSO-d6) δ 3.4.
 19
F NMR (338.8 MHz, DMSO-d6) δ -139.6. IR 
(neat) 1322, 1260, 1056, 957, 794, 662 cm
-1
. HRMS (ESI) m/z calc. for C8H7BF3 [M-K]
-
 
171.0593, found 171.0586. 
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Potassium 4-(naphthalen-1-yl)phenyltrifluoroborate. White solid. mp > 250 ºC. 
1
H 
NMR (500 MHz, DMSO-d6) δ 7.96-7.94 (m, 2H), 7.89-7.86 (m, 1H), 7.63-7.60 (m, 2H), 
7.55-7.40 (m, 4H), 7.30-7.27 (m, 2H). 
13
C NMR (125.8 MHz, DMSO-d6) δ 141.3, 137.2, 
133.9, 131.9, 131.5, 128.6, 128.3, 127.3, 127.0, 126.3, 126.1, 126.0, 125.9. 
11
B NMR 
(128.38 MHz, DMSO-d6) δ 3.7.
 19
F NMR (338.8 MHz, DMSO-d6) δ -139.0. IR (neat) 
3058, 2920, 1647, 1394, 1217, 773.cm
-1
. HRMS (ESI) m/z calc. for C16H11BF3 [M-K]
-
 
271.0906, found 271.0906. 
 
Potassium (3-methoxy-5-methylphenyl)trifluoroborate. White solid. mp > 250 ºC. 
1
H 
NMR (500 MHz, acetone-d6) δ 6.94 (s, 1H), 6.89 (s, 1H), 6.48 (s, 1H), 3.69 (s, 3H), 2.22 
(s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 158.8, 136.3, 124.8, 113.5, 112.1, 54.0, 
20.7. 
11
B NMR (128.38 MHz, acetone-d6) δ 4.3.
 19
F NMR (338.8 MHz, acetone-d6) δ -
142.1. IR (neat) 2918, 1588, 1321, 1287, 1021, 956, 850, 803 cm
-1
. HRMS (ESI) m/z 
calc. for C8H9BOF3 [M-K]
-
 189.0694, found 189.0693. 
 
General Procedure for the Synthesis of 2-Aminostyrenes. To an oven-dried Biotage 
microwave vial equipped with a stir bar was added Pd μ-Cl dimer (0.02 mmol, 0.5 mol 
%), JohnPhos (0.04 mmol, 1 mol %), and NaOt-Bu (5.6 mmol, 1.4 equiv). The vial was 
sealed with a cap lined with a disposable Teflon septum then evacuated under vacuum 
and purged with Ar three times. Toluene (8 mL) was added followed by 2-bromostyrene 
(4 mmol, 1 equiv) and the corresponding amine (4.8 mmol, 1.2 equiv). The resulting 
mixture was heated to 80 °C and stirred until full consumption of 2-bromostyrene was 
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observed by HPLC (~ 24 h). After cooling to rt, the reaction mixture was diluted with 
Et2O (16 mL) and filtered over Celite. The solvent was removed in vacuo, and the 
product was purified by flash column chromatography on silica gel with mixture of 
EtOAc/hexanes as the eluent. The eluent for most of the amines is hexanes to 2% 
EtOAc/hexanes. 
 
N-Benzyl-2-vinylaniline.
71
 The reaction was conducted using 27 mmol of 
2-bromostyrene, and the catalyst loading was reduced to 0.25 mol % Pd μ-Cl dimer and 
0.5 mol % JohnPhos. The product was obtained as a yellow oil (4.44 g, 78%). 
1
H NMR 
(500 MHz, CDCl3) δ 7.41-7.33 (m, 4H), 7.31-7.26 (m, 2H), 7.18-7.12 (m, 1H), 6.82-6.71 
(m, 2H), 6.64 (d, J = 8.1 Hz, 1H), 5.62 (dd, J = 1.6, 17.3 Hz, 1H), 5.31 (dd, J = 1.6, 11.0 
Hz, 1H), 4.36 (d, J = 5.3 Hz, 2H), 4.17 (br s, 1H). 
13
C NMR (125.8 MHz, CDCl3) δ 
145.2, 139.4, 133.1, 129.1, 128.8, 127.6, 127.5, 127.4, 124.4, 117.7, 116.5, 111.1, 48.5. 
 
N-(4-Methoxybenzyl)-2-vinylaniline. The reaction was conducted using 7 mmol of 
2-bromostyrene, and the catalyst loading was reduced to 0.25 mol % Pd μ-Cl dimer and 
0.5 mol % JohnPhos. The product was obtained as a yellow oil (1.12 g, 69%). 
1
H NMR 
(500 MHz, CDCl3) δ 7.33-7.26 (m, 3H), 7.19-7.12 (m, 1H), 6.92-6.86 (m, 2H), 6.80-6.70 
(m, 2H), 6.65 (d, J = 8.2 Hz, 1H), 5.61 (dd, J = 1.6, 17.4 Hz, 1H), 5.29 (dd, J = 1.6, 11.0 
Hz, 1H), 4.28 (s, 2H), 4.08 (br s, 1H), 3.81 (s, 3H). 
13
C NMR (125.8 MHz, CDCl3) δ 
159.1, 145.3, 133.1, 131.4, 129.1, 129.0, 127.5, 124.4, 117.6, 116.4, 114.2, 111.1, 55.4, 
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48.0. IR (neat) 3436, 2840, 1602, 1509, 1246, 747 cm
-1
. HRMS (ESI) m/z calc. for 
C16H18NO [M+H]
+
 240.1388, found 240.1378. 
 
N-Allyl-2-vinylaniline. Obtained as a yellow oil (643 mg, 81%). 
1
H NMR (500 MHz, 
CDCl3) δ 7.31 (dd, J = 7.6 Hz, 1.0 Hz, 1H), 7.23-7.20 (m, 1H), 6.85-6.78 (m, 2H), 6.68 
(d, J = 8.1 Hz, 1H), 6.07-5.99 (m, 1H), 5.66 (dd, J = 17.4 Hz, 1.7 Hz, 1H), 5.38-5.32 (m, 
2H), 5.23 (dd, J = 10.3 Hz, 1.2 Hz, 1H), 3.99 (br s, 1H), 3.85-3.83 (m, 2H). 
13
C NMR 
(125.8 MHz, CDCl3) δ 144.9, 135.3, 132.9, 128.8, 127.4, 124.3, 117.4, 116.3, 116.2, 
111.0, 46.5. IR (neat) 3436, 3082, 1601, 1507, 131, 913, 746 cm
-1
. HRMS (ESI) m/z calc. 
for C11H14N [M+H]
+
 160.1126, found 160.1131. 
 
N-Butyl-2-vinylaniline.
72
 Obtained as a yellow oil (502 mg, 72%). 
1
H NMR (500 MHz, 
CDCl3) δ 7.26-7.23 (m, 1H), 7.19-7.14 (m, 1H), 6.77-6.67 (m, 2H), 6.63 (d, J = 8.2 Hz, 
1H), 5.60 (dd, J = 1.6, 17.3 Hz, 1H), 5.30 (dd, J = 1.6, 11.0 Hz, 1H), 3.74 (br s, 1H), 
3.15-3.11 (m, 2H), 1.68-1.60 (m, 2H), 1.49-1.40 (m, 2H), 0.97 (t, J = 7.4 Hz, 3H). 
13
C 
NMR (125.8 MHz, CDCl3) δ 145.7, 133.2, 129.1, 127.6, 124.2, 117.1, 116.2, 110.7, 43.9, 
31.8, 20.5, 14.1. 
 
N-Phenyl-2-vinylaniline.
73
 Obtained as a yellow oil (661 mg, 85%). 
1
H NMR (500 
MHz, CDCl3) δ 7.48 (dd, J = 1.4, 7.7 Hz, 1H), 7.28-7.18 (m, 4H), 7.04-6.99 (m, 1H), 
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6.96-6.85 (m, 4H), 5.69 (dd, J = 1.4, 17.5 Hz, 1H), 5.53 (br s, 1H), 5.32 (dd, J = 1.4, 11.0 
Hz, 1H). 
13
C NMR (125.8 MHz, CDCl3) δ 144.2, 140.2, 133.0, 130.2, 129.5, 128.7, 
127.3, 122.7, 120.6, 120.2, 117.4, 116.4. 
 
N-Benzhydryl-2-vinylaniline. Obtained as a yellow solid (821 mg, 72%). mp: 76-78 °C. 
1
H NMR (500 MHz, CDCl3) δ 7.41-7.35 (m, 8H), 7.32-7.27 (m, 3H), 7.09-7.05 (m, 1H), 
6.84 (dd, J = 17.4 Hz, 11.0 Hz, 1H), 6.76-6.72 (m, 1H), 6.48 (d, J = 7.8 Hz, 1H), 5.67 (d, 
J = 17.4 Hz, 1H), 5.58 (br s, 1H), 5.33 (dd, J = 10.9 Hz, 1.3 Hz, 1H), 4.41 (br s, 1H). 
13
C 
NMR (125.8 MHz, CDCl3) δ 144.1, 142.8, 136.6, 132.9, 128.7, 127.3, 127.2, 124.3, 
117.6, 116.4, 112.1, 109.5, 62.8. IR (neat) 3423, 3062, 2844, 1735, 1500, 907, 742 cm
-1
. 
HRMS (ESI) m/z calc. for C21H20N [M+H]
+
 286.1596, found 286.1597. 
 
General Procedure for the Wittig Olefination and Buchwald-Hartwig Amination 
For Synthesis of Substituted 2-Aminostyrenes. To an oven dried 25 mL round bottom 
flask with stir bar was added MePh3PBr (6 mmol, 1.2 equiv). The flask was sealed with a 
septum and evacuated and purged three times with Ar. The flask was cooled to -78 °C 
and n-BuLi (1.6 M in hexanes, 6 mmol, 1.2 equiv) was added dropwise, keeping the 
reaction temperature below -70 °C. The reaction was stirred at -78 °C for 1 h and allowed 
to warm to rt. The reaction was cooled to -78 °C, and the corresponding aldehyde (4 
mmol, 1 equiv) was added dropwise (or in small portions if solid) over the course of 10 
min. The reaction was allowed to warm slowly to rt and stirred 18 h. The reaction was 
quenched at 0 °C by addition of sat. aq NH4Cl, extracted with EtOAc, dried (MgSO4), 
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and concentrated. Ph3PO was removed by addition of Et2O, cooling to 0 °C, and filtering 
over a small plug of silica. The crude product was taken directly to the next step after 
confirming the product by NMR. To an oven-dried Biotage microwave vial equipped 
with a stir bar was added Pd μ-Cl dimer (0.02 mmol, 0.5 mol %), JohnPhos (0.04 mmol, 
1 mol %), and NaOt-Bu (5.6 mmol, 1.4 equiv). The vial was sealed with a cap lined with 
a disposable Teflon septum then evacuated under vacuum and purged with Ar three 
times. Toluene (8 mL) was added followed by the substituted-2-bromostyrene (4 mmol, 1 
equiv) and benzylamine (4.8 mmol, 1.2 equiv). The resulting mixture was heated to 80 
°C and stirred until full consumption of 2-bromostyrene was observed by HPLC (~ 24 h). 
After cooling to rt, the reaction mixture was diluted with Et2O (16 mL) and filtered over 
Celite. The solvent was removed in vacuo, and the product was purified by flash column 
chromatography on silica gel with hexanes as the eluent. 
 
N-Benzyl-5-trifluoromethyl-2-vinylaniline. Completed on 2 mmol scale. Obtained as a 
yellow oil (160 mg, 29%). 
1
H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 1.5 Hz, 1H), 7.41-
7.37 (m, 5H), 7.35-7.32 (m, 1H), 6.76 (dd, J = 17.4 Hz, 11.0 Hz, 1H), 6.65 (d, J = 8.6 Hz, 
1H), 5.71 (dd, J = 17.1 Hz, 1.2 Hz, 1H), 5.44 (dd, J = 11.0 Hz, 1.2 Hz, 1H), 4.54 (br s, 
1H), 4.43 (s, 2H). 
13
C NMR (125.8 MHz, CDCl3) δ 147.3, 138.2, 131.8, 128.8, 127.5, 
127.3, 126.3 (q, J = 212 Hz), 125.9 (q, J = 3.7 Hz), 124.52 (q, J = 3.7 Hz), 123.8, 119.0 
(q, J = 32 Hz), 118.17, 109.9, 47.9. IR (neat) 3446, 3031, 2857, 1615, 1523, 1328, 1290, 
1109 cm
-1
. HRMS (ESI) m/z calc. for C16H15NF3 [M+H]
+
 278.1157, found 278.1165. 
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N-Benzyl-3-fluoro-2-vinylaniline. Obtained as a yellow oil (390 mg, 43%). 
1
H NMR 
(500 MHz, CDCl3) δ 7.39-7.35 (m, 4H), 7.31 (d, J = 4.2 Hz, 1H), 7.06-7.04 (m, 1H), 6.60 
(dd, J = 18.0 Hz, 11.6 Hz, 1H), 6.51-6.45 (m, 1H), 6.42 (d, J = 8.3 Hz, 1H), 5.74 (d, J = 
18.1 Hz, 1H), 5.62 (d, J = 11.7 Hz, 1H), 4.58 (br s, 1H), 4.37-4.36 (m, 2H). 
13
C NMR 
(125.8 MHz, CDCl3) δ 161.1 (d, J = 244 Hz), 147.0 (d, J = 6.3 Hz), 139.0, 129.2 (d, J = 
11.3 Hz), 128.9, 127.5, 127.4, 127.0 (d, J = 3.8 Hz), 120.7 (d, J = 3.8 Hz), 111.5 (d, J = 
16.5 Hz), 106.5 (d, J = 3 Hz), 104.4 (d, J = 23 Hz), 48.52. IR (neat) 3428, 3029, 2917, 
2849, 1470, 1120, 735, 698 cm
-1
. HRMS (ESI) m/z calc. for C16H18N [M+H]
+
 224.1439, 
found 224.1442. 
 
N-Benzyl-5-methyl-2-vinylaniline. Obtained as a yellow oil (473 mg, 53%). 
1
H NMR 
(500 MHz, CDCl3) δ 7.45-7.39 (m, 4H), 7.36-7.33 (m, 1H), 7.24 (d, J = 7.8 Hz, 1H), 6.80 
(dd, J = 17.4 Hz, 11.5 Hz, 1H), 6.62 (d, J = 7.8 Hz, 1H), 6.54 (s, 1H), 5.64 (d, J = 17.4 
Hz, 1H), 5.30 (d, J = 11.0 Hz, 1H), 4.39 (s, 2H), 4.17 (br s, 1H), 2.33 (s, 3H). 
13
C NMR 
(125.8 MHz, CDCl3) δ 145.0, 139.3, 138.9, 132.7, 128.6, 127.6, 127.3, 127.2, 121.5, 
118.4, 115.4, 111.6, 48.4, 21.7. IR (neat) 3435, 3027, 2858, 1611, 1514, 1453, 908, 806, 
697 cm
-1
. HRMS (ESI) m/z calc. for C16H18N [M+H]
+
 224.1439, found 224.1442. 
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N-Benzyl-4,5-dimethoxy-2-vinylaniline. Obtained as a yellow oil (430 mg, 40%). 
1
H 
NMR (500 MHz, CDCl3) δ 7.43-7.36 (m, 4H), 7.32-7.29 (m, 1H), 6.93 (s, 1H), 6.77 (dd, 
J = 17.1 Hz, 11.0 Hz, 1H), 6.29 (s, 1H), 5.56 (d, J = 17.4 Hz, 1H), 5.24 (d, J = 11.0 Hz, 
1H), 4.36 (s, 2H), 4.01-3.65 (br s, 1H), 3.86 (s, 3H), 3.80 (s, 3H). 
13
C NMR (125.8 MHz, 
CDCl3) δ 150.0, 141.3, 140.1, 139.3, 132.1, 128.6, 127.5, 127.3, 115.8, 113.8, 111.6, 
97.4, 56.7, 55.8, 49.2. IR (neat) 3430, 2921, 2851, 1612, 1515, 1218, 732 cm
-1
. HRMS 
(ESI) m/z calc. for C17H20NO2 [M+H]
+
 270.1494, found 270.1488. 
 
General Procedure for the Synthesis of 2-Aminostyrene. (2-aminostyrene was 
synthesized according to the literature).
74
 To a 100 mL round bottom flask with stir bar 
was added 2-amino-phenethyl alcohol (20 g, 146 mmol) and potassium hydroxide (8.2 g, 
146 mmol). The flask was connected to a vacuum distillation apparatus, and heated to 
180 ºC under vacuum (0.05 torr). The product was distilled over 4 h and collected as 
colorless oil. 
 
2-Vinylaniline (4.5).
74
 Obtained as a colorless oil (13.15 g, 75%). 
1
H NMR (500 MHz, 
acetone-d6) δ 7.28 (d, J = 7.6 Hz, 1H), 7.00 (dd, J = 7.6, 7.6 Hz, 1H), 6.89 (dd, J = 17.4, 
11.2 Hz, 1H), 6.72-6.69 (m, 1H), 6.64-6.57 (m, 1H), 5.59 (d, J = 17.4 Hz, 1H), 5.18 (d, J 
= 11.0 Hz, 1H), 4.60 (br s, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.3, 133.0, 128.5, 
126.2, 122.6, 117.2, 115.6, 112.9. 
 
General Procedure for the Synthesis of 2,1-Borazaronaphthalenes. To an oven-dried 
Biotage microwave vial equipped with a stir bar was added the potassium 
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organotrifluoroborate (0.5 mmol, 1 equiv). The vial was sealed with a cap lined with a 
disposable Teflon septum, then evacuated under vacuum and purged with Ar three times. 
CPME (0.5 mL) and toluene (0.5 mL) were added followed by the 2-vinylaniline (0.75 
mmol, 1.5 equiv or 0.60 mmol, 1.2 equiv) and SiCl4 (0.5 mmol, 1 equiv) under Ar. The 
resulting mixture was heated either to 60 °C for 4 h or to 40 °C for 18 h, depending on 
the substrate. After cooling to rt, the reaction mixture was diluted with hexanes (2 mL). 
The reaction mixture was filtered over a two-inch plug of silica and flushed with 20% 
CH2Cl2/hexanes (10 mL). The solvent was removed in vacuo to provide the desired 
product. A few B-alkyl 2,1-borazaronaphthalenes required purification via flash column 
chromatography with 30% CH2Cl2/hexanes as the eluent. 
 
1-Benzyl-2-phenyl-2,1-borazaronaphthalene (4.6). Obtained as a tan solid (117 mg, 
79%). mp: 95-98 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.13 (d, J = 11.4 Hz, 1H), 7.70 (d, J 
= 7.6 Hz, 1H), 7.57-7.48 (m, 2H), 7.36-7.27 (m, 7H), 7.24-7.17 (m, 2H), 7.13 (d, J = 7.1 
Hz, 2H), 7.05 (d, J = 11.4 Hz, 1H), 5.44 (s, 2H). 
13
C NMR (125.8 MHz, CDCl3) δ 145.5, 
141.3, 139.4, 132.7, 130.4, 128.9, 128.7, 128.1, 127.9, 127.5, 127.0, 125.9, 121.2, 117.2, 
52.6. 
11
B NMR (128.38 MHz, CDCl3) δ 37.04. IR (neat) 3026, 1609, 1548, 1241, 966, 
814, 701 cm
-1
. HRMS (CI) m/z calc. for C21H18BN [M]
+
 295.1532, found 295.1521. 
 
1-Benzyl-2-(4-tert-butylphenyl)-2,1-borazaronaphthalene (4.7). Obtained as a tan 
solid (78 mg, 44%). mp: 134-136 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.11 (d, J = 11.4 Hz, 
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1H), 7.69 (d, J = 7.6 Hz, 1H), 7.51 (d, J = 8.1 Hz, 2H), 7.36 (d, J = 8.2 Hz, 2H), 7.34-
7.28 (m, 4H), 7.26-7.21 (m, 1H), 7.20-7.13 (m, 3H), 7.08 (d, J = 11.3 Hz, 1H), 5.48 (br s, 
2H), 1.32 (s, 9H). 
13
C NMR (125.8 MHz, CDCl3) δ 151.1, 145.3, 141.4, 139.7, 132.9, 
130.4, 128.9, 128.6, 127.5, 126.9, 125.9, 124.8, 121.1, 117.2, 52.7, 34.8, 31.5. 
11
B NMR 
(128.38 MHz, CDCl3) δ 37.17. IR (neat) 2966, 1610, 1553, 1239, 805, 764 cm
-1
. HRMS 
(CI) m/z calc. for C25H26BN [M]
+
 351.2158, found 351.2167. 
 
1-Benzyl-2-(3-methylphenyl)-2,1-borazaronaphthalene (4.8). Obtained as a yellow oil 
that crystallized in the refrigerator (89 mg, 57%). mp: 97-99 °C. 
1
H NMR (500 MHz, 
CDCl3) δ 8.10 (d, J = 11.4 Hz, 1H), 7.69 (d, J = 8.0 Hz, 1H), 7.38-7.25 (m, 6H), 7.23-
7.09 (m, 6H), 7.04 (d, J = 11.4 Hz, 1H), 5.43 (s, 2H), 2.29 (s, 3H). 
13
C NMR (125.8 
MHz, CDCl3) δ 145.4, 141.3, 139.5, 137.1, 133.6, 130.4, 129.5, 128.9, 128.8, 128.7, 
127.8, 127.5, 126.9, 125.9, 121.1, 117.2, 52.6, 21.7. 
11
B NMR (128.38 MHz, CDCl3) δ 
37.38. IR (neat) 3026, 1610, 1549, 1412, 762 cm
-1
. HRMS (CI) m/z calc. for C22H20BN 
[M]
+
 309.1689, found 309.1700. 
 
1-Benzyl-2-(3-methoxyphenyl)-2,1-borazaronaphthalene (4.9). Obtained as a tan solid 
(105 mg, 64%). mp: 97-100 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.11 (d, J = 11.4 Hz, 1H), 
7.69 (d, J = 7.7 Hz, 1H), 7.36-7.31 (m, 2H), 7.30-7.23 (m, 3H), 7.22-7.15 (m, 2H), 7.13-
7.09 (m, 3H), 7.07-7.01 (m, 2H), 6.88-6.84 (m, 1H), 5.42 (s, 2H), 3.57 (s, 3H). 
13
C NMR 
(125.8 MHz, CDCl3) δ 158.9, 145.6, 141.4, 139.5, 130.4, 129.1, 128.9, 128.8, 127.5, 
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126.9, 125.9, 125.0, 121.2, 117.2, 117.1, 114.2, 54.9, 52.7. 
11
B NMR (128.38 MHz, 
CDCl3) δ 36.77. IR (neat) 3032, 1589, 1547, 1417, 1226, 764 cm
-1
. HRMS (ESI) m/z 
calc. for C22H21BNO [M+H]
+
 326.1716, found 326.1721. 
 
1-Benzyl-2-(2-naphthyl)-2,1-borazaronaphthalene (4.10). Obtained as a tan solid (119 
mg, 69%). mp: 146-148 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.16 (d, J = 11.4 Hz, 1H), 
8.00 (s, 1H), 7.82-7.77 (m, 2H), 7.75-7.70 (m, 2H), 7.62 (dd, J = 1.1, 8.2 Hz, 1H), 7.47-
7.41 (m, 2H), 7.39-7.34 (m, 2H), 7.32-7.28 (m, 2H), 7.26-7.19 (m, 2H), 7.16-7.10 (m, 
3H), 5.48 (s, 2H). 
13
C NMR (125.8 MHz, CDCl3) δ 145.6, 141.4, 139.4, 133.2, 133.1, 
132.8, 130.5, 129.9, 128.9, 128.8, 128.3, 127.8, 127.5, 127.0, 127.0, 126.1, 125.9, 125.9, 
121.2, 117.2, 52.7. 
11
B NMR (128.38 MHz, CDCl3) δ 36.66. IR (neat) 3051, 1608, 1546, 
1227, 804 cm
-1
. HRMS (CI) m/z calc. for C25H20BN [M]
+
 345.1689, found 345.1700. 
 
1-Benzyl-2-(1-naphthyl)-2,1-borazaronaphthalene (4.11). Obtained as a yellow oil that 
crystallized in the refrigerator (26 mg, 15%). mp: 144-146 °C. 
1
H NMR (500 MHz, 
CDCl3) δ 8.15 (d, J = 11.3 Hz, 1H), 7.86 (d, J = 7.9 Hz, 1H), 7.80 (d, J = 8.2 Hz, 1H), 
7.77-7.74 (m, 2H), 7.49 (d, J = 6.6 Hz, 1H), 7.47-7.43 (m, 1H), 7.42-7.34 (m, 4H), 7.24-
7.18 (m, 3H), 7.16-7.12 (m, 1H), 7.07-7.01 (m, 3H), 5.30 (s, 2H). 
13
C NMR (125.8 MHz, 
CDCl3) δ 145.2, 141.3, 139.0, 135.3, 133.3, 130.5, 129.4, 129.1, 128.9, 128.7, 128.6, 
128.6, 127.8, 127.6, 126.8, 125.9, 125.6, 125.5, 121.3, 117.3, 52.9. 
11
B NMR (128.38 
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MHz, CDCl3) δ 30.03. IR (neat) 3026, 1592, 1549, 946, 762 cm
-1
. HRMS (CI) m/z calc. 
for C25H20BN [M]
+
 345.1689, found 345.1689. 
 
1-Benzyl-2-(4-methylphenyl)-2,1-borazaronaphthalene (4.12). Obtained as a white 
solid (111 mg, 72%). mp: 96-98 °C. 
1
H NMR (500 MHz, acetone-d6) δ 8.17 (d, J = 11.2 
Hz, 1H), 7.76 (d, J = 7.6 Hz, 1H), 7.46-7.40 (m, 3H), 7.37-7.34 (m, 1H), 7.30-7.27 (m, 
2H), 7.22-7.18 (m, 2H), 7.14 (d, J = 7.6 Hz, 4H), 7.01 (d, J = 11.2 Hz, 1H), 5.50 (s, 2H), 
2.30 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.3, 141.1, 139.4, 137.4, 130.2, 
132.5, 128.6, 128.5, 128.4, 127.3, 126.7, 125.6, 121.0, 117.0, 51.8, 20.4. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 37.99. IR (neat) 2919, 1606, 1410, 1243, 803, 767 cm
-1
. 
HRMS (CI) m/z calc. for C22H20BN [M]
+
 309.1689, found 309.1688. 
 
Methyl-3-(2-benzyl-2,1-borazaronaphthyl)benzoate (4.13). Obtained as a tan solid 
(115 mg, 65%). mp: 91-93 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.26-8.21 (m, 1H), 8.15 (d, 
J = 11.4 Hz, 1H), 8.00 (td, J = 1.5, 7.9 Hz, 1H), 7.72 (d, J = 7.6 Hz, 1H), 7.68 (td, J = 1.3, 
7.4 Hz, 1H), 7.41-7.35 (m, 3H), 7.32-7.27 (m, 2H), 7.26-7.19 (m, 2H), 7.11 (d, J = 7.1 
Hz, 2H), 7.04 (d, J = 11.4 Hz, 1H), 5.40 (s, 2H), 3.85 (s, 3H). 
13
C NMR (125.8 MHz, 
CDCl3) δ 167.6, 145.9, 141.2, 139.1, 136.9, 134.0, 130.5, 129.5, 129.2, 128.9, 128.9, 
127.9, 127.5, 127.0, 125.8, 121.4, 117.2, 52.6, 52.1. 
11
B NMR (128.38 MHz, CDCl3) δ 
36.78. IR (neat) 3026, 1714, 1548, 1233, 1107, 752 cm
-1
. HRMS (ESI) m/z calc. for 
C23H21BNO2 [M+H]
+
 354.1665, found 354.1657. 
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3-(2-Benzyl-2,1-borazaronaphthyl)benzonitrile (4.14). Obtained as a yellow oil that 
crystallized in the refrigerator (80 mg, 50%). mp: 117-119 °C. 
1
H NMR (500 MHz, 
CDCl3) δ 8.17 (d, J = 11.4 Hz, 1H), 7.79 (s, 1H), 7.75-7.71 (m, 1H), 7.69 (td, J = 1.3, 7.6 
Hz, 1H), 7.60 (td, J = 1.4, 7.8 Hz, 1H), 7.41-7.35 (m, 3H), 7.32-7.28 (m, 2H), 7.26-7.21 
(m, 2H), 7.08 (d, J = 7.2 Hz, 2H), 6.97 (d, J = 11.3 Hz, 1H), 5.35 (s, 2H). 
13
C NMR 
(125.8 MHz, CDCl3) δ 146.5, 141.1, 138.7, 136.6, 136.2, 131.6, 130.7, 129.2, 129.2, 
128.5, 127.6, 127.4, 125.7, 121.7, 119.5, 117.2, 112.1, 52.6. 
11
B NMR (128.38 MHz, 
CDCl3) δ 36.03. IR (neat) 3030, 2227, 1610, 1550, 1414, 763 cm
-1
. HRMS (ESI) m/z 
calc. for C22H17BFN2 [M+F]
-
 339.1469, found 339.1471. 
 
1-Benzyl-2-(3-nitrophenyl)-2,1-borazaronaphthalene (4.15). Obtained as a tan solid 
(84 mg, 49%). mp: 114-117 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.41-8.36 (m, 1H), 8.23-
8.14 (m, 2H), 7.80-7.73 (m, 2H), 7.49-7.45 (m, 1H), 7.41-7.38 (m, 2H), 7.34-7.28 (m, 
2H), 7.27-7.22 (m, 2H), 7.09 (d, J = 7.2 Hz, 2H), 7.01 (d, J = 11.3 Hz, 1H), 5.38 (s, 2H). 
13
C NMR (125.8 MHz, CDCl3) δ 148.0, 146.5, 141.1, 138.6, 138.4, 130.7, 129.2, 129.1, 
128.8, 127.5, 127.4, 127.3, 125.7, 123.0, 121.7, 117.2, 52.6. 
11
B NMR (128.38 MHz, 
CDCl3) δ 35.70. IR (neat) 3030, 1609, 1528, 1342, 808, 730 cm
-1
. HRMS (ESI) m/z calc. 
for C21H17BN2NaO2 [M+Na]
+
 363.1281, found 363.1270. 
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1-Benzyl-2-(3,5-bis(trifluoromethyl)phenyl)-2,1-borazaronaphthalene (4.16). 
Obtained as a tan solid (109 mg, 50%). mp: 88-92 °C. 
1
H NMR (500 MHz, CDCl3) δ 
8.21 (d, J = 11.4 Hz, 1H), 7.90 (s, 2H), 7.82 (s, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.46-7.41 
(m, 2H), 7.33-7.22 (m, 4H), 7.07 (d, J = 7.4 Hz, 2H), 7.01-6.97 (m, 1H), 5.34 (s, 2H). 
13
C 
NMR (125.8 MHz, CDCl3) δ 146.8, 141.2, 138.5, 132.5, 132.4, 130.8 (q, J = 46.3 Hz), 
130.7, 129.4, 129.1, 127.5, 127.4, 125.6, 123.7 (q, J = 273.4 Hz), 121.9, 117.1, 52.7. 
11
B 
NMR (128.38 MHz, CDCl3) δ 36.09. IR (neat) 2921, 1611, 1350, 1277, 1126, 764 cm
-1
. 
HRMS (ESI) m/z calc. for C23H16BF7N [M+F]
-
 450.1264, found 450.1265. 
 
1-Benzyl-2-(4-fluorophenyl)-2,1-borazaronaphthalene (4.17). Obtained as a tan solid 
(110 mg, 70%). mp: 112-114 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.13 (d, J = 11.3 Hz, 
1H), 7.73-7.69 (m, 1H), 7.52-7.46 (m, 2H), 7.38-7.28 (m, 4H), 7.24-7.17 (m, 2H), 7.12 
(d, J = 7.1 Hz, 2H), 7.05-6.99 (m, 3H), 5.41 (s, 2H). 
13
C NMR (125.8 MHz, CDCl3) δ 
163.2 (d, J = 252.5 Hz), 145.7, 141.3, 139.3, 134.6 (d, J = 8.2 Hz), 130.5, 129.0, 128.8, 
127.5, 127.1, 125.8, 121.3, 117.2 (d, J = 20.0 Hz), 114.9, 52.6. 
11
B NMR (128.38 MHz, 
CDCl3) δ 35.99. IR (neat) 2913, 1594, 1216, 812 cm
-1
. HRMS (ESI) m/z calc. for 
C22H20BFNO [M+OCH3]
-
 344.1622, found 344.1627. 
 
1-Benzyl-2-(2,4-difluorophenyl)-2,1-borazaronaphthalene (4.18). Obtained as a tan 
solid (22 mg, 13%). mp: 107-110 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.13 (d, J = 11.3 Hz, 
1H), 7.74-7.70 (m, 1H), 7.39-7.33 (m, 2H), 7.32-7.26 (m, 2H), 7.24-7.17 (m, 3H), 7.06 
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(d, J = 7.2 Hz, 2H), 6.99 (d, J = 11.3 Hz, 1H), 6.86-6.77 (m, 2H), 5.35 (s, 2H). 
13
C NMR 
(125.8 MHz, CDCl3) δ 165.0 (dd, J = 115.3, 12.7 Hz), 163.1 (dd, J = 122.6, 10.9 Hz), 
145.7, 141.1, 138.8, 134.6 (dd, J = 11.8, 9.1 Hz), 130.5, 128.8, 128.8, 127.7, 127.0, 
125.9, 121.5, 117.3, 111.4 (dd, J = 20.0, 2.7 Hz), 103.6 (dd, J = 29.1, 24.5 Hz), 52.8. 
11
B 
NMR (128.38 MHz, CDCl3) δ 35.50. IR (neat) 2923, 1606, 1241, 973, 808 cm
-1
. HRMS 
(ESI) m/z calc. for C21H16BF3N [M+F]
-
 350.1328, found 350.1330. 
 
1-Benzyl-2-(3-thienyl)-2,1-borazaronaphthalene (4.19). Obtained as an off-white solid 
(84 mg, 56%). mp: 108-110 °C. 
1
H NMR (500 MHz, acetone-d6) δ 8.17 (d, J = 11.5 Hz, 
1H), 7.76 (d, J = 7.8 Hz, 1H), 7.65 (s, 1H), 7.49 (dd, J = 4.6, 2.7 Hz, 1 H), 7.43-7.37 (m, 
1H), 7.35-7.31 (m, 4H), 7.30-7.20 (m, 4H), 7.11 (d, J = 11.2 Hz, 1H), 5.57 (s, 2H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 145.2, 141.3, 139.2, 131.7, 131.1, 130.1, 128.8, 128.5, 
127.3, 126.8, 125.6, 125.3, 121.0, 116.8, 52.0. 
11
B NMR (128.38 MHz, acetone-d6) δ 
35.47. IR (neat) 2922, 1551, 2523, 1232, 764 cm
-1
. HRMS (CI) m/z calc. for C19H17BNS 
[M+H]
+
 302.1175, found 302.1183. 
 
1-Benzyl-2-(4-dibenzofuryl)-2,1-borazaronaphthalene (4.20). Obtained as a white 
solid (89 mg, 46%). mp: 106-107 °C. 
1
H NMR (500 MHz, acetone-d6) δ 8.28 (d, J = 11.2 
Hz, 1H), 8.11-8.07 (m, 2H), 7.85 (d, J = 7.8 Hz, 1H), 7.59 (d, J = 7.3 Hz, 1H), 7.55 (d, J 
= 8.6 Hz, 1H), 7.45-7.33 (m, 5H), 7.28-7.22 (m, 3H), 7.17-7.12 (m, 4H), 5.52 (s, 2H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 158.0, 155.9, 145.5, 143.9, 140.1, 138.9, 131.0, 130.3, 
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128.6, 128.3, 127.6, 127.0, 126.6, 125.8, 124.1, 122.8, 122.6, 121.3, 120.7, 120.6, 117.2, 
111.4, 111.3, 52.4. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.20. IR (neat) 3027, 2923, 
1712, 1550, 1186, 757, 737 cm
-1
. HRMS (CI) m/z calc. for C27H20BNO [M]
+
 385.1638, 
found 385.1626. 
 
1-Benzyl-2-(4-dibenzothienyl)-2,1-borazaronaphthalene (4.21). Obtained as a white 
solid (88 mg, 44%). mp: 116-117 °C. 
1
H NMR (500 MHz, acetone-d6) δ 8.30-8.28 (m, 
2H), 8.24 (d, J = 8.1 Hz, 1H), 7.90-7.88 (m, 1H), 7.83 (d, J = 7.8 Hz, 1H), 7.57-7.55 (m, 
2H), 7.49-7.39 (m, 4H), 7.25 (dd, J = 9.5, 7.3 Hz, 1H), 7.21-7.12 (m, 6H), 5.49 (s, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 146.6, 143.4, 141.4, 139.8, 139.3, 136.1, 135.1, 
130.9, 130.2, 129.1, 128.9, 128.1, 127.2, 127.1, 126.2, 124.8, 124.7, 123.0, 122.2, 121.9, 
121.7, 117.8, 52.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.20. IR (neat) 3028, 1711, 
1548, 1371, 1220, 752 cm
-1
. HRMS (CI) m/z calc. for C27H21BNS [M+H]
+
 402.1488, 
found 402.1477. 
 
1-Benzyl-2-((E)-1-propen-1-yl)-2,1-borazaronaphthalene (4.22). Obtained as a yellow 
oil that crystallized in the refrigerator (70 mg, 54%). mp: 70-72 °C. 
1
H NMR (500 MHz, 
acetone-d6) δ 8.02 (d, J = 11.5 Hz, 1H), 7.66-7.64 (m, 1H), 7.41 (d, J = 8.6 Hz, 1H), 7.33-
7.27 (m, 3H), 7.23-7.16 (m, 3H), 7.13-7.08 (m, 2H), 6.87-6.82 (m, 1H), 6.26 (d, J = 17.5 
Hz, 1H), 5.42 (s, 2H), 1.92-1.89 (m, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 146.2, 
144.3, 141.5, 139.0, 130.0, 128.5, 128.2, 127.0, 126.8, 125.8, 120.5, 116.0, 50.2, 21.5. 
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11
B NMR (128.38 MHz, acetone-d6) δ 37.27. IR (neat) 3010, 1713, 1608, 1552, 1358, 
1218, 982, 758 cm
-1
. HRMS (CI) m/z calc. for C18H18BN [M]
+
 259.1532, found 
259.1539. 
 
1-Benzyl-2-((Z)-1-propen-1-yl)-2,1-borazaronaphthalene (4.23). Obtained as a yellow 
oil that crystallized in the refrigerator overnight (74 mg, 57%). mp: 70-72 °C. 
1
H NMR 
(500 MHz, acetone-d6) δ 8.08 (d, J = 11.2 Hz, 1H), 7.70 (d, J = 7.8 Hz, 1H), 7.43 (d, J = 
8.6 Hz, 1H), 7.35-7.31 (m, 1H), 7.29-7.25 (m, 2H), 7.21-7.13 (m, 4H), 7.02-6.99 (m, 1H), 
6.33-6.27 (m, 1H), 6.08 (d, J = 13.7 Hz, 1H), 5.40 (s, 2H), 1.86 (d, J = 6.8 Hz, 3H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 144.4, 141.4, 138.8, 138.7, 130.1, 128.5, 128.2, 127.0, 
126.7, 125.8, 120.7, 116.2, 51.1, 17.7. 
11
B NMR (128.38 MHz, acetone-d6) δ 36.46. IR 
(neat) 3010, 1713, 1608, 1218, 982, 807, 758 cm
-1
. HRMS (CI) m/z calc. for C18H18BN 
[M]
+
 259.1532, found 259.1527. 
 
1-Benzyl-2-((E)-3-phenyl-1-propen-1-yl)-2,1-borazaronaphthalene (4.24). Obtained 
as a yellow oil that crystallized in the refrigerator (85 mg, 51%). mp: 75-77 °C. 
1
H NMR 
(500 MHz, acetone-d6) δ 8.02 (d, J = 11.5 Hz, 1H), 7.67-7.64 (m, 1H), 7.44 (d, J = 8.6 
Hz, 1H), 7.35-7.10 (m, 13H), 6.94-6.88 (m, 1H), 6.37 (d, J = 17.4 Hz, 1H), 5.48 (s, 2H), 
3.59 (d, J = 6.6 Hz, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 149.9, 144.9, 141.9, 139.4, 
130.4, 129.2, 129.0, 128.9, 128.8, 128.7, 127.5, 127.2, 126.4, 126.3, 121.0, 116.5, 50.8, 
43.0. 
11
B NMR (128.38 MHz, acetone-d6) δ 35.32. IR (neat) 3026, 1608, 1416, 1218, 
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990, 763, 748, 700 cm
-1
. HRMS (CI) m/z calc. for C24H23BN [M+H]
+
 336.1924, found 
336.1926. 
 
1-Benzyl-2-(1-butynyl)-2,1-borazaronaphthalene (4.25). Obtained as a yellow oil that 
crystallized upon standing (71 mg, 47%). mp: 46-47 °C. 
1
H NMR (500 MHz, acetone-d6) 
δ 8.53 (d, J = 11.2 Hz, 1H), 8.16 (d, J = 7.8 Hz, 1H), 7.93 (d, J = 8.6 Hz, 1H), 7.84-7.79 
(m, 1H), 7.77-7.58 (m, 7H), 7.37 (d, J = 11.2 Hz, 1H), 6.15 (s, 2H), 2.83 (dd, J = 8.5, 7.0 
Hz, 2H), 1.98-1.93 (m, 2H), 1.87-1.82 (m, 2H), 1.32-1.27 (m, 2H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 145.5, 141.4, 139.3, 130.6, 129.0, 128.8, 127.3, 127.2, 126.6, 121.4, 
116.9, 111.0, 53.3, 31.0, 21.0, 19.6, 13.3. 
11
B NMR (128.38 MHz, acetone-d6) δ 29.01. 
IR (neat) 3029, 2956, 2930, 2185, 1549, 1412, 1228, 806, 762 cm
-1
. HRMS (CI) m/z calc. 
for C21H22BN [M]
+
 299.1845, found 299.1841. 
 
1-Benzyl-2-methyl-2,1-borazaronaphthalene (4.26). Obtained as a tan solid (56 mg, 
48%). mp: 56-60 °C. 
1
H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 11.4 Hz, 1H), 7.61 (d, J 
= 7.6 Hz, 1H), 7.30-7.25 (m, 4H), 7.23-7.18 (m, 1H), 7.13-7.08 (m, 3H), 6.87 (d, J = 11.4 
Hz, 1H), 5.30 (s, 2H), 0.84 (s, 3H). 
13
C NMR (125.8 MHz, CDCl3) δ 144.3, 141.9, 138.7, 
130.3, 128.8, 128.4, 127.0, 126.7, 126.0, 120.5, 116.0, 51.1. 
11
B NMR (128.38 MHz, 
CDCl3) δ 38.99. IR (neat) 2966, 1608, 1355, 1221, 761 cm
-1
. HRMS (CI) m/z calc. for 
C16H16BN [M]
+
 233.1376, found 233.1374. 
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1-Benzyl-2-(4-penten-1-yl)-2,1-borazaronaphthalene (4.27). Obtained as a yellow oil 
(72 mg, 50%). 
1
H NMR (500 MHz, CDCl3) δ 8.00-7.94 (m, 1H), 7.60 (d, J = 7.5 Hz, 
1H), 7.29-7.22 (m, 4H), 7.21-7.16 (m, 1H), 7.12-7.05 (m, 3H), 6.95 (dd, J = 2.1, 11.5 Hz, 
1H), 5.88-5.77 (m, 1H), 5.28 (s, 2H), 5.02-4.89 (m, 2H), 2.11 (q, J = 7.0 Hz, 2H), 1.78-
1.70 (m, 2H), 1.34-1.28 (m, 2H). 
13
C NMR (125.8 MHz, CDCl3) δ 144.7, 141.7, 139.4, 
138.7, 130.3, 128.8, 128.4, 127.0, 126.9, 125.9, 120.5, 116.1, 114.4, 50.6, 37.0, 26.0. 
11
B 
NMR (128.38 MHz, CDCl3) δ 38.94. IR (neat) 2921, 1610, 1415, 759 cm
-1
. HRMS (CI) 
m/z calc. for C20H22BN [M]
+
 287.1845, found 287.1841. 
 
2-Benzyl-1-trifluoroethyl-2,1-borazaronaphthalene (4.28). Obtained as an off white 
solid (60 mg, 40%). mp: 76-78 °C. 
1
H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 11.60 Hz, 
1H), 7.57 (d, J = 7.63 Hz, 1H), 7.24 (d, J = 3.97 Hz, 2H), 7.21-7.15 (m, 2H), 7.13 (d, J = 
7.02 Hz, 1H), 7.11-7.07 (m, 2 H), 7.03-6.98 (m, 1H), 6.95 (d, J = 7.63 Hz, 1H), 5.17 (s, 
2H), 2.20 (q, J = 13.4 Hz, 2H). 
13
C NMR (125.8 MHz, CDCl3) δ 145.9, 141.4, 137.5, 
130.6, 129.1, 129.0, 128.9 (q, J = 274 Hz), 127.5, 127.2, 125.6, 121.6, 116.3, 50.1. 
11
B 
NMR (128.38 MHz, CDCl3) δ 38.94. IR (neat) 3033, 2956, 2924, 2853, 1249, 1088, 
1048, 762 cm
-1
. HRMS (CI) m/z calc. for C17H15BNF3 [M]
+
 301.1250, found 301.1245. 
 
404 
 
1-Benzyl-2-isopropyl-2,1-borazaronaphthalene (4.29). Obtained as a yellow oil that 
crystallized upon standing (76 mg, 58%). mp: 67-69 °C. 
1
H NMR (500 MHz, acetone-d6) 
δ 8.08 (d, J = 11.5 Hz, 1H), 7.67 (dd, J = 7.6, 1.5 Hz, 1H), 7.41-7.38 (m, 1H), 7.34-7.27 
(m, 3H), 7.21 (d, J = 7.3 Hz, 1H), 7.16-7.12 (m, 3H), 6.99 (d, J = 11.7 Hz, 1H), 5.44 (s, 
2H), 1.69-1.62 (m, 1H), 1.15-1.11 (m, 6H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.2, 
141.2, 139.1, 139.0, 128.5, 128.2, 126.8, 126.7, 125.6, 120.5, 116.4, 49.7, 20.0. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 41.05. IR (neat) 2950, 2917, 1558, 1440, 1134, 764 cm
-1
. 
HRMS (CI) m/z calc. for C18H20BN [M]
+
 261.1689, found 269.1688. 
 
1-Benzyl-2-cyclopropyl-2,1-borazaronaphthalene (4.30). Obtained as a yellow oil that 
crystallized in the refrigerator (64 mg, 49%). mp: 41-43 °C. 
1
H NMR (500 MHz, CDCl3) 
δ 7.90 (d, J = 11.6 Hz, 1H), 7.56 (d, J = 7.9 Hz, 1H), 7.32-7.26 (m, 4H), 7.25-7.19 (m, 
3H), 7.12-7.06 (m, 1H), 6.41 (d, J = 11.6 Hz, 1H), 5.48 (s, 2H), 0.87-0.81 (m, 2H), 0.70-
0.64 (m, 2H), 0.36-0.26 (m, 1H). 
13
C NMR (125.8 MHz, CDCl3) δ 145.0, 141.8, 139.1, 
130.2, 128.8, 128.4, 127.0, 126.6, 126.2, 120.4, 115.8, 51.1, 6.4. 
11
B NMR (128.38 MHz, 
CDCl3) δ 38.54. IR (neat) 3000, 1610, 1416, 761 cm
-1
. HRMS (CI) m/z calc. for 
C18H18BN [M]
+
 259.1532, found 259.1534. 
 
1-Benzyl-2-cyclobutyl-2,1-borazaronaphthalene (4.31). Obtained as a yellow oil that 
crystallized in the refrigerator (69 mg, 51%). mp: 44-47 °C. 
1
H NMR (500 MHz, 
acetone-d6) δ 8.11 (d, J = 11.5 Hz, 1H), 7.68 (dd, J = 7.7, 1.3 Hz, 1H), 7.36-7.24 (m, 4H), 
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7.20-7.07 (m, 5H), 5.28 (s, 2H), 2.53-2.51 (m, 1H), 2.22-2.12 (m, 5H), 1.96-1.91 (m, 
1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.2, 141.4, 138.9, 130.0, 128.4, 128.2, 
126.8, 126.6, 125.6, 120.4, 116.1, 50.1, 25.8, 22.0. 
11
B NMR (128.38 MHz, acetone-d6) δ 
39.92. IR (neat) 3027, 2962, 2858, 1551, 1414, 1217, 760 cm
-1
. HRMS (CI) m/z calc. for 
C19H20BN [M]
+
 273.1689, found 273.1692. 
 
1-Benzyl-2-cyclohexyl-2,1-borazaronaphthalene (4.32). Obtained as a yellow oil that 
crystallized in the refrigerator (63 mg, 42%). mp: 48-51 °C. 
1
H NMR (500 MHz, CDCl3) 
δ 8.03 (d, J = 11.60 Hz, 1H), 7.62 (d, J = 7.63 Hz, 1H), 7.33-7.27 (m, 4H), 7.25-7.21 (m, 
1H), 7.15-7.11 (m, 3H), 7.05-7.00 (m, 1H), 5.39 (s, 2H), 1.82-1.69 (m, 5H), 1.60-1.23 
(m, 6H). 
13
C NMR (125.8 MHz, CDCl3) δ 145.0, 139.0, 130.0, 128.6, 128.5, 128.1, 
127.8, 126.2, 125.7, 120.4, 116.4, 50.3, 30.3, 27.8, 27.0. 
11
B NMR (128.38 MHz, CDCl3) 
δ 39.34. IR (neat) 3029, 2917, 2846, 1552, 1418, 802, 761cm
-1
. HRMS (CI) m/z calc. for 
C21H24BN [M]
+
 301.2002, found 301.2008. 
 
1-(4-Methoxybenzyl)-2-phenyl-2,1-borazaronaphthalene (4.33). Obtained as a white 
solid (100 mg, 61%). mp: 134-136 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.11 (d, J = 11.3 
Hz, 1H), 7.69 (d, J = 7.7 Hz, 1H), 7.56-7.51 (m, 2H), 7.36-7.30 (m, 5H), 7.20-7.15 (m, 
1H), 7.06-7.01 (m, 3H), 6.82 (d, J = 8.6 Hz, 2H), 5.37 (s, 2H), 3.75 (s, 3H). 
13
C NMR 
(125.8 MHz, CDCl3) δ 158.6, 145.5, 141.3, 132.7, 131.4, 130.4, 128.7, 128.1, 127.8, 
127.5, 126.9, 121.1, 117.2, 114.3, 55.3, 52.0. 
11
B NMR (128.38 MHz, CDCl3) δ 37.19. IR 
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(neat) 2998, 1609, 1509, 1246, 759 cm
-1
. HRMS (ESI) m/z calc. for C22H20BNNaO 
[M+Na]
+
 348.1536, found 348.1547. 
 
1-Allyl-2-phenyl-2,1-borazaronaphthalene (4.34). Obtained as a yellow oil that 
crystallized in the refrigerator (325 mg, 55%). mp: 44-46 °C. 
1
H NMR (500 MHz, 
acetone-d6) δ 8.13 (d, J = 11.2 Hz, 1H), 7.77-7.74 (m, 1H), 7.64-7.60 (m, 3H), 7.54-7.51 
(m, 1H), 7.42-7.35 (m, 3H), 7.25 (dd, J = 8.5, 7.5 Hz, 1H), 6.91 (d, J = 11.2 Hz, 1H), 
6.15-6.09 (m, 1H), 5.18 (dd, J = 10.6, 1.3 Hz, 1H), 4.95 (dd, J = 17.4, 1.2 Hz, 1H), 4.84-
4.82 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.2, 141.1, 136.0, 132.2, 130.2, 
128.5, 127.8, 127.5, 127.1, 121.0, 116.7, 115.0, 50.2. 
11
B NMR (128.38 MHz, acetone-
d6) δ 37.19. IR (neat) 3029, 2917, 2846, 1552, 1418, 802, 761 cm
-1
. HRMS (CI) m/z calc. 
for C17H16BN [M]
+
 245.1376, found 245.1382. 
 
1-Butyl-2-phenyl-2,1-borazaronaphthalene (4.35). Obtained as a yellow oil (93 mg, 
71%). 
1
H NMR (500 MHz, CDCl3) δ 8.02 (d, J = 11.3 Hz, 1H), 7.70 (dd, J = 7.7, 1.5 Hz, 
1H), 7.63-7.59 (m, 1H), 7.57-7.51 (m, 3H), 7.45-7.40 (m, 2H), 7.39-7.34 (m, 1H), 7.26-
7.21 (m, 1H), 6.89 (d, J = 11.3 Hz, 1H), 4.18-4.12 (m, 2H), 1.82-1.72 (m, 2H), 1.33-1.23 
(m, 2H), 0.84 (t, J = 7.4 Hz, 3H). 
13
C NMR (126 MHz, CDCl3) δ 144.8, 141.1, 132.4, 
130.7, 128.6, 127.8, 127.5, 127.4, 120.8, 115.7, 47.8, 32.4, 20.3, 13.9. 
11
B NMR (128 
MHz, CDCl3) δ 36.35. IR (neat) 2957, 1609, 1551, 1411, 751 cm
-1
. HRMS (CI) m/z calc. 
for C18H20BN [M]
+
 261.1689, found 261.1680. 
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1,2-Diphenyl-2,1-borazaronaphthalene (4.36). Obtained as a tan solid (56 mg, 40%). 
mp: 111-115 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.19 (d, J = 11.4 Hz, 1H), 7.74 (dd, J = 
1.4, 7.8 Hz, 1H), 7.45-7.40 (m, 2H), 7.39-7.31 (m, 2H), 7.26-7.23 (m, 3H), 7.22-7.14 (m, 
6H), 6.97 (d, J = 8.5 Hz, 1H). 
13
C NMR (125.8 MHz, CDCl3) δ 145.4, 144.0, 142.9, 
134.0, 129.9, 129.6, 129.5, 128.4, 127.7, 127.3, 127.2, 126.2, 121.3, 117.8. 
11
B NMR 
(128.38 MHz, CDCl3) δ 35.38. IR (neat) 2921, 1595, 1293, 702 cm
-1
. HRMS (ESI) m/z 
calc. for C20H17BN [M+H]
+
 282.1454, found 282.1455. 
 
1-Benzyl-2-phenyl-6-trifluoromethyl-2,1-borazaronaphthalene (4.38). Obtained as a 
white solid (116 mg, 64%). mp: 110-112 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.34 (d, J = 
11.2 Hz, 1H), 8.18 (s, 1H), 7.69-7.64 (m, 2H), 7.57 (dd, J = 6.2, 3.1 Hz, 2H), 7.36-7.30 
(m, 5H), 7.26-7.22 (m, 1H), 7.17-7.14 (m, 3H), 5.58 (s, 2H). 
13
C NMR (125.8 MHz, 
acetone-d6) δ 145.2, 138.6, 132.2, 128.7, 128.2, 128.1, 127.7, 127.4 (q, J = 24 Hz), 127.0, 
126.9, 126.5 (q, J = 251 Hz), 125.6, 125.5, 124.5 (q, J = 4 Hz), 118.1, 52.0. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 38.76. IR (neat) 3026, 2925, 2851, 1623, 1326, 1120, 902, 
704 cm
-1
. HRMS (CI) m/z calc. for C22H17BNF3 [M]
+
 363.1406, found 363.1397. 
 
408 
 
1-Benzyl-2-phenyl-5-fluoro-2,1-borazaronaphthalene (4.39). Obtained as a white solid 
(117 mg, 73%). mp: 126-127 °C. 
1
H NMR (500 MHz, acetone-d6) δ 8.43 (d, J = 11.5 Hz, 
1H), 7.56 (dd, J = 6.5, 3.1 Hz, 2H), 7.38-7.33 (m, 4H), 7.31-7.26 (m, 3H), 7.23-7.20 (m, 
1H), 7.15 (d, J = 7.6 Hz, 2H), 7.09 (d, J = 11.7 Hz, 1H), 6.98 (dd, J = 9.7, 8.2 Hz, 1H), 
5.51 (s, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 159.8 (d, J = 246 Hz), 142.3 (d, J = 6.3 
Hz), 138.9, 136.0 (d, J = 7.5 Hz), 132.2, 128.7, 128.5 (d, J = 10 Hz), 128.1, 127.7, 126.9, 
125.6, 116.4 (d, J = 16 Hz), 113.3 (d, J = 4 Hz), 106.3 (d, J = 21 Hz), 52.3. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 38.00. IR (neat) 3016, 2926, 1590, 1405, 1234, 974, 783, 728 
cm
-1
. HRMS (CI) m/z calc. for C21H17BNF [M]
+
 313.1438, found 313.1431. 
 
1-Benzyl-2-phenyl-7-methyl-2,1-borazaronaphthalene (4.40). Obtained as a white 
solid (116 mg, 75%). mp: 91-93 °C. 
1
H NMR (500 MHz, acetone-d6) δ 8.14 (d, J = 11.2 
Hz, 1H), 7.64 (d, J = 7.8 Hz, 1H), 7.54 (dd, J = 6.5, 3.1 Hz, 2H), 7.32-7.27 (m, 6H), 7.22-
7.19 (m, 1H), 7.15 (d, J = 7.3 Hz, 2H), 7.04 (d, J = 7.8 Hz, 1H), 6.92 (d, J = 11.2 Hz, 
1H), 5.47 (s, 2H), 2.28 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.2, 141.1, 139.4, 
138.6, 132.2, 130.1, 128.6, 127.7, 127.6, 126.7, 125.6, 125.2, 122.4, 117.2, 51.7, 21.2. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.99. IR (neat) 3055, 3023, 3005, 2921, 1599, 
1349, 963, 830, 699 cm
-1
. HRMS (CI) m/z calc. for C22H20BN [M]
+
 309.1689, found 
309.1675. 
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1-Benzyl-2-phenyl-6,7-dimethoxy-2,1-borazaronaphthalene (4.41). Obtained as a 
white solid (104 mg, 59%). mp: 112-115 °C. 
1
H NMR (500 MHz, acetone-d6) δ 8.09 (d, J 
= 11.29 Hz, 1H), 7.60-7.51 (m, 2H), 7.38-7.28 (m, 6H), 7.25-7.17 (m, 3H), 6.95 (s, 1H), 
6.83 (d, J = 11.29 Hz, 1H), 5.49 (s, 2H), 3.84 (s, 3H), 3.60 (m, 3H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 150.9, 145.0, 144.8, 139.7, 136.3, 132.5, 128.8, 127.8, 127.7, 127.0, 
126.1, 121.2, 111.5, 101.0, 55.5, 55.1, 52.4. 
11
B NMR (128.38 MHz, acetone-d6) δ 38.12. 
IR (neat) 3029, 3004, 2965, 2871, 1546, 1261, 1226, 762, 737cm
-1
. HRMS (CI) m/z calc. 
for C23H23BNO2 [M]
+
 356.1822, found 356.1820. 
 
2-Methyl-2,1-borazaronaphthalene (4.42).
15
 Obtained as a white solid (39 mg, 55%). 
mp: 70-71 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.26 (br s, 1H), 7.94 (d, J = 11.2 Hz, 
1H), 7.60 (d, J = 7.8 Hz, 1H), 7.46-7.42 (m, 1H), 7.38-7.34 (m, 1H), 7.10 (dd, J = 7.3, 7.0 
Hz, 1H), 6.74 (d, J = 11.5 Hz, 1H), 0.69 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 
143.8, 141.0, 128.9, 127.7, 125.0, 120.0, 117.8. 
11
B NMR (128.38 MHz, acetone-d6) δ 
37.72. IR (neat) 3363, 2931, 1560, 1438, 764, 752 cm
-1
. HRMS (CI) m/z calc. for 
C9H10BN [M]
+
 143.0906, found 143.0895. 
 
2-Cyclopropyl-2,1-borazaronaphthalene (4.43). Obtained as a white solid (41 mg, 
52%). mp: 67-68 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.16 (br s, 1H), 7.91 (d, J = 11.5 
Hz, 1H), 7.57-7.55 (m, 1H), 7.43-7.40 (m, 1H), 7.36-7.32 (m, 1H), 7.09-7.05 (m, 1H), 
6.44 (d, J = 11.5 Hz, 1H), 0.80-0.75 (m, 2H), 0.57-0.55 (m, 2H), 0.32-0.28 (m, 1H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 144.3, 140.1, 128.9, 127.8, 125.0, 119.9, 117.7, 5.4. 
11
B 
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NMR (128.38 MHz, acetone-d6) δ 38.06. IR (neat) 3380, 3076, 2998, 1561, 1137, 748 
cm
-1
. HRMS (CI) m/z calc. for C11H12BN [M]
+
 169.1063, found 169.1069. 
 
2-(3-Bromopropyl)-2,1-borazaronaphthalene (4.44). Obtained as a white solid (99 mg, 
80%). mp: 65-67 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.31 (br s, 1H), 8.01 (d, J = 11.5 
Hz, 1H), 7.62 (d, J = 7.6 Hz, 1H), 7.50-7.47 (m, 1H), 7.41-7.37 (m, 1H), 7.14-7.10 (m, 
1H), 6.8 (d, J = 11.7 Hz, 1H), 3.54-3.51 (m, 2H), 2.18-2.12 (m, 2H), 1.40-1.35 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.4, 140.8, 129.0, 127.9, 125.2, 120.3, 118.0, 
36.7, 29.7. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.91. IR (neat) 3362, 3006, 2958, 
1559, 809, 760 cm
-1
. HRMS (CI) m/z calc. for C11H13BNBr [M]
+
 249.0324, found 
249.0317. 
 
2-(3-Iodopropyl)-2,1-borazaronaphthalene (4.45). Obtained as a white solid (103 mg, 
69%). mp: 61-63 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.3 (br s, 1H), 8.0 (d, J = 11.5 
Hz, 1H), 7.62 (d, J = 7.8 Hz, 1H), 7.48 (d, J = 8.1 Hz, 1H), 7.41-7.37 (m 1H), 7.14-7.10 
(m, 1H), 6.79 (d, J = 11.5 Hz, 1H), 3.33 (dd, J = 8.0, 7.1 Hz, 2H), 2.15-2.09 (m, 2H), 
1.37-1.34 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.4, 140.8, 129.0, 127.9, 
125.2, 120.3, 118.0, 30.6, 10.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.78. IR (neat) 
3363, 2950, 2917, 1558, 1440, 763 cm
-1
. HRMS (CI) m/z calc. for C11H13BNI [M]
+
 
297.0186, found 297.0174. 
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2-((E)-1-Propen-1-yl)-2,1-borazaronaphthalene (4.46). Obtained as a white solid (44 
mg, 52%). mp: 56-57 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.23 (br s, 1H), 7.99 (d, J = 
11.5 Hz, 1H), 7.59 (d, J = 7.6 Hz, 1H), 7.46-7.43 (m, 1H), 7.39-7.35 (m, 1H), 7.10 (dd, J 
= 8.3, 7.5 Hz, 1H), 6.98 (d, J = 11.6 Hz, 1H), 6.78-6.71 (m, 1H), 6.09 (d, J = 17.6 Hz, 
1H), 1.91-1.90 (m, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.1, 143.6, 141.0, 129.0, 
127.9, 125.5, 120.2, 118.0, 21.1. 
11
B NMR (128.38 MHz, acetone-d6) δ 32.98. IR (neat) 
3370, 2846, 1612, 1438, 986, 816, 751 cm
-1
. HRMS (CI) m/z calc. for C11H13BN [M+H]
+
 
170.1141, found 170.1142. 
 
2-(1-Butynyl)-2,1-borazaronaphthalene (4.47). Obtained as a yellow oil that 
crystallized in the refrigerator (76 mg, 73%). mp: 42-44 °C. 
1
H NMR (500 MHz, 
acetone-d6) δ 9.65 (br s, 1H), 8.05 (d, J = 11.2 Hz, 1H), 7.64 (d, J = 7.8 Hz, 1H), 7.56 (d, 
J = 8.1 Hz, 1H), 7.43 (dd, J = 8.8, 7.7 Hz, 1H), 7.16 (dd, J = 8.0, 7.3 Hz, 1H), 6.79 (d, J = 
11.5 Hz, 1H), 2.36 (dd, J = 10.0, 7.0 Hz, 2H), 1.57-1.53 (m, 2H), 1.52-1.44 (m, 2H), 
0.94-0.87 (m, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.7, 140.6, 129.0, 128.3, 
125.1, 120.8, 118.1, 30.7, 21.6, 19.1, 12.9. 
11
B NMR (128.38 MHz, acetone-d6) δ 26.72. 
IR (neat) 3385, 2931, 2187, 1560, 1174, 808, 760 cm
-1
. HRMS (CI) m/z calc. for 
C14H17BN [M+H]
+
 210.1454, found 210.1462. 
 
2-Phenyl-2,1-borazaronaphthalene (4.48).
15
 Obtained as a white solid (96 mg, 95%). 
mp: 136-138 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.76 (br s, 1H), 8.18 (d, J = 11.7 Hz, 
1H), 8.06 (d, J = 7.1 Hz, 2H), 7.70-7.66 (m, 2H), 7.47-7.41 (m, 4H), 7.30 (d, J = 11.6, 
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1H), 7.18 (dd, J = 10.8, 7.8 Hz, 1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.4, 141.0, 
133.0, 129.3, 129.1, 128.2, 127.9, 125.6, 120.7, 118.5. 
11
B NMR (128.38 MHz, acetone-
d6) δ 34.23. IR (neat) 3380, 2925, 1560, 1440, 1212, 815, 752 cm
-1
. HRMS (CI) m/z calc. 
for C14H12BN [M]
+
 205.1063, found 205.1065. 
 
2-(4-Methylphenyl)-2,1-borazaronaphthalene (4.49). Obtained as a white solid (102 
mg, 93%). mp: 131-132 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.69 (br s, 1H), 8.15 (d, J 
= 11.5 Hz, 1H), 7.95 (d, J = 7.8 Hz, 2H), 7.67 (dd, J = 8.8, 7.2 Hz, 2H), 7.45-7.42 (m, 
1H), 7.29-7.25 (m, 3H), 7.17 (dd, J = 8.8, 7.5 Hz, 1H), 2.36 (s, 3H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 145.1, 141.0, 139.1, 133.1, 129.1, 128.6, 128.2, 125.6, 120.6, 118.5, 
20.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 34.20. IR (neat) 3380, 3012, 1713, 1561, 
1438, 802, 753 cm
-1
. HRMS (CI) m/z calc. for C15H15BN [M+H]
+
 220.1298, found 
220.1302. 
 
2-(4-Fluorophenyl)-2,1-borazaronaphthalene (4.50). Obtained as a white solid (96 mg, 
86%). mp: 131-132 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.79 (br s, 1H), 8.18 (d, J = 
11.5 Hz, 1H), 8.10-8.07 (m, 2H), 7.69 (d, J = 7.8 Hz, 1H), 7.65 (d, J = 8.3 Hz, 1H), 7.45 
(dd, J = 8.8, 7.6 Hz, 1H), 7.27 (d, J = 11.5 Hz, 1H), 7.21-7.17 (m, 3H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 164.0 (d, J = 246 Hz), 145.5, 141.0, 135.2 (d, J = 7.5 Hz), 129.1, 
128.3, 125.5, 120.7, 118.5, 114.65 (d, J = 20 Hz). 
11
B NMR (128.38 MHz, acetone-d6) δ 
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33.86. IR (neat) 3381, 3064, 2924, 1593, 1205, 813, 758 cm
-1
. HRMS (CI) m/z calc. for 
C14H12BFN [M+H]
+
 224.1047, found 224.1050. 
 
2-(3-Thiophenyl)-2,1-borazaronaphthalene (4.51). Obtained as a white solid (97 mg, 
92%). mp: 154-155 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.73 (br s, 1H), 8.16-8.12 (m, 
2H), 7.75 (d, J = 4.6 Hz, 1H), 7.66 (d, J = 7.8 Hz, 1H), 7.58 (d, J = 8.3 Hz, 1H), 7.53 (dd, 
J = 4.4 Hz, 2.4 Hz, 1H), 7.43 (dd, J = 8.8, 7.3 Hz, 1H), 7.24 (d, J = 11.5 Hz, 1H), 7.16 
(dd, J = 9.0, 7.5 Hz, 1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.2, 141.0, 132.6, 
131.2, 129.1, 128.2, 125.5, 125.4, 120.6, 118.3. 
11
B NMR (128.38 MHz, acetone-d6) δ 
31.77. IR (neat) 3379, 2925, 1563, 1058, 1031, 756 cm
-1
. HRMS (CI) m/z calc. for 
C12H11BNS [M+H]
+
 212.0705, found 212.0710. 
 
2-(4-Dibenzofuryl)-2,1-borazaronaphthalene (4.52). Obtained as a white solid (126 
mg, 82%). mp: 144-146 °C. 
1
H NMR (500 MHz, CDCl3) δ 9.53 (br s, 1H), 8.23 (d, J = 
11.5 Hz, 1H), 8.16 (d, J = 7.1 Hz, 1H), 8.03 (dd, J = 14.9, 7.6 Hz, 2H), 7.73 (d, J = 7.8 
Hz, 2H), 7.55-7.47 (m, 5H), 7.43-7.40 (m, 1H), 7.28-7.25 (m, 1H). 
13
C NMR (125.8 
MHz, CDCl3) δ 160.2, 155.8, 145.4, 140.2, 133.8, 129.4, 128.3, 127.0, 125.7, 124.0, 
123.3, 123.0, 122.8, 122.2, 121.0, 120.7, 118.7, 115.5. 
11
B NMR (128.38 MHz, CDCl3) δ 
33.59. IR (neat) 3392, 2923, 1561, 116, 754, 736, 721 cm
-1
. HRMS (CI) m/z calc. for 
C20H14BNO [M]
+
 295.1168, found 295.1165. 
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2-[p-Toluenesulfonyl-4-piperidinyl]-2,1-borazaronaphthalene (4.53). Obtained as a 
white solid (31 mg, 17%). mp: 72-73 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 11.5 
Hz, 1H), 7.69 (d, J = 8.1 Hz, 1H), 7.66 (s, 1H), 7.60 (d, J = 7.8 Hz, 2H), 7.42-7.40 (m, 
1H), 7.35 (d, J = 8.1 Hz, 2H), 7.26-7.24 (m, 1H), 7.17 (dd, J = 8.3, 7.5 Hz, 2H), 6.78 (d, J 
= 11.5 Hz, 1H), 3.87 (d, J = 11.2 Hz, 2H), 2.46 (s, 3H), 2.34 (dd, J = 12.3, 11.0 Hz, 2H), 
1.98-1.90 (m, 2H), 1.79-1.70 (m, 2H), 1.24-1.17 (m, 1H). 
13
C NMR (125.8 MHz, 
acetone-d6) δ 145.1, 143.2, 139.7, 133.3, 129.5, 129.3, 128.2, 127.7, 125.3, 121.0, 117.9, 
47.6, 28.2, 21.4. 
11
B NMR (128.38 MHz, acetone-d6) δ 36.96. IR (neat) 3343, 2915, 
1597, 1455, 1108, 1057, 1034, 613 cm
-1
. HRMS (ESI) m/z calc. for C20H24BN2O2S [M]
+
 
367.1652, found 367.1647. 
 
1-Phenyl-2-methyl-2,1-borazaronaphthalene (4.54). Obtained as a white solid (47 mg, 
43%). mp: 59-61 °C. 
1
H NMR (500 MHz, CDCl3) δ 7.99 (d, J = 11.6 Hz, 1H), 7.65 (dd, J 
= 7.6, 1.2 Hz, 1H), 7.55-7.51 (m, 2H), 7.45-7.43 (m, 1H), 7.26-7.24 (m, 1H), 7.18-7.14 
(m, 3H), 6.90 (d, J = 11.3 Hz, 1H), 6.77 (d, J = 8.5 Hz, 1H), 0.48 (s, 3H). 
13
C NMR 
(125.8 MHz, acetone-d6) δ 144.3, 144.0, 143.0, 129.7, 129.5, 128.3, 127.9, 127.1, 125.6, 
120.5, 116.8. 
11
B NMR (128.38 MHz, acetone-d6) δ 36.21. IR (neat) 3002, 2929, 1592, 
1490, 1307, 762 cm
-1
. HRMS (CI) m/z calc. for C15H14BN [M]
+
 219.1219, found 
219.1219. 
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2-(β,β,β-Trifluoroethyl)-2,1-borazaronaphthalene. Obtained as an off-white solid (130 
mg, 21%, 3 mmol scale). mp: 59-61 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.74 (br s, 
1H), 8.13 (d, J = 11.2 Hz, 1H), 7.70 (d, J = 7.7 Hz, 1H), 7.56-7.52 (m, 1H), 7.47-7.43 (m, 
1H), 7.23-7.18 (m, 1H), 6.94-6.90 (m, 1H), 2.42-2.30 (m, 2H). 
13
C NMR (125.8 MHz, 
acetone-d6) δ 145.3, 140.3, 129.2, 128.4, 127.3 (q, J = 278 Hz), 125.3, 121.1, 118.3 
11
B 
NMR (128.38 MHz, acetone-d6) δ 33.8. IR (neat) 3361, 2970, 1563, 1278, 1236, 1102, 
1032, 768 cm
-1
. HRMS (CI) m/z calc. for C10H9BNF3 [M]
+
 211.0780, found 211.0778. 
 
2-Isopropyl-2,1-borazaronaphthalene. Obtained as an off-white solid (650 mg, 76%, 5 
mmol scale). mp: 59-61 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.06 (br s, 1H), 8.01 (d, J 
= 11.5 Hz, 1H), 7.6 (d, J = 7.6 Hz, 1H), 7.53-7.49 (m, 1H), 7.40-7.35 (m, 1H), 7.13-7.09 
(m, 1H), 6.87-6.82 (m, 1H), 1.56-1.48 (m, 1H), 1.18-1.11 (m, 6H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 144.5, 140.7, 128.9, 127.8, 125.2, 120.2, 118.2, 19.6. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 37.9. IR (neat) 3361, 2940, 1560, 1438, 1056, 1035, 761 cm
-
1
. HRMS (CI) m/z calc. for C11H14BN [M]
+
 171.1219, found 171.1223. 
 
2-Cyclobutyl-2,1-borazaronaphthalene. Obtained as an off-white solid (379 mg, 69%, 
3 mmol scale). mp: 63-64 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.09 (br s, 1H), 8.02 (d, 
J = 11.5 Hz, 1H), 7.61 (d, J = 7.8 Hz, 1H), 7.51-7.48 (m, 1H), 7.39-7.35 (m, 1H), 7.14-
7.09 (m, 1H), 6.90-6.85 (m, 1H) 2.47-2.40 (m, 1H), 2.27-2.11 (m, 5H), 2.07-2.00 (m, 
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1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.5, 140.7, 128.9, 127.8, 125.2, 120.2, 
118.0, 25.5, 22.1. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.7. IR (neat) 3363, 2960, 
2934, 2858, 1560, 1438, 760 cm
-1
. HRMS (CI) m/z calc. for C12H14BN [M]
+
 183.1219, 
found 183.1212. 
 
2-Cyclopropyl-2,1-borazaronaphthalene. Obtained as an off-white solid (600 mg, 71%, 
5 mmol scale). mp: 68-70 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.18 (br s, 1H), 7.91 (d, 
J = 11.7 Hz, 1H), 7.56 (d, J = 7.6 Hz, 1H), 7.44-7.41 (m, 1H), 7.36-7.33 (m, 1H), 7.09-
7.05 (m, 1H), 6.46-6.41 (m, 1H), 0.81-0.76 (m, 2H), 0.59-0.55 (m, 2H), 0.33-0.26 (m, 
1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.3, 140.8, 128.9, 127.8, 125.0, 119.9, 
117.7, 5.4. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.8. IR (neat) 3381, 3076, 2998, 1614, 
1563, 1442, 1137, 817, 748, 702 cm
-1
. HRMS (CI) m/z calc. for C11H12BN [M]
+
 
169.1063, found 163.1059. 
 
2-(3-Methoxyphenyl)-2,1-borazaronaphthalene. Obtained as an off-white solid (834 
mg, 71%, 5 mmol scale). mp: 80-82 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.77 (br s, 
1H), 8.18 (d, J = 11.5 Hz, 1H), 7.70-7.66 (m, 2H), 7.63-7.60 (m, 2H), 7.46-7.42 (m, 1H), 
7.39-7.35 (m, 1H), 7.31-7.27 (m, 1H), 7.21-7.17 (m, 1H), 7.00-6.97 (m, 1H), 3.85 (s, 
3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 159.6, 145.4, 141.0, 129.0, 129.0, 128.2, 
125.6, 125.4, 120.7, 118.5, 118.1, 114.9, 54.4. 
11
B NMR (128.38 MHz, acetone-d6) δ 
34.0. IR (neat) 3368, 3051, 2406, 1566, 1250, 1039, 763 cm
-1
. HRMS (CI) m/z calc. for 
C15H14BNO [M]
+
 235.1168, found 235.1177. 
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2-(2-Thienyl)-2,1-borazaronaphthalene (4.165). Obtained as an off-white solid (791 
mg, 75%, 5 mmol scale). mp: 90-92 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.73 (br s, 
1H), 8.13 (d, J = 11.5 Hz, 1H), 7.87 (d, J = 3.2 Hz, 1H), 7.76 (d, J = 4.2 Hz, 1H), 7.67-
7.64 (m, 1H), 7.62-7.58 (m, 1H), 7.45-7.42 (m, 1H), 7.29-7.27 (m, 1H), 7.18-7.15 (m, 
2H).
13
C NMR (125.8 MHz, acetone-d6) δ 145.4, 140.8, 133.7, 130.8, 129.2, 128.6, 128.4, 
125.5, 120.7, 118.3. 
11
B NMR (128.38 MHz, acetone-d6) δ 31.1. IR (neat) 3378, 3062, 
1561, 760, 715 cm
-1
. HRMS (CI) m/z calc. for C12H10BNS [M]
+
 211.0627, found 
211.0624. 
 
2-(3-Methoxyphenyl)-1-(4-methylbenzyl)-2,1-borazaronaphthalene. Obtained as an 
off-white solid (569 mg, 56%, 3 mmol scale). mp: 113-115 °C. 
1
H NMR (500 MHz, 
CDCl3) δ 8.15 (d, J = 11.2 Hz, 1H), 7.73 (d, J = 7.6 Hz, 1H), 7.40-7.36 (m, 2H), 7.31-
7.28 (m, 1H), 7.23-7.20 (m, 1H), 7.17-7.11 (m, 3H), 7.09-7.01 (m, 4H), 6.92-6.88 (m, 
1H), 5.43 (br s, 2H), 3.66 (s, 3H), 2.34 (s, 3H). 
13
C NMR (125.8 MHz, CDCl3) δ 162.2, 
158.8, 145.3, 141.2, 136.6, 130.2, 129.3, 128.8, 128.5, 127.2, 125.6, 124.8, 120.9, 117.2, 
117.0, 113.9, 54.8, 52.3, 21.0. 
11
B NMR (128.38 MHz, CDCl3) δ 37.3. IR (neat) 2995, 
1548, 1415, 1255, 1225, 1028, 766 cm
-1
. HRMS (CI) m/z calc. for C23H22BNO [M]
+
 
339.1794, found 339.1781. 
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1-Allyl-2-methyl-2,1-borazaronaphthalene. Obtained as an yellow oil (285 mg, 52%, 3 
mmol scale). 
1
H NMR (500 MHz, acetone-d6) δ 7.91 (d, J = 11.2 Hz, 1H), 7.64 (d, J = 
7.8 Hz, 1H), 7.52-7.59 (m, 1H), 7.46-7.42 (m, 1H), 7.17-7.14 (m, 1H), 6.81-6.78 (m, 1H), 
6.08-6.02 (m, 1H), 5.09 (d, J = 10.5 Hz, 1H), 4.91 (d, J = 17.4 Hz, 1H), 4.70-4.68 (m, 
2H), 0.81 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.0, 141.5, 134.7, 130.0, 128.1, 
126.6, 120.2, 115.5, 114.6, 48.9. 
11
B NMR (128.38 MHz, acetone-d6) δ 39.2. IR (neat) 
3008, 1609, 1551, 1412, 1353, 1219, 757 cm
-1
. HRMS (ESI) m/z calc. for C12H14BN 
[M]
+
 183.1219, found 183.1215. 
 
1-Allyl-2-(3-methoxyphenyl)-2,1-borazaronaphthalene. Obtained as a yellow oil (486 
mg, 59%, 3 mmol scale). 
1
H NMR (500 MHz, acetone-d6) δ 8.13 (d, J = 11.2 Hz, 1H), 
7.76 (d, J = 7.8 Hz, 1H), 7.64-7.61 (m, 1H), 7.56-7.51 (m, 1H), 7.35-7.31 (m, 1H), 7.28-
7.23 (m, 1H), 7.18-7.14 (m, 2H), 6.95-6.89 (m, 2H), 6.18-6.11 (m, 1H), 5.22-5.17 (m, 
1H), 4.99-4.93 (m, 1H), 4.85-4.82 (m, 2H), 3.81 (s, 3H). 
13
C NMR (125.8 MHz, acetone-
d6) δ 159.1, 145.2, 141.0, 136.1, 130.1, 128.7, 128.5, 127.0, 124.3, 121.0, 117.3, 116.7, 
114.9, 113.3, 54.3, 50.3. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.2. IR (neat) 3009, 
2939, 2830, 1549, 1413, 1281, 1049, 764 cm
-1
. HRMS (ESI) m/z calc. for C18H19BNO 
[M+H]
+
 276.1560, found 276.1564. 
 
1-Benzyl-2-(4-trifluoromethylphenyl)-2,1-borazaronaphthalene. Obtained as a white 
solid (585 mg, 54%, 3 mmol scale). mp: 84-86 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.33-
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8.30 (m, 1H), 7.89-7.72 (m, 5H), 7.55-7.35 (m, 6H), 7.28-7.19 (m, 3H), 5.53 (s, 2H). 
13
C 
NMR (125.8 MHz, CDCl3) δ 146.3, 141.3, 139.2, 132.9, 132.5 (q, J = 226 Hz), 130.8, 
130.2 (d, J = 32 Hz), 129.2, 127.8, 127.4, 125.9, 124.6 (d, J = 3 Hz), 123.8, 121.8, 117.4, 
52.8. 
11
B NMR (128.38 MHz, CDCl3) δ 37.1. IR (neat) 2923, 1551, 1233, 859, 762, 682, 
632 cm
-1
. HRMS (CI) m/z calc. for C22H17BNF3 [M]
+
 363.1406, found 363.1403. 
 
2-(4-Fluorophenyl)-1-(4-methoxybenzyl)-2,1-borazaronaphthalene. Obtained as a 
white solid (700 mg, 68%, 3 mmol scale). mp: 95-97 °C. 
1
H NMR (500 MHz, CDCl3) δ 
8.19 (d, J = 11.5 Hz, 1H), 7.77 (d, J = 7.3 Hz, 1H), 7.60-7.57 (m, 2H), 7.46-7.41 (m, 2H), 
7.28-7.25 (m, 1H), 7.11-7.09 (m, 5H), 6.92-6.90 (m, 2H), 5.43 (s, 2H), 3.83 (s, 3H). 
13
C 
NMR (125.8 MHz, CDCl3) δ 163.1 (d, J = 245 Hz), 158.5, 145.5, 141.2, 134.5 (d, J = 7 
Hz), 131.02, 130.3, 128.6, 127.3, 126.7, 121.1, 117.1, 114.7 (d, J = 20 Hz), 114.3, 55.2, 
51.8. 
11
B NMR (128.38 MHz, CDCl3) δ 37.2. IR (neat) 3027, 1550, 1414, 1234, 787, 
761, 731 cm
-1
. HRMS (CI) m/z calc. for C22H19BFNO [M]
+
 343.1544, found 355.1540. 
 
General Procedure For the Bromination of 2,1-Borazaronaphthalenes. To a flame-
dried 100 mL round bottom flask with a stir bar was added the corresponding 2,1-
borazaronaphthalene (2.0 mmol). The flask was sealed with a rubber septum, evacuated 
under vacuum, and purged with Ar three times. Anhydrous CH2Cl2 was added (10 mL), 
and the flask was cooled to 0 °C. Bromine (352 mg, 2.2 mmol, 1.1 equiv) in CH2Cl2 (10 
mL) was added under Ar at a rate of 1.1 mmol/h. After the addition, the reaction was 
slowly warmed to rt. The reaction was monitored by TLC. When complete (usually after 
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warming to rt), the reaction was concentrated in vacuo. The crude 2,1-
borazaronaphthalene was purified by flash column chromatography with 0-30% 
CH2Cl2/hexane as the eluent to provide the desired 3-bromo-2,1-borazaronaphthalene. 
 
3-Bromo-2-methyl-2,1-borazaronaphthalene (4.55). Obtained as an off-white solid 
(1969 mg, 99%, 9 mmol scale). mp: 115-117 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.63 
(br s, 1H), 8.29 (s, 1H), 7.62 (d, J = 7.8 Hz, 1H), 7.47-7.42 (m, 2H), 7.17-7.14 (m, 1H), 
0.79 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.3, 140.2, 128.6, 128.55, 124.9, 
121.2, 118.2. 
11
B NMR (128.38 MHz, acetone-d6) δ 39.2. IR (neat) 3361, 2940, 1560, 
1438, 1056, 1035, 761 cm
-1
. HRMS (CI) m/z calc. for C9H9BrBN [M]
+
 221.0011, found 
221.0019. 
 
3-Bromo-2-(β,β,β-trifluoroethyl)-2,1-borazaronaphthalene (4.56). Obtained as an off-
white solid (138 mg, 96%, 0.5 mmol scale). mp: 61-63 °C. 
1
H NMR (500 MHz, acetone-
d6) δ 9.87 (br s, 1H), 8.44 (s, 1H), 7.71-7.64 (m, 2H), 7.53-7.49 (m, 1H), 7.26-7.23 (m, 
1H), 2.55-5.49 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 146.2, 139.5, 129.3, 128.8, 
128.7 (q, J = 274 Hz), 125.2, 122.3, 118.8. 
11
B NMR (128.38 MHz, acetone-d6) δ 33.4. 
IR (neat) 3361, 2970, 1563, 1278, 1236, 1102, 1032, 768 cm
-1
. HRMS (CI) m/z calc. for 
C10H8BrBNF3 [M]
+ 
288.9885, found 288.9884. 
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3-Bromo-2-isopropyl-2,1-borazaronaphthalene (4.57). Obtained as an off-white solid 
(488 mg, 98%, 2 mmol scale). mp: 57-69 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.26 (br 
s, 1H), 8.33 (s, 1H), 7.65-7.57 (m, 2H), 7.45-7.41 (m, 1H), 7.20-7.15 (m, 1H), 1.85-1.80 
(m, 1H), 1.19-1.15 (m, 6H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.5, 140.1, 128.6, 
128.5, 125.0, 121.4, 118.5, 18.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 38.0. IR (neat) 
3373, 2956, 2852, 1610, 1558, 1424, 1137, 849, 757 cm
-1
. HRMS (CI) m/z calc. for 
C11H13BrBN [M]
+
 249.0324, found 249.0330. 
 
3-Bromo-2-cyclopropyl-2,1-borazaronaphthalene (4.58). Obtained as an off-white 
solid (689 mg, 93%, 3 mmol scale). mp: 83-85 °C. 
1
H NMR (500 MHz, acetone-d6) δ 
8.87 (br s, 1H), 8.28 (s, 1H), 7.61-7.58 (m, 1H), 7.46-7.42 (m, 1H), 7.41-7.38 (m, 1H), 
7.14-7.10 (m, 1H), 0.88-0.86 (m, 2H), 0.85-0.82 (m, 2H), 0.77-0.73 (m, 1H). 
13
C NMR 
(125.8 MHz, acetone-d6) δ 144.6, 140.3, 128.6, 128.5, 124.7, 121.0, 118.1, 6.1. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 37.2. IR (neat) 3374, 2954, 1557, 1428, 1105, 925, 848, 748 
cm
-1
. HRMS (CI) m/z calc. for C11H11BrBN [M]
+
 247.0168, found 247.0159. 
 
3-Bromo-2-cyclobutyl-2,1-borazaronaphthalene (4.59). Obtained as an off-white solid 
(506 mg, 97%, 2 mmol scale). mp: 84-86 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.33 (br 
s, 1H), 8.28 (s, 1H), 7.64-7.60 (m, 2H), 7.46-7.42 (m, 1H), 7.19-7.15 (m, 1H), 2.65-2.61 
(m, 1H), 2.26-2.15 (m, 5H), 1.97-1.93 (m, 1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 
145.0, 140.0, 128.6, 128.5, 125.0, 121.4, 118.5, 25.0, 21.8. 
11
B NMR (128.38 MHz, 
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acetone-d6) δ 37.1. IR (neat) 3353, 2979, 1612, 1557, 1428, 1205, 927, 757 cm
-1
. HRMS 
(CI) m/z calc. for C12H13BrBN [M]
+
 261.0324, found 261.0330. 
 
3-Bromo-2-benzyl-2-methyl-2,1-borazaronaphthalene (4.60). Obtained as an off-white 
solid (886 mg, 95%, 3 mmol scale). mp: 75-77 °C. 
1
H NMR (500 MHz, acetone-d6) δ 
8.34 (s, 1H), 7.65-7.63 (m, 1H), 7.40-7.33 (m, 2H), 7.23-7.12 (m, 6H), 5.38 (s, 2H), 0.97 
(s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.8, 140.6, 138.0, 129.5, 128.8, 128.6, 
127.0, 126.0, 125.7, 121.3, 116.3, 51.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.3. IR 
(neat) 2917, 1608, 1359, 1028, 753, 735, 722, 697 cm
-1
. HRMS (CI) m/z calc. for 
C16H15BrBN [M]
+
 311.0481, found 311.0490. 
 
1-Allyl-3-bromo-2-methyl-2,1-borazaronaphthalene (4.61). Obtained as a yellow oil 
(781 mg, 98%, 3 mmol scale). 
1
H NMR (500 MHz, acetone-d6) δ 8.25 (s, 1H), 7.62 (d, J 
= 7.8 Hz, 1H), 7.48 (d, J = 3.4 Hz, 2H), 7.20-7.16 (m, 1H), 6.08-6.00 (m, 1H), 5.13-5.08 
(m, 1H), 4.94-4.90 (m, 1H), 4.74-4.72 (m, 2H), 0.92 (s, 3H). 
13
C NMR (125.8 MHz, 
acetone-d6) δ 144.5, 140.5, 134.1, 129.5, 128.7, 125.8, 121.1, 115.9, 115.0, 50.0. 
11
B 
NMR (128.38 MHz, acetone-d6) δ 38.9. IR (neat) 3031, 1607, 1362, 1216, 913, 760, 741 
cm
-1
. HRMS (CI) m/z calc. for C12H13BBrN [M]
+
 261.0324, found 261.0330. 
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3-Bromo-2-phenyl-2,1-borazaronaphthalene (4.62). Obtained as an off-white solid 
(840 mg, 99%, 3 mmol scale). mp: 84-86 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.90 (br 
s, 1H), 8.54 (s, 1H), 7.95-7.92 (m, 2H), 7.75-7.71 (m, 2H), 7.54-7.51 (m, 1H), 7.45-7.40 
(m, 3H), 7.27-7.23 (m, 1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 146.7, 140.1, 133.5, 
128.9, 128.8, 128.5, 127.4, 124.9, 121.6, 118.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 
34.0. IR (neat) 3371, 3052, 1552, 1420, 1009, 761, 748, 702 cm
-1
. HRMS (CI) m/z calc. 
for C14H11BrBN [M]
+
 283.0168, found 283.0174. 
 
3-Bromo-2-(3-methoxyphenyl)-2,1-borazaronaphthalene (4.63). Obtained as an off-
white solid (325 mg, 52%, 2 mmol scale). mp: 107-109 °C. 
1
H NMR (500 MHz, acetone-
d6) δ 9.87 (br s, 1H), 8.54 (s, 1H), 7.72-7.69 (m, 2H), 7.53-7.48 (m, 3H), 7.37-7.34 (m, 
1H), 7.26-7.23 (m, 1H), 7.01-6.97 (m, 1H), 3.84 (s, 3H). 
13
C NMR (125.8 MHz, acetone-
d6) δ 159.0, 146.8, 140.1, 128.9, 128.6, 128.5, 125.8, 124.9, 121.7, 119.0, 118.6, 114.4, 
54.5. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.8. IR (neat) 3323, 2970, 2933, 1557, 
1427, 1252, 1047, 791 cm
-1
. HRMS (CI) m/z calc. for C15H14BBrNO [M+H]
+
 314.0352, 
found 314.0341. 
 
3-Bromo-2-(4-fluorophenyl)-2,1-borazaronaphthalene (4.64). Obtained as an off-
white solid (274 mg, 91%, 2 mmol scale). mp: 114-116 °C. 
1
H NMR (500 MHz, acetone-
d6) δ 9.89 (br s, 1H), 8.50 (s, 1H), 7.99-7.96 (m, 2H), 7.69-7.66 (m, 2H), 7.52-7.49 (m, 
1H), 7.24-7.18 (m, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 163.6 (d, J = 246 Hz), 
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146.8, 140.1, 135.9 (d, J = 7.5 Hz), 128.9, 128.5, 124.9, 121.7, 118.6, 114.3 (d, J = 20.2 
Hz). 
11
B NMR (128.38 MHz, acetone-d6) δ 33.1. IR (neat) 3376, 3055, 1615, 1593, 1425, 
1214, 800, 757 cm
-1
. HRMS (CI) m/z calc. for C14H10BBrFN [M]
+
 301.0074, found 
301.0080. 
 
3-Bromo-2-(3-thienyl)-2,1-borazaronaphthalene (4.65). Obtained as a light brown 
solid (305 mg, 53%, 2 mmol scale). mp: 66-68 °C. 
1
H NMR (500 MHz, acetone-d6) δ 
9.91 (br s, 1H), 8.52 (s, 1H), 8.35-8.32 (m, 1H), 7.83 (d, J = 4.9 Hz, 1H), 7.70 (d, J = 8.1 
Hz, 1H), 7.66 (d, J = 8.1 Hz, 1H), 7.57-7.54 (m, 1H), 7.53-7.48 (m, 1H), 7.25-7.20 (m, 
1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 146.8, 140.0, 133.7, 132.0, 128.9, 128.5, 
124.8, 124.7, 121.5, 118.4. 
11
B NMR (128.38 MHz, acetone-d6) δ 30.9. IR (neat) 3749, 
2977, 2349, 1557, 758 cm
-1
. HRMS (CI) m/z calc. for C12H10BBrNS [M+H]
+
 289.9810, 
found 289.9810. 
 
3-Bromo-2-(4-dibenzofuranyl)-2,1-borazaronaphthalene (4.66). Obtained as an off-
white solid (663 mg, 89%, 2 mmol scale). mp: 132-134 °C. 
1
H NMR (500 MHz, acetone-
d6) δ 10.33 (br s, 1H), 8.66 (s, 1H), 8.18-8.13 (m, 2H), 7.96 (d, J = 7.3 Hz, 1H), 7.82 (d, J 
= 7.9 Hz, 1H), 7.78-7.76 (m, 1H), 7.63-7.57 (m, 2H), 7.53-7.47 (m, 2H), 7.41-7.38 (m, 
1H), 7.34-7.31 (m, 1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 159.0, 156.0, 147.0, 140.0, 
133.2, 129.3, 128.9, 127.3, 125.3, 124.3, 123.2, 123.0, 122.6, 122.2, 121.8, 120.9, 119.0, 
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111.8. 
11
B NMR (128.38 MHz, acetone-d6) δ 33.5. IR (neat) 3382, 3036, 1567, 1185, 
748, 726 cm
-1
. HRMS (CI) m/z calc. for C20H13BBrNO [M]
+
 373.0274, found 373.0276. 
 
1-Allyl-3-bromo-2-phenyl-2,1-borazaronaphthalene (4.67). Obtained as a white solid 
(513 mg, 53%, 3 mmol scale). mp: 109-111 °C. 
1
H NMR (500 MHz, acetone-d6) δ 8.51 
(s, 1H), 7.78-7.74 (m, 1H), 7.63-7.56 (m, 2H), 7.50-7.47 (m, 2H), 7.43-7.37 (m, 3H), 
7.33-7.28 (m, 1H), 6.03-5.96 (m, 1H), 5.13 (d, J = 10.5 Hz, 1H), 4.94-4.90 (m, 1H), 4.73-
4.71 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 146.1, 140.0, 135.0, 131.4, 129.6, 
129.0, 127.8, 127.4, 126.4, 121.9, 117.1, 115.3, 51.4. 
11
B NMR (128.38 MHz, acetone-
d6) δ 39.3. IR (neat) 2979, 1607, 1586, 1544, 1368, 1245, 965, 701 cm
-1
. HRMS (ESI) 
m/z calc. for C17H15BrBN [M]
+
 323.0481, found 323.0494. 
 
1-Allyl-3-bromo-2-(3-methoxyphenyl)-2,1-borazaronaphthalene (4.68). Obtained as a 
yellow oil (324 mg, 46%, 2 mmol scale). 
1
H NMR (500 MHz, acetone-d6) δ 8.52 (s, 1H), 
7.80-7.78 (m, 1H), 7.64-7.55 (m, 2H), 7.34-7.30 (m, 2H), 7.06-6.94 (m, 2H), 6.96-6.93 
(m, 1H), 6.05-6.00 (m, 1H), 5.17-5.13 (m, 1H), 4.95-4.92 (m, 1H), 4.76-4.73 (m, 2H), 
3.80 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 158.9, 146.1, 140.0, 135.2, 129.6, 
129.0, 128.7, 126.4, 123.5, 121.9, 117.0, 116.8, 115.2, 113.2, 54.3, 51.4 
11
B NMR 
(128.38 MHz, acetone-d6) δ 36.5. IR (neat) 2953, 1644, 1545, 1366, 1282, 1048, 763 cm
-
1
. HRMS (ESI) m/z calc. for C18H18BrBNO [M+H]
+
 354.0665, found 354.0657. 
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2-Benzyl-3-bromo-1-phenyl-2,1-borazaronaphthalene (4.69). Obtained as an off-white 
solid (710 mg, 95%, 2 mmol scale). mp: 121-124 °C. 
1
H NMR (500 MHz, acetone-d6) δ 
8.58 (br s, 1H), 7.79 (d, J = 7.6 Hz, 1H), 7.49-7.41 (m, 4H), 7.36-7.30 (m, 3H), 7.28-7.23 
(m, 3H), 7.20-7.17 (m, 1H), 7.14-7.09 (m, 2H), 5.39 (s, 2H). 
13
C NMR (125.8 MHz, 
acetone-d6) δ 146.4, 140.0, 138.4, 131.5, 129.7, 129.0, 128.6, 127.9, 127.5, 126.8, 126.7, 
125.5, 122.0, 117.5, 53.0. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.3. IR (neat) 3025, 
1606, 1545, 1367, 1355, 1243, 971, 763, 723, 703 cm
-1
. HRMS (CI) m/z calc. for 
C21H17BrBN [M]
+
 373.0637, found 373.0638. 
 
1-Benzyl-3-bromo-2-(4-trifluoromethylphenyl)-2,1-borazaronaphthalene (4.70). 
Obtained as an off-white solid (211 mg, 48%, 1 mmol scale). mp: 55-57 °C. 
1
H NMR 
(500 MHz, acetone-d6) δ 8.61 (s, 1H), 7.81 (d, J = 7.9 Hz, 1H), 7.71-7.67 (m, 4H), 7.46-
7.42 (m, 2H), 7.29-7.25 (m, 3H), 7.21-7.18 (m, 1H), 7.13-7.11 (m, 2H), 5.36 (s, 2H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 147.0, 140.1, 138.3, 132.3, 130.1, 129.8, 129.5 (q, J = 
4Hz), 128.9, 128.0, 127.3, 127.1, 127.0 (q, J = 272 Hz), 125.8, 122.5, 117.7, 53.4. 
11
B 
NMR (128.38 MHz, acetone-d6) δ 36.5. IR (neat) 3029, 1546, 1323, 1122, 834, 725 cm
-1
. 
HRMS (CI) m/z calc. for C22H16BrBF3N [M]
+
 441.0511, found 441.0511. 
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3-Bromo-2-(4-fluorophenyl)-1-(4-methoxybenzyl)-2,1-borazaronaphthalene (4.71). 
Obtained as an off-white solid (207 mg, 49%, 1 mmol scale). mp: 68-70 °C. 
1
H NMR 
(500 MHz, acetone-d6) δ 8.56 (s, 1H), 7.78 (d, J = 7.8 Hz, 1H), 7.53-7.41 (m, 4H), 7.27-
7.24 (m, 1H), 7.13-7.10 (m, 2H), 7.04-7.00 (m, 2H), 6.87-6.85 (m, 2H), 5.31 (s, 2H), 3.71 
(s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 162.8 (d, J = 245 Hz), 158.8, 146.4, 140.0, 
133.7 (d, J = 8 Hz), 130.0, 129.7, 129.0, 126.7, 126.6, 122.0, 117.5, 114.3 (d, J = 20 Hz), 
114.0, 54.5, 52.4. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.5. IR (neat) 2971, 1550, 
1414, 1234, 762, 625 cm
-1
. HRMS (CI) m/z calc. for C22H18BrBNOF [M]
+
 421.0649, 
found 421.0654. 
 
1-Benzyl-3-bromo-2-(3-thienyl)-2,1-borazaronaphthalene (4.72). Obtained as an off-
white solid (237 mg, 25%, 2.5 mmol scale). mp: 66-68 °C. 
1
H NMR (500 MHz, acetone-
d6) δ 8.56 (s, 1H), 7.81-7.80 (m, 1H), 7.56-7.54 (m, 1H), 7.50-7.48 (m, 1H), 7.46-7.41 
(m, 2H), 7.32-7.29 (m, 2H), 7.27-7.21 (m, 3H), 7.16-7.14 (m, 2H), 5.44 (s, 2H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 146.3, 138.6, 131.7, 131.0, 129.7, 129.6, 129.0, 128.7, 
126.9, 126.6, 125.5, 124.8, 122.0, 117.4, 53.2. 
11
B NMR (128.38 MHz, acetone-d6) δ 
36.3. IR (neat) 2958, 1733, 1540, 758, 719 cm
-1
. HRMS (CI) m/z calc. for C19H15BrBNS 
[M]
+
 379.0202, found 379.0208. 
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3-Bromo-2-(3-methoxyphenyl)-1-(4-methylbenzyl)-2,1-borazaronaphthalene (4.73). 
Obtained as an off-white solid (337 mg, 81%, 1 mmol scale). mp: 116-118 °C. 
1
H NMR 
(500 MHz, acetone-d6) δ 8.57 (s, 1H), 7.79 (d, J = 7.8 Hz, 1H), 7.47-7.42 (m, 2H), 7.29-
7.26 (m, 2H), 7.10-7.05 (m, 2H), 7.03-7.00 (m, 4H), 6.90-6.87 (m, 1H), 5.35 (s, 2H), 3.66 
(s, 3H), 2.24 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 158.9, 146.4, 140.0, 136.3, 
135.5, 129.6, 129.2, 129.0, 128.7, 126.7, 125.5, 123.5, 121.9, 117.5, 116.7, 113.4, 54.2, 
52.8, 20.0. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.0. IR (neat) 3048, 1406, 1336, 1313, 
1094, 875, 792, 704 cm
-1
. HRMS (CI) m/z calc. for C23H21BrBNO [M]
+
 417.0900, found 
417.0913. 
 
3-Bromo-2-(hex-1-yn-1-yl)-2,1-borazaronaphthalene (4.74). Obtained as a yellow oil 
(83 mg, 29%, 1 mmol scale). 
1
H NMR (500 MHz, acetone-d6) δ 9.96 (br s, 1H), 8.40 (s, 
1H), 7.66 (d, J = 8.1 Hz, 1H), 7.59-7.57 (m, 1H), 7.50-7.47 (m, 1H), 7.22-7.19 (m, 1H), 
2.40 (t, J = 6.8 Hz, 2H), 1.59-1.49 (m, 4H), 0.95-0.90 (m, 3H). 
13
C NMR (500 MHz, 
acetone-d6) δ 145.1, 139.6, 128.8, 128.5, 124.7, 121.6, 118.1, 109.5, 30.5, 21.5, 19.1, 
12.9. 
11
B NMR (500 MHz, acetone-d6) δ 26.4. IR (neat) 3649, 2956, 2931, 1613, 1556, 
997, 799, 759 cm
-1
. HRMS (CI) m/z calc. for C14H15BNBr [M]
+
 287.0481, found 
287.0481. 
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1-Benzyl-3-bromo-2,7-dimethyl-2,1-borazaronaphthalene (4.75). Obtained as a white 
solid (50 mg, 77%, 0.2 mmol scale). mp: 85-87 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.25 
(s, 1H), 7.47-7.44 (m, 1H), 7.34-7.31 (m, 2H), 7.28-7.25 (m, 1H), 7.14-7.10 (m, 3H), 
7.00-6.97 (m, 1H), 5.35 (s, 2H), 2.34 (s, 3H), 1.00 (s, 3H). 
13
C NMR (500 MHz, CDCl3) 
δ 144.5, 140.8, 138.9, 137.8, 129.2, 128.7, 127.0, 125.7, 123.9, 122.6, 116.2, 51.9, 22.1. 
11
B NMR (500 MHz, CDCl3) δ 38.1. IR (neat) 2926, 1590, 1452, 1364, 809, 685 cm
-1
. 
HRMS (CI) m/z calc. for C17H17BNBr [M]
+
 325.0637, found 325.0647. 
 
1-Benzyl-3-bromo-6,7-dimethoxy-2-methyl-2,1-borazaronaphthalene (4.76). 
Obtained as a white solid (24 mg, 64%, 0.1 mmol scale). mp: 96-98 °C. 
1
H NMR (500 
MHz, CDCl3) δ 8.17 (s, 1H), 7.31-7.22 (m, 3H), 7.15-7.11 (m, 2H), 6.93 (s, 1H), 6.73 (s, 
1H), 5.31 (s, 2H), 3.89 (s, 3H), 3.67 (s, 3H), 1.01 (s, 3H). 
13
C NMR (500 MHz, CDCl3) 
150.3, 144.4, 140.1, 138.1, 136.2, 129.1, 127.5, 126.0, 119.7, 110.0, 55.2, 55.9, 52.9. 
11
B 
NMR (500 MHz, CDCl3) δ 37.9. IR (neat) 2924, 1258, 1029, 823, 810, 751, 687, 609 cm
-
1
. HRMS (CI) m/z calc. for C18H19BNO2Br [M]
+
 371.0692, found 371.0683. 
 
2-(1,2-Dibromopropyl)-2,1-borazaronaphthalene (4.77). Obtained as an off-white 
solid (221 mg, 34%, 2 mmol scale). mp: 91-93 °C. 
1
H NMR (500 MHz, acetone-d6) δ 
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9.60 (br s, 1H), 8.13 (d, J = 11.6 Hz, 1H), 7.69-7.67 (m, 1H), 7.51-7.43 (m, 2H), 7.21-
7.17 (m, 1H), 6.93-6.91 (m, 1H), 4.91-4.85 (m, 1H), 4.23 (d, J = 10.7 Hz, 1H), 1.98 (d, J 
= 6.4 Hz, 3H). 
13
C NMR (500 MHz, acetone-d6) δ 145.9, 139.7, 129.2, 128.4, 125.5, 
121.2, 118.4, 50.5, 25.4. 
11
B NMR (500 MHz, acetone-d6) δ 34.0. IR (neat) 3360, 2978, 
1614, 1562, 1441, 760 cm
-1
. HRMS (CI) m/z calc. for C11H13BBr2N [M+H]
+
 327.9508, 
found 327.9509. 
 
6-Bromo-3-(3-methoxyphenyl)-2-methyl-2,1-borazaronaphthalene (4.119). Obtained 
as an off-white solid (167 mg, 51%, 1 mmol scale). mp: 100-102 °C. 
1
H NMR (500 MHz, 
acetone-d6) δ 9.47 (br s, 1H), 7.72 (s, 1H), 7.66 (d, J = 7.6 Hz, 1H), 7.55-7.51 (m, 2H), 
7.44-7.41 (m, 1H), 7.17-7.14 (m, 1H), 6.90-6.87 (m, 1H), 6.82-6.80 (m, 1H), 3.80 (s, 
3H), 0.65 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 159.3, 147.1, 141.6, 140.8, 133.0, 
129.5, 128.5, 124.6, 120.8, 117.9, 115.7, 113.7, 113.4, 55.1. 
11
B NMR (128.38 MHz, 
acetone-d6) δ 37.4. IR (neat) 3382, 2987, 1616, 1457, 1345, 122, 1014, 759 cm
-1
. HRMS 
(CI) m/z calc. for C16H16BBrNO [M+H]
+
 328.0508, found 328.0518. 
 
6-Bromo-3-phenyl-2-methyl-2,1-borazaronaphthalene (4.120). Obtained as an off-
white solid (240 mg, 81%, 1 mmol scale). mp: 96-98 °C. 
1
H NMR (500 MHz, acetone-
d6) 9.58 (br s, 1H), 7.86-7.83 (m, 2H), 7.51-7.48 (m, 1H), 7.44-7.38 (m, 5H), 7.30-7.28 
(m, 1H), 0.88 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.6, 140.1, 139.4, 131.3, 
130.6, 128.3, 128.2, 126.8, 126.3, 119.7, 112.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 
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37.6. IR (neat) 3350, 2961, 1606, 1439, 1313, 821, 702 cm
-1
. HRMS (CI) m/z calc. for 
C15H13BBrN [M]
+
 297.0324, found 297.0330. 
 
3-Bromo-2-(3-carbomethoxyphenyl)-2,1-borazaronaphthalene. The title compound 
was obtained as an off-white solid in 62% yield (2 mmol scale, 424 mg). mp 105-107 C; 
1
H NMR (500 MHz, CDCl3): δ 8.51 (s, 1H), 8.47 (s, 1H), 8.17-8.10 (m, 3H), 7.63 (d, J = 
7.9 Hz, 1H), 7.56-7.48 (m, 2H), 7.35 (d, J = 7.9 Hz, 1H), 7.27-7.26 (m, 1H), 3.95 (s, 3H); 
13
C NMR (125.8 MHz, CDCl3): δ 167.6, 147.2, 139.3, 138.3, 134.2, 130.5, 129.7, 129.2, 
128.9, 128.0, 125.3, 112.3, 118.4, 52.3; 
11
B NMR (128.38 MHz, CDCl3) δ 35.5; FT-IR 
(neat): 3352, 1707, 1558, 1427, 1266 cm
-1
; HRMS (ES+) m/z calcd. for C16H14BBrNO2 
(M+H)
+
 342.0301, found 342.0305. 
 
3-Bromo-2-(2,4-difluorophenyl)-2,1-borazaronaphthalene. The title compound was 
obtained as an off-white solid in 92% yield (0.70 mmol scale, 208 mg). mp 93-95 C; 
1
H 
NMR (500 MHz, CDCl3): δ 8.49 (s, 1H), 8.35 (br s, 1H), 7.98-7.94 (m, 1H), 7.63 (d, J = 
8.1 Hz, 1H), 7.52-7.49 (m, 1H), 7.32 (d, J = 8.1 Hz, 1H), 7.28-7.24 (m, 1H), 7.04-6.99 
(m, 1H), 6.92-6.86 (m, 1H); 
13
C NMR (125.8 MHz, CDCl3): δ 165.6 (dd, J = 245, 13 
Hz), 165.5 (dd, J = 206, 13 Hz), 147.2, 138.7, 137.1 (dd, J = 10, 8 Hz), 129.0, 128.7, 
124.9, 122.2, 118.2, 111.1 (dd, J = 19, 4 Hz), 103.5 (dd, J = 29, 24 Hz); 
11
B NMR 
(128.38 MHz, CDCl3) δ 31.3; FT-IR (neat): 2922, 1609, 1560, 1427, 1238 cm
-1
; HRMS 
(CI+) m/z calcd. for C14H9BNBrF2 (M)
+
 318.9979, found 318.9987. 
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3-Bromo-2-(4-dibenzothienyl)-2,1-borazaronaphthalene. The title compound was 
obtained as an off-white solid in 87% yield (0.72 mmol scale, 244 mg). mp 106-108 C; 
1
H NMR (500 MHz, CDCl3): δ 8.56 (s, 1H), 8.52 (br s, 1H), 8.25-8.20 (m, 2H), 7.95 (d, J 
= 7.1 Hz, 1H), 7.87-7.84 (m, 1H), 7.68-7.65 (m, 1H), 7.61-7.57 (m, 1H), 7.50-7.47 (m, 
3H), 7.33-7.29 (m, 2H); 
13
C NMR (125.8 MHz, CDCl3): δ 147.2, 143.2, 139.0, 138.7, 
135.7, 135.0, 132.6, 129.0, 128.7, 126.6, 125.3, 124.4, 124.3, 120.0, 122.6, 122.3, 121.6, 
118.3; 
11
B NMR (128.38 MHz, CDCl3) δ 33.1; FT-IR (neat): 3322, 1616, 1556, 1428 cm
-
1
; HRMS (ES+) m/z calcd. for C20H14BBrNS (M+H)
+
 390.0123, found 390.0129. 
 
1-Allyl-3-bromo-2-(4-methylphenyl)-2,1-borazaronaphthalene. Obtained as an off-
white solid (0.4 mmol scale, 100 mg, 74%). mp: 86-88 °C. 
1
H NMR (500 MHz, acetone-
d6) δ 8.49 (s, 1H), 7.77-7.73 (m, 1H), 7.62-7.54 (m, 2H), 7.38 (d, J = 6.3 Hz, 2H), 7.30-
7.20 (m, 3H), 6.03-5.94 (m, 1H), 5.13 (d, J = 10.3 Hz, 1H), 4.91 (d, J = 17.3 Hz, 1H), 
4.73-4.71 (m, 2H), 2.36 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 146.0, 140.1, 
137.3, 135.2, 131.6, 129.6, 128.9, 128.1, 126.4, 121.8, 117.1, 115.2, 51.4, 20.6. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 37.2. IR (neat) 3013, 2920, 1607, 1367, 918, 764 cm
-1
. 
HRMS (CI) m/z calc. for C18H18BBrN [M+H]
+
 338.0716, found 338.0712. 
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1-Allyl-3-bromo-2-(4-fluorophenyl)-2,1-borazaronaphthalene. Obtained as an off-
white solid (0.74 mmol scale, 141 mg, 56%). mp: 63-65 °C. 
1
H NMR (500 MHz, 
acetone-d6) δ 8.50 (s, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.63-7.50 (m, 4H), 7.32-7.28 (m, 
1H), 7.21-7.16 (m, 2H), 6.04-5.97 (m, 1H), 5.14 (dd, J = 10.5, 1.2 Hz, 1H), 4.91 (dd, J = 
17.4, 1.2 Hz, 1H), 4.71-4.69 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 162.8 (d, J = 
244 Hz), 146.2, 140.0, 135.0, 133.7 (d, J = 8.8 Hz), 129.7, 129.0, 126.4, 122.0, 117.1, 
115.3, 114.3 (d, J = 20.1 Hz), 51.4. 
11
B NMR (128.38 MHz, acetone-d6) δ 36.3. IR (neat) 
3066, 1595, 1370, 920, 764 cm
-1
. HRMS (CI) m/z calc. for C17H14BBrFN [M]
+
 341.0387, 
found 341.0380. 
 
1-Allyl-3-bromo-2-(4-trifluoromethylphenyl)-2,1-borazaronaphthalene. Obtained as 
a yellow oil (1.7 mmol scale, 230 mg, 35%). 
1
H NMR (500 MHz, acetone-d6) δ 8.49 (s, 
1H), 7.77-7.73 (m, 3H), 7.70-7.67 (m, 2H), 7.62-7.56 (m, 2H), 7.32-7.27 (m, 1H), 6.00-
5.95 (m, 1H), 5.13 (d, J = 10.5 Hz, 1H), 4.90 (d, J = 17.4 Hz, 1H), 4.66-4.64 (m, 2H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 146.5, 139.8, 134.7, 132.1, 129.8, 129.4 (q, J = 32 Hz), 
129.2, 126.5, 124.6 (q, J = 271 Hz), 124.0 (q, J = 3.8 Hz), 122.2, 117.0, 115.6, 51.5. 
11
B 
NMR (128.38 MHz, acetone-d6) δ 35.8. IR (neat) 2959, 1323, 1123, 1071, 832, 764 cm
-1
. 
HRMS (CI) m/z calc. for C18H14BBrF3N [M]
+
 391.0355, found 391.0345. 
 
1-Allyl-3-bromo-2-(3-methylphenyl)-2,1-borazaronaphthalene. Obtained as a yellow 
oil (1.7 mmol scale, 505 mg, 88%). 
1
H NMR (500 MHz, acetone-d6) δ 8.48 (s, 1H), 7.74 
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(d, J = 7.8 Hz, 1H), 7.59-7.53 (m, 2H), 7.32-7.26 (m, 4H), 7.19 (d, J = 6.6 Hz, 1H), 6.00-
5.94 (m, 1H), 5.12 (dd, J = 10.5, 1.2 Hz, 1H), 4.90 (dd, J = 17.4, 1.2 Hz, 1H), 4.70-4.68 
(m, 2H), 2.35 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 146.1, 140.0, 136.4, 135.1, 
132.0, 129.6, 129.0, 128.5, 128.5, 127.4, 126.4, 121.8, 117.0, 115.3, 51.4, 20.9. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 37.5. IR (neat) 2980, 1546, 1367, 763, 744 cm
-1
. HRMS (CI) 
m/z calc. for C18H17BBrN [M]
+
 337.0637, found 337.0636. 
 
1-Allyl-3-bromo-2-(3-chlorophenyl)-2,1-borazaronaphthalene. Obtained as a yellow 
oil (1.14 mmol scale, 300 mg, 74%). 
1
H NMR (500 MHz, acetone-d6) δ 8.51 (s, 1H), 7.78 
(dd, J = 7.8, 1 Hz, 1H), 7.63-7.56 (m, 2H), 7.50 (s, 1H), 7.42-7.39 (m, 3H), 7.33-7.29 (m, 
1H), 6.03-5.98 (m, 1H), 5.15 (dd, J = 10.8, 1.2 Hz, 1H), 4.91 (dd, J = 17.4, 1.2 Hz, 1H), 
4.70-4.67 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 146.4, 139.8, 134.8, 133.3, 
131.0, 129.8, 129.7, 129.4, 129.2, 127.8, 126.5, 122.1, 117.1, 115.5, 51.5. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 35.9. IR (neat) 3058, 1545, 1366, 1242, 764 cm
-1
. HRMS 
(CI) m/z calc. for C17H14BNClBr [M]
+
 357.0091, found 357.0098. 
 
1-Allyl-3-bromo-2-(2-methoxyphenyl)-2,1-borazaronaphthalene. Obtained as a 
yellow oil (0.6 mmol scale, 142 mg, 67%). 
1
H NMR (500 MHz, acetone-d6) δ 8.45 (s, 
1H), 7.75 (d, J = 7.6 Hz, 1H), 7.63-7.60 (m, 1H), 7.57-7.53 (m, 1H), 7.39-7.34 (m, 1H), 
7.29-7.25 (m, 2H), 7.02-6.98 (m, 2H), 5.95-5.89 (m, 1H), 5.09 (d, J = 10.5 Hz, 1H), 4.96 
(d, J = 17.4 Hz, 1H), 4.77-4.69 (m, 1H), 4.65-4.58 (m, 1H), 3.72 (s, 3H). 
13
C NMR 
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(125.8 MHz, acetone-d6) δ 160.8, 145.2, 140.0, 135.0, 132.0, 129.6, 129.5, 128.7, 126.5, 
121.7, 120.3, 116.8, 115.4, 109.9, 54.7, 51.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.1. 
IR (neat) 2948, 1596, 1366, 1235, 762 cm
-1
. HRMS (CI) m/z calc. for C18H17BBrNO 
[M]
+
 353.0587, found 353.0598. 
 
1-Allyl-3-bromo-2-(2-naphthyl)-2,1-borazaronaphthalene. Obtained as a yellow oil 
(0.56 mmol scale, 86 mg, 41%). 
1
H NMR (500 MHz, acetone-d6) δ 8.55 (s, 1H), 8.02 (s, 
1H), 7.94-7.89 (m, 3H), 7.8 (dd, J = 7.9, 1.3 Hz, 1H), 7.65-7.57 (m, 3H), 7.53-7.49 (m, 
2H), 7.34-7.30 (m, 1H), 6.04-5.97 (m, 1H), 5.15 (dd, J = 10.5, 1.2 Hz, 1H), 4.94 (dd, J = 
17.4, 1.2 Hz, 1H), 4.75-4.73 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 146.2, 140.0, 
135.1, 133.2. 133.0, 131.3, 129.7, 129.1, 128.9, 128.0, 127.6, 126.6, 126.5, 125.9, 125.8, 
122.0, 117.1, 115.3, 51.5. 
11
B NMR (128.38 MHz, acetone-d6) δ 36.8. IR (neat) 3054, 
1545, 1370, 1226, 819, 764, 748 cm
-1
. HRMS (CI) m/z calc. for C21H17BBrN [M]
+
 
373.0637, found 373.0644. 
 
1-Allyl-3-bromo-2-(3-thienyl)-2,1-borazaronaphthalene. Obtained as an off-white 
solid (1.7 mmol, 210 mg, 37%). mp: 69-71 °C. 
1
H NMR (500 MHz, acetone-d6) δ 8.46 (s, 
1H), 7.76-7.70 (m, 1H), 7.64-7.50 (m, 4H), 7.37-7.26 (m, 2H), 6.08-6.02 (m, 1H), 5.16 
(d, J = 10.3 Hz, 1H), 4.92 (d, J = 17.4 Hz, 1H), 4.75-4.71 (m, 2H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 146.0, 140.2, 135.4, 131.2, 129.6, 129.5, 129.0, 126.3, 124.7, 121.9, 
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117.0, 115.3, 51.5. 
11
B NMR (128.38 MHz, acetone-d6) δ 36.0. IR (neat) 3066, 1545, 
1365, 1237, 763, 707 cm
-1
. HRMS (ESI) m/z calc. for C15H14BBrNS [M+H]
+
 330.0123, 
found 330.0117. 
 
1-Allyl-3-bromo-2-(4-dibenzofuryl)-2,1-borazaronaphthalene. Obtained as an off-
white solid (0.64 mmol scale, 230 mg, 87%). mp: 48-50 °C. 
1
H NMR (500 MHz, 
acetone-d6) δ 8.57 (s, 1H), 8.15-8.10 (m, 2H), 7.84 (d, J = 7.8 Hz, 1H), 7.69-7.67 (m, 
1H), 7.62-7.60 (m, 1H), 7.56 (d, J = 7.1 Hz, 1H), 7.53-7.51 (m, 1H), 7.47-7.43 (m, 2H), 
7.38-7.33 (m, 2H), 5.98-5.90 (m, 1H), 5.06 (dd, J = 10.5, 1.2 Hz, 1H), 4.94 (dd, J = 17.4, 
1.2 Hz, 1H), 4.84-4.79 (m, 1H), 4.72-4.68 (m, 1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 
157.5, 156.0, 146.1, 140.0, 134.7, 130.3, 129.8, 129.1, 127.1, 126.7, 124.2, 122.9, 122.7, 
122.7, 122.2, 120.8, 120.8, 117.0, 115.6, 111.4, 51.9. 
11
B NMR (128.38 MHz, acetone-
d6) δ 37.2. IR (neat) 3055, 2910, 1368, 1187, 757 cm
-1
. HRMS (CI) m/z calc. for 
C23H17BBrNO [M]
+
 413.0587, found 413.0570. 
 
3-Bromo-1-butyl-2-phenyl-2,1-borazaronaphthalene. Obtained as an off-white solid (1 
mmol scale, 242 mg, 71%,). mp: 55-57 °C. 
1
H NMR (500 MHz, acetone-d6) δ 8.45 (s, 
1H), 7.78-7.71 (m, 2H), 7.64-7.58 (m, 1H), 7.50-7.35 (m, 5H), 7.33-7.27 (m, 1H), 4.09-
4.04 (m, 2H), 1.72-1.66 (m, 2H), 1.23-1.17 (m, 2H), 0.77-0.73 (m, 3H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 145.7, 139.9, 131.4, 129.9, 129.1, 127.5, 127.4, 126.6, 121.7, 116.0, 
48.6, 31.9, 19.6, 12.9. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.4. IR (neat) 3066, 3032, 
437 
 
1596, 1223, 765 cm
-1
. HRMS (CI) m/z calc. for C18H19BrBN [M]
+
 339.0794, found 
339.0807. 
 
3-Bromo-1-cyclopropylmethyl-2-phenyl-2,1-borazaronaphthalene. Obtained as an 
off-white solid (3 mmol scale, 371 mg, 37%). mp: 73-75 °C.  
1
H NMR (500 MHz, 
acetone-d6) δ 8.45 (s, 1H), 7.87 (d, J = 8.8 Hz, 1H), 7.78-7.75 (m, 1H), 7.65-7.61 (m, 
1H), 7.48-7.30 (m, 6H), 4.05 (d, J = 6.4 Hz, 2H), 1.24-1.20 (m, 1H), 0.37-0.33 (m, 2H), 
-
0.02-
-
0.05 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.8, 140.2, 132.0, 129.8, 
129.1, 127.6, 127.4, 126.6, 121.8, 116.6, 52.4, 11.0, 4.0. 
11
B NMR (128.38 MHz, 
acetone-d6) δ 37.2. IR (neat) 3008, 1546, 1363, 764, 704 cm
-1
. HRMS (CI) m/z calc. for 
C18H18BBrN [M+H]
+
 338.0716, found 338.0714. 
 
General Procedure For the Dibromination of 2,1-Borazaronaphthalenes. To a flame-
dried 100 mL round bottom flask with a stir bar was added the corresponding 2,1-
borazaronaphthalene (2.0 mmol). The flask was sealed with a rubber septum and 
evacuated under vacuum and purged with Ar three times. Anhydrous CH2Cl2 was added 
(10 mL), and the flask was cooled to 0 °C. Bromine (703 mg, 4.4 mmol, 2.2 equiv) in 
CH2Cl2 (10 mL) was added under Ar at a rate of 1.1 mmol/h. After the addition, the 
reaction was slowly warmed to rt. The reaction was monitored by TLC. When complete 
(usually after warming to rt), the reaction was concentrated in vacuo. The crude 2,1-
borazaronaphthalene was purified by flash column chromatography with 0-30% 
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CH2Cl2/hexane as the eluent to provide the desired 3,6-dibromo-2,1-
borazaronaphthalene. 
 
3,6-Dibromo-2-methyl-2,1-borazaronaphthalene (4.78). Obtained as an off-white solid 
(822 mg, 92%, 3 mmol scale). mp: 80-82 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.70 (br 
s, 1H), 8.26-8.22 (m, 1H), 7.77 (s, 1H), 7.52-7.50 (m, 1H), 7.40-7.38 (m, 1H), 0.78 (s, 
3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 143.2, 139.1, 131.2, 130.5, 126.4, 120.2, 
113.1. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.5. IR (neat) 3350, 2961, 1554, 1423, 
1195, 911, 861, 811 cm
-1
. HRMS (CI) m/z calc. for C9H8Br2BN [M]
+
 298.9117, found 
298.9125. 
 
1-Benzyl-3,6-dibromo-2-phenyl-2,1-borazaronaphthalene. Obtained as an off-white 
solid (710 mg, 95%, 2 mmol scale). mp: 156-158 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.38 
(s, 1H), 7.79 (s, 1H), 7.47-7.42 (m, 3H), 7.38-7.35 (m, 3H), 7.32-7.20 (m, 4H), 7.05-7.02 
(m, 2H), 5.32 (s, 2H). 
13
C NMR (125.8 MHz, CDCl3) δ 145.1, 138.9, 137.8, 131.5, 131.4, 
128.8, 128.2, 128.1, 127.6, 127.1, 125.5, 123.7, 119.1, 114.7, 53.6. 
11
B NMR (128.38 
MHz, CDCl3) δ 34.4. IR (neat) 3065, 3029, 2920, 1536, 1367, 1355, 1242, 816 cm
-1
. 
HRMS (CI) m/z calc. for C21H16BBr2N [M]
+
 450.9743, found 450.9748. 
 
General Procedure for the Cross-Coupling of 3-Bromo-2,1-Borazaronaphthalenes. 
In a Biotage microwave vial equipped with a stir bar was successively introduced t-Bu3P-
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Pd-G2 (3.8 mg, 7.5 μmol, 1 mol %), potassium (hetero)aryltrifluoroborate (0.75 mmol, 1 
equiv), 3-bromo-2-methyl-2,1-borazaronaphthalene (167 mg, 0.75 mmol, 1 equiv) and 
Cs2CO3 (731 mg, 2.25 mmol, 3 equiv). The vial was sealed with a cap lined with a 
disposable Teflon septum, evacuated under vacuum, and purged with Ar three times. 
Degassed CPME (0.75 mL) and degassed H2O (0.75 mL) were added under Ar. The 
resulting mixture was heated at 60 °C and stirred for 18 h. After cooling to rt, the vial 
was uncapped, and the reaction mixture was diluted with EtOAc (3 mL) and H2O (3 mL). 
The reaction mixture was extracted with EtOAc (3 x 3 mL) and dried (MgSO4). The 
solvent was removed in vacuo, and the product was purified by rapid flash column 
chromatography on silica gel or neutral alumina using a 0 to 20% CH2Cl2/hexane as the 
eluent for most 2,1-borazaronaphthalenes. Several heteroarylated 2,1-
borazaronaphthalenes required 20-80% CH2Cl2/hexane as the eluent. The cross-couplings 
for Tables 5-8 were completed on a 0.5 mmol scale. The products of the self-arylation 
were purified by flash column chromatography with Florisil. 
 
 
3-Phenyl-2-methyl-2,1-borazaronaphthalene (4.79). Obtained as a yellow oil (161 mg, 
98%). 
1
H NMR (500 MHz, acetone-d6) δ 9.41 (br s, 1H), 7.91 (s, 1H), 7.69 (d, J = 7.69 
Hz, 1H), 7.51-7.45 (m, 3H), 7.43-7.40 (m, 3H), 7.30-7.27 (m, 1H), 7.17-7.14 (m, 1H), 
0.84 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.0, 141.2, 140.3, 129.3, 128.1, 
128.0, 127.9, 125.8, 125.0, 120.5, 117.5. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.3. IR 
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(neat) 3373, 3054, 1613, 1563, 1454, 1421, 756, 700 cm
-1
. HRMS (CI) m/z calc. for 
C15H14BN [M]
+
 219.1219, found 219.1223. 
 
3-(3-Methoxyphenyl)-2-methyl-2,1-borazaronaphthalene (4.80). Obtained as a yellow 
oil (177 mg, 95%). 
1
H NMR (500 MHz, acetone-d6) 9.43 (br s, 1H), 7.93 (s, 1H), 7.69 (d, 
J = 7.6 Hz, 1H), 7.49 (d, J = 8.3 Hz, 1H), 7.42-7.38 (m, 1H), 7.34-7.30 (m, 1H), 7.17-
7.13 (m, 1H), 7.04-7.00 (m, 2H), 6.88-6.85 (m, 1H), 3.83 (s, 3H), 0.81 (s, 3H). 
13
C NMR 
(125.8 MHz, acetone-d6) δ 159.7, 146.5, 141.1, 140.3, 129.3, 129.0, 127.9, 124.9, 120.5, 
120.5, 117.5, 113.7, 111.3, 54.5. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.4. IR (neat) 
3346, 3001, 1573, 1461, 1225, 1019, 753 cm
-1
. HRMS (CI) m/z calc. for C16H16BNO 
[M]
+
 249.1325, found 249.1325. 
 
3-(2-Methoxyphenyl)-2-methyl-2,1-borazaronaphthalene (4.81). Obtained as a yellow 
oil (176 mg, 94%). 
1
H NMR (500 MHz, acetone-d6) δ 9.28 (br s, 1H), 7.76 (s, 1H), 7.64 
(d, J = 7.6 Hz, 1H), 7.48 (d, J = 8.3 Hz, 1H), 7.40-7.37 (m, 1H), 7.29-7.26 (m, 1H), 7.21-
7.19 (m, 1H), 7.14-7.11 (m, 1H), 7.01-6.98 (m, 2H), 3.74 (s, 3H), 0.62 (s, 3H). 
13
C NMR 
(125.8 MHz, acetone-d6) δ 156.5, 141.0, 140.3, 134.4, 129.5, 129.0, 127.6, 127.5, 125.0, 
120.4, 120.3, 117.5, 110.4, 54.5. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.6. IR (neat) 
3372, 2997, 2939, 2832, 1596, 1458, 1417, 1220, 759, 750, 702 cm
-1
. HRMS (CI) m/z 
calc. for C16H16BNO [M]
+
 249.1325, found 249.1317. 
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3-(1-(4-Naphthyl)-phenyl)-2-methyl-2,1-borazaronaphthalene (4.82). Reaction 
performed with a concentration of 0.1 M. Obtained as an off-white solid (173 mg, 67%). 
mp: 73-75 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.49 (br s, 1H), 8.03-8.01 (m, 2H), 
8.00-7.98 (m, 1H), 7.97-7.95 (m, 1H), 7.73-7.71 (m, 1H), 7.60-7.57 (m, 2H), 7.53-7.45 
(m, 8H), 7.17-7.15 (m, 1H), 0.91 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.1, 
141.4, 140.4, 140.1, 138.2, 134.0, 131.6, 129.8, 129.7, 129.3, 128.3, 128.1, 128.0, 127.5, 
126.8, 126.0, 125.7, 125.6, 125.4, 125.0, 120.6, 117.5. 
11
B NMR (128.38 MHz, acetone-
d6) δ 37.4. IR (neat) 3375, 3051, 1614, 1565, 1425, 1220, 844, 800, 777, 759 cm
-1
. 
HRMS (CI) m/z calc. for C25H20BN [M]
+
 345.1989, found 345.1690. 
 
3-(4-Methylphenyl)-2-methyl-2,1-borazaronaphthalene (4.83). Obtained as an off-
white solid (156 mg, 89%). mp: 53-55 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.41 (br s, 
1H), 7.88 (s, 1H), 7.67 (d, J = 7.8 Hz, 1H), 7.48 (d, J = 7.48 Hz, 1H), 7.40-7.37 (m, 1H), 
7.35-7.33 (m, 2H), 7.21-7.19 (m, 2H), 7.15-7.12 (m, 1H), 2.35 (s, 3H), 0.81 (s, 3H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 142.0, 140.7, 140.2, 135.1, 129.2, 128.7, 127.9, 127.7, 
125.0, 120.5, 117.5, 20.2. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.5. IR (neat) 3383, 
3022, 2938, 1613, 1566, 1454, 1425, 879, 822, 759, 749 cm
-1
. HRMS (CI) m/z calc. for 
C16H16BN [M]
+
 233.1376, found 233.1374. 
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3-(1-Naphthyl)-2-methyl-2,1-borazaronaphthalene (4.84). Obtained as a yellow oil 
(187 mg, 93%). mp: 58-60 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.55 (br s, 1H), 7.93 (d, 
J = 8.1 Hz, 1H), 7.87 (s, 1H), 7.84-7.82 (m, 1H), 7.78 (d, J = 8.6 Hz, 1H), 7.70-7.76 (m, 
1H), 7.59-7.55 (m, 1H), 7.54-7.51 (m, 1H), 7.49-7.44 (m, 2H), 7.41-7.37 (m, 1H), 7.34-
7.31 (m, 1H), 7.20-7.16 (m, 1H), 0.49 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 
143.4, 142.3, 140.6, 133.8, 131.8, 129.2, 128.1, 128.0, 127.7, 136.4, 126.3, 125.7, 125.5, 
125.4, 125.3, 124.8, 120.6, 117.7. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.6. IR (neat) 
3369, 3053, 2980, 1613, 1566, 1421, 777, 759 cm
-1
. HRMS (CI) m/z calc. for C19H16BN 
[M]
+
 269.1376, found 269.1368. 
 
3-(2-Naphthyl)-2-methyl-2,1-borazaronaphthalene (4.85). Obtained as a colorless 
solid (192 mg, 95%). mp: 87-89 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.50 (br s, 1H), 
8.04 (s, 1H), 7.95-7.85 (m, 4H), 7.74-7.71 (m, 1H), 7.67-7.64 (m, 1H), 7.54-7.51 (m, 
1H), 7.50-7.41 (m, 3H), 7.19-7.16 (m, 1H), 0.81 (s, 3H). 
13
C NMR (125.8 MHz, acetone-
d6) δ 142.7, 141.6, 140.4, 133.8, 132.1, 129.3, 128.0, 127.8, 127.7, 127.5, 127.3, 126.1, 
125.9, 125.7, 125.2, 125.0, 120.1, 117.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.3. IR 
(neat) 3366, 3053, 2979, 1561, 1308, 758, 744 cm
-1
. HRMS (CI) m/z calc. for C19H16BN 
[M]
+
 269.1376, found 269.1372. 
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3-(3-Vinylphenyl)-2-methyl-2,1-borazaronaphthalene (4.86). Obtained as a yellow oil 
(128 mg, 71%). 
1
H NMR (500 MHz, acetone-d6) δ 9.45 (br s, 1H), 7.93 (s, 1H), 7.73-7.69 
(m, 1H), 7.56-7.47 (m, 2H), 7.44-7.34 (m, 4H), 7.17-7.13 (m, 1H), 6.86-6.80 (m, 1H), 
5.86 (d, J = 17.4 Hz, 1H), 5.25 (d, J = 10.8 Hz, 1H), 0.81 (s, 3H). 
13
C NMR (125.8 MHz, 
acetone-d6) δ 145.3, 141.2, 140.3, 137.4, 137.2, 129.2, 128.2, 127.9, 127.7, 125.9, 124.9, 
123.6, 120.5, 117.5, 113.0. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.4. IR (neat) 2917, 
2848, 1596, 1422, 1161, 1036, 761 cm
-1
. HRMS (CI) m/z calc. for C16H16BNO [M]
+
 
249.1325, found 249.1325. 
 
3-(3-Methoxy-5-trifluoromethylphenyl)-2-methyl-2,1-borazaronaphthalene (4.87). 
Obtained as a yellow oil (174 mg, 73%). 
1
H NMR (500 MHz, acetone-d6) δ 9.53 (br s, 
1H), 8.00 (s, 1H), 7.72 (d, J = 7.6 Hz, 1H), 7.51-7.48 (m, 1H), 7.46-7.42 (m, 1H), 7.34 (s, 
1H), 7.26 (s, 1H), 7.19-7.15 (m, 2H), 3.93 (s, 3H), 0.81 (s, 3H). 
13
C NMR (125.8 MHz, 
acetone-d6) δ 160.0, 147.7, 142.0, 140.1, 130.9 (q, J = 32 Hz), 129.5, 128.4, 126.6 (q, J = 
260 Hz), 124.6, 120.6, 117.6, 117.4, 116.8 (q, J = 3.7 Hz), 107.9 (q, J = 3.7 Hz), 55.0. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.4. IR (neat) 3378, 2940, 2842, 1598, 1354, 
1121, 1057, 759, 692 cm
-1
. HRMS (CI) m/z calc. for C17H15BNOF3 [M]
+
 317.1199, 
found 317.1207. 
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3-(3-Nitrophenyl)-2-methyl-2,1-borazaronaphthalene (4.88). Obtained as an off white 
solid (105 mg, 53%). mp: 135-137 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.56 (br s, 1H), 
8.26 (s, 1H), 8.13 (d, J = 7.8 Hz, 1H), 8.00 (s, 1H), 7.85 (d, J - 7.6 Hz, 1H), 7.72 (d, J = 
7.8 Hz, 1H), 7.67-7.64 (m, 1H), 7.51-7.48 (m, 1H), 7.47-7.42 (m, 1H), 7.18-7.15 (m, 1H), 
0.80 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 148.4, 146.7, 142.5, 140.6, 134.4, 
129.6, 129.3, 128.6, 124.5, 122.3, 120.7, 120.5, 117.6. 
11
B NMR (128.38 MHz, acetone-
d6) δ 37.5. IR (neat) 3376, 3054, 2967, 1609, 1579, 1417, 1253, 879, 759, 749, 698 cm
-1
. 
HRMS (CI) m/z calc. for C15H13BN2O2 [M]
+
 264.1070, found 264.1080. 
 
3-(3-Carbomethoxyphenyl)-2-methyl-2,1-borazaronaphthalene (4.89). Obtained as a 
yellow oil (182 mg, 88%). 
1
H NMR (500 MHz, acetone-d6) δ 9.45 (br s, 1H), 8.18 (s, 
1H), 7.93 (s, 2H), 7.73-7.69 (m, 2H), 7.52-7.47 (m, 2H), 7.44-7.42 (m, 1H), 7.17-7.13 
(m, 1H), 3.90 (s, 3H), 0.80 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 166.6, 145.3, 
141.7, 140.5, 132.6, 130.2, 129.4, 128.9, 128.3, 128.2, 126.7, 124.8, 120.6, 117.6, 51.4. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.4. IR (neat) 3354, 3051, 2949, 1711, 1567, 
1436, 1306, 756 cm
-1
. HRMS (ESI) m/z calc. for C17H17BNO2 [M+H]
+
 278.1352, found 
278.1342. 
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3-(3-Fluorophenyl)-2-methyl-2,1-borazaronaphthalene (4.90). Obtained as a yellow 
oil (160 mg, 90%). 
1
H NMR (500 MHz, acetone-d6) δ 9.48 (br s, 1H), 7.93 (s, 1H), 7.69 
(d, J = 7.6 Hz, 1H), 7.49 (d, J = 8.1 Hz, 1H), 7.43-7.40 (m, 2H), 7.27-7.24 (m, 1H), 7.20-
7.13 (m, 2H), 7.05-7.02 (m, 1H), 0.81 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 163.8 
(d, J = 248 Hz), 147.6 (d, J = 7.6 Hz), 141.7, 140.5, 129.70 (d, J = 8.8 Hz), 129.3, 128.2, 
124.7, 120.1 (d, J = 2.5 Hz), 120.6, 117.6, 116.5 (d, J = 20.1 Hz), 112.3 (d, J = 11.2 Hz). 
11
B NMR (128.38 MHz, acetone-d6) δ 37.0. IR (neat) 3376, 3054, 2967, 1609, 1579, 
1417, 1253, 879, 759, 749, 698 cm
-1
. HRMS (CI) m/z calc. for C15H13BNF [M]
+
 
237.1125, found 237.1120. 
 
3-(4-Trifluoromethylphenyl)-2-methyl-2,1-borazaronaphthalene (4.91). Obtained as 
an off-white solid (156 mg, 88%). mp: 116-118 °C. 
1
H NMR (500 MHz, acetone-d6) 9.54 
(br s, 1H), 7.95 (s, 1H), 7.73-7.69 (m, 3H), 7.63-7.61 (m, 2H), 7.52-7.49 (m, 1H), 7.45-
7.42 (m, 1H), 7.17-7.14 (m, 1H), 0.80 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 
149.2, 142.2, 140.6, 129.5, 128.6, 128.5, 127.3 (q, J = 32 Hz), 124.8 (q, J = 276 Hz), 
124.9 (q, J = 3.8 Hz), 123.7, 120.7, 117.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.1. IR 
(neat) 3346, 3030, 1614, 1334, 1325, 110, 1071, 762, 755 cm
-1
. HRMS (CI) m/z calc. for 
C16H13BNF3 [M]
+
 287.1093, found 287.1093. 
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3-(3-Cyanophenyl)-2-methyl-2,1-borazaronaphthalene (4.92). Obtained as an off-
white solid (145 mg, 79%). mp: 61-63 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.59 (br s, 
1H), 8.00 (s, 1H), 7.81 (s, 1H), 7.78-7.73 (m, 2H), 7.70-7.67 (m, 1H), 7.65-7.60 (m, 1H), 
7.52-7.49 (m, 1H), 7.46-7.43 (m, 1H), 7.17-7.14 (m, 1H), 0.79 (s, 3H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 146.3, 142.3, 140.6, 132.7, 131.3, 129.5, 129.3, 129.2, 128.5, 124.6, 
120.7, 118.7, 117.6, 112.1. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.5. IR (neat) 3338, 
2980, 1558, 1260, 1088, 945, 793 cm
-1
. HRMS (CI) m/z calc. for C16H13BN2 [M]
+
 
244.1172, found 244.1174. 
 
3-(7-N-Boc-Indolyl)-2-methyl-2,1-borazaronaphthalene (4.93). Obtained as an off-
white solid (150 mg, 56%). mp: 80-82 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.42 (br s, 
1H), 8.20 (d, J = 8.3 Hz, 1H), 7.94 (s, 1H), 7.70-7.67 (m, 1H), 7.66-7.64 (m, 2H), 7.50-
7.48 (m, 1H), 7.44-7.38 (m, 2H), 7.16-7.13 (m, 1H), 6.69-6.67 (m, 1H), 1.69 (s, 9H), 0.83 
(s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 149.4, 141.0, 140.2, 139.7, 133.8, 130.8, 
129.1, 127.7, 126.0, 125.0, 124.8, 120.5, 120.0, 117.5, 114.5, 107.4, 83.3, 27.3. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 37.5. IR (neat) 3375, 2976, 1730, 1370, 1160, 1134, 759, 
749, 727 cm
-1
. HRMS (CI) m/z calc. for C22H23BN2O2 [M]
+
 358.1853, found 358.1856. 
 
3-(3-Thienyl)-2-methyl-2,1-borazaronaphthalene (4.94). Obtained as an off-white 
solid (145 mg, 86%). mp: 62-64 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.41 (br s, 1H). 
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8.10 (s, 1H), 7.67-7.64 (m, 1H), 7.47-7.44 (m, 2H), 7.40-7.37 (m, 3H), 7.16-7.13 (m, 
1H), 0.90 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 145.8, 140.41, 140.4, 129.4, 
128.1, 128.0, 128.0, 125.2, 120.8, 120.8, 117.9. 
11
B NMR (128.38 MHz, acetone-d6) δ 
37.2. IR (neat) 3372, 3052, 2938, 1612, 1563, 1426, 878, 777, 758, 748 cm
-1
. HRMS (CI) 
m/z calc. for C13H12BNS [M]
+
 225.0784, found 225.0789. 
 
3-(2-Thienyl)-2-methyl-2,1-borazaronaphthalene (4.95). Obtained as a yellow oil (142 
mg, 84%). 
1
H NMR (500 MHz, acetone-d6) δ 9.50 (br s, 1H), 8.13 (s, 1H), 7.68 (d, J = 
7.8 Hz, 1H), 7.47-7.44 (m, 1H), 7.42-7.39 (m, 1H), 7.36-7.34 (m, 1H), 7.28-7.25 (m, 1H), 
7.16-7.13 (m, 1H), 7.11-7.08 (m, 1H), 0.95 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 
147.7, 140.1, 139.8, 129.1, 128.0, 127.6, 124.6, 124.5, 123.9, 120.8, 117.5. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 37.0. IR (neat) 3371, 3056, 2945, 1612, 1560, 1426, 1336, 
877, 757, 693 cm
-1
. HRMS (CI) m/z calc. for C13H12BNS [M]
+
 225.0784, found 
225.0784. 
 
3-(4-(3,5-Dimethylisoxazolyl))-2-methyl-2,1-borazaronaphthalene (4.96). Obtained as 
an off white solid (91 mg, 51%). mp: 69-71 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.58 
(br s, 1H), 8.27 (s, 1H), 7.6 (d, J = 7.3 Hz, 1H), 7.47-7.41 (m, 2H), 7.16-7.13 (m, 1H), 
1.58 (s, 3H), 1.39 (s, 3H), 0.81 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 163.1, 
158.3, 144.1, 140.6, 129.1, 128.3, 124.5, 120.5, 118.3, 117.7, 10.5, 9.7. 
11
B NMR (128.38 
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MHz, acetone-d6) δ 38.1. IR (neat) 3372, 3052, 2967, 1613, 1566, 1449, 1187, 777, 749 
cm
-1
. HRMS (CI) m/z calc. for C14H15BN2O [M]
+
 238.1277, found 238.1283. 
 
3-(3-Furanyl)-2-methyl-2,1-borazaronaphthalene (4.97). Obtained as a yellow oil (113 
mg, 72%). 
1
H NMR (500 MHz, acetone-d6) δ 9.41 (br s, 1H), 8.09 (s, 1H), 7.79 (s, 1H), 
7.67-7.65 (m, 1H), 7.61-7.58 (m, 1H), 7.47-7.43 (m, 1H), 7.38-7.35 (m, 1H), 7.14-7.11 
(m, 1H), 6.87-6.89 (m, 1H), 0.89 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 142.9, 
139.9, 139.7, 138.8, 128.9, 128.6, 127.5, 124.9, 120.5, 117.4, 109.4. 
11
B NMR (128.38 
MHz, acetone-d6) δ 37.5. IR (neat) 3362, 2932, 1614, 1426, 1031, 872, 760 cm
-1
. HRMS 
(CI) m/z calc. for C13H12BNO [M]
+
 209.1012, found 209.1006. 
 
3-(4-Dibenzofuranyl)-2-methyl-2,1-borazaronaphthalene (4.98). Reaction performed 
with a concentration of 0.1 M. Obtained as an off white solid (125 mg, 54%). mp: 63-65 
°C. 
1
H NMR (500 MHz, acetone-d6) δ 9.56 (br s, 1H), 8.13 (s, 1H), 8.09 (d, J = 7.6 Hz, 
1H), 8.00 (dd, J = 7.1 Hz, 1.5 Hz, 1H), 7.74-7.71 (m, 1H), 7.59-7.54 (m, 2H), 7.49-7.41 
(m, 4H), 7.38-7.34 (m, 1H), 7.19-7.17 (m, 1H), 0.73 (s, 3H). 
13
C NMR (125.8 MHz, 
acetone-d6) δ 155.9, 153.5, 142.8, 140.6, 129.8, 129.4, 128.3, 127.6, 127.0, 124.7, 124.4, 
123.9, 123.0, 122.7, 120.7, 120.6, 118.6, 117.7, 111.4. 
11
B NMR (128.38 MHz, acetone-
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d6) δ 37.6. IR (neat) 3374, 3052, 2968, 1614, 1566, 1425, 1187, 777, 749 cm
-1
. HRMS 
(CI) m/z calc. for C21H16BNO [M]
+
 309.1325, found 309.1313. 
 
3-(4-Dibenzothienyl)-2-methyl-2,1-borazaronaphthalene (4.99). Reaction performed 
with a concentration of 0.1 M. Obtained as an off white solid (127 mg, 52%). mp: 62-64 
°C. 
1
H NMR (500 MHz, acetone-d6) δ 9.63 (br s, 1H), 8.31 (d, J = 7.8 Hz, 1H), 8.22 (d, J 
= 7.8 Hz, 1H), 8.10 (s, 1H), 7.90-7.88 (m, 1H), 7.72-7.70 (m, 1H), 7.59-7.54 (m, 2H), 
7.50-7.45 (m, 3H), 7.38-7.35 (m, 1H), 7.21-7.18 (m, 1H), 0.66 (s, 3H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 142.1, 140.8, 140.2, 139.5, 138.6, 136.1, 135.5, 129.4, 128.5, 126.6, 
126.4, 124.8, 124.4, 124.3, 122.5, 121.8, 120.7, 119.3, 117.7. 
11
B NMR (128.38 MHz, 
acetone-d6) δ 38.2. IR (neat) 3366, 3056, 2980, 1707, 1567, 1440, 1021, 749 cm
-1
. HRMS 
(CI) m/z calc. for C21H16BNS [M]
+
 325.1097, found 325.1086. 
 
3-(3-Methoxyphenyl)-2-methyl-1-benzyl-2,1-borazaronaphthalene (4.100). Obtained 
as a yellow oil (157 mg, 93%). 
1
H NMR (500 MHz, acetone-d6) 7.92 (s, 1H), 7.74 (d, J = 
7.6 Hz, 1H), 7.42 (d, J = 8.3 Hz, 1H), 7.35-7.27 (m, 4H), 7.23-7.21 (m, 1H), 7.20-7.16 
(m, 3H), 7.01-6.98 (m, 2H), 6.90-6.87 (m, 1H), 5.44 (s, 2H), 3.83 (s, 3H), 0.86 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 159.6, 146.8, 141.8, 141.0, 138.5, 130.3, 128.9, 
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128.6, 128.3, 126.7, 126.1, 125.7, 120.9, 120.8, 115.8, 114.1, 111.3, 54.5, 50.9. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 39.5. IR (neat) 3027, 1734, 1604, 1368, 1046, 727 cm
-1
. 
HRMS (CI) m/z calc. for C23H22BNO [M]
+
 339.1794, found 339.1786. 
 
3-(3-Methoxyphenyl)-2-methyl-1-allyl-2,1-borazaronaphthalene (4.101). Obtained as 
a yellow oil (120 mg, 83%). 
1
H NMR (500 MHz, acetone-d6) 7.85 (s, 1H), 7.72 (d, J = 
7.3 Hz, 1H), 7.56-7.53 (m, 1H), 7.49-7.45 (m, 1H), 7.33-7.28 (m, 1H), 7.21-7.17 (m, 1H), 
6.95-6.93 (m, 2H), 6.88-6.84 (m, 1H), 6.14-6.07 (m, 1H), 5.13 (d, J = 10.5 Hz, 1H), 4.97 
(d, J = 17.4 Hz, 1H), 4.81-4.79 (m, 2H), 3.83 (s, 3H), 0.84 (s, 3H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 159.6, 146.8, 141.5, 140.8, 134.7, 130.3, 128.9, 128.2, 125.9, 120.8, 
120.6, 115.4, 114.7, 114.0, 111.2, 54.5, 49.3. 
11
B NMR (128.38 MHz, acetone-d6) δ 39.3. 
IR (neat) 3648, 2979, 1734, 1367, 1047, 761 cm
-1
. HRMS (CI) m/z calc. for C19H20BNO 
[M]
+
 289.1638, found 289.1649. 
 
3-(3-Methoxyphenyl)-2-(β,β,β-trifluoroethyl)-2,1-borazaronaphthalene (4.102). 
Obtained as a yellow oil (71 mg, 67%). 
1
H NMR (500 MHz, acetone-d6) δ 9.66 (br s, 
1H), 8.03 (s, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.70 (d, J = 8.1 Hz, 1H), 7.51-7.48 (m, 1H), 
7.37-7.33 (m, 1H), 7.28-7.24 (m, 1H), 6.98-6.96 (m, 2H), 6.91-6.88 (m, 1H), 3.84 (s, 
3H), 2.48 (q, J = 14.2 Hz, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 159.9, 145.6, 143.0, 
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139.7, 129.4, 129.2, 128.9 (q, J = 272 Hz), 128.5, 125.0, 121.6, 120.5, 118.2, 113.7, 
111.6, 54.5. 
11
B NMR (128.38 MHz, acetone-d6) δ 33.6. IR (neat) 3408, 2961, 1699, 
1596, 1240, 1038, 760 cm
-1
. HRMS (ESI) m/z calc. for C17H14BNOF3 [M-H]
-
 316.1121, 
found 345.1120. 
 
3-(3-Methoxyphenyl)-2-isopropyl-2,1-borazaronaphthalene (4.103). Obtained as a 
yellow oil (107 mg, 77%). 
1
H NMR (500 MHz, acetone-d6) δ 9.12 (br s, 1H), 7.87 (s, 
1H), 7.67 (d, J = 7.6 Hz, 1H), 7.61 (d, J = 8.1 Hz, 1H), 7.42-7.39 (m, 1H), 7.33-7.30 (m, 
1H), 7.17-7.14 (m, 1H), 6.98-6.96 (m, 2H), 6.88-6.86 (m, 1H), 3.83 (s, 3H), 1.93-1.90 
(m, 1H), 1.10-1.07 (m, 6H). 
13
C NMR (125.8 MHz, acetone-d6) δ 159.6, 146.9, 142.1, 
140.3, 129.1, 128.9, 127.9, 124.7, 120.7, 120.4, 117.9, 113.7, 111.1, 54.5, 19.3. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 38.5. IR (neat) 3380, 2938, 1732, 1574, 1461, 1280, 760 cm
-
1
. HRMS (CI) m/z calc. for C18H20BNO [M]
+
 277.1638, found 277.1637. 
 
3-(3-Methoxyphenyl)-2-cyclopropyl-2,1-borazaronaphthalene (4.104). Obtained as 
yellow oil (115 mg, 84%). 
1
H NMR (500 MHz, acetone-d6) δ 8.64 (br s, 1H), 7.88 (s, 
1H), 7.66 (d, J = 7.8 Hz, 1H), 7.48 (d, J = 8.3 Hz, 1H), 7.37-7.31 (m, 2H), 7.15-7.10 (m, 
3H), 6.68-6.65 (m, 1H), 3.83 (s, 3H), 0.83-0.80 (m, 2H), 0.75-0.72 (m, 2H), 0.54-0.50 
(m, 1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 159.6, 146.3, 141.0, 140.4, 129.2, 128.9, 
127.9, 124.7, 120.7, 120.4, 117.6, 113.9, 111.3, 54.5, 6.4. 
11
B NMR (128.38 MHz, 
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acetone-d6) δ 37.6. IR (neat) 3382, 2993, 1597, 1464, 1258, 1046, 760 cm
-1
. HRMS (CI) 
m/z calc. for C18H18BNO [M]
+
 275.1481, found 375.1468. 
 
3-(3-Methoxyphenyl)-2-cyclobutyl-2,1-borazaronaphthalene (4.105). Obtained as 
yellow oil (101 mg, 70%). 
1
H NMR (500 MHz, acetone-d6) δ 9.18 (br s, 1H), 7.88 (s, 
1H), 7.68 (d, J = 7.6 Hz, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.43-7.40 (m, 1H), 7.30-7.27 (m, 
1H), 7.17-7.14 (m, 1H), 6.96-6.92 (m, 2H), 6.86-6.83 (m, 1H), 3.82 (s, 3H), 2.75-2.70 
(m, 1H), 2.12-2.04 (m, 5H), 1.93-1.85 (m, 1H). 
13
C NMR (125.8 MHz, acetone-d6) δ 
159.6, 146.5, 141.6, 140.2, 129.2, 128.8, 127.9, 124.9, 120.7, 120.3, 117.8, 113.4, 111.2, 
54.5, 25.6, 21.5. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.4. IR (neat) 3381, 2962, 1596, 
1461, 1046, 758, 703 cm
-1
. HRMS (CI) m/z calc. for C19H20BNO [M]
+
 289.1638, found 
289.1635. 
 
2,3-Diphenyl-2,1-borazaronaphthalene (4.106). Obtained as a white solid oil (108 mg, 
77%). mp: 106-108 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.70 (br s, 1H), 8.07 (s, 1H), 
7.79 (d, J = 7.8 Hz, 1H), 7.73-7.70 (m, 1H), 7.50-7.45 (m, 3H), 7.31-7.22 (m, 9H).
13
C 
NMR (125.8 MHz, acetone-d6) δ 144.6, 143.3, 140.4, 133.5, 129.3, 128.6, 128.3, 128.1, 
127.8, 127.3, 125.8, 125.2, 121.1, 118.2. 
11
B NMR (128.38 MHz, acetone-d6) δ 35.3. IR 
(neat) 3371, 3051, 2923, 1560, 1420, 1307, 756 cm
-1
. HRMS (CI) m/z calc. for C20H16BN 
[M]
+
 281.1376, found 281.1371. 
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3-(4-Fluorophenyl)-2-phenyl-2,1-borazaronaphthalene (4.107). Obtained as a yellow 
oil (106 mg, 71%). 
1
H NMR (500 MHz, acetone-d6) δ 9.70 (br s, 1H), 8.06 (s, 1H), 7.77-
7.75 (m, 1H), 7.71 (d, J = 8.1 Hz, 1H), 7.48-7.45 (m, 3H), 7.31-7.24 (m, 6H), 7.06-7.01 
(m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 161.6 (d, J = 243 Hz), 143.4, 140.8 (d, J = 
2.5 Hz), 140.4, 133.4, 130.3 (d, J = 7.5 Hz), 129.4, 128.4, 128.2, 127.4, 125.1, 121.1, 
118.2, 114.5 (d, J = 21 Hz). 
11
B NMR (128.38 MHz, acetone-d6) δ 34.8. IR (neat) 3381, 
3050, 2979, 2348, 1698, 1218, 834, 753 cm
-1
. HRMS (CI) m/z calc. for C20H15BFN [M]
+
 
299.1282, found 299.1280. 
 
3-(3-Nitrophenyl)-2-phenyl-2,1-borazaronaphthalene (4.108). Obtained as an off-
white solid (52 mg, 32%). mp: 140-142 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.83 (br s, 
1H), 8.25 (s, 1H), 8.22 (s, 1H), 8.13-8.08 (m, 1H), 7.84 (d, J = 7.8 Hz, 1H), 7.75-7.72 (m, 
1H), 7.68-7.65 (m, 1H), 7.54-7.50 (m, 2H), 7.46-7.43 (m, 2H), 7.33-7.24 (m, 4H).
13
C 
NMR (125.8 MHz, acetone-d6) δ 148.2, 146.4, 144.5, 140.7, 135.1, 133.3, 129.7, 129.0, 
128.9, 128.3, 127.5, 124.9, 122.9, 121.4, 120.5, 118.3. 
11
B NMR (128.38 MHz, acetone-
d6) δ 35.4. IR (neat) 3371, 3051, 2780, 1560, 1286, 1264, 756, 699 cm
-1
. HRMS (ESI) 
m/z calc. for C20H15BN2O2Na [M+Na]
+
 349.1124, found 349.1125. 
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3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-phenyl-2,1-borazaronaphthalene (4.109). 
Obtained as an off-white solid (88 mg, 52%). mp: 55-57 °C. 
1
H NMR (500 MHz, 
acetone-d6) δ 9.61 (br s, 1H), 8.04 (s, 1H), 7.76 (d, J = 7.8 Hz, 1H), 7.70-7.68 (m, 1H), 
7.53-7.51 (m, 2H), 7.47-7.43 (m, 1H), 7.33-7.27 (m, 3H), 7.23-7.20 (m, 1H), 6.82 (s, 
1H), 6.74-6.72 (m, 2H), 4.25-4.20 (m, 4H). 
13
C NMR (125.8 MHz, acetone-d6) δ 143.3, 
142.7, 142.3, 140.2, 137.8, 133.3, 129.2, 128.1, 128.0, 127.3, 125.2, 121.7, 121.1, 118.1, 
117.0, 116.4, 65.2, 64.1. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.8. IR (neat) 3355, 
2980, 1560, 1506, 1412, 1307, 1281, 1244, 754 cm
-1
. HRMS (CI) m/z calc. for 
C22H19BNO2 [M+H]
+
 340.1509, found 340.1516. 
 
2-Phenyl-3-(3-thienyl)-2,1-borazaronaphthalene (4.110). Obtained as an off-white 
solid (100 mg, 70%). mp: 72-74 °C. 
1
H NMR (500 MHz, acetone-d6) 9.63 (br s, 1H), 
8.22 (s, 1H), 7.75 (d, J = 7.8 Hz, 1H), 7.70-7.67 (m, 1H), 7.56-7.52 (m, 2H), 7.47-7.43 
(m, 1H), 7.36-7.29 (m, 4H), 7.23-7.20 (m, 1H), 7.16-7.14 (m, 1H), 7.08-7.06 (m, 1H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 145.1, 142.3, 140.2, 133.1, 129.2, 128.4, 128.2, 128.1, 
127.4, 125.2, 124.6, 121.2, 120.8, 118.2. 
11
B NMR (128.38 MHz, acetone-d6) δ 35.0. IR 
(neat) 3372, 2979, 2919, 1613, 1559, 1423, 754 cm
-1
. HRMS (CI) m/z calc. for 
C18H14BNS [M]
+
 287.0940, found 287.0939. 
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3-(3-Furanyl)-2-phenyl-2,1-borazaronaphthalene (4.111). Obtained as a dark yellow 
oil (104 mg, 80%). 
1
H NMR (500 MHz, acetone-d6) δ 9.61 (br s, 1H), 8.24 (s, 1H), 7.75 
(d, J = 7.8 Hz, 1H), 7.66-7.64 (m, 1H), 7.60-7.57 (m, 2H), 7.49-7.43 (m, 2H), 7.39-7.37 
(m, 3H), 7.23-7.21 (m, 2H), 6.85 (s, 1H).
13
C NMR (125.8 MHz, acetone-d6) δ 142.6, 
140.8, 140.0, 139.8, 132.6, 129.0, 128.2, 128.0, 127.9, 127.5, 125.2, 121.2, 118.1, 109.9 
11
B NMR (128.38 MHz, acetone-d6) δ 35.3. IR (neat) 3353, 2979, 1706, 1506, 1318, 951, 
815, 703 cm
-1
. HRMS (CI) m/z calc. for C18H14BNO [M]
+
 271.1168 found 271.1156. 
 
3-(4-(3,5-Dimethylisoxazolyl))-2-phenyl-2,1-borazaronaphthalene (4.112). Obtained 
as a white solid (132 mg, 88%). mp: 80-82 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.84 
(br s, 1H), 8.04 (s, 1H), 7.78-7.74 (m, 2H), 7.54-7.50 (m, 3H), 7.34-7.29 (m, 3H), 7.26-
7.23 (m, 1H), 2.11 (s, 3H), 1.86 (s, 3H).
13
C NMR (125.8 MHz, acetone-d6) δ 163.4, 
158.5, 146.0, 140.7, 132.8, 129.2, 128.7, 128.5, 127.6, 124.8, 121.2, 118.4, 118.3, 10.5, 
9.8. 
11
B NMR (128.38 MHz, acetone-d6) δ 34.5. IR (neat) 3378, 1615, 1423, 1156, 756, 
709 cm
-1
. HRMS (ESI) m/z calc. for C19H18BN2O [M+H]
+
 301.1512, found 301.1521. 
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3-(7-N-Boc-Indolyl)-2-phenyl-2,1-borazaronaphthalene (4.113). Obtained as an off-
white solid (168 mg, 75%). mp: 96-98 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.65 (br s, 
1H), 8.11 (s, 1H), 8.07-8.04 (m, 1H), 7.79-7.77 (m, 1H), 7.73-7.71 (m, 1H), 7.63-7.62 
(m, 1H), 7.53-7.47 (m, 4H), 7.29-7.21 (m, 5H), 6.57-6.56 (m, 1H), 1.67 (s, 9H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 149.4, 143.4, 140.3, 139.4, 133.5, 130.7, 129.2, 128.1, 
128.0, 127.3, 125.9, 125.5, 125.3, 121.1, 120.5, 118.2, 114.2, 107.3, 83.3, 59.6, 27.4. 
11
B 
NMR (128.38 MHz, acetone-d6) δ 35.1. IR (neat) 3371, 2975, 1731, 1370, 1162, 1135, 
764, 752 cm
-1
. HRMS (ESI) m/z calc. for C27H25BN2O2Na [M+Na]
+
 443.1907, found 
443.1902. 
 
2-(4-Fluorophenyl)-3-(3-methoxyphenyl)-2,1-borazaronaphthalene (4.114). Obtained 
as an off-white solid (102 mg, 62%). mp: 74-76 °C. 
1
H NMR (500 MHz, acetone-d6) δ 
9.73 (br s, 1H), 8.08 (s, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.69 (d, J = 8.3 Hz, 1H), 7.53-7.44 
(m, 3H), 7.25-7.18 (m, 2H), 7.05-7.00 (m, 2H), 6.87-6.80 (m, 3H), 3.67 (s, 3H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 163.2 (d, J = 250 Hz), 159.5, 145.9, 143.3, 140.4, 
135.7, 135.6, 129.4, 128.9, 128.4, 125.1, 121.2, 120.9, 118.2, 114.1 (d, J = 20.5 Hz), 
111.6, 54.3 
11
B NMR (128.38 MHz, acetone-d6) δ 34.6. IR (neat) 3371, 2928, 1595, 
1570, 1417, 1277, 1161, 760 cm
-1
. HRMS (CI) m/z calc. for C21H18BNOF [M+H]
+
 
230.1465, found 230.1466. 
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2,3-Di(3-Methoxyphenyl)-2,1-borazaronaphthalene (4.115). Obtained as an off-white 
solid (185 mg, 50%). mp: 85-87 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.68 (br s, 1H), 
8.10 (s, 1H), 7.79-7.77 (m, 1H), 7.72-7.70 (m, 1H), 7.49-7.46 (m, 1H), 7.24-7.18 (m, 
3H), 7.09-7.05 (m, 2H), 6.90-6.86 (m, 3H), 6.81-6.79 (m, 1H), 3.67 (s, 3H), 3.65 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 159.4, 158.9, 146.0, 143.1, 140.4, 129.3, 128.7, 
128.4, 128.3, 125.6, 125.1, 121.2, 120.9, 118.6, 118.2, 114.2, 113.9, 115.6, 54.3, 54.1. 
11
B NMR (128.38 MHz, acetone-d6) δ 34.8. IR (neat) 3344, 3006, 2938, 1597, 1223, 
1037, 786, 703 cm
-1
. HRMS (ESI) m/z calc. for C22H21BNO2 [M+H]
+
 342.1665, found 
342.1650. 
 
3-(3-Methoxyphenyl)-2-(3-thienyl)-2,1-borazaronaphthalene (4.116). Obtained as a 
yellow oil (39 mg, 24%). 
1
H NMR (500 MHz, acetone-d6) δ 9.74 (br s, 1H), 8.01 (s, 1H), 
7.75 (d, J = 8.1 Hz, 1H), 7.66 (d, J = 8.1 Hz, 1H), 7.57-7.55 (m, 1H), 7.48-7.45 (m, 1H), 
7.39-7.36 (m, 1H), 7.27-7.18 (m, 3H), 6.93-6.84 (m, 3H), 3.73 (s, 3H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 159.4, 146.5, 143.1, 140.3, 132.0, 131.9, 129.3, 128.8, 128.3, 124.9, 
124.3, 121.0, 120.8, 118.0, 114.0, 111.7, 54.3. 
11
B NMR (128.38 MHz, acetone-d6) δ 
32.2. IR (neat) 3374, 2924, 1562, 1261, 852, 761, 685 cm
-1
. HRMS (CI) m/z calc. for 
C19H17BNOS [M+H]
+
 318.1124, found 318.1109. 
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2-(4-Dibenzofuranyl)-3-(3-methoxyphenyl)-2,1-borazaronaphthalene (4.117). 
Obtained as a white solid (64 mg, 32%). mp: 71-73 °C. 
1
H NMR (500 MHz, acetone-d6) 
δ 10.11 (br s, 1H), 8.24 (s, 1H), 8.08-8.04 (m, 2H), 7.87 (d, J = 7.8 Hz, 1H), 7.78-7.76 
(m, 1H), 7.55-7.41 (m, 4H), 7.37-7.34 (m, 1H), 7.31-7.25 (m, 2H), 7.13-7.10 (m, 1H), 
6.94-6.92 (m, 1H), 6.91-6.90 (m, 1H), 6.71-6.68 (m, 1H), 3.53 (s, 3H).
13
C NMR (125.8 
MHz, acetone-d6) δ 159.4, 158.9, 155.8, 145.9, 143.1, 140.0, 132.8, 129.5, 128.7, 128.4, 
126.9, 125.3, 124.1, 122.8, 122.5, 122.3, 121.4, 120.7, 120.6, 120.5, 118.3, 113.6, 111.7, 
111.4, 54.2. 
11
B NMR (128.38 MHz, acetone-d6) δ 33.9. IR (neat) 3390, 3051, 2929, 
1564, 1450, 1165, 756 cm
-1
. HRMS (ESI) m/z calc. for C27H21BNO2 [M+H]
+
 402.1665, 
found 402.1673. 
 
3,6-Di(3-Methoxyphenyl)-2-methyl-2,1-borazaronaphthalene (4.118). Obtained as a 
yellow oil (172 mg, 97%). 
1
H NMR (500 MHz, acetone-d6) δ 9.50 (br s, 1H), 8.04-8.01 
(m, 2H), 7.75-7.71 (m, 1H), 7.57-7.55 (m, 1H), 7.39-7.27 (m, 4H), 7.03-7.01 (m, 2H), 
6.90-6.86 (m, 2H), 3.86 (s, 3H), 3.84 (s, 3H), 0.85 (s, 3H). 
13
C NMR (125.8 MHz, 
acetone-d6) δ 160.3, 159.7, 146.4, 142.2, 141.3, 139.9, 133.3, 129.7, 129.0, 127.4, 126.9, 
125.1, 120.5, 118.9, 118.0, 113.7, 112.2, 112.1, 111.4, 54.6, 54.5. 
11
B NMR (128.38 
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MHz, acetone-d6) δ 38.6. IR (neat) 3366, 2954, 1733, 1576, 1038, 933, 776, 699 cm
-1
. 
HRMS (CI) m/z calc. for C23H23BNO2 [M+H]
+
 356.1822, found 356.1829. 
 
6-(3-Methoxy-5-methylphenyl)-3-(3-methoxyphenyl)-2-methyl-2,1-
borazaronaphthalene (4.121). Obtained as an off-white solid (158 mg, 86%). mp: 143-
145 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.10 (br s, 1H), 7.82 (s, 1H), 7.63-7.61 (m, 
1H), 7.40-7.35 (m, 3H), 7.12-7.10 (m, 1H), 6.96-6.94 (m, 1H), 6.72 (s, 1H), 6.53 (s, 1H), 
6.52-6.50 (m, 2H), 3.85 (s, 3H), 3.43 (s, 3H), 2.16 (s, 3H), 0.21 (s, 3H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 158.9, 158.8, 145.1, 143.0, 141.6, 140.2, 138.2, 132.6, 130.6, 128.9, 
127.6, 124.9, 123.0, 120.3, 117.4, 115.0, 112.9, 112.5, 111.8, 54.6, 54.0, 20.6. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 37.9. IR (neat) 3390, 3052, 2932, 1595, 1451, 1164, 758 cm
-
1
. HRMS (ESI) m/z calc. for C24H25BNO2 [M+H]
+
 370.1978, found 370.1960. 
 
3-Phenyl-6-(3-thienyl)-2-methyl-2,1-borazaronaphthalene (4.122). Obtained as a 
white solid (126 mg, 84%). mp: 72-74 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.49 (br s, 
1H), 8.04 (s, 1H), 7.95 (s, 1H), 7.78-7.78 (m, 1H), 7.68-7.66 (m, 1H), 7.58-7.56 (m, 1H), 
7.53-7.51 (m, 2H), 7.47-7.45 (m, 2H), 7.43-7.40 (m, 2H), 7.30-7.27 (m, 1H), 0.81 (s, 
3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 144.9, 142.0, 141.2, 139.6, 128.5, 128.1, 
128.0, 126.5, 126.4, 126.2, 126.1, 125.8, 125.2, 119.1, 118.0. 
11
B NMR (128.38 MHz, 
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acetone-d6) δ 37.9. IR (neat) 3366, 3058, 2931, 1596, 1450, 1220, 750, 700 cm
-1
. HRMS 
(CI) m/z calc. for C19H16BNS [M]
+
 301.1097, found 301.1099. 
 
6-(3-Furanyl)-3-phenyl-2-methyl-2,1-borazaronaphthalene (4.123). Obtained as a 
dark yellow oil (98 mg, 69%). 
1
H NMR (500 MHz, acetone-d6) δ 9.50 (br s, 1H), 8.01 (s, 
1H), 7.94-7.92 (m, 2H), 7.68-7.66 (m, 2H), 7.63 (s, 1H), 7.51-7.48 (m, 1H), 7.47-7.44 
(m, 2H), 7.42-7.38 (m, 2H), 7.30-7.27 (m, 1H), 0.79 (s, 3H). 
13
C NMR (125.8 MHz, 
acetone-d6) δ 144.9, 143.8, 141.0, 139.4, 138.2, 128.0, 128.0, 126.3, 125.9, 125.9, 125.8, 
125.2, 125.0, 118.0, 108.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.7. IR (neat) 3366, 
3058, 2929, 1596, 1450, 1220, 1163, 750, 760 cm
-1
. HRMS (CI) m/z calc. for 
C19H16BNO [M]
+
 285.1325, found 285.1318. 
 
2,3,6-Triphenyl-2,1-borazaronaphthalene (4.166). Obtained as an off-white solid. mp: 
75-77 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.77 (br s, 1H), 8.16 (s, 1H), 8.08 (s, 1H), 
7.81-7.79 (m, 2H), 7.77-7.74 (m, 2H), 7.50-7.46 (m, 4H), 7.32-7.22 (m, 9H). 
13
C NMR 
(125.8 MHz, acetone-d6) δ 144.6, 143.6, 140.7, 139.9, 133.5, 133.5, 128.8, 128.6, 128.2, 
127.9, 127.8, 127.3, 127.3, 127.3, 127.2, 126.7, 125.9, 118.9. 
11
B NMR (128.38 MHz, 
acetone-d6) δ 37.7. IR (neat) 3368, 3046, 1567, 1435, 766 cm
-1
. HRMS (CI) m/z calc. for 
C26H20BN [M]
+
 357.1689, found 357.1685. 
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2-Methyl-3,6-di(4-naphthylphenyl)-2,1-borazaronaphthalene (4.167). Obtained as an 
off-white solid. mp: 155-157 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.63 (br s, 1H), 8.14-
8.11 (m, 2H), 8.01 (d, J = 8.6 Hz, 1H), 7.99-7.6 (m, 3H), 7.92 (d, J = 8.1 Hz, 1H), 7.88-
7.83 (m, 3H), 7.65-7.61 (m, 3H), 7.58-7.45 (m, 12H), 0.92 (s, 3H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 144.0, 141.6, 140.0, 140.0, 139.7, 139.7, 139.0, 138.2, 134.0, 134.0, 
132.9, 131.5, 131.5, 130.4, 130.3, 129.7, 128.3, 128.3, 128.1, 127.6, 127.5, 127.4, 126.9, 
126.8, 126.8, 126.6, 126.4, 126.1, 126.0, 125.8, 125.7, 125.7, 125.6, 125.4, 125.4, 118.2. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.5. IR (neat) 3379, 3046, 1569, 1395, 799 cm
-1
. 
HRMS (CI) m/z calc. for C26H20BN [M]
+
 547.2471, found 547.2477. 
 
3,6-Di(4-naphthylphenyl)-2-phenyl-2,1-borazaronaphthalene (4.168). Obtained as an 
off-white solid. mp: 120-122 °C. 
1
H NMR (500 MHz, acetone-d6) δ 9.87 (br s, 1H), 8.33 
(s, 1H), 8.26-8.24 (m, 1H), 8.00-7.87 (m, 10H), 7.62-7.46 (m, 14H), 7.44-7.41 (m, 2H), 
7.35-7.31 (m, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 143.7, 143.7, 140.1, 140.0, 
139.7, 139.7, 139.2, 138.2, 134.0, 133.6, 133.5, 131.5, 131.5, 130.4, 129.5, 129.7, 128.3, 
128.3, 127.6, 127.4, 127.4, 127.3, 126.8, 126.7, 126.6, 126.1, 126.0, 125.8, 125.7, 125.7, 
125.6, 125.6, 125.4, 125.4, 118.9. 
11
B NMR (128.38 MHz, acetone-d6) δ 38.0. IR (neat) 
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3367, 3046, 1569, 1435, 777 cm
-1
. HRMS (CI) m/z calc. for C46H32BN [M]
+
 609.2628, 
found 609.2621. 
 
General Procedure for the Self-Arylation of 1-Alkyl-2-Aryl-3-Bromo-2,1-
Borazaronaphthalenes: To a Biotage microwave vial equipped with a stir bar was 
successively introduced SPhos-Pd-G2 (7.2 mg, 10 μmol, 2 mol %), KOH (84 mg, 1.5 
mmol, 3 equiv), and 3-bromo-2-aryl-2,1-borazaronaphthalene (0.50 mmol, 1 equiv). The 
vial was sealed with a cap lined with a disposable Teflon septum, evacuated under 
vacuum, and purged with Ar three times. Anhydr degassed THF (0.9 mL) and degassed 
H2O (0.1 mL) were added under Ar, and the vial was stirred at rt for 18 h. The reaction 
was diluted with H2O (2 mL), extracted with EtOAc (3 x 2 mL), and dried (MgSO4). The 
solvent was removed in vacuo, and the product was purified by flash column 
chromatography on Florisil using a 0 to 40% CH2Cl2/hexane as the eluent to yield the 
anhydride. The column was flushed successively with 100% CH2Cl2 and 100% EtOAc to 
yield the 2,1-borazaronaphthol. For reactions that went to completion without side-
product formation, crude reaction mixtures were passed through a plug of Florisil to 
afford the desired product. Characterization of monomer and/or anhydride is provided for 
each self-arylated product. For those compounds in which complete separation was 
achieved, both the monomer and anhydride were characterized. 
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1-Allyl-3-phenyl-2,1-borazaronaphthol (4.125). Obtained as a yellow oil (123 mg, 
94%). 
1
H NMR (500 MHz, acetone-d6) δ 7.80 (s, 1H), 7.61 (d, J = 7.8 Hz, 1H), 7.49-7.45 
(m, 2H), 7.42-7.33 (m, 4H), 7.30-7.26 (m, 1H), 7.08-7.04 (m, 1H), 6.64 (br s, 1H), 6.07-
6.00 (m, 1H), 5.12-5.07 (m, 2H), 4.75-4.70 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 
143.2, 142.7, 141.6, 135.4, 130.0, 128.4, 128.2, 127.7, 126.2, 124.3, 119.2, 114.6, 114.5, 
44.7. 
11
B NMR (128.38 MHz, acetone-d6) δ 28.5. IR (neat) 3629, 3066, 2980, 1384, 759 
cm
-1
. HRMS (ESI) m/z calc. for C17H17BNO [M+H]
+
 262.1403, found 262.1408. 
 
1-Butyl-3-phenyl-2,1-borazaronaphthol (4.126). Obtained as a yellow oil (133 mg, 
96%). 
1
H NMR (500 MHz, acetone-d6) δ 7.78 (s, 1H), 7.63-7.60 (m, 1H), 7.49-7.38 (m, 
6H), 7.29-7.25 (m, 1H), 7.10-7.05 (m, 1H), 6.54 (s, 1H), 4.11-4.05 (m, 2H), 1.74-1.70 
(m, 2H), 1.53-1.43 (m, 2H), 1.00-0.93 (m, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 
143.0, 142.9, 141.6, 130.3, 128.5, 128.4, 127.8, 126.2, 124.4, 119.0, 113.8, 42.2, 31.2, 
20.1, 13.4. 
11
B NMR (128.38 MHz, acetone-d6) δ 29.2. IR (neat) 3635, 2957, 2870, 1387, 
760 cm
-1
. HRMS (CI) m/z calc. for C18H20BNO [M]
+
 277.1638, found 277.1636. 
 
1-Cyclopropylmethyl-3-phenyl-2,1-borazaronaphthol (4.127). Obtained as a yellow 
oil (135 mg, 98%). 
1
H NMR (500 MHz, acetone-d6) δ 7.78 (s, 1H), 7.64-7.55 (m, 2H), 
7.48-7.45 (m, 3H), 7.42-7.37 (m, 2H), 7.30-7.26 (m, 1H), 7.09-7.06 (m, 1H), 6.48 (s, 
1H), 4.02-3.98 (m, 2H), 1.38-1.32 (m, 1H), 0.51-0.45 (m, 4H).
13
C NMR (125.8 MHz, 
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acetone-d6) δ 143.2, 142.9, 141.9, 130.3, 128.5, 128.4, 127.7, 126.2, 124.3, 119.0, 114.2, 
46.1, 10.8, 3.5. 
11
B NMR (128.38 MHz, acetone-d6) δ 29.2. IR (neat) 3627, 3019, 2916, 
1381, 759 cm
-1
. HRMS (CI) m/z calc. for C18H18BNO [M]
+
 275.1481, found 275.1493. 
 
1-Benzyl-3-phenyl-2,1-borazaronaphthol (4.128). Obtained as a yellow oil (151 mg, 
97%). 
1
H NMR (500 MHz, acetone-d6) δ 7.86 (s, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.55 (d, J 
= 7.3 Hz, 2H), 7.44-7.40 (m, 2H), 7.32-7.20 (m, 8H), 7.04-7.01 (m, 1H), 6.85 (s, 1H), 
5.35 (s, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 143.4, 142.7, 141.7, 139.4, 130.1, 
128.6, 128.5, 128.4, 127.8, 126.5, 126.3, 126.3, 124.5, 119.4, 115.0, 46.3. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 29.4. IR (neat) 3632, 3030, 2924, 1387, 760 cm
-1
. HRMS 
(CI) m/z calc. for C21H18BNO [M]
+
 311.1481, found 311.1477. 
 
1-Allyl-3-(4-methylphenyl)-2,1-borazaronaphthol (4.129-Monomer). Obtained as a 
yellow oil (0.26 mmol scale, 62 mg, 87%, 62:38 monomer:anhydride). 
1
H NMR (500 
MHz, acetone-d6) δ 7.77 (s, 1H), 7.61-7.58 (m, 1H), 7.41-7.33 (m, 4H), 7.22-7.18 (m, 
2H), 7.08-7.03 (m, 1H), 6.56 (s, 1H), 6.07-6.00 (m, 1H), 5.12-5.06 (m, 2H), 4.72-4.70 
(m, 2H), 2.35 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 142.8, 141.5, 139.8, 135.6, 
135.4, 129.9, 129.1, 128.0, 127.6, 124.3, 119.1, 114.6, 114.5, 44.7, 20.1. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 28.5. IR (neat) 3607, 3062, 2979, 1384, 1353, 750 cm
-1
. 
HRMS (CI) m/z calc. for C18H18BNO [M]
+
 275.1481, found 275.1477. 
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Bis-(1-allyl-3-(4-methylphenyl)-2,1-borazaro-2-naphthyl) Ether (4.129-Anhydride). 
Obtained as a yellow oil (0.26 mmol scale, 62 mg, 87%, 62:38 monomer:anhydride). 
1
H 
NMR (500 MHz, acetone-d6) δ 7.67 (s, 2H), 7.58 (d, J = 7.6 Hz, 2H), 7.40-7.36 (m, 4H), 
7.10-7.05 (m, 6H), 6.89 (d, J = 7.8 Hz, 4H), 6.05-5.97 (m, 2H), 5.13 (dd, J = 10.4, 1.3 
Hz, 2H), 5.04 (dd, J = 17.5, 1.3 Hz, 2H), 4.72-4.69 (m, 4H), 2.12 (s, 6H). 
13
C NMR 
(125.8 MHz, acetone-d6) δ 142.8, 141.1, 139.2, 135.2, 135.0, 129.8, 128.2, 127.9, 127.9, 
124.7, 119.6, 115.0, 114.9, 45.6, 20.0. 
11
B NMR (128.38 MHz, acetone-d6) δ 29.4. IR 
(neat) 2980, 2890, 1384, 1353, 748 cm
-1
. HRMS (ESI) m/z calc. for C18H18BNO [M-
C18H16BNO]
+
 275.1481, found 275.1478. HRMS found for [monomer]
+
. 
 
1-Allyl-3-(3-methylphenyl)-2,1-borazaronaphthol (4.130-Monomer). Obtained as a 
yellow oil (0.5 mmol scale, 98 mg, 71%, 77:23 monomer:anhydride). 
1
H NMR (500 
MHz, acetone-d6) δ 7.78 (s, 1H), 7.61 (d, J = 7.6 Hz, 1H), 7.41-7.34 (m, 2H), 7.29-7.25 
(m, 3H), 7.11-7.04 (m, 2H), 6.61 (s, 1H), 6.07-6.01 (m, 1H), 5.12-5.07 (m, 2H), 4.72-
4.70 (m, 2H), 2.36 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 143.0, 142.6, 141.6, 
137.8, 135.4, 130.5, 130.0, 128.4, 128.1, 127.0, 124.7, 124.3, 119.1, 114.6, 114.5, 44.7, 
20.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 28.6. IR (neat) 3623, 2977, 2922, 1608, 
1383, 761 cm
-1
. HRMS (ESI) m/z calc. for C18H17BNO [M-H]
+
 274.1403, found 
274.1404. 
466 
 
 
Bis-(1-allyl-3-(3-methylphenyl)-2,1-borazaro-2-naphthyl) Ether (4.130-Anhydride). 
Obtained as a yellow oil (0.5 mmol scale, 98 mg, 71%, 77:23 monomer:anhydride). 
1
H 
NMR (500 MHz, acetone-d6) δ 7.61 (s, 2H), 7.56 (d, J = 7.6 Hz, 2H), 7.40-7.36 (m, 4H), 
7.08 (d, J = 5.9 Hz, 2H), 6.94-6.88 (m, 6H), 6.79 (d, J = 6.8 Hz, 2H), 6.11-6.06 (m, 2H), 
5.18-5.12 (m, 4H), 4.87-4.83 (m, 2H), 4.75-4.72 (m, 2H), 2.04 (s, 6H). 
13
C NMR (125.8 
MHz, acetone-d6) δ 142.9, 141.8, 141.2, 136.8, 135.2, 129.9, 128.7, 128.1, 127.4, 126.5, 
125.2, 124.6, 119.6, 115.1, 114.9, 45.7, 20.3. 
11
B NMR (128.38 MHz, acetone-d6) δ 29.1. 
IR (neat) 3034, 2982, 1605, 1384, 1352, 760 cm
-1
. HRMS (ESI) m/z calc. for C18H17BNO 
[M-C18H17BNO]
+
 274.1403, found 274.1410. HRMS found for [monomer-H]
+
. 
 
Bis-(1-allyl-3-(3-chlorophenyl)-2,1-borazaro-2-naphthyl) Ether (4.131-Anhydride). 
Obtained as a yellow oil (0.45 mmol scale, 76 mg, 59%, >95:5 monomer:anhydride).
1
H 
NMR (500 MHz, acetone-d6) δ 7.66 (s, 2H), 7.58 (d, J = 7.3 Hz, 2H), 7.47-7.39 (m, 4H), 
7.12-7.08 (m, 2H), 7.05-6.97 (m, 8H), 6.17-6.10 (m, 2H), 5.21-5.12 (m, 4H), 4.87-4.79 
(m, 4H). 
13
C NMR (125.8 MHz, acetone-d6) δ 147.9, 141.4, 136.4, 134.8, 132.6, 131.4, 
131.3, 131.2, 130.1, 130.7, 129.4, 128.0, 123.6, 118.6, 117.0, 51.5. 
11
B NMR (128.38 
MHz, acetone-d6) δ 28.8. IR (neat) 3063, 2974, 1384, 1352, 1187, 749 cm
-1
. HRMS (ESI) 
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m/z calc. for C31H24B2Cl2N2O [M-C3H4]
+
 532.1452, found 532.1424. HRMS found for 
[M-allyl]
+
. 
 
Bis-(1-allyl-3-(4-fluorophenyl)-2,1-borazaro-2-naphthyl) Ether (4.132-Anhydride). 
Obtained as an off-white solid (0.31 mmol scale, 71 mg, 82%, >95:5 
monomer:anhydride). mp: 120-122 °C. 
1
H NMR (500 MHz, acetone-d6) δ 7.66 (s, 2H), 
7.58 (d, J = 7.8 Hz, 2H), 7.43-7.39 (m, 4H), 7.17-7.08 (m, 6H), 6.84-6.80 (m, 4H), 6.13-
6.04 (m, 2H), 5.18 (d, J = 10.5 Hz, 2H), 5.07 (d, J = 17.1 Hz, 2H), 4.79-4.77 (m, 4H). 
13
C 
NMR (125.8 MHz, acetone-d6) δ 161.4 (d, J = 243 Hz), 143.4, 141.1, 138.2 (d, J = 3.9 
Hz), 135.0, 130.0, 129.7, 129.7, 128.3, 124.4, 119.8, 115.0 (d, J = 5.0 Hz), 114.2 (d, J = 
22 Hz), 45.6.  
11
B NMR (128.38 MHz, acetone-d6) δ 29.2. IR (neat) 3063, 2926, 1384, 
1352, 749 cm
-1
. HRMS (CI) m/z calc. for C17H15BNOF [M-C17H13BNOF]
+
 279.1231, 
found 279.1237. HRMS found for [monomer]
+
. 
 
Bis-(1-allyl-3-(4-trifluoromethylphenyl)-2,1-borazaro-2-naphthyl) Ether (4.133-
Anhydride). Obtained as an off-white solid (0.5 mmol scale, 110 mg, 67%, >95:5 
monomer:anhydride). mp: 133-135 °C. 
1
H NMR (500 MHz, acetone-d6) δ 7.78 (s, 2H), 
7.6 (d, J = 7.3 Hz, 2H), 7.48-7.37 (m, 8H), 7.28 (d, J = 7.6 Hz, 4H), 7.13-7.08 (m, 2H), 
6.15-6.10 (m, 2H), 5.20 (d, J = 10.5 Hz, 2H), 5.09 (d, J = 17.1 Hz, 2H), 4.83-4.81 (m, 
4H). 
13
C NMR (125.8 MHz, acetone-d6) δ 146.0, 144.5, 141.3, 134.9, 130.4, 128.9, 
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128.5, 127.5, 126.7 (q, J = 264 Hz), 124.4 (q, J = 5.0 Hz), 124.2, 120.0, 115.2, 115.1, 
45.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 28.8. IR (neat) 3056, 3+36, 2384, 1324, 
1110, 761 cm
-1
. HRMS (CI) m/z calc. for C18H15BF3NO [M-C18H13BF3NO]
+
 329.1199, 
found 329.1197. HRMS found for [monomer]
+
. 
 
1-Allyl-3-(2-methoxyphenyl)-2,1-borazaronaphthol (4.134-Monomer). Obtained as a 
yellow oil (0.36 mmol scale, 94 mg, 90%, 15:85 monomer:anhydride). 
1
H NMR (500 
MHz, acetone-d6) δ 7.70 (s, 1H), 7.58 (d, J = 7.6 Hz, 1H), 7.40-7.34 (m, 2H), 7.30-7.25 
(m, 2H), 7.05-6.99 (m, 3H), 6.34 (s, 1H), 6.04-5.98 (m, 1H), 5.10 (dd, J = 13.7, 1.7 Hz, 
2H), 4.72-4.70 (m, 2H), 3.83 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 156.4, 143.8, 
141.7, 135.6, 132.0, 129.9, 129.9, 128.0, 128.0, 124.3, 120.9, 118.9, 114.5, 114.0, 110.9, 
54.9, 44.6. 
11
B NMR (128.38 MHz, acetone-d6) δ 29.1. IR (neat) 3628, 2980, 1386, 1352, 
1187, 750 cm
-1
. HRMS (ESI) m/z calc. for C18H19BNO2 [M+H]
+
 292.1509, found 
292.1501. 
 
Bis-(1-allyl-3-(2-naphthyl)-2,1-borazaro-2-naphthyl) Ether (4.135-Anhydride). 
Obtained as an off-white solid (0.20 mmol scale, 35 mg, 56%, >95:5 
monomer:anhydride). mp: 90-92 °C. 
1
H NMR (500 MHz, acetone-d6) δ 7.68 (d, J = 6.4 
Hz, 2H), 7.59 (s, 2H), 7.55-7.52 (m, 4H), 7.48-7.37 (m, 8H), 7.34-7.30 (m, 4H), 7.23 (d, 
J = 8.3 Hz, 2H), 7.06-7.01 (m, 2H), 6.19-6.11 (m, 2H), 5.22-5.14 (m, 4H), 4.93-4.83 (m, 
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4H). 
13
C NMR (125.8 MHz, acetone-d6) δ 143.6, 141.2, 139.5, 135.2, 133.3, 132.0, 
130.0, 128.2, 127.6, 127.2, 126.9, 126.8, 126.3, 125.4, 125.1, 124.5, 119.6, 115.2, 115.0, 
45.7. 
11
B NMR (128.38 MHz, acetone-d6) δ 29.3. IR (neat) 3057, 2923, 1390, 1354, 
1215, 742 cm
-1
. HRMS (CI) m/z calc. for C21H18BNO [M-C21H16BNO]
+
 311.1481, found 
311.1472. HRMS found for [monomer]
+
. 
 
1-Allyl-3-(3-thienyl)-2,1-borazaronaphthol (4.136-Monomer). Obtained as a yellow 
oil (0.5 mmol scale, 114 mg, 85%, 60:40 monomer:anhydride). 
1
H NMR (500 MHz, 
acetone-d6) δ 7.99 (s, 1H), 7.63-7.58 (m, 2H), 7.49-7.46 (m, 1H), 7.45-7.42 (m, 1H), 
7.39-7.32 (m, 2H), 7.08-7.04 (m, 1H), 6.70 (s, 1H), 6.07-5.97 (m, 1H), 5.11-5.04 (m, 
2H), 4.72-4.70 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 142.1, 141.9, 141.4, 135.2, 
129.9, 128.0, 127.2, 125.3, 124.3, 121.1, 119.3, 114.6, 114.4, 44.8. 
11
B NMR (128.38 
MHz, acetone-d6) δ 28.9. IR (neat) 3627, 3064, 2932, 1385, 1352, 1187, 750 cm
-1
. 
HRMS (ESI) m/z calc. for C15H15BNOS [M+H]
+
 268.0967, found 268.0978. 
 
1-Allyl-3-(4-dibenzofuryl)-2,1-borazaronaphthol (4.137-Monomer). Obtained as a 
yellow oil (0.5 mmol scale, 111 mg, 63%, 36:64 monomer:anhydride). 
1
H NMR (500 
MHz, acetone-d6) δ 8.13-8.10 (m, 1H), 8.06 (s, 1H), 8.04-8.00 (m, 1H), 7.71-7.67 (m, 
1H), 7.66-7.62 (m, 1H), 7.56-7.39 (m, 6H), 7.15-7.11 (m, 1H), 7.02 (m, 1H), 6.14-6.02 
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(m, 1H), 5.22-5.15 (m, 2H), 4.84-4.82 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 
157.0, 154.6, 146.3, 143.1, 136.6, 131.3, 129.7, 128.5, 128.5, 128.2, 125.4, 125.2, 125.0, 
124.4, 123.8, 121.8, 120.2, 120.0, 115.8, 115.8, 112.7, 45.9. 
11
B NMR (128.38 MHz, 
acetone-d6) δ 29.0. IR (neat) 3623, 3063, 2928, 1385, 1187, 750 cm
-1
. HRMS (ESI) m/z 
calc. for C23H19BNO2 [M+H]
+
 352.1509, found 352.1523. 
 
General Procedure for the Self-Arylation and Cross-Coupling of 1-Benzyl-3,6-
Dibromo-2-Phenyl-2,1-Borazaronaphthalenes: To a Biotage microwave vial equipped 
with a stir bar was successively introduced t-Bu3P-Pd-G2 (2.3 mg, 5 μmol, 2 mol %), 
Cs2CO3 (84 mg, 1.5 mmol, 3 equiv), phenylboronic acid (31 mg, 1.0 equiv) and 1-benzyl-
3,6-dibromo-2-phenyl-2,1-borazaronaphthalene (0.25 mmol, 1 equiv). The vial was 
sealed with a cap lined with a disposable Teflon septum, evacuated under vacuum, and 
purged with Ar three times. Anhydr degassed THF (0.6 mL) and degassed H2O (0.6 mL) 
were added under Ar, and the vial was stirred at rt for 18 h. The reaction was diluted with 
H2O (2 mL), extracted with EtOAc (3 x 2 mL), and dried (MgSO4). The solvent was 
removed in vacuo, and the product was purified by passing through a short plug of 
Florisil. 
 
1-Benzyl-3,6-diphenyl-22,1-borazaronaphthol (4.142). Obtained as an off-white solid 
(89 mg, 92%). mp: 68-70 °C. 
1
H NMR (500 MHz, acetone-d6) δ 7.98-7.94 (m, 2H), 7.67 
(d, J = 7.3 Hz, 2H), 7.61-7.55 (m, 3H), 7.45-7.40 (m, 4H), 7.35-7.27 (m, 7H), 7.24-7.20 
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(m, 1H), 6.97 (br s, 1H), 5.38 (s, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 143.9, 142.9, 
141.4, 140.7, 139.6, 132.3, 128.9, 128.7, 128.6, 128.3, 128.0, 127.0, 126.8, 126.7, 126.6, 
126.6, 126.6, 125.0, 115.8, 45.6 
11
B NMR (128.38 MHz, acetone-d6) δ 29.8. IR (neat) 
3602, 3026, 1387, 763, 698 cm
-1
. HRMS (ESI) m/z calc. for C27H23BNO [M+H]
+
 
388.1873, found 388.1874. 
 
General Procedure for the Kumada Coupling of 3-Bromo-2-Aryl-2,1-
Borazaronaphthalenes: To a Biotage microwave vial equipped with a stir bar was 
successively introduced t-Bu3P-Pd-G2 (1.7 mg, 3.3 μmol, 1 mol %), and 3-bromo-2-aryl-
2,1-borazaronaphthalene (0.33 mmol, 1 equiv). The vial was sealed with a cap lined with 
a disposable Teflon septum, evacuated under vacuum, and purged with Ar three times. 
Anhydr degassed THF (0.8 mL) was added under Ar, and the vial was cooled to 0 °C. 
PhMgBr (1 M in THF, 0.4 mL diluted to 0.8 mL) was added dropwise over 15 min at 0 
°C. The reaction was slowly warmed to rt overnight. The reaction was quenched with sat. 
aq NH4Cl (0.5 mL), extracted with EtOAc (3 x 2 mL), and dried (MgSO4). The solvent 
was removed in vacuo, and the product was purified by flash column chromatography on 
silica gel using a 0 to 20% CH2Cl2/hexane as the eluent. 
 
1-Allyl-2,3-diphenyl-2,1-borazaronaphthalene (4.125). Obtained as a yellow oil (89 
mg, 84%). 
1
H NMR (500 MHz, acetone-d6) δ 8.09 (s, 1H), 7.85 (d, J = 7.8 Hz, 1H), 7.66-
7.62 (m, 1H), 7.57-7.52 (m, 1H), 7.33-7.23 (m, 6H), 7.14-7.05 (m, 5H), 6.08-6.01 (m, 
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1H), 5.15 (d, J = 10.5 Hz, 1H), 4.98 (d, J = 17.4 Hz, 1H), 4.76-4.74 (m, 2H). 
13
C NMR 
(125.8 MHz, acetone-d6) δ 144.4, 143.0, 140.3, 135.7, 131.7, 130.4, 128.6, 128.5, 127.4, 
127.2, 127.0, 126.6, 125.4, 121.3, 116.6, 115.0, 50.1. 
11
B NMR (128.38 MHz, acetone-
d6) δ 38.0. IR (neat) 3051, 2922, 1370, 763, 700 cm
-1
. HRMS (CI) m/z calc. for 
C23H20BN [M]
+
 321.1689, found 321.1684. 
 
1-Allyl-3-(4-fluorophenyl)-2-phenyl-2,1-borazaronaphthalene (4.138). Obtained as a 
yellow oil (101 mg, 89%). 
1
H NMR (500 MHz, acetone-d6) δ 8.08 (s, 1H), 7.84 (d, J = 
7.6 Hz, 1H), 7.65-7.62 (m, 1H), 7.57-7.52 (m, 1H), 7.33-7.25 (m, 6H), 7.15-7.10 (m, 2H), 
6.91-6.85 (m, 2H), 6.07-6.01 (m, 1H), 5.15 (d, J = 10.5 Hz, 1H), 4.97 (d, J = 17.2 Hz, 
1H), 4.74-4.72 (m, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 161.5 (d, J = 243 Hz), 
143.3, 140.9 (d, J = 4 Hz), 140.6, 135.9, 132.0, 130.7, 130.5 (d, J = 8 Hz), 128.8, 127.5 
(d, J = 20 Hz), 126.7, 121.7, 116.9, 115.3, 114.4, 114.3, 51.0. 
11
B NMR (128.38 MHz, 
acetone-d6) δ 37.7. IR (neat) 3068, 1506, 1370, 1220, 832, 766 cm
-1
. HRMS (CI) m/z 
calc. for C24H19BFN [M]
+
 339.1595, found 339.1604. 
 
1-Allyl-3-(2-methoxyphenyl)-2-phenyl-2,1-borazaronaphthalene (4.139). Obtained as 
an off-white solid (86 mg, 73%). mp: 64-66 °C. 
1
H NMR (500 MHz, acetone-d6) δ 7.91 
(s, 1H), 7.78 (d, J = 7.9 Hz, 1H), 7.63 (d, J = 8.5 Hz, 1H), 7.54-7.50 (m, 1H), 7.29-7.25 
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(m, 3H), 7.16-7.12 (m, 4H), 7.10-7.06 (m, 1H), 6.86-6.83 (m, 1H), 6.65 (d, J = 8.2 Hz, 
1H), 6.10-6.03 (m, 1H), 5.17 (dd, J = 10.5, 1.4 Hz, 1H), 5.01 (dd, J = 17.1, 1.5 Hz, 1H), 
4.76-4.74 (m, 2H), 3.33 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 156.3, 142.9, 
140.5, 136.2, 134.4, 131.8, 130.3, 129.7, 128.3, 127.6, 127.0, 126.9, 126.7, 121.3, 120.2, 
116.8, 115.2, 110.2, 54.3, 50.9. 
11
B NMR (128.38 MHz, acetone-d6) δ 37.5. IR (neat) 
3006, 2830, 1489, 1370, 1340, 748 cm
-1
. HRMS (CI) m/z calc. for C24H22BNO [M]
+
 
351.1794, found 351.1800. 
 
1-Allyl-3-(3-fluoro-3-methylphenyl)-2-phenyl-2,1-borazaronaphthalene (4.140). 
Obtained as an off-white solid (93 mg, 79%). mp: 71-73 °C. 
1
H NMR (500 MHz, 
acetone-d6) δ 8.08 (s, 1H), 7.83 (d, J = 7.6 Hz, 1H), 7.63 (d, J = 8.6 Hz, 1H), 7.55-7.51 
(m, 1H), 7.34-7.25 (m, 6H), 7.00 (d, J = 6.6 Hz, 1H), 6.93-6.89 (m, 1H), 6.81-6.77 (m, 
1H), 6.07-6.01 (m, 1H), 5.15 (d, J = 10.5 Hz, 1H), 4.97 (d, J = 17.4 Hz, 1H), 4.75-4.73 
(m, 2H), 2.09 (s, 3H). 
13
C NMR (125.8 MHz, acetone-d6) δ 159.7 (d, J = 243 Hz), 142.8, 
140.3, 135.7, 131.8 (d, J = 5 Hz), 131.7, 130.4, 128.5, 127.7 (d, J = 6 Hz), 127.3, 127.1, 
126.5, 123.3, 123.1, 121.4, 116.6, 115.1, 113.7 (d, J = 22 Hz), 50.1, 13.5. 
11
B NMR 
(128.38 MHz, acetone-d6) δ 37.3. IR (neat) 3046, 1498, 1367, 1223, 1118, 766, 704 cm
-1
. 
HRMS (CI) m/z calc. for C24H21BFN [M]
+
 353.1751, found 353.1761. 
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1-Benzyl-2,3-Diphenyl-2,1-borazaronaphthalene (4.141). Obtained as an off-white 
solid (105 mg, 85%). mp: 90-92 °C. 
1
H NMR (500 MHz, acetone-d6) δ 8.16 (s, 1H), 7.86 
(d, J = 7.6 Hz, 1H), 7.64 (d, J = 7.3 Hz, 1H), 7.47-7.43 (m, 2H), 7.39-7.35 (m, 1H), 7.31-
7.25 (m, 5H), 7.21-7.11 (m, 9H), 5.42 (s, 2H). 
13
C NMR (125.8 MHz, acetone-d6) δ 
144.4, 143.4, 140.3, 139.1, 131.2, 130.5, 128.8, 128.7, 128.5, 128.5, 127.5, 127.3, 126.8, 
126.7, 125.6, 125.5, 121.5, 117.1, 52.3. 
11
B NMR (128.38 MHz, acetone-d6) δ 34.5. IR 
(neat) 3064, 2922, 1547, 1376, 767, 702 cm
-1
. HRMS (CI) m/z calc. for C27H22BN [M]
+
 
371.1845, found 371.1840. 
 
Procedure for the reductive cross-coupling of alkyl iodides with 3-bromo-2,1-
borazaronaphthalenes. An oven-dried Biotage 10 mL microwave vial equipped with a 
magnetic stirbar was charged with the 3-bromo-2,1-borazaronaphthalene (0.5 mmol), 
alkyl iodide (0.6 mmol), NiCl2glyme (0.025 mmol, 5.5 mg), 4,4’-dimethyl-2,2’-
bipyridine (0.025 mmol, 4.6 mg), NaBF4 (0.25 mmol, 27.5 mg), and Mn powder (1.0 
mmol, 55.0 mg). The vial was sealed with a disposable Teflon septum cap and was 
evacuated and purged with Ar three times. A 2:1 mixture of cyclohexane/DMA (1.67 mL 
cyclohexane, 0.83 mL DMA) and 4-ethylpyridine (0.5 mmol, 54 mg) was added via 
syringe. The reaction was stirred under Ar with conventional heating at 40 C for 18 h, 
after which the solution was cooled and diluted with 5 mL of EtOAc. The resulting 
mixture was filtered through Celite, which was rinsed with EtOAc (~ 10 mL). The 
solution was concentrated, and the product was isolated by column chromatography, 
eluting with a gradient of EtOAc in hexanes (0 to 10% EtOAc).  
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3-(4-(N-Boc)-Piperidenyl)-2-phenyl-2,1-borazaronaphthalene (4.144). The title 
compound was obtained as an off-white solid in 78% yield (151 mg). mp 174-174 C. 
1
H 
NMR (500 MHz, CDCl3): δ 8.03 (br s, 1H), 7.91 (s, 1H), 7.70-7.65 (m, 3H), 7.50-7.46 
(m, 3H), 7.45-7.41 (m, 1H), 7.30-7.27 (m, 1H), 7.26-7.24 (m, 1H), 4.23 (br, 2H), 3.02-
2.96 (m, 1H), 2.73 (br, 2H), 1.81 (d, J = 11.7 Hz, 2H), 1.66-1.61 (m, 2H), 1.53 (s, 9H). 
13
C NMR (125.8 MHz, CDCl3): δ 154.9, 139.6, 138.9, 132.3, 129.1, 128.3, 128.0, 127.8, 
125.3, 121.3, 117.7, 79.2, 44.2, 39.3, 33.2, 28.5. 
11
B NMR (128.38 MHz, CDCl3) δ 37.9. 
FT-IR (neat): 1664, 1431, 1165 cm
-1
. HRMS (ES+) m/z calcd. for C24H30BN2O2 (M+H)
+
 
389.2400, found 389.2399. 
 
3-(4-(N-Boc)-Piperidenyl)-2-(4-fluorophenyl)-2,1-borazaronaphthalene (4.145). The 
title compound was obtained as a white solid in 96% yield (195 mg). mp 169-171 C. 
1
H 
NMR (500 MHz, CDCl3): δ 8.00 (br s, 1H), 7.89 (s, 1H), 7.66 (d, J = 7.8 Hz, 1H), 7.63-
7.60 (m, 2H), 7.43-7.40 (m, 1H), 7.30 (d, J = 8.1 Hz, 1H), 7.24-7.20 (m, 1H), 7.19-7.15 
(m, 2H), 4.17 (br, 2H), 2.94-2.90 (m, 1H), 2.69 (br, 2H), 1.80-1.76 (m, 2H), 1.66-1.62 
(m, 2H), 1.50 (s, 9H). 
13
C NMR (125.8 MHz, CDCl3): δ 163.2 (d, J = 247 Hz), 154.9, 
139.7, 138.8, 134.1 (d, J = 7.6 Hz), 129.1, 127.8, 125.3, 121.4, 117.7, 115.1 (d, J = 20 
Hz), 79.2, 44.7, 39.4, 33.1, 28.6. 
11
B NMR (128.38 MHz, CDCl3) δ 34.2. FT-IR (neat): 
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3260, 1670, 1420, 1162 cm
-1
. HRMS (ES+) m/z calcd. for C24H28BN2O2FNa (M+Na)
+
 
429.2126, found 429.2118. 
 
3-(4-(N-Boc)-Piperidenyl)-2-(3-methoxyphenyl)-2,1-borazaronaphthalene (4.146). 
The title compound was obtained a white solid in 77% yield (161 mg). mp 93-94 C. 
1
H 
NMR (500 MHz, CDCl3): δ 8.02 (br s, 1H), 7.90 (s, 1H), 7.66 (d, J = 7.8 Hz, 1H), 7.43-
7.40 (m, 2H), 7.28 (d, J = 8.3 Hz, 1H), 7.24-7.19 (m, 3H), 7.02-6.98 (m, 1H), 4.28 (br, 
2H), 3.88 (s, 3H), 3.02-2.96 (m, 1H), 2.73 (br, 2H), 1.82-1.79 (m, 2H), 1.62-1.60 (m, 
2H), 1.51 (s, 9H). 
13
C NMR (125.8 MHz, CDCl3): δ 159.1, 154.9, 139.6, 138.8, 129.2, 
129.1, 127.8, 125.3, 124.6, 121.3, 117.8, 117.7, 113.5, 79.2, 55.1, 45.0, 39.3, 33.2, 28.5 . 
11
B NMR (128.38 MHz, CDCl3) δ 35.4. FT-IR (neat): 1674, 1569, 1422, 1168 cm
-1
. 
HRMS (ES+) m/z calcd. for C25H32BN2O3 (M+H)
+
 419.2506, found 419.2518. 
 
3-(4-(N-Boc)-Piperidenyl)-2-(2,4-difluorophenyl)-2,1-borazaronaphthalene (4.147). 
The title compound was obtained as a white solid in 80% yield (170 mg). mp 170-172 
C. 
1
H NMR (500 MHz, CDCl3): δ 8.17 (br s, 1H), 7.91 (s, 1H), 7.67 (d, J = 7.8 Hz, 1H), 
7.45-7.40 (m, 2H), 7.30 (d, J = 8.1 Hz, 1H), 7.25-7.22 (m, 1H), 7.00-6.97 (m, 1H), 6.90-
6.87 (m, 1H), 4.18 (br, 2H), 2.73-2.61 (m, 3H), 1.76-1.73 (m, 2H), 1.58-1.55 (m, 2H), 
1.49 (s, 9H). 
13
C NMR (125.8 MHz, CDCl3): δ 164.8 (dd, J = 256, 13 Hz), 163.6 (dd, J = 
256, 13 Hz), 154.8, 139.9, 138.6, 134.9 (dd, J = 1, 10 Hz), 129.1, 127.8, 125.4, 121.5, 
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117.8, 111.3 (dd, J = 20, 4 Hz), 103.5 (dd, J = 29, 5 Hz), 79.2, 44.3, 39.8, 33.1, 28.4.. 
11
B 
NMR (128.38 MHz, CDCl3) δ 33.4. FT-IR (neat): 3276, 1668, 1436, 1167 cm
-1
. HRMS 
(ES+) m/z calcd. for C24H27BF2N2O2Na (M+Na)
+
 447.2031, found 447.2045. 
 
3-(4-(N-Boc)-Piperidenyl)-2-(3-carbomethoxyphenyl)-2,1-borazaronaphthalene 
(4.148). The title compound was obtained as a white solid in 74% yield (165 mg). mp 
172-174 C. 
1
H NMR (500 MHz, CDCl3): δ 8.32 (br s, 1H), 8.21 (s, 1H), 8.08 (d, J = 7.6 
Hz, 1H), 7.89 (s, 1H), 7.82 (d, J = 6.8 Hz, 1H), 7.65 (d, J = 7.6 Hz, 1H), 7.52-7.50 (m, 
1H), 7.42-7.39 (m, 1H), 7.34-7.31 (m, 1H), 7.23-7.20 (m, 1H), 4.18 (br, 2H), 3.93 (s, 
3H), 2.90-2.87 (m, 1H), 2.65 (br, 2H), 1.77-1.74 (m, 2H), 1.58-1.55 (m, 2H), 1.48 (s, 
9H). 
13
C NMR (125.8 MHz, CDCl3): δ 167.4, 154.8, 139.8, 138.8, 136.8, 136.8, 133.4, 
129.6, 129.3, 129.1, 127.9, 127.9, 125.3, 121.4, 117.8, 79.2, 52.1, 44.5, 39.4, 33.1, 28.4. 
11
B NMR (128.38 MHz, CDCl3) δ 35.0. FT-IR (neat): 3324, 1707, 1682, 1427, 1231, 
1167 cm
-1
. HRMS (ES+) m/z calcd. for C26H31BN2O4Na (M+Na)
+
 469.2275, found 
469.2273. 
 
3-(4-(N-Boc)-Piperidenyl)-2-(4-dibenzothienyl)-2,1-borazaronaphthalene (4.149). 
The title compound was obtained as an off-white solid in 74% yield (183 mg). mp 107-
109C. 
1
H NMR (500 MHz, CDCl3): δ 8.31 (br s, 1H), 8.21 (d, J = 7.6 Hz, 2H), 7.99 (s, 
478 
 
1H), 7.82 (d, J = 7.6 Hz, 1H), 7.71 (d, J = 7.6 Hz, 1H), 7.59-7.53 (m, 2H), 7.50-7.41 (m, 
3H), 7.29-7.25 (m, 2H), 4.11 (br, 2H), 2.88-2.83 (m, 1H), 2.59-2.54 (m, 2H), 1.80-1.76 
(m, 2H), 1.62-1.59 (m, 2H), 1.45 (s, 9H). 
13
C NMR (125.8 MHz, CDCl3): δ 155.1, 143.4, 
140.5, 139.7, 138.9, 137.9, 136.0, 134.9, 130.9, 129.4, 128.1, 126.8, 125.8, 124.6, 124.3, 
122.9, 121.8, 121.6, 118.2, 79.4, 44.5, 39.9, 33.3, 28.7.
 11
B NMR (128.38 MHz, CDCl3) δ 
35.0. FT-IR (neat): 1684, 1424, 1166 cm
-1
. HRMS (ES+) m/z calcd. for 
C30H31BN2O2NaS (M+Na)
+
 517.2097, found 517.2096. 
 
3-(4-(N-Boc)-Piperidenyl)-2-(4-dibenzofuranyl)-2,1-borazaronaphthalene (4.150). 
The title compound was obtained as a white solid in 89% yield (213 mg). mp 54-56 C. 
1
H NMR (500 MHz, CDCl3): δ 8.47 (br s, 1H), 8.07-8.00 (m, 3H), 7.74-7.68 (m, 2H), 
7.57 (d, J = 7.8 Hz, 1H), 7.50-7.43 (m, 3H), 7.41-7.38 (m, 1H), 7.36-7.34 (m, 1H), 7.28-
7.25 (m, 1H), 4.19 (br, 2H), 3.02-2.99 (m, 1H), 2.64 (br, 2H), 1.92-1.89 (m, 2H), 1.68-
1.65 (m, 2H), 1.49 (s, 9H). 
13
C NMR (125.8 MHz, CDCl3): δ 158.8, 155.9, 154.9, 140.0, 
138.8, 131.7, 129.1, 127.8, 127.0, 125.5, 124.3, 123.2, 122.7, 122.6, 121.4, 121.0, 120.7, 
117.9, 111.5, 79.1, 44.8, 39.7, 33.2, 28.5. 
11
B NMR (128.38 MHz, CDCl3) δ 34.4. FT-IR 
(neat): 1684, 1425, 1186, 1168 cm
-1
. HRMS (ES+) m/z calcd. for C30H32BN2O3 (M+H)
+
 
479.2506, found 479.2509. 
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3-(4-(N-Boc)-Piperidenyl)-2-methyl-2,1-borazaronaphthalene (4.151). The title 
compound was obtained as a white solid in 62% yield (101 mg). mp 131-133 C. 
1
H 
NMR (500 MHz, CDCl3): δ 7.76 (br s, 1H), 7.64 (s, 1H), 7.56 (d, J = 7.8 Hz, 1H), 7.37-
7.33 (m, 1H), 7.19 (d, J = 8.1 Hz, 1H), 7.15-7.11 (m, 1H), 4.31 (br, 2H), 2.85 (br, 2H), 
2.75-2.71 (m, 1H), 1.82-1.78 (m, 2H), 1.63-1.60 (m, 2H), 1.53 (s, 9H), 0.79 (s, 3H). 
13
C 
NMR (125.8 MHz, CDCl3): δ 154.9, 139.1, 137.2, 128.9, 127.2, 125.0, 120.6, 117.1, 
79.2, 44.5, 40.8, 32.5, 28.5. 
11
B NMR (128.38 MHz, CDCl3) δ 37.0. FT-IR (neat): 3314, 
1672, 1435, 1164 cm
-1
. HRMS (ES+) m/z calcd. for C19H27BN2O2Na (M+Na)
+
 349.2063, 
found 349.2076. 
 
3-(4-(N-Boc)-Piperidenyl)-2-cyclobutyl-2,1-borazaronaphthalene (4.152). The title 
compound was obtained as a yellow oil in 37% yield (68 mg). 
1
H NMR (500 MHz, 
CDCl3): δ 7.75 (br s, 1H), 7.66 (s, 1H), 7.56 (d, J = 7.6 Hz, 1H), 7.38-7.34 (m, 1H), 7.26 
(d, J = 8.3 Hz, 1H), 7.16-7.12 (m, 1H), 4.27 (br, 2H), 2.81 (br, 2H), 2.70-2.64 (m, 2H), 
2.29-2.26 (m, 3H), 2.13-2.10 (m, 2H), 2.01-1.99 (m, 1H), 1.77-1.74 (m, 2H), 1.59-1.54 
(m, 2H), 1.50 (s, 9H). 
13
C NMR (125.8 MHz, CDCl3): δ 154.9, 138.8, 137.8, 128.8, 
127.3, 125.2, 120.7, 117.3, 79.2, 44.8, 39.9, 32.3, 28.4, 25.7, 22.2. 
11
B NMR (128.38 
MHz, CDCl3) δ 36.8. FT-IR (neat): 1684, 1674, 1425, 1168 cm
-1
. HRMS (ES+) m/z 
calcd. for C22H32BN2O2 (M+H)
+
 367.2557, found 367.2551. 
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3-(4-(N-Boc)-Piperidenyl)-2-cyclopropyl-2,1-borazaronaphthalene (4.153). The title 
compound was obtained as a white solid in 88% yield (155 mg). mp 199-202 C. 
1
H 
NMR (500 MHz, CDCl3): δ 7.62 (s, 1H), 7.54 (d, J = 7.6 Hz, 1H), 7.33-7.29 (m, 1H), 
7.14-7.10 (m, 3H), 4.30 (br, 2H), 2.93-2.86 (m, 3H), 1.94-1.92 (m, 2H), 1.68-1.64 (m, 
2H), 1.52 (s, 9H), 0.92-0.89 (m, 2H), 0.56-0.52 (m, 3H). 
13
C NMR (125.8 MHz, CDCl3): 
δ 154.9, 138.9, 136.9, 128.8, 127.2, 124.9, 120.5, 117.1, 79.2, 44.6, 40.6, 32.6, 28.5, 6.1. 
11
B NMR (128.38 MHz, CDCl3) δ 36.7. FT-IR (neat): 3318, 1670, 1430, 1159, 1122 cm
-
1
. HRMS (CI) m/z calcd. for C21H29BN2O2 (M)
+
 352.2322, found 352.2321. 
 
1-Benzyl-3-(4-(N-Boc)-piperidenyl)-2-methyl-2,1-borazaronaphthalene (4.154). The 
title compound was obtained as a light yellow solid in 84% yield (175 mg). mp 47-50 C. 
1
H NMR (500 MHz, CDCl3): δ 7.72 (s, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.33-7.29 (m, 4H), 
7.27-7.24 (m, 1H), 7.17-7.13 (m, 3H), 5.36 (s, 2H), 4.36 (br, 2H), 2.91-2.85 (m, 3H), 
1.92-1.88 (m, 2H), 1.68-1.65 (m, 2H), 1.57 (s, 9H), 0.90 (s, 3H).. 
13
C NMR (125.8 MHz, 
CDCl3): δ 154.9, 140.5, 138.4, 137.5, 129.8, 128.7, 127.6, 126.8, 126.3, 125.7, 120.6, 
115.6, 79.3, 51.2, 44.8, 40.3, 32.7, 28.5.
 11
B NMR (128.38 MHz, CDCl3) δ 39.2. FT-IR 
(neat): 1689, 1424, 1364, 1230, 1168 cm
-1
. HRMS (ES+) m/z calcd. for C26H33BN2O2Na 
(M+Na)
+
 439.2533, found 439.2530. 
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1-Allyl-3-(4-(N-Boc)-piperidenyl)-2-methyl-2,1-borazaronaphthalene (4.155). The 
title compound was obtained as an off-white solid in 51% yield (93 mg). mp 146-148 C. 
1
H NMR (500 MHz, CDCl3): δ 7.62-7.58 (m, 2H), 7.42-7.39 (m, 2H), 7.17-7.15 (m, 1H), 
6.08-6.01 (m, 1H), 5.15 (dd, J = 10.5, 1.5 Hz 1H), 4.98 (dd, J = 17.2, 1.3 Hz, 1H), 4.72-
4.69 (m, 2H), 4.31 (br, 2H), 2.86-2.79 (m, 3H), 1.83-1.80 (m, 2H), 1.58-1.52 (m, 2H), 
1.48 (s, 9H), 0.84 (s, 3H). 
13
C NMR (125.8 MHz, CDCl3): δ 154.9, 140.3, 137.1, 134.3, 
129.7, 127.4, 126.1, 120.3, 115.5, 115.0, 79.2, 49.5, 44.5, 40.3, 32.6, 28.5.
 11
B NMR 
(128.38 MHz, CDCl3) δ 39.2. FT-IR (neat): 1671, 1426, 1162, 1120cm
-1
. HRMS (ES+) 
m/z calcd. for C22H31BN2O2Na (M+Na)
+
 389.2376, found 389.2367. 
 
1-Allyl-3-(4-(N-Boc)-piperidenyl)-2-phenyl-2,1-borazaronaphthalene (4.156). The 
title compound was obtained as a light yellow oil in 90% yield (193 mg). 
1
H NMR (500 
MHz, CDCl3): δ 7.87 (s, 1H), 7.72-7.69 (m, 1H), 7.52-7.42 (m, 7H), 7.28-7.25 (m, 1H), 
5.97-5.94 (m, 1H), 5.16 (d, J = 10.3 Hz, 1H), 4.96 (d, J = 17.4 Hz, 1H), 4.65-4.62 (m, 
2H), 4.17 (br, 2H), 2.57-2.50 (m, 3H), 1.72-1.70 (m, 2H), 1.56-1.48 (m, 11H). 
13
C NMR 
(125.8 MHz, CDCl3): δ 154.8, 139.8, 139.3, 135.1, 130.1, 129.9, 127.8, 127.6, 127.3, 
127.7, 121.1, 116.2, 115.8, 79.1, 51.1, 44.6, 39.9, 32.9, 28.5. 
11
B NMR (128.38 MHz, 
CDCl3) δ 37.5. FT-IR (neat): 1689, 1427, 1364, 1168 cm
-1
. HRMS (ES+) m/z calcd. for 
C27H33BN2O2Na (M+Na)
+
 451.2533, found 451.2533 
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3-(3-(N-Boc)-Azetidinyl)-2-phenyl-2,1-borazaronaphthalene (4.157). The title 
compound was obtained as an off-white solid in 61% yield (110 mg). mp 46-48 C. 
1
H 
NMR (500 MHz, CDCl3): δ 8.02 (s, 1H), 7.96 (s, 1H), 7.70-7.67 (m, 1H), 7.57-7.54 (m, 
2H), 7.45-7.41 (m, 4H), 7.30-7.26 (m, 1H), 7.25-7.22 (m, 1H), 4.17-4.14 (m, 2H), 4.12-
4.08 (m, 1H), 3.95 (br, 2H), 1.46 (s, 9H). 
13
C NMR (125.8 MHz, CDCl3): δ 156.5, 139.9, 
139.1, 132.2, 129.1, 128.6, 128.2, 128.0, 124.9, 121.4, 117.8, 79.2, 32.2, 28.4, 27.6. 
11
B 
NMR (128.38 MHz, CDCl3) δ 34.5. FT-IR (neat): 1682, 1410, 1366, 1150 cm
-1
. HRMS 
(ES+) m/z calcd. for C22H26BN2O2 (M+H)
+
 361.2087, found 361.2094. 
 
2-Phenyl-3-(4-tetrahydro-2H-pyranyl)-2,1-borazaronaphthalene (4.158). The title 
compound was obtained as a light brown oil in 90% yield (130 mg). 
1
H NMR (500 MHz, 
CDCl3): δ 8.01 (br s, 1H), 7.96 (s, 1H), 7.72-7.68 (m, 3H), 7.53-7.43 (m, 4H), 7.32-7.24 
(m, 2H), 4.09-4.06 (m, 2H), 3.51-3.46 (m, 2H), 3.14-3.09 (m, 1H), 1.84-1.74 (m, 4H). 
13
C 
NMR (125.8 MHz, CDCl3): δ 139.6, 138.9, 132.2, 129.1, 128.3, 128.0, 127.8, 125.3, 
121.3, 117.7, 117.6, 68.6, 38.4, 34.0. 
11
B NMR (128.38 MHz, CDCl3) δ 34.5. FT-IR 
(neat): 1734, 1721, 1242 cm
-1
. HRMS (CI+) m/z calcd. for C19H21BNO (M+H)
+
 
290.1716, found 290.1730. 
 
2-Phenyl-3-(3-tetrahydrofuranyl)-2,1-borazaronaphthalene (4.159). The title 
compound was obtained as a light brown oil in 48% yield (66 mg). 
1
H NMR (500 MHz, 
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CDCl3): δ 8.03 (s, 1H), 8.00 (s, 1H), 7.70-7.76 (m, 3H), 7.50-7.44 (m, 4H), 7.30-7.24 (m, 
2H), 4.09-4.04 (m, 2H), 3.94-3.89 (m, 1H), 3.79-3.68 (m, 2H), 2.31-2.25 (m, 1H), 2.07-
2.00 (m, 1H). 
13
C NMR (125.8 MHz, CDCl3): δ 140.0, 138.9, 132.4, 129.2, 128.4, 128.0, 
127.9, 125.2, 121.3, 117.7, 74.8, 68.2, 42.3, 34.5. 
11
B NMR (128.38 MHz, CDCl3) δ 34.5. 
FT-IR (neat): 1615, 1567, 1429, 1239 cm
-1
. HRMS (CI+) m/z calcd. for C18H19BNO 
(M+H)
+
 276.1560, found 276.1567. 
 
3-(3-Oxetanyl)-2-phenyl-2,1-borazaronaphthalene (4.160). The title compound was 
obtained as an off-white solid in 59% yield (77 mg). mp 117-119 C. 
1
H NMR (500 
MHz, CDCl3): δ 8.10 (s, 2H), 7.74 (d, J = 7.8 Hz, 1H), 7.60-7.55 (m, 2H), 7.49-7.44 (m, 
4H), 7.32-7.26 (m, 2H), 4.96-4.93 (m, 2H), 4.82-4.79 (m, 2H), 4.65-4.62 (m, 1H). 
13
C 
NMR (125.8 MHz, CDCl3): δ 139.9, 139.1, 132.2, 129.2, 128.6, 128.1, 125.1, 121.5, 
117.8, 117.8, 78.6, 38.7. 
11
B NMR (128.38 MHz, CDCl3) δ 34.0. FT-IR (neat): 3286, 
1616, 1574, 1458 cm
-1
. HRMS (ES+) m/z calcd. for C7H16BNO (M)
 +
 261.1325, found 
261.1326. 
 
3-Cyclohexyl-2-phenyl-2,1-borazaronaphthalene (4.161). The title compound was 
obtained as a white solid in 62% yield (89 mg). mp 86-87 C. 
1
H NMR (500 MHz, 
CDCl3): δ 7.90 (s, 1H), 7.66-7.62 (m, 3H), 7.46-7.42 (m, 3H), 7.38-7.35 (m, 1H), 7.24-
7.20 (m, 2H), 7.18-7.15 (m, 1H), 2.83-2.80 (m, 1H), 1.86-1.83 (m, 2H), 1.80-1.76 (m, 
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2H), 1.72-1.69 (m, 1H), 1.41-1.27 (m, 5H). 
13
C NMR (125.8 MHz, CDCl3): δ 139.0, 
138.8, 132.5, 129.0, 127.9, 127.4, 125.6, 121.1, 117.7, 117.6, 41.1, 34.6, 27.1, 26.4. 
11
B 
NMR (128.38 MHz, CDCl3) δ 34.4. FT-IR (neat): 2927, 1613, 1422 cm
-1
. HRMS (ES+) 
m/z calcd. for C20H22BN (M)
+
 287.1845, found 287.1845. 
 
3-Butyl-2-phenyl-2,1-borazaronaphthalene (4.162). The title compound was obtained 
as a light brown oil in 70% yield (91 mg). 
1
H NMR (500 MHz, CDCl3): δ 7.91 (s, 1H), 
7.86 (s, 1H), 7.72-7.69 (m, 2H), 7.65-7.62 (m, 1H), 7.48-7.42 (m, 3H), 7.41-7.38 (m, 
1H), 7.27-7.23 (m, 1H), 7.22-7.18 (m, 1H), 2.77-2.73 (m, 2H), 1.52-1.48 (m, 2H), 1.37-
1.32 (m, 2H), 0.90-0.87 (m, 3H). 
13
C NMR (125.8 MHz, CDCl3): δ 141.8, 139.0, 132.5, 
128.8, 128.4, 128.0, 127.3, 125.5, 121.1, 117.7, 34.9, 33.5, 22.7, 14.0. 
11
B NMR (128.38 
MHz, CDCl3) δ33.6. FT-IR (neat): 1614, 1566, 1423 cm
-1
. HRMS (ES+) m/z calcd. for 
C18H20BN (M)
+
 261.1689, found 261.1697. 
 
4-(2-Phenyl-2,1-borazaronaphthyl)butyl acetate (4.163). The title compound was 
obtained as a light brown oil in 91% yield (145 mg). 
1
H NMR (500 MHz, CDCl3): δ 7.99 
(br s, 1H), 7.88 (s, 1H), 7.73-7.70 (m, 2H), 7.67 (d, J = 7.8 Hz, 1H), 7.51-7.40 (m, 4H), 
7.31-7.28 (m, 1H), 7.24-7.21 (m, 1H), 4.04 (t, J = 6.5 Hz, 2H), 2.81 (t, J = 7.5 Hz, 2H), 
2.03 (s, 3H), 1.67-1.62 (m, 2H), 1.61-1.56 (m, 2H). 
13
C NMR (125.8 MHz, CDCl3): δ 
171.2, 142.1, 139.1, 132.3, 128.8, 128.4, 128.0, 127.5, 125.3, 121.2, 117.7, 64.4, 34.8, 
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28.4, 27.3, 21.0. 
11
B NMR (128.38 MHz, CDCl3) δ 34.6. FT-IR (neat): 1734, 1722, 1615, 
1241 cm
-1
. HRMS (CI) m/z calcd. for C20H22BNO2 (M)
+
 319.1744, found 319.1732. 
 
6-(4-(N-Boc)-Piperidinyl)-2-methyl-3-phenyl-2,1-borazaronaphthalene (4.164). The 
title compound was obtained as a white solid in 51% yield (102 mg). mp 62-64 C. 1H 
NMR (500 MHz, CDCl3): δ 7.86 (br s, 2H), 7.48-7.44 (m, 5H), 7.35-7.32 (m, 1H), 7.29-
7.26 (m, 1H), 7.21 (d, J = 8.1 Hz, 1H), 4.31 (br, 2H), 2.86 (br, 2H), 2.75-2.72 (m, 1H), 
1.91-1.88 (m, 2H), 1.72-1.67 (m, 2H), 1.54 (s, 9H), 0.85 (s, 3H). 13C NMR (125.8 MHz, 
CDCl3): δ 154.8, 144.8, 141.3, 138.3, 138.2, 128.1, 128.1, 127.0, 126.9, 125.9, 124.9, 
117.4, 79.4, 44.7, 42.1, 33.5, 28.5. 
11
B NMR (128.38 MHz, CDCl3) δ 37.3. FT-IR (neat): 
3314, 2932, 1673, 1164 cm-1. HRMS (ES+) m/z calcd. for C25H31BN2O2Na (M+Na)+ 
425.2376, found 425.2377. 
Computational Study. Calculations were performed using the Gaussian 09 software 
package.
75
 The geometries were optimized at the B3LYP/6-311G(d) level, and molecular 
orbitals and molecular energies were calculated at the same level. 
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Appendix 1A: High-Throughput Experimentation Data Relevant to Chapter 2  
494 
 
High Throughput Experimentation was performed at the Penn/Merck Center for 
High Throughput Experimentation at the University of Pennsylvania. The screens were 
analyzed by HPLC with addition of an internal standard. The areas for the internal 
standard (IS), aryl chloride (ArCl), and product (P or Prod) from each of the four screens 
are shown in the tables below. The ratios calculated are pertinent only to that specific 
screen; the ratios from one screen should not be qualitatively compared to those from a 
different screen. 
The results of the screens can be illustrated in a heat map. The information 
conveyed in these heat maps is two-fold. First, the size of the circle corresponds to the 
amount of product. The larger the circle, the more product formed during the reaction. 
Secondly, the shade of the circle corresponds to the amount of starting material, in this 
case aryl chloride, remaining. The darker the circle, the less aryl chloride remaining after 
24 h. Therefore, for a reaction resulting in high conversion and product formation, the 
circle will be both large and dark.  
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Table A1A.1. Structures of Ligands From Various Screens 
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Screen 1 (Figure 2.4): 
 
Solvent 
 
Base (3 equiv) 
 
L-Pd-G2 
4:1 t-BuOH:H2O 
 
CsHCO3 
 
XPhos 
4:1 t-BuOH:t-amylOH 
 
Cs2CO3 
 
cataCXium A 
4:1 t-BuOH:THF 
 
K3PO4 
 
P-tBu3 
4:1 CPME:H2O 
 
K2CO3 
 
A
ta
-Phos 
4:1 CPME:t-amylOH 
    4:1 CPME: t-BuOH 
    
Screen 1 Heat Map: 
 
Screen 1 Results: 
Location 
 
IS Area 
 
ArCl Area 
 
Prod Area 
 
P/IS 
 
ArCl/IS 
A01 
 
273.01259 
 
1001.98423 
   
0 
 
3.6701 
B01 
 
229.21245 
 
644.85011 
   
0 
 
2.8133 
C01 
 
271.25792 
 
646.6404 
 
16.15361 
 
0.06 
 
2.3839 
D01 
 
265.69036 
 
679.98881 
   
0 
 
2.5593 
E01 
 
293.80846 
 
1006.57144 
   
0 
 
3.4259 
F01 
 
265.38338 
 
745.36269 
 
15.55413 
 
0.06 
 
2.8086 
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G01 
 
255.81008 
 
575.07393 
 
25.78752 
 
0.1 
 
2.2481 
H01 
 
267.38812 
 
818.45457 
   
0 
 
3.0609 
A02 
 
257.99959 
 
962.25614 
   
0 
 
3.7297 
B02 
 
226.56284 
 
629.69197 
   
0 
 
2.7793 
C02 
 
313.18454 
 
872.02727 
   
0 
 
2.7844 
D02 
 
244.64375 
 
741.13471 
 
11.2149 
 
0.05 
 
3.0294 
E02 
 
219.24168 
 
882.18114 
   
0 
 
4.0238 
F02 
 
251.75325 
 
533.85036 
 
25.73414 
 
0.1 
 
2.1205 
G02 
 
309.80169 
 
795.11938 
 
19.73312 
 
0.06 
 
2.5665 
H02 
 
257.91858 
 
765.45904 
   
0 
 
2.9678 
A03 
 
316.99316 
 
1825.25427 
 
45.09387 
 
0.14 
 
5.758 
B03 
 
262.47303 
 
709.9745 
 
11.16186 
 
0.04 
 
2.7049 
C03 
 
308.54396 
 
230.9185 
 
5.18003 
 
0.02 
 
0.7484 
D03 
 
275.29838 
 
822.97389 
   
0 
 
2.9894 
E03 
 
258.36931 
 
991.68266 
   
0 
 
3.8382 
F03 
 
250.425 
 
739.64514 
 
22.0175 
 
0.09 
 
2.9536 
G03 
 
288.15452 
 
801.43935 
   
0 
 
2.7813 
H03 
 
279.7989 
 
830.2226 
 
13.37134 
 
0.05 
 
2.9672 
A04 
 
215.56077 
 
1249.63404 
   
0 
 
5.7971 
B04 
 
195.59833 
 
617.41005 
 
19.4483 
 
0.1 
 
3.1565 
C04 
 
222.47653 
 
869.09351 
 
28.19541 
 
0.13 
 
3.9065 
D04 
 
226.60899 
 
892.5033 
   
0 
 
3.9385 
E04 
 
222.81986 
 
1005.11493 
   
0 
 
4.5109 
F04 
 
239.43893 
 
1044.85185 
   
0 
 
4.3638 
G04 
 
212.0377 
 
831.55122 
 
25.28966 
 
0.12 
 
3.9217 
H04 
 
212.33726 
 
802.39642 
   
0 
 
3.7789 
A05 
 
259.15407 
 
974.62049 
   
0 
 
3.7608 
B05 
 
209.10606 
 
997.81072 
   
0 
 
4.7718 
C05 
 
252.77011 
 
1299.64994 
   
0 
 
5.1416 
D05 
 
214.35548 
 
790.29836 
 
14.09689 
 
0.07 
 
3.6869 
E05 
 
212.70046 
 
936.56478 
   
0 
 
4.4032 
F05 
 
227.85866 
 
1127.90709 
   
0 
 
4.95 
G05 
 
241.71385 
 
1110.84072 
   
0 
 
4.5957 
H05 
 
217.2052 
 
867.24478 
   
0 
 
3.9927 
A06 
 
196.05566 
 
839.89239 
   
0 
 
4.2839 
B06 
 
192.51888 
 
1043.04605 
 
23.31962 
 
0.12 
 
5.4179 
C06 
 
215.99574 
 
792.65936 
 
36.02015 
 
0.17 
 
3.6698 
D06 
 
183.30396 
 
707.03115 
   
0 
 
3.8572 
E06 
 
200.20934 
 
978.95304 
   
0 
 
4.8896 
F06 
 
198.76781 
 
960.39916 
 
11.62938 
 
0.06 
 
4.8318 
G06 
 
200.91813 
 
824.41393 
 
11.14574 
 
0.06 
 
4.1032 
H06 
 
189.26827 
 
852.71168 
 
9.46851 
 
0.05 
 
4.5053 
A07 
 
200.80761 
 
790.04669 
 
61.25332 
 
0.31 
 
3.9343 
B07 
 
196.08237 
 
618.51315 
 
113.54289 
 
0.58 
 
3.1544 
C07 
 
207.00702 
 
654.87341 
 
100.53889 
 
0.49 
 
3.1635 
D07 
 
196.73183 
 
631.7219 
 
57.63741 
 
0.29 
 
3.2111 
E07 
 
199.65492 
 
959.28514 
 
10.78712 
 
0.05 
 
4.8047 
F07 
 
193.04549 
 
711.98377 
 
24.1984 
 
0.13 
 
3.6882 
498 
 
G07 
 
194.70098 
 
753.76806 
 
29.92275 
 
0.15 
 
3.8714 
H07 
 
205.20112 
 
772.93214 
 
25.0077 
 
0.12 
 
3.7667 
A08 
 
200.59681 
 
1466.65866 
 
24.95898 
 
0.12 
 
7.3115 
B08 
 
223.51014 
 
847.84763 
 
32.70336 
 
0.15 
 
3.7933 
C08 
 
216.08867 
 
589.69492 
 
26.3456 
 
0.12 
 
2.7289 
D08 
 
184.13735 
 
688.91307 
   
0 
 
3.7413 
E08 
 
205.2393 
 
982.52858 
   
0 
 
4.7872 
F08 
 
236.76923 
 
1068.04627 
 
10.3631 
 
0.04 
 
4.5109 
G08 
 
225.24082 
 
808.58874 
   
0 
 
3.5899 
H08 
 
238.60697 
 
828.72846 
   
0 
 
3.4732 
A09 
 
205.31236 
 
724.65595 
   
0 
 
3.5295 
B09 
 
221.0624 
 
727.00912 
 
20.12311 
 
0.09 
 
3.2887 
C09 
 
225.4228 
 
518.23398 
 
6.61018 
 
0.03 
 
2.2989 
D09 
 
229.70311 
 
1342.67285 
 
48.54437 
 
0.21 
 
5.8453 
E09 
 
216.33379 
 
1002.65833 
   
0 
 
4.6348 
F09 
 
239.69731 
 
822.79315 
 
11.88522 
 
0.05 
 
3.4326 
G09 
 
220.7015 
 
1181.43171 
 
16.37392 
 
0.07 
 
5.3531 
H09 
 
214.15892 
 
638.54436 
 
10.91521 
 
0.05 
 
2.9816 
A10 
 
198.90236 
 
700.58945 
 
53.23427 
 
0.27 
 
3.5223 
B10 
 
197.18681 
 
599.84543 
 
233.11075 
 
1.18 
 
3.042 
C10 
 
190.60375 
 
552.83933 
 
235.70918 
 
1.24 
 
2.9005 
D10 
 
194.84579 
 
1442.84037 
 
91.85798 
 
0.47 
 
7.405 
E10 
 
204.55364 
 
892.8795 
 
12.04972 
 
0.06 
 
4.365 
F10 
 
205.19195 
 
879.79314 
 
15.16576 
 
0.07 
 
4.2877 
G10 
 
197.87299 
 
867.2642 
 
30.29703 
 
0.15 
 
4.3829 
H10 
 
205.54436 
 
876.90032 
 
14.22274 
 
0.07 
 
4.2662 
A11 
 
183.09199 
 
660.36146 
   
0 
 
3.6067 
B11 
 
195.27976 
 
1045.23509 
   
0 
 
5.3525 
C11 
 
204.09621 
 
817.10002 
 
27.78075 
 
0.14 
 
4.0035 
D11 
 
186.00974 
 
692.60217 
 
12.30907 
 
0.07 
 
3.7235 
E11 
 
207.11689 
 
932.07889 
   
0 
 
4.5003 
F11 
 
214.3589 
 
1204.83569 
   
0 
 
5.6206 
G11 
 
217.82467 
 
908.20707 
 
12.43616 
 
0.06 
 
4.1694 
H11 
 
196.62217 
 
845.24676 
   
0 
 
4.2988 
A12 
 
192.43033 
 
707.45739 
   
0 
 
3.6764 
B12 
 
228.16678 
 
1150.66535 
 
53.2765 
 
0.23 
 
5.0431 
C12 
 
192.20769 
 
734.61952 
 
30.86396 
 
0.16 
 
3.822 
D12 
 
187.11993 
 
640.84863 
 
14.20638 
 
0.08 
 
3.4248 
E12 
 
196.2484 
 
915.0931 
   
0 
 
4.6629 
F12 
 
202.19771 
 
1079.19054 
   
0 
 
5.3373 
G12 
 
183.4634 
 
722.71876 
   
0 
 
3.9393 
H12 
 
198.86228 
 
905.49961 
   
0 
 
4.5534 
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Screen 2 (Figure 2.5): 
 
Solvent 
 
Base (3 equiv) 
 
Palladium 
 
Ligand 
4:1 CPME:H2O 
 
K3PO4 
 
cataCXium A-Pd-G2 
 
cataCXium A 
1:1 CPME:H2O 
 
Cs2CO3 
 
Pd(OAc)2 
  
    
[Pd(allyl)Cl]2 
  
    
Pd(dba)2 
  
    
Pd(cod)Cl2 
  
    
[(Cinnamyl)PdCl]2 
  Note: 20% Ligand added for non-precatalyst 
Screen 2 Heat Map: 
 
Information from Screen 2: 
Location 
 
IS Area 
 
Prod Area 
 
ArCl Area 
 
P/IS 
 
ArCl/IS 
A01 
 
366.67552 
 
313.69574 
 
702.97969 
 
0.8555 
 
1.9172 
B01 
 
390.85083 
 
657.26345 
 
432.03701 
 
1.6816 
 
1.1054 
C01 
 
397.54437 
   
1287.42158 
 
0 
 
3.2384 
D01 
 
400.45724 
   
1354.43888 
 
0 
 
3.3822 
E01 
 
366.06179 
 
321.19127 
 
826.03711 
 
0.8774 
 
2.2566 
F01 
 
394.4888 
 
662.82335 
 
529.72384 
 
1.6802 
 
1.3428 
G01 
 
373.31322 
   
1204.3483 
 
0 
 
3.2261 
H01 
 
397.3634 
   
1218.63361 
 
0 
 
3.0668 
A02 
 
363.59806 
 
229.70879 
 
758.5674 
 
0.6318 
 
2.0863 
B02 
 
408.07703 
 
597.81479 
 
541.70434 
 
1.465 
 
1.3275 
C02 
 
361.96313 
   
947.32074 
 
0 
 
2.6172 
D02 
 
393.54764 
   
1264.33916 
 
0 
 
3.2127 
500 
 
E02 
 
356.60776 
 
238.63577 
 
738.33712 
 
0.6692 
 
2.0704 
F02 
 
380.46389 
 
434.10184 
 
650.9882 
 
1.141 
 
1.711 
G02 
 
423.4466 
   
1116.52388 
 
0 
 
2.6368 
H02 
 
381.40903 
   
1075.04679 
 
0 
 
2.8186 
A03 
 
375.7211 
 
238.18664 
 
853.22893 
 
0.6339 
 
2.2709 
B03 
 
395.89561 
 
553.5754 
 
702.54098 
 
1.3983 
 
1.7746 
C03 
 
381.10489 
   
1037.69233 
 
0 
 
2.7229 
D03 
 
401.31974 
   
1332.92551 
 
0 
 
3.3214 
E03 
 
375.82019 
 
211.17661 
 
1041.30482 
 
0.5619 
 
2.7708 
F03 
 
351.31015 
 
440.59621 
 
606.72903 
 
1.2542 
 
1.727 
G03 
 
369.48841 
   
1347.81917 
 
0 
 
3.6478 
H03 
 
376.55526 
   
1173.3259 
 
0 
 
3.1159 
A04 
 
373.37499 
 
92.49766 
 
1171.55909 
 
0.2477 
 
3.1378 
B04 
 
396.8295 
 
121.47787 
 
1198.4994 
 
0.3061 
 
3.0202 
C04 
 
370.09618 
   
1056.27346 
 
0 
 
2.8541 
D04 
 
417.10652 
   
1316.8788 
 
0 
 
3.1572 
E04 
 
331.3206 
 
108.55002 
 
1275.03058 
 
0.3276 
 
3.8483 
F04 
 
357.78148 
 
127.65154 
 
1011.11374 
 
0.3568 
 
2.8261 
G04 
 
358.54736 
   
1251.37167 
 
0 
 
3.4901 
H04 
 
377.11878 
   
1078.3757 
 
0 
 
2.8595 
A05 
 
388.55317 
 
13.81871 
 
1269.81986 
 
0.0356 
 
3.2681 
B05 
 
398.53135 
 
27.63039 
 
1527.0883 
 
0.0693 
 
3.8318 
C05 
 
399.64078 
   
1418.1123 
 
0 
 
3.5485 
D05 
 
396.54656 
   
1684.11168 
 
0 
 
4.2469 
E05 
 
361.9178 
 
22.18704 
 
1265.7568 
 
0.0613 
 
3.4974 
F05 
 
381.55221 
 
17.40626 
 
1431.21755 
 
0.0456 
 
3.751 
G05 
 
390.35236 
   
1421.93608 
 
0 
 
3.6427 
H05 
 
382.14138 
   
1647.49897 
 
0 
 
4.3112 
A06 
 
368.33707 
 
171.00205 
 
885.49953 
 
0.4643 
 
2.404 
B06 
 
400.97098 
 
417.17059 
 
754.81638 
 
1.0404 
 
1.8825 
C06 
 
343.20969 
   
951.22999 
 
0 
 
2.7716 
D06 
 
387.76579 
   
1313.71102 
 
0 
 
3.3879 
E06 
 
354.52513 
 
172.06766 
 
862.39965 
 
0.4853 
 
2.4325 
F06 
 
377.13769 
 
381.86172 
 
761.48614 
 
1.0125 
 
2.0191 
G06 
 
411.1072 
   
1009.84329 
 
0 
 
2.4564 
H06 
 
416.5657 
   
1459.96826 
 
0 
 
3.5048 
A07 
 
309.07965 
 
67.83319 
 
971.7857 
 
0.2195 
 
3.1441 
B07 
 
310.7952 
 
379.23833 
 
667.41426 
 
1.2202 
 
2.1474 
C07 
 
312.828 
   
1301.8756 
 
0 
 
4.1616 
D07 
 
327.36212 
   
1359.85975 
 
0 
 
4.154 
E07 
 
298.51818 
 
51.58065 
 
1015.79716 
 
0.1728 
 
3.4028 
F07 
 
293.68037 
 
275.65657 
 
670.70228 
 
0.9386 
 
2.2838 
G07 
 
336.15936 
   
1596.22077 
 
0 
 
4.7484 
H07 
 
326.40841 
   
1372.38357 
 
0 
 
4.2045 
A08 
 
314.59912 
 
18.12377 
 
1351.35466 
 
0.0576 
 
4.2955 
B08 
 
325.571 
 
21.93253 
 
1476.45106 
 
0.0674 
 
4.535 
C08 
 
311.30719 
   
1048.11878 
 
0 
 
3.3668 
D08 
 
337.92968 
   
1284.26648 
 
0 
 
3.8004 
501 
 
E08 
 
294.84666 
 
25.95656 
 
1351.79183 
 
0.088 
 
4.5847 
F08 
 
315.2447 
 
62.30438 
 
1398.14149 
 
0.1976 
 
4.4351 
G08 
 
317.8964 
   
2054.17454 
 
0 
 
6.4618 
H08 
 
331.69916 
   
1628.22267 
 
0 
 
4.9087 
A09 
 
313.28462 
   
1347.01269 
 
0 
 
4.2996 
B09 
 
297.9903 
   
1428.49236 
 
0 
 
4.7938 
C09 
 
311.91612 
   
1052.55118 
 
0 
 
3.3745 
D09 
 
331.01794 
   
1385.84227 
 
0 
 
4.1866 
E09 
 
297.93419 
   
1311.43624 
 
0 
 
4.4018 
F09 
 
285.7645 
   
1260.13699 
 
0 
 
4.4097 
G09 
 
355.97512 
   
1410.34508 
 
0 
 
3.9619 
H09 
 
393.61931 
   
1216.15624 
 
0 
 
3.0897 
A10 
 
322.04676 
 
19.92597 
 
1385.09681 
 
0.0619 
 
4.3009 
B10 
 
280.19549 
   
1229.84363 
 
0 
 
4.3892 
C10 
 
324.71203 
   
1169.9111 
 
0 
 
3.6029 
D10 
 
339.37893 
   
1427.31497 
 
0 
 
4.2057 
E10 
 
299.06458 
 
17.7064 
 
1351.0983 
 
0.0592 
 
4.5177 
F10 
 
323.32254 
 
64.08475 
 
1424.59962 
 
0.1982 
 
4.4061 
G10 
 
354.59055 
   
1160.31803 
 
0 
 
3.2723 
H10 
 
317.31458 
   
1107.28758 
 
0 
 
3.4896 
A11 
 
315.69217 
   
1471.55032 
 
0 
 
4.6613 
B11 
 
282.58658 
   
1436.21791 
 
0 
 
5.0824 
C11 
 
315.80072 
   
1392.85275 
 
0 
 
4.4105 
D11 
 
336.33282 
   
1831.71645 
 
0 
 
5.4461 
E11 
 
306.12592 
   
1492.76988 
 
0 
 
4.8763 
F11 
 
282.27745 
 
11.14552 
 
1386.60423 
 
0.0395 
 
4.9122 
G11 
 
330.03778 
   
1710.13686 
 
0 
 
5.1816 
H11 
 
329.4421 
   
1106.76325 
 
0 
 
3.3595 
A12 
 
318.75391 
 
13.12016 
 
1294.32972 
 
0.0412 
 
4.0606 
B12 
 
278.40727 
 
13.25234 
 
1292.76396 
 
0.0476 
 
4.6434 
C12 
 
322.34297 
   
1058.9555 
 
0 
 
3.2852 
D12 
 
331.83339 
 
16.39966 
 
1347.25606 
 
0.0494 
 
4.06 
E12 
 
296.54588 
 
18.48805 
 
1290.78297 
 
0.0623 
 
4.3527 
F12 
 
325.08075 
 
31.6795 
 
1450.89965 
 
0.0975 
 
4.4632 
G12 
 
327.4695 
   
904.73715 
 
0 
 
2.7628 
H12 
 
329.19278 
 
27.0437 
 
468.34031 
 
0.0822 
 
1.4227 
 
  
502 
 
Screen 3 (Figure 2.6): Note that in cases where a precatalyst was used, [Pd(allyl)Cl]2was 
not added. 
 
Solvent 
 
Palladium 
 
Base 
 
Ligand 
1:1 THF:H2O 
 
[Pd(allyl)Cl]2 
 
Cs2CO3 
 
See table below 
1:1 Dioxane:H2O 
      
       Note: 20% Ligand added for non-precatalyst 
Screen 3 Heat Map: 
 
Information from Screen 3: 
  1/7 2/8 3/9 4/10 5/11 6/12 
A PtBu3 
Catacxium  
Pint B RuPhos Qphos CyJohnPhos 
Catacxium  
POMeCy 
B Xphos JohnPhos P(o-tol)3 tBuXPhos Symphos I tBuMePhos 
C tBu-Xphos A
ta
-Phos BrettPhos 
Me4-tBu-
XPhos Symphos II MePhos 
D RuPhos Trippyphos PCy3 DPPF 
Catacxium 
Pcy 
Catacxium  
POMetB 
503 
 
E SPhos Bippyphos BINAP DTBPF 
Catacxium 
PtB PPh3 
F BrettPhos MorDalPhos PtBu3 A
ca
-Phos 
Catacxium 
PICy XPhos 
G 
Catacxium 
A tBuBrettPhos Xantphos MeDalPhos 
Catacxium 
PinCy DPPF 
H PCy3 SPhos DavePhos 
Catacxium 
ABn 
cataCXium 
A XPhos 
 
L-Pd-G2 (Buchwald’s 2
nd
 
Generation Precatalyst) 
    
 
L-Pd-G1 (Buchwald’s 1
st
 
Generation Precatalyst) 
 
 
     
Location 
 
IS Area 
 
Prod Area 
 
ArCl Area 
 
P/IS 
 
ArCl/IS 
    A01 
 
81.768 
 
15.0058 
 
153.16039 
 
0.1835 
 
1.87312 
B01 
 
66.053 
 
8.84916 
 
174.26099 
 
0.134 
 
2.63821 
C01 
 
80.067 
   
136.15915 
 
0 
 
1.70057 
D01 
 
83.632 
 
5.39888 
 
183.47646 
 
0.0646 
 
2.19386 
E01 
 
80.938 
 
13.98691 
 
183.06621 
 
0.1728 
 
2.26181 
F01 
 
87.832 
   
179.84553 
 
0 
 
2.0476 
G01 
 
82.141 
 
197.82539 
 
55.63007 
 
2.4084 
 
0.67725 
H01 
 
81.831 
 
6.76706 
 
214.02613 
 
0.0827 
 
2.61546 
A02 
 
77.744 
   
142.85891 
 
0 
 
1.83755 
B02 
 
71.904 
 
9.50329 
 
222.24072 
 
0.1322 
 
3.09078 
C02 
 
73.332 
   
173.46059 
 
0 
 
2.36542 
D02 
 
74.501 
 
4.61458 
 
221.03586 
 
0.0619 
 
2.96687 
E02 
 
78.113 
 
10.62191 
 
245.59376 
 
0.136 
 
3.14407 
F02 
 
88.977 
   
203.16062 
 
0 
 
2.2833 
G02 
 
76.585 
 
109.04359 
 
137.80235 
 
1.4238 
 
1.79935 
H02 
 
76.181 
 
11.51574 
 
206.7403 
 
0.1512 
 
2.7138 
A03 
 
89.055 
   
198.62228 
 
0 
 
2.23034 
B03 
 
70.069 
   
158.65173 
 
0 
 
2.26422 
C03 
 
72.926 
 
80.21536 
 
92.94789 
 
1.1 
 
1.27455 
D03 
 
71.234 
 
13.34339 
 
214.53633 
 
0.1873 
 
3.01171 
E03 
 
77.395 
   
208.80621 
 
0 
 
2.69793 
F03 
 
74.461 
   
269.07336 
 
0 
 
3.61362 
G03 
 
78.213 
   
261.35014 
 
0 
 
3.3415 
H03 
 
78.852 
 
10.18551 
 
210.98984 
 
0.1292 
 
2.67578 
A04 
 
78.463 
 
10.26388 
 
181.43962 
 
0.1308 
 
2.31244 
B04 
 
68.361 
   
237.71092 
 
0 
 
3.47727 
504 
 
C04 
 
80.06 
 
6.79472 
 
184.85796 
 
0.0849 
 
2.30901 
D04 
 
75.052 
 
14.01543 
 
252.55427 
 
0.1867 
 
3.36505 
E04 
 
76.696 
 
16.9203 
 
231.13185 
 
0.2206 
 
3.01363 
F04 
 
71.923 
 
14.74086 
 
166.58574 
 
0.205 
 
2.31616 
G04 
 
75.813 
   
288.00159 
 
0 
 
3.79887 
H04 
 
82.205 
 
5.93415 
 
168.9645 
 
0.0722 
 
2.0554 
A05 
 
98.096 
 
44.42562 
 
198.64351 
 
0.4529 
 
2.025 
B05 
 
75.537 
   
180.92802 
 
0 
 
2.39523 
C05 
 
95.529 
   
141.45493 
 
0 
 
1.48076 
D05 
 
71.494 
   
161.08786 
 
0 
 
2.25318 
E05 
 
71.059 
 
23.81508 
 
127.2731 
 
0.3351 
 
1.79108 
F05 
 
74.596 
   
228.93561 
 
0 
 
3.06901 
G05 
 
82.259 
 
4.11918 
 
197.0788 
 
0.0501 
 
2.39583 
H05 
 
78.424 
   
249.03926 
 
0 
 
3.17555 
A06 
 
72.467 
   
254.43589 
 
0 
 
3.51106 
B06 
 
72.482 
   
207.14904 
 
0 
 
2.85794 
C06 
 
72.623 
 
43.64483 
 
151.54125 
 
0.601 
 
2.08669 
D06 
 
74.308 
   
280.38107 
 
0 
 
3.77324 
E06 
 
70.597 
 
4.01017 
 
213.92511 
 
0.0568 
 
3.03021 
F06 
 
72.092 
 
4.9441 
 
204.29528 
 
0.0686 
 
2.8338 
G06 
 
68.903 
 
7.4047 
 
267.7895 
 
0.1075 
 
3.88648 
H06 
 
81.546 
 
178.06719 
 
49.1067 
 
2.1836 
 
0.6022 
A07 
 
73.102 
 
5.20214 
 
212.72262 
 
0.0712 
 
2.90994 
B07 
 
73.99 
   
143.06362 
 
0 
 
1.93355 
C07 
 
72.023 
 
3.40571 
 
245.47156 
 
0.0473 
 
3.40823 
D07 
 
71.9 
 
8.15237 
 
206.25058 
 
0.1134 
 
2.86859 
E07 
 
70.629 
   
243.51435 
 
0 
 
3.44779 
F07 
 
70.393 
 
39.20694 
 
176.52059 
 
0.557 
 
2.50765 
G07 
 
75.671 
 
4.71686 
 
142.25659 
 
0.0623 
 
1.87994 
H07 
 
84.085 
 
57.13841 
 
183.69699 
 
0.6795 
 
2.18465 
A08 
 
76.752 
 
9.06044 
 
156.34153 
 
0.118 
 
2.03698 
B08 
 
74.758 
   
134.1962 
 
0 
 
1.79508 
C08 
 
76.595 
 
37.1768 
 
136.2682 
 
0.4854 
 
1.77906 
D08 
 
70.091 
 
14.61425 
 
166.21122 
 
0.2085 
 
2.37136 
E08 
 
65.435 
 
4.25033 
 
151.97606 
 
0.065 
 
2.32254 
F08 
 
70.919 
   
255.3317 
 
0 
 
3.60035 
G08 
 
74.213 
   
193.54438 
 
0 
 
2.60796 
H08 
 
71.191 
 
16.49112 
 
144.52759 
 
0.2316 
 
2.03014 
A09 
 
71.968 
 
6.21234 
 
203.08055 
 
0.0863 
 
2.82181 
B09 
 
75.369 
   
246.29568 
 
0 
 
3.26788 
C09 
 
78.152 
 
4.31323 
 
170.27759 
 
0.0552 
 
2.1788 
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D09 
 
71.843 
 
7.94039 
 
231.4507 
 
0.1105 
 
3.22161 
E09 
 
76.184 
 
12.39076 
 
263.28777 
 
0.1626 
 
3.45595 
F09 
 
78.864 
 
3.9999 
 
171.50865 
 
0.0507 
 
2.17474 
G09 
 
74.452 
   
249.95483 
 
0 
 
3.35727 
H09 
 
79.401 
   
44.53338 
 
0 
 
0.56087 
A10 
 
94.767 
 
78.6426 
 
180.03758 
 
0.8299 
 
1.89979 
B10 
 
197.28 
   
72.29847 
 
0 
 
0.36649 
C10 
 
97.222 
   
107.08145 
 
0 
 
1.10141 
D10 
 
68.665 
   
151.79673 
 
0 
 
2.21069 
E10 
 
76.906 
 
13.71129 
 
174.75256 
 
0.1783 
 
2.27228 
F10 
 
76.273 
 
4.84167 
 
226.18793 
 
0.0635 
 
2.96551 
G10 
 
74.317 
 
2.77126 
 
140.54681 
 
0.0373 
 
1.89119 
H10 
 
75.336 
   
291.20539 
 
0 
 
3.86545 
A11 
 
72.992 
   
276.51731 
 
0 
 
3.78831 
B11 
 
71.251 
   
210.98364 
 
0 
 
2.96112 
C11 
 
68.908 
 
25.54468 
 
237.07169 
 
0.3707 
 
3.44042 
D11 
 
64.154 
   
269.28644 
 
0 
 
4.1975 
E11 
 
71.47 
   
249.45431 
 
0 
 
3.49033 
F11 
 
70.008 
   
249.18803 
 
0 
 
3.55941 
G11 
 
65.925 
 
5.31783 
 
270.67558 
 
0.0807 
 
4.10582 
H11 
 
69.872 
   
229.7194 
 
0 
 
3.28774 
A12 
 
71.901 
   
251.25804 
 
0 
 
3.49451 
B12 
 
74.985 
   
113.97531 
 
0 
 
1.51997 
C12 
 
74.1 
 
6.67956 
 
286.01518 
 
0.0901 
 
3.85984 
D12 
 
68.5 
 
8.55192 
 
188.81051 
 
0.1248 
 
2.75636 
E12 
 
62.396 
   
202.62627 
 
0 
 
3.24744 
F12 
 
74.578 
 
16.29611 
 
180.36421 
 
0.2185 
 
2.41848 
G12 
 
65.229 
   
141.10969 
 
0 
 
2.16329 
H12 
 
76.003 
 
21.12223 
 
199.24708 
 
0.2779 
 
2.62157 
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Screen 4 (Figure 2.7): 
 
Solvent 
 
Palladium 
 
Base 
 
1:1 THF:H2O 
 
[Pd(allyl)Cl]2 
 
3 equiv Cs2CO3  
 1:1 Dioxane:H2O 
 
µ-Chloro dimer 
 
5 equiv Cs2CO3  
 1:1 CPME:H2O 
 
cataCXium A-Pd-G2 
 
3 equiv CsOH 
 1:1 MeTHF:H2O 
   
5 equiv CsOH 
  
Ligand 
 
M:L  
Ratio 
cataCXium A 
 
1:1 
meCgPPh 
 
1:2 
 
Screen 4 Heat Map: 
 
Information from Screen 4: 
Location 
 
IS Area 
 
Prod Area 
 
ArCl Area 
 
P/IS 
 
ArCl/IS 
A01 
 
835.27545 
 
856.39003 
 
1075.23042 
 
1.025 
 
1.2873 
B01 
 
739.5962 
 
1663.47635 
 
696.72186 
 
2.249 
 
0.942 
C01 
 
733.31978 
 
734.79467 
 
1258.11097 
 
1.002 
 
1.7156 
D01 
 
779.76421 
 
1199.00669 
 
960.65517 
 
1.538 
 
1.232 
507 
 
E01 
 
780.2218 
 
1171.25432 
 
949.27253 
 
1.501 
 
1.2167 
F01 
 
824.65911 
 
811.71237 
 
1720.53298 
 
0.984 
 
2.0864 
G01 
 
860.1457 
 
903.75188 
 
1704.52892 
 
1.051 
 
1.9817 
H01 
 
6.23661 
 
6.93549 
 
10.54072 
 
1.112 
 
1.6901 
A02 
 
697.47444 
 
521.45039 
 
1199.00853 
 
0.748 
 
1.7191 
B02 
 
739.04142 
 
1616.27864 
 
821.62287 
 
2.187 
 
1.1117 
C02 
 
740.41447 
 
705.9654 
 
1376.70221 
 
0.953 
 
1.8594 
D02 
 
741.58816 
 
709.308 
 
1457.13039 
 
0.956 
 
1.9649 
E02 
 
857.86052 
 
1210.47395 
 
1488.71205 
 
1.411 
 
1.7354 
F02 
 
744.05333 
 
1468.7578 
 
939.31378 
 
1.974 
 
1.2624 
G02 
 
779.54213 
 
1185.34802 
 
1328.22733 
 
1.521 
 
1.7039 
H02 
 
645.66987 
 
929.75127 
 
837.81827 
 
1.44 
 
1.2976 
A03 
 
743.06918 
 
303.13037 
 
2215.05432 
 
0.408 
 
2.981 
B03 
 
716.85594 
 
1129.34511 
 
1593.77489 
 
1.575 
 
2.2233 
C03 
 
732.05011 
 
834.1176 
 
1673.78434 
 
1.139 
 
2.2864 
D03 
 
772.34962 
 
963.24419 
 
1726.8401 
 
1.247 
 
2.2358 
E03 
 
794.1141 
 
343.90212 
 
2413.17635 
 
0.433 
 
3.0388 
F03 
 
751.06255 
 
804.32014 
 
1878.74279 
 
1.071 
 
2.5014 
G03 
 
786.27011 
 
436.59507 
 
2167.83853 
 
0.555 
 
2.7571 
H03 
 
652.94451 
 
156.95538 
 
1958.08251 
 
0.24 
 
2.9988 
A04 
 
769.31978 
 
921.18062 
 
1255.79831 
 
1.197 
 
1.6323 
B04 
 
770.47372 
 
2361.90018 
 
572.44534 
 
3.066 
 
0.743 
C04 
 
720.81847 
 
1061.78753 
 
1052.54084 
 
1.473 
 
1.4602 
D04 
 
741.76056 
 
1555.3093 
 
877.63454 
 
2.097 
 
1.1832 
E04 
 
815.28003 
 
1245.88515 
 
1024.9246 
 
1.528 
 
1.2571 
F04 
 
752.6713 
 
1957.17726 
 
769.48711 
 
2.6 
 
1.0223 
G04 
 
722.96939 
 
1373.49342 
 
924.7616 
 
1.9 
 
1.2791 
H04 
 
676.84871 
 
1444.26467 
 
342.30795 
 
2.134 
 
0.5057 
A05 
 
690.36984 
 
684.07039 
 
1149.82488 
 
0.991 
 
1.6655 
B05 
 
768.09982 
 
2009.42696 
 
616.76311 
 
2.616 
 
0.803 
C05 
 
714.0817 
 
843.08937 
 
1207.9531 
 
1.181 
 
1.6916 
D05 
 
733.66088 
 
1155.19389 
 
970.49703 
 
1.575 
 
1.3228 
E05 
 
766.87218 
 
1142.71063 
 
1375.02247 
 
1.49 
 
1.793 
F05 
 
789.33278 
 
1783.40572 
 
734.10973 
 
2.259 
 
0.93 
G05 
 
776.5249 
 
1264.89422 
 
1123.35621 
 
1.629 
 
1.4466 
H05 
 
678.18222 
 
1273.80992 
 
289.42824 
 
1.878 
 
0.4268 
A06 
 
765.54981 
 
280.33535 
 
2621.59369 
 
0.366 
 
3.4245 
B06 
 
733.85049 
 
1191.41808 
 
1951.4273 
 
1.624 
 
2.6592 
C06 
 
827.0786 
 
66.52997 
 
2170.16812 
 
0.08 
 
2.6239 
D06 
 
761.87025 
 
179.34758 
 
2436.7303 
 
0.235 
 
3.1984 
E06 
 
740.3576 
 
91.12428 
 
3136.80822 
 
0.123 
 
4.2369 
F06 
 
784.30309 
   
3472.50911 
 
0 
 
4.4275 
G06 
 
717.72749 
 
31.4182 
 
3070.27824 
 
0.044 
 
4.2778 
H06 
 
787.35512 
 
30.96059 
 
2350.27771 
 
0.039 
 
2.985 
A07 
 
686.1344 
 
829.58436 
 
1367.41548 
 
1.209 
 
1.9929 
B07 
 
719.51256 
 
640.14431 
 
1657.27247 
 
0.89 
 
2.3033 
C07 
 
667.69857 
 
818.83782 
 
1613.81303 
 
1.226 
 
2.417 
D07 
 
725.04274 
 
1120.35355 
 
1440.05067 
 
1.545 
 
1.9862 
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E07 
 
817.98718 
 
861.20501 
 
1727.36791 
 
1.053 
 
2.1117 
F07 
 
740.1856 
 
1628.78317 
 
957.8974 
 
2.201 
 
1.2941 
G07 
 
752.26404 
 
963.06634 
 
1345.47612 
 
1.28 
 
1.7886 
H07 
 
799.95284 
 
1078.66551 
 
1038.3213 
 
1.348 
 
1.298 
A08 
 
690.57502 
 
633.7839 
 
1615.14908 
 
0.918 
 
2.3388 
B08 
 
734.93987 
 
771.81592 
 
1472.03397 
 
1.05 
 
2.0029 
C08 
 
775.3318 
 
1141.84157 
 
1478.89138 
 
1.473 
 
1.9074 
D08 
 
728.0148 
 
1406.28324 
 
1195.85245 
 
1.932 
 
1.6426 
E08 
 
763.78777 
 
797.21212 
 
1635.78915 
 
1.044 
 
2.1417 
F08 
 
729.57595 
 
1383.74573 
 
990.30146 
 
1.897 
 
1.3574 
G08 
 
732.81988 
 
885.16081 
 
1319.0244 
 
1.208 
 
1.7999 
H08 
 
759.11557 
 
907.02204 
 
1182.43073 
 
1.195 
 
1.5576 
A09 
 
724.63694 
 
264.69544 
 
2189.66376 
 
0.365 
 
3.0217 
B09 
 
688.306 
 
132.02075 
 
2192.143 
 
0.192 
 
3.1848 
C09 
 
773.06501 
 
550.36267 
 
2096.76339 
 
0.712 
 
2.7123 
D09 
 
725.53907 
 
610.31383 
 
1914.48343 
 
0.841 
 
2.6387 
E09 
 
734.05966 
 
422.04838 
 
2089.56349 
 
0.575 
 
2.8466 
F09 
 
738.08555 
 
1072.10827 
 
1526.18473 
 
1.453 
 
2.0678 
G09 
 
731.30302 
 
206.18027 
 
2282.75488 
 
0.282 
 
3.1215 
H09 
 
738.63661 
 
334.1704 
 
1813.6159 
 
0.452 
 
2.4554 
A10 
 
693.98641 
 
769.81809 
 
1408.2026 
 
1.109 
 
2.0292 
B10 
 
716.47431 
 
771.36464 
 
1440.89533 
 
1.077 
 
2.0111 
C10 
 
809.40369 
 
1367.04939 
 
1420.93808 
 
1.689 
 
1.7555 
D10 
 
683.07153 
 
1644.35103 
 
860.08953 
 
2.407 
 
1.2592 
E10 
 
711.93256 
 
884.67156 
 
1355.85271 
 
1.243 
 
1.9045 
F10 
 
750.43625 
 
1921.85542 
 
807.92029 
 
2.561 
 
1.0766 
G10 
 
771.08244 
 
1378.84389 
 
1122.43144 
 
1.788 
 
1.4557 
H10 
 
814.0669 
 
1263.5224 
 
1477.08866 
 
1.552 
 
1.8145 
A11 
 
743.47927 
 
788.42551 
 
1578.44686 
 
1.06 
 
2.1231 
B11 
 
791.19073 
 
800.81913 
 
1449.41163 
 
1.012 
 
1.8319 
C11 
 
726.50544 
 
1039.08995 
 
1387.09338 
 
1.43 
 
1.9093 
D11 
 
740.37119 
 
1601.72134 
 
1054.40989 
 
2.163 
 
1.4242 
E11 
 
709.67298 
 
921.69489 
 
1271.88022 
 
1.299 
 
1.7922 
F11 
 
737.66595 
 
1769.3539 
 
669.47044 
 
2.399 
 
0.9076 
G11 
 
748.57362 
 
1124.04768 
 
1214.48764 
 
1.502 
 
1.6224 
H11 
 
726.37718 
 
1171.66514 
 
960.27043 
 
1.613 
 
1.322 
A12 
 
755.40528 
 
99.5043 
 
2856.51758 
 
0.132 
 
3.7814 
B12 
 
726.06643 
   
2420.53934 
 
0 
 
3.3338 
C12 
 
735.70426 
 
179.6684 
 
2916.15006 
 
0.244 
 
3.9638 
D12 
 
718.97181 
 
73.06328 
 
3117.91681 
 
0.102 
 
4.3366 
E12 
 
720.45746 
 
460.84995 
 
2513.42489 
 
0.64 
 
3.4887 
F12 
 
769.02212 
 
782.8131 
 
2100.9299 
 
1.018 
 
2.7319 
G12 
 
768.94055 
 
40.43646 
 
3209.69569 
 
0.053 
 
4.1742 
H12 
 
762.19695 
 
44.41873 
 
2959.27734 
 
0.058 
 
3.8826 
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Figure A1B.1. SFC Chromatogram of (4S, 5S)-2-((R)-1-Chloro-3-phenylpropyl)-4,5-
dicyclohexyl-1,3,2-dioxaborolane. Analysis was performed using Column AD-H, 15 % i-
PrOH in CO2, 2 mL, 10 MPa. Retention time is 6.04 min. 
 
Figure A1B.2. SFC Chromatogram of (4R, 5R)-2-((S)-1-Chloro-3-phenylpropyl)-4,5-
dicyclohexyl-1,3,2-dioxaborolane. Analysis was performed using Column AD-H, 15 % i-
PrOH in CO2, 2 mL, 10 MPa. Retention time is 5.07 min. 
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Figure A1B.3. SFC Chromatogram of (4S, 5S)-2-((S)-1-(Benzyloxy)-3-phenylpropyl)-
4,5-dicyclohexyl-1,3,2-dioxaborolane 2.94-S. Analysis was performed using Column 
OD-H, 15 % i-PrOH in CO2, 2 mL, 10 MPa. Retention time is 7.87 min. 
 
Figure A1B.4. SFC Chromatogram of (4R, 5R)-2-((R)-1-(Benzyloxy)-3-phenylpropyl)-
4,5-dicyclohexyl-1,3,2-dioxaborolane 2.94-R. Analysis was performed using Column 
OD-H, 15 % i-PrOH in CO2, 2 mL, 10 MPa. Retention time is 6.92 min 
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Figure A1B.5. SFC Chromatogram of (±)-1-(4-Methoxyphenyl)-3-phenylpropan-1-ol. 
Analysis was performed using Column AD-H, 15 % i-PrOH in CO2, 2 mL, 10 MPa. 
Retention times: (R)-enantiomer is 11.21 min and for the (S)-enantiomer is 12.87 min. 
 
Figure A1B.6. SFC Chromatogram of (S)-1-(4-Methoxyphenyl)-3-phenylpropan-1-ol. 
Analysis was performed using Column AD-H, 15 % i-PrOH in CO2, 2 mL, 10 MPa. 
Retention times: (R)-enantiomer is 11.21 min and for the (S)-enantiomer is 12.87 min. 
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Figure A1B.7. SFC Chromatogram of (±)-1-(1-(Benzyloxy)-3-phenylpropyl)-4-
methoxybenzene 2.49. Analysis was performed using Column OJ-H, 10 % i-PrOH in 
CO2, 2 mL, 10 MPa. Retention times: (R)-enantiomer is 15.55 min and for the (S)-
enantiomer is 17.30 min
 
Figure A1B.8.  SFC Chromatogram of (S)-1-(1-(Benzyloxy)-3-phenylpropyl)-4-
methoxybenzene through benzylation of an enantioenriched alcohol. Analysis was 
performed using Column OJ-H, 10 % i-PrOH, 2 mL, 10 MPa. 
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Figure A1B.9. SFC Chromatogram of (S)-1-(1-(Benzyloxy)-3-phenylpropyl)-4-
methoxybenzene 2.96. Analysis was performed using Column OJ-H, 10 % i-PrOH in 
CO2, 2 mL, 10 MPa. Retention time for the (R)-enantiomer is 15.55 min 
 
Figure A1B.10. SFC Chromatogram of (±)-2-(1-(benzyloxy)-3-phenylpropyl)-6-
methoxypyridine 2.70. Analysis was performed using Column OD-H, 30 % i-PrOH in 
CO2, 2 mL, 10 MPa. Retention times: 2.98 min and 3.23 min. 
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Figure A1B.11. SFC Chromatogram of enantioenriched 2-(1-(benzyloxy)-3-
phenylpropyl)-6-methoxypyridine 2.104. Analysis was performed using Column OD-H, 
30 % i-PrOH in CO2, 2 mL, 10 MPa. Retention times: 2.98 min and 3.23 min. 
 
 
Figure A1B.12. SFC Chromatogram of (±)-1-(1-(benzyloxy)-3-phenylpropyl)-4-
(trifluoromethyl)benzene 2.41. Analysis was performed using Column OD-H, 2 % i-
PrOH in CO2, 2 mL, 10 MPa 
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Figure A1B.13. SFC Chromatogram of enantiomerically enriched-1-(1-(benzyloxy)-3-
phenylpropyl)-4-(trifluoromethyl)benzene 2.97. Analysis was performed using Column 
OD-H, 2 % i-PrOH in CO2, 2 mL, 10 MPa. 
 
Figure A1B.14. SFC Chromatogram of (±)-methyl 4-(1-(benzyloxy)-3-
phenylpropyl)benzoate 2.45. Analysis was performed using Column OD-H, 10 % i-PrOH 
in CO2, 2 mL, 10 MPa. Retention times: 12.65 min and 13.07 min. 
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Figure A1B.15. SFC Chromatogram of enantioenriched-methyl 4-(1-(benzyloxy)-3-
phenylpropyl)benzoate 2.98. Analysis was performed using Column OD-H, 10 % i-PrOH 
in CO2, 2 mL, 10 MPa. Retention times: 12.65 min and 13.07 min. 
 
Figure A1B.16. SFC Chromatogram of (±)-1-(1-(benzyloxy)-3-phenylpropyl)-4-
fluorobenzene 2.42. Analysis was performed using Column OD-H, 5 % i-PrOH in CO2, 2 
mL, 10 MPa. Retention times: 10.1 min and 10.5 min. 
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Figure A1B.17. SFC Chromatogram of enantioenriched-1-(1-(benzyloxy)-3-
phenylpropyl)-4-fluorobenzene 2.102. Analysis was performed using Column OD-H, 5 % 
i-PrOH in CO2, 2 mL, 10 MPa. Retention times: 10.1 min and 10.5 min. 
 
Figure A1B.18. SFC Spectrum of enantioenriched-1-(1-(benzyloxy)-3-phenylpropyl)-4-
fluorobenzene 2.101. Analysis was performed using Column OD-H, 5 % i-PrOH in CO2, 
2 mL, 10 MPa. Retention times: 10.1 min and 10.5 min. 
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Figure A1B.19. SFC Spectrum of (±)-1-(4-(1-(benzyloxy)-3-phenylpropyl)phenyl)-1H-
pyrrole 2.53. Analysis was performed using Column AS-H, 20 % i-PrOH in CO2, 2 mL, 
10 MPa. Retention times: 13.1 min and 14.3 min. 
 
Figure A1B.20. SFC Spectrum of enantioenriched-1-(4-(1-(benzyloxy)-3-
phenylpropyl)phenyl)-1H-pyrrole 2.103. Analysis was performed using Column AS-H, 
20 % i-PrOH in CO2, 2 mL, 10 MPa. Retention times: 13.1 min and 14.3 min. 
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Figure A1B.21. SFC Spectrum of (±)-3-(1-(benzyloxy)-3-phenylpropyl)pyridine 2.62. 
Analysis was performed using Column OD-H, 10 % i-PrOH in CO2, 2 mL, 10 MPa. 
Retention times: 13.1 min and 14.3 min 
 
 
Figure A1B.22. SFC Chromatogram of enantioenriched-3-(1-(benzyloxy)-3-
phenylpropyl)pyridine 2.100. Analysis was performed using Column OD-H, 10 % i-
PrOH in CO2, 2 mL, 10 MPa. Retention times: 13.1 min and 13.6 min 
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Figure A1B.23. SFC Chromatogram of (±)-tert-butyl (4-(1-(benzyloxy)-3-
phenylpropyl)phenyl)carbamate 2.51. Analysis was performed using Column OD-H, 20 
% i-PrOH in CO2, 2 mL, 10 MPa. Retention times: 7.1 min and 7.5 min. 
 
 
Figure A1B.24. SFC Chromatorgram of enantioenriched-tert-butyl (4-(1-(benzyloxy)-3-
phenylpropyl)phenyl)carbamate 2.99. Analysis was performed using Column OD-H, 20 
% i-PrOH in CO2, 2 mL, 10 MPa. Retention times: 7.1 min and 7.5 min.
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Figure A1B.25. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-(hydroxy)-3-
phenylpropyltrifluoroborate 2.4 
 
Figure A1B.26. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(hydroxy)-3-
phenylpropyltrifluoroborate 2.4 
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Figure A1B.27. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-(hydroxy)-3-
phenylpropyltrifluoroborate 2.4 
 
Figure A1B.28.
 19
F NMR (DMSO-d6, 338.8 MHz) of Potassium 1-(hydroxy)-3-
phenylpropyltrifluoroborate 2.4 
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Figure A1B.29. IR Spectrum of Potassium 1-(hydroxy)-3-phenylpropyltrifluoroborate 
2.4 
 
Figure A1B.30. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium 1-(hydroxy)-2-
ethylbutyltrifluoroborate 2.5 
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Figure A1B.31.
 13
C NMR (Acetone-d6, 125.8 MHz) of Potassium 1-(hydroxy)-2-
ethylbutyltrifluoroborate 2.5 
 
Figure A1B.32. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-(hydroxy)-2-
ethylbutyltrifluoroborate 2.5 
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Figure A1B.33. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 1-(hydroxy)-2-
ethylbutyltrifluoroborate 2.5 
 
Figure A1B.34. IR Spectrum of Potassium 1-(hydroxy)-2-ethylbutyltrifluoroborate 2.5 
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Figure A1B.35. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-(hydroxy)-1-
methylethyltrifluoroborate 2.6 
 
Figure A1B.36. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(hydroxy)-1-
methylethyltrifluoroborate 2.6 
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Figure A1B.37. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-(hydroxy)-1-
methylethyltrifluoroborate 2.6 
 
Figure A1B.38. 
19
F NMR (DMSO-d6, 338.8 MHz) of Potassium 1-(hydroxy)-1-
methylethyltrifluoroborate 2.6 
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Figure A1B.39. IR Spectrum of Potassium 1-(hydroxy)-1-methylethyltrifluoroborate 2.6 
 
Figure A1B.40. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-(hydroxy)-2,2-
dimethylpropyltrifluoroborate 2.7 
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Figure A1B.41. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(hydroxy)-2,2-
dimethylpropyltrifluoroborate 2.7 
 
Figure A1B.42. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-(hydroxy)-2,2-
dimethylpropyltrifluoroborate 2.7 
531 
 
 
Figure A1B.43. 
19
F NMR (DMSO-d6, 338.8 MHz) of Potassium 1-(hydroxy)-2,2-
dimethylpropyltrifluoroborate 2.7 
 
Figure A1B.44. IR Spectrum of Potassium 1-(hydroxy)-2,2-
dimethylpropyltrifluoroborate 2.7 
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Figure A1B.45. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-(hydroxy)-2-
methylpropyltrifluoroborate 2.8 
 
 
Figure A1B.46.
 13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(hydroxy)-2-
methylpropyltrifluoroborate 2.8 
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Figure A1B.47. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-(hydroxy)-2-
methylpropyltrifluoroborate 2.8 
 
 
Figure A1B.48. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 1-(hydroxy)-2-
methylpropyltrifluoroborate 2.8 
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Figure A1B.49. IR Spectrum of 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 1-
(hydroxy)-2-methylpropyltrifluoroborate 2.8 
 
 
Figure A1B.50. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium (1-hydroxyundec-10-en-1-
yl)trifluoroborate 2.9 
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Figure A1B.51. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium (1-hydroxyundec-10-
en-1-yl)trifluoroborate 2.9 
 
Figure A1B.52. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium (1-hydroxyundec-10-
en-1-yl)trifluoroborate 2.9 
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Figure A1B.53. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium (1-hydroxyundec-10-
en-1-yl)trifluoroborate 2.9 
 
Figure A1B.54. IR Spectrum of Potassium (1-hydroxyundec-10-en-1-yl)trifluoroborate 
2.9 
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Figure A1B.55. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium (Z)-(1-hydroxydec-7-en-
1-yl)trifluoroborate 2.10 
 
 
Figure A1B.56. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium (Z)-(1-hydroxydec-7-
en-1-yl)trifluoroborate 2.10 
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Figure A1B.57. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium (Z)-(1-hydroxydec-7-
en-1-yl)trifluoroborate 2.10 
 
 
Figure A1B.58. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium (Z)-(1-hydroxydec-7-
en-1-yl)trifluoroborate 2.10 
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Figure A1B.59. IR Spectrum of Potassium (Z)-(1-hydroxydec-7-en-1-yl)trifluoroborate 
2.10 
 
 
Figure A1B.60. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-
hydroxyoctyltrifluoroborate 2.11 
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Figure A1B.61. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-
hydroxyoctyltrifluoroborate 2.11 
 
 
Figure A1B.62. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-
hydroxyoctyltrifluoroborate 2.11 
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Figure A1B.63. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 1-
hydroxyoctyltrifluoroborate 2.11 
 
Figure A1B.64. IR Spectrum of Potassium 1-hydroxyoctyltrifluoroborate 2.11 
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Figure A1B.65. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 4-(benzyloxy)-1-
hydroxybutyltrifluoroborate 2.12 
 
 
Figure A1B.66. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 4-(benzyloxy)-1-
hydroxybutyltrifluoroborate 2.12 
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Figure A1B.67.
 11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 4-(benzyloxy)-1-
hydroxybutyltrifluoroborate 2.12 
 
 
Figure A1B.68. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 4-(benzyloxy)-1-
hydroxybutyltrifluoroborate 2.12 
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Figure A1B.69. IR Spectrum of Potassium 4-(benzyloxy)-1-hydroxybutyltrifluoroborate 
2.12 
 
Figure A1B.70. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium (1-hydroxy)-2-
phenylethyltrifluoroborate 2.13 
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Figure A1B.71. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium (1-hydroxy)-2-
phenylethyltrifluoroborate 2.13 
 
 
Figure A1B.72. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium (1-hydroxy)-2-
phenylethyltrifluoroborate 2.13 
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Figure A1B.73. IR Spectrum of 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium (1-
hydroxy)-2-phenylethyltrifluoroborate 2.13 
 
Figure A1B.74. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium (1-hydroxy)-2-
phenylethyltrifluoroborate 2.13 
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Figure A1B.75. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium ((3-(2-chlorophenyl)-1-
hydroxypropyl)trifluoroborate 2.14 
 
 
Figure A1B.76. 
13
C NMR (Acetone-d6, 125.8 MHz) of Potassium ((3-(2-chlorophenyl)-
1-hydroxypropyl)trifluoroborate 2.14 
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Figure A1B.77. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium ((3-(2-chlorophenyl)-1-
hydroxypropyl)trifluoroborate 2.14 
 
 
Figure A1B.78. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium ((3-(2-chlorophenyl)-1-
hydroxypropyl)trifluoroborate 2.14 
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Figure A1B.79. IR Spectrum of Potassium ((3-(2-chlorophenyl)-1-
hydroxypropyl)trifluoroborate 2.14 
 
Figure A1B.80. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium 1-hydroxy-3-
phenylbutyltrifluoroborate 2.15 
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Figure A1B.81. 
13
C NMR (Acetone-d6, 125.8 MHz) of Potassium 1-hydroxy-3-
phenylbutyltrifluoroborate 2.15 
 
 
Figure A1B.82. 
11
B NMR (Acetone-d6, 128.4 MHz) of Potassium 1-hydroxy-3-
phenylbutyltrifluoroborate 2.15 
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Figure A1B.83. 
19
F NMR (Acetone-d6, 470.8 MHz) of Potassium 1-hydroxy-3-
phenylbutyltrifluoroborate 2.15 
 
Figure A1B.84. IR Spectrum of Potassium 1-hydroxy-3-phenylbutyltrifluoroborate 2.15 
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Figure A1B.85. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-hydroxy-4-
phenylbutyltrifluoroborate 2.16 
 
 
Figure A1B.86. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-hydroxy-4-
phenylbutyltrifluoroborate 2.16 
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Figure A1B.87. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-hydroxy-4-
phenylbutyltrifluoroborate 2.16 
 
 
Figure A1B.88. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 1-hydroxy-4-
phenylbutyltrifluoroborate 2.16 
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Figure A1B.89. IR Spectrum of Potassium 1-hydroxy-4-phenylbutyltrifluoroborate 2.16 
 
Figure A1B.90. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium (1-hydroxy)-1-
phenyltrifluoroborate 2.17 
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Figure A1B.91. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium (1-hydroxy)-1-
phenyltrifluoroborate 2.17 
 
 
Figure A1B.92. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium (1-hydroxy)-1-
phenyltrifluoroborate 2.17 
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Figure A1B.93. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium (1-hydroxy)-1-
phenyltrifluoroborate  2.17 
 
Figure A1B.94. IR Spectrum of Potassium (1-hydroxy)-1-phenyltrifluoroborate  2.17 
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Figure A1B.95. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-(hydroxy)-(4-
methoxyphenyl)methyltrifluoroborate 2.18 
 
 
Figure A1B.96. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(hydroxy)-(4-
methoxyphenyl)methyltrifluoroborate 2.18 
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Figure A1B.97. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-(hydroxy)-(4-
methoxyphenyl)methyltrifluoroborate 2.18 
 
 
Figure A1B.98. 
19
F NMR (DMSO-d6, 338.8 MHz) of Potassium 1-(hydroxy)-(4-
methoxyphenyl)methyltrifluoroborate 2.18 
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Figure A1B.99. IR Spectrum of Potassium 1-(hydroxy)-(4-
methoxyphenyl)methyltrifluoroborate 2.18 
 
Figure A1B.100. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-(hydroxy)-(2,6-
dimethylphenyl)methyltrifluoroborate 2.19 
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Figure A1B.101. 
13
C NMR (DMSO-d6, 125.8 MHz)  of Potassium 1-(hydroxy)-(2,6-
dimethylphenyl)methyltrifluoroborate 2.19 
 
Figure A1B.102. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-(hydroxy)-(2,6-
dimethylphenyl)methyltrifluoroborate 2.19 
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Figure A1B.103. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 1-(hydroxy)-(2,6-
dimethylphenyl)methyltrifluoroborate 2.19 
 
Figure A1B.104. IR Spectrum of Potassium 1-(hydroxy)-(2,6-
dimethylphenyl)methyltrifluoroborate 2.19 
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Figure A1B.105. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-(hydroxy)-1-(2-
naphthyl)methyltrifluoroborate 2.20 
 
Figure A1B.106. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(hydroxy)-1-(2-
naphthyl)methyltrifluoroborate 2.20 
563 
 
 
Figure A1B.107. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-(hydroxy)-1-(2-
naphthyl)methyltrifluoroborate 2.20 
 
Figure A1B.108. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 1-(hydroxy)-1-(2-
naphthyl)methyltrifluoroborate 2.20 
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Figure A1B.109. IR Spectrum of Potassium 1-(hydroxy)-1-(2-
naphthyl)methyltrifluoroborate 2.20 
 
Figure A1B.110. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-(hydroxy)-2-methyl-2-
phenylethyltrifluoroborate 2.21 
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Figure A1B.111. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(hydroxy)-2-methyl-
2-phenylethyltrifluoroborate 2.21 
 
Figure A1B.112.
 11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-(hydroxy)-2-methyl-
2-phenylethyltrifluoroborate 2.21 
566 
 
 
Figure A1B.113. 
19
F NMR (DMSO-d6, 338.8 MHz) of Potassium 1-(hydroxy)-2-methyl-
2-phenylethyltrifluoroborate 2.21 
 
Figure A1B.114. IR Spectrum of Potassium 1-(hydroxy)-2-methyl-2-
phenylethyltrifluoroborate 2.21 
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Figure A1B.115. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium 1-(hydroxy)-2-methyl-
2-phenylethyltrifluoroborate 2.22 
 
 
Figure A1B.116. 
13
C NMR (Acetone-d6, 125.8 MHz) of Potassium 1-(hydroxy)-2-
methyl-2-phenylethyltrifluoroborate 2.22 
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Figure A1B.117. 
11
B NMR (Acetone-d6, 128.4 MHz) of Potassium 1-(hydroxy)-2-
methyl-2-phenylethyltrifluoroborate 2.22 
 
 
Figure A1B.118. 
19
F NMR (Acetone-d6, 338.8 MHz) of Potassium 1-(hydroxy)-2-
methyl-2-phenylethyltrifluoroborate 2.22 
569 
 
 
Figure A1B.119. IR Spectrum of Potassium 1-(hydroxy)-2-methyl-2-
phenylethyltrifluoroborate 2.22 
 
 
Figure A1B.120. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-(hydroxy)-((S)-((R)-3-
(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)(hydroxy)methyl)trifluoroborate 2.23 
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Figure A1B.121. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(hydroxy)-((S)-((R)-
3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)(hydroxy)methyl)trifluoroborate 
2.23 
 
Figure A1B.122. 
11
B NMR (DMSO-d6, 128.4 MHz) of Potassium 1-(hydroxy)-((S)-((R)-
3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)(hydroxy)methyl)trifluoroborate 
2.23 
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Figure A1B.123. 
19
F NMR (DMSO-d6, 338.8 MHz) of Potassium 1-(hydroxy)-((S)-((R)-
3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)(hydroxy)methyl)trifluoroborate 
2.23 
 
Figure A1B.124. IR Spectrum of Potassium 1-(hydroxy)-((S)-((R)-3-(tert-
butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)(hydroxy)methyl)trifluoroborate 2.23 
572 
 
 
Figure A1B.125. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium 1-(benzoyloxy)-3-
phenylpropyltrifluoroborate 2.24 
 
Figure A1B.126. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(benzoyloxy)-3-
phenylpropyltrifluoroborate 2.24 
573 
 
 
Figure A1B.127. 
11
B NMR (DMSO-d6, 128.38 MHz) of Potassium 1-(benzoyloxy)-3-
phenylpropyltrifluoroborate 2.24 
 
Figure A1B.128. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 1-(benzoyloxy)-3-
phenylpropyltrifluoroborate 2.24 
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Figure A1B.129. IR Spectrum of Potassium 1-(benzoyloxy)-3-
phenylpropyltrifluoroborate 2.24 
 
Figure A1B.130. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-(pivaloyloxy)-3-
phenylpropyltrifluoroborate 2.25 
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Figure A1B.131. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(pivaloyloxy)-3-
phenylpropyltrifluoroborate 2.25 
 
Figure A1B.132. 
11
B NMR (DMSO-d6, 128.38 MHz) of Potassium 1-(pivaloyloxy)-3-
phenylpropyltrifluoroborate 2.25 
576 
 
 
 
Figure A1B.133. 
19
F NMR (DMSO-d6, 338.8 MHz) of Potassium 1-(pivaloyloxy)-3-
phenylpropyltrifluoroborate 2.25 
 
Figure A1B.134. IR Spectrum of Potassium 1-(pivaloyloxy)-3-
phenylpropyltrifluoroborate 2.25 
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Figure A1B.135. 
1
H NMR (CD3CN, 500 MHz) of Potassium 1-(N,N-
diisopropylcarbamoyl)-3-phenylpropyltrifluoroborate 2.2 
 
 
Figure A1B.136. 
13
C NMR (CD3CN, 125.8 MHz) of Potassium 1-(N,N-
diisopropylcarbamoyl)-3-phenylpropyltrifluoroborate 2.2 
578 
 
 
Figure A1B.137. 
11
B NMR (DMSO-d6, 128.38 MHz) of Potassium 1-(N,N-
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Figure A1B.139. IR Spectrum of Potassium 1-(N,N-diisopropylcarbamoyl)-3-
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Figure A1B.141. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(acetyloxy)-3-
phenylpropyltrifluoroborate 2.26 
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Figure A1B.143. 
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Figure A1B.145. 
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Figure A1B.153. 
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Figure A1B.155. 
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Figure A1B.163. 
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Figure A1B.165. 
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Figure A1B.167. 
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Figure A1B.168. 
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Figure A1B.171. 
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11
B NMR (Acetone-d6, 128.38 MHz) of Potassium 1-(3-
methoxybenzyl)oxy)-3-phenylpropyltrifluoroborate 2.32 
596 
 
 
Figure A1B.173. 
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Figure A1B.175. 
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Figure A1B.177. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium 1-(4-
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Figure A1B.179. IR Spectrum of Potassium 1-(4-methoxybenzyl)oxy)-3-
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Figure A1B.181. 
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Figure A1B.183. 
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F NMR (Acetone-d6, 470.8 MHz) of Potassium 1-(2-
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Figure A1B.184. IR Spectrum of Potassium 1-(2-methybenzyl)oxy)-3-
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Figure A1B.185. 
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Figure A1B.187. 
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Figure A1B.191. 
13
C NMR (Acetone-d6, 125.8 MHz) of Potassium 1-((2-
bromothiophen-3-yl)methoxy))-3-phenylpropyltrifluoroborate 2.36 
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11
B NMR (Acetone-d6, 128.38 MHz) of Potassium 1-((2-
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Figure A1B.193. 
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Figure A1B.195. 
1
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Figure A1B.201. 
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Figure A1B.203. 
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Figure A1B.205. 
1
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13
C NMR (CDCl3, 125.8 MHz) of 1-(1-(benzyloxy)-3-phenylpropyl)-
3,5-difluorobenzene 2.43 
 
Figure A1B.218. IR Spectrum of 1-(1-(benzyloxy)-3-phenylpropyl)-3,5-difluorobenzene 
2.43 
619 
 
 
Figure A1B.219. 
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Figure A1B.301. 
13
C NMR (Acetone-d6, 125.8 MHz) of Potassium 1-(benzyloxy)-2-
methylpropyltrifluoroborate 2.71 
 
Figure A1B.302. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium 1-(benzyloxy)-2-
methylpropyltrifluoroborate  2.71 
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Figure A1B.303. 
19
F NMR (Acetone-d6, 470.8 MHz) of Potassium 1-(benzyloxy)-2-
methylpropyltrifluoroborate 2.71 
 
Figure A1B.304. IR Spectrum of Potassium 1-(benzyloxy)-2-
methylpropyltrifluoroborate 2.71 
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Figure A1B.305. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-(benzyloxy)-2,2-
dimethylpropyltrifluoroborate  2.72 
 
 
Figure A1B.306. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(benzyloxy)-2,2-
dimethylpropyltrifluoroborate  2.72 
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Figure A1B.307. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium 1-(benzyloxy)-2,2-
dimethylpropyltrifluoroborate  2.72 
 
 
Figure A1B.308. 
19
F NMR (Acetone-d6, 470.8 MHz) of Potassium 1-(benzyloxy)-2,2-
dimethylpropyltrifluoroborate  2.72 
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Figure A1B.309. IR Spectrum of Potassium 1-(benzyloxy)-2,2-
dimethylpropyltrifluoroborate  2.72 
 
 
Figure A1B.310. 
1
H NMR (DMSOe-d6, 500 MHz) of Potassium 1-(benzyloxy)-2-
ethylbutyltrifluoroborate 2.73 
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Figure A1B.311. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(benzyloxy)-2-
ethylbutyltrifluoroborate 2.73 
 
Figure A1B.312. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium 1-(benzyloxy)-2-
ethylbutyltrifluoroborate 2.73 
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Figure A1B.313. 
19
F NMR (Acetone-d6, 338.8 MHz) of Potassium 1-(benzyloxy)-2-
ethylbutyltrifluoroborate 2.73 
 
Figure A1B.314. IR Spectrum of Potassium 1-(benzyloxy)-2-ethylbutyltrifluoroborate 
2.73 
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Figure A1B.315. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium 1-(benzyloxy)-2-
phenylethyltrifluoroborate 2.74 
 
 
Figure A1B.316. 
13
C NMR (Acetone-d6, 125.8 MHz) of Potassium 1-(benzyloxy)-2-
phenylethyltrifluoroborate 2.74 
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Figure A1B.317. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium 1-(benzyloxy)-2-
phenylethyltrifluoroborate 2.74 
 
 
Figure A1B.318.
 19
F NMR (Acetone-d6, 470.8 MHz) of Potassium 1-(benzyloxy)-2-
phenylethyltrifluoroborate 2.74 
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Figure A1B.319. IR Spectrum of Potassium 1-(benzyloxy)-2-phenylethyltrifluoroborate 
2.74 
 
 
Figure A1B.320. 
1
H NMR (acetone-d6, 500 MHz) of Potassium 1-(benzyloxy)-3-
phenylbutyltrifluoroborate 2.75 
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Figure A1B.321. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(benzyloxy)-3-
phenylbutyltrifluoroborate 2.75 
 
Figure A1B.322. 
11
B NMR (DMSO-d6, 128.38 MHz) of Potassium 1-(benzyloxy)-3-
phenylbutyltrifluoroborate 2.75 
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Figure A1B.323. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 1-(benzyloxy)-3-
phenylbutyltrifluoroborate 2.75 
 
Figure A1B.324. IR Spectrum of Potassium 1-(benzyloxy)-3-phenylbutyltrifluoroborate 
2.75 
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Figure A1B.325. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium 1-(benzyloxy)-3-(2-
chlorophenyl)propyltrifluoroborate 2.76 
 
 
Figure A1B.326. 
13
C NMR (Acetone-d6, 125.8 MHz) of Potassium 1-(benzyloxy)-3-(2-
chlorophenyl)propyltrifluoroborate 2.76 
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Figure A1B.327. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium 1-(benzyloxy)-3-(2-
chlorophenyl)propyltrifluoroborate 2.76 
 
 
Figure A1B.328. 
19
F NMR (Acetone-d6, 470.8 MHz) of Potassium 1-(benzyloxy)-3-(2-
chlorophenyl)propyltrifluoroborate 2.76 
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Figure A1B.329. IR Spectrum of Potassium 1-(benzyloxy)-3-(2-
chlorophenyl)propyltrifluoroborate 2.76 
 
Figure A1B.330. 
1
H NMR (acetone-d6, 500 MHz) of Potassium 1-(benzyloxy)-4-
phenylbutyltrifluoroborate 2.77 
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Figure A1B.331. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-(benzyloxy)-4-
phenylbutyltrifluoroborate 2.77 
 
 
Figure A1B.332. 
11
B NMR (DMSO-d6, 128.38 MHz) of Potassium 1-(benzyloxy)-4-
phenylbutyltrifluoroborate 2.77 
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Figure A1B.333. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 1-(benzyloxy)-4-
phenylbutyltrifluoroborate 2.77 
 
Figure A1B.334. IR Spectrum of Potassium 1-(benzyloxy)-4-phenylbutyltrifluoroborate 
2.77 
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Figure A1B.335. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium 1,4-
bis(benzyloxy)butyltrifluoroborate 2.78 
 
 
Figure A1B.336. 
13
C NMR (Acetone-d6, 125.8 MHz) of Potassium 1,4-
bis(benzyloxy)butyltrifluoroborate 2.78 
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Figure A1B.337. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium 1,4-
bis(benzyloxy)butyltrifluoroborate 2.78 
 
 
Figure A1B.338. 
19
F NMR (Acetone-d6, 470.8 MHz) of Potassium 1,4-
bis(benzyloxy)butyltrifluoroborate 2.78 
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Figure A1B.339. IR Spectrum of Potassium 1,4-bis(benzyloxy)butyltrifluoroborate 2.78 
 
 
Figure A1B.340. 
1
H NMR (DMSO-d6, 500 MHz) of Potassium 1-
(benzyloxy)octyltrifluoroborate 2.79 
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Figure A1B.341. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 1-
(benzyloxy)octyltrifluoroborate 2.79 
 
Figure A1B.342. 
11
B NMR (DMSO-d6, 128.38 MHz) of Potassium 1-
(benzyloxy)octyltrifluoroborate 2.79 
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Figure A1B.343. 
19
F NMR (DMSO-d6, 470.8 MHz) of Potassium 1-
(benzyloxy)octyltrifluoroborate 2.79 
 
Figure A1B.344. IR Spectrum of Potassium 1-(benzyloxy)octyltrifluoroborate 2.79 
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Figure A1B.345. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium (Z)-1-(benzyloxy)dec-
7-en-1-yltrifluoroborate 2.80 
 
 
Figure A1B.346. 
13
C NMR (Acetone-d6, 125.8 MHz) of Potassium (Z)-1-
(benzyloxy)dec-7-en-1-yltrifluoroborate 2.80 
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Figure A1B.347. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium (Z)-1-
(benzyloxy)dec-7-en-1-yltrifluoroborate 2.80 
 
 
Figure A1B.348. 
19
F NMR (Acetone-d6, 470.8 MHz) of Potassium (Z)-1-
(benzyloxy)dec-7-en-1-yltrifluoroborate 2.80 
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Figure A1B.349. IR Spectrum of Potassium (Z)-1-(benzyloxy)dec-7-en-1-
yltrifluoroborate 2.80 
 
Figure A1B.350. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium 
(benzyloxy)(phenyl)methyltrifluoroborate 2.81 
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Figure A1B.351. 
13
C NMR (Acetone-d6, 125.8 MHz) of Potassium 
(benzyloxy)(phenyl)methyltrifluoroborate 2.81 
 
 
Figure A1B.352. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium 
(benzyloxy)(phenyl)methyltrifluoroborate 2.81 
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Figure A1B.353. 
19
F NMR (Acetone-d6, 470.8 MHz) of Potassium 
(benzyloxy)(phenyl)methyltrifluoroborate 2.81 
 
Figure A1B.354. IR Spectrum of Potassium (benzyloxy)(phenyl)methyltrifluoroborate 
2.81 
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Figure A1B.355. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium 
(benzyloxy)(naphthalen-2-yl)methyltrifluoroborate 2.82 
 
 
Figure A1B.356. 
13
C NMR (DMSO-d6, 125.8 MHz) of Potassium 
(benzyloxy)(naphthalen-2-yl)methyltrifluoroborate 2.82 
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Figure A1B.357. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium 
((benzyloxy)(naphthalen-2-yl)methyltrifluoroborate 2.82 
 
 
Figure A1B.358. 
19
F NMR (Acetone-d6, 470.8 MHz) of Potassium 
(benzyloxy)(naphthalen-2-yl)methyltrifluoroborate 2.82 
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Figure A1B.359. IR Spectrum of Potassium (benzyloxy)(naphthalen-2-
yl)methyltrifluoroborate 2.82 
 
Figure A1B.360. 
1
H NMR (CDCl3, 500 MHz) of 1-(1-(benzyloxy)octyl)-4-
methoxybenzene 2.83 
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Figure A1B.361. 
13
C NMR (CDCl3, 125.8 MHz) of 1-(1-(benzyloxy)octyl)-4-
methoxybenzene 2.83 
 
Figure A1B.362. IR Spectrum of 1-(1-(benzyloxy)octyl)-4-methoxybenzene 2.83 
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Figure A1B.363. 
1
H NMR (CDCl3, 500 MHz) of 1-(1-(benzyloxy)-4-phenylbutyl)-4-
methoxybenzene 2.84 
 
 
Figure A1B.364. 
13
C NMR (CDCl3, 125.8 MHz) of 1-(1-(benzyloxy)-4-phenylbutyl)-4-
methoxybenzene 2.84 
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Figure A1B.365. IR Spectrum of 1-(1-(benzyloxy)-4-phenylbutyl)-4-methoxybenzene 
2.84 
 
Figure A1B.366. 
1
H NMR (CDCl3, 500 MHz) of 1-(1-(benzyloxy)-3-phenylbutyl)-4-
methoxybenzene 2.85 
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Figure A1B.367. 
13
C NMR (CDCl3, 125.8 MHz) of 1-(1-(benzyloxy)-3-phenylbutyl)-4-
methoxybenzene 2.85 
 
Figure A1B.368. IR Spectrum of 1-(1-(benzyloxy)-3-phenylbutyl)-4-methoxybenzene 
2.85 
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Figure A1B.369. 
1
H NMR (CDCl3, 500 MHz) of 1-(1-(benzyloxy)-2-phenylethyl)-4-
methoxybenzene 2.86 
 
 
Figure A1B.370. 
13
C NMR (CDCl3, 125.8 MHz) of 1-(1-(benzyloxy)-2-phenylethyl)-4-
methoxybenzene 2.86 
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Figure A1B.371. IR Spectrum of 1-(1-(benzyloxy)-2-phenylethyl)-4-methoxybenzene 
2.86 
 
Figure A1B.372. 
1
H NMR (CDCl3, 500 MHz) of 1-((benzyloxy)(phenyl)methyl)-4-
methoxybenzene 2.87 
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Figure A1B.373. 
13
C NMR (CDCl3, 125.8 MHz) of 1-((benzyloxy)(phenyl)methyl)-4-
methoxybenzene 2.87 
 
Figure A1B.374. IR Spectrum of 1-((benzyloxy)(phenyl)methyl)-4-methoxybenzene 
2.87 
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Figure A1B.375. 
1
H NMR (CDCl3, 500 MHz) of 1-((1-(4-Methoxyphenyl)-3-
phenylpropoxy)methyl)-2-methylbenzene 2.88 
 
 
Figure A1B.376. 
13
C NMR (CDCl3, 125.8 MHz) of 1-((1-(4-Methoxyphenyl)-3-
phenylpropoxy)methyl)-2-methylbenzene 2.88 
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Figure A1B.377. IR Spectrum of 1-((1-(4-Methoxyphenyl)-3-phenylpropoxy)methyl)-2-
methylbenzene 2.88 
 
 
Figure A1B.378. 
1
H NMR (CDCl3, 500 MHz) of 1-Methoxy-3-((1-(4-methoxyphenyl)-
3-phenylpropoxy)methyl)benzene 2.89 
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Figure A1B.379. 
13
C NMR (CDCl3, 125.8 MHz) of 1-Methoxy-3-((1-(4-
methoxyphenyl)-3-phenylpropoxy)methyl)benzene 2.89 
 
Figure A1B.380. IR Spectrum of 1-Methoxy-3-((1-(4-methoxyphenyl)-3-
phenylpropoxy)methyl)benzene 2.89 
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Figure A1B.381. 
1
H NMR (CDCl3, 500 MHz) of 1-Methoxy-4-(1-((4-
methoxybenzyl)oxy)-3-phenylpropyl)benzene 2.90 
 
 
Figure A1B.382. 
13
C NMR (CDCl3, 125.8 MHz) of 1-Methoxy-4-(1-((4-
methoxybenzyl)oxy)-3-phenylpropyl)benzene 2.90 
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Figure A1B.383. IR Spectrum of 1-Methoxy-4-(1-((4-methoxybenzyl)oxy)-3-
phenylpropyl)benzene 2.90 
 
 
Figure A1B.384. 
1
H NMR (CDCl3, 500 MHz) of 1-phenethyl-1,3-dihydroisobenzofuran 
2.91 
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Figure A1B.385. 
13
C NMR (CDCl3, 125.8 MHz) of 1-phenethyl-1,3-
dihydroisobenzofuran 2.91 
 
Figure A1B.386. IR Spectrum of 1-phenethyl-1,3-dihydroisobenzofuran 2.91 
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Figure A1B.387. 
1
H NMR (CDCl3, 500 MHz) of 1-(benzyloxy)-2,3-dihydro-1H-indene 
2.92 
 
 
Figure A1B.388. 
13
C NMR (CDCl3, 125.8 MHz) of 1-(benzyloxy)-2,3-dihydro-1H-
indene 2.92 
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Figure A1B.389. IR Spectrum of 1-(benzyloxy)-2,3-dihydro-1H-indene 2.92 
 
 
Figure A1B.390. 
1
H NMR (CDCl3, 500 MHz) of 1-(4-methoxyphenyl)-3-phenylpropan-
1-ol 2.93 
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Figure A1B.391. 
13
C NMR (CDCl3, 125.8 MHz) of 1-(4-methoxyphenyl)-3-
phenylpropan-1-ol 2.93 
 
Figure A1B.392. IR Spectrum of 1-(4-methoxyphenyl)-3-phenylpropan-1-ol 2.93 
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Figure A1B.393. 
1
H NMR (CDCl3, 500 MHz) of cataCXium A aminobiphenyl 
palladium precatalyst 2.40 
 
 
Figure A1B.394. 
13
C NMR (CDCl3, 125.8 MHz) of cataCXium A aminobiphenyl 
palladium precatalyst 2.40 
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Figure A1B.395. 
31
P NMR (CDCl3, 125.8 MHz) of cataCXium A aminobiphenyl 
palladium precatalyst 2.40 
 
Figure A1B.396. IR Spectrum of cataCXium A aminobiphenyl palladium precatalyst 
2.40 
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Figure A1B.397. 
1
H NMR (CDCl3, 500 MHz) of 1,2-dicyclohexyl-1,2-ethanediol 
 
Figure A1B.398. 
13
C NMR (CDCl3, 125.8 MHz) of 1,2-dicyclohexyl-1,2-ethanediol 
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Figure A1B.399. 
1
H NMR (CDCl3, 500 MHz) of (4R, 5R)-4,5-dicyclohexyl-2-phenethyl-
1,3,2-dioxaborolane 
 
 
Figure A1B.400. 
13
C NMR (CDCl3, 125.8 MHz) of (4R, 5R)-4,5-dicyclohexyl-2-
phenethyl-1,3,2-dioxaborolane 
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Figure A1B.401. 
11
B NMR (CDCl3, 128.38 MHz) of (4R, 5R)-4,5-dicyclohexyl-2-
phenethyl-1,3,2-dioxaborolane 
 
Figure A1B.402. IR Spectrum of (4R, 5R)-4,5-dicyclohexyl-2-phenethyl-1,3,2-
dioxaborolane 
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Figure A1B.403. 
1
H NMR (CDCl3, 500 MHz) of (4S, 5S)-4,5-dicyclohexyl-2-phenethyl-
1,3,2-dioxaborolane 
 
 
Figure A1B.404. 
13
C NMR (CDCl3, 125.8 MHz) of (4S, 5S)-4,5-dicyclohexyl-2-
phenethyl-1,3,2-dioxaborolane 
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Figure A1B.405. 
11
B NMR (CDCl3, 128.38 MHz) of (4S, 5S)-4,5-dicyclohexyl-2-
phenethyl-1,3,2-dioxaborolane 
 
Figure A1B.406. 
1
H NMR (CDCl3, 500 MHz) of (4R, 5R)-2-((S)-1-chloro-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 
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Figure A1B.407. 
13
C NMR (CDCl3, 125.8 MHz) of (4R, 5R)-2-((S)-1-chloro-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 
 
Figure A1B.408. 
11
B NMR (CDCl3, 128.38 MHz) of (4R, 5R)-2-((S)-1-chloro-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 
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Figure A1B.409. IR Spectrum of (4R, 5R)-2-((S)-1-chloro-3-phenylpropyl)-4,5-
dicyclohexyl-1,3,2-dioxaborolane 
 
Figure A1B.410. 
1
H NMR (CDCl3, 500 MHz) of (4S, 5S)-2-((R)-1-chloro-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 
 
715 
 
 
Figure A1B.411. 
13
C NMR (CDCl3, 125.8 MHz) of (4S, 5S)-2-((R)-1-chloro-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 
 
 
Figure A1B.412. 
11
B NMR (CDCl3, 128.38 MHz) of (4S, 5S)-2-((R)-1-chloro-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 
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Figure A1B.413. 
1
H NMR (CDCl3, 500 MHz) of (4R, 5R)-2-((R)-1-(benzyloxy)-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 
 
 
Figure A1B.414. 
13
C NMR (CDCl3, 125.8 MHz) of (4R, 5R)-2-((R)-1-(benzyloxy)-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 2.94-R 
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Figure A1B.415. 
11
B NMR (CDCl3, 128.38 MHz) of (4R, 5R)-2-((R)-1-(benzyloxy)-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 2.94-R 
 
Figure A1B.416. IR Spectrum of (4R, 5R)-2-((R)-1-(benzyloxy)-3-phenylpropyl)-4,5-
dicyclohexyl-1,3,2-dioxaborolane 2.94-R 
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Figure A1B.417. 
1
H NMR (CDCl3, 500 MHz) of (4S, 5S)-2-((S)-1-(benzyloxy)-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 2.94-S 
 
 
Figure A1B.418. 
13
C NMR (CDCl3, 125.8 MHz) of (4S, 5S)-2-((S)-1-(benzyloxy)-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 2.94-S 
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Figure A1B.419. 
11
B NMR (CDCl3, 128.38 MHz) of (4S, 5S)-2-((S)-1-(benzyloxy)-3-
phenylpropyl)-4,5-dicyclohexyl-1,3,2-dioxaborolane 2.94-S 
 
 
Figure A1B.420. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium (R)-1-(benzyloxy)-3-
phenylpropyltrifluorate 2.97-R 
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Figure A1B.421. 
13
C NMR (CD3CN, 125.8 MHz) of Potassium (R)-1-(benzyloxy)-3-
phenylpropyltrifluorate 2.97-R 
 
 
Figure A1B.422. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium (R)-1-(benzyloxy)-
3-phenylpropyltrifluorate 2.97-R 
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Figure A1B.423. 
19
F NMR (Acetone-d6, 470.8 MHz) of Potassium (R)-1-(benzyloxy)-3-
phenylpropyltrifluorate 2.97-R 
 
 
Figure A1B.424. 
1
H NMR (Acetone-d6, 500 MHz) of Potassium (S)-1-(benzyloxy)-3-
phenylpropyltrifluorate 2.97-S 
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Figure A1B.425. 
13
C NMR (CD3CN, 125.8 MHz) of Potassium (S)-1-(benzyloxy)-3-
phenylpropyltrifluorate 2.97-S 
 
 
Figure A1B.426. 
11
B NMR (Acetone-d6, 128.38 MHz) of Potassium (S)-1-(benzyloxy)-
3-phenylpropyltrifluorate 2.97-S 
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Figure A1B.427. 
19
F NMR (Acetone-d6, 470.8 MHz) of Potassium (S)-1-(benzyloxy)-3-
phenylpropyltrifluorate 2.97-S 
 
 
Figure A1B.428. 
1
H NMR (CDCl3, 500 MHz) of (S)-1-(4-Methoxyphenyl)-3-
phenylpropan-1-ol 
724 
 
 
 
Figure A1B.429. 
13
C NMR (CDCl3, 125.8 MHz) of (S)-1-(4-Methoxyphenyl)-3-
phenylpropan-1-ol 
 
 
Figure A1B.430. 
1
H NMR (CDCl3, 500 MHz) of (S)-1-(1-(Benzyloxy)-3-phenylpropyl)-
4-methoxybenzene 2.96-S 
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Figure A1B.431. 
13
C NMR (CDCl3, 125.8 MHz) of (S)-1-(1-(Benzyloxy)-3-
phenylpropyl)-4-methoxybenzene 2.96-S 
 
726 
 
Appendix 2A: High-Throughput Experimentation Data Relevant to Chapter 3  
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High Throughput Experimentation was performed at the Penn/Merck Center for 
High Throughput Experimentation at the University of Pennsylvania. The screens were 
completed on a 10 µmol scale. After the reaction was complete, 1 µmol of 4,4’-di-tert-
butylbiphenyl (500 µL of a 0.002 µM solution in acetonitrile) was added to each reaction 
as an internal standard. The screens were then analyzed by HPLC. A single stock solution 
of internal standard was used for addition to all plates that were completed in order to test 
50 different ligands. Therefore, the P/IS ratios can be roughly correlated among screens 
in order to determine if a ligand provided a significant amount of product. The ratios 
from one screen should not be quantitatively compared to those from a different screen 
(i.e. a 2.9 P/IS ratio is not necessarily better than 2.8 P/IS; however, it can be concluded 
that both of these ratios provide a significant amount of product). To directly compare 
results, the top conditions in the screens should be scaled up and compared to ensure an 
accurate comparison of P/IS and SM/IS ratios. 
The areas for the internal standard (IS), starting amide (SM) and product (P or 
Prod) from each screen are shown in the tables below. 
 
Screen 1 (Figure 3.2):  
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The ligand abbreviations shown below are used throughout the supporting information. 
Ligand Abbreviation 
 
Ligand Name 
Josiphos SL-J015-1 
 
(R)-1-{(SP)-2-[Di(2-furyl)phosphino]ferrocenyl}ethyldi(3,5-xylyl)phosphine 
Josiphos SL-J505-1 
 
(R)-1-[(SP)-2-(Di-tert-butylphosphino)ferrocenyl]ethylbis(2-
methylphenyl)phosphine 
Josiphos SL-J004-1 
 
(R)-1-[(SP)-2-(Dicyclohexylphosphino)ferrocenylethyl]diphenylphosphine 
Josiphos SL-J011-1 
 
(R)-1-{(SP)-2-[Bis[4-(trifluoromethyl)phenyl]phosphino]ferrocenyl}ethyldi-
tert-butylphosphine 
Josiphos SL-J009-1 
 
(R)-1-[(SP)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine 
Josiphos SL-J013-1 
 
(R)-1-[(SP)-2-[Bis(4-methoxy-3,5-
dimethylphenyl)phosphino]ferrocenyl}ethyldi-tert-butylphosphine 
Josiphos SL-J005-1 
 
(R)-1-[(SP)-2-(Diphenylphosphino)ferrocenyl]ethyldi(3,5-xylyl)phosphine 
Josiphos SL-J006-1 
 
(R)-1-{(SP)-2-[Bis[3,5-
bis(trifluoromethyl)phenyl]phosphino]ferrocenyl}ethyldicyclohexylphosphine 
Josiphos SL-J007-1 
 
(R)-1-{(SP)-2-[Bis(4-methoxy-3,5-
dimethylphenyl)phosphino]ferrocenyl}ethyldicyclohexylphosphine 
Josiphos SL-J002-1 
 
(R)-1-[(SP)-2-(Diphenylphosphino)ferrocenyl]ethyldi-tert-butylphosphine 
Josiphos SL-J003-1 
 
(R)-1-[(SP)-2-
(Dicyclohexylphosphino)ferrocenyl]ethyldicyclohexylphosphine 
Josiphos SL-J008-1 
 
(R)-1-{(SP)-2-[Bis[3,5-
bis(trifluoromethyl)phenyl]phosphino]ferrocenyl}ethyldi(3,5-xylyl)phosphine 
Josiphos SL-J001-1 
 
(R)-1-[(SP)-2-(Diphenylphosphino)ferrocenyl]ethyldicyclohexylphosphine 
Josiphos SL-J502-1 
 
(R)-1-[(SP)-2-(Di-tert-butylphosphino)ferrocenyl]ethyldiphenylphosphine 
SL-A116 
 
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis(diisopropylphosphine) 
SL-A101-1 
 
(R)-(+)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis(diphenylphosphine) 
MeOBIPHEP SL-A104-1 
 
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,4,5-
trimethoxyphenyl)phosphine] 
MeOBIPHEP SL-A108-1 
 
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis(di-2-furylphosphine) 
MeOBIPHEP SL-A107-1 
 
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis{bis[3,5-diisopropyl-4-
(dimethylamino)phenyl]phosphine} 
MeOBIPHEP SL-A121-1 
 
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,5-di-tert-
butylphenyl)phosphine] 
MeOBIPHEP SL-A120-1 
 
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,5-dimethylphenyl)phosphine] 
MeOBIPHEP SL-A109-1 
 
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,5-di-tert-butyl-4-
methoxyphenyl)phosphine] 
MeOBIPHEP SL-A102-1 
 
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(4-methylphenyl)phosphine] 
TaniaPhos T001 
 
(RP)-1-[(R)-α-(Dimethylamino)-2-(diphenylphosphino)benzyl]-2-
diphenylphosphinoferrocene 
TaniaPhos T002 
 
(RP)-1-Dicyclohexylphosphino-2-[(R)-α-(dimethylamino)-2-
(dicyclohexylphosphino)benzyl]ferrocene 
WalPhos W001 
 
(R)-1-{(RP)-2-[2-(Diphenylphosphino)phenyl]ferrocenyl}ethylbis[3,5-bis-
(trifluoromethyl)phenyl]phosphine 
WalPhos W002 
 
(R)-1-{(RP)-2-[2-
(Diphenylphosphino)phenyl]ferrocenyl}ethyldiphenylphosphine 
MandyPhos M001 
 
(RP,R′P)-1,1′-Bis[(S)-α-(dimethylamino)benzyl]-2,2′-
bis(diphenylphosphino)ferrocene 
MandyPhos M004 
 
(SP,S′P)-1,1′-Bis[bis(4-methoxy-3,5-dimethylphenyl)phosphino]-2,2′-bis[(R)-
α-(dimethylamino)benzyl]ferrocene 
ROPhos P001 
 
(+)-1,2-Bis[(2S,5S)-2,5-dimethyl-(3S,4S)-3,4-
dihydroxyphospholano]benzene bis(trifluoromethanesulfonate)salt 
TSDPEN 
 
(1S,2S)-1,2-Bis(2-hydroxyphenyl)ethylenediamine 
L4019 
 
 (R)-4,5-Dihydro-1,3-bis-([2.2]paracyclophan-4-yl)imidazolinium chloride 
729 
 
P-PHOS 
 
(R)-(+)-2,2′,6,6′-Tetramethoxy-4,4′-bis(diphenylphosphino)-3,3′-bipyridine 
BDPP 
 
(2S,4S)-2,4-Bis(diphenylphosphino)pentane 
T-BINAP 
 
(R)-(+)-2,2′-Bis(di-p-tolylphosphino)-1,1′-binaphthyl 
SI-PHOS 
 
N-Dimethyl-[(R)-1,1′-spirobiindane-7,7′-diyl]phosphoramidite 
SEGPHOS 
 
(R)-(+)-5,5′-Bis(diphenylphosphino)-4,4′-bi-1,3-benzodioxole 
QUINOXP 
 
(R,R)-(–)-2,3-Bis(tert-butylmethylphosphino)quinoxaline 
H8BINAP 
 
(R)-(+)-2,2′-Bis(diphenylphospino)-5,5′,6,6′,7,7′,8,8′-octahydro-1,1′-
binaphthyl 
DMSEG 
 
(R)-(−)-5,5′-Bis(diphenylphosphino)-4,4′-bi-1,3-benzodioxole 
DTBMSEG 
 
(R)-(−)-5,5′-Bis[di(3,5-di-tert-butyl-4-methoxyphenyl)phosphino]-4,4′-bi-1,3-
benzodioxole 
PYBOX 
 
2,6-Bis[(3aS,8aR)-3a,8a-dihydro-8H-indeno[1,2-d]oxazolin-2-yl]pyridine 
DIOP 
 
(+)-2,3-O-Isopropylidene-2,3-dihydroxy-1,4-bis(diphenylphosphino)butane 
ISOBORNEOL 
 
(2S)-(−)-3-exo-(morpholino)isoborneol 
L680192 
 
2,2-Bis((4S)-(–)-4-isopropyloxazoline)propane 
L4026 
 
 (2R,5R)-1-{[(2R,5R)-2,5-Diphenylpyrrolidin-1-yl]methylene}-2,5-
diphenylpyrrolidinium tetrafluoroborate 
 
Ligand Screen 1A: Variables 
 
Ligand 
 
Copper Source 
 
Base (30 mol %) 
 
Solvent 
Josiphos SL-J015-1 L1 CuCl  
NaOt-Bu 
 
MeOH 
Josiphos SL-J505-1 L2 CuBr  
KOt-Bu 
 
EtOH 
Josiphos SL-J004-1 L3 Cu(MeCN)4PF6     
Josiphos SL-J011-1 L4 
     
Josiphos SL-J009-1 L5 
     
Josiphos SL-J013-1 L6      
Josiphos SL-J005-1 L7      
Josiphos SL-J006-1 L8 
     
Josiphos SL-J007-1 L9 
     
Josiphos SL-J002-1 L10      
Josiphos SL-J003-1 L11      
Josiphos SL-J008-1 L12 
     
Josiphos SL-J001-1 L13 
     
Josiphos SL-J502-1 L14      
SL-A116 L15      
SL-A101-1 L16 
     
MeOBIPHEP SL-A104-1 L17 
     
MeOBIPHEP SL-A108-1 L18      
MeOBIPHEP SL-A107-1 L19      
MeOBIPHEP SL-A121-1 L20 
     
MeOBIPHEP SL-A120-1 L21 
     
MeOBIPHEP SL-A109-1 L22      
MeOBIPHEP SL-A102-1 L23      
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Ligand Screen 1A: Results 
P/IS Ratio 
 
Ligand 
 
Copper Source 
 
Base 
 
Solvent 
5.1815957 
 
L23 
 
CuBr 
 
KOt-Bu 
 
MeOH 
3.5209512 
 
L11 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
3.4242128 
 
L21 
 
CuBr 
 
KOt-Bu 
 
MeOH 
2.8981354 
 
L19 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
2.7733037 
 
L20 
 
CuBr 
 
KOt-Bu 
 
MeOH 
2.753119 
 
L22 
 
CuBr 
 
KOt-Bu 
 
MeOH 
2.3361372 
 
L10 
 
CuCl 
 
KOt-Bu 
 
MeOH 
2.288571 
 
L7 
 
CuCl 
 
KOt-Bu 
 
MeOH 
2.2857122 
 
L19 
 
CuCl 
 
KOt-Bu 
 
EtOH 
2.248521 
 
L8 
 
CuCl 
 
KOt-Bu 
 
MeOH 
2.1804968 
 
L5 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
2.1759229 
 
L8 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
2.1143227 
 
L8 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
2.0879089 
 
L13 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
2.0775867 
 
L20 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
1.9956174 
 
L1 
 
CuBr 
 
KOt-Bu 
 
MeOH 
1.9753252 
 
L3 
 
CuCl 
 
KOt-Bu 
 
MeOH 
1.9294818 
 
L11 
 
CuBr 
 
KOt-Bu 
 
MeOH 
1.8862749 
 
L22 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
1.8791554 
 
L14 
 
CuCl 
 
KOt-Bu 
 
MeOH 
1.8355295 
 
L23 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
1.830146 
 
L12 
 
CuCl 
 
KOt-Bu 
 
MeOH 
1.7998462 
 
L13 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
1.7578815 
 
L13 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
1.7450918 
 
L1 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
1.735722 
 
L19 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
1.7217788 
 
L4 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
1.6503016 
 
L7 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
1.6297101 
 
L16 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
1.5446449 
 
L15 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
1.4735063 
 
L4 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
1.4706487 
 
L9 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
1.4655357 
 
L2 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
1.4583922 
 
L6 
 
CuCl 
 
KOt-Bu 
 
MeOH 
1.4580482 
 
L2 
 
CuCl 
 
KOt-Bu 
 
EtOH 
1.422413 
 
L2 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
1.3715489 
 
L17 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
1.3554783 
 
L8 
 
CuBr 
 
KOt-Bu 
 
EtOH 
1.3387182 
 
L10 
 
CuBr 
 
KOt-Bu 
 
MeOH 
1.3387039 
 
L17 
 
CuBr 
 
KOt-Bu 
 
MeOH 
1.3302043 
 
L15 
 
CuCl 
 
KOt-Bu 
 
MeOH 
1.3166086 
 
L13 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
1.2462017 
 
L13 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
1.1738028 
 
L9 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
1.1073189 
 
L19 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
731 
 
1.0950859 
 
L2 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
1.0781532 
 
L9 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
1.0677621 
 
L3 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
1.0598252 
 
L14 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
1.0236911 
 
L19 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
1.0003225 
 
L18 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0.96552 
 
L15 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.949236 
 
L21 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.9382016 
 
L2 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0.8846775 
 
L13 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.8781422 
 
L16 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0.8291511 
 
L13 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.8168806 
 
L18 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0.8074212 
 
L18 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0.7431558 
 
L17 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.7326495 
 
L22 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.7269983 
 
L12 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0.6920651 
 
L2 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.6838702 
 
L3 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0.6134066 
 
L14 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0.5708991 
 
L19 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.5607072 
 
L9 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0.5592665 
 
L23 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0.5584539 
 
L8 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.5503319 
 
L22 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.5254209 
 
L9 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.5207451 
 
L3 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.5141005 
 
L18 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0.5101089 
 
L14 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0.5016822 
 
L21 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0.4716704 
 
L13 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0.470385 
 
L22 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.4656538 
 
L5 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0.4570425 
 
L4 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.4413788 
 
L20 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0.3823386 
 
L16 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0.3715961 
 
L3 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0.3677342 
 
L10 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.3659699 
 
L3 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0.3632828 
 
L23 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.3504728 
 
L23 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0.3482278 
 
L14 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0.3379646 
 
L1 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.3295165 
 
L23 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0.3212447 
 
L15 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.3118746 
 
L3 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0.3064601 
 
L4 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.3061667 
 
L21 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
732 
 
0.3030459 
 
L3 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.3000598 
 
L5 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.2981196 
 
L13 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.2871638 
 
L8 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0.2838412 
 
L8 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.2751768 
 
L22 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.2732097 
 
L11 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.2692618 
 
L7 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0.2672304 
 
L22 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.2627649 
 
L16 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0.2554264 
 
L22 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0.2522681 
 
L19 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0.246865 
 
L6 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.2443828 
 
L5 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.2306184 
 
L12 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0.2284295 
 
L17 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.2243858 
 
L7 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.211917 
 
L20 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.2105184 
 
L21 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0.2088291 
 
L20 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0.2010387 
 
L10 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0.1998889 
 
L18 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.1965897 
 
L10 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0.1916305 
 
L5 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.1905169 
 
L14 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.1817896 
 
L4 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0.1748053 
 
L15 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.1715462 
 
L22 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0.1688617 
 
L3 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0.1670469 
 
L8 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0.1644124 
 
L10 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.1605525 
 
L12 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.1604024 
 
L20 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0.1566821 
 
L8 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0.1555004 
 
L1 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.1552631 
 
L15 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0.1542552 
 
L21 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.1514722 
 
L14 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.150343 
 
L7 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.150045 
 
L6 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.146497 
 
L4 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0.1443798 
 
L10 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.142014 
 
L19 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0.1399975 
 
L2 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0.1277715 
 
L20 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.1248193 
 
L11 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.1242313 
 
L17 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.1186426 
 
L3 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
733 
 
0.1097075 
 
L1 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.1075336 
 
L1 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0.1038708 
 
L21 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.1034881 
 
L23 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.1024719 
 
L14 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.1001058 
 
L6 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.0969009 
 
L12 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.0938199 
 
L2 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0.0918177 
 
L6 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.0857416 
 
L11 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.0839042 
 
L16 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0.0831615 
 
L10 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.077284 
 
L20 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0.0765419 
 
L19 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.0750435 
 
L22 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0.0701963 
 
L12 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.0690844 
 
L23 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.0667371 
 
L9 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0.0667357 
 
L5 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.066605 
 
L13 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.0658738 
 
L10 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.061306 
 
L21 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0.061048 
 
L1 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0.0601905 
 
L5 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0.0596733 
 
L12 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.0572902 
 
L18 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0.0532798 
 
L19 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0.052635 
 
L17 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0.0516058 
 
L11 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0.050182 
 
L11 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0.0499384 
 
L9 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0.0499384 
 
L15 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.0494709 
 
L16 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0.0464837 
 
L10 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0.0456447 
 
L2 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0.0420021 
 
L12 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0 
 
L1 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0 
 
L1 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L1 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L1 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0 
 
L1 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0 
 
L10 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0 
 
L10 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L11 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L11 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L11 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L11 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0 
 
L11 
 
CuCl 
 
KOt-Bu 
 
MeOH 
734 
 
0 
 
L12 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L12 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L12 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L12 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0 
 
L13 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L13 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0 
 
L14 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0 
 
L14 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0 
 
L14 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L14 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0 
 
L15 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L15 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0 
 
L15 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L15 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0 
 
L15 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0 
 
L16 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0 
 
L16 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0 
 
L16 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L16 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0 
 
L16 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L16 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0 
 
L17 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0 
 
L17 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0 
 
L17 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L17 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L17 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0 
 
L17 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0 
 
L18 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0 
 
L18 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L18 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0 
 
L18 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L18 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0 
 
L18 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0 
 
L19 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L19 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0 
 
L2 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0 
 
L2 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L2 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0 
 
L20 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0 
 
L20 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L20 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0 
 
L20 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0 
 
L21 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0 
 
L21 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L21 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L21 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0 
 
L22 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L22 
 
CuCl 
 
KOt-Bu 
 
MeOH 
735 
 
0 
 
L23 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
EtOH 
0 
 
L23 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L23 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L23 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0 
 
L3 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0 
 
L3 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0 
 
L4 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L4 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0 
 
L4 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L4 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0 
 
L4 
 
CuCl 
 
KOt-Bu 
 
MeOH 
0 
 
L4 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0 
 
L5 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0 
 
L5 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0 
 
L5 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L5 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L5 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L6 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0 
 
L6 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L6 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0 
 
L6 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L6 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L6 
 
CuBr 
 
KOt-Bu 
 
MeOH 
0 
 
L6 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
MeOH 
0 
 
L7 
 
CuCl 
 
NaOt-Bu 
 
EtOH 
0 
 
L7 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0 
 
L7 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L7 
 
CuBr 
 
KOt-Bu 
 
EtOH 
0 
 
L7 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L7 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L7 
 
Cu(MeCN)4PF6  
NaOt-Bu 
 
MeOH 
0 
 
L8 
 
Cu(MeCN)4PF6  
KOt-Bu 
 
EtOH 
0 
 
L8 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L8 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0 
 
L9 
 
CuBr 
 
NaOt-Bu 
 
EtOH 
0 
 
L9 
 
CuCl 
 
KOt-Bu 
 
EtOH 
0 
 
L9 
 
CuCl 
 
NaOt-Bu 
 
MeOH 
0 
 
L9 
 
CuBr 
 
NaOt-Bu 
 
MeOH 
0 
 
L9 
 
CuCl 
 
KOt-Bu 
 
MeOH 
         
 
  
    
Ligand Screen 1B: Variables 
Ligand 
 
Copper Source 
 
Solvent 
 
Base 
Josiphos J001 L1 CuCl 
 
EtOH 
 
NaOt-Bu 
Josiphos J002 L2 Cu(MeCN)4PF6 
 
MeOH 
 
KOt-Bu 
Josiphos J003 L3 
    
NaOMe 
736 
 
Josiphos J005 L4 
     TaniaPhos T001 L5 
     TaniaPhos T002 L6 
     WalPhos W001 L7 
     WalPhos W002 L8 
     MandyPhos M001 L9 
     MandyPhos M004 L10 
     ROPhos P001 L11 
     SL-A101 L12 
     SL-A109 L13 
     1,2-Bis[(2S,5S)-2,5-
diisopropylphospholano]ethane L14      
(S,S)-i-Pr-DUPHOS L15      
S,S-Me-BozPhos L16 
      
 
Ligand Screen 1B: Results 
P/IS Ratio 
 
Ligand 
 
Copper Source 
 
Solvent 
 
Base (30 mol %) 
2.80917 
 
L6 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
2.734584 
 
L3 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
2.709178 
 
L14 
 
CuCl 
 
EtOH 
 
KOt-Bu 
2.653652 
 
L6 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
2.653563 
 
L8 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
2.629091 
 
L8 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
2.621967 
 
L3 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
2.610651 
 
L14 
 
CuCl 
 
EtOH 
 
NaOMe 
2.600703 
 
L14 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
2.591787 
 
L8 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
2.553191 
 
L6 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
2.518972 
 
L8 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
2.217391 
 
L4 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
2.171893 
 
L14 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
2.171679 
 
L4 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
2.107868 
 
L3 
 
CuCl 
 
MeOH 
 
KOt-Bu 
2.086902 
 
L4 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
2.075935 
 
L14 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
2.07314 
 
L4 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
1.988138 
 
L16 
 
CuCl 
 
EtOH 
 
NaOMe 
1.971903 
 
L3 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
737 
 
1.93833 
 
L14 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
1.933758 
 
L3 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
1.914081 
 
L16 
 
CuCl 
 
EtOH 
 
KOt-Bu 
1.88642 
 
L6 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
1.812956 
 
L14 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
1.764097 
 
L16 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
1.743295 
 
L3 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
1.722721 
 
L3 
 
CuCl 
 
EtOH 
 
NaOMe 
1.695599 
 
L9 
 
CuCl 
 
EtOH 
 
KOt-Bu 
1.692884 
 
L4 
 
CuCl 
 
MeOH 
 
KOt-Bu 
1.690931 
 
L16 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
1.650064 
 
L3 
 
CuCl 
 
MeOH 
 
NaOMe 
1.56168 
 
L1 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
1.555961 
 
L9 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
1.537844 
 
L16 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
1.530414 
 
L11 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
1.515672 
 
L14 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
1.5086 
 
L9 
 
CuCl 
 
MeOH 
 
KOt-Bu 
1.507937 
 
L9 
 
CuCl 
 
MeOH 
 
NaOMe 
1.493743 
 
L16 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
1.465844 
 
L14 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
1.454982 
 
L9 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
1.418634 
 
L9 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
1.402174 
 
L9 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
1.376579 
 
L16 
 
CuCl 
 
MeOH 
 
KOt-Bu 
1.347191 
 
L16 
 
CuCl 
 
MeOH 
 
NaOMe 
1.337947 
 
L16 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
1.328475 
 
L9 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
1.242063 
 
L1 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
1.238876 
 
L9 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
1.220681 
 
L4 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
1.212714 
 
L8 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
1.195214 
 
L4 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
1.185232 
 
L6 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
1.181058 
 
L14 
 
CuCl 
 
MeOH 
 
NaOMe 
1.165012 
 
L11 
 
CuCl 
 
EtOH 
 
NaOMe 
1.154817 
 
L9 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
1.103659 
 
L8 
 
CuCl 
 
EtOH 
 
NaOMe 
1.093902 
 
L8 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
1.09201 
 
L8 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
1.091856 
 
L14 
 
CuCl 
 
MeOH 
 
KOt-Bu 
738 
 
1.069913 
 
L4 
 
CuCl 
 
EtOH 
 
NaOMe 
1.044677 
 
L9 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
1.033898 
 
L11 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
1.028143 
 
L14 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
1.025575 
 
L3 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
0.974684 
 
L3 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
0.918987 
 
L4 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
0.889976 
 
L10 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
0.868586 
 
L5 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
0.836045 
 
L7 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
0.825062 
 
L10 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
0.788945 
 
L11 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
0.771684 
 
L11 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.727848 
 
L6 
 
CuCl 
 
EtOH 
 
NaOMe 
0.720627 
 
L1 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
0.678478 
 
L1 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
0.675309 
 
L11 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.65703 
 
L1 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.644815 
 
L11 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
0.626919 
 
L10 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
0.604423 
 
L10 
 
CuCl 
 
EtOH 
 
NaOMe 
0.6 
 
L5 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
0.587719 
 
L4 
 
CuCl 
 
MeOH 
 
NaOMe 
0.577157 
 
L7 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
0.574755 
 
L10 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
0.567127 
 
L6 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
0.565 
 
L4 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.560248 
 
L8 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.545932 
 
L1 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
0.533854 
 
L2 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
0.520732 
 
L11 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
0.515892 
 
L10 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
0.510996 
 
L1 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
0.50601 
 
L12 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
0.502475 
 
L13 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
0.493888 
 
L10 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
0.477723 
 
L10 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.455808 
 
L4 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.451613 
 
L13 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.44881 
 
L15 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
0.446886 
 
L15 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
739 
 
0.43309 
 
L11 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
0.429963 
 
L15 
 
CuCl 
 
EtOH 
 
NaOMe 
0.428925 
 
L12 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
0.427148 
 
L7 
 
CuCl 
 
EtOH 
 
NaOMe 
0.420526 
 
L13 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.412639 
 
L12 
 
CuCl 
 
EtOH 
 
NaOMe 
0.397638 
 
L1 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
0.396635 
 
L15 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.353374 
 
L12 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
0.324228 
 
L15 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
0.310513 
 
L12 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
0.302184 
 
L15 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
0.292653 
 
L12 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.285714 
 
L15 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
0.269279 
 
L6 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
0.252682 
 
L12 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
0.24625 
 
L5 
 
CuCl 
 
EtOH 
 
NaOMe 
0.242718 
 
L15 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.240537 
 
L15 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
0.236641 
 
L2 
 
CuCl 
 
EtOH 
 
NaOMe 
0.225885 
 
L15 
 
CuCl 
 
MeOH 
 
KOt-Bu 
0.222494 
 
L15 
 
CuCl 
 
MeOH 
 
NaOMe 
0.217337 
 
L5 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
0.19401 
 
L1 
 
CuCl 
 
EtOH 
 
NaOMe 
0.192308 
 
L5 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
0.174505 
 
L5 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.167506 
 
L5 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.160494 
 
L13 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
0.15942 
 
L12 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
0.159402 
 
L7 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.159228 
 
L12 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
0.15889 
 
L11 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
0.156212 
 
L7 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
0.153563 
 
L12 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.143033 
 
L7 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
0.142331 
 
L10 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
0.138015 
 
L13 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
0.137136 
 
L10 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.135741 
 
L12 
 
CuCl 
 
MeOH 
 
NaOMe 
0.134085 
 
L5 
 
CuCl 
 
MeOH 
 
KOt-Bu 
0.131611 
 
L10 
 
CuCl 
 
MeOH 
 
NaOMe 
740 
 
0.120051 
 
L2 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.115764 
 
L10 
 
CuCl 
 
MeOH 
 
KOt-Bu 
0.110837 
 
L13 
 
CuCl 
 
EtOH 
 
NaOMe 
0.110444 
 
L7 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
0.10111 
 
L7 
 
CuCl 
 
MeOH 
 
KOt-Bu 
0.09878 
 
L8 
 
CuCl 
 
MeOH 
 
KOt-Bu 
0.09637 
 
L5 
 
CuCl 
 
MeOH 
 
NaOMe 
0.091954 
 
L2 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
0.088918 
 
L2 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
0.086683 
 
L6 
 
CuCl 
 
MeOH 
 
KOt-Bu 
0.084263 
 
L6 
 
CuCl 
 
MeOH 
 
NaOMe 
0.083541 
 
L6 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.082324 
 
L13 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
0.079853 
 
L13 
 
CuCl 
 
MeOH 
 
NaOMe 
0.078067 
 
L7 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.071951 
 
L7 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
0.069051 
 
L7 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
0.063882 
 
L13 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
0.059776 
 
L5 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOt-Bu 
0.059418 
 
L6 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.05625 
 
L5 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
0.049751 
 
L11 
 
CuCl 
 
MeOH 
 
NaOMe 
0.04703 
 
L5 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
0.036939 
 
L1 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.036891 
 
L1 
 
CuCl 
 
MeOH 
 
NaOMe 
0.036458 
 
L1 
 
CuCl 
 
MeOH 
 
KOt-Bu 
0.034739 
 
L12 
 
CuCl 
 
MeOH 
 
KOt-Bu 
0.034653 
 
L13 
 
CuCl 
 
MeOH 
 
KOt-Bu 
0.021028 
 
L13 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
0.020645 
 
L2 
 
CuCl 
 
MeOH 
 
NaOMe 
0.015544 
 
L2 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.015385 
 
L2 
 
CuCl 
 
MeOH 
 
KOt-Bu 
0.01476 
 
L11 
 
CuCl 
 
MeOH 
 
KOt-Bu 
0.013141 
 
L2 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
0.01039 
 
L2 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
0.010363 
 
L2 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
0.010243 
 
L3 
 
CuCl 
 
EtOH 
 
KOt-Bu 
0.007874 
 
L3 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
0.007762 
 
L2 
 
Cu(MeCN)4PF6  
MeOH 
 
NaOMe 
0.006196 
 
L7 
 
CuCl 
 
MeOH 
 
NaOMe 
0.006127 
 
L8 
 
CuCl 
 
MeOH 
 
NaOMe 
741 
 
0.004938 
 
L8 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0.00122 
 
L15 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
0.001198 
 
L13 
 
Cu(MeCN)4PF6  
MeOH 
 
KOt-Bu 
0.001091 
 
L9 
 
CuCl 
 
EtOH 
 
NaOMe 
0 
 
L16 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOt-Bu 
0 
 
L16 
 
Cu(MeCN)4PF6  
EtOH 
 
KOt-Bu 
0 
 
L16 
 
Cu(MeCN)4PF6  
EtOH 
 
NaOMe 
         
 
Ligand Screen 1C: Variables 
Ligand   Copper Source 
 
Base  Solvent 
TSDPEN  L1 CuCl 
 
KOMe (1 eq)  THF/EtOH 
L4019  L2 
  
NaOt-Bu (1 eq)  EtOH 
P-PHOS  L3 
  
KOMe (30 mol %)  
 
BDPP  L4 
  
  
 
T-BINAP  L5 
  
  
 
SI-PHOS  L6 
  
  
 
SEGPHOS  L7 
  
  
 
QUINOXP  L8 
  
  
 
H8BINAP  L9 
   
 
 
DMSEG  L10 
   
 
 
DTBMSEG  L11 
   
 
 
PYBOX  L12 
   
 
 
DIOP  L13 
   
 
 
ISOBORNEOL  L14 
   
 
 
L680192  L15 
   
 
 
L4026  L16 
   
 
 
 
Ligand Screen 1C: Results 
P/IS Ratio 
 
Ligand 
 
Base 
 
Solvent 
2.484418 
 
L15 
 
100% NaOt-Bu 
 
EtOH 
2.482793 
 
L16 
 
100% NaOt-Bu 
 
THF/EtOH 
2.458053 
 
L15 
 
100% KOMe 
 
EtOH 
2.442484 
 
L15 
 
100% NaOt-Bu 
 
THF/EtOH 
2.315701 
 
L11 
 
100% NaOt-Bu 
 
THF/EtOH 
2.312283 
 
L1 
 
100% KOMe 
 
EtOH 
2.295937 
 
L14 
 
100% NaOt-Bu 
 
EtOH 
2.274281 
 
L6 
 
100% NaOt-Bu 
 
EtOH 
2.258977 
 
L2 
 
100% NaOt-Bu 
 
EtOH 
742 
 
2.218701 
 
L8 
 
100% KOMe 
 
EtOH 
2.206374 
 
L16 
 
100% NaOt-Bu 
 
EtOH 
2.186578 
 
L16 
 
30% KOMe 
 
EtOH 
2.148606 
 
L8 
 
30% KOMe 
 
THF/EtOH 
2.135887 
 
L11 
 
100% NaOt-Bu 
 
EtOH 
2.121193 
 
L7 
 
30% KOMe 
 
EtOH 
2.114155 
 
L7 
 
100% KOMe 
 
THF/EtOH 
2.076045 
 
L4 
 
100% NaOt-Bu 
 
EtOH 
2.046092 
 
L13 
 
100% KOMe 
 
EtOH 
2.041838 
 
L4 
 
30% KOMe 
 
THF/EtOH 
2.032076 
 
L5 
 
100% NaOt-Bu 
 
THF/EtOH 
2.030701 
 
L4 
 
100% KOMe 
 
EtOH 
2.02251 
 
L13 
 
30% KOMe 
 
THF/EtOH 
2.021933 
 
L6 
 
30% KOMe 
 
THF/EtOH 
2.020534 
 
L14 
 
100% KOMe 
 
EtOH 
2.020201 
 
L5 
 
100% KOMe 
 
EtOH 
2.017474 
 
L6 
 
30% KOMe 
 
EtOH 
2.00649 
 
L7 
 
100% NaOt-Bu 
 
THF/EtOH 
1.990982 
 
L15 
 
100% KOMe 
 
THF/EtOH 
1.980405 
 
L1 
 
100% NaOt-Bu 
 
EtOH 
1.97988 
 
L13 
 
100% NaOt-Bu 
 
EtOH 
1.949496 
 
L14 
 
100% KOMe 
 
THF/EtOH 
1.92415 
 
L14 
 
30% KOMe 
 
EtOH 
1.907065 
 
L2 
 
30% KOMe 
 
EtOH 
1.897321 
 
L8 
 
100% NaOt-Bu 
 
EtOH 
1.879143 
 
L13 
 
100% KOMe 
 
THF/EtOH 
1.872404 
 
L4 
 
100% KOMe 
 
THF/EtOH 
1.843662 
 
L3 
 
100% NaOt-Bu 
 
THF/EtOH 
1.830777 
 
L3 
 
100% KOMe 
 
THF/EtOH 
1.81734 
 
L14 
 
100% NaOt-Bu 
 
THF/EtOH 
1.807193 
 
L13 
 
100% NaOt-Bu 
 
THF/EtOH 
1.79532 
 
L12 
 
100% KOMe 
 
THF/EtOH 
1.586868 
 
L5 
 
100% KOMe 
 
THF/EtOH 
1.585064 
 
L4 
 
30% KOMe 
 
EtOH 
1.582472 
 
L2 
 
100% NaOt-Bu 
 
THF/EtOH 
1.565135 
 
L6 
 
100% NaOt-Bu 
 
THF/EtOH 
1.561378 
 
L6 
 
100% KOMe 
 
THF/EtOH 
1.536486 
 
L10 
 
100% KOMe 
 
THF/EtOH 
1.463468 
 
L16 
 
100% KOMe 
 
THF/EtOH 
1.453354 
 
L3 
 
100% KOMe 
 
EtOH 
1.452351 
 
L10 
 
100% NaOt-Bu 
 
EtOH 
1.376753 
 
L3 
 
30% KOMe 
 
THF/EtOH 
1.333286 
 
L9 
 
100% NaOt-Bu 
 
THF/EtOH 
1.313059 
 
L1 
 
100% NaOt-Bu 
 
THF/EtOH 
1.310541 
 
L8 
 
100% KOMe 
 
THF/EtOH 
1.299504 
 
L1 
 
100% KOMe 
 
THF/EtOH 
1.222838 
 
L5 
 
100% NaOt-Bu 
 
EtOH 
1.222081 
 
L12 
 
100% NaOt-Bu 
 
EtOH 
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1.221851 
 
L10 
 
100% NaOt-Bu 
 
THF/EtOH 
1.187942 
 
L9 
 
100% KOMe 
 
THF/EtOH 
1.133252 
 
L5 
 
30% KOMe 
 
THF/EtOH 
1.11044 
 
L6 
 
100% KOMe 
 
EtOH 
1.066018 
 
L10 
 
100% KOMe 
 
EtOH 
0.966893 
 
L14 
 
30% KOMe 
 
THF/EtOH 
0.942743 
 
L13 
 
30% KOMe 
 
EtOH 
0.939396 
 
L12 
 
100% NaOt-Bu 
 
THF/EtOH 
0.908348 
 
L1 
 
30% KOMe 
 
EtOH 
0.81329 
 
L16 
 
100% KOMe 
 
EtOH 
0.795546 
 
L9 
 
100% NaOt-Bu 
 
EtOH 
0.791761 
 
L3 
 
30% KOMe 
 
EtOH 
0.790196 
 
L7 
 
30% KOMe 
 
THF/EtOH 
0.785619 
 
L12 
 
30% KOMe 
 
THF/EtOH 
0.778548 
 
L7 
 
100% KOMe 
 
EtOH 
0.747695 
 
L11 
 
30% KOMe 
 
EtOH 
0.727864 
 
L10 
 
30% KOMe 
 
THF/EtOH 
0.702564 
 
L12 
 
100% KOMe 
 
EtOH 
0.67906 
 
L2 
 
100% KOMe 
 
THF/EtOH 
0.668491 
 
L2 
 
30% KOMe 
 
THF/EtOH 
0.656245 
 
L1 
 
30% KOMe 
 
THF/EtOH 
0.636224 
 
L11 
 
30% KOMe 
 
THF/EtOH 
0.633348 
 
L11 
 
100% KOMe 
 
EtOH 
0.614301 
 
L9 
 
100% KOMe 
 
EtOH 
0.606539 
 
L9 
 
30% KOMe 
 
THF/EtOH 
0.586587 
 
L11 
 
100% KOMe 
 
THF/EtOH 
0.536845 
 
L5 
 
30% KOMe 
 
EtOH 
0.517263 
 
L16 
 
30% KOMe 
 
THF/EtOH 
0.472921 
 
L8 
 
100% NaOt-Bu 
 
THF/EtOH 
0.472133 
 
L9 
 
30% KOMe 
 
EtOH 
0.409246 
 
L12 
 
30% KOMe 
 
EtOH 
0.366804 
 
L10 
 
30% KOMe 
 
EtOH 
0.365572 
 
L7 
 
100% NaOt-Bu 
 
EtOH 
0.317455 
 
L8 
 
30% KOMe 
 
EtOH 
0.288743 
 
L15 
 
30% KOMe 
 
EtOH 
0.260064 
 
L2 
 
100% KOMe 
 
EtOH 
0.139049 
 
L4 
 
100% NaOt-Bu 
 
THF/EtOH 
0.071429 
 
L3 
 
100% NaOt-Bu 
 
EtOH 
0 
 
L15 
 
30% KOMe 
 
THF/EtOH 
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Optimization with 3.1 as the Ligand: 
 
Optimization with 3.1: Variables 
Copper Source 
 
Solvent 
 
Base 
CuCl 
 
THF/EtOH 
 
LiOMe 
  
EtOH 
 
KOMe (2 equiv) 
  
Tol/EtOH 
 
NaOt-Bu 
  
MeOH 
 
KOMe (1 equiv) 
Optimization with L2: Results 
P/IS 
 
SM/IS 
 
Copper Source 
 
Solvent 
 
Base 
0.904621 
 
1.919561 
 
CuCl 
 
THF/EtOH LiOMe 
1.284356 
 
1.935944 
 
CuCl 
 
EtOH 
 
LiOMe 
0.455347 
 
2.249269 
 
CuCl 
 
Tol/EtOH 
 
LiOMe 
1.299996 
 
1.573508 
 
CuCl 
 
MeOH 
 
LiOMe 
1.820372 
 
1.308925 
 
CuCl 
 
THF/EtOH KOMe (2 equiv) 
2.020508 
 
0.779745 
 
CuCl 
 
EtOH 
 
KOMe (2 equiv) 
2.599796 
 
1.040214 
 
CuCl 
 
Tol/EtOH 
 
KOMe (2 equiv) 
2.930012 
 
0.405905 
 
CuCl 
 
MeOH 
 
KOMe (2 equiv) 
2.498416 
 
1.035116 
 
CuCl 
 
THF/EtOH KOMe (1 equiv) 
2.996465 
 
0.585672 
 
CuCl 
 
EtOH 
 
KOMe (1 equiv) 
3.121672 
 
0.548854 
 
CuCl 
 
Tol/EtOH 
 
KOMe (1 equiv) 
3.164455 
 
0.121214 
 
CuCl 
 
MeOH 
 
KOMe (1 equiv) 
3.34314 
 
0.342271 
 
CuCl 
 
THF/EtOH NaOt-Bu 
3.313477 
 
0.459934 
 
CuCl 
 
EtOH 
 
NaOt-Bu 
3.255249 
 
0.41157 
 
CuCl 
 
Tol/EtOH 
 
NaOt-Bu 
3.22456 
 
0.123677 
 
CuCl 
 
MeOH 
 
NaOt-Bu 
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Appendix 2B: 
1
H, 
13
C, 
11
B, 
19
F, IR Spectra, and SFC Traces Relevant to Chapter 3  
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Figure A2B.1. SFC Chromatogram of 3-Hydroxy-N-(4-methoxyphenyl)butanamide 3.2-
OH (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.2. SFC Chromatogram of (R)-3-Hydroxy-N-(4-methoxyphenyl)butanamide 
3.2-OH from the borylation with BBA (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.3. SFC Chromatogram of (R)-3-Hydroxy-N-(4-methoxyphenyl)butanamide 
3.2-OH from the borylation with tetrakis(dimethylamino)diboron (Column OD-H, 10% i-
PrOH, 2 mL, 10 MPa)
 
 
Figure A2B.4. SFC Chromatogram of 3-Hydroxy-N-(4-methoxyphenyl)octanamide 3.3-
OH (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.5. SFC Chromatogram of (R)-3-Hydroxy-N-(4-methoxyphenyl)octanamide 
3.3-OH from the borylation with BBA (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa)
 
 
Figure A2B.6. SFC Chromatogram of 3-Hydroxy-N-phenylbutanamide 3.4-OH (Column 
OD-H, 10% i-PrOH, 2 mL, 10 MPa)
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Figure A2B.7. SFC Chromatogram of (R)-3-Hydroxy-N-phenylbutanamide 3.4-OH from 
the borylation with BBA (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa)
 
 
Figure A2B.8. SFC Chromatogram of N-Cyclohexyl-3-hydroxybutanamide 3.5-OH 
(Column AS-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.9. SFC Chromatogram of (R)-N-Cyclohexyl-3-hydroxybutanamide 3.5-OH 
from the borylation with BBA (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa)
 
 
Figure A2B.10. SFC Chromatogram of (R)-N-Cyclohexyl-3-hydroxybutanamide 3.5-OH 
from the borylation with tetrakis(dimethylamino)diboron (Column AS-H, 10% i-PrOH, 2 
mL, 10 MPa)
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Figure A2B.11. SFC Chromatogram of N-Cyclopropyl-3-hydroxyoctanamide 3.6-OH 
(Column AS-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.12. SFC Chromatogram of (R)-N-Cyclopropyl-3-hydroxyoctanamide 3.6-
OH from the borylation with BBA (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa)
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Figure A2B.13. SFC Chromatogram of N-Cyclohexyl-3-hydroxypentanamide 3.7-OH 
(Column AS-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
 
Figure A2B.14. SFC Chromatogram of (R)-N-Cyclohexyl-3-hydroxypentanamide 3.7-
OH from the borylation with BBA (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa)
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Figure A2B.15. SFC Chromatogram of 3-Hydroxy-1-(piperidin-1-yl)butan-1-one 3.8-
OH (Column AD-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.16. SFC Chromatogram of (R)-3-Hydroxy-1-(piperidin-1-yl)butan-1-one 
3.8-OH from the borylation with BBA (Column AD-H, 10% i-PrOH, 2 mL, 10 MPa)
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Figure A2B.17. SFC Chromatogram of 3-Hydroxy-1-morpholinobutan-1-one 3.9-OH 
(Column AD-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.18. SFC Chromatogram of (R)-3-Hydroxy-1-morpholinobutan-1-one 3.9-
OH from the borylation with BBA (Column AD-H, 10% i-PrOH, 2 mL, 10 MPa)
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Figure A2B.19. SFC Chromatogram of (R)-3-Hydroxy-1-morpholinobutan-1-one 3.9-
OH from the borylation with tetrakis(dimethylamino)diboron (Column AD-H, 10% i-
PrOH, 2 mL, 10 MPa)
 
 
Figure A2B.20. SFC Chromatogram of N-Ethyl-3-hydroxy-N-(o-tolyl)butanamide 3.11-
OH (Column AD-H, 10% i-PrOH:CH3CN (85:15), 2 mL, 10 MPa) 
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Figure A2B.21. SFC Chromatogram of (R)-N-Ethyl-3-hydroxy-N-(o-tolyl)butanamide 
3.11 from the borylation with BBA (Column AD-H, 10% i-PrOH:CH3CN (85:15), 2 mL, 
10 MPa)
 
 
Figure A2B.22. SFC Chromatogram of (R)-N-Ethyl-3-hydroxy-N-(o-tolyl)butanamide 
3.11-OH from the borylation with tetrakis(dimethylamino)diboron (Column AD-H, 10% 
i-PrOH:CH3CN (85:15), 2 mL, 10 MPa)
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Figure A2B.23. SFC Chromatogram of 3-Hydroxy-N,N-dimethylbutanamide 3.12-OH 
using (Column R,R-Whelk, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.24. SFC Chromatogram of (R)-3-Hydroxy-N,N-dimethylbutanamide 3.12-
OH from the borylation with BBA (Column R,R-Whelk, 10% i-PrOH, 2 mL, 10 MPa)
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Figure A2B.25. SFC Chromatogram of (R)-3-Hydroxy-N,N-dimethylbutanamide 3.12-
OH from the borylation with tetrakis(dimethylamino)diboron (Column R,R-Whelk, 10% 
i-PrOH, 2 mL, 10 MPa)
 
 
Figure A2B.26. SFC Chromatogram of N,N-Dibenzyl-3-hydroxybutanamide 3.13-OH 
using SFC (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.27. SFC Chromatogram of (R)-N,N-Dibenzyl-3-hydroxybutanamide 3.13-
OH from the borylation with BBA (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa)
 
 
Figure A2B.28. SFC Chromatogram of (R)-N,N-Dibenzyl-3-hydroxybutanamide 3.13-
OH from the borylation with tetrakis(dimethylamino)diboron (Column OD-H, 10% i-
PrOH, 2 mL, 10 MPa) 
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Figure A2B.29. SFC Chromatogram of N-Cyclohexyl-3-hydroxy-3-phenylpropanamide 
3.14-OH (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.30. SFC Chromatogram of (S)-N-Cyclohexyl-3-hydroxy-3-
phenylpropanamide 3.14-OH from the borylation with BBA (Column OD-H, 10% i-
PrOH, 2 mL, 10 MPa)
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Figure A2B.31. SFC Chromatogram of (S)-N-Cyclohexyl-3-hydroxy-3-
phenylpropanamide 3.14-OH from the borylation with tetrakis(dimethylamino)diboron 
(Column OD-H, 10% i-PrOH, 2 mL, 10 MPa)
 
 
Figure A2B.32. SFC Chromatogram of 3-Hydroxy-3-phenyl-1-(pyrrolidin-1-yl)propan-
1-one 3.15-OH (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.33. SFC Chromatogram of (S)-3-Hydroxy-3-phenyl-1-(pyrrolidin-1-
yl)propan-1-one 3.15-OH from the borylation with BBA (Column OD-H, 10% i-PrOH, 2 
mL, 10 MPa)
 
 
Figure A2B.34. SFC Chromatogram of Ethyl 3-hydroxybutanoate 3.16-OH (Column 
AD-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.35. SFC Chromatogram of (R)-Ethyl 3-hydroxybutanoate 3.16-OH from the 
borylation with BBA (Column AD-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.36. SFC Chromatogram of Ethyl-3-hydroxyoctanoate 3.17-OH (Column 
AD-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.37. SFC Chromatogram of (R)-Ethyl-3-hydroxyoctanoate 3.17-OH from the 
borylation with BBA (Column AD-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.38. SFC Chromatogram of 3-Hydroxy-1-phenylbutan-1-one 3.17-OH 
(Column AS-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.39. SFC Chromatogram of (R)-3-Hydroxy-1-phenylbutan-1-one 3.18-OH 
from the borylation with BBA (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.40. SFC Chromatogram of 3-Hydroxy-1,3-diphenylpropan-1-one 3.19-OH 
(Column R,R-Whelk, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.41. SFC Chromatogram of (S)-3-Hydroxy-1,3-diphenylpropan-1-one 3.19-
OH from the borylation with BBA (Column R,R-Whelk, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.42. SFC Chromatogram of N-(4-Methoxyphenyl)-3-phenylbutanamide 3.22 
(Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.43. SFC Chromatogram of (S)-N-(4-Methoxyphenyl)-3-phenylbutanamide 
3.22 from cross-coupling with aryl chloride (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa)
 
 
Figure A2B.44. SFC Chromatogram of (S)-N-(4-Methoxyphenyl)-3-phenylbutanamide 
3.22 from cross-coupling with aryl bromide (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.45. SFC Chromatogram of (S)-N-(4-Methoxyphenyl)-3-phenylbutanamide 
3.22 from cross-coupling with aryl mesylate (Column OJ-H, 10% i-PrOH, 2 mL, 10 
MPa) 
 
Figure A2B.46. SFC Chromatogram of (S)-N-(4-Methoxyphenyl)-3-phenylbutanamide 
3.22 from cross-coupling with aryl triflate (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.47. SFC Chromatogram of N-(4-Methoxyphenyl)-3-(pyridin-3-
yl)butanamide 3.23 (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.48. SFC Chromatogram of (S)-N-(4-Methoxyphenyl)-3-(pyridin-3-
yl)butanamide 3.23 using SFC (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.49. SFC Chromatogram of N-(4-Methoxyphenyl)-3-(thiophen-3-
yl)butanamide 3.24 (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.50. SFC Chromatogram of (S)-N-(4-Methoxyphenyl)-3-(thiophen-3-
yl)butanamide 3.24 (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.51. SFC Chromatogram of N-(4-Methoxyphenyl)-3-(thiophen-2-
yl)butanamide 3.25 (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.52. SFC Chromatogram of (S)-N-(4-Methoxyphenyl)-3-(thiophen-2-
yl)butanamide 3.25 (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.53. SFC Chromatogram of N-(4-Methoxyphenyl)-3-(quinolin-6-
yl)butanamide 3.26 (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.54. SFC Chromatogram of (S)-N-(4-Methoxyphenyl)-3-(quinolin-6-
yl)butanamide 3.26 (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
773 
 
 
Figure A2B.55. SFC Chromatogram of tert-Butyl-5-(4-((4-methoxyphenyl)amino)-4-
oxobutan-2-yl)-1H-indole-1-carboxylate 3.27 (Column AS-H, 10% i-PrOH, 2 mL, 10 
MPa) 
 
Figure A2B.56. SFC Chromatogram of (S)-tert-Butyl-5-(4-((4-methoxyphenyl)amino)-4-
oxobutan-2-yl)-1H-indole-1-carboxylate (3.27 (Column AS-H, 10% i-PrOH, 2 mL, 10 
MPa)
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Figure A2B.57. SFC Chromatogram of 3-(4-Fluorophenyl)-N-(4-
methoxyphenyl)butanamide 3.28 (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.58. SFC Chromatogram of (S)-3-(4-Fluorophenyl)-N-(4-
methoxyphenyl)butanamide 3.28 (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.59. SFC Chromatogram of 3-(4-Fluorophenyl)-N-phenylbutanamide 3.29 
(Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.60. SFC Chromatogram of (S)-3-(4-Fluorophenyl)-N-phenylbutanamide 
3.29 (Column OJ-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.61. SFC Chromatogram of N-Ethyl-3-(4-fluorophenyl)-N-(o-
tolyl)butanamide 3.30 (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.62. SFC Chromatogram of (S)-N-Ethyl-3-(4-fluorophenyl)-N-(o-
tolyl)butanamide 3.30 (Column OD-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.63. SFC Chromatogram of N-Cyclohexyl-3-(4-fluorophenyl)butanamide 
3.31 using SFC (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa) 
 
Figure A2B.64. SFC Chromatogram  of (S)-N-Cyclohexyl-3-(4-fluorophenyl)butanamide 
3.31 (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa) 
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Figure A2B.65. SFC Chromatogram of N-Cyclohexyl-3-(4-fluorophenyl)pentanamide 
3.32 (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa)
 
 
Figure A2B.66. SFC Chromatogram of (S)-N-Cyclohexyl-3-(4-
fluorophenyl)pentanamide 3.32 (Column AS-H, 10% i-PrOH, 2 mL, 10 MPa)
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Figure A2B.67. 
1
H NMR (Acetone, 360 MHz) spectrum of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide 3.2 
 
 
Figure A2B.68. 
13
C NMR (Acetone, 125.8 MHz) spectrum of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide 3.2 
N
H
O BF3K
MeO
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Figure A2B.69. 
19
F NMR (Acetone, 338.8 MHz) spectrum of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide 3.2
 
 
 
Figure A2B.70. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide 3.2
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Figure A2B.71. 
1
H NMR (DMSO, 360 MHz) spectrum of Potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)methyloctanamide 3.3 
 
 
Figure A2B.72. 
13
C NMR (DMSO, 90.5 MHz) spectrum of Potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)methyloctanamide 3.3 
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Figure A2B.73. 
19
F NMR (DMSO, 338.8 MHz) spectrum of Potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)methyloctanamide 3.3
 
 
 
Figure A2B.74. 
11
B NMR (DMSO, 128.4 MHz) spectrum of Potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)methyloctanamide 3.3 
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Figure A2B.75. IR Spectrum of Potassium (R)-N-(4-methoxyphenyl)-3-
(trifluoroborato)methyloctanamide 3.3 
 
 
Figure A2B.76. 
1
H NMR (Acetone, 300 MHz) spectrum of potassium (R)-N-phenyl-3-
(trifluoroborato)butanamide 3.4 
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Figure A2B.77. 
13
C NMR (Acetone, 75.4 MHz) spectrum of potassium (R)-N-phenyl-3-
(trifluoroborato)butanamide 3.4 
 
 
Figure A2B.78. 
19
F NMR (Acetone, 282.4 MHz) spectrum of potassium (R)-N-phenyl-3-
(trifluoroborato)butanamide 3.4
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Figure A2B.79. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (R)-N-phenyl-3-
(trifluoroborato)butanamide 3.4 
 
Figure A2B.80. IR Spectrum of potassium (R)-N-phenyl-3-(trifluoroborato)butanamide 
3.4 
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Figure A2B.81. 
1
H NMR (DMSO, 300 MHz) spectrum of potassium (R)-N-cyclohexyl-
3-(trifluoroborato)butanamide 3.5 
 
 
Figure A2B.82. 
13
C NMR (DMSO, 75.4 MHz) spectrum of potassium (R)-N-cyclohexyl-
3-(trifluoroborato)butanamide  3.5 
787 
 
 
Figure A2B.83. 
19
F NMR (DMSO, 282.4 MHz) spectrum of potassium (R)-N-
cyclohexyl-3-(trifluoroborato)butanamide 3.5 
 
 
Figure A2B.84. 
11
B NMR (DMSO, 128.4 MHz) spectrum of potassium (R)-N-
cyclohexyl-3-(trifluoroborato)butanamide  3.5 
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Figure A2B.85. 
1
H NMR (DMSO, 500 MHz) spectrum of potassium (R)-N-cyclopropyl-
3-(trifluoroborato)butanamide  3.6 
 
 
Figure A2B.86. 
13
C NMR (DMSO, 125.8 MHz) spectrum of potassium (R)-N-
cyclopropyl-3-(trifluoroborato)butanamide 3.6 
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Figure A2B.87. 
19
F NMR (DMSO, 470.8 MHz) spectrum of potassium (R)-N-
cyclopropyl-3-(trifluoroborato)butanamide 3.6
 
 
 
Figure A2B.88. 
11
B NMR (DMSO, 128.4 8MHz) spectrum of potassium (R)-N-
cyclopropyl-3-(trifluoroborato)butanamide 3.6
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Figure A2B.89. 
1
H NMR (DMSO, 300 MHz) spectrum of Potassium (R)-N-cyclohexyl-
3-(trifluoroborato)pentanamide 3.7 
 
 
Figure A2B.90. 
13
C NMR (DMSO, 75.4 MHz) spectrum of Potassium (R)-N-cyclohexyl-
3-(trifluoroborato)pentanamide 3.7 
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Figure A2B.91. 
19
F NMR (DMSO, 338.8 MHz) spectrum of Potassium (R)-N-
cyclohexyl-3-(trifluoroborato)pentanamide 3.7 
 
 
Figure A2B.92. 
11
B NMR (DMSO, 128.4 MHz) spectrum of Potassium (R)-N-
cyclohexyl-3-(trifluoroborato)pentanamide 3.7
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Figure A2B.93. 
1
H NMR (Acetone, 500 MHz) spectrum of potassium 1-(piperidin-1-yl)-
3-(trifluoroborato)butan-1-one 3.8 
 
 
Figure A2B.94. 
13
C NMR (Aceton, 125.8 MHz) spectrum of potassium 1-(piperidin-1-
yl)-3-(trifluoroborato)butan-1-one 3.8 
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Figure A2B.95. 
19
F NMR (Aceton, 470.8 MHz) spectrum of potassium 1-(piperidin-1-
yl)-3-(trifluoroborato)butan-1-one 3.8
 
 
 
Figure A2B.96. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium 1-(piperidin-1-
yl)-3-(trifluoroborato)butan-1-one 3.8 
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Figure A2B.97. 
1
H NMR (DMSO, 500 MHz) spectrum of potassium (R)-1-morpholino-
3-(trifluoroborato)butan-1-one 3.9 
 
 
Figure A2B.98. 
13
C NMR (DMSO, 125.8 MHz) spectrum of potassium (R)-1-
morpholino-3-(trifluoroborato)butan-1-one 3.9 
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Figure A2B.99. 
19
F NMR (DMSO, 470.8 MHz) spectrum of potassium (R)-1-
morpholino-3-(trifluoroborato)butan-1-one 3.9
 
 
 
Figure A2B.100. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (R)-1-
morpholino-3-(trifluoroborato)butan-1-one 3.9 
796 
 
 
Figure A2B.101. 
1
H NMR (Acetone, 300 MHz) spectrum of potassium (S)-N-(4-
methoxyphenyl)-3-phenyl-3-(trifluoroborato)propanamide 3.10 
 
 
Figure A2B.102. 
13
C NMR (Acetone, 75.4 MHz) spectrum of potassium (S)-N-(4-
methoxyphenyl)-3-phenyl-3-(trifluoroborato)propanamide 3.10 
797 
 
 
Figure A2B.103. 
19
F NMR (DMSO, 282.4 MHz) spectrum of potassium (S)-N-(4-
methoxyphenyl)-3-phenyl-3-(trifluoroborato)propanamide 3.10 
 
 
Figure A2B.104. 
11
B NMR (DMSO, 128.4 MHz) spectrum of potassium (S)-N-(4-
methoxyphenyl)-3-phenyl-3-(trifluoroborato)propanamide 3.10 
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Figure A2B.105. IR Spectrum of potassium (S)-N-(4-methoxyphenyl)-3-phenyl-3-
(trifluoroborato)propanamide 3.10
 
 
Figure A2B.106. 
1
H NMR (DMSO, 300 MHz) spectrum of potassium N-ethyl-N-(o-
tolyl)-3-(trifluoroborato)butanamide 3.11 
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Figure A2B.107. 
13
C NMR (DMSO, 75.4 MHz) spectrum of potassium N-ethyl-N-(o-
tolyl)-3-(trifluoroborato)butanamide 3.11 
 
 
Figure A2B.108. 
19
F NMR (DMSO, 470.8 MHz) spectrum of potassium N-ethyl-N-(o-
tolyl)-3-(trifluoroborato)butanamide 3.11
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Figure A2B.109. 
11
B NMR (DMSO, 128.4 MHz) spectrum of potassium N-ethyl-N-(o-
tolyl)-3-(trifluoroborato)butanamide 3.11
 
 
 
Figure A2B.110. 
1
H NMR (Acetone, 500 MHz) spectrum of potassium (R)-N,N-
dimethyl-3-(trifluoroborato)butanamide 3.12 
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Figure A2B.111. 
13
C NMR (Acetone, 125.8 MHz) spectrum of potassium (R)-N,N-
dimethyl-3-(trifluoroborato)butanamide 3.12 
 
 
Figure A2B.112. 
19
F NMR (Acetone, 470.8 MHz) spectrum of Potassium (R)-N,N-
dimethyl-3-(trifluoroborato)butanamide 3.12
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Figure A2B.113. 
11
B NMR (Acetone, 128.4 MHz) spectrum of Potassium (R)-N,N-
dimethyl-3-(trifluoroborato)butanamide 3.12
 
 
 
Figure A2B.114. 
1
H NMR (DMSO, 360 MHz) spectrum of potassium (R)-N,N-dibenzyl-
3-(trifluoroborato)butanamide 3.13
 
803 
 
 
Figure A2B.115. 
13
C NMR (DMSO, 90.5 MHz) spectrum of potassium (R)-N,N-
dibenzyl-3-(trifluoroborato)butanamide 3.13 
 
 
Figure A2B.116. 
19
F NMR (Acetone, 338.8 MHz) spectrum of potassium (R)-N,N-
dibenzyl-3-(trifluoroborato)butanamide 3.13
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Figure A2B.117. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (R)-N,N-
dibenzyl-3-(trifluoroborato)butanamide 3.13
 
 
 
Figure A2B.118. 
1
H NMR (DMSO, 500 MHz) spectrum of potassium (S)-N-cyclohexyl-
3-phenyl-3-(trifluoroborato)propanamide 3.14 
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Figure A2B.119. 
13
C NMR (DMSO, 125.8 MHz) spectrum of potassium (S)-N-
cyclohexyl-3-phenyl-3-(trifluoroborato)propanamide 3.14 
 
 
Figure A2B.120. 
19
F NMR (DMSO, 470.8 MHz) spectrum of potassium (S)-N-
cyclohexyl-3-phenyl-3-(trifluoroborato)propanamide 3.14
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Figure A2B.121. 
11
B NMR (DMSO, 128.4 MHz) spectrum of potassium (S)-N-
cyclohexyl-3-phenyl-3-(trifluoroborato)propanamide 3.14 
 
Figure A2B.122. IR Spectrum of potassium (S)-N-cyclohexyl-3-phenyl-3-
(trifluoroborato)propanamide 3.14 
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Figure A2B.123. 
1
H NMR (Acetone, 500 MHz) spectrum of potassium 3-phenyl-1-
(pyrrolidin-1-yl)-3-(trifluoroborato)propan-1-one 3.15 
 
 
Figure A2B.124. 
13
C NMR (Acetone, 125.8 MHz) spectrum of potassium 3-phenyl-1-
(pyrrolidin-1-yl)-3-(trifluoroborato)propan-1-one 3.15 
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Figure A2B.125. 
19
F NMR (Acetone, 470.8 MHz) spectrum of potassium 3-phenyl-1-
(pyrrolidin-1-yl)-3-(trifluoroborato)propan-1-one 3.15
 
 
 
Figure A2B.126. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium 3-phenyl-1-
(pyrrolidin-1-yl)-3-(trifluoroborato)propan-1-one 3.15
 
 
809 
 
 
Figure A2B.127. 
1
H NMR (DMSO, 500 MHz) spectrum of potassium (R)-ethyl 3-
(trifluoroborato)butanoate 3.16 
 
 
Figure A2B.128. 
13
C NMR (Acetone, 125.8 MHz) spectrum of potassium (R)-ethyl 3-
(trifluoroborato)butanoate 3.16 
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Figure A2B.129. 
19
F NMR (Acetone, 470.8 MHz) spectrum of potassium (R)-ethyl 3-
(trifluoroborato)butanoate 3.16
 
 
 
Figure A2B.130. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (R)-ethyl 3-
(trifluoroborato)butanoate 3.16
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Figure A2B.131. 
1
H NMR (Acetone, 500 MHz) spectrum of potassium (R)-ethyl 3-
(trifluoroborato)octanoate 3.17 
 
 
Figure A2B.132. 
13
C NMR (Acetone, 125.8 MHz) spectrum of potassium (R)-ethyl 3-
(trifluoroborato)octanoate 3.17 
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Figure A2B.133. 
19
F NMR (Acetone, 470.8 MHz) spectrum of potassium (R)-ethyl 3-
(trifluoroborato)octanoate 3.17
 
 
 
Figure A2B.134. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (R)-ethyl 3-
(trifluoroborato)octanoate 3.17 
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Figure A2B.135. IR Spectrum of potassium (R)-ethyl 3-(trifluoroborato)octanoate 3.17 
 
 
Figure A2B.136. 
1
H NMR (Acetone, 300 MHz) spectrum of potassium (R)-3-
trifluoroborato-1-phenylbutan-1-one 3.18 
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Figure A2B.137. 
13
C NMR (Acetone, 75.4 MHz) spectrum of potassium (R)-3-
trifluoroborato-1-phenylbutan-1-one 3.18 
 
 
Figure A2B.138. 
19
F NMR (Acetone, 282.4 MHz) spectrum of potassium (R)-3-
trifluoroborato-1-phenylbutan-1-one 3.18
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Figure A2B.139. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (R)-3-
trifluoroborato-1-phenylbutan-1-one 3.18 
 
Figure A2B.140. IR Spectrum of potassium (R)-3-trifluoroborato-1-phenylbutan-1-one 
3.18 
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Figure A2B.141. 
1
H NMR (Acetone, 500 MHz) spectrum of potassium (S)-1,3-diphenyl-
3-(trifluororborato)butan-1-one 3.19 
 
 
Figure A2B.142. 
13
C NMR (Acetone, 125.8 MHz) spectrum of potassium (S)-1,3-
diphenyl-3-(trifluororborato)butan-1-one 3.19 
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Figure A2B.143. 
19
F NMR (Acetone, 470.8 MHz) spectrum of potassium (S)-1,3-
diphenyl-3-(trifluororborato)butan-1-one 3.19
 
 
 
Figure A2B.144. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (S)-1,3-
diphenyl-3-(trifluororborato)butan-1-one 3.19 
818 
 
 
Figure A2B.145. 
1
H NMR (DMSO, 360 MHz) spectrum of potassium (R)-3-
(Trifluoroborato)cyclohexanone 3.20 
 
 
Figure A2B.146. 
13
C NMR (DMSO, 90.5 MHz) spectrum of potassium (R)-3-
(Trifluoroborato)cyclohexanone 3.20
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Figure A2B.147. 
19
F NMR (DMSO, 338.8 MHz) spectrum of potassium (R)-3-
(Trifluoroborato)cyclohexanone 3.20
 
 
 
Figure A2B.148. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (R)-3-
(Trifluoroborato)cyclohexanone 3.20
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Figure A2B.149. 
1
H NMR (CDCl3, 300 MHz) spectrum of (R)-3-Hydroxy-N-(4-
methoxyphenyl)butanamide 3.2-OH
 
 
 
Figure A2B.150. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (R)-3-Hydroxy-N-(4-
methoxyphenyl)butanamide 3.2-OH
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Figure A2B.151. 
1
H NMR (CDCl3, 300 MHz) spectrum of (R)-3-hydroxy-N-(4-
methoxyphenyl)octanamide 3.3-OH 
 
 
Figure A2B.152. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (R)-3-hydroxy-N-(4-
methoxyphenyl)octanamide 3.3-OH 
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Figure A2B.153. IR Spectrum of (R)-3-hydroxy-N-(4-methoxyphenyl)octanamide 3.3-
OH 
 
 
Figure A2B.154. 
1
H NMR (CDCl3, 500 MHz) spectrum of (R)-3-Hydroxy-N-
phenylbutanamide 3.4-OH 
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Figure A2B.155. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (R)-3-Hydroxy-N-
phenylbutanamide 3.4-OH 
 
 
Figure A2B.156. 
1
H NMR (CDCl3, 300 MHz) spectrum of (R)-N-cyclohexyl-3-
hydroxybutanamide 3.5-OH 
824 
 
 
Figure A2B.157. 
13
C NMR (CDCl3, 75.4 MHz) spectrum of ((R)-N-cyclohexyl-3-
hydroxybutanamide 3.5-OH 
 
 
Figure A2B.158. 
1
H NMR (CDCl3, 500 MHz) spectrum of (R)-N-Cyclopropyl-3-
hydroxyoctanamide 3.6-OH 
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Figure A2B.159. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (R)-N-Cyclopropyl-3-
hydroxyoctanamide 3.6-OH 
 
Figure A2B.160. IR Spectrum of (R)-N-Cyclopropyl-3-hydroxyoctanamide 3.6-OH 
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Figure A2B.161. 
1
H NMR (CDCl3, 300 MHz) spectrum of (R)-N-cyclohexyl-3-
hydroxypentanamide 3.7-OH 
 
 
Figure A2B.162. 
13
C NMR (CDCl3, 75.4 MHz) spectrum of (R)-N-cyclohexyl-3-
hydroxypentanamide 3.7-OH 
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Figure A2B.163. 
1
H NMR (CDCl3, 500 MHz) spectrum of (R)-3-Hydroxy-1-(piperidin-
1-yl)butan-1-one 3.8-OH 
 
 
Figure A2B.164. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (R)-3-Hydroxy-1-
(piperidin-1-yl)butan-1-one 3.8-OH 
828 
 
 
Figure A2B.165. 
1
H NMR (CDCl3, 360 MHz) spectrum of (R)-3-Hydroxy-1-
morpholinobutan-1-one 3.9-OH 
 
 
Figure A2B.166. 
13
C NMR (CDCl3, 90.5 MHz) spectrum of (R)-3-Hydroxy-1-
morpholinobutan-1-one 3.9-OH 
829 
 
 
Figure A2B.167. 
1
H NMR (CDCl3, 500 MHz) spectrum of (S)-3-Hydroxy-N-(4-
methoxyphenyl)-3-phenylpropanamide 3.10-OH 
 
 
Figure A2B.168. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (S)-3-Hydroxy-N-(4-
methoxyphenyl)-3-phenylpropanamide 3.10-OH 
830 
 
 
Figure A2B.169. IR Spectrum of (S)-3-Hydroxy-N-(4-methoxyphenyl)-3-
phenylpropanamide 3.10-OH 
 
 
Figure A2B.170. 
1
H NMR (CDCl3, 500 MHz) spectrum of potassium (R)-N-ethyl-3-
hydroxy-N-(o-tolyl)butanamide 3.11-OH 
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Figure A2B.171. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of potassium (R)-N-ethyl-3-
hydroxy-N-(o-tolyl)butanamide 3.11-OH 
 
Figure A2B.172. IR Spectrum of potassium (R)-N-ethyl-3-hydroxy-N-(o-
tolyl)butanamide 3.11-OH 
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Figure A2B.173. 
1
H NMR (CDCl3, 500 MHz) spectrum of (R)-3-hydroxy-N,N-
dimethylbutanamide 3.12-OH
 
 
 
Figure A2B.174. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (R)-3-hydroxy-N,N-
dimethylbutanamide 3.12-OH 
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Figure A2B.175. 
1
H NMR (CDCl3, 500 MHz) spectrum of (R)-N,N-Dibenzyl-3-
hydroxybutanamide 3.13-OH 
 
 
Figure A2B.176. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (R)-N,N-Dibenzyl-3-
hydroxybutanamide 3.13-OH 
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Figure A2B.177. 
1
H NMR (CDCl3, 300 MHz) spectrum of (S)-N-Cyclohexyl-3-hydroxy-
3-phenylpropanamide 3.14-OH 
 
 
Figure A2B.178. 
13
C NMR (CDCl3, 75.4 MHz) spectrum of (S)-N-Cyclohexyl-3-
hydroxy-3-phenylpropanamide 3.14-OH 
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Figure A2B.179. 
1
H NMR (CDCl3, 500 MHz) spectrum of (S)-3-Hydroxy-3-phenyl-1-
(pyrrolidin-1-yl)propan-1-one 3.15-OH 
 
 
Figure A2B.180. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (S)-3-Hydroxy-3-phenyl-1-
(pyrrolidin-1-yl)propan-1-one 3.15-OH 
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Figure A2B.181. 
19
F NMR (CDCl3, 383.8 MHz) spectrum of (R)- and (S)-MTPA ester of 
3-Hydroxy-N-(4-methoxyphenyl)-3-phenylpropanamide
 
 
 
Figure A2B.182. 
19
F NMR (CDCl3, 383.8 MHz) spectrum of (R)- and (S)-MTPA ester of 
(S)-3-Hydroxy-N-(4-methoxyphenyl)-3-phenylpropanamide
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Figure A2B.183. 
1
H NMR (CDCl3, 300 MHz) spectrum of ethyl-(R)-3-hydroxybutanoate 
3.16-OH 
 
 
Figure A2B.184. 
13
C NMR (CDCl3, 75.4 MHz) spectrum of ethyl-(R)-3-
hydroxybutanoate 3.16-OH 
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Figure A2B.185. 
1
H NMR (CDCl3, 300 MHz) spectrum of Ethyl (R)-3-hydroxyoctanoate 
3.17-OH 
 
 
Figure A2B.186. 
13
C NMR (CDCl3, 75.4 MHz) spectrum of Ethyl (R)-3-
hydroxyoctanoate 3.17-OH 
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Figure A2B.187. 
1
H NMR (CDCl3, 300 MHz) spectrum of (R)-3-Hydroxy-1-
phenylbutan-1-one 3.18-OH 
 
 
Figure A2B.188. 
13
C NMR (CDCl3, 75.4 MHz) spectrum of (R)-3-Hydroxy-1-
phenylbutan-1-one 3.18-OH 
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Figure A2B.189. 
1
H NMR (CDCl3, 360 MHz) spectrum of (S)-3-hydroxy-1,3-
diphenylpropan-1-one 3.19-OH 
 
 
Figure A2B.190. 
13
C NMR (CDCl3, 90.5 MHz) spectrum of (S)-3-hydroxy-1,3-
diphenylpropan-1-one 3.18-OH 
841 
 
 
Figure A2B.191. 
1
H NMR (CDCl3, 500 MHz) spectrum of (R)-3-Hydroxycyclohexane-
1-one 3.20-OH 
 
 
Figure A2B.192. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (R)-3-
Hydroxycyclohexane-1-one 3.19-OH
 
842 
 
 
Figure A2B.193. 
19
F NMR (CDCl3, 383.8 MHz) spectrum of (R)- and (S)-MTPA ester of 
(S)-3-Hydroxy-N-(4-methoxyphenyl)-3-phenylpropanamide
 
 
 
Figure A2B.194. 
1
H NMR (CDCl3, 300 MHz) spectrum of (S)-N-(4-Methoxyphenyl)-3-
(pyridin-3-yl)butanamide 3.23 
843 
 
 
Figure A2B.195. 
13
C NMR (CDCl3, 75.4 MHz) spectrum of (S)-N-(4-Methoxyphenyl)-3-
(pyridin-3-yl)butanamide 3.23 
 
 
Figure A2B.196. 
1
H NMR (CDCl3, 300 MHz) spectrum of (S)-N-(4-Methoxyphenyl)-3-
(thiophen-3-yl)butanamide 3.24 
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Figure A2B.197. 
13
C NMR (CDCl3, 75.4 MHz) spectrum of (S)-N-(4-Methoxyphenyl)-3-
(thiophen-3-yl)butanamide 3.24 
 
Figure A2B.198. IR Spectrum of (S)-N-(4-Methoxyphenyl)-3-(thiophen-3-yl)butanamide 
3.24 
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Figure A2B.199. 
1
H NMR (CDCl3, 360 MHz) spectrum of (S)-N-(4-methoxyphenyl)-3-
(thiophen-2-yl)butanamide 3.25 
 
 
Figure A2B.200. 
13
C NMR (CDCl3, 90.5 MHz) spectrum of (S)-N-(4-methoxyphenyl)-3-
(thiophen-2-yl)butanamide 3.25 
846 
 
 
Figure A2B.201. IR Spectrum of  (S)-N-(4-methoxyphenyl)-3-(thiophen-2-
yl)butanamide 3.25 
 
 
Figure A2B.202. 
1
H NMR (CDCl3, 500 MHz) spectrum of N-(4-methoxyphenyl)-3-
(quinolin-6-yl)butanamide 3.26 
847 
 
 
Figure A2B.203. 
13
C NMR (CDCl3, 500 MHz) spectrum of (S)-N-(4-methoxyphenyl)-3-
(quinolin-6-yl)butanamide 3.26 
 
Figure A2B.204. IR Spectrum of (S)-N-(4-methoxyphenyl)-3-(quinolin-6-yl)butanamide 
3.26 
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Figure A2B.205. 
1
H NMR (CDCl3, 500 MHz) spectrum of tert-Butyl-(S)-5-(4-((4-
methoxyphenyl)amino)-4-oxobutan-2-yl)-1H-indole-1-carboxylate 3.27 
 
 
Figure A2B.206. 
13
C NMR (CDCl3, 90.5 MHz) spectrum of tert-Butyl-(S)-5-(4-((4-
methoxyphenyl)amino)-4-oxobutan-2-yl)-1H-indole-1-carboxylate 3.27 
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Figure A2B.207. IR Spectrum of tert-Butyl-(S)-5-(4-((4-methoxyphenyl)amino)-4-
oxobutan-2-yl)-1H-indole-1-carboxylate 3.27 
 
 
Figure A2B.208. 
1
H NMR (CDCl3, 360 MHz) spectrum of (S)-N-(4-Methoxyphenyl)-3-
phenylbutanamide 3.22 
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Figure A2B.209. 
13
C NMR (CDCl3, 90.5 MHz) spectrum of (S)-N-(4-Methoxyphenyl)-3-
phenylbutanamide 3.22 
 
 
Figure A2B.210. 
1
H NMR (CDCl3, 300 MHz) spectrum of (S)-3-(4-Fluorophenyl)-N-(4-
methoxyphenyl)butanamide 3.28 
851 
 
 
Figure A2B.211. 
13
C NMR (CDCl3, 75.4 MHz) spectrum of (S)-3-(4-Fluorophenyl)-N-
(4-methoxyphenyl)butanamide 3.28 
 
 
Figure A2B.212. 
19
F NMR (CDCl3, 282.4 MHz) spectrum of (S)-3-(4-Fluorophenyl)-N-
(4-methoxyphenyl)butanamide 3.28 
852 
 
 
Figure A2B.213. 
1
H NMR (CDCl3, 500 MHz) spectrum of (S)-3-(4-Fluorophenyl)-N-
phenylbutanamide 3.29 
 
 
Figure A2B.214. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (S)-3-(4-Fluorophenyl)-N-
phenylbutanamide 3.29 
853 
 
 
Figure A2B.215. 
19
F NMR (CDCl3,470.8 MHz) spectrum of (S)-3-(4-Fluorophenyl)-N-
phenylbutanamide 3.29 
 
Figure A2B.216. IR Spectrum of 
19
F NMR (CDCl3,470.8 MHz) spectrum of (S)-3-(4-
Fluorophenyl)-N-phenylbutanamide 3.29 
854 
 
 
Figure A2B.217. 
1
H NMR (CDCl3, 360 MHz) spectrum of (S)-N-Ethyl-3-(4-
fluorophenyl)-N-(o-tolyl)butanamide 3.30 
 
 
Figure A2B.218. 
13
C NMR (CDCl3, 90.5 MHz) spectrum of (S)-N-Ethyl-3-(4-
fluorophenyl)-N-(o-tolyl)butanamide 3.30 
855 
 
 
Figure A2B.219. 
19
F NMR (CDCl3, 338.8 MHz) spectrum of (S)-N-Ethyl-3-(4-
fluorophenyl)-N-(o-tolyl)butanamide 3.30 
 
Figure A2B.220. IR Spectrum of 
19
F NMR (CDCl3, 338.8 MHz) spectrum of (S)-N-
Ethyl-3-(4-fluorophenyl)-N-(o-tolyl)butanamide 3.30 
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Figure A2B.221. 
1
H NMR (CDCl3, 300 MHz) spectrum of (S)-N-Cyclohexyl-3-(4-
fluorophenyl)butanamide 3.31 
 
 
Figure A2B.222. 
13
C NMR (CDCl3, 75.4 MHz) spectrum of (S)-N-Cyclohexyl-3-(4-
fluorophenyl)butanamide 3.31 
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Figure A2B.223. 
19
F NMR (CDCl3, 282.4 MHz) spectrum of (S)-N-Cyclohexyl-3-(4-
fluorophenyl)butanamide 3.32 
 
 
Figure A2B.224. 
1
H NMR (CDCl3, 360 MHz) spectrum of (S)-N-Cyclohexyl-3-(4-
fluorophenyl)pentanamide 3.32 
858 
 
 
Figure A2B.225. 
13
C NMR (CDCl3, 125.8 MHz) spectrum of (S)-N-Cyclohexyl-3-(4-
fluorophenyl)pentanamide 3.32 
 
 
Figure A2B.226. 
19
F NMR (DMSO, 470.8 MHz) spectrum of (S)-N-Cyclohexyl-3-(4-
fluorophenyl)pentanamide 3.32 
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Figure A2B.227. IR Spectrum of (S)-N-Cyclohexyl-3-(4-fluorophenyl)pentanamide 3.32 
 
 
Figure A2B.228. 
1
H NMR (Acetone, 500 MHz) spectrum of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide 3.2 from borylation with 
tetrakis(dimethylamino)diboron 
860 
 
 
Figure A2B.229. 
13
C NMR (DMSO, 125.8 MHz) spectrum of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide 3.2 from borylation with 
tetrakis(dimethylamino)diboron 
 
Figure A2B.230. 
19
F NMR (Acetone, 470.8 MHz) spectrum of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide 3.2 from borylation with  B2(NMe2)4
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Figure A2B.231. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (R)-N-(4-
methoxyphenyl)-3-(trifluoroborato)butanamide 3.2 from borylation with B2(NMe2)4
 
 
 
Figure A2B.232. 
1
H NMR (DMSO, 500 MHz) spectrum of potassium (R)-N-cyclohexyl-
3-(trifluoroborato)butanamide 3.5  from borylation with B2(NMe2)4 
862 
 
 
Figure A2B.233. 
13
C NMR (DMSO, 125.8 MHz) spectrum of potassium (R)-N-
cyclohexyl-3-(trifluoroborato)butanamide  3.5 from borylation with B2(NMe2)4 
 
Figure A2B.234. 
19
F NMR (DMSO, 470.8 MHz) spectrum of potassium (R)-N-
cyclohexyl-3-(trifluoroborato)butanamide 3.5  from borylation with B2(NMe2)4 
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Figure A2B.235. 
11
B NMR (DMSO, 128.4 MHz) spectrum of potassium (R)-N-
cyclohexyl-3-(trifluoroborato)butanamide  3.5 from borylation with B2(NMe2)4 
 
 
Figure A2B.236. 
1
H NMR (DMSO, 500 MHz) spectrum of potassium (R)-1-morpholino-
3-(trifluoroborato)butan-1-one 3.9 from borylation with B2(NMe2)4 
864 
 
 
 
Figure A2B.237. 
13
C NMR (DMSO, 125.8 MHz) spectrum of potassium (R)-1-
morpholino-3-(trifluoroborato)butan-1-one 3.9 from borylation with B2(NMe2)4 
 
Figure A2B.238. 
19
F NMR (DMSO, 470.8 MHz) spectrum of potassium (R)-1-
morpholino-3-(trifluoroborato)butan-1-one 3.9 from borylation with B2(NMe2)4
 
865 
 
 
 
Figure A2B.239. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (R)-1-
morpholino-3-(trifluoroborato)butan-1-one 3.9 from borylation with B2(NMe2)4 
 
Figure A2B.240. 
1
H NMR (DMSO, 500 MHz) spectrum of potassium N-ethyl-N-(o-
tolyl)-3-(trifluoroborato)butanamide 3.11 from borylation with B2(NMe2)4 
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Figure A2B.241. 
13
C NMR (DMSO, 125.8 MHz) spectrum of potassium N-ethyl-N-(o-
tolyl)-3-(trifluoroborato)butanamide 3.11 from borylation with B2(NMe2)4 
 
Figure A2B.242. 
19
F NMR (DMSO, 470.8 MHz) spectrum of potassium N-ethyl-N-(o-
tolyl)-3-(trifluoroborato)butanamide 3.11 from borylation with B2(NMe2)4
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Figure A2B.243. 
11
B NMR (DMSO, 128.4 MHz) spectrum of potassium N-ethyl-N-(o-
tolyl)-3-(trifluoroborato)butanamide 3.11 from borylation with B2(NMe2)4
 
 
 
Figure A2B.244. 
1
H NMR (Acetone, 500 MHz) spectrum of potassium (R)-N,N-
dimethyl-3-(trifluoroborato)butanamide 3.12 from borylation with B2(NMe2)4 
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Figure A2B.245. 
13
C NMR (Acetone, 125.8 MHz) spectrum of potassium (R)-N,N-
dimethyl-3-(trifluoroborato)butanamide 3.12  from borylation with B2(NMe2)4 
 
Figure A2B.246. 
19
F NMR (Acetone, 470.8 MHz) spectrum of Potassium (R)-N,N-
dimethyl-3-(trifluoroborato)butanamide 3.12 from borylation with B2(NMe2)4
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Figure A2B.247. 
11
B NMR (Acetone, 128.4 MHz) spectrum of Potassium (R)-N,N-
dimethyl-3-(trifluoroborato)butanamide 3.12 from borylation with B2(NMe2)4 
 
Figure A2B.248. 
1
H NMR (DMSO, 500 MHz) spectrum of potassium (R)-N,N-dibenzyl-
3-(trifluoroborato)butanamide 3.13 from borylation with B2(NMe2)4
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Figure A2B.249. 
13
C NMR (DMSO, 125.8 MHz) spectrum of potassium (R)-N,N-
dibenzyl-3-(trifluoroborato)butanamide 3.13 from borylation with B2(NMe2)4 
 
 
Figure A2B.250. 
19
F NMR (Acetone, 470.8 MHz) spectrum of potassium (R)-N,N-
dibenzyl-3-(trifluoroborato)butanamide 3.13 from borylation with B2(NMe2)4
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Figure A2B.251. 
11
B NMR (Acetone, 128.4 MHz) spectrum of potassium (R)-N,N-
dibenzyl-3-(trifluoroborato)butanamide 3.13 from borylation with 
tetrakis(dimethylamino)diboron B2(NMe2)4 
 
Figure A2B.252. 
1
H NMR (DMSO, 500 MHz) spectrum of potassium (S)-N-cyclohexyl-
3-phenyl-3-(trifluoroborato)propanamide 3.14 from borylation with B2(NMe2)4 
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Figure A2B.253. 
13
C NMR (DMSO, 125.8 MHz) spectrum of potassium (S)-N-cyclo-
hexyl-3-phenyl-3-(trifluoroborato)propanamide 3.14 from borylation with B2(NMe2)4 
 
Figure A2B.254. 
19
F NMR (DMSO, 470.8 MHz) spectrum of potassium (S)-N-cyclo-
hexyl-3-phenyl-3-(trifluoroborato)propanamide 3.14 from borylation with B2(NMe2)4
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Figure A2B.255. 
11
B NMR (DMSO, 128.4 MHz) spectrum of potassium (S)-N-cyclo-
hexyl-3-phenyl-3-(trifluoroborato)propanamide 3.14 from borylation with B2(NMe2)4 
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Appendix 3A: High-Throughput Experimentation Data Relevant to Chapter 4  
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High Throughput Experimentation was performed at the Penn/Merck Center for 
High Throughput Experimentation at the University of Pennsylvania. The screens were 
analyzed by HPLC with addition of an internal standard (4,4’-di-tert-butylbiphenyl). The 
areas for the internal standard (IS), 1-allyl-3-bromo-2-phenyl-2,1-borazaronaphthalene 
(SM), and product (Prod or P) from the screen are shown in the table below.  
 
Screen 1 (Figure 4.12): 
 
Screen 1 Variables: 
Solvent Ratio (CPME/H2O) 
 
Base 
 
Ligand 
9:1 
 
Cs2CO3 
 
P-tBu3 
4:1 
 
CsOH 
 
XPhos 
1:1 
   
Ata-Phos 
    
Sphos 
Structures of Ligands Screened: 
 
 
Screen 1 Results: 
IS Area 
 
SM 
Area  
Prod 
Area  
P/IS 
 
SM/IS 
 
Ligand 
 
Ratio 
 
Base 
542.926 
 
39.73 
 
3698 
 
6.811 
 
0.073 
 
Sphos 
 
9:1 
 
CsOH 
520.882 
 
50.72 
 
3375 
 
6.48 
 
0.097 
 
Sphos 
 
1:1 
 
CsOH 
500.299 
 
24.17 
 
2959 
 
5.914 
 
0.048 
 
A-taPhos 
 
9:1 
 
CsOH 
546.809 
 
25.82 
 
3229 
 
5.905 
 
0.047 
 
P-tBu3 
 
9:1 
 
CsOH 
526.359 
 
101.2 
 
3036 
 
5.768 
 
0.192 
 
A-taPhos 
 
1:1 
 
CsOH 
531.103 
 
0 
 
2918 
 
5.495 
 
0 
 
Sphos 
 
4:1 
 
CsOH 
563.849 
 
32.65 
 
3030 
 
5.374 
 
0.058 
 
Sphos 
 
1:1 
 
Cs2CO3 
503.186 
 
30.2 
 
2692 
 
5.351 
 
0.06 
 
A-taPhos 
 
4:1 
 
CsOH 
876 
 
558.027 
 
0 
 
2673 
 
4.79 
 
0 
 
P-tBu3 
 
1:1 
 
CsOH 
547.251 
 
140.6 
 
2545 
 
4.651 
 
0.257 
 
Sphos 
 
4:1 
 
Cs2CO3 
569.118 
 
38.68 
 
2557 
 
4.492 
 
0.068 
 
XPhos 
 
4:1 
 
CsOH 
364.976 
 
61.13 
 
1637 
 
4.485 
 
0.167 
 
Sphos 
 
9:1 
 
Cs2CO3 
547.981 
 
31.92 
 
2439 
 
4.451 
 
0.058 
 
P-tBu3 
 
4:1 
 
CsOH 
511.243 
 
0 
 
2057 
 
4.024 
 
0 
 
XPhos 
 
9:1 
 
CsOH 
632.639 
 
53.51 
 
2320 
 
3.667 
 
0.085 
 
XPhos 
 
1:1 
 
Cs2CO3 
605.808 
 
117.8 
 
1998 
 
3.298 
 
0.194 
 
P-tBu3 
 
1:1 
 
Cs2CO3 
581.948 
 
228.8 
 
1744 
 
2.997 
 
0.393 
 
XPhos 
 
4:1 
 
Cs2CO3 
538.885 
 
45.98 
 
1532 
 
2.844 
 
0.085 
 
A-taPhos 
 
1:1 
 
Cs2CO3 
551.582 
 
41.34 
 
1203 
 
2.181 
 
0.075 
 
XPhos 
 
1:1 
 
CsOH 
479.876 
 
305.2 
 
882.4 
 
1.839 
 
0.636 
 
A-taPhos 
 
4:1 
 
Cs2CO3 
600.4 
 
969.7 
 
1057 
 
1.761 
 
1.615 
 
XPhos 
 
9:1 
 
Cs2CO3 
707.163 
 
640.9 
 
1183 
 
1.673 
 
0.906 
 
P-tBu3 
 
4:1 
 
Cs2CO3 
2.83263 
 
5.606 
 
3.218 
 
1.136 
 
1.979 
 
A-taPhos 
 
9:1 
 
Cs2CO3 
637.485 
 
1898 
 
551.5 
 
0.865 
 
2.977 
 
P-tBu3 
 
9:1 
 
Cs2CO3 
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Appendix 3B: Absorption and Emission Spectra of 2,1-Borazaronaphthalenes 
(Spectroscopic data collected on the Saven and Kagan Fluorimeters with Shorouk 
Badir and Adriel Koschitzky)  
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Figure A3B.1. Absorption and Emission Spectra of 2-(4-Methylphenyl)-2,1-
borazaronaphthalene 4.49 (excitation wavelength of 317 nm) 
 
Figure A3B.2. Absorption and Emission Spectra of 2-(4-Fluorophenyl)-2,1-
borazaronaphthalene 4.50 (excitation wavelength of 317 nm) 
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Figure A3B.3. Absorption and Emission Spectra of 2-(4-Dibenzofuryl)-2,1-
borazaronaphthalene 4.52 (excitation wavelength of 317 nm) 
 
Figure A3B.4. Absorption and Emission Spectra of 2-(3-Thienyl)-2,1-
borazaronaphthalene 4.51 (excitation wavelength of 317 nm) 
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Figure A3B.5. Absorption and Emission Spectra of 2-(2-Thienyl)-2,1-
borazaronaphthalene 4.153 (excitation wavelength of 317 nm) 
 
Figure A3B.6. Absorption and Emission Spectra of 1-Benzyl-2-phenyl-2,1-
borazaronaphthalene 4.6 (excitation wavelength of 317 nm) 
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Figure A3B.7. Absorption and Emission Spectra of 1-Benzyl-2-(4-tert-butylphenyl)-2,1-
borazaronaphthalene 4.7 (excitation wavelength of 317 nm) 
 
Figure A3B.8. Absorption and Emission Spectra of 2-(4-Methoxybenzyl)-1-phenyl-2,1-
borazaronaphthalene 4.33 (excitation wavelength of 317 nm) 
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Figure A3B.9. Absorption and Emission Spectra of 1-Butyl-2-phenyl-2,1-
borazaronaphthalene 4.35 (excitation wavelength of 317 nm) 
 
Figure A3B.10. Absorption and Emission Spectra of 1-Benzyl-2-((E)-3-phenyl-1-
propen-1-yl)-2,1-borazaronaphthalene 4.24 (excitation wavelength of 317 nm) 
883 
 
 
Figure A3B.11. Absorption and Emission Spectra of 3-Phenyl-2-methyl-2,1-
borazaronaphthalene 4.79 (excitation wavelength of 317 nm) 
 
Figure A3B.12. Absorption and Emission Spectra of 3-(3-Cyanophenyl)-2-methyl-2,1-
borazaronaphthalene 4.92 (excitation wavelength of 317 nm) 
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Figure A3B.13. Absorption and Emission Spectra of 3-(7-N-Boc-Indolyl)-2-methyl-2,1-
borazaronaphthalene 4.93 (excitation wavelength of 317 nm) 
 
Figure A3B.14. Absorption and Emission Spectra of 3-(1-(4-Naphthyl)-phenyl)-2-
methyl-2,1-borazaronaphthalene 4.82 (excitation wavelength of 317 nm) 
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Figure A3B.15. Absorption and Emission Spectra of 2,3-Diphenyl-2,1-
borazaronaphthalene 4.106 (excitation wavelength of 317 nm) 
 
Figure A3B.16. Absorption and Emission Spectra of 2,3-Di(3-Methoxyphenyl)-2,1-
borazaronaphthalene 4.115 (excitation wavelength of 317 nm) 
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Figure A3B.17. Absorption and Emission Spectra of 2-Phenyl-3-(3-thienyl)-2,1-
borazaronaphthalene 4.110 (excitation wavelength of 317 nm) 
 
Figure A3B.18. Absorption and Emission Spectra of 1-Benzyl-2,3-diphenyl-2,1-
borazaronaphthalene 4.149 (excitation wavelength of 317 nm) 
887 
 
 
Figure A3B.19. Absorption and Emission Spectra of 6-(3-Methoxy-5-methylphenyl)-3-
(3-methoxyphenyl)-2-methyl-2,1-borazaronaphthalene 4.121 (excitation wavelength of 
317 nm) 
 
Figure A3B.20. Absorption and Emission Spectra of 3-Phenyl-6-(3-thienyl)-2-methyl-
2,1-borazaronaphthalene 4.122 (excitation wavelength of 317 nm) 
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Figure A3B.21. Absorption and Emission Spectra of 2,3,6-Triphenyl-2,1-
borazaronaphthalene 4.150 (excitation wavelength of 317 nm) 
 
Figure A3B.22. Absorption and Emission Spectra of 3,6-Di(1-(4-naphthylphenyl))-2-
methyl-2,1-borazaronaphthalene 4.151 (excitation wavelength of 317 nm) 
889 
 
 
Figure A3B.23. Absorption and Emission Spectra of 3,6-Di(1-(4-naphthylphenyl))-2-
phenyl-2,1-borazaronaphthalene 4.152 (excitation wavelength of 317 nm) 
 
Figure A3B.24. Absorption and Emission Spectra of 1-Allyl-3-phenyl-2,1-
borazaronaphthol 4.125 (excitation wavelength of 317 nm) 
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Figure A3B.25. Absorption and Emission Spectra of 2,1-Borazaronaphthalene 
(excitation wavelength of 317 nm) 
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Appendix 3C: Atom Coordinates and Total Energies for Computational Studies 
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Computational Study: 
  
Bromination at the C3 position: 
 
RB3LYP Energy -3000.10320482 Hartree 
------- ----------- ------------ ---------------- ------------ ----------- 
Center Atomic Atomic 
 
Coordinates (Angstroms) 
Number Number Type X Y Z 
------ ----------- ------------ ---------------- ------------ ------------ 
1 6 0 -1.133214 -0.013382 0.989343 
2 5 0 -0.933701 1.446418 0.401827 
3 7 0 0.384839 1.682178 -0.128971 
4 6 0 1.435571 0.810027 -0.097858 
5 6 0 2.688596 1.155349 -0.630053 
6 6 0 3.738889 0.254777 -0.57146 
7 6 0 3.603946 -1.034383 0.014054 
8 6 0 2.397068 -1.405863 0.535694 
9 6 0 1.271751 -0.506434 0.503124 
10 6 0 0.05744 -0.8821 1.031976 
11 1 0 -0.039656 -1.867151 1.485119 
12 1 0 2.257021 -2.384639 0.984903 
13 1 0 4.453984 -1.707108 0.037847 
14 1 0 4.699654 0.545217 -0.987341 
15 1 0 2.829652 2.131573 -1.084641 
16 1 0 0.589167 2.580766 -0.558791 
17 6 0 -2.032927 2.55004 0.406158 
18 1 0 -2.15841 2.944438 1.426063 
19 1 0 -1.814664 3.402714 -0.245684 
20 1 0 -3.008955 2.141893 0.118412 
21 35 0 -2.177773 -0.921241 -0.492397 
22 1 0 -1.773822 -0.119793 1.865799 
------ ----------- ------------ ---------------- ------------ ------------ 
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SCF Done:  E(RB3LYP) =  -3000.10320482     A.U. after    7 cycles 
            NFock=  7  Conv=0.75D-08     -V/T= 2.0067 
 
 
1\1\GINC-HOUSE-09\FOpt\RB3LYP\6-31G(d)\C9H10B1Br1N1(1+)\WEBMO\18-Mar-2 
 014\0\\#N B3LYP/6-31G(d) OPT Geom=Connectivity\\C3 Br Routine\\1,1\C,0 
 .0030647125,-0.0315555179,0.0075720169\B,0.011778557,-0.0169442966,1.5 
 936702915\N,1.3340859165,-0.0117654562,2.1658180942\C,2.511747812,-0.0 
 869081972,1.4779832448\C,3.7483284546,-0.0946999921,2.1438359795\C,4.9 
 251984142,-0.185619973,1.4197580285\C,4.9403603679,-0.2710823249,0.000 
 0979416\C,3.7557071138,-0.2596299663,-0.6804346387\C,2.5019025571,-0.1 
 6905756,0.0239400258\C,1.3094044933,-0.1605477061,-0.6639806624\H,1.32 
 52833663,-0.2328513518,-1.7500804251\H,3.7305658237,-0.317326135,-1.76 
 46133849\H,5.8861766358,-0.3408479102,-0.5255012062\H,5.8695853736,-0. 
 192536432,1.9568491915\H,3.7762852038,-0.0316707277,3.2277207877\H,1.4 
 329603967,0.0339298388,3.1768036777\C,-1.2713144445,-0.0310420842,2.47 
 67168432\H,-1.7234421558,-1.0343994956,2.4578631377\H,-1.0954675366,0. 
 2247032034,3.5270802723\H,-2.0340492243,0.6509189284,2.0827897719\Br,- 
 0.4255637484,1.9021365904,-0.425988299\H,-0.7907242438,-0.593786311,-0 
 .4860600032\\Version=IA32L-G09RevD.01\State=1-A\HF=-3000.1032048\RMSD= 
 7.543e-09\RMSF=6.539e-06\Dipole=1.6248249,-1.3120245,0.6256635\Quadrup 
 ole=11.0849154,-12.0850441,1.0001287,-2.7953313,1.0206225,-0.1373358\P 
 G=C01 [X(C9H10B1Br1N1)]\\@ 
 
 
 
Bromination at the C6 position: 
 
RB3LYP Energy -3000.09145851 Hartree 
------ ----------- --------------- ------------- ------------ ------------ 
Center Atomic Atomic 
 
Coordinates (Angstrom) 
Number Number Type X Y Z 
------ ----------- --------------- ------------- ------------ ------------ 
1 6 0 1.586345 0.199571 0.905188 
2 6 0 1.102704 1.57179 0.628397 
3 6 0 -0.186317 1.811225 0.305661 
4 6 0 -1.133492 0.727959 0.209406 
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5 6 0 -0.728944 -0.644572 0.472304 
6 6 0 0.574648 -0.87288 0.809296 
7 1 0 0.912544 -1.884816 1.014728 
8 6 0 -1.702813 -1.721632 0.367998 
9 6 0 -2.993026 -1.490198 0.028456 
10 5 0 -3.468123 -0.056772 -0.263295 
11 7 0 -2.39984 0.965331 -0.127496 
12 1 0 -2.63562 1.940448 -0.304828 
13 6 0 -4.90219 0.394158 -0.673019 
14 1 0 -5.030877 1.472504 -0.817192 
15 1 0 -5.203252 -0.105477 -1.605008 
16 1 0 -5.635046 0.065938 0.077363 
17 1 0 -3.669057 -2.339582 -0.032614 
18 1 0 -1.332449 -2.723635 0.577157 
19 1 0 -0.531284 2.821336 0.102449 
20 1 0 1.823702 2.380268 0.693912 
21 35 0 2.959403 -0.231247 -0.504414 
22 1 0 2.160232 0.14069 1.835342 
------ ----------- --------------- ------------- ------------ ------------ 
 
SCF Done:  E(RB3LYP) =  -3000.09145851     A.U. after    7 cycles 
            NFock=  7  Conv=0.86D-08     -V/T= 2.0067 
 
1\1\GINC-HOUSE-09\FOpt\RB3LYP\6-31G(d)\C9H10B1Br1N1(1+)\WEBMO\18-Mar-2 
 014\0\\#N B3LYP/6-31G(d) OPT Geom=Connectivity\\C6 Routine\\1,1\C,0.00 
 85616111,0.0198210709,0.01096557\C,0.0091195925,-0.0028591679,1.491840 
 7794\C,1.1619541692,0.0039538272,2.1946840108\C,2.4354065859,0.0221271 
 518,1.5180289984\C,2.5099006564,0.0494796792,0.0653357075\C,1.33715255 
 87,0.0542153445,-0.6344353806\H,1.3536850917,0.0765203905,-1.720537896 
 5\C,3.8070255138,0.066590335,-0.59537052\C,4.9668614539,0.0566199606,0 
 .1033298931\B,4.9403378451,0.023483107,1.6407771411\N,3.5707801293,0.0 
 098153957,2.21391672\H,3.4688676115,-0.0123242034,3.2273348793\C,6.165 
 8363702,0.0000606168,2.6027362908\H,5.9228198476,-0.0044465551,3.67095 
 7989\H,6.7893108716,-0.8822423711,2.3985358765\H,6.8190326862,0.862800 
 3024,2.4106555354\H,5.9017368191,0.0695176203,-0.4516867577\H,3.789588 
 1193,0.0860233506,-1.6836002851\H,1.1521509123,-0.014756656,3.28104275 
 01\H,-0.9530590386,-0.0257799095,1.9932927311\Br,-0.8393443902,-1.7025 
 457891,-0.5992613539\H,-0.6640121979,0.7830443745,-0.3929345099\\Versi 
 on=IA32L-G09RevD.01\State=1-A\HF=-3000.0914585\RMSD=8.568e-09\RMSF=1.6 
 42e-05\Dipole=1.0204631,1.1673509,1.1057335\Quadrupole=9.6272122,-11.8 
 509521,2.2237399,0.9518544,4.3419064,0.9583031\PG=C01 [X(C9H10B1Br1N1) 
 ]\\@ 
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Bromination at the C8 position: 
 
RB3LYP Energy -3000.08843624 Hartree 
------ ----------- --------------- ------------- ------------ ------------ 
Center Atomic Atomic 
 
Coordinates (Angstroms) 
Number Number Type X Y Z 
------ ----------- --------------- ------------- ------------ ------------ 
1 6 0 1.081612 0.217064 0.731667 
2 6 0 1.86472 1.466942 0.554321 
3 6 0 1.278099 2.605841 0.114108 
4 6 0 -0.116981 2.61522 -0.199735 
5 6 0 -0.947339 1.505987 -0.09824 
6 6 0 -0.366632 0.273271 0.330463 
7 7 0 -1.122572 -0.815921 0.413301 
8 5 0 -2.571595 -0.879391 0.09812 
9 6 0 -3.156019 0.467474 -0.348595 
10 6 0 -2.357028 1.561467 -0.434176 
11 1 0 -2.738939 2.528422 -0.757242 
12 1 0 -4.204637 0.576793 -0.614516 
13 6 0 -3.318843 -2.241471 0.236359 
14 1 0 -2.697009 -3.081649 0.564757 
15 1 0 -4.154639 -2.148519 0.94402 
16 1 0 -3.781003 -2.52244 -0.720335 
17 1 0 -0.635053 -1.676106 0.663633 
18 1 0 -0.556802 3.548012 -0.546088 
19 1 0 1.851973 3.518966 -0.001326 
20 1 0 2.917369 1.423555 0.813756 
21 35 0 1.993816 -1.221843 -0.309093 
22 1 0 1.16162 -0.124908 1.770876 
------ ----------- --------------- ------------- ------------ ------------ 
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SCF Done:  E(RB3LYP) =  -3000.08843624     A.U. after    7 cycles 
            NFock=  7  Conv=0.82D-08     -V/T= 2.0067 
 
1\1\GINC-HOUSE-09\FOpt\RB3LYP\6-31G(d)\C9H10B1Br1N1(1+)\WEBMO\18-Mar-2 
 014\0\\#N B3LYP/6-31G(d) OPT Geom=Connectivity\\C8 Routine\\1,1\C,0.15 
 2151394,0.3449091652,0.0640412759\C,0.2137434398,-0.0331421709,1.49937 
 71773\C,1.3853004214,-0.0177239587,2.1792435964\C,2.5933160995,0.35642 
 68956,1.5117535436\C,2.6671910667,0.7058012315,0.1691166553\C,1.462332 
 8598,0.6723849507,-0.5975615072\N,1.4975340022,0.973050114,-1.89100978 
 12\B,2.7136449341,1.3628437223,-2.6474296078\C,3.9820739298,1.39512186 
 28,-1.7841817391\C,3.9176654642,1.0725754706,-0.4672357569\H,4.8008067 
 564,1.076168901,0.1693797003\H,4.9509149919,1.6615961438,-2.1996368874 
 \C,2.5913273401,1.6771569466,-4.1702544839\H,1.5818553495,1.5810724225 
 ,-4.5851723899\H,2.9419963712,2.6976629136,-4.3790111821\H,3.254370319 
 6,1.0201588031,-4.7503628468\H,0.6168339987,0.868602173,-2.394713589\H 
 ,3.515460716,0.362623479,2.0889135796\H,1.4224452669,-0.2823282537,3.2 
 304613974\H,-0.7248759804,-0.2997073141,1.9739250063\Br,-0.7211952001, 
 -1.1562706764,-0.9205788123\H,-0.5450666682,1.1813812638,-0.0682584525 
 \\Version=IA32L-G09RevD.01\State=1-A\HF=-3000.0884362\RMSD=8.182e-09\R 
 MSF=6.250e-06\Dipole=0.7557405,0.9413141,1.0397283\Quadrupole=2.054323 
 1,-10.2614361,8.207113,3.4405352,-0.463351,-3.4496629\PG=C01 [X(C9H10B 
 1Br1N1)]\\@ 
 
 
Molecular Energy of 2,1-Borazaronaphthalene: 
 
RB3LYP Energy -389.330835679 Hartree 
 
--------------------------------------------------------------------------------- 
Center Atomic Atomic Coordinates (Angstroms) 
 Number Number Type X Y Z 
      1 5 0 2.488549 0.772606 0 
2 6 0 2.483827 -0.754812 0 
3 6 0 1.287193 -1.410254 0 
4 6 0 0.023118 -0.717487 0 
5 6 0 -1.208765 -1.407148 0 
897 
 
6 6 0 -2.41575 -0.729611 0 
7 6 0 -2.42306 0.676596 0 
8 6 0 -1.23231 1.38473 0 
9 6 0 0 0.703827 0 
10 7 0 1.203105 1.388472 0 
11 1 0 1.114464 2.398373 0 
12 1 0 -1.238241 2.47295 0 
13 1 0 -3.367202 1.214475 0 
14 1 0 -3.352628 -1.278912 0 
15 1 0 -1.191342 -2.494673 0 
16 1 0 1.23878 -2.500267 0 
17 1 0 3.394703 -1.350529 0 
18 1 0 3.451478 1.481194 0 
--------------------------------------------------------------------------------- 
 
SCF Done:  E(RB3LYP) =  -389.330835679     A.U. after   14 cycles 
            NFock= 14  Conv=0.87D-08     -V/T= 2.0098 
 
1\1\GINC-HOUSE-09\SP\RB3LYP\6-31G(d)\C8H8B1N1\WEBMO\06-Dec-2013\0\\#N  
 B3LYP/6-31G(d) SP Geom=Connectivity\\C8H8NB\\0,1\B\C,1,1.5274257\C,2,1 
 .3643813,1,118.8883\C,3,1.4414612,2,122.56419,1,0.,0\C,4,1.4117962,3,1 
 22.0334,2,180.,0\C,5,1.3841495,4,121.45051,3,180.,0\C,6,1.4062259,5,11 
 9.60537,4,0.,0\C,7,1.3854028,6,120.44191,5,0.,0\C,4,1.4215019,5,118.31 
 011,6,0.,0\N,9,1.3842684,4,118.71083,5,180.,0\H,10,1.0137837,9,114.626 
 59,4,180.,0\H,8,1.0882359,9,119.23476,4,180.,0\H,7,1.0866083,6,119.968 
 08,5,180.,0\H,6,1.0860351,7,120.08572,8,180.,0\H,5,1.0876647,6,120.225 
 37,7,180.,0\H,3,1.0910875,2,121.25426,1,180.,0\H,2,1.0883817,1,123.007 
 72,10,180.,0\H,1,1.1955458,2,126.52523,3,180.,0\\Version=IA32L-G09RevD 
 .01\State=1-A'\HF=-389.3308357\RMSD=8.677e-09\Dipole=0.575808,0.,-0.23 
 01202\Quadrupole=-1.3790465,-4.023611,5.4026575,0.,-0.8545531,0.\PG=CS 
  [SG(C8H8B1N1)]\\@ 
 
 
 
Optimized Geometry of 1-Allyl-3-Bromo-2-Phenyl-2,1-Borazaronaphthalene: 
 B3LYP/6-31G(d,p) 
898 
 
RB3LYP Energy -3310.83227934 Hartree 
------ ----------- ------------ ---------------- ------------ ------------ 
Center Atomic Atomic Coo rdinates  (Angstroms) 
Number Number Type X Y Z 
------ ----------- ------------ ---------------- ------------ ------------ 
1 6 0 -0.80591 2.252258 0.444992 
2 7 0 -0.891512 0.787927 0.253731 
3 6 0 -2.165291 0.210008 0.21844 
4 6 0 -3.34215 0.969883 0.35455 
5 6 0 -4.585754 0.366896 0.333257 
6 6 0 -4.710814 -1.015669 0.170062 
7 6 0 -3.571782 -1.776902 0.028259 
8 6 0 -2.290097 -1.194565 0.048453 
9 6 0 -1.129127 -2.020909 -0.098388 
10 6 0 0.110224 -1.485969 -0.071238 
11 5 0 0.313763 0.018846 0.118155 
12 6 0 1.734035 0.699981 0.169298 
13 6 0 2.452206 0.786886 1.36998 
14 6 0 3.714524 1.369955 1.418503 
15 6 0 4.294165 1.876364 0.259869 
16 6 0 3.604316 1.791802 -0.94473 
17 6 0 2.340546 1.21081 -0.98587 
18 1 0 1.825105 1.14641 -1.93873 
19 1 0 4.05132 2.176013 -1.85448 
20 1 0 5.278589 2.328174 0.294561 
21 1 0 4.247773 1.424044 2.360741 
22 1 0 2.023167 0.387743 2.283475 
23 35 0 1.617396 -2.666001 -0.276295 
24 1 0 -1.286635 -3.086681 -0.230078 
25 1 0 -3.644089 -2.850951 -0.100851 
26 1 0 -5.688672 -1.480346 0.152751 
27 1 0 -5.471364 0.982023 0.439609 
28 1 0 -3.291831 2.041685 0.457464 
29 6 0 -1.126545 3.050481 -0.790401 
30 6 0 -1.825413 4.177808 -0.800646 
31 1 0 -1.976011 4.741804 -1.712798 
32 1 0 -2.267561 4.58531 0.103364 
33 1 0 -0.699247 2.671189 -1.714679 
34 1 0 -1.441842 2.555019 1.279482 
35 1 0 0.221409 2.464172 0.737276 
------ ----------- ------------ ---------------- ------------ ------------ 
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SCF Done:  E(RB3LYP) =  -3310.83227934     A.U. after    8 cycles 
            NFock=  8  Conv=0.54D-08     -V/T= 2.0018 
 
1\1\GINC-HOUSE-06\FOpt\RB3LYP\6-311+G(2d,p)\C17H15B1Br1N1\WEBMO\01-Jun 
 -2014\0\\#N B3LYP/6-311+G(2d,p) OPT Geom=Connectivity\\AllylPhBr 6-31G 
 (d)p\\0,1\C,0.0262144275,0.0537984331,0.0146522276\N,0.0250511657,0.00 
 41017396,1.4930645057\C,1.2632329264,0.0024790368,2.1447180321\C,2.483 
 6306533,0.0486732891,1.4451271511\C,3.6912066071,0.0277150122,2.117377 
 7748\C,3.7351856175,-0.0342804942,3.5130780556\C,2.5521177689,-0.07333 
 32443,4.2172108858\C,1.305440731,-0.0564748121,3.5631824083\C,0.096844 
 5856,-0.1023482936,4.3309367835\C,-1.1096890946,-0.098212425,3.7250091 
 496\B,-1.2241271383,-0.0454597867,2.1999239366\C,-2.6021470426,-0.0491 
 924712,1.4352141535\C,-3.2468581007,-1.2510233929,1.1113156289\C,-4.47 
 26078609,-1.2610524636,0.4531308092\C,-5.0888684493,-0.0628270843,0.10 
 76684876\C,-4.4724950332,1.1419347299,0.4281892878\C,-3.2447777454,1.1 
 451018302,1.0832168594\H,-2.7872404183,2.0970974043,1.3324799583\H,-4. 
 9489702802,2.0809310848,0.170638754\H,-6.0451001892,-0.0680250949,-0.4 
 022532366\H,-4.949027945,-2.2051165767,0.2146748943\H,-2.7888600305,-2 
 .1970124377,1.3818814506\Br,-2.6850509443,-0.1612863737,4.829702869\H, 
 0.1913451517,-0.1414995506,5.4114732834\H,2.5613790126,-0.1203520749,5 
 .3003463259\H,4.6851726311,-0.0486363869,4.0324528476\H,4.612042522,0. 
 0657684518,1.5476325645\H,2.4947181528,0.1221482636,0.3697847494\C,0.3 
 184651659,1.4176971456,-0.5515040611\C,1.0731420006,1.6466233494,-1.61 
 80133473\H,1.2017170837,2.6454625293,-2.016236212\H,1.5854732813,0.843 
 9464712,-2.1395629527\H,-0.1787276017,2.2456938421,-0.0535509646\H,0.7 
 224700717,-0.6887075742,-0.380772983\H,-0.9708690022,-0.2468187524,-0. 
 3034292885\\Version=IA32L-G09RevD.01\State=1-A\HF=-3310.8322793\RMSD=5 
 .358e-09\RMSF=2.100e-06\Dipole=0.9398675,0.0640903,-0.840817\Quadrupol 
 e=2.8742626,-2.2827208,-0.5915418,-0.2810856,2.8527779,-0.2642207\PG=C 
 01 [X(C17H15B1Br1N1)]\\@ 
 
 
 
Optimized Geometry of 3-Bromo-2-Phenyl-2,1-Borazaronaphthalene: 
 
 B3LYP/6-31G(d,p) 
RB3LYP Energy -3194.11040676 Hartree 
------ ----------- ------------ ----------------- ----------- ------------ 
Center Atomic Atomic Coor dinates  (Angstroms) 
Number Number Type X Y Z 
900 
 
------ ----------- ------------ ----------------- ----------- ------------ 
1 6 0 -4.384331 -1.925471 0.076009 
2 6 0 -3.420113 -2.516878 -0.733346 
3 6 0 -2.123214 -2.015077 -0.746641 
4 6 0 -1.754968 -0.905091 0.031074 
5 5 0 -0.27582 -0.390831 0.029192 
6 7 0 0.77127 -1.358868 0.076382 
7 6 0 2.12627 -1.095961 0.075597 
8 6 0 3.07442 -2.128283 0.1362 
9 6 0 4.423489 -1.83486 0.135753 
10 6 0 4.861729 -0.504781 0.074843 
11 6 0 3.937577 0.517073 0.016129 
12 6 0 2.555159 0.250091 0.016827 
13 6 0 1.581945 1.304547 -0.042997 
14 6 0 0.251355 1.051261 -0.033496 
15 35 0 -0.937964 2.563309 -0.159524 
16 1 0 1.956293 2.32176 -0.103512 
17 1 0 4.266688 1.549065 -0.031046 
18 1 0 5.92145 -0.282614 0.074056 
19 1 0 5.146381 -2.64038 0.182533 
20 1 0 2.736831 -3.158301 0.183091 
21 1 0 0.529248 -2.339028 0.145725 
22 6 0 -2.749749 -0.32071 0.8294 
23 6 0 -4.043705 -0.828036 0.860561 
24 1 0 -4.789728 -0.362365 1.494167 
25 1 0 -2.50924 0.540142 1.440995 
26 1 0 -1.389756 -2.484096 -1.395525 
27 1 0 -3.67873 -3.365966 -1.355561 
28 1 0 -5.395675 -2.314765 0.09233 
SCF Done:  E(RB3LYP) =  -3194.11040676     A.U. after    8 cycles 
            NFock=  8  Conv=0.35D-08     -V/T= 2.0017 
 
1\1\GINC-HOUSE-06\FOpt\RB3LYP\6-311+G(2d,p)\C14H11B1Br1N1\WEBMO\30-May 
 -2014\0\\#N B3LYP/6-311+G(2d,p) OPT Geom=Connectivity\\NH Ph Br 6-31G( 
 d)(p)\\0,1\C,0.0197939501,0.0184083306,-0.0211348763\C,0.0068643458,-0 
 .0798761576,1.3662022747\C,1.2043904574,-0.0715298115,2.0731606733\C,2 
 .4445181606,0.0192746189,1.4202037258\B,3.7739276302,0.0716214829,2.24 
 62035201\N,3.8048383561,0.8863602206,3.4170853543\C,4.8784722362,1.050 
 5417774,4.2688486899\C,4.8036079164,1.8889847955,5.3912378059\C,5.8946 
 144643,2.0351505789,6.2245590519\C,7.0880871101,1.3491367236,5.9602014 
 746\C,7.1720270254,0.5235130795,4.8588436407\C,6.0775023668,0.35523603 
 51,3.9893270574\C,6.151464716,-0.5006061318,2.8383869109\C,5.103116689 
 4,-0.6575574984,1.9951502587\Br,5.333073292,-1.8697121933,0.5137819975 
901 
 
 \H,7.0859096634,-1.0274124563,2.6716283257\H,8.0908716488,-0.011190876 
 ,4.6458579271\H,7.9391911637,1.4682212521,6.6188409061\H,5.8248995366, 
 2.6850953675,7.0884665728\H,3.8804730268,2.4204235499,5.5973841767\H,2 
 .9857429787,1.4300117493,3.6571341421\C,2.4292374974,0.1056273693,0.01 
 99448033\C,1.2350421634,0.1153106097,-0.6917273511\H,1.2528299816,0.19 
 27839479,-1.7727158535\H,3.3638302048,0.1724636184,-0.5232216657\H,1.1 
 715416762,-0.1622467995,3.1546785494\H,-0.9345862366,-0.1658830862,1.8 
 965426497\H,-0.9109145666,0.0155411128,-0.5764797912\\Version=IA32L-G0 
 9RevD.01\State=1-A\HF=-3194.1104068\RMSD=3.517e-09\RMSF=1.921e-05\Dipo 
 le=-0.1819244,0.7572896,0.8912301\Quadrupole=3.8844022,-6.1329151,2.24 
 85129,-1.3051271,2.7172598,2.9706514\PG=C01 [X(C14H11B1Br1N1)]\\@ 
 
 
 
Optimized Geometry of 1-Allyl-2-Phenyl-2,1-Borazaronaphthalene: 
 
 B3LYP/6-31G(d,p) 
RB3LYP Energy -737.292011563 Hartree 
 
------ ----------- ------------ ----------------- ----------- ------------ 
Center Atomic Atomic Coor dinates  (Angstroms) 
Number Number Type X Y Z 
------ ----------- ------------ ----------------- ----------- ------------ 
1 6 0 -0.029262 1.647036 0.40295 
2 7 0 -0.429759 0.241171 0.195467 
3 6 0 -1.798602 -0.048419 0.175037 
4 6 0 -2.777973 0.932898 0.422389 
5 6 0 -4.123364 0.615548 0.42083 
6 6 0 -4.553424 -0.689286 0.165194 
7 6 0 -3.611384 -1.662514 -0.087962 
8 6 0 -2.234094 -1.375761 -0.090791 
9 6 0 -1.280325 -2.412954 -0.359433 
10 6 0 0.05244 -2.176641 -0.348369 
11 5 0 0.564369 -0.775378 -0.028084 
902 
 
12 6 0 2.114284 -0.486039 0.057088 
13 6 0 2.749074 -0.119218 1.253824 
14 6 0 4.127529 0.055335 1.324691 
15 6 0 4.912457 -0.124126 0.19014 
16 6 0 4.309042 -0.492005 -1.007782 
17 6 0 2.931364 -0.680204 -1.066323 
18 1 0 2.482711 -0.982854 -2.007079 
19 1 0 4.912424 -0.638886 -1.896431 
20 1 0 5.985927 0.015948 0.240898 
21 1 0 4.589403 0.329755 2.266345 
22 1 0 2.158442 0.019967 2.154097 
23 1 0 0.730088 -3.000612 -0.547607 
24 1 0 -1.681422 -3.402608 -0.566733 
25 1 0 -3.920336 -2.682007 -0.291381 
26 1 0 -5.609286 -0.929654 0.163718 
27 1 0 -4.848778 1.39619 0.617725 
28 1 0 -2.492719 1.956296 0.604903 
29 6 0 -0.248362 2.525162 -0.801118 
30 6 0 -0.690096 3.775051 -0.757314 
31 1 0 -0.772286 4.37795 -1.653228 
32 1 0 -0.98144 4.24659 0.176298 
33 1 0 0.032149 2.083436 -1.753808 
34 1 0 -0.530149 2.05952 1.281841 
35 1 0 1.035926 1.636485 0.62428 
------ ----------- ------------ ----------------- ----------- ------------ 
 
SCF Done:  E(RB3LYP) =  -737.292011540     A.U. after   10 cycles 
            NFock= 10  Conv=0.95D-09     -V/T= 2.0044 
 
1\1\GINC-HOUSE-06\FOpt\RB3LYP\6-311+G(2d,p)\C17H16B1N1\WEBMO\19-May-20 
 14\0\\#N B3LYP/6-311+G(2d,p) OPT Geom=Connectivity\\AllylPh 6-31G(d)p\ 
 \0,1\C,-0.0014521708,0.0131604093,0.0071612353\N,0.0024357964,0.004380 
 6252,1.483579766\C,1.2433357585,-0.002641813,2.1302082415\C,2.45866852 
 93,-0.0813147696,1.4230226259\C,3.6706894321,-0.111606337,2.0870088976 
 \C,3.7270645005,-0.0567038642,3.4822509608\C,2.5495026434,0.0294502705 
 ,4.1926207494\C,1.298456585,0.0588930624,3.5498313011\C,0.0918971273,0 
 .1502279202,4.3202110301\C,-1.1288079168,0.1586754273,3.7353715145\B,- 
 1.2351028056,0.0538658037,2.2168499029\C,-2.6469443834,-0.0054658643,1 
 .512299902\C,-3.096628541,-1.13866739,0.8170795978\C,-4.3743680211,-1. 
 1995040529,0.2699881721\C,-5.23926059,-0.1171092149,0.3961063708\C,-4. 
 8201382302,1.0166891266,1.0840747088\C,-3.5460738221,1.0632155465,1.64 
 21402434\H,-3.2448425389,1.9511432676,2.188723918\H,-5.4882395061,1.86 
 36520678,1.1919407044\H,-6.233448745,-0.1594658069,-0.033233069\H,-4.6 
 957257405,-2.0928878495,-0.2534056286\H,-2.4422039596,-1.9984768746,0. 
903 
 
 7114080133\H,-2.0094621834,0.2182766409,4.3668202164\H,0.206079549,0.2 
 060960229,5.4005395632\H,2.5672856297,0.075632864,5.2760178991\H,4.680 
 5343569,-0.078874148,3.9951133338\H,4.5857988254,-0.1750178133,1.50999 
 2108\H,2.4636032441,-0.105930914,0.3453423448\C,0.3756282982,1.3420577 
 116,-0.5934490466\C,1.132895737,1.499227559,-1.6709989983\H,1.32230822 
 93,2.4791030401,-2.0915598408\H,1.5884883156,0.6543364263,-2.178400901 
 5\H,-0.0627094133,2.2105774696,-0.1087215485\H,0.6374140889,-0.7841387 
 48,-0.3796759109\H,-1.0181009152,-0.2210213474,-0.3015572086\\Version= 
 IA32L-G09RevD.01\State=1-A\HF=-737.2920116\RMSD=4.118e-09\RMSF=3.427e- 
 06\Dipole=0.3559584,0.0161967,-0.3133103\Quadrupole=1.7154845,-2.95573 
 27,1.2402483,-1.2046608,0.4397017,2.0358123\PG=C01 [X(C17H16B1N1)]\\@ 
 
 
 
 
Optimized Geometry of 2-Phenyl-2,1-Borazaronaphthalene: 
 
 B3LYP/6-31G(d,p) 
RB3LYP Energy -620.571318024 Hartree 
------ ----------- ------------ ----------------- ------------ ----------- 
Center Atomic Atomic Coor dinates (Angstroms) 
Number Number Type X Y Z 
------ ----------- ------------ ----------------- ------------ ----------- 
1 6 0 -4.816941 -0.451895 0.04465 
2 6 0 -3.925306 -1.433963 -0.376197 
3 6 0 -2.561475 -1.166877 -0.405282 
4 6 0 -2.044467 0.081892 -0.024106 
5 5 0 -0.508279 0.396086 -0.047177 
6 7 0 0.43591 -0.664976 0.099251 
7 6 0 1.80821 -0.514496 0.080384 
8 6 0 2.66559 -1.614857 0.237057 
9 6 0 4.035252 -1.442684 0.212261 
10 6 0 4.587855 -0.167713 0.031127 
11 6 0 3.75339 0.920571 -0.12098 
12 6 0 2.35365 0.779793 -0.099012 
13 6 0 1.469754 1.905129 -0.248745 
14 6 0 0.118091 1.781255 -0.224542 
904 
 
15 1 0 -0.476142 2.680143 -0.355028 
16 1 0 1.941522 2.875525 -0.387166 
17 1 0 4.170699 1.911953 -0.260031 
18 1 0 5.662945 -0.039612 0.011954 
19 1 0 4.684897 -2.301352 0.333282 
20 1 0 2.240483 -2.603531 0.3763 
21 1 0 0.120132 -1.613223 0.254127 
22 6 0 -2.968735 1.056267 0.384026 
23 6 0 -4.333831 0.795882 0.426189 
24 1 0 -5.022177 1.566487 0.75404 
25 1 0 -2.612184 2.035072 0.685464 
26 1 0 -1.891043 -1.945267 -0.757323 
27 1 0 -4.294365 -2.405117 -0.685807 
28 1 0 -5.880962 -0.656505 0.070333 
------ ----------- ------------ ----------------- ------------ ----------- 
 
SCF Done:  E(RB3LYP) =  -620.571318024     A.U. after    8 cycles 
            NFock=  8  Conv=0.69D-08     -V/T= 2.0044 
 
1\1\GINC-HOUSE-06\FOpt\RB3LYP\6-311+G(2d,p)\C14H12B1N1\WEBMO\19-May-20 
 14\0\\#N B3LYP/6-311+G(2d,p) OPT Geom=Connectivity\\NH Ph 6-31G(d)(p)\ 
 \0,1\C,0.0110007238,-0.0039448222,0.0032123634\C,0.0089318352,0.003783 
 1907,1.3948000027\C,1.2122136729,0.0082739225,2.0907226392\C,2.4498865 
 298,-0.0008360833,1.4273229576\B,3.8151005974,0.0089126209,2.198827331 
 4\N,3.8884977734,0.5804279155,3.5052614265\C,5.0263358309,0.6338134066 
 ,4.2854428326\C,5.0103600102,1.2203019051,5.5606748714\C,6.1589590587, 
 1.26071247,6.3257377816\C,7.355848845,0.7176953918,5.8396120211\C,7.38 
 23696625,0.1415087628,4.5861624238\C,6.230192712,0.085412699,3.7806092 
 455\C,6.2427292149,-0.5051461416,2.4686807178\C,5.1381751283,-0.560495 
 724,1.6813930115\H,5.2317640458,-1.0325976272,0.70851103\H,7.192616411 
 1,-0.9144592042,2.131678854\H,8.3038717129,-0.2801306539,4.1996734579\ 
 H,8.2530270803,0.7520164858,6.4449949144\H,6.1315109104,1.7155051564,7 
 .3087962563\H,4.0846485762,1.6405394322,5.9401996139\H,3.0739174013,1. 
 0116191855,3.921683848\C,2.4203307244,-0.0208425728,0.024120828\C,1.22 
 22675985,-0.015371427,-0.6813434461\H,1.2321449926,-0.0226733446,-1.76 
 53117347\H,3.3537302198,-0.029766027,-0.5279093345\H,1.1801493128,-0.0 
 061585143,3.1761102138\H,-0.9304096773,0.0013959497,1.9359426091\H,-0. 
 9249462479,-0.0058808149,-0.5432908809\\Version=IA32L-G09RevD.01\State 
 =1-A\HF=-620.571318\RMSD=6.865e-09\RMSF=9.035e-06\Dipole=-0.061906,0.1 
 951187,0.3655267\Quadrupole=3.9039774,-7.0182245,3.1142472,-2.0176932, 
 0.1321647,3.1297464\PG=C01 [X(C14H12B1N1)]\\@ 
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Optimized Geometry of 1-Allyl-2-Phenyl-2,1-Borazaronaphthalene: 
 
 B3LYP/LANL2DZ 
RB3LYP Energy -736.977499201 Hartree 
------ ----------- ------------ ----------------- ----------- ------------ 
Center Atomic Atomic Coor dinates  (Angstroms) 
Number Number Type X Y Z 
------ ----------- ------------ ----------------- ----------- ------------ 
1 6 0 -0.038184 1.681073 0.372282 
2 7 0 -0.42558 0.24991 0.194437 
3 6 0 -1.809184 -0.055968 0.180775 
4 6 0 -2.805161 0.930224 0.424852 
5 6 0 -4.163137 0.597632 0.429531 
6 6 0 -4.585688 -0.729955 0.184196 
7 6 0 -3.623647 -1.707914 -0.065635 
8 6 0 -2.236051 -1.402144 -0.073876 
9 6 0 -1.264356 -2.44155 -0.338767 
10 6 0 0.081971 -2.181207 -0.32763 
11 5 0 0.584078 -0.767131 -0.017498 
12 6 0 2.132572 -0.474948 0.066001 
13 6 0 2.763818 0.015228 1.240016 
14 6 0 4.158647 0.190894 1.310469 
15 6 0 4.965472 -0.110544 0.196043 
16 6 0 4.365609 -0.602767 -0.979053 
17 6 0 2.971417 -0.791959 -1.034093 
18 1 0 2.528334 -1.188355 -1.946705 
19 1 0 4.979974 -0.844357 -1.843969 
20 1 0 6.043161 0.029621 0.244756 
21 1 0 4.61271 0.55836 2.228388 
22 1 0 2.162404 0.241574 2.120195 
23 1 0 0.77915 -2.997227 -0.51587 
24 1 0 -1.651548 -3.442305 -0.538013 
25 1 0 -3.92468 -2.735799 -0.259366 
26 1 0 -5.643205 -0.979674 0.188233 
906 
 
27 1 0 -4.899561 1.374605 0.621359 
28 1 0 -2.527603 1.961556 0.595967 
29 6 0 -0.310121 2.536563 -0.853663 
30 6 0 -0.762244 3.805249 -0.824177 
31 1 0 -0.881141 4.387065 -1.734707 
32 1 0 -1.022086 4.303484 0.109683 
33 1 0 -0.060088 2.068242 -1.807351 
34 1 0 -0.524784 2.106309 1.259264 
35 1 0 1.03725 1.695743 0.560932 
------ ----------- ------------ ----------------- ----------- ------------ 
 
SCF Done:  E(RB3LYP) =  -736.977499201     A.U. after    7 cycles 
            NFock=  7  Conv=0.80D-08     -V/T= 2.0063 
 
1\1\GINC-HOUSE-06\FOpt\RB3LYP\LANL2DZ\C17H16B1N1\WEBMO\08-Jun-2014\0\\ 
 #N B3LYP/LANL2DZ OPT Geom=Connectivity\\AllylPh LAN\\0,1\C,0.002948088 
 1,-0.0111844119,-0.0238695546\N,-0.0048135811,-0.0037001856,1.46938712 
 74\C,1.249055398,-0.0016085987,2.1296281796\C,2.4783316258,-0.10341143 
 57,1.4206609766\C,3.7014696042,-0.1232933853,2.097622253\C,3.751126178 
 7,-0.035420156,3.5086635624\C,2.5564221385,0.0737489363,4.2193727926\C 
 ,1.2975662904,0.0933004875,3.560673544\C,0.0768051646,0.2096585756,4.3 
 29391397\C,-1.1530917241,0.205168392,3.7228998805\B,-1.2536756753,0.06 
 21511314,2.2006210359\C,-2.6665582511,-0.0140451929,1.5019557266\C,-3. 
 0881828878,-1.1304782851,0.7319783708\C,-4.3838662566,-1.205172952,0.1 
 870057418\C,-5.2967714638,-0.1518644517,0.3892979251\C,-4.9059954694,0 
 .9647937805,1.1530626438\C,-3.6136626518,1.0225175165,1.7090649599\H,- 
 3.3358211824,1.8875743038,2.3097274335\H,-5.6051007575,1.7815594326,1. 
 3205049944\H,-6.2969928428,-0.2033521179,-0.0353667562\H,-4.6795524211 
 ,-2.0792673901,-0.3894575803\H,-2.4047570184,-1.9645106027,0.573973011 
 8\H,-2.0471569893,0.2781974063,4.3415244474\H,0.1797231047,0.291398162 
 5,5.4128368867\H,2.5694848072,0.1450405281,5.3053958495\H,4.706073609, 
 -0.0501501001,4.0269074564\H,4.6234004343,-0.2039484318,1.5263578264\H 
 ,2.4876547922,-0.1513937935,0.3401171645\C,0.4255226747,1.3157475543,- 
 0.6316823784\C,1.1929945131,1.4513591678,-1.7305214014\H,1.4128080598, 
 2.4287192238,-2.1526111525\H,1.6205102661,0.5910876392,-2.2453155586\H 
 ,0.014240656,2.1995635787,-0.1406861154\H,0.627746954,-0.8296390613,-0 
 .4034737248\H,-1.0206468349,-0.2169354145,-0.3436869201\\Version=IA32L 
 -G09RevD.01\State=1-A\HF=-736.9774992\RMSD=7.967e-09\RMSF=7.172e-06\Di 
 pole=0.3695793,0.0151418,-0.3325834\Quadrupole=2.4696535,-4.0707479,1. 
 6010943,-1.5552355,0.5607016,2.9628301\PG=C01 [X(C17H16B1N1)]\\@ 
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Optimized Geometry of 2-Phenyl-2,1-Borazaronaphthalene: 
 
B3LYP/LANL2DZ 
RB3LYP Energy -620.309620231 Hartree 
------ ----------- ------------ ----------------- ------------ ----------- 
Center Atomic Atomic Coor dinates (Angstroms) 
Number Number Type X Y Z 
------ ----------- ------------ ----------------- ------------ ----------- 
1 6 0 -4.862851 -0.450376 0.036628 
2 6 0 -3.954446 -1.483463 -0.26656 
3 6 0 -2.573498 -1.219384 -0.29182 
4 6 0 -2.053348 0.074516 -0.020984 
5 5 0 -0.515634 0.385432 -0.036665 
6 7 0 0.437076 -0.685023 0.074851 
7 6 0 1.826546 -0.522664 0.058763 
8 6 0 2.697668 -1.635529 0.173914 
9 6 0 4.083426 -1.451882 0.155401 
10 6 0 4.633067 -0.151707 0.022624 
11 6 0 3.78054 0.94909 -0.088488 
12 6 0 2.368379 0.793717 -0.07191 
13 6 0 1.471163 1.929027 -0.181778 
14 6 0 0.10356 1.78615 -0.166013 
15 1 0 -0.506045 2.684306 -0.264692 
16 1 0 1.934524 2.912235 -0.282945 
17 1 0 4.193085 1.951356 -0.189315 
18 1 0 5.711232 -0.016703 0.008659 
19 1 0 4.742606 -2.312238 0.243135 
20 1 0 2.279133 -2.635783 0.275499 
21 1 0 0.122846 -1.645227 0.193519 
22 6 0 -2.993277 1.097368 0.271612 
23 6 0 -4.376444 0.843386 0.306352 
24 1 0 -5.070903 1.647407 0.540567 
25 1 0 -2.638371 2.103473 0.484894 
26 1 0 -1.898652 -2.036294 -0.549657 
27 1 0 -4.321698 -2.483945 -0.485339 
908 
 
28 1 0 -5.932035 -0.650069 0.058601 
------ ----------- ------------ ----------------- ------------ ----------- 
 
SCF Done:  E(RB3LYP) =  -620.309620114     A.U. after   11 cycles 
            NFock= 11  Conv=0.40D-08     -V/T= 2.0062 
 
#N B3LYP/LANL2DZ OPT Geom=Connectivity\\Nh Ph LAN\\0,1\C,-0.0299227325 
 ,-0.0155007043,-0.0339039308\C,-0.0338057633,0.1042973545,1.3696716605 
 \C,1.181420348,0.1126418449,2.0771659215\C,2.4337141658,-0.0004533422, 
 1.4160638659\B,3.79934039,0.0152116803,2.1882660076\N,3.865833124,0.54 
 21554588,3.5238841295\C,5.0246843277,0.5923148681,4.3060569265\C,5.002 
 7703339,1.1293374477,5.6181962101\C,6.1718766212,1.170105434,6.3836519 
 751\C,7.3920093295,0.6764705507,5.8565941638\C,7.4210608695,0.14867704 
 72,4.5637316502\C,6.2494012169,0.0948396689,3.7619034117\C,6.266365993 
 2,-0.4465519236,2.4155736981\C,5.1364257436,-0.5013858567,1.6337616163 
 \H,5.2244807016,-0.9323448303,0.636485559\H,7.2252923265,-0.8165399166 
 ,2.0478706802\H,8.3533457427,-0.2313504698,4.1498217912\H,8.2967031232 
 ,0.7111164079,6.4575848372\H,6.1438635884,1.5828561823,7.3892758817\H, 
 4.0673010389,1.5089337229,6.0266118513\H,3.037597529,0.933898975,3.965 
 8987117\C,2.4055798476,-0.1296443364,0.0026197963\C,1.1964113728,-0.13 
 24455048,-0.7162465008\H,1.2087243665,-0.2262741345,-1.8000471148\H,3. 
 3419681054,-0.2192241712,-0.5440497468\H,1.1425999091,0.1866274512,3.1 
 644829206\H,-0.9768501665,0.1858546901,1.9060663449\H,-0.9674389637,-0 
 .0212004907,-0.5857593473\\Version=IA32L-G09RevD.01\State=1-A\HF=-620. 
 3096202\RMSD=3.822e-09\RMSF=1.373e-05\Dipole=-0.0618705,0.1878297,0.39 
 40105\Quadrupole=4.9142237,-8.8412325,3.9270089,-2.4256998,0.2072776,3 
 .9614117\PG=C01 [X(C14H12B1N1)]\\@ 
 
 
 
Optimized Geometry of 1-Allyl-2-Phenyl-2,1-Borazaronaphthalene ‘Ate’ Complex: 
 
B3LYP/LANL2DZ 
RB3LYP Energy -1143.77525729 Hartree 
 
------ ----------- --------------- ------------- ------------- ----------- 
Center Atomic Atomic Coo rdinates  (Angstroms) 
Number Number Type X Y Z 
------ ----------- --------------- ------------- ------------- ----------- 
909 
 
1 6 0 -2.568451 1.15637 1.541037 
2 7 0 -2.530688 0.147957 0.458236 
3 6 0 -3.737379 -0.448262 0.06589 
4 6 0 -4.992435 -0.076139 0.630773 
5 6 0 -6.185465 -0.701793 0.240111 
6 6 0 -6.184143 -1.721744 -0.733765 
7 6 0 -4.960624 -2.091663 -1.30914 
8 6 0 -3.74222 -1.480492 -0.936505 
9 6 0 -2.492526 -1.894392 -1.56666 
10 6 0 -1.300083 -1.319866 -1.251292 
11 5 0 -1.167409 -0.206142 -0.129205 
12 6 0 -0.235762 1.071801 -0.574891 
13 6 0 0.559755 1.838994 0.330988 
14 6 0 1.297307 2.972891 -0.095209 
15 6 0 1.277148 3.361749 -1.442435 
16 6 0 0.513861 2.608862 -2.365492 
17 6 0 -0.218235 1.490703 -1.936652 
18 1 0 -0.814361 0.932306 -2.655402 
19 1 0 0.48416 2.907096 -3.412121 
20 1 0 1.826218 4.241364 -1.772401 
21 1 0 1.855716 3.555684 0.635647 
22 1 0 0.512935 1.631863 1.399973 
23 8 0 -0.246063 -0.806111 1.081307 
24 46 0 1.750046 -0.480109 0.582312 
25 6 0 2.306776 -2.264032 1.293555 
26 6 0 2.129047 -3.449389 0.675611 
27 1 0 2.377183 -4.38695 1.179101 
28 1 0 1.712659 -3.536825 -0.32619 
29 1 0 2.710415 -2.205042 2.310556 
30 15 0 4.002645 -0.18781 -0.126453 
31 6 0 4.537286 1.552893 -0.604776 
32 1 0 4.524758 2.19452 0.281432 
33 1 0 5.548724 1.534277 -1.027607 
34 1 0 3.835804 1.963353 -1.33532 
35 6 0 4.394589 -1.198467 -1.663729 
36 1 0 3.772484 -0.85023 -2.49404 
37 1 0 5.452352 -1.100133 -1.934746 
38 1 0 4.160818 -2.248209 -1.465632 
39 6 0 5.337016 -0.71675 1.090441 
40 1 0 5.244876 -0.133167 2.011901 
41 1 0 5.206814 -1.775536 1.329903 
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42 1 0 6.332645 -0.560079 0.659668 
43 1 0 -0.509581 -1.704929 1.360832 
44 1 0 -0.404601 -1.667998 -1.776845 
45 1 0 -2.566291 -2.68351 -2.319153 
46 1 0 -4.930922 -2.872796 -2.068327 
47 1 0 -7.110502 -2.204164 -1.034958 
48 1 0 -7.122329 -0.383745 0.694232 
49 1 0 -5.046898 0.725068 1.356956 
50 6 0 -3.003698 2.543749 1.092221 
51 6 0 -3.803324 3.370057 1.79603 
52 1 0 -4.051918 4.366669 1.438274 
53 1 0 -4.236862 3.073642 2.751508 
54 1 0 -2.596226 2.866404 0.132717 
55 1 0 -3.204435 0.815995 2.370542 
56 1 0 -1.555684 1.220663 1.951196 
------ ----------- --------------- ------------- ------------- ----------- 
 
SCF Done:  E(RB3LYP) =  -1143.77525734     A.U. after    7 cycles 
            NFock=  7  Conv=0.58D-08     -V/T= 2.0865 
 
1\1\GINC-HOUSE-06\FOpt\RB3LYP\LANL2DZ\C22H29B1N1O1P1Pd1\WEBMO\06-Jun-2 
 014\0\\#N B3LYP/LANL2DZ OPT Geom=Connectivity\\N-Allyl Pd Ate -Br\\0,1 
 \C,-0.6846290035,-0.6537684061,-0.0920183033\N,-0.5257302083,-0.479245 
 7406,-1.5532067065\C,-1.6523911148,-0.6582481721,-2.3681347997\C,-2.94 
 35458806,-0.9430448582,-1.8347090296\C,-4.0531430932,-1.1412889056,-2. 
 6694984022\C,-3.9291956731,-1.0597606139,-4.0718989629\C,-2.6696020226 
 ,-0.7679767031,-4.6133619792\C,-1.5330648641,-0.5634491999,-3.79890209 
 18\C,-0.2421777701,-0.2564410803,-4.4067666499\C,0.8730184192,-0.03404 
 41312,-3.6595494416\B,0.8707636899,-0.1574054444,-2.0778286137\C,1.644 
 3111175,1.0774853344,-1.3186143451\C,2.3417049898,0.9452877977,-0.0783 
 663369\C,2.9396518943,2.0575451784,0.5671527545\C,2.8751251355,3.33070 
 0806,-0.0172650609\C,2.2080525958,3.4876490556,-1.2549487228\C,1.61364 
 7274,2.3839613392,-1.8863804486\H,1.0891386589,2.524015117,-2.82927494 
 09\H,2.1444421509,4.4731698709,-1.7131631694\H,3.3160595971,4.19126878 
 04,0.4818124931\H,3.4237922082,1.9211634543,1.5328789407\H,2.318468399 
 2,-0.0042427293,0.4561192722\O,1.8553721199,-1.3941609072,-1.659303496 
 1\Pd,3.7991588905,-0.6520842919,-1.5556694338\C,4.5632718962,-2.301757 
 0712,-2.3880797446\C,4.5286575057,-2.6111369481,-3.700177602\H,4.88593 
 2706,-3.5800746931,-4.0574008659\H,4.1269407492,-1.9382173944,-4.45544 
 6632\H,4.9556960813,-3.0055651932,-1.6455492378\P,6.0018975034,0.24720 
 57253,-1.5904351386\C,6.3262391776,1.7753538952,-0.5396025531\H,6.2362 
 964913,1.5153155441,0.5194047293\H,7.3332575255,2.1618536249,-0.736252 
 6952\H,5.5818551134,2.5418625177,-0.7689633856\C,6.5133209326,0.792643 
 9606,-3.3164728795\H,5.8552843862,1.6008444989,-3.6503887754\H,7.55222 
 17347,1.1428404651,-3.3219773637\H,6.4058608193,-0.0534892222,-4.00084 
 11713\C,7.3881365759,-0.9169934793,-1.0764926747\H,7.2260076507,-1.247 
911 
 
 3722961,-0.0456133498\H,7.3845318304,-1.7924852251,-1.7313380643\H,8.3 
 586114118,-0.4124930073,-1.1475284707\H,1.7003108693,-2.2069920643,-2. 
 1796017833\H,1.8042482516,0.2088965733,-4.1821211231\H,-0.2205393815,- 
 0.1998184219,-5.4979687521\H,-2.5461735639,-0.6932103063,-5.6934509855 
 \H,-4.7911758909,-1.2131365134,-4.7161446726\H,-5.021786879,-1.3525396 
 944,-2.2198370914\H,-3.0939053532,-0.9816649482,-0.7631954043\C,-1.281 
 280177,0.5497612141,0.6229786387\C,-2.1744654639,0.4874345135,1.630882 
 5379\H,-2.5394120621,1.3837340223,2.1273555568\H,-2.5709005583,-0.4630 
 350157,1.9889360894\H,-0.9138434273,1.5182408106,0.2797226734\H,-1.276 
 6757502,-1.5523674981,0.1325015222\H,0.3127557845,-0.8465479231,0.3155 
 601432\\Version=IA32L-G09RevD.01\State=1-A\HF=-1143.7752573\RMSD=4.099 
 e-09\RMSF=2.192e-06\Dipole=4.4852441,0.547822,0.6287968\Quadrupole=6.2 
 049421,-2.8325314,-3.3724106,3.0540434,-2.3268781,-0.5455677\PG=C01 [X 
 (C22H29B1N1O1P1Pd1)]\\@ 
 
 
 
Optimized Geometry of 2-Phenyl-2,1-Borazaronaphthalene ‘Ate’ Complex: 
 
B3LYP/LANL2DZ 
RB3LYP Energy -1027.10391232 Hartree 
 
------ ----------- ------------ ---------------- ------------ ------------ 
Center Atomic Atomic Coo rdinates  (Angstroms) 
Number Number Type X Y Z 
------ ----------- ------------ ---------------- ------------ ------------ 
1 5 0 1.475456 0.135811 0.028462 
2 7 0 2.709485 0.510329 -0.749003 
3 6 0 4.014361 0.142177 -0.446173 
4 6 0 5.098983 0.483321 -1.299363 
5 6 0 6.411724 0.112318 -0.97844 
6 6 0 6.683793 -0.611222 0.205579 
7 6 0 5.620154 -0.947867 1.056024 
8 6 0 4.285586 -0.586329 0.758698 
9 6 0 3.181547 -0.920221 1.657017 
10 6 0 1.887462 -0.580214 1.38481 
11 1 0 1.121355 -0.85836 2.116342 
12 1 0 3.447961 -1.452331 2.573969 
912 
 
13 1 0 5.814477 -1.500513 1.974951 
14 1 0 7.702577 -0.899259 0.452363 
15 1 0 7.225306 0.384906 -1.648203 
16 1 0 4.897681 1.040707 -2.213943 
17 1 0 2.607162 1.055352 -1.601669 
18 6 0 0.391268 1.353897 0.119411 
19 6 0 -0.350361 1.789916 -1.022467 
20 6 0 -1.174729 2.943144 -0.981226 
21 6 0 -1.299598 3.675517 0.208802 
22 6 0 -0.602042 3.247381 1.362874 
23 6 0 0.220838 2.110816 1.314088 
24 1 0 0.778566 1.813284 2.199592 
25 1 0 -0.688056 3.815616 2.287571 
26 1 0 -1.915379 4.572214 0.242575 
27 1 0 -1.688048 3.271262 -1.883751 
28 1 0 -0.196501 1.292097 -1.979694 
29 8 0 0.599987 -0.927357 -0.871863 
30 46 0 -1.401336 -0.585181 -0.451537 
31 6 0 -1.848123 -2.527544 -0.61837 
32 6 0 -1.684459 -3.466902 0.335307 
33 1 0 -1.861683 -4.523323 0.119319 
34 1 0 -1.347555 -3.23207 1.343456 
35 1 0 -2.167319 -2.795175 -1.632089 
36 15 0 -3.676772 -0.238136 0.153142 
37 6 0 -4.287705 1.53968 0.247713 
38 1 0 -3.650233 2.110785 0.927443 
39 1 0 -4.227991 2.001062 -0.74197 
40 1 0 -5.324887 1.563036 0.602422 
41 6 0 -4.953644 -1.061356 -0.957765 
42 1 0 -4.870369 -0.656881 -1.971474 
43 1 0 -4.761345 -2.137173 -0.991157 
44 1 0 -5.966479 -0.883096 -0.578301 
45 6 0 -4.084928 -0.917391 1.85936 
46 1 0 -3.480672 -0.396533 2.608537 
47 1 0 -5.148033 -0.77901 2.088735 
48 1 0 -3.837608 -1.982133 1.886682 
49 1 0 0.945775 -1.841317 -0.867777 
------ ----------- ------------ ---------------- ------------ ------------ 
 
SCF Done:  E(RB3LYP) =  -1027.10391232     A.U. after    7 cycles 
            NFock=  7  Conv=0.80D-08     -V/T= 2.0965 
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1\1\GINC-HOUSE-09\FOpt\RB3LYP\LANL2DZ\C19H25B1N1O1P1Pd1\WEBMO\05-Jun-2 
 014\0\\#N B3LYP/LANL2DZ OPT Geom=Connectivity\\NH Ate Pd -Br\\0,1\B,0. 
 2032007959,0.0502529008,0.3675095069\N,0.660756373,0.0659624182,1.8020 
 610924\C,1.9007480156,-0.3466812596,2.2733246347\C,2.2578573476,-0.209 
 3495294,3.6423866223\C,3.5092938986,-0.6366028144,4.1063752447\C,4.444 
 6477833,-1.2154339961,3.2178370705\C,4.0988516693,-1.3594747574,1.8659 
 521197\C,2.843369429,-0.9384396178,1.3692857557\C,2.4774487692,-1.1087 
 211139,-0.0358713395\C,1.270622908,-0.7068131343,-0.5322581218\H,1.071 
 3532012,-0.8815989866,-1.5948802955\H,3.2225707451,-1.5896389882,-0.67 
 49562418\H,4.8068705662,-1.8087397499,1.1699090086\H,5.4154328599,-1.5 
 452050284,3.5792458435\H,3.7595100771,-0.5202182889,5.1592991748\H,1.5 
 426562343,0.235972304,4.3336412258\H,0.0377042554,0.4412695115,2.51305 
 33593\C,-1.3621076633,-0.387605359,0.2076406479\C,-2.4299672155,0.4622 
 200327,0.6336494494\C,-3.7780155435,0.0218046842,0.6380225865\C,-4.096 
 7904402,-1.2697768689,0.1926826277\C,-3.0628787918,-2.1202850451,-0.26 
 49528113\C,-1.7286729216,-1.6830965239,-0.2577167319\H,-0.9400680358,- 
 2.359977317,-0.5796459159\H,-3.3021819907,-3.126698572,-0.6043932373\H 
 ,-5.1266726873,-1.6210541491,0.2111050686\H,-4.5591998157,0.6811310908 
 ,1.0131887717\H,-2.1965859615,1.4333739414,1.0697398507\O,0.0949749002 
 ,1.605814725,-0.1577248433\Pd,-1.4651412466,1.6861522341,-1.5210428478 
 \C,-0.520872345,3.0501932994,-2.6381692725\C,0.4314191967,2.8029612367 
 ,-3.5605017028\H,0.964444684,3.6213156729,-4.0506687973\H,0.7339010882 
 ,1.7956255064,-3.841202303\H,-0.7900530791,4.0751415262,-2.3585945821\ 
 P,-3.1832154655,1.7040623506,-3.1677331864\C,-4.7853641953,0.804452893 
 8,-2.7595261216\H,-4.5655696207,-0.2314921893,-2.4892059894\H,-5.26717 
 37708,1.2840274939,-1.9029174472\H,-5.4611134506,0.8284865773,-3.62259 
 97527\C,-3.7831867734,3.4047251736,-3.7062379\H,-4.2154442883,3.928012 
 1738,-2.8474802946\H,-2.9346132342,3.9837477688,-4.0805807505\H,-4.539 
 7675262,3.3145578327,-4.4943104855\C,-2.6472476362,0.9023792612,-4.783 
 0360372\H,-2.4023381122,-0.1484126752,-4.599892614\H,-3.4456542885,0.9 
 650057683,-5.5317545238\H,-1.7537115668,1.4121161362,-5.1536445072\H,0 
 .9526714596,2.0183977545,-0.3791772526\\Version=IA32L-G09RevD.01\State 
 =1-A\HF=-1027.1039123\RMSD=8.014e-09\RMSF=4.771e-06\Dipole=-3.1394439, 
 1.2319792,-2.7354993\Quadrupole=1.5046089,-4.2702362,2.7656273,-0.8748 
 074,1.4746387,1.6844394\PG=C01 [X(C19H25B1N1O1P1Pd1)]\\@ 
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Appendix 3D: 
1
H, 
13
C, 
11
B, 
19
F, IR Spectra, and Crystallographic Data Relevant to 
Chapter 4 
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Figure A3D.1. 
1
H NMR (500 MHz, acetone-d6) of Potassium β,β,β-
trifluoroethyltrifluoroborate 
 
Figure A3D.2. 
13
C NMR (125.8 MHz, acetone-d6) of Potassium β,β,β-
trifluoroethyltrifluoroborate 
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Figure A3D.3. 
11
B NMR (128.38 MHz, acetone-d6) of Potassium β,β,β-
trifluoroethyltrifluoroborate 
 
Figure A3D.4. 
19
F NMR (338.8 MHz, acetone-d6) of Potassium β,β,β-
trifluoroethyltrifluoroborate
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Figure A3D.5. 
1
H NMR (500 MHz, acetone-d6) of Potassium 3-
Bromopropyltrifluoroborate 
 
Figure A3D.6. 
13
C NMR (125.8 MHz, acetone-d6) of Potassium 3-
Bromopropyltrifluoroborate 
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Figure A3D.7. 
11
B NMR (128.38 MHz, acetone-d6) of Potassium 3-
Bromopropyltrifluoroborate 
 
Figure A3D.8. 
19
F NMR (338.8 MHz, acetone-d6) of Potassium 3-
Bromopropyltrifluoroborate 
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Figure A3D.9. 
1
H NMR (500 MHz, acetone-d6) of Potassium 3-
Iodopropyltrifluoroborate 
 
Figure A3D.10. 
13
C NMR (125.8 MHz, acetone-d6) of Potassium 3-
Iodopropyltrifluoroborate 
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Figure A3D.11. 
11
B NMR (128.38 MHz, acetone-d6) of Potassium 3-
Iodopropyltrifluoroborate 
 
Figure A3D.12. 
19
F NMR (338.8 MHz, acetone-d6) of Potassium 3-
Iodopropyltrifluoroborate 
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Figure A3D.13. 
1
H NMR (500 MHz, acetone-d6) of Potassium Dibenzo[b,d]thiophen-4-
yltrifluoroborate 
 
Figure A3D.14. 
13
C NMR (125.8 MHz, acetone-d6) of Potassium Dibenzo[b,d]thiophen-
4-yltrifluoroborate 
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Figure A3D.15. 
11
B NMR (128.38 MHz, acetone-d6) of Potassium 
Dibenzo[b,d]thiophen-4-yltrifluoroborate 
 
Figure A3D.16. 
19
F NMR (338.8 MHz, acetone-d6) of Potassium Dibenzo[b,d]thiophen-
4-yltrifluoroborate 
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Figure A3D.17. 
1
H NMR (500 MHz, DMSO-d6) of Potassium 3-
vinylphenyltrifluoroborate 
 
 
Figure A3D.18. 
13
C NMR (125.8 MHz, DMSO-d6) of Potassium 3-
vinylphenyltrifluoroborate 
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Figure A3D.19. 
11
B NMR (128.38 MHz, DMSO-d6) of Potassium 3-
vinylphenyltrifluoroborate 
 
 
Figure A3D.20. 
19
F NMR (338.8 MHz, DMSO-d6) of Potassium 3-
vinylphenyltrifluoroborate 
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Figure A3D.21. 
1
H NMR (500 MHz, DMSO-d6) of Potassium 4-(naphthalen-1-
yl)phenyltrifluoroborate 
 
 
Figure A3D.22. 
13
C NMR (125.8 MHz, DMSO-d6) of Potassium 4-(naphthalen-1-
yl)phenyltrifluoroborate 
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Figure A3D.23. 
11
B NMR (128.38 MHz, DMSO-d6) of Potassium 4-(naphthalen-1-
yl)phenyltrifluoroborate 
 
 
Figure A3D.24. 
19
F NMR (338.8 MHz, DMSO-d6) of Potassium 4-(naphthalen-1-
yl)phenyltrifluoroborate 
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Figure A3D.25. 
1
H NMR (500 MHz, acetone-d6) of Potassium (3-methoxy-5-
methylphenyl)trifluoroborate 
 
 
 
Figure A3D.26. 
13
C NMR (125.8 MHz, acetone-d6) of Potassium (3-methoxy-5-
methylphenyl)trifluoroborate 
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Figure A3D.27. 
11
B NMR (128.38 MHz, acetone-d6) of Potassium (3-methoxy-5-
methylphenyl)trifluoroborate 
 
 
Figure A3D.28. 
19
F NMR (338.8 MHz, acetone-d6) of Potassium (3-methoxy-5-
methylphenyl)trifluoroborate 
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Figure A3D.29. 
1
H NMR (500 MHz, CDCl3) of N-Benzyl-2-vinylaniline 4.5 
 
 
Figure A3D.30. 
13
C NMR (125.8 MHz, CDCl3) of N-Benzyl-2-vinylaniline 4.5 
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Figure A3D.31. 
1
H NMR (500 MHz, CDCl3) of N-(4-Methoxybenzyl)-2-vinylaniline 
4.33-amine 
 
 
Figure A3D.32. 
13
C NMR (125.8 MHz, CDCl3) of N-(4-Methoxybenzyl)-2-vinylaniline 
4.33-amine 
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Figure A3D.33. 
1
H NMR (500 MHz, CDCl3) of N-Allyl-2-vinylaniline 4.34-amine 
 
 
Figure A3D.34. 
13
C NMR (125.8 MHz, CDCl3) of N-Allyl-2-vinylaniline 4.34-amine 
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Figure A3D.35. IR Spectrum of N-Allyl-2-vinylaniline 4.34-amine 
 
Figure A3D.36. 
1
H NMR (500 MHz, CDCl3) of N-Butyl-2-vinylaniline 4.35-amine 
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Figure A3D.37. 
13
C NMR (125.8 MHz, CDCl3) of N-Butyl-2-vinylaniline 4.35-amine 
 
 
Figure A3D.38. 
1
H NMR (500 MHz, CDCl3) of N-Phenyl-2-vinylaniline 4.36-amine 
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Figure A3D.39. 
13
C NMR (125.8 MHz, CDCl3) of N-Phenyl-2-vinylaniline 4.36-amine 
 
 
Figure A3D.40. 
1
H NMR (500 MHz, CDCl3) of N-Benzhydryl-2-vinylaniline 4.37-amine 
 
935 
 
 
Figure A3D.41. 
13
C NMR (125.8 MHz, CDCl3) of N-Benzhydryl-2-vinylaniline 4.37-
amine 
 
 
Figure A3D.42. 
1
H NMR (500 MHz, CDCl3) of N-Benzyl-5-trifluoromethyl-2-
vinylaniline 4.38-amine 
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Figure A3D.43. 
13
C NMR (125.8 MHz, CDCl3) of N-Benzyl-5-trifluoromethyl-2-
vinylaniline 4.38-amine 
 
Figure A3D.44. IR Spectrum of N-Benzyl-5-trifluoromethyl-2-vinylaniline 4.38-amine 
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Figure A3D.45. 
1
H NMR (500 MHz, CDCl3) of N-Benzyl-3-fluoro-2-vinylaniline 4.39-
amine 
 
 
Figure A3D.46. 
13
C NMR (125.8 MHz, CDCl3) of N-Benzyl-3-fluoro-2-vinylaniline 
4.39-amine 
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Figure A3D.47. IR Spectrum of N-Benzyl-3-fluoro-2-vinylaniline 4.39-amine 
 
 
Figure A3D.48. 
1
H NMR (500 MHz, CDCl3) of N-Benzyl-5-methyl-2-vinylaniline 4.40-
amine 
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Figure A3D.49. 
13
C NMR (125.8 MHz, CDCl3) of N-Benzyl-5-methyl-2-vinylaniline 
4.40-amine 
 
Figure A3D.50. IR Spectrum of N-Benzyl-5-methyl-2-vinylaniline 4.40-amine 
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Figure A3D.51. 
1
H NMR (500 MHz, CDCl3) of N-Benzyl-4,5-dimethoxy-2-vinylaniline 
4.41-amine 
 
 
Figure A3D.52. 
13
C NMR (125.8 MHz, CDCl3) of N-Benzyl-4,5-dimethoxy-2-
vinylaniline 4.41-amine 
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Figure A3D.53. IR Spectrum of N-Benzyl-4,5-dimethoxy-2-vinylaniline 4.41-amine 
 
Figure A3D.54. 
1
H NMR (500 MHz, acetone-d6) of 2-Vinylaniline 4.1 
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Figure A3D.55. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Vinylaniline 4.1 
 
Figure A3D.56. 
1
H NMR (500 MHz, CDCl3) of 1-Benzyl-2-phenyl-2,1-
borazaronaphthalene 4.6 
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Figure A3D.57. 
13
C NMR (125.8 MHz, CDCl3) of 1-Benzyl-2-phenyl-2,1-
borazaronaphthalene 4.6 
 
Figure A3D.58. 
11
B NMR (128.38 MHz, CDCl3) of 1-Benzyl-2-phenyl-2,1-
borazaronaphthalene 4.6 
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Figure A3D.59. IR Spectrum of 1-Benzyl-2-phenyl-2,1-borazaronaphthalene 4.6 
 
 
Figure A3D.60. 
1
H NMR (500 MHz, CDCl3) of 1-Benzyl-2-(4-tert-butylphenyl)-2,1-
borazaronaphthalene 4.7 
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Figure A3D.61. 
13
C NMR (125.8 MHz, CDCl3) of 1-Benzyl-2-(4-tert-butylphenyl)-2,1-
borazaronaphthalene 4.7 
 
 
Figure A3D.62. 
11
B NMR (128.38 MHz, CDCl3) of 1-Benzyl-2-(4-tert-butylphenyl)-2,1-
borazaronaphthalene 4.7 
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Figure A3D.63. IR Spectrum of 1-Benzyl-2-(4-tert-butylphenyl)-2,1-
borazaronaphthalene 4.7 
 
Figure A3D.64. 
1
H NMR (500 MHz, CDCl3) of 1-Benzyl-2-(3-methylphenyl)-2,1-
borazaronaphthalene 4.8 
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Figure A3D.65. 
13
C NMR (125.8 MHz, CDCl3) of 1-Benzyl-2-(3-methylphenyl)-2,1-
borazaronaphthalene 4.8 
 
Figure A3D.66. 
11
B NMR (128.38 MHz, CDCl3) of 1-Benzyl-2-(3-methylphenyl)-2,1-
borazaronaphthalene 4.8 
948 
 
 
Figure A3D.67. IR Spectrum of 1-Benzyl-2-(3-methylphenyl)-2,1-borazaronaphthalene 
4.8 
 
 
Figure A3D.68. 
1
H NMR (500 MHz, CDCl3) of 1-Benzyl-2-(3-methoxyphenyl)-2,1-
borazaronaphthalene 4.9 
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Figure A3D.69. 
13
C NMR (125.8 MHz, CDCl3) of 1-Benzyl-2-(3-methoxyphenyl)-2,1-
borazaronaphthalene 4.9 
 
 
Figure A3D.70. 
11
B NMR (128.38 MHz, CDCl3) of 1-Benzyl-2-(3-methoxyphenyl)-2,1-
borazaronaphthalene 4.9 
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Figure A3D.71. IR Spectrum of 1-Benzyl-2-(3-methoxyphenyl)-2,1-borazaronaphthalene 
4.9 
 
Figure A3D.72. 
1
H NMR (500 MHz, CDCl3) of 1-Benzyl-2-(2-naphthyl)-2,1-
borazaronaphthalene 4.10 
 
951 
 
 
Figure A3D.73. 
13
C NMR (125.8 MHz, CDCl3) of 1-Benzyl-2-(2-naphthyl)-2,1-
borazaronaphthalene 4.10 
 
Figure A3D.74. 
11
B NMR (128.38 MHz, CDCl3) of 1-Benzyl-2-(2-naphthyl)-2,1-
borazaronaphthalene 4.10 
952 
 
 
Figure A3D.75. IR Spectrum of 1-Benzyl-2-(2-naphthyl)-2,1-borazaronaphthalene 4.10 
 
Figure A3D.76. 
1
H NMR (500 MHz, CDCl3) of 1-Benzyl-2-(1-naphthyl)-2,1-
borazaronaphthalene 4.11 
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Figure A3D.77. 
13
C NMR (125.8 MHz, CDCl3) of 1-Benzyl-2-(1-naphthyl)-2,1-
borazaronaphthalene 4.11 
 
 
Figure A3D.78. 
11
B NMR (128.38 MHz, CDCl3) of 1-Benzyl-2-(1-naphthyl)-2,1-
borazaronaphthalene 4.11 
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Figure A3D.79. IR Spectrum of 1-Benzyl-2-(1-naphthyl)-2,1-borazaronaphthalene 4.11 
 
Figure A3D.80. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2-(4-methylphenyl)-2,1-
borazaronaphthalene 4.12 
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Figure A3D.81. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-2-(4-methylphenyl)-2,1-
borazaronaphthalene 4.12 
 
Figure A3D.82. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-2-(4-methylphenyl)-
2,1-borazaronaphthalene 4.12 
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Figure A3D.83. IR Spectrum of 1-Benzyl-2-(4-methylphenyl)-2,1-borazaronaphthalene 
4.12 
 
 
Figure A3D.84. 
1
H NMR (500 MHz, CDCl3) of Methyl-3-(2-benzyl-2,1-
borazaronaphthyl)benzoate 4.13 
957 
 
 
Figure A3D.85. 
13
C NMR (125.8 MHz, CDCl3) of Methyl-3-(2-benzyl-2,1-
borazaronaphthyl)benzoate 4.13 
 
Figure A3D.86. 
11
B NMR (128.38 MHz, CDCl3) of Methyl-3-(2-benzyl-2,1-
borazaronaphthyl)benzoate 4.13 
958 
 
 
Figure A3D.87. IR Spectrum of Methyl-3-(2-benzyl-2,1-borazaronaphthyl)benzoate 4.13 
 
Figure A3D.88. 
1
H NMR (500 MHz, CDCl3) of 3-(2-Benzyl-2,1-
borazaronaphthyl)benzonitrile 4.14 
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Figure A3D.89. 
13
C NMR (125.8 MHz, CDCl3) of 3-(2-Benzyl-2,1-
borazaronaphthyl)benzonitrile 4.14 
 
 
Figure A3D.90. 
11
B NMR (128.38 MHz, CDCl3) of 3-(2-Benzyl-2,1-
borazaronaphthyl)benzonitrile 4.14 
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Figure A3D.91. IR Spectrum of 3-(2-Benzyl-2,1-borazaronaphthyl)benzonitrile 4.14 
 
Figure A3D.92. 
1
H NMR (500 MHz, CDCl3) of 2-Benzyl-1-(3-nitrophenyl)-2,1-
borazaronaphthalene 4.15 
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Figure A3D.93. 
13
C NMR (125.8 MHz, CDCl3) of 2-Benzyl-1-(3-nitrophenyl)-2,1-
borazaronaphthalene 4.15 
 
Figure A3D.94. 
11
B NMR (128.38 MHz, CDCl3) of 2-Benzyl-1-(3-nitrophenyl)-2,1-
borazaronaphthalene 4.15 
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Figure A3D.95. IR Spectrum of 2-Benzyl-1-(3-nitrophenyl)-2,1-borazaronaphthalene 
4.15 
 
Figure A3D.96. 
1
H NMR (500 MHz, CDCl3) of 2-Benzyl-1-(3,5-
bis(trifluoromethyl)phenyl)-2,1-borazaronaphthalene 4.16 
963 
 
 
Figure A3D.97. 
13
C NMR (125.8 MHz, CDCl3) of 2-Benzyl-1-(3,5-
bis(trifluoromethyl)phenyl)-2,1-borazaronaphthalene 4.16 
 
 
Figure A3D.98. 
11
B NMR (128.38 MHz, CDCl3) of 2-Benzyl-1-(3,5-
bis(trifluoromethyl)phenyl)-2,1-borazaronaphthalene 4.16 
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Figure A3D.99. IR Spectrum of 2-Benzyl-1-(3,5-bis(trifluoromethyl)phenyl)-2,1-
borazaronaphthalene 4.16 
 
Figure A3D.100. 
1
H NMR (500 MHz, CDCl3) of 2-Benzyl-1-(4-fluorophenyl)-2,1-
borazaronaphthalene 4.17 
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Figure A3D.101. 
13
C NMR (125.8 MHz, CDCl3) of 2-Benzyl-1-(4-fluorophenyl)-2,1-
borazaronaphthalene 4.17 
 
Figure A3D.102. 
11
B NMR (128.38 MHz, CDCl3) of 2-Benzyl-1-(4-fluorophenyl)-2,1-
borazaronaphthalene 4.17 
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Figure A3D.103. IR Spectrum of 2-Benzyl-1-(4-fluorophenyl)-2,1-borazaronaphthalene 
4.17 
 
Figure A3D.104. 
1
H NMR (500 MHz, CDCl3) of 2-Benzyl-1-(2,4-difluorophenyl)-2,1-
borazaronaphthalene 4.18 
967 
 
 
Figure A3D.105. 
13
C NMR (125.8 MHz, CDCl3) of 2-Benzyl-1-(2,4-difluorophenyl)-
2,1-borazaronaphthalene 4.18 
 
 
Figure A3D.106. 
11
B NMR (128.38 MHz, CDCl3) of 2-Benzyl-1-(2,4-difluorophenyl)-
2,1-borazaronaphthalene 4.18 
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Figure A3D.107. IR Spectrum of 2-Benzyl-1-(2,4-difluorophenyl)-2,1-
borazaronaphthalene 4.18 
 
Figure A3D.108. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2-(3-thienyl)-2,1-
borazaronaphthalene 4.19 
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Figure A3D.109. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-2-(3-thienyl)-2,1-
borazaronaphthalene 4.19 
 
 
Figure A3D.110. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-2-(3-thienyl)-2,1-
borazaronaphthalene 4.19 
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Figure A3D.111. IR Spectrum of 1-Benzyl-2-(3-thienyl)-2,1-borazaronaphthalene 4.19 
 
Figure A3D.112. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2-(4-dibenzofuryl)-2,1-
borazaronaphthalene 4.20 
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Figure A3D.113. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-2-(4-dibenzofuryl)-
2,1-borazaronaphthalene 4.20 
 
 
Figure A3D.114. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-2-(4-dibenzofuryl)-
2,1-borazaronaphthalene 4.20 
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Figure A3D.115. IR Spectrum of 1-Benzyl-2-(4-dibenzofuryl)-2,1-borazaronaphthalene 
4.20 
 
Figure A3D.116. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2-(4-dibenzothienyl)-2,1-
borazaronaphthalene 4.21 
973 
 
 
Figure A3D.117. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-2-(4-dibenzothienyl)-
2,1-borazaronaphthalene 4.21 
 
 
Figure A3D.118. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-2-(4-dibenzothienyl)-
2,1-borazaronaphthalene 4.21 
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Figure A3D.119. IR Spectrum of 1-Benzyl-2-(4-dibenzothienyl)-2,1-
borazaronaphthalene 4.21 
 
 
Figure A3D.120. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2-((E)-1-propen-1-yl)-
2,1-borazaronaphthalene 4.22 
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Figure A3D.121. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-2-((E)-1-propen-1-yl)-
2,1-borazaronaphthalene 4.22 
 
 
Figure A3D.122. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-2-((E)-1-propen-1-
yl)-2,1-borazaronaphthalene 4.22 
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Figure A3D.123. IR Spectrum of 1-Benzyl-2-((E)-1-propen-1-yl)-2,1-
borazaronaphthalene 4.22 
 
Figure A3D.124. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2-((Z)-1-propen-1-yl)-
2,1-borazaronaphthalene 4.23 
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Figure A3D.125. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-2-((Z)-1-propen-1-yl)-
2,1-borazaronaphthalene 4.23 
 
Figure A3D.126. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-2-((Z)-1-propen-1-
yl)-2,1-borazaronaphthalene 4.23 
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Figure A3D.127. IR Spectrum of 1-Benzyl-2-((Z)-1-propen-1-yl)-2,1-
borazaronaphthalene 4.23 
 
Figure A3D.128. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2-((E)-3-phenyl-1-
propen-1-yl)-2,1-borazaronaphthalene 4.24 
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Figure A3D.129. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2-((E)-3-phenyl-1-
propen-1-yl)-2,1-borazaronaphthalene 4.24 
 
 
Figure A3D.130. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-2-((E)-3-phenyl-1-
propen-1-yl)-2,1-borazaronaphthalene 4.24 
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Figure A3D.131. IR Spectrum of 1-Benzyl-2-((E)-3-phenyl-1-propen-1-yl)-2,1-
borazaronaphthalene 4.24 
 
Figure A3D.132. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2-(1-butynyl)-2,1-
borazaronaphthalene 4.25 
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Figure A3D.133. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-2-(1-butynyl)-2,1-
borazaronaphthalene 4.25 
 
Figure A3D.134. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-2-(1-butynyl)-2,1-
borazaronaphthalene 4.25 
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Figure A3D.135. IR Spectrum of 1-Benzyl-2-(1-butynyl)-2,1-borazaronaphthalene 4.25 
 
 
Figure A3D.136. 
1
H NMR (500 MHz, CDCl3) of 2-Benzyl-1-methyl-2,1-
borazaronaphthalene 4.26 
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Figure A3D.137. 
13
C NMR (125.8 MHz, CDCl3) of 2-Benzyl-1-methyl-2,1-
borazaronaphthalene 4.26 
 
Figure A3D.138. 
11
B NMR (128.38 MHz, CDCl3) of 2-Benzyl-1-methyl-2,1-
borazaronaphthalene 4.26 
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Figure A3D.139. IR Spectrum of 2-Benzyl-1-methyl-2,1-borazaronaphthalene 4.26 
 
Figure A3D.140. 
1
H NMR (500 MHz, CDCl3) of 2-Benzyl-1-(4-penten-1-yl)-2,1-
borazaronaphthalene 4.27 
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Figure A3D.141. 
13
C NMR (125.8 MHz, CDCl3) of 2-Benzyl-1-(4-penten-1-yl)-2,1-
borazaronaphthalene 4.27 
 
Figure A3D.142. 
11
B NMR (128.38 MHz, CDCl3) of 2-Benzyl-1-(4-penten-1-yl)-2,1-
borazaronaphthalene 4.27 
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Figure A3D.143. IR Spectrum of 2-Benzyl-1-(4-penten-1-yl)-2,1-borazaronaphthalene 
4.27 
 
 
Figure A3D.144. 
1
H NMR (500 MHz, CDCl3) of 2-Benzyl-1-trifluoroethyl-2,1-
borazaronaphthalene 4.28 
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Figure A3D.145. 
13
C NMR (125.8 MHz, CDCl3) of 2-Benzyl-1-trifluoroethyl-2,1-
borazaronaphthalene 4.28 
 
 
Figure A3D.146. 
11
B NMR (128.38 MHz, CDCl3) of 2-Benzyl-1-trifluoroethyl-2,1-
borazaronaphthalene 4.28 
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Figure A3D.147. IR Spectrum of 2-Benzyl-1-trifluoroethyl-2,1-borazaronaphthalene 
4.28 
 
Figure A3D.148. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2-isopropyl-2,1-
borazaronaphthalene 4.29 
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Figure A3D.149. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-2-isopropyl-2,1-
borazaronaphthalene 4.29 
 
Figure A3D.150. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-2-isopropyl-2,1-
borazaronaphthalene 4.29 
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Figure A3D.151. IR Spectrum of 1-Benzyl-2-isopropyl-2,1-borazaronaphthalene 4.29 
 
 
Figure A3D.152. 
1
H NMR (500 MHz, CDCl3) of 2-Benzyl-1-cyclopropyl-2,1-
borazaronaphthalene 4.30 
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Figure A3D.153. 
13
C NMR (125.8 MHz, CDCl3) of 2-Benzyl-1-cyclopropyl-2,1-
borazaronaphthalene 4.30 
 
 
Figure A3D.154. 
11
B NMR (128.38 MHz, CDCl3) of 2-Benzyl-1-cyclopropyl-2,1-
borazaronaphthalene 4.30 
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Figure A3D.155. IR Spectrum of 2-Benzyl-1-cyclopropyl-2,1-borazaronaphthalene 4.30 
 
Figure A3D.156. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2-cyclobutyl-2,1-
borazaronaphthalene 4.31 
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Figure A3D.157. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-2-cyclobutyl-2,1-
borazaronaphthalene 4.31 
 
Figure A3D.158. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-2-cyclobutyl-2,1-
borazaronaphthalene 4.31 
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Figure A3D.159. IR Spectrum of 1-Benzyl-2-cyclobutyl-2,1-borazaronaphthalene 4.31 
 
 
Figure A3D.160. 
1
H NMR (500 MHz, CDCl3) of 1-Benzyl-2-cyclohexyl-2,1-
borazaronaphthalene 4.32 
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Figure A3D.161. 
13
C NMR (125.8 MHz, CDCl3) of 1-Benzyl-2-cyclohexyl-2,1-
borazaronaphthalene 4.32 
 
 
Figure A3D.162. 
11
B NMR (128.38 MHz, CDCl3) of 1-Benzyl-2-cyclohexyl-2,1-
borazaronaphthalene 4.32 
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Figure A3D.163. IR Spectrum of 1-Benzyl-2-cyclohexyl-2,1-borazaronaphthalene 4.32 
 
Figure A3D.164. 
1
H NMR (500 MHz, CDCl3) of 1-(4-Methoxybenzyl)-2-phenyl-2,1-
borazaronaphthalene 4.33 
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Figure A3D.165. 
13
C NMR (125.8 MHz, CDCl3) of 1-(4-Methoxybenzyl)-2-phenyl-2,1-
borazaronaphthalene 4.33 
 
Figure A3D.166. 
11
B NMR (128.38 MHz, CDCl3) of 1-(4-Methoxybenzyl)-2-phenyl-
2,1-borazaronaphthalene 4.33 
998 
 
 
Figure A3D.167. IR Spectrum of 1-(4-Methoxybenzyl)-2-phenyl-2,1-
borazaronaphthalene 4.33 
 
 
Figure A3D.168. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-2-phenyl-2,1-
borazaronaphthalene 4.34 
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Figure A3D.169. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-2-phenyl-2,1-
borazaronaphthalene 4.34 
 
 
Figure A3D.170. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-2-phenyl-2,1-
borazaronaphthalene 4.34 
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Figure A3D.171. IR Spectrum of 1-Allyl-2-phenyl-2,1-borazaronaphthalene 4.34 
 
Figure A3D.172. 
1
H NMR (500 MHz, CDCl3) of 1-Butyl-2-phenyl-2,1-
borazaronaphthalene 4.35 
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Figure A3D.173. 
13
C NMR (125.8 MHz, CDCl3) of1-Butyl-2-phenyl-2,1-
borazaronaphthalene 4.35 
 
Figure A3D.174. 
11
B NMR (128.38 MHz, CDCl3) of 1-Butyl-2-phenyl-2,1-
borazaronaphthalene 4.35 
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Figure A3D.175. IR Spectrum of 1-Butyl-2-phenyl-2,1-borazaronaphthalene 4.35 
 
 
Figure A3D.176. 
1
H NMR (500 MHz, CDCl3) of 1,2-Diphenyl-2,1-borazaronaphthalene 
4.36 
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Figure A3D.177. 
13
C NMR (125.8 MHz, CDCl3) of 1,2-Diphenyl-2,1-
borazaronaphthalene 4.36 
 
 
Figure A3D.178. 
11
B NMR (128.38 MHz, CDCl3) of 1,2-Diphenyl-2,1-
borazaronaphthalene 4.36 
1004 
 
 
Figure A3D.179. IR Spectrum of 1,2-Diphenyl-2,1-borazaronaphthalene 4.36 
 
Figure A3D.180. 
1
H NMR (500 MHz, CDCl3) of 2-Benzyl-1-phenyl-6-trifluoromethyl-
2,1-borazaronaphthalene 4.38 
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Figure A3D.181. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Benzyl-1-phenyl-6-
trifluoromethyl-2,1-borazaronaphthalene 4.38 
 
Figure A3D.182. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Benzyl-1-phenyl-6-
trifluoromethyl-2,1-borazaronaphthalene 4.38 
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Figure A3D.183. IR Spectrum of 2-Benzyl-1-phenyl-6-trifluoromethyl-2,1-
borazaronaphthalene 4.38 
 
 
Figure A3D.184. 
1
H NMR (500 MHz, acetone-d6) of 2-Benzyl-1-phenyl-5-fluoro-2,1-
borazaronaphthalene 4.39 
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Figure A3D.185. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Benzyl-1-phenyl-5-fluoro-2,1-
borazaronaphthalene 4.39 
 
 
Figure A3D.186. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Benzyl-1-phenyl-5-fluoro-
2,1-borazaronaphthalene 4.39 
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Figure A3D.187. IR Spectrum of 2-Benzyl-1-phenyl-5-fluoro-2,1-borazaronaphthalene 
4.39 
 
Figure A3D.188. 
1
H NMR (500 MHz, acetone-d6) of 2-Benzyl-1-phenyl-7-methyl-2,1-
borazaronaphthalene 4.40 
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Figure A3D.189. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Benzyl-1-phenyl-7-methyl-
2,1-borazaronaphthalene 4.40 
 
Figure A3D.190. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Benzyl-1-phenyl-7-methyl-
2,1-borazaronaphthalene 4.40 
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Figure A3D.191. IR Spectrum of 2-Benzyl-1-phenyl-7-methyl-2,1-borazaronaphthalene 
4.40 
 
 
Figure A3D.192. 
1
H NMR (500 MHz, acetone-d6) of 2-Benzyl-1-phenyl-6,7-dimethoxy-
2,1-borazaronaphthalene 4.41 
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Figure A3D.193. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Benzyl-1-phenyl-6,7-
dimethoxy-2,1-borazaronaphthalene 4.41 
 
 
Figure A3D.194. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Benzyl-1-phenyl-6,7-
dimethoxy-2,1-borazaronaphthalene 4.41 
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Figure A3D.195. IR Spectrum of 2-Benzyl-1-phenyl-6,7-dimethoxy-2,1-
borazaronaphthalene 4.41 
 
 
Figure A3D.196. 
1
H NMR (500 MHz, acetone-d6) of 2-Methyl-2,1-borazaronaphthalene 
4.42 
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Figure A3D.197. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Methyl-2,1-
borazaronaphthalene 4.42 
 
 
Figure A3D.198. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Methyl-2,1-
borazaronaphthalene 4.42 
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Figure A3D.199. IR Spectrum of 2-Methyl-2,1-borazaronaphthalene 4.42 
 
Figure A3D.200. 
1
H NMR (500 MHz, acetone-d6) of 2-Cyclopropyl-2,1-
borazaronaphthalene 4.43 
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Figure A3D.201. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Cyclopropyl-2,1-
borazaronaphthalene 4.43 
 
 
Figure A3D.202. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Cyclopropyl-2,1-
borazaronaphthalene 4.43 
1016 
 
 
Figure A3D.203. IR Spectrum of 2-Cyclopropyl-2,1-borazaronaphthalene 4.43 
 
Figure A3D.204. 
1
H NMR (500 MHz, acetone-d6) of 2-(3-Bromopropyl)-2,1-
borazaronaphthalene 4.44 
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Figure A3D.205. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(3-Bromopropyl)-2,1-
borazaronaphthalene 4.44 
 
Figure A3D.206. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(3-Bromopropyl)-2,1-
borazaronaphthalene 4.44 
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Figure A3D.207. IR Spectrum of 2-(3-Bromopropyl)-2,1-borazaronaphthalene 4.44 
 
 
Figure A3D.208. 
1
H NMR (500 MHz, acetone-d6) of 2-(3-Iodopropyl)-2,1-
borazaronaphthalene 4.45 
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Figure A3D.209. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(3-Iodopropyl)-2,1-
borazaronaphthalene 4.45 
 
 
Figure A3D.210. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(3-Iodopropyl)-2,1-
borazaronaphthalene 4.45 
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Figure A3D.211. IR Spectrum of 2-(3-Iodopropyl)-2,1-borazaronaphthalene 4.45 
 
Figure A3D.212. 
1
H NMR (500 MHz, acetone-d6) of 2-((E)-1-Propen-1-yl)-2,1-
borazaronaphthalene 4.46 
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Figure A3D.213. 
13
C NMR (125.8 MHz, acetone-d6) of 2-((E)-1-Propen-1-yl)-2,1-
borazaronaphthalene 4.46 
 
Figure A3D.214. 
11
B NMR (128.38 MHz, acetone-d6) of 2-((E)-1-Propen-1-yl)-2,1-
borazaronaphthalene 4.46 
1022 
 
 
Figure A3D.215. IR Spectrum of 2-((E)-1-Propen-1-yl)-2,1-borazaronaphthalene 4.46 
 
 
Figure A3D.216. 
1
H NMR (500 MHz, acetone-d6) of 2-(1-Butynyl)-2,1-
borazaronaphthalene 4.47 
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Figure A3D.217. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(1-Butynyl)-2,1-
borazaronaphthalene 4.47 
 
 
Figure A3D.218. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(1-Butynyl)-2,1-
borazaronaphthalene 4.47 
1024 
 
 
Figure A3D.219. IR Spectrum of 2-(1-Butynyl)-2,1-borazaronaphthalene 4.47 
 
Figure A3D.220. 
1
H NMR (500 MHz, acetone-d6) of 2-Phenyl-2,1-borazaronaphthalene 
4.48 
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Figure A3D.221. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Phenyl-2,1-
borazaronaphthalene 4.48 
 
 
Figure A3D.222. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Phenyl-2,1-
borazaronaphthalene 4.48 
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Figure A3D.223. IR Spectrum of 2-Phenyl-2,1-borazaronaphthalene 4.48 
 
 
Figure A3D.224. 
1
H NMR (500 MHz, acetone-d6) of 2-(4-Methylphenyl)-2,1-
borazaronaphthalene 4.49 
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Figure A3D.225. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(4-Methylphenyl)-2,1-
borazaronaphthalene 4.49 
 
 
Figure A3D.226. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(4-Methylphenyl)-2,1-
borazaronaphthalene 4.49 
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Figure A3D.227. IR Spectrum of 2-(4-Methylphenyl)-2,1-borazaronaphthalene 4.49 
 
Figure A3D.228. 
1
H NMR (500 MHz, acetone-d6) of 2-(4-Fluorophenyl)-2,1-
borazaronaphthalene 4.50 
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Figure A3D.229. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(4-Fluorophenyl)-2,1-
borazaronaphthalene 4.50 
 
Figure A3D.230. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(4-Fluorophenyl)-2,1-
borazaronaphthalene 4.50 
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Figure A3D.231. IR Spectrum of 2-(4-Fluorophenyl)-2,1-borazaronaphthalene 4.50 
 
Figure A3D.232. 
1
H NMR (500 MHz, acetone-d6) of 2-(3-Thienyl)-2,1-
borazaronaphthalene 4.51 
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Figure A3D.233. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(3-Thienyl)-2,1-
borazaronaphthalene 4.51 
 
 
Figure A3D.234. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(3-Thienyl)-2,1-
borazaronaphthalene 4.51 
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Figure A3D.235. IR Spectrum of 2-(3-Thienyl)-2,1-borazaronaphthalene 4.51 
 
Figure A3D.236. 
1
H NMR (500 MHz, CDCl3) of 2-(4-Dibenzofuryl)-2,1-
borazaronaphthalene 4.52 
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Figure A3D.237. 
13
C NMR (125.8 MHz, CDCl3) of 2-(4-Dibenzofuryl)-2,1-
borazaronaphthalene 4.52 
 
Figure A3D.238. 
11
B NMR (128.38 MHz, CDCl3) of 2-(4-Dibenzofuryl)-2,1-
borazaronaphthalene 4.52 
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Figure A3D.239. IR Spectrum of 2-(4-Dibenzofuryl)-2,1-borazaronaphthalene 4.52 
 
 
Figure A3D.240. 
1
H NMR (500 MHz, CDCl3) of 2-(1-Tosyl-4-piperidinyl)-2,1-
borazaronaphthalene 4.53 
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Figure A3D.241. 
13
C NMR (125.8 MHz, CDCl3) of 2-(1-Tosyl-4-piperidinyl)-2,1-
borazaronaphthalene 4.53 
 
 
Figure A3D.242. 
11
B NMR (128.38 MHz, CDCl3) of 2-(1-Tosyl-4-piperidinyl)-2,1-
borazaronaphthalene 4.53 
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Figure A3D.243. IR Spectrum of 2-(1-Tosyl-4-piperidinyl)-2,1-borazaronaphthalene 
4.53 
 
Figure A3D.244. 
1
H NMR (500 MHz, CDCl3) of 2-Phenyl-1-methyl-2,1-
borazaronaphthalene 4.54 
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Figure A3D.245. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Phenyl-1-methyl-2,1-
borazaronaphthalene 4.54 
 
Figure A3D.246. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Phenyl-1-methyl-2,1-
borazaronaphthalene 4.54 
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Figure A3D.247. IR Spectrum of 2-Phenyl-1-methyl-2,1-borazaronaphthalene 4.54 
 
Figure A3D.248. 
1
H NMR (500 MHz, acetone-d6) of 2-(β,β,β-Trifluoroethyl)-2,1-
borazaronaphthalene 
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Figure A3D.249. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(β,β,β-Trifluoroethyl)-2,1-
borazaronaphthalene 
 
Figure A3D.250. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(β,β,β-Trifluoroethyl)-2,1-
borazaronaphthalene 
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Figure A3D.251. IR Spectrum of 2-(β,β,β-Trifluoroethyl)-2,1-borazaronaphthalene 
 
Figure A3D.252. 
1
H NMR (500 MHz, acetone-d6) of 2-Isopropyl-2,1-
borazaronaphthalene
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Figure A3D.253. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Isopropyl-2,1-
borazaronaphthalene 
 
 
Figure A3D.254. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Isopropyl-2,1-
borazaronaphthalene 
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Figure A3D.255. IR Spectrum of 2-Isopropyl-2,1-borazaronaphthalene 
 
Figure A3D.256. 
1
H NMR (500 MHz, acetone-d6) of 2-Cyclobutyl-2,1-
borazaronaphthalene 
 
1043 
 
 
Figure A3D.257. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Cyclobutyl-2,1-
borazaronaphthalene 
 
Figure A3D.258. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Cyclobutyl-2,1-
borazaronaphthalene 
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Figure A3D.259. IR Spectrum of 2-Cyclobutyl-2,1-borazaronaphthalene 
 
 
Figure A3D.260. 
1
H NMR (500 MHz, acetone-d6) of 2-(3-Methoxyphenyl)-2,1-
borazaronaphthalene 
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Figure A3D.261. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(3-Methoxyphenyl)-2,1-
borazaronaphthalene 
 
Figure A3D.262. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(3-Methoxyphenyl)-2,1-
borazaronaphthalene 
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Figure A3D.263. IR Spectrum of 2-(3-Methoxyphenyl)-2,1-borazaronaphthalene 
 
Figure A3D.264. 
1
H NMR (500 MHz, acetone-d6) of 2-(2-Thienyl)-2,1-
borazaronaphthalene 4.165 
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Figure A3D.265. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(2-Thienyl)-2,1-
borazaronaphthalene 4.165 
 
Figure A3D.266. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(2-Thienyl)-2,1-
borazaronaphthalene 4.165 
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Figure A3D.267. IR Spectrum of 2-(2-Thienyl)-2,1-borazaronaphthalene 4.165 
 
Figure A3D.268. 
1
H NMR (500 MHz, CDCl3) of 2-(3-Methoxyphenyl)-1-(4-
methylbenzyl)-2,1-borazaronaphthalene 
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Figure A3D.269. 
13
C NMR (125.8 MHz, CDCl3) of 2-(3-Methoxyphenyl)-1-(4-
methylbenzyl)-2,1-borazaronaphthalene 
 
Figure A3D.270. 
11
B NMR (128.38 MHz, CDCl3) of 2-(3-Methoxyphenyl)-1-(4-
methylbenzyl)-2,1-borazaronaphthalene 
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Figure A3D.271. IR Spectrum of 2-(3-Methoxyphenyl)-1-(4-methylbenzyl)-2,1-
borazaronaphthalene 
 
Figure A3D.272. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-2-methyl-2,1-
borazaronaphthalene 
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Figure A3D.273. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-2-methyl-2,1-
borazaronaphthalene 
 
Figure A3D.274. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-2-methyl-2,1-
borazaronaphthalene 
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Figure A3D.275. IR Spectrum of 1-Allyl-2-methyl-2,1-borazaronaphthalene 
 
Figure A3D.276. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-2-(3-methoxyphenyl)-2,1-
borazaronaphthalene 
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Figure A3D.277. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-2-(3-methoxyphenyl)-
2,1-borazaronaphthalene 
 
Figure A3D.278. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-2-(3-methoxyphenyl)-
2,1-borazaronaphthalene 
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Figure A3D.279. IR Spectrum of 1-Allyl-2-(3-methoxyphenyl)-2,1-borazaronaphthalene 
 
Figure A3D.280. 
1
H NMR (500 MHz, CDCl3) of 1-Benzyl-2-(4-trifluoromethylphenyl)-
2,1-borazaronaphthalene
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Figure A3D.281. 
13
C NMR (125.8 MHz, CDCl3) of 1-Benzyl-2-(4-
trifluoromethylphenyl)-2,1-borazaronaphthalene
 
 
Figure A3D.282. 
11
B NMR (128.38 MHz, CDCl3) of 1-Benzyl-2-(4-
trifluoromethylphenyl)-2,1-borazaronaphthalene 
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Figure A3D.283. IR Spectrum of 1-Benzyl-2-(4-trifluoromethylphenyl)-2,1-
borazaronaphthalene 
 
 
Figure A3D.284. 
1
H NMR (500 MHz, CDCl3) of 2-(4-Fluorophenyl)-1-(4-
methoxybenzyl)-2,1-borazaronaphthalene
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Figure A3D.285. 
13
C NMR (125.8 MHz, CDCl3) of 2-(4-Fluorophenyl)-1-(4-
methoxybenzyl)-2,1-borazaronaphthalene 
 
 
Figure A3D.286. 
11
B NMR (128.38 MHz, CDCl3) of 2-(4-Fluorophenyl)-1-(4-
methoxybenzyl)-2,1-borazaronaphthalene 
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Figure A3D.287. IR Spectrum of 2-(4-Fluorophenyl)-1-(4-methoxybenzyl)-2,1-
borazaronaphthalene 
 
Figure A3D.288. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-methyl-2,1-
borazaronaphthalene 4.55 
1059 
 
 
Figure A3D.289. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-methyl-2,1-
borazaronaphthalene 4.55 
 
Figure A3D.290. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-methyl-2,1-
borazaronaphthalene 4.55 
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Figure A3D.291. IR Spectrum of 3-Bromo-2-methyl-2,1-borazaronaphthalene 4.55 
 
 
Figure A3D.292. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-(β,β,β-trifluoroethyl)-
2,1-borazaronaphthalene 4.56 
1061 
 
 
 
Figure A3D.293. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-(β,β,β-
trifluoroethyl)-2,1-borazaronaphthalene 4.56 
 
Figure A3D.294. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-(β,β,β-
trifluoroethyl)-2,1-borazaronaphthalene 4.56 
1062 
 
 
Figure A3D.295. IR spectrum of 3-Bromo-2-(β,β,β-trifluoroethyl)-2,1-
borazaronaphthalene 4.56 
 
Figure A3D.296. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-isopropyl-2,1-
borazaronaphthalene 4.57 
1063 
 
 
Figure A3D.297. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-isopropyl-2,1-
borazaronaphthalene 4.57 
 
 
Figure A3D.298. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-isopropyl-2,1-
borazaronaphthalene 4.57 
1064 
 
 
Figure A3D.299. IR Spectrum of 3-Bromo-2-isopropyl-2,1-borazaronaphthalene 4.57 
 
Figure A3D.300. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-cyclopropyl-2,1-
borazaronaphthalene 4.58 
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Figure A3D.301. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-cyclopropyl-2,1-
borazaronaphthalene 4.58 
 
 
Figure A3D.302. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-cyclopropyl-2,1-
borazaronaphthalene 4.58 
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Figure A3D.303. IR Spectrum of 3-Bromo-2-cyclopropyl-2,1-borazaronaphthalene 4.58 
 
Figure A3D.304. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-cyclobutyl-2,1-
borazaronaphthalene 4.59 
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Figure A3D.305. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-cyclobutyl-2,1-
borazaronaphthalene 4.59 
 
Figure A3D.306. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-cyclobutyl-2,1-
borazaronaphthalene 4.59 
1068 
 
 
Figure A3D.307. IR Spectrum of 3-Bromo-2-cyclobutyl-2,1-borazaronaphthalene 4.59 
 
 
Figure A3D.308. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-benzyl-2-methyl-2,1-
borazaronaphthalene 4.60 
1069 
 
 
 
Figure A3D.309. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-benzyl-2-methyl-2,1-
borazaronaphthalene 4.60 
 
Figure A3D.310. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-benzyl-2-methyl-
2,1-borazaronaphthalene 4.60 
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Figure A3D.311. IR Spectrum of 3-Bromo-2-benzyl-2-methyl-2,1-borazaronaphthalene 
4.60 
 
Figure A3D.312. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-methyl-2,1-
borazaronaphthalene 4.61 
1071 
 
 
 
Figure A3D.313. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-methyl-2,1-
borazaronaphthalene 4.61 
 
Figure A3D.314. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-methyl-2,1-
borazaronaphthalene 4.61 
1072 
 
 
Figure A3D.315. IR Spectrum of 1-Allyl-3-bromo-2-methyl-2,1-borazaronaphthalene 
4.61 
 
Figure A3D.316. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-phenyl-2,1-
borazaronaphthalene 4.62 
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Figure A3D.317. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-phenyl-2,1-
borazaronaphthalene 4.62 
 
Figure A3D.318. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-phenyl-2,1-
borazaronaphthalene 4.62 
1074 
 
 
Figure A3D.319. IR Spectrum of 3-Bromo-2-phenyl-2,1-borazaronaphthalene 4.62 
 
Figure A3D.320. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-(3-methoxyphenyl)-
2,1-borazaronaphthalene 4.63 
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Figure A3D.321. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-(3-methoxyphenyl)-
2,1-borazaronaphthalene 4.63 
 
Figure A3D.322. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-(3-methoxyphenyl)-
2,1-borazaronaphthalene 4.63 
1076 
 
 
Figure A3D.323. IR Spectrum of 3-Bromo-2-(3-methoxyphenyl)-2,1-
borazaronaphthalene 4.63 
 
Figure A3D.324. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-(4-fluorophenyl)-2,1-
borazaronaphthalene 4.64 
1077 
 
 
 
Figure A3D.325. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-(4-fluorophenyl)-
2,1-borazaronaphthalene 4.64 
 
Figure A3D.326. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-(4-fluorophenyl)-
2,1-borazaronaphthalene 4.64 
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Figure A3D.327. IR Spectrum of 3-Bromo-2-(4-fluorophenyl)-2,1-borazaronaphthalene 
4.64 
 
Figure A3D.328. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-(3-thienyl)-2,1-
borazaronaphthalene 4.65 
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Figure A3D.329. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-(3-thienyl)-2,1-
borazaronaphthalene 4.65 
 
Figure A3D.330. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-(3-thienyl)-2,1-
borazaronaphthalene 4.65 
1080 
 
 
Figure A3D.331. IR Spectrum of 3-Bromo-2-(3-thienyl)-2,1-borazaronaphthalene 4.65 
 
Figure A3D.332. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-(4-dibenzofuranyl)-2,1-
borazaronaphthalene 4.66 
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Figure A3D.333. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-(4-dibenzofuranyl)-
2,1-borazaronaphthalene 4.66 
 
Figure A3D.334. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-(4-dibenzofuranyl)-
2,1-borazaronaphthalene 4.66 
1082 
 
 
Figure A3D.335. IR Spectrum of of 3-Bromo-2-(4-dibenzofuranyl)-2,1-
borazaronaphthalene 4.66 
 
Figure A3D.336. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-phenyl-2,1-
borazaronaphthalene 4.67 
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Figure A3D.337. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-phenyl-2,1-
borazaronaphthalene 4.67 
 
Figure A3D.338. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-phenyl-2,1-
borazaronaphthalene 4.67 
1084 
 
 
Figure A3D.339. IR Spectrum of 1-Allyl-3-bromo-2-phenyl-2,1-borazaronaphthalene 
4.67 
 
Figure A3D.340. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.68 
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Figure A3D.341. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.68 
 
Figure A3D.342. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.68 
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Figure A3D.343. IR Spectrum of 1-Allyl-3-bromo-2-(3-methoxyphenyl)-2,1-
borazaronaphthalene 4.68 
 
Figure A3D.344. 
1
H NMR (500 MHz, acetone-d6) of 2-Benzyl-3-bromo-1-phenyl-2,1-
borazaronaphthalene 4.69 
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Figure A3D.345. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Benzyl-3-bromo-1-phenyl-2,1-
borazaronaphthalene 4.69 
 
Figure A3D.346. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Benzyl-3-bromo-1-phenyl-
2,1-borazaronaphthalene 4.69 
1088 
 
 
Figure A3D.347. IR Spectrum of 2-Benzyl-3-bromo-1-phenyl-2,1-borazaronaphthalene 
4.69 
 
Figure A3D.348. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-3-bromo-2-(4-
trifluoromethylphenyl)-2,1-borazaronaphthalene 4.70 
1089 
 
 
 
Figure A3D.349. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-3-bromo-2-
(trifluoromethylphenyl)-2,1-borazaronaphthalene 4.70 
 
Figure A3D.350. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-3-bromo-2-
(trifluoromethylphenyl)-2,1-borazaronaphthalene 4.70 
1090 
 
 
Figure A3D.351. IR Spectrum of 1-Benzyl-3-bromo-2-(trifluoromethylphenyl)-2,1-
borazaronaphthalene 4.70 
 
Figure A3D.352. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-(4-fluorophenyl)-1-(4-
methoxybenzyl)-2,1-borazaronaphthalene 4.71 
1091 
 
 
 
Figure A3D.353. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-(4-fluorophenyl)-1-
(4-methoxybenzyl)-2,1-borazaronaphthalene 4.71 
 
Figure A3D.354. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-(4-fluorophenyl)-1-
(4-methoxybenzyl)-2,1-borazaronaphthalene 4.71 
1092 
 
 
Figure A3D.355. IR Spectrum of 3-Bromo-2-(4-fluorophenyl)-1-(4-methoxybenzyl)-2,1-
borazaronaphthalene 4.71 
 
 
Figure A3D.356. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-3-bromo-2-(3-thienyl)-
2,1-borazaronaphthalene 4.72 
1093 
 
 
Figure A3D.357. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-3-bromo-2-(3-thienyl)-
2,1-borazaronaphthalene 4.72 
 
Figure A3D.358. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-3-bromo-2-(3-
thienyl)-2,1-borazaronaphthalene 4.72 
1094 
 
 
Figure A3D.359. IR Spectrum of 1-Benzyl-3-bromo-2-(3-thienyl)-2,1-
borazaronaphthalene 4.72 
 
Figure A3D.360. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-(3-methoxyphenyl)-1-
(4-methylbenzyl)-2,1-borazaronaphthalene 4.73 
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Figure A3D.361. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-(3-methoxyphenyl)-
1-(4-methylbenzyl)-2,1-borazaronaphthalene 4.73 
 
Figure A3D.362. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-(3-methoxyphenyl)-
1-(4-methylbenzyl)-2,1-borazaronaphthalene 4.73 
1096 
 
 
Figure A3D.363. IR Spectrum of 3-Bromo-2-(3-methoxyphenyl)-1-(4-methylbenzyl)-
2,1-borazaronaphthalene 4.73 
 
 
Figure A3D.364. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-2-(hex-1-yn-1-yl)-2,1-
borazaronaphthalene 4.74 
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Figure A3D.365. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-2-(hex-1-yn-1-yl)-2,1-
borazaronaphthalene 4.74 
 
Figure A3D.366. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-2-(hex-1-yn-1-yl)-
2,1-borazaronaphthalene 4.74 
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Figure A3D.367. IR Spectrum of 3-Bromo-2-(hex-1-yn-1-yl)-2,1-borazaronaphthalene 
4.74 
 
Figure A3D.368. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-3-bromo-2,7-dimethyl-
2,1-borazaronaphthalene 4.75 
1099 
 
 
 
Figure A3D.369. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-3-bromo-2,7-dimethyl-
2,1-borazaronaphthalene 4.75 
 
Figure A3D.370. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-3-bromo-2,7-
dimethyl-2,1-borazaronaphthalene 4.75 
1100 
 
 
Figure A3D.371. IR Spectrum of 1-Benzyl-3-bromo-2,7-dimethyl-2,1-
borazaronaphthalene 4.75 
 
Figure A3D.372. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-3-bromo-6,7-dimethoxy-
2-methyl-2,1-borazaronaphthalene 4.76 
1101 
 
 
 
Figure A3D.373. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-3-bromo-6,7-
dimethoxy-2-methyl-2,1-borazaronaphthalene 4.76 
 
Figure A3D.374. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-3-bromo-6,7-
dimethoxy-2-methyl-2,1-borazaronaphthalene 4.76 
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Figure A3D.375. IR Spectrum of 1-Benzyl-3-bromo-6,7-dimethoxy-2-methyl-2,1-
borazaronaphthalene 4.76 
 
Figure A3D.376. 
1
H NMR (500 MHz, acetone-d6) of 2-(1,2-Dibromopropyl)-2,1-
borazaronaphthalene 4.77 
1103 
 
 
Figure A3D.377. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(1,2-Dibromopropyl)-2,1-
borazaronaphthalene 4.77 
 
Figure A3D.378. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(1,2-Dibromopropyl)-2,1-
borazaronaphthalene 4.77 
1104 
 
 
Figure A3D.379. IR Spectrum of 2-(1,2-Dibromopropyl)-2,1-borazaronaphthalene 4.77 
 
 
Figure A3D.380. 
1
H NMR (500 MHz, acetone-d6) of 6-Bromo-3-(3-methoxyphenyl)-2-
methyl-2,1-borazaronaphthalene 4.119 
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Figure A3D.381. 
13
C NMR (125.8 MHz, acetone-d6) of 6-Bromo-3-(3-methoxyphenyl)-
2-methyl-2,1-borazaronaphthalene 4.119 
 
Figure A3D.382. 
11
B NMR (128.38 MHz, acetone-d6) of 6-Bromo-3-(3-methoxyphenyl)-
2-methyl-2,1-borazaronaphthalene 4.119 
1106 
 
 
Figure A3D.383. IR Spectrum of 6-Bromo-3-(3-methoxyphenyl)-2-methyl-2,1-
borazaronaphthalene 4.119 
 
Figure A3D.384. 
1
H NMR (500 MHz, acetone-d6) of 6-Bromo-3-phenyl-2-methyl-2,1-
borazaronaphthalene 4.120 
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Figure A3D.385. 
13
C NMR (125.8 MHz, acetone-d6) of 6-Bromo-3-phenyl-2-methyl-
2,1-borazaronaphthalene 4.120 
 
Figure A3D.386. 
11
B NMR (128.38 MHz, acetone-d6) of 6-Bromo-3-phenyl-2-methyl-
2,1-borazaronaphthalene 4.120 
1108 
 
 
Figure A3D.387. IR Spectrum of 6-Bromo-3-phenyl-2-methyl-2,1-borazaronaphthalene 
4.120 
 
Figure A3D.388. 
1
H NMR (500 MHz, acetone-d6) of 3,6-Dibromo-2-methyl-2,1-
borazaronaphthalene 4.78 
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Figure A3D.389. 
13
C NMR (125.8 MHz, acetone-d6) of 3,6-Dibromo-2-methyl-2,1-
borazaronaphthalene 4.78 
 
Figure A3D.390. 
11
B NMR (128.38 MHz, acetone-d6) of 3,6-Dibromo-2-methyl-2,1-
borazaronaphthalene 4.78 
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Figure A3D.391. IR Spectrum of 3,6-Dibromo-2-methyl-2,1-borazaronaphthalene 4.78 
 
Figure A3D.392. 
1
H NMR (500 MHz, CDCl3) of 3-Bromo-2-(3-carbomethoxyphenyl)-
2,1-borazaronaphthalene 
1111 
 
 
Figure A3D.393. 
13
C NMR (125.8 MHz, CDCl3) of 3-Bromo-2-(3-
carbomethoxyphenyl)-2,1-borazaronaphthalene 
 
Figure A3D.394. 
11
B NMR (128.38 MHz, CDCl3) of 3-Bromo-2-(3-
carbomethoxyphenyl)-2,1-borazaronaphthalene 
1112 
 
 
Figure A3D.395. IR Spectrum of 3-Bromo-2-(3-carbomethoxyphenyl)-2,1-
borazaronaphthalene 
 
Figure A3D.396. 
1
H NMR (500 MHz, CDCl3) of 3-Bromo-2-(2,4-difluorophenyl)-2,1-
borazaronaphthalene 
1113 
 
 
Figure A3D.397. 
13
C NMR (125.8 MHz, CDCl3) of 3-Bromo-2-(2,4-difluorophenyl)-2,1-
borazaronaphthalene 
 
Figure A3D.398. 
11
B NMR (128.38 MHz, CDCl3) of 3-Bromo-2-(2,4-difluorophenyl)-
2,1-borazaronaphthalene 
1114 
 
 
Figure A3D.399. IR Spectrum of 3-Bromo-2-(2,4-difluorophenyl)-2,1-
borazaronaphthalene 
 
Figure A3D.400. 
1
H NMR (500 MHz, CDCl3) of 3-Bromo-2-(4-dibenzothienyl)-2,1-
borazaronaphthalene 
1115 
 
 
Figure A3D.401. 
13
C NMR (125.8 MHz, CDCl3) of 3-Bromo-2-(4-dibenzothienyl)-2,1-
borazaronaphthalene 
 
Figure A3D.402. 
11
B NMR (128.38 MHz, CDCl3) of 3-Bromo-2-(4-dibenzothienyl)-2,1-
borazaronaphthalene 
1116 
 
 
Figure A3D.403. IR Spectrum of 3-Bromo-2-(4-dibenzothienyl)-2,1-
borazaronaphthalene 
 
Figure A3D.A3C.404. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
methylphenyl)-2,1-borazaronaphthalene 
 
1117 
 
 
 
Figure A3D.405. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
methylphenyl)-2,1-borazaronaphthalene 
 
Figure A3D.406. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
methylphenyl)-2,1-borazaronaphthalene 
1118 
 
 
Figure A3D.407. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
fluorophenyl)-2,1-borazaronaphthalene 
 
 
Figure A3D.408. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
fluorophenyl)-2,1-borazaronaphthalene 
1119 
 
 
Figure A3D.409. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
fluorophenyl)-2,1-borazaronaphthalene 
 
Figure A3D.410. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
trifluoromethylphenyl)-2,1-borazaronaphthalene 
 
1120 
 
 
Figure A3D.411. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
trifluoromethylphenyl)-2,1-borazaronaphthalene 
 
 
Figure A3D.412. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
trifluoromethylphenyl)-2,1-borazaronaphthalene 
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Figure A3D.413. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-
methylphenyl)-2,1-borazaronaphthalene
 
 
 
Figure A3D.414. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-
methylphenyl)-2,1-borazaronaphthalene
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Figure A3D.415. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-
methylphenyl)-2,1-borazaronaphthalene 
 
 
Figure A3D.416. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-
chlorophenyl)-2,1-borazaronaphthalene 
1123 
 
 
Figure A3D.417. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-
chlorophenyl)-2,1-borazaronaphthalene
 
 
 
Figure A3D.418. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-
chlorophenyl)-2,1-borazaronaphthalene 
1124 
 
 
Figure A3D.419. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(2-
methoxyphenyl)-2,1-borazaronaphthalene
 
 
 
Figure A3D.420. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(2-
methoxyphenyl)-2,1-borazaronaphthalene 
1125 
 
 
Figure A3D.421. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(2-
methoxyphenyl)-2,1-borazaronaphthalene 
 
 
Figure A3D.422. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(2-naphthyl)-
2,1-borazaronaphthalene 
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Figure A3D.423. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(2-naphthyl)-
2,1-borazaronaphthalene 
 
 
Figure A3D.424. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(2-
naphthyl)-2,1-borazaronaphthalene 
1127 
 
 
Figure A3D.425. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-thienyl)-2,1-
borazaronaphthalene 
 
 
Figure A3D.426. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-thienyl)-
2,1-borazaronaphthalene 
1128 
 
 
Figure A3D.427. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(3-thienyl)-
2,1-borazaronaphthalene 
 
 
Figure A3D.428. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
dibenzofuryl)-2,1-borazaronaphthalene
 
1129 
 
 
Figure A3D.429. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
dibenzofuryl)-2,1-borazaronaphthalene 
 
 
Figure A3D.430. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-bromo-2-(4-
dibenzofuryl)-2,1-borazaronaphthalene 
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Figure A3D.431. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-1-butyl-2-phenyl-2,1-
borazaronaphthalene 
 
 
Figure A3D.432. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-1-butyl-2-phenyl-2,1-
borazaronaphthalene 
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Figure A3D.433. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-1-butyl-2-phenyl-2,1-
borazaronaphthalene 
 
 
Figure A3D.434. 
1
H NMR (500 MHz, acetone-d6) of 3-Bromo-1-cyclopropylmethyl-2-
phenyl-2,1-borazaronaphthalene
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Figure A3D.435. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Bromo-1-cyclopropylmethyl-
2-phenyl-2,1-borazaronaphthalene 
 
 
Figure A3D.436. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Bromo-1-cyclopropylmethyl-
2-phenyl-2,1-borazaronaphthalene 
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Figure A3D.437. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-3,6-dibromo-2-phenyl-
2,1-borazaronaphthalene 
 
Figure A3D.438. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-3,6-dibromo-2-phenyl-
2,1-borazaronaphthalene 
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Figure A3D.439. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-3,6-dibromo-2-
phenyl-2,1-borazaronaphthalene 
 
Figure A3D.440. 
1
H NMR (500 MHz, acetone-d6) of 3-Phenyl-2-methyl-2,1-
borazaronaphthalene 4.79 
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Figure A3D.441. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Phenyl-2-methyl-2,1-
borazaronaphthalene 4.79 
 
Figure A3D.442. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Phenyl-2-methyl-2,1-
borazaronaphthalene 4.79 
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Figure A3D.443. IR Spectrum of 3-Phenyl-2-methyl-2,1-borazaronaphthalene 4.79 
 
 
Figure A3D.444. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-methyl-
2,1-borazaronaphthalene 4.80 
1137 
 
 
Figure A3D.445. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-methyl-
2,1-borazaronaphthalene 4.80 
 
Figure A3D.446. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-
methyl-2,1-borazaronaphthalene 4.80 
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Figure A3D.447. IR Spectrum of 3-(3-Methoxyphenyl)-2-methyl-2,1-
borazaronaphthalene 4.80 
 
Figure A3D.448. 
1
H NMR (500 MHz, acetone-d6) of 3-(2-Methoxyphenyl)-2-methyl-
2,1-borazaronaphthalene 4.81 
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Figure A3D.449. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(2-Methoxyphenyl)-2-methyl-
2,1-borazaronaphthalene 4.81 
 
Figure A3D.450. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(2-Methoxyphenyl)-2-
methyl-2,1-borazaronaphthalene 4.81 
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Figure A3D.451. IR Spectrum of 3-(2-Methoxyphenyl)-2-methyl-2,1-
borazaronaphthalene 4.81 
 
Figure A3D.452. 
1
H NMR (500 MHz, acetone-d6) of 3-(1-(4-Naphthyl)-phenyl)-2-
methyl-2,1-borazaronaphthalene 4.82 
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Figure A3D.453. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(1-(4-Naphthyl)-phenyl)-2-
methyl-2,1-borazaronaphthalene 4.82 
 
Figure A3D.454. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(1-(4-Naphthyl)-phenyl)-2-
methyl-2,1-borazaronaphthalene 4.82 
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Figure A3D.455. IR Spectrum of 3-(1-(4-Naphthyl)-phenyl)-2-methyl-2,1-
borazaronaphthalene 4.82 
 
Figure A3D.456. 
1
H NMR (500 MHz, acetone-d6) of 3-(4-Methylphenyl)-2-methyl-2,1-
borazaronaphthalene 4.83 
1143 
 
 
 
Figure A3D.457. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(4-Methylphenyl)-2-methyl-
2,1-borazaronaphthalene 4.83 
 
Figure A3D.458. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(4-Methylphenyl)-2-methyl-
2,1-borazaronaphthalene 4.83 
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Figure A3D.459. IR Spectrum of 3-(4-Methylphenyl)-2-methyl-2,1-borazaronaphthalene 
4.83 
 
Figure A3D.460. 
1
H NMR (500 MHz, acetone-d6) of 3-(1-Naphthyl)-2-methyl-2,1-
borazaronaphthalene 4.84 
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Figure A3D.461. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(1-Naphthyl)-2-methyl-2,1-
borazaronaphthalene 4.84 
 
Figure A3D.462. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(1-Naphthyl)-2-methyl-2,1-
borazaronaphthalene 4.84 
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Figure A3D.463. IR Spectrum of 3-(1-Naphthyl)-2-methyl-2,1-borazaronaphthalene 4.84 
 
 
Figure A3D.464. 
1
H NMR (500 MHz, acetone-d6) of 3-(2-Naphthyl)-2-methyl-2,1-
borazaronaphthalene 4.85 
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Figure A3D.465. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(2-Naphthyl)-2-methyl-2,1-
borazaronaphthalene 4.85 
 
Figure A3D.466. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(2-Naphthyl)-2-methyl-2,1-
borazaronaphthalene 4.85 
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Figure A3D.467. IR Spectrum of 3-(2-Naphthyl)-2-methyl-2,1-borazaronaphthalene 4.85 
 
 
Figure A3D.468. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Vinylphenyl)-2-methyl-2,1-
borazaronaphthalene 4.86 
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Figure A3D.469. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Vinylphenyl)-2-methyl-2,1-
borazaronaphthalene 4.86 
 
Figure A3D.470. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Vinylphenyl)-2-methyl-
2,1-borazaronaphthalene 4.86 
1150 
 
 
Figure A3D.471. IR Spectrum of 3-(3-Vinylphenyl)-2-methyl-2,1-borazaronaphthalene 
4.86 
 
Figure A3D.472. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Methoxy-5-
trifluoromethylphenyl)-2-methyl-2,1-borazaronaphthalene 4.87 
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Figure A3D.473. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Methoxy-5-
trifluoromethylphenyl)-2-methyl-2,1-borazaronaphthalene 4.87 
 
Figure A3D.474. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Methoxy-5-
trifluoromethylphenyl)-2-methyl-2,1-borazaronaphthalene 4.87 
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Figure A3D.475. IR Spectrum of 3-(3-Methoxy-5-trifluoromethylphenyl)-2-methyl-2,1-
borazaronaphthalene 4.87 
 
 
Figure A3D.476. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Nitrophenyl)-2-methyl-2,1-
borazaronaphthalene 4.88 
1153 
 
 
Figure A3D.477. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Nitrophenyl)-2-methyl-2,1-
borazaronaphthalene 4.88 
 
Figure A3D.478. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Nitrophenyl)-2-methyl-
2,1-borazaronaphthalene 4.88 
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Figure A3D.479. IR Spectrum of 3-(3-Nitrophenyl)-2-methyl-2,1-borazaronaphthalene 
4.88 
 
 
Figure A3D.480. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Carbomethoxyphenyl)-2-
methyl-2,1-borazaronaphthalene 4.89 
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Figure A3D.481. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Carbomethoxyphenyl)-2-
methyl-2,1-borazaronaphthalene 4.89 
 
Figure A3D.482. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Carbomethoxyphenyl)-2-
methyl-2,1-borazaronaphthalene 4.89 
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Figure A3D.483. IR Spectrum of 3-(3-Carbomethoxyphenyl)-2-methyl-2,1-
borazaronaphthalene 4.89 
 
 
Figure A3D.484. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Fluorophenyl)-2-methyl-2,1-
borazaronaphthalene 4.90 
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Figure A3D.485. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Fluorophenyl)-2-methyl-
2,1-borazaronaphthalene 4.90 
 
Figure A3D.486. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Fluorophenyl)-2-methyl-
2,1-borazaronaphthalene 4.90 
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Figure A3D.487. IR Spectrum of 3-(3-Fluorophenyl)-2-methyl-2,1-borazaronaphthalene 
4.90 
 
Figure A3D.488. 
1
H NMR (500 MHz, acetone-d6) of 3-(4-Trifluoromethylphenyl)-2-
methyl-2,1-borazaronaphthalene 4.91 
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Figure A3D.489. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(4-Trifluoromethylphenyl)-2-
methyl-2,1-borazaronaphthalene 4.91 
 
 
Figure A3D.490. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(4-Trifluoromethylphenyl)-2-
methyl-2,1-borazaronaphthalene 4.91 
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Figure A3D.491. IR Spectrum of 3-(4-Trifluoromethylphenyl)-2-methyl-2,1-
borazaronaphthalene 4.91 
 
 
Figure A3D.492. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Cyanophenyl)-2-methyl-2,1-
borazaronaphthalene 4.92 
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Figure A3D.493. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Cyanophenyl)-2-methyl-
2,1-borazaronaphthalene 4.92 
 
Figure A3D.494. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Cyanophenyl)-2-methyl-
2,1-borazaronaphthalene 4.92 
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Figure A3D.495. IR Spectrum of 3-(3-Cyanophenyl)-2-methyl-2,1-borazaronaphthalene 
4.92 
 
Figure A3D.496. 
1
H NMR (500 MHz, acetone-d6) of 3-(7-N-Boc-Indolyl)-2-methyl-2,1-
borazaronaphthalene 4.93 
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Figure A3D.497. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(7-N-Boc-Indolyl)-2-methyl-
2,1-borazaronaphthalene 4.93 
 
Figure A3D.498. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(7-N-Boc-Indolyl)-2-methyl-
2,1-borazaronaphthalene 4.93 
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Figure A3D.499. IR Spectrum of 3-(7-N-Boc-Indolyl)-2-methyl-2,1-
borazaronaphthalene 4.93 
 
Figure A3D.500. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Thienyl)-2-methyl-2,1-
borazaronaphthalene 4.94 
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Figure A3D.501. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Thienyl)-2-methyl-2,1-
borazaronaphthalene 4.94 
 
Figure A3D.502. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Thienyl)-2-methyl-2,1-
borazaronaphthalene 4.94 
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Figure A3D.503. IR Spectrum of 3-(3-Thienyl)-2-methyl-2,1-borazaronaphthalene 4.94 
 
Figure A3D.504. 
1
H NMR (500 MHz, acetone-d6) of 3-(2-Thienyl)-2-methyl-2,1-
borazaronaphthalene 4.95 
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Figure A3D.505. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(2-Thienyl)-2-methyl-2,1-
borazaronaphthalene 4.95 
 
Figure A3D.506. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(2-Thienyl)-2-methyl-2,1-
borazaronaphthalene 4.95 
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Figure A3D.507. IR Spectrum of 3-(2-Thienyl)-2-methyl-2,1-borazaronaphthalene 4.95 
 
 
Figure A3D.508. 
1
H NMR (500 MHz, acetone-d6) of 3-(4-(3,5-Dimethylisoxazolyl))-2-
methyl-2,1-borazaronaphthalene 4.96 
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Figure A3D.509. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(4-(3,5-Dimethylisoxazolyl))-
2-methyl-2,1-borazaronaphthalene 4.96 
 
Figure A3D.510. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(4-(3,5-Dimethylisoxazolyl))-
2-methyl-2,1-borazaronaphthalene 4.96 
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Figure A3D.511. IR Spectrum of 3-(4-(3,5-Dimethylisoxazolyl))-2-methyl-2,1-
borazaronaphthalene 4.96 
 
Figure A3D.512. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Furanyl)-2-methyl-2,1-
borazaronaphthalene 4.97 
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Figure A3D.513. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Furanyl)-2-methyl-2,1-
borazaronaphthalene 4.97 
 
Figure A3D.514. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Furanyl)-2-methyl-2,1-
borazaronaphthalene 4.97 
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Figure A3D.515. IR Spectrum of 3-(3-Furanyl)-2-methyl-2,1-borazaronaphthalene 4.97 
 
 
Figure A3D.516. 
1
H NMR (500 MHz, acetone-d6) of 3-(4-Dibenzofuranyl)-2-methyl-
2,1-borazaronaphthalene 4.98 
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Figure A3D.517. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(4-Dibenzofuranyl)-2-methyl-
2,1-borazaronaphthalene 4.98 
 
Figure A3D.518. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(4-Dibenzofuranyl)-2-
methyl-2,1-borazaronaphthalene 4.98 
1174 
 
 
Figure A3D.519. IR Spectrum of 3-(4-Dibenzofuranyl)-2-methyl-2,1-
borazaronaphthalene 4.98 
 
Figure A3D.520. 
1
H NMR (500 MHz, acetone-d6) of 3-(4-Dibenzothienyl)-2-methyl-2,1-
borazaronaphthalene 4.99 
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Figure A3D.521. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(4-Dibenzothienyl)-2-methyl-
2,1-borazaronaphthalene 4.99 
 
Figure A3D.522. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(4-Dibenzothienyl)-2-methyl-
2,1-borazaronaphthalene 4.99 
1176 
 
 
Figure A3D.523. IR Spectrum of 3-(4-Dibenzothienyl)-2-methyl-2,1-
borazaronaphthalene 4.99 
 
 
Figure A3D.524. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-methyl-1-
benzyl-2,1-borazaronaphthalene 4.100 
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Figure A3D.525. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-methyl-
1-benzyl-2,1-borazaronaphthalene 4.100 
 
 
Figure A3D.526. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-
methyl-1-benzyl-2,1-borazaronaphthalene 4.100 
1178 
 
 
Figure A3D.527. IR Spectrum of 3-(3-Methoxyphenyl)-2-methyl-1-benzyl-2,1-
borazaronaphthalene 4.100 
 
Figure A3D.528. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-methyl-1-
allyl-2,1-borazaronaphthalene 4.101 
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Figure A3D.529. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-methyl-
1-allyl-2,1-borazaronaphthalene 4.101 
 
Figure A3D.530. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-
methyl-1-allyl-2,1-borazaronaphthalene 4.101 
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Figure A3D.531. IR Spectrum of 3-(3-Methoxyphenyl)-2-methyl-1-allyl-2,1-
borazaronaphthalene 4.101 
 
Figure A3D.532. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-(β,β,β-
trifluoroethyl)-2,1-borazaronaphthalene 4.102 
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Figure A3D.533. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-(β,β,β-
trifluoroethyl)-2,1-borazaronaphthalene 4.102 
 
Figure A3D.534. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-(β,β,β-
trifluoroethyl)-2,1-borazaronaphthalene 4.102 
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Figure A3D.535. IR Spectrum of 3-(3-Methoxyphenyl)-2-(β,β,β-trifluoroethyl)-2,1-
borazaronaphthalene 4.102 
 
Figure A3D.536. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-isopropyl-
2,1-borazaronaphthalene 4.103 
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Figure A3D.537. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-
isopropyl-2,1-borazaronaphthalene 4.103 
 
Figure A3D.538. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-
isopropyl-2,1-borazaronaphthalene 4.103 
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Figure A3D.539. IR Spectrum of 3-(3-Methoxyphenyl)-2-isopropyl-2,1-
borazaronaphthalene 4.103 
 
Figure A3D.540. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-
cyclopropyl-2,1-borazaronaphthalene 4.104 
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Figure A3D.541. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-
cyclopropyl-2,1-borazaronaphthalene 4.104 
 
Figure A3D.542. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-
cyclopropyl-2,1-borazaronaphthalene 4.104 
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Figure A3D.543. IR Spectrum of 3-(3-Methoxyphenyl)-2-cyclopropyl-2,1-
borazaronaphthalene 4.104 
 
Figure A3D.544. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-
cyclobutyl-2,1-borazaronaphthalene 4.105 
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Figure A3D.545. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-
cyclobutyl-2,1-borazaronaphthalene 4.105 
 
Figure A3D.546. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-
cyclobutyl-2,1-borazaronaphthalene 4.105 
1188 
 
 
Figure A3D.547. IR Spectrum of 3-(3-Methoxyphenyl)-2-cyclobutyl-2,1-
borazaronaphthalene 4.105 
 
Figure A3D.548. 
1
H NMR (500 MHz, acetone-d6) of 2,3-Diphenyl-2,1-
borazaronaphthalene 4.106 
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Figure A3D.549. 
13
C NMR (125.8 MHz, acetone-d6) of 2,3-Diphenyl-2,1-
borazaronaphthalene 4.106 
 
Figure A3D.550. 
11
B NMR (128.38 MHz, acetone-d6) of 2,3-Diphenyl-2,1-
borazaronaphthalene 4.106 
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Figure A3D.551. IR Spectrum of 2,3-Diphenyl-2,1-borazaronaphthalene 4.106 
 
Figure A3D.552. 
1
H NMR (500 MHz, acetone-d6) of 3-(4-Fluorophenyl)-2-phenyl-2,1-
borazaronaphthalene 4.107 
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Figure A3D.553. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(4-Fluorophenyl)-2-phenyl-
2,1-borazaronaphthalene 4.107 
 
Figure A3D.554. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(4-Fluorophenyl)-2-phenyl-
2,1-borazaronaphthalene 4.107 
1192 
 
 
Figure A3D.555. IR Spectrum of 3-(4-Fluorophenyl)-2-phenyl-2,1-borazaronaphthalene 
4.107 
 
Figure A3D.556. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Nitrophenyl)-2-phenyl-2,1-
borazaronaphthalene 4.108 
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Figure A3D.557. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Nitrophenyl)-2-phenyl-2,1-
borazaronaphthalene 4.108 
 
Figure A3D.558. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Nitrophenyl)-2-phenyl-
2,1-borazaronaphthalene 4.108 
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Figure A3D.559. IR Spectrum of 3-(3-Nitrophenyl)-2-phenyl-2,1-borazaronaphthalene 
4.108 
 
Figure A3D.560. 
1
H NMR (500 MHz, acetone-d6) of 3-(2,3-
Dihydrobenzo[b][1,4]dioxin-6-yl)-2-phenyl-2,1-borazaronaphthalene 4.109 
1195 
 
 
 
Figure A3D.561. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(2,3-
Dihydrobenzo[b][1,4]dioxin-6-yl)-2-phenyl-2,1-borazaronaphthalene 4.109 
 
Figure A3D.562. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(2,3-
Dihydrobenzo[b][1,4]dioxin-6-yl)-2-phenyl-2,1-borazaronaphthalene 4.109 
1196 
 
 
Figure A3D.563. IR Spectrum of 3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-phenyl-2,1-
borazaronaphthalene 4.109 
 
Figure A3D.564. 
1
H NMR (500 MHz, acetone-d6) of 2-Phenyl-3-(3-thienyl)-2,1-
borazaronaphthalene 4.110 
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Figure A3D.565. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Phenyl-3-(3-thienyl)-2,1-
borazaronaphthalene 4.110 
 
Figure A3D.566. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Phenyl-3-(3-thienyl)-2,1-
borazaronaphthalene 4.110 
1198 
 
 
Figure A3D.567. IR Spectrum of 2-Phenyl-3-(3-thienyl)-2,1-borazaronaphthalene 4.110 
 
Figure A3D.568. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Furanyl)-2-phenyl-2,1-
borazaronaphthalene 4.111 
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Figure A3D.569. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Furanyl)-2-phenyl-2,1-
borazaronaphthalene 4.111 
 
Figure A3D.570. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Furanyl)-2-phenyl-2,1-
borazaronaphthalene 4.111 
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Figure A3D.571. IR Spectrum of 3-(3-Furanyl)-2-phenyl-2,1-borazaronaphthalene 4.111 
 
 
Figure A3D.572. 
1
H NMR (500 MHz, acetone-d6) of 3-(4-(3,5-Dimethylisoxazolyl))-2-
phenyl-2,1-borazaronaphthalene 4.112 
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Figure A3D.573. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(4-(3,5-Dimethylisoxazolyl))-
2-phenyl-2,1-borazaronaphthalene 4.112 
 
Figure A3D.574. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(4-(3,5-Dimethylisoxazolyl))-
2-phenyl-2,1-borazaronaphthalene 4.112 
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Figure A3D.575. 
1
H NMR (500 MHz, acetone-d6) of 3-(7-N-Boc-Indolyl)-2-phenyl-2,1-
borazaronaphthalene 4.113 
 
Figure A3D.576. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(7-N-Boc-Indolyl)-2-phenyl-
2,1-borazaronaphthalene 4.113 
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Figure A3D.577. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(7-N-Boc-Indolyl)-2-phenyl-
2,1-borazaronaphthalene 4.113 
 
Figure A3D.578. IR Spectrum of 3-(7-N-Boc-Indolyl)-2-phenyl-2,1-borazaronaphthalene 
4.113 
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Figure A3D.579. 
1
H NMR (500 MHz, acetone-d6) of 2-(4-Fluorophenyl)-3-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.114 
 
Figure A3D.580. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(4-Fluorophenyl)-3-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.114 
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Figure A3D.581. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(4-Fluorophenyl)-3-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.114 
 
Figure A3D.582. IR Spectrum of 2-(4-Fluorophenyl)-3-(3-methoxyphenyl)-2,1-
borazaronaphthalene 4.114 
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Figure A3D.583. 
1
H NMR (500 MHz, acetone-d6) of 2,3-Di(3-Methoxyphenyl)-2,1-
borazaronaphthalene 4.115 
 
Figure A3D.584. 
13
C NMR (125.8 MHz, acetone-d6) of 2,3-Di(3-Methoxyphenyl)-2,1-
borazaronaphthalene 4.115 
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Figure A3D.585. 
11
B NMR (128.38 MHz, acetone-d6) of 2,3-Di(3-Methoxyphenyl)-2,1-
borazaronaphthalene 4.115 
 
Figure A3D.586. IR Spectrum of 2,3-Di(3-Methoxyphenyl)-2,1-borazaronaphthalene 
4.115 
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Figure A3D.587. 
1
H NMR (500 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-(3-
thienyl)-2,1-borazaronaphthalene 4.116 
 
Figure A3D.588. 
13
C NMR (125.8 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-(3-
thienyl)-2,1-borazaronaphthalene 4.116 
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Figure A3D.589. 
11
B NMR (128.38 MHz, acetone-d6) of 3-(3-Methoxyphenyl)-2-(3-
thienyl)-2,1-borazaronaphthalene 4.116 
 
Figure A3D.590. IR Spectrum of 3-(3-Methoxyphenyl)-2-(3-thienyl)-2,1-
borazaronaphthalene 4.116 
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Figure A3D.591. 
1
H NMR (500 MHz, acetone-d6) of 2-(4-Dibenzofuranyl)-3-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.117 
 
Figure A3D.592. 
13
C NMR (125.8 MHz, acetone-d6) of 2-(4-Dibenzofuranyl)-3-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.117 
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Figure A3D.593. 
11
B NMR (128.38 MHz, acetone-d6) of 2-(4-Dibenzofuranyl)-3-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.117 
 
Figure A3D.594. IR Spectrum of 2-(4-Dibenzofuranyl)-3-(3-methoxyphenyl)-2,1-
borazaronaphthalene 4.117 
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Figure A3D.595. 
1
H NMR (500 MHz, acetone-d6) of 3,6-Di(3-Methoxyphenyl)-2-
methyl-2,1-borazaronaphthalene 4.118 
 
Figure A3D.596. 
13
C NMR (125.8 MHz, acetone-d6) of 3,6-Di(3-Methoxyphenyl)-2-
methyl-2,1-borazaronaphthalene 4.118 
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Figure A3D.597. 
11
B NMR (128.38 MHz, acetone-d6) of 3,6-Di(3-Methoxyphenyl)-2-
methyl-2,1-borazaronaphthalene 4.118 
 
Figure A3D.598. IR Spectrum of 3,6-Di(3-Methoxyphenyl)-2-methyl-2,1-
borazaronaphthalene 4.118 
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Figure A3D.599. 
1
H NMR (500 MHz, acetone-d6) of 6-(3-Methoxy-5-methylphenyl)-3-
(3-methoxyphenyl)-2-methyl-2,1-borazaronaphthalene 4.121 
 
Figure A3D.600. 
13
C NMR (125.8 MHz, acetone-d6) of 6-(3-Methoxy-5-methylphenyl)-
3-(3-methoxyphenyl)-2-methyl-2,1-borazaronaphthalene 4.121 
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Figure A3D.601. 
11
B NMR (128.38 MHz, acetone-d6) of 6-(3-Methoxy-5-
methylphenyl)-3-(3-methoxyphenyl)-2-methyl-2,1-borazaronaphthalene 4.121 
 
Figure A3D.602. IR Spectrum of 6-(3-Methoxy-5-methylphenyl)-3-(3-methoxyphenyl)-
2-methyl-2,1-borazaronaphthalene 4.121 
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Figure A3D.603. 
1
H NMR (500 MHz, acetone-d6) of 3-Phenyl-6-(3-thienyl)-2-methyl-
2,1-borazaronaphthalene 4.122 
 
 
Figure A3D.604. 
13
C NMR (125.8 MHz, acetone-d6) of 3-Phenyl-6-(3-thienyl)-2-methyl-
2,1-borazaronaphthalene 4.122 
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Figure A3D.605. 
11
B NMR (128.38 MHz, acetone-d6) of 3-Phenyl-6-(3-thienyl)-2-
methyl-2,1-borazaronaphthalene 4.122 
 
Figure A3D.606. IR Spectrum of 3-Phenyl-6-(3-thienyl)-2-methyl-2,1-
borazaronaphthalene 4.122 
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Figure A3D.607. 
1
H NMR (500 MHz, acetone-d6) of 6-(3-Furanyl)-3-phenyl-2-methyl-
2,1-borazaronaphthalene 4.123 
 
Figure A3D.608. 
13
C NMR (125.8 MHz, acetone-d6) of 6-(3-Furanyl)-3-phenyl-2-
methyl-2,1-borazaronaphthalene 4.123 
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Figure A3D.609. 
11
B NMR (128.38 MHz, acetone-d6) of 6-(3-Furanyl)-3-phenyl-2-
methyl-2,1-borazaronaphthalene 4.123 
 
Figure A3D.610. IR Spectrum of 6-(3-Furanyl)-3-phenyl-2-methyl-2,1-
borazaronaphthalene 4.123 
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Figure A3D.611. 
1
H NMR (500 MHz, acetone-d6) of 2,3,6-Triphenyl-2,1-
borazaronaphthalene 4.166 
 
Figure A3D.612. 
13
C NMR (125.8 MHz, acetone-d6) of 2,3,6-Triphenyl-2,1-
borazaronaphthalene 4.166 
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Figure A3D.613. 
11
B NMR (128.38 MHz, acetone-d6) of 2,3,6-Triphenyl-2,1-
borazaronaphthalene 4.166 
 
Figure A3D.614. IR Spectrum of 2,3,6-Triphenyl-2,1-borazaronaphthalene 4.166 
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Figure A3D.615. 
1
H NMR (500 MHz, acetone-d6) of 2-Methyl-3,6-di(4-
naphthylphenyl)-2,1-borazaronaphthalene 4.167 
 
Figure A3D.616. 
13
C NMR (125.8 MHz, acetone-d6) of 2-Methyl-3,6-di(4-
naphthylphenyl)-2,1-borazaronaphthalene 4.167 
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Figure A3D.617. 
11
B NMR (128.38 MHz, acetone-d6) of 2-Methyl-3,6-di(4-
naphthylphenyl)-2,1-borazaronaphthalene 4.167 
 
Figure A3D.618. IR Spectrum of 2-Methyl-3,6-di(4-naphthylphenyl)-2,1-
borazaronaphthalene 4.167 
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Figure A3D.619. 
1
H NMR (500 MHz, acetone-d6) of 3,6-Di(4-naphthylphenyl)-2-
phenyl-2,1-borazaronaphthalene 4.168 
 
Figure A3D.620. 
13
C NMR (125.8 MHz, acetone-d6) of 3,6-Di(4-naphthylphenyl)-2-
phenyl-2,1-borazaronaphthalene 4.168 
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Figure A3D.621. 
11
B NMR (128.38 MHz, acetone-d6) of 3,6-Di(4-naphthylphenyl)-2-
phenyl-2,1-borazaronaphthalene 4.168 
 
Figure A3D.622. IR Spectrum of 3,6-Di(4-naphthylphenyl)-2-phenyl-2,1-
borazaronaphthalene 4.168 
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Figure A3D.623. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-phenyl-2,1-
borazaronaphthol 4.125 
 
 
Figure A3D.624. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-phenyl-2,1-
borazaronaphthol 4.125 
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Figure A3D.625. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-phenyl-2,1-
borazaronaphthol 4.125 
 
Figure A3D.626. IR Spectrum of 1-Allyl-3-phenyl-2,1-borazaronaphthol 4.125 
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Figure A3D.627. 
1
H NMR (500 MHz, acetone-d6) of 1-Butyl-3-phenyl-2,1-
borazaronaphthol 4.126 
 
 
Figure A3D.628. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Butyl-3-phenyl-2,1-
borazaronaphthol 4.126 
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Figure A3D.629. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Butyl-3-phenyl-2,1-
borazaronaphthol 4.126 
 
 
Figure A3D.630. 
1
H NMR (500 MHz, acetone-d6) of 1-Cyclopropylmethyl-3-phenyl-
2,1-borazaronaphthol 4.127 
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Figure A3D.631. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Cyclopropylmethyl-3-phenyl-
2,1-borazaronaphthol 4.127 
 
 
Figure A3D.632. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Cyclopropylmethyl-3-phenyl-
2,1-borazaronaphthol 4.127 
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Figure A3D.633. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-3-phenyl-2,1-
borazaronaphthol 4.128 
 
 
Figure A3D.634. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-3-phenyl-2,1-
borazaronaphthol 4.128 
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Figure A3D.635. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-3-phenyl-2,1-
borazaronaphthol 4.128 
 
 
Figure A3D.636. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-(4-methylphenyl)-2,1-
borazaronaphthol 4.129-Monomer 
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Figure A3D.637. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-(4-methylphenyl)-2,1-
borazaronaphthol 4.129-Monomer 
 
 
Figure A3D.638. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-(4-methylphenyl)-
2,1-borazaronaphthol 4.129-Monomer 
1234 
 
  
Figure A3D.639. 
1
H NMR (500 MHz, acetone-d6) of Bis-(1-allyl-3-(4-methylphenyl)-
2,1-borazaro-2-naphthyl) Ether 4.129-Anhydride 
 
 
Figure A3D.640. 
13
C NMR (125.8 MHz, acetone-d6) of Bis-(1-allyl-3-(4-methylphenyl)-
2,1-borazaro-2-naphthyl) Ether 4.129-Anhydride 
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Figure A3D.641. 
11
B NMR (128.38 MHz, acetone-d6) of Bis-(1-allyl-3-(4-
methylphenyl)-2,1-borazaro-2-naphthyl) Ether 4.129-Anhydride 
 
 
Figure A3D.642. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-(3-methylphenyl)-2,1-
borazaronaphthol 4.130-Monomer 
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Figure A3D.643. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-(3-methylphenyl)-2,1-
borazaronaphthol 4.130-Monomer 
 
 
Figure A3D.644. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-(3-methylphenyl)-2,1-
borazaronaphthol 4.130-Monomer 
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Figure A3D.645. 
1
H NMR (500 MHz, acetone-d6) of Bis-(1-allyl-3-(3-methylphenyl)-
2,1-borazaro-2-naphthyl) Ether 4.130-Anhydride 
 
 
Figure A3D.646. 
13
C NMR (125.8 MHz, acetone-d6) of Bis-(1-allyl-3-(3-methylphenyl)-
2,1-borazaro-2-naphthyl) Ether 4.130-Anhydride 
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Figure A3D.647. 
11
B NMR (128.38 MHz, acetone-d6) of Bis-(1-allyl-3-(3-
methylphenyl)-2,1-borazaro-2-naphthyl) Ether 4.130-Anhydride 
 
 
Figure A3D.648. 
1
H NMR (500 MHz, acetone-d6) of Bis-(1-allyl-3-(3-chlorophenyl)-
2,1-borazaro-2-naphthyl) Ether 4.131-Anhydride 
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Figure A3D.649. 
13
C NMR (125.8 MHz, acetone-d6) of Bis-(1-allyl-3-(3-chlorophenyl)-
2,1-borazaro-2-naphthyl) Ether 4.131-Anhydride 
 
 
Figure A3D.650. 
11
B NMR (128.38 MHz, acetone-d6) of Bis-(1-allyl-3-(3-
chlorophenyl)-2,1-borazaro-2-naphthyl) Ether 4.131-Anhydride 
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Figure A3D.651. 
1
H NMR (500 MHz, acetone-d6) of Bis-(1-allyl-3-(4-fluorophenyl)-2,1-
borazaro-2-naphthyl) Ether 4.132-Anhydride 
 
 
Figure A3D.652. 
13
C NMR (125.8 MHz, acetone-d6) of Bis-(1-allyl-3-(4-fluorophenyl)-
2,1-borazaro-2-naphthyl) Ether 4.132-Anhydride 
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Figure A3D.653. 
11
B NMR (128.38 MHz, acetone-d6) of Bis-(1-allyl-3-(4-fluorophenyl)-
2,1-borazaro-2-naphthyl) Ether 4.132-Anhydride 
 
 
Figure A3D.654. 
1
H NMR (500 MHz, acetone-d6) of Bis-(1-allyl-3-(4-
trifluoromethylphenyl)-2,1-borazaro-2-naphthyl) Ether 4.133-Anhydride 
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Figure A3D.655. 
13
C NMR (125.8 MHz, acetone-d6) of Bis-(1-allyl-3-(4-
trifluoromethylphenyl)-2,1-borazaro-2-naphthyl) Ether 4.133-Anhydride 
 
 
Figure A3D.656. 
11
B NMR (128.38 MHz, acetone-d6) of Bis-(1-allyl-3-(4-
trifluoromethylphenyl)-2,1-borazaro-2-naphthyl) Ether 4.133-Anhydride 
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Figure A3D.657. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-(2-methoxyphenyl)-2,1-
borazaronaphthol 4.134-Monomer 
 
 
Figure A3D.658. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-(2-methoxyphenyl)-
2,1-borazaronaphthol 4.134-Monomer 
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Figure A3D.659. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-(2-methoxyphenyl)-
2,1-borazaronaphthol 4.134-Monomer 
 
 
Figure A3D.660. 
1
H NMR (500 MHz, acetone-d6) of Bis-(1-allyl-3-(2-naphthyl)-2,1-
borazaro-2-naphthyl) Ether 4.135-Anhydride 
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Figure A3D.661. 
13
C NMR (125.8 MHz, acetone-d6) of Bis-(1-allyl-3-(2-naphthyl)-2,1-
borazaro-2-naphthyl) Ether 4.135-Anhydride 
 
 
Figure A3D.662. 
11
B NMR (128.38 MHz, acetone-d6) of Bis-(1-allyl-3-(2-naphthyl)-2,1-
borazaro-2-naphthyl) Ether 4.135-Anhydride 
1246 
 
 
Figure A3D.663. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-(3-thienyl)-2,1-
borazaronaphthol 4.136-Monomer 
 
 
Figure A3D.664. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-(3-thienyl)-2,1-
borazaronaphthol 4.136-Monomer 
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Figure A3D.665. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-(3-thienyl)-2,1-
borazaronaphthol 4.136-Monomer 
 
 
Figure A3D.666. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-(4-dibenzofuryl)-2,1-
borazaronaphthol 4.137-Monomer 
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Figure A3D.667. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-(4-dibenzofuryl)-2,1-
borazaronaphthol 4.137-Monomer 
 
 
Figure A3D.668. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-(4-dibenzofuryl)-2,1-
borazaronaphthol 4.137-Monomer  
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Figure A3D.669. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-3,6-diphenyl-22,1-
borazaronaphthol 4.142 
 
 
Figure A3D.670. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-3,6-diphenyl-22,1-
borazaronaphthol 4.142 
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Figure A3D.671. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-3,6-diphenyl-22,1-
borazaronaphthol 4.142 
 
Figure A3D.672. IR Spectrum of 1-Benzyl-3,6-diphenyl-2,1-borazaronaphthol 4.126 
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Figure A3D.673. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-2,3-diphenyl-2,1-
borazaronaphthalene 4.124 
 
 
Figure A3D.674. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-2,3-diphenyl-2,1-
borazaronaphthalene 4.124 
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Figure A3D.675. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-2,3-diphenyl-2,1-
borazaronaphthalene 4.124 
 
 
Figure A3D.676. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-(4-fluorophenyl)-2-
phenyl-2,1-borazaronaphthalene 4.138 
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Figure A3D.677. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-(4-fluorophenyl)-2-
phenyl-2,1-borazaronaphthalene 4.138 
 
 
Figure A3D.678. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-(4-fluorophenyl)-2-
phenyl-2,1-borazaronaphthalene 4.138 
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Figure A3D.679. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-(2-methoxyphenyl)-2-
phenyl-2,1-borazaronaphthalene 4.139 
 
 
Figure A3D.680. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-(2-methoxyphenyl)-2-
phenyl-2,1-borazaronaphthalene 4.139 
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Figure A3D.681. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-(2-methoxyphenyl)-
2-phenyl-2,1-borazaronaphthalene 4.139 
  
 
Figure A3D.682. 
1
H NMR (500 MHz, acetone-d6) of 1-Allyl-3-(3-fluoro-3-
methylphenyl)-2-phenyl-2,1-borazaronaphthalene 4.140 
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Figure A3D.683. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Allyl-3-(3-fluoro-3-
methylphenyl)-2-phenyl-2,1-borazaronaphthalene 4.140 
 
 
Figure A3D.684. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Allyl-3-(3-fluoro-3-
methylphenyl)-2-phenyl-2,1-borazaronaphthalene 4.140 
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Figure A3D.685. 
1
H NMR (500 MHz, acetone-d6) of 1-Benzyl-2,3-Diphenyl-2,1-
borazaronaphthalene 4.141 
 
 
Figure A3D.686. 
13
C NMR (125.8 MHz, acetone-d6) of 1-Benzyl-2,3-Diphenyl-2,1-
borazaronaphthalene 4.141 
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Figure A3D.687. 
11
B NMR (128.38 MHz, acetone-d6) of 1-Benzyl-2,3-Diphenyl-2,1-
borazaronaphthalene 4.141 
 
Figure A3D.688. IR Spectrum of 1-Benzyl-2,3-Diphenyl-2,1-borazaronaphthalene 4.141 
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Figure A3D.689. 
1
H NMR (500 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-phenyl-
2,1-borazaronaphthalene 4.127 
 
Figure A3D.690. 
13
C NMR (125.8 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-phenyl-
2,1-borazaronaphthalene 4.127 
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Figure A3D.691. 
11
B NMR (128.38 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-
phenyl-2,1-borazaronaphthalene 4.127 
 
Figure A3D.692. IR Spectrum of 3-(4-(N-Boc)-piperidenyl)-2-phenyl-2,1-
borazaronaphthalene 4.127 
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Figure A3D.693. 
1
H NMR (500 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(4-
fluorophenyl)-2,1-borazaronaphthalene 4.128 
 
Figure A3D.694. 
13
C NMR (125.8 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(4-
fluorophenyl)-2,1-borazaronaphthalene 4.128 
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Figure A3D.695. 
11
B NMR (128.38 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(4-
fluorophenyl)-2,1-borazaronaphthalene 4.128 
 
Figure A3D.696. IR Spectrum of 3-(4-(N-Boc)-piperidenyl)-2-(4-fluorophenyl)-2,1-
borazaronaphthalene 4.128 
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Figure A3D.697. 
1
H NMR (500 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.129 
 
Figure A3D.698. 
13
C NMR (125.8 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.129 
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Figure A3D.699. 
11
B NMR (128.38 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(3-
methoxyphenyl)-2,1-borazaronaphthalene 4.129 
 
Figure A3D.700. IR Spectrum of 3-(4-(N-Boc)-piperidenyl)-2-(3-methoxyphenyl)-2,1-
borazaronaphthalene 4.129 
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Figure A3D.701. 
1
H NMR (500 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(2,4-
difluorophenyl)-2,1-borazaronaphthalene 4.130 
 
Figure A3D.702. 
13
C NMR (125.8 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(2,4-
difluorophenyl)-2,1-borazaronaphthalene 4.130 
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Figure A3D.703. 
11
B NMR (128.38 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(2,4-
difluorophenyl)-2,1-borazaronaphthalene 4.130 
 
Figure A3D.704. IR spectrum of 3-(4-(N-Boc)-piperidenyl)-2-(2,4-difluorophenyl)-2,1-
borazaronaphthalene 4.130 
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Figure A3D.705. 
1
H NMR (500 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(3-
carbomethoxyphenyl)-2,1-borazaronaphthalene 4.131 
 
Figure A3D.706. 
13
C NMR (125.8 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(3-
carbomethoxyphenyl)-2,1-borazaronaphthalene 4.131 
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Figure A3D.707. 
11
B NMR (128.38 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(3-
carbomethoxyphenyl)-2,1-borazaronaphthalene 4.131 
 
Figure A3D.708. IR Spectrum of 3-(4-(N-Boc)-piperidenyl)-2-(3-carbomethoxyphenyl)-
2,1-borazaronaphthalene 4.131 
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Figure A3D.709. 
1
H NMR (500 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(4-
dibenzothienyl)-2,1-borazaronaphthalene 4.132
 
 
Figure A3D.710. 
13
C NMR (125.8 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(4-
dibenzothienyl)-2,1-borazaronaphthalene 4.132 
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Figure A3D.711. 
11
B NMR (128.38 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(4-
dibenzothienyl)-2,1-borazaronaphthalene 4.132
 
 
Figure A3D.712. IR Spectrum of 3-(4-(N-Boc)-piperidenyl)-2-(4-dibenzothienyl)-2,1-
borazaronaphthalene 4.132 
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Figure A3D.713. 
1
H NMR (500 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(4-
dibenzofuranyl)-2,1-borazaronaphthalene 4.133 
 
Figure A3D.714. 
13
C NMR (125.8 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(4-
dibenzofuranyl)-2,1-borazaronaphthalene 4.133 
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Figure A3D.715. 
11
B NMR (128.38 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-(4-
dibenzofuranyl)-2,1-borazaronaphthalene 4.133 
 
Figure A3D.716. IR Spectrum of 3-(4-(N-Boc)-piperidenyl)-2-(4-dibenzofuranyl)-2,1-
borazaronaphthalene 4.133 
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Figure A3D.717. 
1
H NMR (500 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-methyl-
2,1-borazaronaphthalene 4.134 
 
Figure A3D.718. 
13
C NMR (125.8 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-methyl-
2,1-borazaronaphthalene 4.134 
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Figure A3D.719. 
11
B NMR (128.38 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-
methyl-2,1-borazaronaphthalene 4.134 
 
Figure A3D.720. IR Spectrum of 3-(4-(N-Boc)-piperidenyl)-2-methyl-2,1-
borazaronaphthalene 4.134 
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Figure A3D.721. 
1
H NMR (500 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-
cyclobutyl-2,1-borazaronaphthalene 4.135 
 
Figure A3D.722. 
13
C NMR (125.8 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-
cyclobutyl-2,1-borazaronaphthalene 4.135 
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Figure A3D.723. 
11
B NMR (128.38 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-
cyclobutyl-2,1-borazaronaphthalene 4.135 
 
Figure A3D.724. IR Spectrum of 3-(4-(N-Boc)-piperidenyl)-2-cyclobutyl-2,1-
borazaronaphthalene 4.135 
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Figure A3D.725. 
1
H NMR (500 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-
cyclopropyl-2,1-borazaronaphthalene 4.136 
 
Figure A3D.726. 
13
C NMR (125.8 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-
cyclopropyl-2,1-borazaronaphthalene 4.136 
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Figure A3D.727. 
11
B NMR (128.38 MHz, CDCl3) of 3-(4-(N-Boc)-piperidenyl)-2-
cyclopropyl-2,1-borazaronaphthalene 4.136 
 
Figure A3D.728. IR Spectrum of 3-(4-(N-Boc)-piperidenyl)-2-cyclopropyl-2,1-
borazaronaphthalene 4.136 
1279 
 
 
Figure A3D.729. 
1
H NMR (500 MHz, CDCl3) of 1-Benzyl-3-(4-(N-Boc)-piperidenyl)-2-
methyl-2,1-borazaronaphthalene 4.137 
 
Figure A3D.730. 
13
C NMR (125.8 MHz, CDCl3) of 1-Benzyl-3-(4-(N-Boc)-piperidenyl)-
2-methyl-2,1-borazaronaphthalene 4.137 
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Figure A3D.731. 
11
B NMR (128.38 MHz, CDCl3) of 1-Benzyl-3-(4-(N-Boc)-
piperidenyl)-2-methyl-2,1-borazaronaphthalene 4.137 
 
Figure A3D.732. IR Spectrum of 1-Benzyl-3-(4-(N-Boc)-piperidenyl)-2-methyl-2,1-
borazaronaphthalene 4.137 
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Figure A3D.733. 
1
H NMR (500 MHz, CDCl3) of 1-Allyl-3-(4-(N-Boc)-piperidenyl)-2-
methyl-2,1-borazaronaphthalene 4.138 
 
Figure A3D.734. 
13
C NMR (125.8 MHz, CDCl3) of 1-Allyl-3-(4-(N-Boc)-piperidenyl)-2-
methyl-2,1-borazaronaphthalene 4.138 
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Figure A3D.735. 
11
B NMR (128.38 MHz, CDCl3) of 1-Allyl-3-(4-(N-Boc)-piperidenyl)-
2-methyl-2,1-borazaronaphthalene 4.138 
 
Figure A3D.736. IR Spectrum of 1-Allyl-3-(4-(N-Boc)-piperidenyl)-2-methyl-2,1-
borazaronaphthalene 4.138 
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Figure A3D.737. 
1
H NMR (500 MHz, CDCl3) of 1-Allyl-3-(4-(N-Boc)--piperidenyl)-2-
phenyl-2,1-borazaronaphthalene 4.139 
 
Figure A3D.738. 
13
C NMR (125.8 MHz, CDCl3) of 1-Allyl-3-(4-(N-Boc)-piperidenyl)-2-
phenyl-2,1-borazaronaphthalene 4.139 
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Figure A3D.739. 
11
B NMR (128.38 MHz, CDCl3) of 1-Allyl-3-(4-(N-Boc)-piperidenyl)-
2-phenyl-2,1-borazaronaphthalene 4.139 
 
Figure A3D.740. IR Spectrum of 1-Allyl-3-(4-(N-Boc)-piperidenyl)-2-phenyl-2,1-
borazaronaphthalene 4.139 
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Figure A3D.741. 
1
H NMR (500 MHz, CDCl3) of 3-(3-(N-Boc)-azetindyl)-2-phenyl-2,1-
borazaronaphthalene 4.140 
 
Figure A3D.742. 
13
C NMR (125.8 MHz, CDCl3) of 3-(3-(N-Boc)-azetidinyl)-2-phenyl-
2,1-borazaronaphthalene 4.140 
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Figure A3D.743. 
11
B NMR (128.38 MHz, CDCl3) of 3-(3-(N-Boc)-azetidinyl)-2-phenyl-
2,1-borazaronaphthalene 4.140
 
Figure A3D.744. IR Spectrum of 3-(3-(N-Boc)-azetidinyl)-2-phenyl-2,1-
borazaronaphthalene 4.140 
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Figure A3D.745. 
1
H NMR (500 MHz, CDCl3) of 2-Phenyl-3-(4-tetrahydro-2H-pyranyl)-
2,1-borazaronaphthalene 4.141 
 
Figure A3D.746. 
13
C NMR (125.8 MHz, CDCl3) of 2-Phenyl-3-(4-tetrahydro-2H-
pyranyl)-2,1-borazaronaphthalene 4.141 
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Figure A3D.747. 
11
B NMR (128.38 MHz, CDCl3) of 2-Phenyl-3-(4-tetrahydro-2H-
pyranyl)-2,1-borazaronaphthalene 4.141 
 
Figure A3D.748. IR Spectrum of 2-Phenyl-3-(4-tetrahydro-2H-pyranyl)-2,1-
borazaronaphthalene 4.141 
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Figure A3D.749. 
1
H NMR (500 MHz, CDCl3) of 2-Phenyl-3-(3-tetrahydrofuranyl)-2,1-
borazaronaphthalene 4.142 
 
Figure A3D.750. 
13
C NMR (125.8 MHz, CDCl3) of 2-Phenyl-3-(3-tetrahydrofuranyl)-
2,1-borazaronaphthalene 4.142 
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Figure A3D.751. 
11
B NMR (128.38 MHz, CDCl3) of 2-Phenyl-3-(3-tetrahydrofuranyl)-
2,1-borazaronaphthalene 4.142 
 
Figure A3D.752. IR Spectrum of 2-Phenyl-3-(3-tetrahydrofuranyl)-2,1-
borazaronaphthalene 4.142 
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Figure A3D.753. 
1
H NMR (500 MHz, CDCl3) of 3-(3-Oxetanyl)-2-phenyl-2,1-
borazaronaphthalene 4.143 
 
Figure A3D.754. 
13
C NMR (125.8 MHz, CDCl3) of 3-(3-Oxetanyl)-2-phenyl-2,1-
borazaronaphthalene 4.143 
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Figure A3D.755. 
11
B NMR (128.38 MHz, CDCl3) of 3-(3-Oxetanyl)-2-phenyl-2,1-
borazaronaphthalene 4.143 
 
Figure A3D.756. IR Spectrum of 3-(3-Oxetanyl)-2-phenyl-2,1-borazaronaphthalene 
4.143 
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Figure A3D.757. 
1
H NMR (500 MHz, CDCl3) of 3-Cyclohexyl-2-phenyl-2,1-
borazaronaphthalene 4.144 
 
Figure A3D.758. 
13
C NMR (125.8 MHz, CDCl3) of 3-Cyclohexyl-2-phenyl-2,1-
borazaronaphthalene 4.144 
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Figure A3D.759. 
11
B NMR (128.38 MHz, CDCl3) of 3-Cyclohexyl-2-phenyl-2,1-
borazaronaphthalene 4.144 
 
Figure A3D.760. IR Spectrum of 3-Cyclohexyl-2-phenyl-2,1-borazaronaphthalene 4.144 
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Figure A3D.761. 
1
H NMR (500 MHz, CDCl3) of 3-Butyl-2-phenyl-2,1-
borazaronaphthalene 4.145 
 
Figure A3D.762. 
13
C NMR (125.8 MHz, CDCl3) of 3-Butyl-2-phenyl-2,1-
borazaronaphthalene 4.145 
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Figure A3D.763. 
11
B NMR (128.38 MHz, CDCl3) of 3-Butyl-2-phenyl-2,1-
borazaronaphthalene 4.145 
 
Figure A3D.764. IR Spectrum of 3-Butyl-2-phenyl-2,1-borazaronaphthalene 4.145 
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Figure A3D.765. 
1
H NMR (500 MHz, CDCl3) of 4-(2-Phenyl-2,1-
borazaronaphthalene)butyl acetate 4.146 
 
Figure A3D.766. 
13
C NMR (125.8 MHz, CDCl3) of 4-(2-Phenyl-2,1-
borazaronaphthalene)butyl acetate 4.146 
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Figure A3D.767. 
11
B NMR (128.38 MHz, CDCl3) of 4-(2-Phenyl-2,1-
borazaronaphthalene)butyl acetate 4.146 
 
Figure A3D.768. IR Spectrum of 4-(2-Phenyl-2,1-borazaronaphthalene)butyl acetate 
4.146 
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Figure A3D.769. 
1
H NMR (500 MHz, CDCl3) of 6-(4-(N-Boc)-Piperidinyl)-2-methyl-3-
phenyl-2,1-borazaronaphthalene 4.147 
 
Figure A3D770. 
13
C NMR (125.8 MHz, CDCl3) of 6-(4-(N-Boc)-Piperidinyl)-2-methyl-
3-phenyl-2,1-borazaronaphthalene 4.147 
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Figure A3D.771. 
11
B NMR (128.38 MHz, CDCl3) of 6-(4-(N-Boc)-Piperidinyl)-2-
methyl-3-phenyl-2,1-borazaronaphthalene 4.147 
 
Figure A3D.772. IR Spectrum of 6-(4-(N-Boc)-Piperidinyl)-2-methyl-3-phenyl-2,1-
borazaronaphthalene 4.147 
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X-Ray Structure of Bis-(1-benzyl-3-phenyl-2,1-borazaro-2-naphthyl) Ether: 
Compound 4.128-Anhydride, C42B2H34N2O, crystallizes in the monoclinic space group 
P21/c (systematic absences 0k0: k=odd and h0l: l=odd) with a=9.7741(3)Å, 
b=21.4114(6)Å, c=16.2306(4)Å, b=107.6160(10)°, V=3237.41(16)Å3, Z=4, and 
dcalc=1.240 g/cm3 . X-ray intensity data were collected on a Bruker APEXII CCD area 
detector employing graphite-monochromated Mo-Ka radiation (l=0.71073 Å) at a 
temperature of 100(1)K. Preliminary indexing was performed from a series of thirty-six 
0.5° rotation frames with exposures of 10 seconds. A total of 1597 frames were collected 
with a crystal to detector distance of 37.5 mm, rotation widths of 0.5° and exposures of 5 
seconds: 
scan type     frames 
 19.50 59.55 348.71 -26.26 739 
 -23.00 333.49 158.99 -70.01 69 
 17.00 321.50 184.44 82.07 116 
 -10.50 300.13 227.42 39.97 92 
 -15.50 242.98 18.69 41.79 212 
 -23.00 334.21 56.09 73.66 369 
 Rotation frames were integrated using SAINT,
1
 producing a listing of unaveraged 
F2 and s(F2) values which were then passed to the SHELXTL
2
 program package for 
further processing and structure solution. A total of 49932 reflections were measured 
over the ranges 1.62 £ q £ 27.53°, -11 £ h £ 12, -27 £ k £ 27, -21 £ l £ 21 yielding 7448 
unique reflections (Rint = 0.0286). The intensity data were corrected for Lorentz and 
polarization effects and for absorption using SADABS
3
 (minimum and maximum 
transmission 0.6940, 0.7456). 
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The structure was solved by direct methods (SHELXS-97).
4
 Refinement was by 
full-matrix least squares based on F2 using SHELXL-97. All reflections were used during 
refinement. The weighting scheme used was w=1/[s2(Fo2 )+ (0.0496P)2 + 1.4849P] 
where P = (Fo 2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically and 
hydrogen atoms were refined using a riding model.  Refinement converged to R1=0.0414 
and wR2=0.1007 for 6034 observed reflections for which F > 4s(F) and R1=0.0548 and 
wR2=0.1090 and GOF =1.018 for all 7448 unique, non-zero reflections and 425 
variables.
5
 The maximum D/s in the final cycle of least squares was 0.001 and the two 
most prominent peaks in the final difference Fourier were +0.355 and -0.213 e/Å3. 
Table 1. lists cell information, data collection parameters, and refinement data. 
Final positional and equivalent isotropic thermal parameters are given in Tables 2. and 3.  
Anisotropic thermal parameters are in Table 4.  Tables 5. and 6. list bond distances and 
bond angles.  Figure 1. is an ORTEP representation of the molecule with 50% probability 
thermal ellipsoids displayed. 
 
Table A3C.1. Summary of Structure Determination of Compound 4.128-Anhydride 
Empirical formula  C42B2H34N2O 
Formula weight  604.33 
Temperature  100(1) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P21/c 
Cell constants: 
a  9.7741(3) Å 
b  21.4114(6) Å 
c  16.2306(4) Å 
 107.6160(10)° 
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Volume 3237.41(16) Å3 
Z 4 
Density (calculated) 1.240 Mg/m3 
Absorption coefficient 0.073 mm-1 
F(000) 1272 
Crystal size 0.36 x 0.25 x 0.08 mm3 
Theta range for data collection 1.62 to 27.53° 
Index ranges - - -  
Reflections collected 49932 
Independent reflections 7448 [R(int) = 0.0286] 
Completeness to theta = 27.53° 99.9 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.6940 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7448 / 0 / 425 
Goodness-of-fit on F2 1.018 
Final R indices [I>2sigma(I)] R1 = 0.0414, wR2 = 0.1007 
R indices (all data) R1 = 0.0548, wR2 = 0.1090 
Largest diff. peak and hole 0.355 and -0.213 e.Å-3 
 
Table A3C.2. Refined Positional Parameters for Compound 4.128-Anhydride 
  Atom x y z Ueq, Å
2
 
C1 0.25797(13) 0.16547(6) 0.49440(8) 0.0179(2) 
C2 0.13614(14) 0.15954(6) 0.42192(9) 0.0238(3) 
C3 0.02802(14) 0.11828(6) 0.42320(9) 0.0257(3) 
C4 0.03539(14) 0.08207(6) 0.49536(9) 0.0236(3) 
C5 0.15417(13) 0.08727(6) 0.56703(8) 0.0204(3) 
C6 0.26657(13) 0.12874(6) 0.56869(8) 0.0173(2) 
C7 0.38395(13) 0.13658(6) 0.64683(8) 0.0179(2) 
C8 0.48928(13) 0.17971(6) 0.65561(8) 0.0174(2) 
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C9 0.36664(14) 0.24248(6) 0.41940(8) 0.0201(3) 
C10 0.29599(13) 0.30587(6) 0.41490(8) 0.0193(3) 
C11 0.21417(14) 0.32235(6) 0.46809(9) 0.0241(3) 
C12 0.15286(16) 0.38116(7) 0.46240(9) 0.0291(3) 
C13 0.17183(16) 0.42417(7) 0.40323(10) 0.0312(3) 
C14 0.25375(17) 0.40838(7) 0.35006(10) 0.0329(3) 
C15 0.31591(15) 0.34976(7) 0.35622(9) 0.0279(3) 
C16 0.60224(13) 0.18925(6) 0.74089(8) 0.0182(2) 
C17 0.67300(14) 0.13942(7) 0.78912(8) 0.0240(3) 
C18 0.77711(15) 0.14924(8) 0.86818(9) 0.0301(3) 
C19 0.81007(15) 0.20944(8) 0.89942(9) 0.0314(3) 
C20 0.73805(15) 0.25958(7) 0.85167(9) 0.0289(3) 
C21 0.63501(14) 0.24986(7) 0.77229(9) 0.0241(3) 
C22 0.94180(13) 0.33634(6) 0.63862(8) 0.0184(2) 
C23 0.99880(14) 0.39701(6) 0.65469(9) 0.0228(3) 
C24 1.14563(15) 0.40635(7) 0.68553(9) 0.0262(3) 
C25 1.24080(14) 0.35625(7) 0.70153(9) 0.0258(3) 
C26 1.18670(14) 0.29649(6) 0.68799(8) 0.0226(3) 
C27 1.03758(13) 0.28510(6) 0.65753(8) 0.0191(2) 
C28 0.98502(13) 0.22199(6) 0.64489(8) 0.0191(2) 
C29 0.84356(13) 0.20733(6) 0.61695(8) 0.0177(2) 
C30 0.69670(14) 0.37710(6) 0.57056(8) 0.0196(3) 
C31 0.63715(13) 0.41069(6) 0.63475(8) 0.0184(2) 
C32 0.70111(14) 0.40658(6) 0.72315(9) 0.0239(3) 
C33 0.64518(15) 0.43910(7) 0.77986(9) 0.0259(3) 
C34 0.52491(15) 0.47621(6) 0.74850(9) 0.0255(3) 
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C35 0.46014(15) 0.48052(7) 0.65991(10) 0.0275(3) 
C36 0.51540(14) 0.44762(6) 0.60323(9) 0.0235(3) 
C37 0.80055(13) 0.14042(6) 0.60446(8) 0.0188(2) 
C38 0.87350(15) 0.09543(6) 0.66421(9) 0.0241(3) 
C39 0.83911(16) 0.03252(6) 0.65093(10) 0.0293(3) 
C40 0.72946(16) 0.01345(7) 0.57908(10) 0.0307(3) 
C41 0.65542(15) 0.05737(7) 0.52025(10) 0.0273(3) 
C42 0.69109(14) 0.12027(6) 0.53241(9) 0.0217(3) 
N1 0.37028(11) 0.20648(5) 0.49701(7) 0.0178(2) 
N2 0.79485(11) 0.32486(5) 0.60550(7) 0.0177(2) 
O1 0.59016(9) 0.25846(4) 0.56795(6) 0.01935(19) 
B1 0.48767(15) 0.21616(7) 0.57360(9) 0.0175(3) 
B2 0.73710(15) 0.26257(7) 0.59746(8) 0.0172(3) 
Ueq=
1
/3[U11(aa*)
2
+U22(bb*)
2
+U33(cc*)
2
+2U12aa*bb*cos g+2U13aa*cc*cos b+2U23bb*cc*cosa] 
 
Table A3C.3. Positional Parameters for Hydrogens in Compound 4.128-Anhydride 
  Atom x y z Uiso, Å
2
 
H2 0.1281 0.1835 0.3729 0.032 
H3 -0.0517 0.1147 0.3745 0.034 
H4 -0.0386 0.0548 0.4953 0.031 
H5 0.1602 0.0628 0.6154 0.027 
H7 0.3878 0.1108 0.6936 0.024 
H9a 0.3154 0.2185 0.3687 0.027 
H9b 0.4642 0.2483 0.4177 0.027 
H11 0.2004 0.2937 0.5079 0.032 
H12 0.0987 0.3918 0.4986 0.039 
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H13 0.1298 0.4635 0.3992 0.041 
H14 0.2670 0.4371 0.3102 0.044 
H15 0.3716 0.3396 0.3208 0.037 
H17 0.6510 0.0989 0.7686 0.032 
H18 0.8247 0.1154 0.9001 0.040 
H19 0.8801 0.2161 0.9521 0.042 
H20 0.7587 0.3000 0.8728 0.038 
H21 0.5879 0.2837 0.7401 0.032 
H23 0.9372 0.4312 0.6445 0.030 
H24 1.1813 0.4468 0.6958 0.035 
H25 1.3394 0.3630 0.7210 0.034 
H26 1.2498 0.2629 0.6992 0.030 
H28 1.0515 0.1896 0.6565 0.025 
H30a 0.6167 0.3613 0.5239 0.026 
H30b 0.7470 0.4074 0.5459 0.026 
H32 0.7823 0.3818 0.7449 0.032 
H33 0.6889 0.4359 0.8392 0.034 
H34 0.4877 0.4981 0.7864 0.034 
H35 0.3794 0.5055 0.6383 0.037 
H36 0.4707 0.4503 0.5440 0.031 
H38 0.9458 0.1078 0.7134 0.032 
H39 0.8900 0.0030 0.6905 0.039 
H40 0.7059 -0.0286 0.5706 0.041 
H41 0.5812 0.0448 0.4722 0.036 
H42 0.6411 0.1493 0.4918 0.029 
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Table A3C.4. Refined Thermal Parameters (U's) for Compound 4.128-Anhydride 
  Atom U11 U22 U33 U23 U13 U12 
C1 0.0164(6) 0.0181(6) 0.0201(6) -0.0009(5) 0.0069(5) 0.0015(5) 
C2 0.0220(6) 0.0248(7) 0.0225(6) 0.0026(5) 0.0035(5) 0.0010(5) 
C3 0.0179(6) 0.0261(7) 0.0286(7) -0.0029(5) 0.0004(5) 0.0003(5) 
C4 0.0179(6) 0.0198(6) 0.0337(7) -0.0043(5) 0.0089(5) -0.0013(5) 
C5 0.0212(6) 0.0179(6) 0.0247(6) -0.0016(5) 0.0108(5) -0.0001(5) 
C6 0.0166(6) 0.0169(6) 0.0200(6) -0.0026(5) 0.0078(5) 0.0012(4) 
C7 0.0209(6) 0.0180(6) 0.0169(6) 0.0007(5) 0.0089(5) 0.0018(5) 
C8 0.0172(6) 0.0192(6) 0.0170(6) -0.0007(5) 0.0070(5) 0.0014(5) 
C9 0.0203(6) 0.0258(7) 0.0154(6) 0.0022(5) 0.0071(5) -0.0003(5) 
C10 0.0168(6) 0.0234(6) 0.0165(6) 0.0016(5) 0.0030(5) -0.0031(5) 
C11 0.0271(7) 0.0257(7) 0.0219(6) 0.0054(5) 0.0109(5) 0.0020(5) 
C12 0.0301(7) 0.0314(8) 0.0272(7) 0.0010(6) 0.0108(6) 0.0055(6) 
C13 0.0345(8) 0.0228(7) 0.0328(8) 0.0031(6) 0.0051(6) 0.0037(6) 
C14 0.0401(8) 0.0281(8) 0.0314(8) 0.0104(6) 0.0121(6) -0.0024(6) 
C15 0.0306(7) 0.0312(8) 0.0257(7) 0.0070(6) 0.0140(6) -0.0006(6) 
C16 0.0177(6) 0.0231(6) 0.0180(6) -0.0019(5) 0.0117(5) -0.0040(5) 
C17 0.0228(6) 0.0290(7) 0.0212(6) 0.0015(5) 0.0083(5) -0.0038(5) 
C18 0.0257(7) 0.0424(9) 0.0206(6) 0.0083(6) 0.0048(5) -0.0001(6) 
C19 0.0247(7) 0.0521(10) 0.0167(6) -0.0021(6) 0.0055(5) -0.0092(7) 
C20 0.0284(7) 0.0360(8) 0.0250(7) -0.0090(6) 0.0122(6) -0.0117(6) 
C21 0.0240(6) 0.0274(7) 0.0228(6) -0.0014(5) 0.0100(5) -0.0027(5) 
C22 0.0209(6) 0.0203(6) 0.0168(6) -0.0021(5) 0.0099(5) -0.0025(5) 
C23 0.0262(7) 0.0193(6) 0.0261(7) -0.0024(5) 0.0129(5) -0.0012(5) 
C24 0.0296(7) 0.0228(7) 0.0300(7) -0.0075(5) 0.0148(6) -0.0099(6) 
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C25 0.0204(6) 0.0326(8) 0.0262(7) -0.0070(6) 0.0096(5) -0.0082(5) 
C26 0.0211(6) 0.0263(7) 0.0217(6) -0.0024(5) 0.0086(5) -0.0007(5) 
C27 0.0218(6) 0.0208(6) 0.0166(6) -0.0025(5) 0.0086(5) -0.0021(5) 
C28 0.0205(6) 0.0192(6) 0.0192(6) -0.0002(5) 0.0081(5) 0.0026(5) 
C29 0.0211(6) 0.0177(6) 0.0160(6) -0.0001(4) 0.0082(5) -0.0006(5) 
C30 0.0231(6) 0.0173(6) 0.0189(6) 0.0017(5) 0.0072(5) 0.0015(5) 
C31 0.0183(6) 0.0146(6) 0.0230(6) -0.0010(5) 0.0073(5) -0.0026(5) 
C32 0.0215(6) 0.0254(7) 0.0246(7) -0.0012(5) 0.0068(5) 0.0038(5) 
C33 0.0269(7) 0.0279(7) 0.0242(7) -0.0039(5) 0.0097(5) -0.0003(6) 
C34 0.0273(7) 0.0210(7) 0.0341(7) -0.0053(5) 0.0179(6) -0.0020(5) 
C35 0.0228(6) 0.0238(7) 0.0383(8) 0.0038(6) 0.0130(6) 0.0048(5) 
C36 0.0216(6) 0.0238(7) 0.0254(7) 0.0032(5) 0.0074(5) 0.0002(5) 
C37 0.0207(6) 0.0173(6) 0.0229(6) -0.0004(5) 0.0133(5) 0.0003(5) 
C38 0.0263(7) 0.0246(7) 0.0247(6) 0.0016(5) 0.0129(5) 0.0006(5) 
C39 0.0385(8) 0.0202(7) 0.0372(8) 0.0070(6) 0.0232(7) 0.0037(6) 
C40 0.0374(8) 0.0182(7) 0.0465(9) -0.0049(6) 0.0278(7) -0.0061(6) 
C41 0.0262(7) 0.0264(7) 0.0348(7) -0.0102(6) 0.0173(6) -0.0069(6) 
C42 0.0214(6) 0.0220(6) 0.0257(6) -0.0024(5) 0.0131(5) -0.0014(5) 
N1 0.0180(5) 0.0191(5) 0.0173(5) 0.0028(4) 0.0070(4) 0.0013(4) 
N2 0.0186(5) 0.0173(5) 0.0183(5) 0.0000(4) 0.0075(4) 0.0014(4) 
O1 0.0174(4) 0.0207(4) 0.0206(4) 0.0023(3) 0.0066(3) -0.0007(3) 
B1 0.0166(6) 0.0174(6) 0.0204(7) 0.0000(5) 0.0086(5) 0.0019(5) 
B2 0.0191(6) 0.0203(7) 0.0134(6) 0.0000(5) 0.0069(5) -0.0005(5) 
The form of the anisotropic displacement parameter is: 
exp[-2p
2
(a*
2
U11h
2
+b*
2
U22k
2
+c*
2
U33l
2
+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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  Table A3C.5. Bond Distances in Compound 4.128-Anhydride, Å 
C1-N1  1.3964(16) C1-C2  1.4036(18) C1-C6  1.4204(17) 
C2-C3  1.3824(19) C3-C4  1.388(2) C4-C5  1.3769(18) 
C5-C6  1.4065(17) C6-C7  1.4395(17) C7-C8  1.3579(17) 
C8-C16  1.5005(17) C8-B1  1.5391(18) C9-N1  1.4679(15) 
C9-C10  1.5145(18) C10-C11  1.3882(18) C10-C15  1.3930(18) 
C11-C12  1.386(2) C12-C13  1.383(2) C13-C14  1.385(2) 
C14-C15  1.385(2) C16-C17  1.3791(19) C16-C21  1.3956(18) 
C17-C18  1.3914(19) C18-C19  1.387(2) C19-C20  1.385(2) 
C20-C21  1.3901(19) C22-N2  1.3947(16) C22-C23  1.4065(18) 
C22-C27  1.4143(18) C23-C24  1.3840(19) C24-C25  1.392(2) 
C25-C26  1.3764(19) C26-C27  1.4113(18) C27-C28  1.4382(18) 
C28-C29  1.3551(17) C29-C37  1.4896(17) C29-B2  1.5435(18) 
C30-N2  1.4710(16) C30-C31  1.5194(17) C31-C32  1.3835(18) 
C31-C36  1.3908(18) C32-C33  1.3913(18) C33-C34  1.382(2) 
C34-C35  1.388(2) C35-C36  1.3911(19) C37-C42  1.3931(18) 
C37-C38  1.3993(18) C38-C39  1.3894(19) C39-C40  1.385(2) 
C40-C41  1.379(2) C41-C42  1.3901(19) N1-B1  1.4289(17) 
N2-B2  1.4386(17) O1-B2  1.3724(16) O1-B1  1.3740(16) 
 
Table A3C.6. Bond Angles in Compound 4d-Anhydride, ° 
N1-C1-C2 122.82(11) N1-C1-C6 118.58(11) C2-C1-C6 118.60(11) 
C3-C2-C1 120.24(12) C2-C3-C4 121.66(12) C5-C4-C3 118.87(12) 
C4-C5-C6 121.42(12) C5-C6-C1 119.21(11) C5-C6-C7 120.01(11) 
C1-C6-C7 120.66(11) C8-C7-C6 123.27(11) C7-C8-C16 120.82(11) 
C7-C8-B1 116.43(11) C16-C8-B1 122.73(11) N1-C9-C10 113.84(10) 
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C11-C10-C15 118.66(12) C11-C10-C9 122.54(11) C15-C10-C9 118.79(11) 
C12-C11-C10 120.57(12) C13-C12-C11 120.35(13) C12-C13-C14 119.62(14) 
C15-C14-C13 120.00(13) C14-C15-C10 120.78(13) C17-C16-C21 119.46(12) 
C17-C16-C8 121.39(11) C21-C16-C8 119.14(12) C16-C17-C18 120.52(13) 
C19-C18-C17 120.12(14) C20-C19-C18 119.56(13) C19-C20-C21 120.37(14) 
C20-C21-C16 119.97(13) N2-C22-C23 122.56(12) N2-C22-C27 118.94(11) 
C23-C22-C27 118.50(12) C24-C23-C22 120.64(12) C23-C24-C25 121.17(12) 
C26-C25-C24 118.94(12) C25-C26-C27 121.52(13) C26-C27-C22 119.18(12) 
C26-C27-C28 119.92(12) C22-C27-C28 120.89(11) C29-C28-C27 123.34(12) 
C28-C29-C37 119.05(11) C28-C29-B2 116.58(11) C37-C29-B2 124.34(11) 
N2-C30-C31 115.85(10) C32-C31-C36 119.04(12) C32-C31-C30 122.29(11) 
C36-C31-C30 118.66(11) C31-C32-C33 120.63(12) C34-C33-C32 120.32(13) 
C33-C34-C35 119.36(12) C34-C35-C36 120.32(13) C31-C36-C35 120.33(13) 
C42-C37-C38 117.99(12) C42-C37-C29 121.70(11) C38-C37-C29 120.27(12) 
C39-C38-C37 120.75(13) C40-C39-C38 120.37(13) C41-C40-C39 119.48(13) 
C40-C41-C42 120.39(14) C41-C42-C37 121.00(13) C1-N1-B1 122.31(10) 
C1-N1-C9 119.31(10) B1-N1-C9 118.35(10) C22-N2-B2 121.89(11) 
C22-N2-C30 119.34(10) B2-N2-C30 118.54(10) B2-O1-B1 136.56(11) 
O1-B1-N1 116.57(11) O1-B1-C8 125.12(11) N1-B1-C8 118.31(11) 
O1-B2-N2 115.56(11) O1-B2-C29 126.28(12) N2-B2-C29 118.04(11) 
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X-ray Structure Determination of 4.142. C27BH22NO, crystallizes in the monoclinic 
space group C2/c (systematic absences hkl: h+k=odd and h0l: l=odd) with 
a=29.4000(16)Å, b=5.6484(3)Å, c=23.9962(15)Å, b=97.043(2)°, V=3954.8(4)Å3, Z=8, 
and dcalc=1.301 g/cm3 . X-ray intensity data were collected on a Bruker APEXII CCD 
area detector employing graphite-monochromated Mo-Ka radiation (l=0.71073 Å) at a 
temperature of 100(1)K. Preliminary indexing was performed from a series of thirty-six 
0.5° rotation frames with exposures of 10 seconds. A total of 2409 frames were collected 
with a crystal to detector distance of 37.5 mm, rotation widths of 0.5° and exposures of 5 
seconds: 
scan type 2q w f c frames 
f -15.50 258.48 8.28 19.46 739 
w -15.50 340.80 341.11 -63.64 99 
f -8.00 320.02 251.48 55.93 103 
f -20.50 342.55 336.77 -73.06 209 
w -15.50 242.98 18.69 41.79 212 
f 19.50 59.55 12.98 -26.26 459 
f 8.00 349.95 117.65 19.46 508 
w -10.50 306.95 272.07 99.72 80 
 
Rotation frames were integrated using SAINT
1
, producing a listing of unaveraged 
F2 and s(F2) values which were then passed to the SHELXTL
2
 program package for 
further processing and structure solution. A total of 43446 reflections were measured 
over the ranges 2.07 £ q £ 25.39°, -34 £ h £ 35, -6 £ k £ 6, -28 £ l £ 28 yielding 3631 
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unique reflections (Rint = 0.0269). The intensity data were corrected for Lorentz and 
polarization effects and for absorption using SADABS
3
 (minimum and maximum 
transmission 0.7107, 0.7452). 
The structure was solved by direct methods (SHELXS-97).
4
 Refinement was by 
full-matrix least squares based on F2 using SHELXL-97. All reflections were used during 
refinement. The weighting scheme used was w=1/[s2(Fo2 )+ (0.0470P)2 + 3.7963P] 
where P = (Fo 2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically and 
hydrogen atoms were refined using a riding model.  Refinement converged to R1=0.0360 
and wR2=0.0925 for 3168 observed reflections for which F > 4s(F) and R1=0.0426 and 
wR2=0.0981 and GOF =1.040 for all 3631 unique, non-zero reflections and 273 
variables.
5
 The maximum D/s in the final cycle of least squares was 0.001 and the two 
most prominent peaks in the final difference Fourier were +0.516 and -0.248 e/Å3. 
Table A3C.7. Summary of Structure Determination of 4.126 
Formula weight 387.27 
Temperature 100(1) K 
Wavelength 0.71073 Å 
Crystal system monoclinic 
Space group C2/c 
Cell constants: 
 a 29.4000(16) Å 
b 5.6484(3) Å 
c 23.9962(15) Å 
b 97.043(2)° 
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Volume 3954.8(4) Å3 
Z 8 
Density (calculated) 1.301 Mg/m3 
Absorption coefficient 0.077 mm-1 
F(000) 1632 
Crystal size 0.46 x 0.15 x 0.10 mm3 
Theta range for data collection 2.07 to 25.39° 
Index ranges -34 £ h £ 35, -6 £ k £ 6, -28 £ l £ 28 
Reflections collected 43446 
Independent reflections 3631 [R(int) = 0.0269] 
Completeness to theta = 25.39° 99.90% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.7107 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3631 / 0 / 273 
Goodness-of-fit on F2 1.04 
Final R indices [I>2sigma(I)] R1 = 0.0360, wR2 = 0.0925 
R indices (all data) R1 = 0.0426, wR2 = 0.0981 
Largest diff. peak and hole 0.516 and -0.248 e.Å-3 
 
Table A3C.8. Refined Positional Parameters for 4.126 
Atom x y z Ueq, Å
2
 
C1 0.60187(4) 0.1613(2) 0.15601(5) 0.0186(3) 
C2 0.63780(4) -0.0026(2) 0.16401(5) 0.0204(3) 
C3 0.67056(4) 0.0100(2) 0.21018(5) 0.0197(3) 
C4 0.66948(4) 0.1849(2) 0.25166(5) 0.0174(3) 
C5 0.63258(4) 0.3404(2) 0.24475(5) 0.0185(3) 
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C6 0.59881(4) 0.3333(2) 0.19830(5) 0.0184(3) 
C7 0.56035(4) 0.4933(2) 0.19461(5) 0.0201(3) 
C8 0.52739(4) 0.5004(2) 0.14994(5) 0.0208(3) 
C9 0.57332(4) -0.0177(2) 0.06495(5) 0.0218(3) 
C10 0.61308(4) 0.0099(2) 0.03090(5) 0.0199(3) 
C11 0.62162(5) -0.1721(2) -0.00558(5) 0.0226(3) 
C12 0.65774(5) -0.1579(3) -0.03728(5) 0.0253(3) 
C13 0.68624(5) 0.0383(3) -0.03278(6) 0.0266(3) 
C14 0.67804(5) 0.2208(3) 0.00300(6) 0.0247(3) 
C15 0.64145(4) 0.2068(2) 0.03460(5) 0.0217(3) 
C16 0.70581(4) 0.1997(2) 0.30058(5) 0.0182(3) 
C17 0.73785(4) 0.0187(2) 0.31265(5) 0.0215(3) 
C18 0.77171(5) 0.0329(2) 0.35822(6) 0.0234(3) 
C19 0.77426(4) 0.2274(2) 0.39343(5) 0.0226(3) 
C20 0.74311(4) 0.4102(3) 0.38185(5) 0.0230(3) 
C21 0.70968(4) 0.3976(2) 0.33588(5) 0.0208(3) 
C22 0.48696(4) 0.6575(2) 0.15049(5) 0.0207(3) 
C23 0.49035(4) 0.8766(2) 0.17771(5) 0.0225(3) 
C24 0.45190(5) 1.0145(3) 0.18111(6) 0.0264(3) 
C25 0.40920(5) 0.9396(3) 0.15643(6) 0.0270(3) 
C26 0.40531(5) 0.7250(3) 0.12829(6) 0.0257(3) 
C27 0.44362(4) 0.5850(3) 0.12549(5) 0.0234(3) 
B1 0.53390(5) 0.3363(3) 0.10002(6) 0.0227(3) 
N1 0.56997(4) 0.1645(2) 0.10779(4) 0.0207(2) 
O1 0.50893(3) 0.34444(19) 0.04757(4) 0.0302(2) 
Ueq=
1
/3[U11(aa*)
2
+U22(bb*)
2
+U33(cc*)
2
+2U12aa*bb*cos g+2U13aa*cc*cos b+2U23bb*cc*cosa] 
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Table A3C.9. Positional Parameters for Hydrogens in 4.126 
Atom x y z Uiso, Å
2
 
H2 0.6396 -0.1220 0.1377 0.027 
H3 0.6941 -0.1008 0.2140 0.026 
H5 0.6302 0.4544 0.2722 0.025 
H7 0.5581 0.5966 0.2243 0.027 
H9a 0.5451 -0.0174 0.0394 0.029 
H9b 0.5758 -0.1710 0.0833 0.029 
H11 0.6028 -0.3049 -0.0087 0.030 
H12 0.6629 -0.2802 -0.0617 0.034 
H13 0.7108 0.0470 -0.0537 0.035 
H14 0.6970 0.3533 0.0060 0.033 
H15 0.6360 0.3307 0.0584 0.029 
H17 0.7365 -0.1143 0.2897 0.029 
H18 0.7928 -0.0894 0.3651 0.031 
H19 0.7965 0.2354 0.4244 0.030 
H20 0.7446 0.5425 0.4051 0.031 
H21 0.6894 0.5232 0.3284 0.028 
H23 0.5189 0.9306 0.1938 0.030 
H24 0.4547 1.1584 0.2001 0.035 
H25 0.3834 1.0325 0.1588 0.036 
H26 0.3768 0.6748 0.1112 0.034 
H27 0.4405 0.4407 0.1067 0.031 
H1 0.4917 0.4593 0.0457 0.045 
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Table A3C.10. Refined Thermal Parameters (U's) for 4.126 
Atom U11 U22 U33 U23 U13 U12 
C1 0.0160(6) 0.0226(7) 0.0174(6) 0.0008(5) 0.0034(5) -0.0019(5) 
C2 0.0214(6) 0.0206(7) 0.0199(6) -0.0040(5) 0.0051(5) 0.0011(5) 
C3 0.0170(6) 0.0208(7) 0.0218(6) 0.0018(5) 0.0043(5) 0.0032(5) 
C4 0.0161(6) 0.0193(6) 0.0177(6) 0.0026(5) 0.0050(5) -0.0021(5) 
C5 0.0194(6) 0.0198(6) 0.0169(6) -0.0019(5) 0.0044(5) -0.0013(5) 
C6 0.0168(6) 0.0207(6) 0.0182(6) 0.0003(5) 0.0042(5) -0.0004(5) 
C7 0.0209(6) 0.0208(7) 0.0194(6) -0.0020(5) 0.0053(5) 0.0015(5) 
C8 0.0183(6) 0.0235(7) 0.0211(6) 0.0007(5) 0.0039(5) 0.0011(5) 
C9 0.0185(6) 0.0250(7) 0.0211(6) -0.0050(5) 0.0000(5) 0.0006(5) 
C10 0.0191(6) 0.0238(7) 0.0156(6) -0.0004(5) -0.0026(5) 0.0051(5) 
C11 0.0252(7) 0.0220(7) 0.0193(6) -0.0020(5) -0.0023(5) 0.0026(5) 
C12 0.0317(7) 0.0266(7) 0.0178(6) -0.0008(5) 0.0034(5) 0.0102(6) 
C13 0.0256(7) 0.0344(8) 0.0207(7) 0.0055(6) 0.0064(5) 0.0084(6) 
C14 0.0244(7) 0.0260(7) 0.0232(7) 0.0039(6) 0.0011(5) 0.0006(6) 
C15 0.0237(7) 0.0218(7) 0.0188(6) -0.0019(5) -0.0002(5) 0.0042(5) 
C16 0.0160(6) 0.0221(7) 0.0176(6) 0.0028(5) 0.0059(5) -0.0029(5) 
C17 0.0223(7) 0.0213(7) 0.0211(6) 0.0002(5) 0.0031(5) -0.0001(5) 
C18 0.0205(7) 0.0250(7) 0.0246(7) 0.0060(5) 0.0018(5) 0.0008(5) 
C19 0.0185(6) 0.0312(7) 0.0177(6) 0.0047(5) 0.0008(5) -0.0051(6) 
C20 0.0219(7) 0.0265(7) 0.0212(6) -0.0033(6) 0.0049(5) -0.0043(6) 
C21 0.0177(6) 0.0227(7) 0.0225(6) 0.0001(5) 0.0040(5) 0.0006(5) 
C22 0.0204(6) 0.0259(7) 0.0161(6) 0.0022(5) 0.0026(5) 0.0027(5) 
C23 0.0221(7) 0.0264(7) 0.0189(6) 0.0018(5) 0.0020(5) 0.0021(6) 
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C24 0.0325(8) 0.0257(7) 0.0211(7) -0.0007(6) 0.0029(6) 0.0070(6) 
C25 0.0252(7) 0.0332(8) 0.0229(7) 0.0033(6) 0.0039(5) 0.0120(6) 
C26 0.0195(6) 0.0345(8) 0.0226(7) 0.0034(6) 0.0003(5) 0.0039(6) 
C27 0.0237(7) 0.0266(7) 0.0194(6) -0.0005(6) 0.0008(5) 0.0030(6) 
B1 0.0187(7) 0.0280(8) 0.0213(7) 0.0003(6) 0.0020(6) 0.0003(6) 
N1 0.0176(5) 0.0263(6) 0.0180(5) -0.0048(5) 0.0019(4) 0.0003(5) 
O1 0.0292(5) 0.0376(6) 0.0227(5) -0.0043(4) -0.0013(4) 0.0106(4) 
The form of the anisotropic displacement parameter is: 
exp[-2p
2
(a*
2
U11h
2
+b*
2
U22k
2
+c*
2
U33l
2
+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
 
Table A3C.11. Bond Distances in 4.126 (Å) 
C1-N1 1.3975(16) C1-C2 1.3999(18) C1-C6 1.4158(18) 
C2-C3 1.3778(18) C3-C4 1.4055(18) C4-C5 1.3901(18) 
C4-C16 1.4893(17) C5-C6 1.3994(18) C6-C7 1.4416(18) 
C7-C8 1.3547(18) C8-C22 1.4848(18) C8-B1 1.545(2) 
C9-N1 1.4665(16) C9-C10 1.5142(18) C10-C15 1.3867(19) 
C10-C11 1.3929(18) C11-C12 1.3822(19) C12-C13 1.385(2) 
C13-C14 1.382(2) C14-C15 1.3922(19) C16-C17 1.3963(18) 
C16-C21 1.3985(18) C17-C18 1.3878(19) C18-C19 1.382(2) 
C19-C20 1.3856(19) C20-C21 1.3865(18) C22-C23 1.3975(19) 
C22-C27 1.4013(19) C23-C24 1.3835(19) C24-C25 1.387(2) 
C25-C26 1.385(2) C26-C27 1.3846(19) B1-O1 1.3779(17) 
B1-N1 1.4325(19)     
 
Table A3C.12. Bond Angles in 4.126 (°) 
N1-C1-C2 122.72(11) N1-C1-C6 119.32(11) C2-C1-C6 117.94(11) 
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C3-C2-C1 121.17(12) C2-C3-C4 122.11(12) C5-C4-C3 116.41(11) 
C5-C4-C16 122.16(11) C3-C4-C16 121.43(11) C4-C5-C6 122.95(12) 
C5-C6-C1 119.31(11) C5-C6-C7 120.36(11) C1-C6-C7 120.29(11) 
C8-C7-C6 123.14(12) C7-C8-C22 120.43(12) C7-C8-B1 116.82(12) 
C22-C8-B1 122.75(11) N1-C9-C10 115.38(11) C15-C10-C11 118.61(12) 
C15-C10-C9 123.11(12) C11-C10-C9 118.28(12) C12-C11-C10 120.85(13) 
C11-C12-C13 120.13(13) C14-C13-C12 119.68(13) C13-C14-C15 120.09(13) 
C10-C15-C14 120.64(12) C17-C16-C21 117.18(12) C17-C16-C4 121.51(12) 
C21-C16-C4 121.30(11) C18-C17-C16 121.45(12) C19-C18-C17 120.49(12) 
C18-C19-C20 119.00(12) C19-C20-C21 120.52(13) C20-C21-C16 121.34(12) 
C23-C22-C27 117.91(12) C23-C22-C8 121.48(12) C27-C22-C8 120.56(12) 
C24-C23-C22 120.93(12) C23-C24-C25 120.43(13) C26-C25-C24 119.43(12) 
C27-C26-C25 120.30(13) C26-C27-C22 120.96(13) O1-B1-N1 116.40(12) 
O1-B1-C8 125.82(12) N1-B1-C8 117.75(12) C1-N1-B1 121.82(11) 
C1-N1-C9 118.39(10) B1-N1-C9 119.77(11)   
 
References: 
 
(1)  Bruker (2009) SAINT. Bruker AXS Inc., Madison, Wisconsin, USA. 
(2)  Bruker (2009) SHELXTL. Bruker AXS Inc., Madison, Wisconsin, USA. 
(3)  Sheldrick, G.M. (2007) SADABS. University of Gottingen, Germany. 
(4)  Sheldrick, G.M. Acta Cryst. 2008, A64,112. 
(5) R1 = S||Fo| - |Fc|| / S |Fo|; wR2 = [Sw(Fo2 - Fc2)2/Sw(Fo2)2]
½
; GOF = [Sw(Fo2 - 
Fc2)2/(n - p)]
½
; where n = the number of reflections and p = the number of 
parameters refined. 
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